Citrus Sinensis ID: 015797

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400
Protein Sequence
MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYNDGKAVAEDSTDSISEEKDLKQVKEEIEPEKAQ
Secondary Structure (PSIPRED)
ccEEEEEccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEEccccccHHHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccHHHHHccccccccccccccccccccccccHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEEEcccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHcccHEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHccccEccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHccccccHHcccccccc
Coil and Loop (DISEMBL)
mafgsifccgkvsdrkekgkkqptwrIFSLKELhsatnnfnydnklgeggfgsvywgqlwdgsQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGycaegqerlivydympnlsllshlhgqhsseCLLNWNRRMDIAIGSAEGIVYLHhhatphiihrdikasnvlldaDFKAQVADFgfaklipdgathvttrvkgtlgylapeyamlgkasescdvySFGILLLELasgkkpieKVNSAIKRTITDWALPLACERkfseladprlngnfveEELKRVVLVALTcahskpekrptMLEVLDLLKGESKEKLTElendelfkshqvadyndgkavAEDSAEKLAELEndelfkshqvadyndgkavaedstdsiseekDLKQVKEEIEPEKAQ
Flexible Loop (DISEMBL)
mafgsifccgkvsdrkekgkkqptWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKlipdgathvttrVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALtcahskpekrptmlEVLDLLKGESKEKLTelendelfkshqvadyndGKAVAEDSAEKLAELENDELfkshqvadyndgkavaedstdsiseekdlkqvkeeiepekaq
Low Complexity Region (SEG)
MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNlsllshlhgqhssECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYNDGKAVAEDSTDSISEEKDLKQVKEEIEPEKAQ
Disordered region (IsUnstruct)
***GSIFCCGKV**********PTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAH***********VL********************************************************************************************
Disordered Region (DISOPRED)
*AF***********************IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW***AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK************************************************************************************
Disordered Region (DISEMBL)
MAFGSIFCCGKVS*********PTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYNDGK************EKDLKQ***********
Disordered Region (DISPRO)
MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE**************************************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMxxxxxxxxxxxxxxxxxxxxxELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYNDGKAVAEDSTDSISEEKDLKQVKEEIEPEKAQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	400	2.2.26 [Sep-21-2011]
Q9LSC2	361	PTI1-like tyrosine-protei	no	no	0.862	0.955	0.632	1e-131
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.78	0.439	0.464	2e-78
Q9SX31	708	Proline-rich receptor-lik	no	no	0.757	0.427	0.460	9e-77
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.765	0.596	0.457	2e-76
Q9LV48	652	Proline-rich receptor-lik	no	no	0.82	0.503	0.432	6e-76
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.77	0.452	0.465	1e-75
Q9LK03	717	Proline-rich receptor-lik	no	no	0.877	0.489	0.404	2e-74
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.702	0.390	0.494	8e-74
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.717	0.454	0.491	2e-73
Q8GX23	670	Proline-rich receptor-lik	no	no	0.905	0.540	0.404	4e-73

>sp|Q9LSC2|Y3589_ARATH PTI1-like tyrosine-protein kinase At3g15890 OS=Arabidopsis thaliana GN=At3g15890 PE=1 SV=1

 Score =  467 bits (1202), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 219/346 (63%), Positives = 278/346 (80%), Gaps = 1/346 (0%)

Query: 8   CCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAV 67
           CCGK  D K+K K++P+WR+FSLKELH+ATN+FNYDNKLGEG FGSVYWGQLWDGSQIAV
Sbjct: 7   CCGKGFDGKKKEKEEPSWRVFSLKELHAATNSFNYDNKLGEGRFGSVYWGQLWDGSQIAV 66

Query: 68  KRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHG 127
           KRLK WSN+ E++FAVEVEILAR+RHKNLLS+RGYCAEGQERL+VY+YM NLSL+SHLHG
Sbjct: 67  KRLKEWSNREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHG 126

Query: 128 QHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
           QHS+ECLL+W +RM IAI SA+ I YLH HATPHI+H D++ASNVLLD++F+A+V DFG+
Sbjct: 127 QHSAECLLDWTKRMKIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGY 186

Query: 188 AKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            KL+PD  T    T+ K   GY++PE    GK SE+ DVYSFGILL+ L SGK+P+E++N
Sbjct: 187 GKLMPDDDTGDGATKAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLN 246

Query: 247 SAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLE 306
               R IT+W LPL  ER F E+ D RL+   V E+LK+VVLV L CA + P+KRPTM E
Sbjct: 247 PTTTRCITEWVLPLVYERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKRPTMSE 306

Query: 307 VLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAE 352
           V+++L  ESKEK++ELE + LFK+   ++ N+ + VAE+S++ + E
Sbjct: 307 VVEMLVNESKEKISELEANPLFKNPYSSNENNREHVAEESSDVILE 352

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  293 bits (750), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 156/336 (46%), Positives = 213/336 (63%), Gaps = 24/336 (7%)

Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
           F+ +EL   T  F+  N LGEGGFG VY G+L DG  +AVK+LKV S + + EF  EVEI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS 147
           ++RV H++L+SL GYC    ERL++Y+Y+PN +L  HLHG+     +L W RR+ IAIGS
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGK--GRPVLEWARRVRIAIGS 458

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           A+G+ YLH    P IIHRDIK++N+LLD +F+AQVADFG AKL     THV+TRV GT G
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFG 518

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL---ACER 264
           YLAPEYA  GK ++  DV+SFG++LLEL +G+KP+++     + ++ +WA PL   A E 
Sbjct: 519 YLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIET 578

Query: 265 -KFSELADPRLNGNFVEEELKRVVLVALTCA-HSKPEKRPTMLEVLDLLKGESKEKLTEL 322
             FSEL D RL  ++VE E+ R++  A  C  HS P KRP M++V+  L  E        
Sbjct: 579 GDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGP-KRPRMVQVVRALDSEG------- 630

Query: 323 ENDELFKSHQVADYNDGKAVAEDSAEKLAELENDEL 358
                     + D ++G  V + SA    +  ND +
Sbjct: 631 ---------DMGDISNGNKVGQSSAYDSGQYNNDTM 657

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  287 bits (735), Expect = 9e-77,   Method: Compositional matrix adjust.
 Identities = 144/313 (46%), Positives = 201/313 (64%), Gaps = 10/313 (3%)

Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE 86
           +FS +EL  ATN F+ +N LGEGGFG VY G L DG  +AVK+LK+   + + EF  EVE
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423

Query: 87  ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG 146
            L+R+ H++L+S+ G+C  G  RL++YDY+ N  L  HLHG+ S   +L+W  R+ IA G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKS---VLDWATRVKIAAG 480

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           +A G+ YLH    P IIHRDIK+SN+LL+ +F A+V+DFG A+L  D  TH+TTRV GT 
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTF 540

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE--- 263
           GY+APEYA  GK +E  DV+SFG++LLEL +G+KP++        ++ +WA PL      
Sbjct: 541 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIE 600

Query: 264 -RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLT-- 320
             +F  LADP+L GN+VE E+ R++  A  C      KRP M +++   +  + E LT  
Sbjct: 601 TEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNG 660

Query: 321 -ELENDELFKSHQ 332
             L   E+F S Q
Sbjct: 661 MRLGESEVFNSAQ 673

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  286 bits (733), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 146/319 (45%), Positives = 203/319 (63%), Gaps = 13/319 (4%)

Query: 6   IFCCGKVSDRKEKGKKQPTWRI-------FSLKELHSATNNFNYDNKLGEGGFGSVYWGQ 58
            F C K   R +K    P   +       F+  EL  ATN F+  N LGEGGFG VY G 
Sbjct: 142 FFLCKKKRPRDDKALPAPIGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGI 201

Query: 59  LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN 118
           L +G+++AVK+LKV S + E EF  EV I++++ H+NL+SL GYC  G +RL+VY+++PN
Sbjct: 202 LNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPN 261

Query: 119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF 178
            +L  HLHG+      + W+ R+ IA+ S++G+ YLH +  P IIHRDIKA+N+L+D  F
Sbjct: 262 NTLEFHLHGK--GRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKF 319

Query: 179 KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASG 238
           +A+VADFG AK+  D  THV+TRV GT GYLAPEYA  GK +E  DVYSFG++LLEL +G
Sbjct: 320 EAKVADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITG 379

Query: 239 KKPIEKVNSAIKRTITDWALPLAC----ERKFSELADPRLNGNFVEEELKRVVLVALTCA 294
           ++P++  N     ++ DWA PL      E  F  LAD +LN  +  EE+ R+V  A  C 
Sbjct: 380 RRPVDANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACV 439

Query: 295 HSKPEKRPTMLEVLDLLKG 313
                +RP M +V+ +L+G
Sbjct: 440 RYTARRRPRMDQVVRVLEG 458

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  285 bits (728), Expect = 6e-76,   Method: Compositional matrix adjust.
 Identities = 148/342 (43%), Positives = 217/342 (63%), Gaps = 14/342 (4%)

Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
           F+ +EL  ATN F+  N LG+GGFG V+ G L  G ++AVK+LK  S + E EF  EVEI
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS 147
           ++RV H++L+SL GYC  G +RL+VY+++PN +L  HLHG+      + W+ R+ IA+GS
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGK--GRPTMEWSTRLKIALGS 385

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           A+G+ YLH    P IIHRDIKASN+L+D  F+A+VADFG AK+  D  THV+TRV GT G
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL----ACE 263
           YLAPEYA  GK +E  DV+SFG++LLEL +G++P++  N  +  ++ DWA PL    + E
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEE 505

Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELE 323
             F  LAD ++   +  EE+ R+V  A  C      +RP M +++  L+G     L++L 
Sbjct: 506 GDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNV--SLSDL- 562

Query: 324 NDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVA 365
           N+ +   H     + G +   D+++      ND++ K  ++A
Sbjct: 563 NEGMRPGHSNVYSSYGGSTDYDTSQY-----NDDMIKFRKMA 599

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  283 bits (725), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 149/320 (46%), Positives = 200/320 (62%), Gaps = 12/320 (3%)

Query: 22  QPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEF 81
           Q +W  FS  EL   T+ F+  N LGEGGFG VY G L DG ++AVK+LK+  ++ E EF
Sbjct: 323 QRSW--FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREF 380

Query: 82  AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRM 141
             EVEI++RV H++L++L GYC   Q RL+VYDY+PN +L  HLH       ++ W  R+
Sbjct: 381 KAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA--PGRPVMTWETRV 438

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP--DGATHVT 199
            +A G+A GI YLH    P IIHRDIK+SN+LLD  F+A VADFG AK+    D  THV+
Sbjct: 439 RVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVS 498

Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALP 259
           TRV GT GY+APEYA  GK SE  DVYS+G++LLEL +G+KP++        ++ +WA P
Sbjct: 499 TRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARP 558

Query: 260 LACE----RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES 315
           L  +     +F EL DPRL  NF+  E+ R+V  A  C      KRP M +V+  L  ++
Sbjct: 559 LLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL--DT 616

Query: 316 KEKLTELENDELFKSHQVAD 335
            E+ T++ N       QV D
Sbjct: 617 LEEATDITNGMRPGQSQVFD 636

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  279 bits (714), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 150/371 (40%), Positives = 227/371 (61%), Gaps = 20/371 (5%)

Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
           F+ +EL  ATN F+  N LG+GGFG V+ G L +G ++AVK+LK  S++ E EF  EV I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS 147
           ++RV H++L++L GYC    +RL+VY+++PN +L  HLHG+      + W+ R+ IA+GS
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGK--GRPTMEWSSRLKIAVGS 459

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           A+G+ YLH +  P IIHRDIKASN+L+D  F+A+VADFG AK+  D  THV+TRV GT G
Sbjct: 460 AKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 519

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE---- 263
           YLAPEYA  GK +E  DV+SFG++LLEL +G++PI+  N     ++ DWA PL  +    
Sbjct: 520 YLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSEL 579

Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG-----ESKEK 318
             F  + D +LN  + +EE+ R+V  A  C  S   +RP M +V  +L+G     +  + 
Sbjct: 580 GNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDLNQG 639

Query: 319 LTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYN--------DG 370
           +T   ++    S    DY+  +     +  +   LE  +L+ S+ +++Y+        DG
Sbjct: 640 ITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLETQDLY-SNPISEYDLYPSWSSTDG 698

Query: 371 KAVAEDSTDSI 381
           +     +T +I
Sbjct: 699 QTTQGKATGNI 709

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  278 bits (710), Expect = 8e-74,   Method: Compositional matrix adjust.
 Identities = 143/289 (49%), Positives = 194/289 (67%), Gaps = 8/289 (2%)

Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
           FS +EL   T  F   N LGEGGFG VY G L DG  +AVK+LK  S + + EF  EVEI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS 147
           ++RV H++L+SL GYC   Q RL++Y+Y+ N +L  HLHG+     +L W++R+ IAIGS
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGK--GLPVLEWSKRVRIAIGS 476

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           A+G+ YLH    P IIHRDIK++N+LLD +++AQVADFG A+L     THV+TRV GT G
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFG 536

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL---ACER 264
           YLAPEYA  GK ++  DV+SFG++LLEL +G+KP+++     + ++ +WA PL   A E 
Sbjct: 537 YLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIET 596

Query: 265 -KFSELADPRLNGNFVEEELKRVVLVALTCA-HSKPEKRPTMLEVLDLL 311
              SEL D RL   +VE E+ R++  A  C  HS P KRP M++V+  L
Sbjct: 597 GDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGP-KRPRMVQVVRAL 644

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  276 bits (706), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 142/289 (49%), Positives = 191/289 (66%), Gaps = 2/289 (0%)

Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS-NKAEMEFAVEVE 86
           ++ KEL SATN+FN  N LG GG+G VY G L DG+ +AVKRLK  +    E++F  EVE
Sbjct: 289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVE 348

Query: 87  ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG 146
            ++   H+NLL LRG+C+  QER++VY YMPN S+ S L      E  L+W+RR  IA+G
Sbjct: 349 TISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVG 408

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           +A G+VYLH    P IIHRD+KA+N+LLD DF+A V DFG AKL+    +HVTT V+GT+
Sbjct: 409 TARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 468

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT-DWALPLACERK 265
           G++APEY   G++SE  DV+ FGILLLEL +G+K ++   SA ++ +  DW   L  E K
Sbjct: 469 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGK 528

Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE 314
             +L D  LN  F   EL+ +V VAL C    P  RP M EV+ +L+G+
Sbjct: 529 LKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGD 577

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  275 bits (704), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 153/378 (40%), Positives = 227/378 (60%), Gaps = 16/378 (4%)

Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE 86
            F+  EL  AT  F   N LG+GGFG V+ G L  G ++AVK LK+ S + E EF  EV+
Sbjct: 299 TFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVD 358

Query: 87  ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG 146
           I++RV H++L+SL GYC  G +RL+VY+++PN +L  HLHG+     +L+W  R+ IA+G
Sbjct: 359 IISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGK--GRPVLDWPTRVKIALG 416

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           SA G+ YLH    P IIHRDIKA+N+LLD  F+ +VADFG AKL  D  THV+TRV GT 
Sbjct: 417 SARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTF 476

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL----AC 262
           GYLAPEYA  GK S+  DV+SFG++LLEL +G+ P++ +   ++ ++ DWA PL    A 
Sbjct: 477 GYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLD-LTGEMEDSLVDWARPLCLKAAQ 535

Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE-SKEKLTE 321
           +  +++LADPRL  N+  +E+ ++   A         +RP M +++  L+G+ S + L+E
Sbjct: 536 DGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLSE 595

Query: 322 ----LENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYNDGKAVAEDS 377
                ++  L      ++Y+     A+    K   LEN E    +Q ++Y        + 
Sbjct: 596 GTRPGQSTYLSPGSVSSEYDASSYTADMKKFKKLALENKE----YQSSEYGGTSEYGLNP 651

Query: 378 TDSISEEKDLKQVKEEIE 395
           + S SEE +   +K   +
Sbjct: 652 SASSSEEMNRGSMKRNPQ 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	400
255553221	365	ATP binding protein, putative [Ricinus c	0.88	0.964	0.877	0.0
224134935	371	predicted protein [Populus trichocarpa]	0.88	0.948	0.857	0.0
388505796	366	unknown [Lotus japonicus]	0.88	0.961	0.826	1e-176
225442933	375	PREDICTED: PTI1-like tyrosine-protein ki	0.887	0.946	0.845	1e-175
357455265	367	Somatic embryogenesis receptor kinase [M	0.87	0.948	0.839	1e-175
356550622	367	PREDICTED: PTI1-like tyrosine-protein ki	0.915	0.997	0.755	1e-174
147833902	375	hypothetical protein VITISV_019852 [Viti	0.887	0.946	0.842	1e-174
356555052	367	PREDICTED: PTI1-like tyrosine-protein ki	0.915	0.997	0.755	1e-174
224054338	357	predicted protein [Populus trichocarpa]	0.875	0.980	0.769	1e-173
255635866	333	unknown [Glycine max]	0.832	1.0	0.855	1e-172

>gi|255553221|ref|XP_002517653.1| ATP binding protein, putative [Ricinus communis] gi|223543285|gb|EEF44817.1| ATP binding protein, putative [Ricinus communis]

 Score =  656 bits (1693), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/352 (87%), Positives = 335/352 (95%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF SIFCCGK SDRKE+ KKQP WRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFASIFCCGKGSDRKERSKKQPKWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIAVKRLKVWSNKA+MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAVKRLKVWSNKADMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHS+ECLL+W RRM+IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD+DF+A
Sbjct: 121 LLSHLHGQHSAECLLDWKRRMNIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDSDFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK
Sbjct: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           P+EK+N+ +KRTI DWALPLACERKFSELADP+LNG F E+ELKRVVLVAL CAHS+PEK
Sbjct: 241 PLEKLNATMKRTIIDWALPLACERKFSELADPKLNGKFEEQELKRVVLVALMCAHSQPEK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAE 352
           RPTML+V++LLKGESK+K +ELE+DELFK+   A YNDG +VAEDS++ ++E
Sbjct: 301 RPTMLDVVELLKGESKDKFSELESDELFKAPLPAGYNDGASVAEDSSDFISE 352

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224134935|ref|XP_002327526.1| predicted protein [Populus trichocarpa] gi|222836080|gb|EEE74501.1| predicted protein [Populus trichocarpa]

 Score =  649 bits (1673), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 302/352 (85%), Positives = 333/352 (94%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF S+FCC K SDRKE+GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFASMFCCVKNSDRKERGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIAVKRLKVWS+KA+MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAVKRLKVWSDKADMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHSSECLL+W RRM+IAIGSAEGI YLHHHATPHIIHRDIKASNVLLD+DF+A
Sbjct: 121 LLSHLHGQHSSECLLDWKRRMNIAIGSAEGIAYLHHHATPHIIHRDIKASNVLLDSDFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA+GKK
Sbjct: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELATGKK 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           P+EK+++ +KR IT+WA PLACERKFSELADP+LNG + EEELKRVVLV+L C  ++PE+
Sbjct: 241 PLEKLSATVKRIITEWAQPLACERKFSELADPKLNGKYDEEELKRVVLVSLVCTQNQPER 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAE 352
           RPTML+V++LLKGESKE+L+ELENDELFK  Q  DYNDG +VAEDS++ ++E
Sbjct: 301 RPTMLDVVELLKGESKERLSELENDELFKPPQAVDYNDGISVAEDSSDFISE 352

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388505796|gb|AFK40964.1| unknown [Lotus japonicus]

 Score =  625 bits (1612), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 291/352 (82%), Positives = 327/352 (92%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF  IFCCG  SDRK +GKKQP WR+FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFCPIFCCGNASDRKGRGKKQPAWRVFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIAVKRLKVWSNKA+MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAVKRLKVWSNKADMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHSSECLL+WNRRM+IAIGSAEGIVYLHH ATPHIIHRDIKASNVLLD+DF+A
Sbjct: 121 LLSHLHGQHSSECLLDWNRRMNIAIGSAEGIVYLHHQATPHIIHRDIKASNVLLDSDFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           +VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA+E CDV+SFGILLLELASGKK
Sbjct: 181 RVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKANECCDVFSFGILLLELASGKK 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           P+EK++S +KR+I DWALPLAC +KF+E ADPRLNG +VEEELKR+VLVAL CA S+P+K
Sbjct: 241 PLEKLSSTVKRSINDWALPLACAKKFTEFADPRLNGEYVEEELKRIVLVALICAQSQPDK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAE 352
           RPTM+EV++LLKGESK+KL++LEN ELFK+     +++G + AE S++ ++E
Sbjct: 301 RPTMIEVVELLKGESKDKLSQLENHELFKNPPGVGHDEGTSAAEGSSDFISE 352

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225442933|ref|XP_002265603.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890 [Vitis vinifera]

 Score =  620 bits (1598), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 301/356 (84%), Positives = 328/356 (92%), Gaps = 1/356 (0%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF S+FCCGK SD KE+GKK+ TWRIFSLKELH+ATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFCSMFCCGKGSDGKEQGKKEVTWRIFSLKELHAATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIA+KRLKVWSNKA+MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAIKRLKVWSNKADMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHS+EC L+WNRRM+IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD++F+A
Sbjct: 121 LLSHLHGQHSAECHLDWNRRMNIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDSEFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM GKASESCDVYSFGILLLEL SGK+
Sbjct: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMFGKASESCDVYSFGILLLELVSGKR 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           PIEK++S +KRTITDWALPLACE+KF++LADP+LNG FVEEELKRVVLVAL  A SKPEK
Sbjct: 241 PIEKMSSTMKRTITDWALPLACEKKFNDLADPKLNGKFVEEELKRVVLVALVSADSKPEK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELEND 356
           RPTMLEVL+LLKG SKEKL +LEN++LFK  Q   Y DG    E S + ++E END
Sbjct: 301 RPTMLEVLELLKGNSKEKLADLENNDLFKGPQTGGYTDGGTGPEASPDIISE-END 355

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357455265|ref|XP_003597913.1| Somatic embryogenesis receptor kinase [Medicago truncatula] gi|355486961|gb|AES68164.1| Somatic embryogenesis receptor kinase [Medicago truncatula]

 Score =  619 bits (1597), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 293/349 (83%), Positives = 326/349 (93%), Gaps = 1/349 (0%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF  IFCC  VSDRK +GKKQP WR+FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFCPIFCCLNVSDRKGRGKKQPPWRVFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIAVKRLKVWSNKA+MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAVKRLKVWSNKADMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHS+E LL+WNRRM+IAIGSAEGIVYLH  ATPHIIHRD+KASNVLLD+DF+A
Sbjct: 121 LLSHLHGQHSTESLLDWNRRMNIAIGSAEGIVYLHVQATPHIIHRDVKASNVLLDSDFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           +VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA+ESCDVYSFGILLLELASGKK
Sbjct: 181 RVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKANESCDVYSFGILLLELASGKK 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           P+EK++S++KR I DWALPLACE+KFSELADPRLNG++VEEELKRV+LVAL CA ++PEK
Sbjct: 241 PLEKLSSSVKRAINDWALPLACEKKFSELADPRLNGDYVEEELKRVILVALICAQNQPEK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSH-QVADYNDGKAVAEDSAE 348
           RPTM+EV++LLKGESKEK+ +LEN+ELFK+   V + ND  + AE S++
Sbjct: 301 RPTMVEVVELLKGESKEKVLQLENNELFKNPLAVGNTNDEISAAEGSSD 349

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356550622|ref|XP_003543684.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max]

 Score =  619 bits (1595), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 300/397 (75%), Positives = 336/397 (84%), Gaps = 31/397 (7%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF  IFCCG  SDRK +GKKQP WR+FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFCPIFCCGNGSDRKGRGKKQPPWRVFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIAVKRLKVWSNKA+MEFAVEVE+LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAVKRLKVWSNKADMEFAVEVEMLARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHS+E LL+WNRRM+IAIGSAEGI YLHH +TPHIIHRDIKASNVLLD+DF+A
Sbjct: 121 LLSHLHGQHSAESLLDWNRRMNIAIGSAEGIAYLHHQSTPHIIHRDIKASNVLLDSDFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           +VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA+ESCDVYSFGILLLELASGKK
Sbjct: 181 RVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKANESCDVYSFGILLLELASGKK 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           P+EK++SA+KR+I DWALPLACE+KFSELADP+L GN+ EEELKRVVL+AL CA S+ EK
Sbjct: 241 PLEKLSSAVKRSINDWALPLACEKKFSELADPKLEGNYAEEELKRVVLIALLCAQSQAEK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFK 360
           RPT+LEV++LLKGESK+KL +LEN+ELF++     + D                      
Sbjct: 301 RPTILEVVELLKGESKDKLAQLENNELFQNPPAVGHTD---------------------- 338

Query: 361 SHQVADYNDGKAVAEDSTDSISEEKDLK-QVKEEIEP 396
                   DG   AE S+D ISEEK+ K +++E  EP
Sbjct: 339 --------DGTVAAEGSSDFISEEKESKHELEENTEP 367

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147833902|emb|CAN66493.1| hypothetical protein VITISV_019852 [Vitis vinifera]

 Score =  618 bits (1593), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 300/356 (84%), Positives = 327/356 (91%), Gaps = 1/356 (0%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF S+FCCGK SD KE+GKK+ TWRIFSLKELH+ATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFCSMFCCGKGSDGKEQGKKEVTWRIFSLKELHAATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIA+KRLKVWSNKA+MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAIKRLKVWSNKADMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHS+EC L+WNRRM+IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD++F+A
Sbjct: 121 LLSHLHGQHSAECHLDWNRRMNIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDSEFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM GKASESCDVYSFGILLLEL SGK+
Sbjct: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMFGKASESCDVYSFGILLLELVSGKR 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           PIEK++S +KRTITDWALPLACE+KF++LADP+LNG FVEEELKRVVLVAL  A SKPEK
Sbjct: 241 PIEKMSSTMKRTITDWALPLACEKKFNDLADPKLNGKFVEEELKRVVLVALVSADSKPEK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELEND 356
           RPTMLEVL+LLKG SKEK  +LEN++LFK  Q   Y DG    E S + ++E END
Sbjct: 301 RPTMLEVLELLKGNSKEKXADLENNDLFKGPQTGGYTDGGTGPEASPDIISE-END 355

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555052|ref|XP_003545853.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max]

 Score =  616 bits (1589), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 300/397 (75%), Positives = 334/397 (84%), Gaps = 31/397 (7%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF  IFCCG  SDRK +GKKQP WR+FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFCPIFCCGNSSDRKGRGKKQPPWRVFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIAVKRLKVWSNKA+MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAVKRLKVWSNKADMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHS+E LL+WNRRM+IAIGSAEGI YLH+ + PHIIHRDIKASNVLLD+DF+A
Sbjct: 121 LLSHLHGQHSAESLLDWNRRMNIAIGSAEGIGYLHNQSMPHIIHRDIKASNVLLDSDFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA+ESCDVYSFGILLLELASGKK
Sbjct: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKANESCDVYSFGILLLELASGKK 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           P+EK++SA+KR+I DWALPLACE+KFSELADP+L GN+ EEELKRVVL AL C  S+PEK
Sbjct: 241 PLEKLSSAVKRSINDWALPLACEKKFSELADPKLEGNYAEEELKRVVLTALLCVQSQPEK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFK 360
           RPT+LEV++LLKGESK+KL +LEN+ELFK+     + D                      
Sbjct: 301 RPTILEVVELLKGESKDKLAQLENNELFKNPPAVGHTD---------------------- 338

Query: 361 SHQVADYNDGKAVAEDSTDSISEEKDLK-QVKEEIEP 396
                   DG   AE S+D ISE+K+ K +++E  EP
Sbjct: 339 --------DGTVAAEGSSDFISEDKESKPELEENTEP 367

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224054338|ref|XP_002298210.1| predicted protein [Populus trichocarpa] gi|222845468|gb|EEE83015.1| predicted protein [Populus trichocarpa]

 Score =  612 bits (1579), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 293/381 (76%), Positives = 332/381 (87%), Gaps = 31/381 (8%)

Query: 16  KEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN 75
           KE+GKKQ TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN
Sbjct: 1   KERGKKQLTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN 60

Query: 76  KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLL 135
           K +MEF+VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS+ECLL
Sbjct: 61  KGDMEFSVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSAECLL 120

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
           +W RRM+IAIGSA GI YLHHHATPHIIHRDIKASNVLLD+DF+AQVADFGFAKLIPDGA
Sbjct: 121 DWKRRMNIAIGSAAGITYLHHHATPHIIHRDIKASNVLLDSDFQAQVADFGFAKLIPDGA 180

Query: 196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITD 255
           THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA+GK+P+EK++  +KRTITD
Sbjct: 181 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELATGKRPLEKMSPTVKRTITD 240

Query: 256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES 315
           WALPLACERKFSELADP+LNG + EEEL+RVV V+L C H++PE+RPTML+V++LLKGES
Sbjct: 241 WALPLACERKFSELADPKLNGKYDEEELRRVVFVSLVCTHTQPERRPTMLDVVELLKGES 300

Query: 316 KEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYNDGKAVAE 375
           KEKL+ELENDE+FK+ Q AD++D +                               ++AE
Sbjct: 301 KEKLSELENDEMFKAPQAADFDDEEI------------------------------SIAE 330

Query: 376 DSTDSISEEKDL-KQVKEEIE 395
           +S+D ISEEKD+ ++VKE ++
Sbjct: 331 NSSDFISEEKDVNREVKEIVQ 351

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255635866|gb|ACU18280.1| unknown [Glycine max]

 Score =  611 bits (1575), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 285/333 (85%), Positives = 316/333 (94%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
           MAF  IFCCG  SDRK +GKKQP WR+FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW
Sbjct: 1   MAFCPIFCCGNGSDRKGRGKKQPPWRVFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60

Query: 61  DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           DGSQIAVKRLKVWSNKA+MEFAVEVE+LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS
Sbjct: 61  DGSQIAVKRLKVWSNKADMEFAVEVEMLARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS 120

Query: 121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
           LLSHLHGQHS+E LL+WNRRM+IAIGSAEGI YLHH +TPHIIHRDIKASNVLLD+DF+A
Sbjct: 121 LLSHLHGQHSAESLLDWNRRMNIAIGSAEGIAYLHHQSTPHIIHRDIKASNVLLDSDFQA 180

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           +VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA+ESCDVYSFGILLLELASGKK
Sbjct: 181 RVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKANESCDVYSFGILLLELASGKK 240

Query: 241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
           P+EK++SA+KR+I DWALPLACE+KFSELADP+L GN+ EEELKRVVL+AL CA S+ EK
Sbjct: 241 PLEKLSSAVKRSINDWALPLACEKKFSELADPKLEGNYAEEELKRVVLIALLCAQSQAEK 300

Query: 301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQV 333
           RPT+LEV++LLKGESK+KL +LEN+ELF++ Q+
Sbjct: 301 RPTILEVVELLKGESKDKLAQLENNELFQTLQL 333

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	400
TAIR|locus:2035099	350	AT1G52540 [Arabidopsis thalian	0.875	1.0	0.602	8.2e-115
TAIR|locus:2093900	361	AT3G15890 [Arabidopsis thalian	0.862	0.955	0.601	8.4e-113
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.765	0.430	0.468	1.3e-68
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.717	0.454	0.480	5.6e-68
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.77	0.452	0.459	1.2e-67
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.73	0.451	0.464	4e-67
TAIR|locus:2026925	708	PERK9 "proline-rich extensin-l	0.757	0.427	0.447	5.1e-67
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.82	0.503	0.421	1.1e-66
TAIR|locus:2019938	718	PERK11 "proline-rich extensin-	0.812	0.452	0.408	4.8e-66
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.815	0.519	0.424	9.4e-66

TAIR|locus:2035099 AT1G52540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1132 (403.5 bits), Expect = 8.2e-115, P = 8.2e-115
 Identities = 215/357 (60%), Positives = 272/357 (76%)

Query:     1 MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW 60
             M   S FCCGK  DR++K K +P+WRIFSLKELH+ATN+FNYDNKLGEG FGSVYWGQLW
Sbjct:     1 MQIFSCFCCGKGFDRQKKVKTEPSWRIFSLKELHAATNSFNYDNKLGEGRFGSVYWGQLW 60

Query:    61 DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXX 120
             DGSQIAVKRLK WS++ E++FAVEVEILAR+RHKNLLS+RGYCAEGQERLIVYDYMPN  
Sbjct:    61 DGSQIAVKRLKAWSSREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLIVYDYMPNLS 120

Query:   121 XXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA 180
                        E LL+W RRM+IA+ SA+ I YLHH ATP I+H D++ASNVLLD++F+A
Sbjct:   121 LVSHLHGQHSSESLLDWTRRMNIAVSSAQAIAYLHHFATPRIVHGDVRASNVLLDSEFEA 180

Query:   181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
             +V DFG+ KL+PD   + +T+    +GYL+PE    GK S+  DVYSFG+LLLEL +GK+
Sbjct:   181 RVTDFGYDKLMPDDGANKSTK-GNNIGYLSPECIESGKESDMGDVYSFGVLLLELVTGKR 239

Query:   241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
             P E+VN   KR IT+W LPL  ERKF E+ D RLNG +VEEELKR+VLV L CA  + EK
Sbjct:   240 PTERVNLTTKRGITEWVLPLVYERKFGEIVDQRLNGKYVEEELKRIVLVGLMCAQRESEK 299

Query:   301 RPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDE 357
             RPTM EV+++L  ESKEK+ +LE + LF  +     NDG+ + ++S+E ++E+ + +
Sbjct:   300 RPTMSEVVEMLMIESKEKMAQLEANPLFNGN-----NDGEVI-DESSEIISEVRDHQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2093900 AT3G15890 [Arabidopsis thaliana (taxid:3702)]

 Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
 Identities = 208/346 (60%), Positives = 265/346 (76%)

Query:     8 CCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAV 67
             CCGK  D K+K K++P+WR+FSLKELH+ATN+FNYDNKLGEG FGSVYWGQLWDGSQIAV
Sbjct:     7 CCGKGFDGKKKEKEEPSWRVFSLKELHAATNSFNYDNKLGEGRFGSVYWGQLWDGSQIAV 66

Query:    68 KRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXX 127
             KRLK WSN+ E++FAVEVEILAR+RHKNLLS+RGYCAEGQERL+VY+YM N         
Sbjct:    67 KRLKEWSNREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHG 126

Query:   128 XXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
                 ECLL+W +RM IAI SA+ I YLH HATPHI+H D++ASNVLLD++F+A+V DFG+
Sbjct:   127 QHSAECLLDWTKRMKIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGY 186

Query:   188 AKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
              KL+PD  T    T+ K   GY++PE    GK SE+ DVYSFGILL+ L SGK+P+E++N
Sbjct:   187 GKLMPDDDTGDGATKAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLN 246

Query:   247 SAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLE 306
                 R IT+W LPL  ER F E+ D RL+   V E+LK+VVLV L CA + P+KRPTM E
Sbjct:   247 PTTTRCITEWVLPLVYERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKRPTMSE 306

Query:   307 VLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAE 352
             V+++L  ESKEK++ELE + LFK+   ++ N+ + VAE+S++ + E
Sbjct:   307 VVEMLVNESKEKISELEANPLFKNPYSSNENNREHVAEESSDVILE 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 696 (250.1 bits), Expect = 1.3e-68, P = 1.3e-68
 Identities = 149/318 (46%), Positives = 206/318 (64%)

Query:    28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
             F+ +EL   T  F+  N LGEGGFG VY G+L DG  +AVK+LKV S + + EF  EVEI
Sbjct:   341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query:    88 LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS 147
             ++RV H++L+SL GYC    ERL++Y+Y+PN               +L W RR+ IAIGS
Sbjct:   401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRP--VLEWARRVRIAIGS 458

Query:   148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
             A+G+ YLH    P IIHRDIK++N+LLD +F+AQVADFG AKL     THV+TRV GT G
Sbjct:   459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFG 518

Query:   208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL---ACER 264
             YLAPEYA  GK ++  DV+SFG++LLEL +G+KP+++     + ++ +WA PL   A E 
Sbjct:   519 YLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIET 578

Query:   265 -KFSELADPRLNGNFVEEELKRVVLVALTCA-HSKPEKRPTMLEVLDLLKGESKEKLTEL 322
               FSEL D RL  ++VE E+ R++  A  C  HS P KRP M++V+  L  +S+  + ++
Sbjct:   579 GDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGP-KRPRMVQVVRAL--DSEGDMGDI 635

Query:   323 ENDELFKSHQVADYNDGK 340
              N    K  Q + Y+ G+
Sbjct:   636 SNGN--KVGQSSAYDSGQ 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 690 (248.0 bits), Expect = 5.6e-68, P = 5.6e-68
 Identities = 139/289 (48%), Positives = 187/289 (64%)

Query:    28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-EMEFAVEVE 86
             ++ KEL SATN+FN  N LG GG+G VY G L DG+ +AVKRLK  +    E++F  EVE
Sbjct:   289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVE 348

Query:    87 ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG 146
              ++   H+NLL LRG+C+  QER++VY YMPN             E  L+W+RR  IA+G
Sbjct:   349 TISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVG 408

Query:   147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
             +A G+VYLH    P IIHRD+KA+N+LLD DF+A V DFG AKL+    +HVTT V+GT+
Sbjct:   409 TARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 468

Query:   207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT-DWALPLACERK 265
             G++APEY   G++SE  DV+ FGILLLEL +G+K ++   SA ++ +  DW   L  E K
Sbjct:   469 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGK 528

Query:   266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE 314
               +L D  LN  F   EL+ +V VAL C    P  RP M EV+ +L+G+
Sbjct:   529 LKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGD 577

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
 Identities = 147/320 (45%), Positives = 196/320 (61%)

Query:    22 QPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEF 81
             Q +W  FS  EL   T+ F+  N LGEGGFG VY G L DG ++AVK+LK+  ++ E EF
Sbjct:   323 QRSW--FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREF 380

Query:    82 AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
               EVEI++RV H++L++L GYC   Q RL+VYDY+PN               ++ W  R+
Sbjct:   381 KAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRP--VMTWETRV 438

Query:   142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP--DGATHVT 199
              +A G+A GI YLH    P IIHRDIK+SN+LLD  F+A VADFG AK+    D  THV+
Sbjct:   439 RVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVS 498

Query:   200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALP 259
             TRV GT GY+APEYA  GK SE  DVYS+G++LLEL +G+KP++        ++ +WA P
Sbjct:   499 TRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARP 558

Query:   260 L---ACERK-FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES 315
             L   A E + F EL DPRL  NF+  E+ R+V  A  C      KRP M +V+  L  ++
Sbjct:   559 LLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL--DT 616

Query:   316 KEKLTELENDELFKSHQVAD 335
              E+ T++ N       QV D
Sbjct:   617 LEEATDITNGMRPGQSQVFD 636

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 682 (245.1 bits), Expect = 4.0e-67, P = 4.0e-67
 Identities = 139/299 (46%), Positives = 193/299 (64%)

Query:    28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
             F+ +EL  ATN F+  N LG+GGFG V+ G L  G ++AVK+LKV S + E EF  EVEI
Sbjct:   263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEI 322

Query:    88 LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS 147
             ++RV H++L+SL GYC  G +RL+VY+++PN                + W+ R+ IA+GS
Sbjct:   323 ISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPT--MEWSTRLKIALGS 380

Query:   148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
             A+G+ YLH    P IIHRDIKASN+L+D  F+A+VADFG AK+  D  THV+TRV GT G
Sbjct:   381 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 440

Query:   208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL---ACER 264
             YLAPEYA  GK +E  DV+SFG++LLEL +G++P++  N  +  ++ DWA PL   A E+
Sbjct:   441 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEQ 500

Query:   265 -KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE-SKEKLTE 321
               F  LAD ++N  +  EE+ R+V  A  C      +RP M +++  L+G  S   L E
Sbjct:   501 GDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNE 559

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 681 (244.8 bits), Expect = 5.1e-67, P = 5.1e-67
 Identities = 140/313 (44%), Positives = 197/313 (62%)

Query:    27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE 86
             +FS +EL  ATN F+ +N LGEGGFG VY G L DG  +AVK+LK+   + + EF  EVE
Sbjct:   364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423

Query:    87 ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG 146
              L+R+ H++L+S+ G+C  G  RL++YDY+ N             + +L+W  R+ IA G
Sbjct:   424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGE---KSVLDWATRVKIAAG 480

Query:   147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
             +A G+ YLH    P IIHRDIK+SN+LL+ +F A+V+DFG A+L  D  TH+TTRV GT 
Sbjct:   481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTF 540

Query:   207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL---ACE 263
             GY+APEYA  GK +E  DV+SFG++LLEL +G+KP++        ++ +WA PL   A E
Sbjct:   541 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIE 600

Query:   264 -RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTE- 321
               +F  LADP+L GN+VE E+ R++  A  C      KRP M +++   +  + E LT  
Sbjct:   601 TEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNG 660

Query:   322 --LENDELFKSHQ 332
               L   E+F S Q
Sbjct:   661 MRLGESEVFNSAQ 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 678 (243.7 bits), Expect = 1.1e-66, P = 1.1e-66
 Identities = 144/342 (42%), Positives = 210/342 (61%)

Query:    28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
             F+ +EL  ATN F+  N LG+GGFG V+ G L  G ++AVK+LK  S + E EF  EVEI
Sbjct:   268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query:    88 LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS 147
             ++RV H++L+SL GYC  G +RL+VY+++PN                + W+ R+ IA+GS
Sbjct:   328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPT--MEWSTRLKIALGS 385

Query:   148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
             A+G+ YLH    P IIHRDIKASN+L+D  F+A+VADFG AK+  D  THV+TRV GT G
Sbjct:   386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Query:   208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL---ACER 264
             YLAPEYA  GK +E  DV+SFG++LLEL +G++P++  N  +  ++ DWA PL   A E 
Sbjct:   446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEE 505

Query:   265 -KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELE 323
               F  LAD ++   +  EE+ R+V  A  C      +RP M +++  L+G     L++L 
Sbjct:   506 GDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVS--LSDL- 562

Query:   324 NDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVA 365
             N+ +   H     + G +   D+++      ND++ K  ++A
Sbjct:   563 NEGMRPGHSNVYSSYGGSTDYDTSQY-----NDDMIKFRKMA 599

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 650 (233.9 bits), Expect = 4.8e-66, Sum P(2) = 4.8e-66
 Identities = 137/335 (40%), Positives = 207/335 (61%)

Query:    28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
             F+ +EL   T  F     +GEGGFG VY G L++G  +A+K+LK  S +   EF  EVEI
Sbjct:   358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417

Query:    88 LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS 147
             ++RV H++L+SL GYC   Q R ++Y+++PN               +L W+RR+ IAIG+
Sbjct:   418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLP--VLEWSRRVRIAIGA 475

Query:   148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
             A+G+ YLH    P IIHRDIK+SN+LLD +F+AQVADFG A+L     +H++TRV GT G
Sbjct:   476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFG 535

Query:   208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL---ACER 264
             YLAPEYA  GK ++  DV+SFG++LLEL +G+KP++      + ++ +WA P    A E+
Sbjct:   536 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEK 595

Query:   265 -KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELE 323
                SE+ DPRL  ++VE E+ +++  A +C      KRP M++V+  L  ++++ L++L 
Sbjct:   596 GDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL--DTRDDLSDLT 653

Query:   324 NDELFKSHQVADYNDGKAVAEDSAEKLAELENDEL 358
             N    K  Q   Y+ G+   E    + A  ++ +L
Sbjct:   654 NG--VKVGQSRVYDSGQYSNEIRIFRRASEDSSDL 686

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 669 (240.6 bits), Expect = 9.4e-66, P = 9.4e-66
 Identities = 141/332 (42%), Positives = 202/332 (60%)

Query:    28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-EMEFAVEVE 86
             FSL+EL  AT++F+  N LG GGFG VY G+L DG+ +AVKRLK       E++F  EVE
Sbjct:   293 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVE 352

Query:    87 ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG 146
             +++   H+NLL LRG+C    ERL+VY YM N             +  L W+ R  IA+G
Sbjct:   353 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALG 412

Query:   147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
             SA G+ YLH H  P IIHRD+KA+N+LLD +F+A V DFG A+L+    THVTT V+GT+
Sbjct:   413 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTI 472

Query:   207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT--DWALPLACER 264
             G++APEY   GK+SE  DV+ +GI+LLEL +G++  +    A    +   DW   L  E+
Sbjct:   473 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 532

Query:   265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES-KEKLTELE 323
             K   L DP L  N+ E E+++++ VAL C  S P +RP M EV+ +L+G+   EK  E +
Sbjct:   533 KLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAEKWDEWQ 592

Query:   324 NDELFKSH-QVADYNDGKAVAEDSAEKLAELE 354
               E+ +   +++ +     +  DS + L  +E
Sbjct:   593 KVEVLRQEVELSSHPTSDWIL-DSTDNLHAME 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	400
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-35
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-35
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-31
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (424), Expect = 3e-49
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 31/277 (11%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS-----QIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNL 96
             KLGEG FG VY G+L         ++AVK LK  ++ +   EF  E  I+ ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G C E +   IV +YM    LLS+L     +   L+ +  +  A+  A G+ YL  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               + IHRD+ A N L+  +   +++DFG ++ + D   +     K  + ++APE    
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 217 GKASESCDVYSFGILLLELAS-GKKP-IEKVNSAIKRTITDWALPLACERKFSELADPRL 274
           GK +   DV+SFG+LL E+ + G++P     N  +   +          R       P  
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK------NGYRLPQPPNCP-- 229

Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                      +  + L C    PE RPT  E++++L
Sbjct: 230 ---------PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  166 bits (422), Expect = 6e-49
 Identities = 79/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS-----QIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNL 96
             KLGEG FG VY G L         ++AVK LK  ++ +   EF  E  I+ ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G C E +  +IV +YMP   LL +L      E  L+ +  +  A+  A G+ YL  
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLES 121

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               + IHRD+ A N L+  +   +++DFG ++ + D   +     K  + ++APE    
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 217 GKASESCDVYSFGILLLELAS-GKKP-IEKVNSAIKRTITDWALPLACERKFSELADPRL 274
           GK +   DV+SFG+LL E+ + G++P     N+ +   +                     
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-------------------- 218

Query: 275 NGNFVEEEL---KRVVLVALTCAHSKPEKRPTMLEVLDLL 311
            G  + +       +  + L C    PE RPT  E++++L
Sbjct: 219 KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (406), Expect = 4e-47
 Identities = 74/203 (36%), Positives = 110/203 (54%), Gaps = 11/203 (5%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           LGEGGFG+VY  +    G ++A+K +K   S+    E   E+EIL ++ H N++ L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
            +     +V +Y    SL   L     +E  L+ +  + I +   EG+ YLH +    II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 164 HRDIKASNVLLDAD-FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE-YAMLGKASE 221
           HRD+K  N+LLD+D  K ++ADFG +KL+    + + T V GT  Y+APE     G  SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173

Query: 222 SCDVYSFGILLLELASGKKPIEK 244
             D++S G++L EL   K  I K
Sbjct: 174 KSDIWSLGVILYELPELKDLIRK 196

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  153 bits (389), Expect = 4e-44
 Identities = 84/270 (31%), Positives = 124/270 (45%), Gaps = 26/270 (9%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRG 101
           KLG G FG+VY  +    G  +AVK LK  S K   +     E+ IL R+ H N++ L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
              +     +V +Y     L  +L    S    L+ +    IA+    G+ YLH +    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK-AS 220
           IIHRD+K  N+LLD +   ++ADFG AK +   ++ +TT V GT  Y+APE  + G    
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177

Query: 221 ESCDVYSFGILLLELASGKKP--IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNF 278
              DV+S G++L EL +GK P   E +   ++                  L       + 
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLI---------RRILGPPLEFDEPKWSS 228

Query: 279 VEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
             EE K ++   L   +  P KRPT  E+L
Sbjct: 229 GSEEAKDLIKKCL---NKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  151 bits (383), Expect = 3e-43
 Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 41/286 (14%)

Query: 44  NKLGEGGFGSVYWGQLWDGS----QIAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLLS 98
            KLGEG FG VY G+L        ++AVK LK  +++ E  +F  E  ++ ++ H N++ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHL-----HGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           L G C E +   +V +YM    LL +L           +  L+    +  AI  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-----VKGTLGY 208
           L        +HRD+ A N L+  D   +++DFG ++ + D   +         ++    +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKP-IEKVNSAIKRTITDWALPLACERKF 266
           +APE    G  +   DV+SFG+LL E+ + G  P     N  +   +          RK 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL----------RKG 223

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
             L  P        +EL  ++   L+C    PE RPT  E+++ L+
Sbjct: 224 YRLPKPEY----CPDELYELM---LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  148 bits (375), Expect = 5e-42
 Identities = 76/271 (28%), Positives = 120/271 (44%), Gaps = 32/271 (11%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
            KLGEG FG VY  +    G  +A+K +K    K + E  + E++IL +++H N++ L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
              +  +  +V +Y     L   L  +   SE                  + YLH     
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-----FYLRQILSALEYLHSK--- 116

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
            I+HRD+K  N+LLD D   ++ADFG A+ +  G   +TT V GT  Y+APE  +     
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGKGYG 174

Query: 221 ESCDVYSFGILLLELASGKKP---IEKVNSAIKRTITDWALPLACERKFSELADPRLNGN 277
           ++ D++S G++L EL +GK P    +++    K+           E   S  A      +
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK-----D 229

Query: 278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            + + L +            PEKR T  E L
Sbjct: 230 LIRKLLVK-----------DPEKRLTAEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  145 bits (369), Expect = 4e-41
 Identities = 82/281 (29%), Positives = 133/281 (47%), Gaps = 42/281 (14%)

Query: 45  KLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLL 97
           KLGEG FG VY G    G       ++AVK LK  +++ E  EF  E  I+ ++ H N++
Sbjct: 6   KLGEGAFGEVYKG-TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C +G+   IV +YMP   LL  L  +H  +  L     + +A+  A+G+ YL   
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEK--LTLKDLLQMALQIAKGMEYLESK 121

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-----RVKGTLGYLAPE 212
              + +HRD+ A N L+  +   +++DFG ++ I +   +         +K    ++APE
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPE 174

Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPI-EKVNSAIKRTITDWALPLACERKFSELA 270
               GK +   DV+SFG+LL E+ + G++P     N  +   + D        R    L 
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED------GYR----LP 224

Query: 271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
            P    + + E + +       C    PE RPT  E+++ L
Sbjct: 225 RPENCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 3e-37
 Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 54/287 (18%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAE--MEFAVEVEILARVRHKNLLSLR 100
             LG G FGSVY       G  +AVK +++  +  E       E+ IL+ ++H N++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 101 GYC--AEGQERLIVYDYMPNLSLLSHLHG---------QHSSECLLNWNRRMDIAIGSAE 149
           G     E     I  +Y+   SL S L           +  +  +L             E
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-------------E 112

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-VKGTLGY 208
           G+ YLH +    I+HRDIK +N+L+D+D   ++ADFG AK + D  T   T  V+GT  +
Sbjct: 113 GLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKP---IEKVNSAIKRTITDWALPLACERK 265
           +APE     +   + D++S G  ++E+A+GK P   +    +A+ +  +    P   E  
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229

Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
             E  D      F+             C    P+KRPT     +LL+
Sbjct: 230 SEEAKD------FLR-----------KCLRRDPKKRPT---ADELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  130 bits (329), Expect = 2e-35
 Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 43/275 (15%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+GGFG VY       G ++A+K +K+ S + + +   E++IL + +H N++   G  
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD------IAIGSAEGIVYLHHH 157
            +  E  IV ++    SL          + L + N+ +       +     +G+ YLH +
Sbjct: 67  LKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTLGYLAPEYAML 216
               IIHRDIKA+N+LL +D + ++ DFG +  L    A +      GT  ++APE    
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING 171

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNS--AIKRTITDWALPLACERKFS-ELADPR 273
                  D++S GI  +ELA GK P  ++    A+ +  T+    L    K+S E  D  
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD-- 229

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               F+++           C    PEKRPT  ++L
Sbjct: 230 ----FLKK-----------CLQKNPEKRPTAEQLL 249

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  129 bits (326), Expect = 5e-35
 Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 31/269 (11%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           F  + KLG G FG V+ G   +  ++A+K LK      + +F  EV+ L R+RHK+L+SL
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
              C+ G+   I+ + M   SLL+ L  +     +L     +D+A   AEG+ YL     
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            + IHRD+ A N+L+  D   +VADFG A+LI +   ++++  K    + APE A  G  
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGTF 181

Query: 220 SESCDVYSFGILLLELAS-GKKPIEKVNS--AIKRTITDWAL--PLACERKFSELADPRL 274
           S   DV+SFGILL E+ + G+ P   +N+     +    + +  P  C ++         
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQE--------- 232

Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPT 303
                      +  + L C  ++PE RP+
Sbjct: 233 -----------IYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (312), Expect = 7e-33
 Identities = 86/273 (31%), Positives = 126/273 (46%), Gaps = 49/273 (17%)

Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG G FG V+ G  W+G+ ++AVK LK  +   E  F  E +I+ ++RH  L+ L   C
Sbjct: 13  KLGAGQFGEVWMG-TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM   SLL  L      +  L   + +D+A   AEG+ YL      + I
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKK--LRLPQLVDMAAQIAEGMAYLESR---NYI 125

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR------VKGTLGYLAPEYAMLG 217
           HRD+ A N+L+  +   ++ADFG A+LI D     T R      +K T    APE A  G
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWT----APEAANYG 179

Query: 218 KASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWAL------PLACERKFSELA 270
           + +   DV+SFGILL E+ + G+ P   + +     +           P  C  +  +L 
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGYRMPRPPNCPEELYDL- 236

Query: 271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT 303
                               L C    PE+RPT
Sbjct: 237 -------------------MLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 9e-32
 Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 9/199 (4%)

Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG G FG V+ G LW+ +  +AVK LK  +   + +F  E +I+ ++RH  L+ L   C
Sbjct: 13  KLGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
              +   IV + M   SLL +L G       L   + +D+A   A G+ YL      + I
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLP--QLIDMAAQVASGMAYLEAQ---NYI 125

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD+ A NVL+  +   +VADFG A++I +         K  + + APE A+  + S   
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 224 DVYSFGILLLELAS-GKKP 241
           DV+SFGILL E+ + G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  118 bits (299), Expect = 4e-31
 Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 39/276 (14%)

Query: 45  KLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA-EMEFAVEVEILARVRHKNLLSLRG- 101
            LG+G  G VY  +    G   A+K++ V  ++    +   E++ L       ++   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRM--DIAIGSAEGIVYLHHHAT 159
           +  EG+   IV +YM   SL + L  +            +   IA    +G+ YLH    
Sbjct: 68  FYKEGEIS-IVLEYMDGGSL-ADLLKKV-----GKIPEPVLAYIARQILKGLDYLHT--K 118

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            HIIHRDIK SN+L+++  + ++ADFG +K++ +      T V GT+ Y++PE  + G++
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-RIQGES 176

Query: 220 -SESCDVYSFGILLLELASGKKPIEKVNS----AIKRTITDWALPLACERKFS-ELADPR 273
            S + D++S G+ LLE A GK P           + + I D   P     +FS E  D  
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD-- 234

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
               F+             C    P+KRP+  E+L 
Sbjct: 235 ----FIS-----------ACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  118 bits (298), Expect = 7e-31
 Identities = 86/290 (29%), Positives = 135/290 (46%), Gaps = 46/290 (15%)

Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG V+ G+ +      D   +AVK LK   SN A  +F  E E+L   +H+N++ 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHL--HGQH--------SSECLLNWNRRMDIAIGSA 148
             G C EG   ++V++YM +  L   L  HG          S    L  ++ + IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT--- 205
            G+VYL   A+ H +HRD+   N L+  D   ++ DFG ++   D  T    RV G    
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186

Query: 206 -LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP-IEKVNSAIKRTITDWALPLAC 262
            + ++ PE  M  K +   DV+SFG++L E+ + GK+P     N  +   IT   L    
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL---- 242

Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                 L  PR   + V +       + L C    P++R  + ++ + L+
Sbjct: 243 ------LQRPRTCPSEVYD-------IMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  114 bits (287), Expect = 2e-29
 Identities = 81/261 (31%), Positives = 132/261 (50%), Gaps = 26/261 (9%)

Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 13  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM   SLL  L G+      L   + +D+A   A G+ Y+      + +
Sbjct: 71  SE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 124

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P    +  +  
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPECPESLHD-- 234

Query: 283 LKRVVLVALTCAHSKPEKRPT 303
                 +   C   +PE+RPT
Sbjct: 235 ------LMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (292), Expect = 2e-29
 Identities = 82/313 (26%), Positives = 126/313 (40%), Gaps = 23/313 (7%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV---WSNKAEMEFAVEVEILARVRH-K 94
           ++    KLGEG FG VY     D   +A+K L       +K    F  E++ILA + H  
Sbjct: 1   SYRILRKLGEGSFGEVY--LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           N++ L  +  +     +V +Y+   SL   L  +   +  L+ +  + I       + YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117

Query: 155 HHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAKLIPDGATHVTTRVK-----GTLGY 208
           H      IIHRDIK  N+LLD D    ++ DFG AKL+PD  +  +         GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 209 LAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERK 265
           +APE  +   L  AS S D++S GI L EL +G  P E   ++   + T   + L     
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIILELPTP 233

Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELEND 325
                    N   + +    ++   L      P+ R +    L        +      +D
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLA---KDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 326 ELFKSHQVADYND 338
            L           
Sbjct: 291 LLKPDDSAPLRLS 303

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 2e-29
 Identities = 77/271 (28%), Positives = 131/271 (48%), Gaps = 25/271 (9%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G FG VY G L   +++AVK  +       + +F  E EIL +  H N++ L G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
            + Q   IV + +P  SLL+ L      +  L   + + +++ +A G+ YL    + + I
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-LGYLAPEYAMLGKASES 222
           HRD+ A N L+  +   +++DFG ++    G   V+  +K   + + APE    G+ +  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 223 CDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
            DV+S+GILL E  S G  P   +++   R   +    +           P+L      E
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA---------PQL----CPE 222

Query: 282 ELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
           E+ R++   L C    PE RP+  E+ + L+
Sbjct: 223 EIYRLM---LQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 1e-28
 Identities = 71/201 (35%), Positives = 105/201 (52%), Gaps = 12/201 (5%)

Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G+G FG V  G  + G ++AVK LK  S  A+  F  E  ++  +RH NL+ L G   +
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHR 165
           G    IV +YM   SL+ +L  +  +  ++   +++  A+   EG+ YL      + +HR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRA--VITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 166 DIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDV 225
           D+ A NVL+  D  A+V+DFG AK    G       VK T    APE     K S   DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDV 182

Query: 226 YSFGILLLELAS-GKKPIEKV 245
           +SFGILL E+ S G+ P  ++
Sbjct: 183 WSFGILLWEIYSFGRVPYPRI 203

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 6e-28
 Identities = 81/272 (29%), Positives = 130/272 (47%), Gaps = 34/272 (12%)

Query: 46  LGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG G FG V+ G+ W G   +A+K ++  +  +E +F  E +++ ++ H NL+ L G C 
Sbjct: 12  LGSGQFGVVHLGK-WRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 105 EGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           + +   IV +YM N  LL++L    G+  +E LL      D+     E + YL  +    
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL------DMCSDVCEAMEYLESNG--- 120

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  D   +V+DFG A+ + D     +   K  + +  PE     + S 
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 222 SCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
             DV+SFG+L+ E+ S GK P E   NS +  +++           +  L  P+L     
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---------AGY-RLYRPKLAP--- 227

Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                 V  +  +C H KPE RP   ++L  L
Sbjct: 228 ----TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (278), Expect = 6e-28
 Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 31/286 (10%)

Query: 44  NKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVEILARVRHKNL 96
            +LGEG FG V   + +D      G Q+AVK L     +    +F  E+EIL  + H+N+
Sbjct: 10  KQLGEGHFGKVELCR-YDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 97  LSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           +  +G C +   R   ++ +Y+P+ SL  +L         +N  R +  +    +G+ YL
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYL 125

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--YLAPE 212
               +   IHRD+ A N+L++++   +++DFG AK++P+   +   +  G     + APE
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD- 271
                K S + DV+SFG+ L EL +   P +   +   R I      +   R    L + 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 272 PRLNG-----NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
            RL       + V + +K        C  ++P+ RP+  +++ ++ 
Sbjct: 243 ERLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 1e-27
 Identities = 82/261 (31%), Positives = 117/261 (44%), Gaps = 36/261 (13%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+G FG V   +  D  ++ A+K LK    +   + E     E  IL+R+ H  ++ L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKL- 58

Query: 101 GYCA-EGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGSAEGIVYLHHH 157
            + A + +E+L +V +Y P   L SHL              R   A I  A  + YLH  
Sbjct: 59  -HYAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLA--LEYLHSL 112

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               II+RD+K  N+LLDAD   ++ DFG AK +    +   T   GT  YLAPE  +  
Sbjct: 113 ---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELA------ 270
              ++ D +S G+LL E+ +GK P    +   I   I     PL      S  A      
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLRFPEFLSPEARDLISG 226

Query: 271 ----DP--RLNGNFVEEELKR 285
               DP  RL G+   EE+K 
Sbjct: 227 LLQKDPTKRL-GSGGAEEIKA 246

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 46  LGEGGFGSVYWGQLW----DGSQI--AVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G +W    +  +I  A+K L+  ++ KA  E   E  ++A V H +++ 
Sbjct: 15  LGSGAFGTVYKG-VWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS----SECLLNWNRRMDIAIGSAEGIVYL 154
           L G C   Q +LI    MP   LL ++   H     S+ LLNW  ++      A+G+ YL
Sbjct: 74  LLGICLSSQVQLIT-QLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAP 211
                  ++HRD+ A NVL+      ++ DFG AKL+           +G    + ++A 
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMAL 180

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           E  +    +   DV+S+G+ + EL + G KP E + + 
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (268), Expect = 1e-26
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 47/287 (16%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKV-WSNKAEMEFAV-EVEILARVRHKN 95
            +    ++G+G FG VY  +   DG    +K + +   ++ E E A+ EV+IL ++ H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLH-----GQHSSECLLNWNRRMDIAIGSAEG 150
           ++       E  +  IV +Y     L   +      G+   E      + +D  +     
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-----EQILDWFVQLCLA 115

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           + YLH      I+HRDIK  N+ L ++   ++ DFG +K++        T V GT  YL+
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171

Query: 211 PEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
           PE     K  +   D++S G +L EL + K P E                        EL
Sbjct: 172 PE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-------------------ENLLEL 211

Query: 270 ADPRLNGNF------VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL 310
           A   L G +         EL+ +V   L      PE+RP++ ++L  
Sbjct: 212 ALKILKGQYPPIPSQYSSELRNLVSSLLQ---KDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  106 bits (265), Expect = 2e-26
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 30/268 (11%)

Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           +LG G FG V +G+ W G   +A+K +K  S  +E EF  E +++ ++ H+ L+ L G C
Sbjct: 11  ELGTGQFGVVKYGK-WRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 104 AEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            + +   IV +YM N  LL++L  HG+      L     +++     EG+ YL       
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESK---Q 120

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+D     +V+DFG ++ + D     +   K  + +  PE  +  K S 
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180

Query: 222 SCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVE 280
             DV++FG+L+ E+ S GK P E+ N+      ++    ++   +   L  P L      
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGLR---LYRPHLAS---- 227

Query: 281 EELKRVVLVALTCAHSKPEKRPTMLEVL 308
              ++V  +  +C H K E+RPT  ++L
Sbjct: 228 ---EKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 3e-26
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAE--MEFAVEVEILARVRHKN 95
           N+   + +G G FG VY G   +     A+K++ +   K E       E+++L  ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGSA---EGI 151
           ++   G         I+ +Y  N SL   +       E L        +A+      +G+
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL--------VAVYVYQVLQGL 112

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            YLH      +IHRDIKA+N+L   D   ++ADFG A  + D  +     V GT  ++AP
Sbjct: 113 AYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAP 168

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKP 241
           E   +  AS + D++S G  ++EL +G  P
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 2e-25
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 18/208 (8%)

Query: 44  NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLR 100
           NK+G G FG VY    L  G  +AVK +++  N  +   E A E+++L  ++H NL+   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
           G     ++  I  +Y    +L   L HG+   E ++   R   + +   EG+ YLH H  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RVYTLQL--LEGLAYLHSH-- 118

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG---YLAPEYAML 216
             I+HRDIK +N+ LD +   ++ DFG A  + +  T +   V+   G   Y+APE    
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 217 GKASE---SCDVYSFGILLLELASGKKP 241
           GK      + D++S G ++LE+A+GK+P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (257), Expect = 3e-25
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 32/272 (11%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G+     ++A+K +   +  +E +F  E +++ ++ H  L+ L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 105 EGQERLIVYDYMPNLSLLSHL---HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           + +   IV ++M N  LL++L    G+ S + LL+      +     EG+ YL  ++   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS------MCQDVCEGMEYLERNS--- 120

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+ +    +V+DFG  + + D     ++  K  + +  PE     K S 
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 222 SCDVYSFGILLLELAS-GKKPIEK-VNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
             DV+SFG+L+ E+ + GK P EK  N  +   I+          +   L  P+L    V
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS----------RGFRLYRPKLASMTV 230

Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
            E       V  +C H KPE RPT  E+L  +
Sbjct: 231 YE-------VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  102 bits (254), Expect = 7e-25
 Identities = 71/205 (34%), Positives = 108/205 (52%), Gaps = 10/205 (4%)

Query: 45  KLGEGGFGSVYWGQLWDG-SQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG G FG V W   W+G +++AVK LK  +   E  F  E +I+ ++RH  L+ L    
Sbjct: 13  KLGNGQFGEV-WMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM   SLL  L         L     +D+A   A G+ Y+      + I
Sbjct: 71  SE-EPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIERM---NYI 124

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++++N+L+      ++ADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 224 DVYSFGILLLELAS-GKKPIEKVNS 247
           DV+SFGILL EL + G+ P   +N+
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 9e-25
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 32/214 (14%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV----EVEILARVRHKNLLS 98
            ++GEG +G VY  +    G  +A+K++++ + K    F +    E+++L ++RH N++ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62

Query: 99  LRGYCAEGQERLI--VYDYMPN-LSLLSHLHGQHSSE----CLLNWNRRMDIAIGSAEGI 151
           L+       +  I  V++YM + L+ L        +E    C +   +++       EG+
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM---KQL------LEGL 113

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLA 210
            YLH +    I+HRDIK SN+L++ D   ++ADFG A+      +   T RV  TL Y  
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 211 PEYAMLG--KASESCDVYSFGILLLELASGKKPI 242
           PE  +LG  +     D++S G +L EL  G KPI
Sbjct: 170 PEL-LLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  100 bits (251), Expect = 2e-24
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 16/204 (7%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           D KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +I+ ++RH  L+ L  
Sbjct: 11  DVKLGQGCFGEVWMGT-WNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA 68

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             +E +   IV ++M   SLL  L    G++     L   + +D+A   A+G+ Y+    
Sbjct: 69  VVSE-EPIYIVTEFMGKGSLLDFLKEGDGKY-----LKLPQLVDMAAQIADGMAYIERM- 121

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
             + IHRD++A+N+L+  +   ++ADFG A+LI D         K  + + APE A+ G+
Sbjct: 122 --NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 219 ASESCDVYSFGILLLELAS-GKKP 241
            +   DV+SFGILL EL + G+ P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  100 bits (250), Expect = 3e-24
 Identities = 82/262 (31%), Positives = 128/262 (48%), Gaps = 28/262 (10%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           KLG G FG V+ G     +++A+K LK  S   E  F  E  ++ +++H  L+ L  Y  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRL--YAV 69

Query: 105 EGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N SL+  L      +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 70  VTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERK---NYI 124

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 224 DVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P     N  + + +         ER +     PR +     E
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---------ERGYRM---PRPDN--CPE 230

Query: 282 ELKRVVLVALTCAHSKPEKRPT 303
           EL  ++     C   KPE+RPT
Sbjct: 231 ELYELM---RLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  100 bits (249), Expect = 4e-24
 Identities = 80/269 (29%), Positives = 130/269 (48%), Gaps = 26/269 (9%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           KLG G FG V+ G   + +++AVK LK  +   +  F  E  ++  ++H  L+ L     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIH 164
           + +   I+ +YM   SLL  L      + LL   + +D +   AEG+ Y+      + IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERK---NYIH 126

Query: 165 RDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCD 224
           RD++A+NVL+      ++ADFG A++I D         K  + + APE    G  +   D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 225 VYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEEL 283
           V+SFGILL E+ + GK P   ++++   +        A +R +     PR+      +EL
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMS--------ALQRGYRM---PRMEN--CPDEL 233

Query: 284 KRVVLVALTCAHSKPEKRPT---MLEVLD 309
             ++    TC   K E+RPT   +  VLD
Sbjct: 234 YDIM---KTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 41/275 (14%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV-----EVEILARVRHKNLLSL 99
           LG G FGSVY G  L DG   AVK + +  +    + AV     E+ +L++++H N++  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            G   E     I  + +P  SL   L  +G      +  + R++        G+ YLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM-L 216
              + +HRDIK +N+L+D +   ++ADFG AK + + +       KG+  ++APE     
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQ 176

Query: 217 GKASESCDVYSFGILLLELASGKKP---IEKVNSAIKRTITDWALPLACERKFSELADPR 273
           G    + D++S G  +LE+A+GK P   +E V +A+ +      LP   +    E  D  
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFKIGRSKELPPIPDHLSDEAKD-- 233

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               F+           L C    P  RPT  E+L
Sbjct: 234 ----FI-----------LKCLQRDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.4 bits (248), Expect = 5e-24
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 25/273 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS-NKAEMEFAV-EVEILARVRHKN 95
           +F    KLG+G +GSVY  + L D    A+K + + S ++ E E AV E+ ILA V H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++S +    +G +  IV +Y P   L   +  +     L+       I I    G+  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
                 I+HRD+K++N+LL A+   ++ D G +K++            GT  Y+APE   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWK 174

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN 275
               S   D++S G LL E+A+   P E       R++ D    +    K+     P + 
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE------ARSMQDLRYKV-QRGKY-----PPIP 222

Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
             +  ++L+  +    +    KP+ RP   ++L
Sbjct: 223 PIY-SQDLQNFI---RSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 6e-24
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 19/209 (9%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLL 97
           +  +G G FG V  G+L    +    +A+K LK   S+K  ++F  E  I+ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 98  SLRGYCAEGQERLIVYDYMPNLSL---LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
            L G   + +  +I+ +YM N SL   L    G+ +   L+       +  G A G+ YL
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVG------MLRGIASGMKYL 122

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV-KGTLGYLAPEY 213
                   +HRD+ A N+L++++   +V+DFG ++ + D     TT+  K  + + APE 
Sbjct: 123 SEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKP 241
               K + + DV+SFGI++ E+ S G++P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (255), Expect = 2e-23
 Identities = 84/330 (25%), Positives = 148/330 (44%), Gaps = 33/330 (10%)

Query: 2   AFGSIFCCGK-VSDRKEKGKKQPTW--RIFSLKELHSATNN-----FNYDNKLGEGGFGS 53
           AFG +F  G+   + K    +  TW  + F  K   S T N        +N +  G  G+
Sbjct: 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGA 705

Query: 54  VYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV 112
            Y G+ + +G Q  VK +   ++    E A     + +++H N++ L G C   +   ++
Sbjct: 706 SYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLI 761

Query: 113 YDYMPNLSLLSHLHGQHSSECLLN--WNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKAS 170
           ++Y         + G++ SE L N  W RR  IAIG A+ + +LH   +P ++  ++   
Sbjct: 762 HEY---------IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPE 812

Query: 171 NVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGI 230
            +++D        D    +L   G     T+   +  Y+APE       +E  D+Y FG+
Sbjct: 813 KIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGL 866

Query: 231 LLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV--EEELKRVVL 288
           +L+EL +GK P +     +  +I +WA     +       DP + G+    + E+  V+ 
Sbjct: 867 ILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN 925

Query: 289 VALTCAHSKPEKRPTMLEVLDLLKGESKEK 318
           +AL C  + P  RP   +VL  L+  S+  
Sbjct: 926 LALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.3 bits (240), Expect = 8e-23
 Identities = 77/277 (27%), Positives = 119/277 (42%), Gaps = 33/277 (11%)

Query: 45  KLGEGGFGSVYWGQLWDGS-----QIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLS 98
           KLG+G FG V     W  S      +AVK LK    +    +F  E  I+  + H+NL+ 
Sbjct: 2   KLGDGSFGVV-RRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L G        ++V +  P  SLL  L        L++     D A+  A G+ YL    
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLE--- 114

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT--RVKGTLGYLAPEYAML 216
           +   IHRD+ A N+LL +D K ++ DFG  + +P    H      +K    + APE    
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 217 GKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADPRL 274
              S + DV+ FG+ L E+ + G++P   ++ S I + I         +++   L  P  
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---------DKEGERLERP-- 223

Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                E   + +  V L C    P  RPT   + + L
Sbjct: 224 -----EACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.8 bits (238), Expect = 1e-22
 Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 32/269 (11%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           ++G G FG V+ G   +  ++A+K ++  +  +E +F  E +++ ++ H  L+ L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 105 EGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           E     +V+++M +  L  +L    G+ S E LL       + +   EG+ YL       
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL------GMCLDVCEGMAYLESSN--- 120

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     K S 
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 222 SCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
             DV+SFG+L+ E+ S GK P E + NS +  TI       A  R    L  PRL    V
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN------AGFR----LYKPRLASQSV 230

Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            E ++        C   +PE RP+   +L
Sbjct: 231 YELMQH-------CWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 79/295 (26%), Positives = 140/295 (47%), Gaps = 45/295 (15%)

Query: 45  KLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +LGEG FG V+  + +      D   +AVK LK  +  A  +F  E E+L  ++H++++ 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHS----------SECLLNWNRRMDIAIG 146
             G C +G   ++V++YM +  L   L  HG  +          ++  L  ++ + IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG-- 204
            A G+VYL   A+ H +HRD+   N L+ A+   ++ DFG ++   D  +    RV G  
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGHT 185

Query: 205 --TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLA 261
              + ++ PE  M  K +   DV+SFG++L E+ + GK+P  ++++            + 
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---------TEVIE 236

Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK 316
           C  +   L  PR+         K V  + L C   +P++R  + E+  +L    K
Sbjct: 237 CITQGRVLERPRVCP-------KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.3 bits (239), Expect = 1e-22
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 30/260 (11%)

Query: 34  HSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEI 87
           H   +N     +LGEG FG V+  + +      D   +AVK LK  S+ A  +F  E E+
Sbjct: 1   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECL---------LNWN 138
           L  ++H++++   G C EG   ++V++YM +  L   L        L         L  +
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV 198
           + + IA   A G+VYL   A+ H +HRD+   N L+  +   ++ DFG ++   D  +  
Sbjct: 121 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTD 174

Query: 199 TTRVKG----TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRT 252
             RV G     + ++ PE  M  K +   DV+S G++L E+ + GK+P  ++ N+ +   
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234

Query: 253 ITDWAL---PLACERKFSEL 269
           IT   +   P  C ++  +L
Sbjct: 235 ITQGRVLQRPRTCPKEVYDL 254

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 12  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M   +LL +L  +  +   +N    + +A   +  + YL      +
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---N 124

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 222 SCDVYSFGILLLELAS 237
             DV++FG+LL E+A+
Sbjct: 185 KSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 30/274 (10%)

Query: 40  FNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           F+   KLGEG +GSVY       G  +A+K + V  +  E+    E+ IL +     ++ 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVK 62

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             G   +  +  IV +Y    S+   +   + +   L       I   + +G+ YLH + 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGLEYLHSN- 118

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
               IHRDIKA N+LL+ + +A++ADFG +  + D      T V GT  ++APE      
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175

Query: 219 ASESCDVYSFGILLLELASGKKPIEKVNS--AIKRTITDWALP-LACERKFSELADPRLN 275
            +   D++S GI  +E+A GK P   ++   AI   I +   P L+   K+S    P  N
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWS----PEFN 230

Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            +FV+            C    PE+RP+ +++L 
Sbjct: 231 -DFVK-----------KCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 86/298 (28%), Positives = 132/298 (44%), Gaps = 50/298 (16%)

Query: 42  YDN--KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLL 97
           Y N  K+GEG  G VY       G ++A+K++++   K   E  + E+ I+   +H N++
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL--RKQNKELIINEILIMKDCKHPNIV 78

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNR-RMD---IAIGSAE---G 150
                   G E  +V +YM   SL            ++  N  RM+   IA    E   G
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVCREVLQG 128

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           + YLH     ++IHRDIK+ N+LL  D   ++ADFGFA  +    +   + V GT  ++A
Sbjct: 129 LEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMA 184

Query: 211 PEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALPLACERKFS 267
           PE  +  K      D++S GI+ +E+A G+ P  +     A+    T    PL    K+S
Sbjct: 185 PE-VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS 243

Query: 268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLTEL 322
                    +F+             C    PEKRP+  E+L    L K   KE+   L
Sbjct: 244 PEFK-----DFLN-----------KCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 94.4 bits (235), Expect = 5e-22
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 30/220 (13%)

Query: 46  LGEGGFGSVYWGQLWDGSQ------IAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG VY G+L   ++      +A+K LK  +  K + EF  E E+++ ++H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSS----------ECLLNWNRRMDIAIG 146
           L G C + Q   ++++Y+ +  L   L  +  HS           +  L+ +  + IAI 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT- 205
            A G+ YL  H   H +HRD+ A N L+      +++DFG ++   D  +    RV+   
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186

Query: 206 ---LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
              + ++ PE  + GK +   D++SFG++L E+ S G +P
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.9 bits (233), Expect = 8e-22
 Identities = 69/239 (28%), Positives = 123/239 (51%), Gaps = 24/239 (10%)

Query: 46  LGEGGFGSVYWGQL----WDGSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V+ G L         +A+K LK  ++ K   +F  E  I+ +  H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
           G   + +  +I+ +YM N +L  +L    G+ SS  L+   R      G A G+ YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR------GIAAGMKYL--- 123

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAM 215
           +  + +HRD+ A N+L++++ + +V+DFG ++++ D    T+ T+  K  + + APE   
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 216 LGKASESCDVYSFGILLLELAS-GKKPI-EKVNSAIKRTITD---WALPLACERKFSEL 269
             K + + DV+SFGI++ E+ S G++P  +  N  + + I D      P+ C     +L
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQL 242

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 93.9 bits (233), Expect = 8e-22
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 22/216 (10%)

Query: 45  KLGEGGFGSVYWGQL------WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +LGEG FG V+  +        D   +AVK LK  S  A  +F  E E+L  ++H++++ 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 99  LRGYCAEGQERLIVYDYMP----NLSLLSH-------LHGQHSSECLLNWNRRMDIAIGS 147
             G C EG+  L+V++YM     N  L SH         G+  +   L   + + IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTL 206
           A G+VYL   A+ H +HRD+   N L+      ++ DFG ++ I     + V  R    +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            ++ PE  +  K +   D++SFG++L E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 9e-22
 Identities = 74/264 (28%), Positives = 123/264 (46%), Gaps = 24/264 (9%)

Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG+G FG V+ G L D + +AVK  K     + +++F  E  IL +  H N++ L G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIH 164
           + Q   IV + +P    LS L  +      L   + +  A+ +A G+ YL    + + IH
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLE---SKNCIH 116

Query: 165 RDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCD 224
           RD+ A N L+  +   +++DFG ++   DG    +   +  + + APE    G+ S   D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 225 VYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEEL 283
           V+S+GILL E  S G  P   + +   R   +    ++C +K               +++
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK-------------CPDDV 223

Query: 284 KRVVLVALTCAHSKPEKRPTMLEV 307
            +V+     C   KPE RP   E+
Sbjct: 224 YKVM---QRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 27/217 (12%)

Query: 46  LGEGGFGSVYWGQLWD-------GSQIAVKRLKVWSNKAE-MEFAVEVEILARVRHKNLL 97
           LG G FG VY G   D         ++AVK L+  +   E  EF  E  +++   H N++
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHG---QHSSECLLNWNRRMDIAIGSAEGIVYL 154
            L G C   + + I+ + M    LLS+L     +     LL     +DI +  A+G VYL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 155 HHHATPHIIHRDIKASNVLL-----DADFKAQVADFGFAKLIPDGATHVTTRVKG----T 205
                 H IHRD+ A N L+     DAD   ++ DFG A+ I     +   R +G     
Sbjct: 123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGLLP 176

Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLE-LASGKKP 241
           + ++APE  + GK +   DV+SFG+L+ E L  G++P
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 20/201 (9%)

Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG V     +D      G  +AVK LK     +    +  E+ IL  + H+N++ 
Sbjct: 12  LGEGHFGKVSL-YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 99  LRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
            +G C+E   +   ++ +Y+P  SL  +L  +H     LN  + +  A    EG+ YLH 
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHK----LNLAQLLLFAQQICEGMAYLH- 124

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT--LGYLAPEYA 214
             + H IHRD+ A NVLLD D   ++ DFG AK +P+G  +   R  G   + + A E  
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 215 MLGKASESCDVYSFGILLLEL 235
              K S + DV+SFG+ L EL
Sbjct: 183 KENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)

Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLKVWSNKAEMEFAVEVEILA--RVRHKNLL 97
           LG G FG+V+ G +W  +G  I    A+K ++  S +   +  +   +LA   + H  ++
Sbjct: 15  LGSGVFGTVHKG-IWIPEGDSIKIPVAIKTIQDRSGRQTFQ-EITDHMLAMGSLDHAYIV 72

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYL 154
            L G C     +L+     P  SLL H+         + LLNW       +  A+G+ YL
Sbjct: 73  RLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYL 125

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEY 213
             H    ++HR++ A N+LL +D   Q+ADFG A L+ PD   +  +  K  + ++A E 
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKP 241
            + G+ +   DV+S+G+ + E+ S G +P
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 82/280 (29%), Positives = 128/280 (45%), Gaps = 38/280 (13%)

Query: 44  NKLGEGGFGSVYWG--QLWDGSQI--AVKRLKVWSNKA-EMEFAVEVEILARVRHKNLLS 98
            +LG G FGSV  G   +  G ++  AVK LK     A + EF  E  ++A++ H  ++ 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           L G C +G+  ++V +  P   LL +L    +     L         A   A G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE- 112

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT--LGYLAPEYA 214
             + H +HRD+ A NVLL    +A+++DFG ++ +  G+ +      G   L + APE  
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPI-EKVNSAIKRTITDWALPLACERKFSELADP 272
             GK S   DV+S+G+ L E  S G KP  E   + +   +       + ER    L  P
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE------SGER----LPRP 220

Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                  EE  + +  + L+C   +PE RPT  E+    +
Sbjct: 221 -------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 91.6 bits (227), Expect = 3e-21
 Identities = 75/262 (28%), Positives = 127/262 (48%), Gaps = 24/262 (9%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           + KLG G FG V+       +++AVK +K  S   E  F  E  ++  ++H  L+ L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAV 69

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
             + +   I+ ++M   SLL  L     S+  L   + +D +   AEG+ ++      + 
Sbjct: 70  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---NY 123

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           IHRD++A+N+L+ A    ++ADFG A++I D         K  + + APE    G  +  
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 223 CDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
            DV+SFGILL+E+ + G+ P   +++          +  A ER +     PR       E
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRM---PRPEN--CPE 230

Query: 282 ELKRVVLVALTCAHSKPEKRPT 303
           EL  ++   + C  ++PE+RPT
Sbjct: 231 ELYNIM---MRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.6 bits (227), Expect = 4e-21
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 14/203 (6%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
            +GEG FG+V  G+ + G ++AVK +K   +     F  E  ++ ++ HKNL+ L G   
Sbjct: 13  IIGEGEFGAVLQGE-YTGQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIH 164
                 IV + M   +L++ L  +     L++  + +  ++  AEG+ YL    +  ++H
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123

Query: 165 RDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCD 224
           RD+ A N+L+  D  A+V+DFG A++   G  +    VK T    APE     K S   D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179

Query: 225 VYSFGILLLELAS-GKKPIEKVN 246
           V+S+G+LL E+ S G+ P  K++
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 62/296 (20%)

Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAE-MEFAVEVEILARVRHKNLLS 98
           LG+G FG VY G           +++A+K +   ++  E +EF  E  ++      +++ 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLN------WNRRMDIAIGSAEGIV 152
           L G  + GQ  L+V + M    L S+L  +                + + +A   A+G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-------PDGATHVTTRVKGT 205
           YL   A    +HRD+ A N ++  D   ++ DFG  + I         G        KG 
Sbjct: 134 YL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG--------KGL 182

Query: 206 LG--YLAPEYAMLGKASESCDVYSFGILLLELAS-------GKKPIEKVNSAIKRTITDW 256
           L   ++APE    G  +   DV+SFG++L E+A+       G    E +   I     D 
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD- 241

Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
            LP  C  K  EL                       C    P+ RPT LE++  LK
Sbjct: 242 -LPENCPDKLLEL--------------------MRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 32/280 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           ++  Y  +LG G  G V        G  +AVK +++  N+A   +   E++IL +     
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSL---LSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           ++   G      +  I  +YM   SL   L  + G+     L        IA+   +G+ 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL------GKIAVAVLKGLT 114

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGA-THVTTRVKGTLGYLA 210
           YLH      IIHRD+K SN+L+++  + ++ DFG + +L+   A T V     GT  Y+A
Sbjct: 115 YLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMA 167

Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA 270
           PE       S   D++S G+ L+ELA+G+ P    N                 +      
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-------PPDGIFELLQYIVNEP 220

Query: 271 DPRL-NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            PRL +G F  +           C    P +RP+  E+L+
Sbjct: 221 PPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.6 bits (225), Expect = 7e-21
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 9/211 (4%)

Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWS-NKAEMEFAV-EVEILARVRHKN 95
           +F   NK+G+G FG V+   +  D    A+K++ +   N+ E E A+ E  +LA++    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++       +  +  IV +Y  N  L   L  Q      L  ++     I    G+ +LH
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP--LPEDQVWRFFIQILLGLAHLH 118

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
              +  I+HRDIK+ N+ LDA    ++ D G AKL+ D      T V GT  YL+PE   
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCE 174

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVN 246
               +E  DV++ G++L E  +GK P +  N
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANN 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 58/288 (20%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV------EVEILARVRHKNLLS 98
           LG G F S Y  + +  G+ +AVK++    N +  +  V      E+ ++AR+ H +++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLH--GQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           + G   E     +  ++M   S+   L   G      ++N+  ++        G+ YLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLHE 121

Query: 157 HATPHIIHRDIKASNVLLDADFK-AQVADFGFA-KLIPD--GATHVTTRVKGTLGYLAPE 212
           +    IIHRD+K +N+L+D+  +  ++ADFG A +L     GA     ++ GT+ ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKP------------IEKVNSAIKRTITDWALPL 260
                +   SCDV+S G +++E+A+ K P            I K+ SA          P 
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-------TAPS 231

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
             E     L D                 V L C   +PE RP   E+L
Sbjct: 232 IPEHLSPGLRD-----------------VTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 90.0 bits (223), Expect = 1e-20
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 22/206 (10%)

Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+ L G   E
Sbjct: 14  IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 106 GQERL-IVYDYMPNLSLLSHLHGQHSS----ECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
            +  L IV +YM   SL+ +L  +  S    +CLL ++  +D+     E + YL  +   
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVC----EAMEYLEAN--- 121

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           + +HRD+ A NVL+  D  A+V+DFG  K     A+      K  + + APE     K S
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177

Query: 221 ESCDVYSFGILLLELAS-GKKPIEKV 245
              DV+SFGILL E+ S G+ P  ++
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRI 203

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 93/283 (32%), Positives = 128/283 (45%), Gaps = 54/283 (19%)

Query: 46  LGEGGFGSVYWGQLWDGSQI----AVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLR 100
           +G+G FG VY G L D        AVK L   ++  E+E F  E  I+    H N+LSL 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 101 GYC--AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRR----------MDIAIGSA 148
           G C  +EG   L+V  YM         HG      L N+ R           +   +  A
Sbjct: 63  GICLPSEGSP-LVVLPYM--------KHGD-----LRNFIRSETHNPTVKDLIGFGLQVA 108

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGT 205
           +G+ YL   A+   +HRD+ A N +LD  F  +VADFG A+ I D    + H  T  K  
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165

Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACER 264
           + ++A E     K +   DV+SFG+LL EL + G  P   V+S     IT + L      
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL------ 216

Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEV 307
           +   L  P    + + E       V L+C H KPE RPT  E+
Sbjct: 217 QGRRLLQPEYCPDPLYE-------VMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 20/207 (9%)

Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L    +    +A+K LK  ++ K   +F  E  I+ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
           G   + +  +IV +YM N SL + L    GQ +   L+   R      G A G+ YL   
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR------GIASGMKYL--- 122

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAM 215
           +    +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K  + + APE   
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 216 LGKASESCDVYSFGILLLELAS-GKKP 241
             K + + DV+S+GI++ E+ S G++P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.4 bits (219), Expect = 5e-20
 Identities = 71/281 (25%), Positives = 129/281 (45%), Gaps = 40/281 (14%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK---AEMEFAV---EVEILARVRHKNLL 97
             LG+G +G+VY G    G  IAVK++++ ++    AE E+     EV++L  ++H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLH--GQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
              G C +     I  +++P  S+ S L+  G         + +++       +G+ YLH
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLH 119

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT-----TRVKGTLGYLA 210
           ++    ++HRDIK +NV+L  +   ++ DFG A+ +     H T       + GT  ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALPLACERKFSE 268
           PE           D++S G  + E+A+GK P+  ++  +A+        L       FS 
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236

Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            A      +FV            +C      +RP+ L++L 
Sbjct: 237 AA-----IDFVT-----------SCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 75/308 (24%), Positives = 127/308 (41%), Gaps = 66/308 (21%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRL---KVWSNKAEMEFAVEVEILARV-R 92
           ++F +   +GEG F +V   +      + A+K L   ++   K      +E E+L R+  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLH--GQHSSECLLNWNRRMDIAIGSAE 149
           H  ++ L  Y  + +E L  V +Y PN  LL ++   G    +C   +         +AE
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY---------AAE 110

Query: 150 ---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK--- 203
               + YLH      IIHRD+K  N+LLD D   ++ DFG AK++   ++  + +     
Sbjct: 111 ILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 204 ----------------GTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKV 245
                           GT  Y++PE  +L    A +S D+++ G ++ ++ +GK P    
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPE--LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225

Query: 246 NS-AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
           N     + I      L  E  F     P    + +E+ L              P+ R  +
Sbjct: 226 NEYLTFQKI------LKLEYSFPPNFPPDAK-DLIEKLLVL-----------DPQDRLGV 267

Query: 305 LEVLDLLK 312
            E  D LK
Sbjct: 268 NEGYDELK 275

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 65/224 (29%), Positives = 92/224 (41%), Gaps = 21/224 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI-AVK---RLKVWSNKAEMEFAVEVEILARVRHK 94
           +F     +G+G FG V   Q  D  ++ A+K   + K     +      E  IL  + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMDIA-IGSAEGIV 152
            L++L     + +   +V D +    L  HL      SE  +    +  I  I  A  + 
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV----KFWICEIVLA--LE 114

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH      IIHRDIK  N+LLD      + DF  A  +      +TT   GT GY+APE
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
                  S + D +S G+   E   GK+P         RTI D 
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG----HSRTIRDQ 209

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 69/211 (32%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 44  NKLGEGGFGSVYWGQL--WDGS----QIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNL 96
             LG G FG VY G     DG     Q+AVK L +  S + E +F +E  I+++  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHL-----HGQHSSECLLNWNRRMDIAIGSAEGI 151
           + L G   E   R I+ + M    L S L       +  S   L     +  A   A+G 
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS--SLTMKDLLFCARDVAKGC 129

Query: 152 VYLHHHATPHIIHRDIKASNVLLD---ADFKAQVADFGFAKLIPDGATHVTTRVKGTL-- 206
            YL      H IHRDI A N LL        A++ADFG A+ I   A++     +  L  
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY-RASYYRKGGRAMLPI 185

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS 237
            ++ PE  + G  +   DV+SFG+LL E+ S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.5 bits (214), Expect = 3e-19
 Identities = 67/234 (28%), Positives = 120/234 (51%), Gaps = 34/234 (14%)

Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L    +    +A+K LK  ++ K   +F  E  I+ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
           G   + +  +I+ ++M N +L S L    GQ +   L+   R      G A G+ YL   
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR------GIAAGMKYL--- 122

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG------YLAP 211
           +  + +HRD+ A N+L++++   +V+DFG ++ + D  +  T     +LG      + AP
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAP 180

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKPI-----EKVNSAIKRTITDWALP 259
           E     K + + DV+S+GI++ E+ S G++P      + V +AI++   D+ LP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 61/203 (30%), Positives = 109/203 (53%), Gaps = 15/203 (7%)

Query: 42  YDNKLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           +  +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 97  LSLRGYC-AEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           +  +G C + G+  L +V +Y+P  SL  +L  +H      +  + +  A    +G+ YL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERL--DHRKLLLYASQICKGMEYL 124

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT--LGYLAPE 212
               +   +HRD+   N+L++++ + ++ DFG  K++P    +   R  G   + + APE
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 213 YAMLGKASESCDVYSFGILLLEL 235
                K S + DV+SFG++L EL
Sbjct: 182 SLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.6 bits (212), Expect = 5e-19
 Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 43/276 (15%)

Query: 46  LGEGGFGS-VYWGQLWDGSQIAVKRLKVWS-NKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           LG+G FG    + +  D S +  K + +   ++ E   A+ E+ IL+ ++H N+++   +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 103 CAEGQERLIVYDYMPNLSL---LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
             +    LI  +Y    +L   +    GQ   E ++ W       I SA  + Y+H    
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSA--VSYIHKAG- 121

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
             I+HRDIK  N+ L      ++ DFG +K++    +   T V GT  Y++PE     K 
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178

Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
           +   D+++ G +L EL + K+  +  N                      L    + GN+ 
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNP-------------------LNLVVKIVQGNYT 219

Query: 280 EE------ELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                   EL  +V    +     PEKRPT  EVLD
Sbjct: 220 PVVSVYSSELISLV---HSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 86.7 bits (214), Expect = 5e-19
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 36/272 (13%)

Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           ++G G FG+VY+ +    +++ A+K++      SN+   +   EV+ L R++H N +  +
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 101 G-YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
           G Y  E    L++   + + S L  +H +   E  +       I  G+ +G+ YLH H  
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLHSH-- 144

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML--- 216
            ++IHRDIKA N+LL    + ++ADFG A +     + V     GT  ++APE  +    
Sbjct: 145 -NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDE 198

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
           G+     DV+S GI  +ELA  K P+  +N+            ++     ++   P L  
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNESPTLQS 246

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           N   +  +  V    +C    P+ RPT  E+L
Sbjct: 247 NEWSDYFRNFV---DSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL---KVWSNKAEMEFAVEVEILARVRH 93
           ++F +   LG G FG V   +     +  A+K L   K+   K       E  IL  +RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG---SAE- 149
             L++L G   +     +V +Y+P   L SHL            + R    +    +A+ 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFPEPVARFYAAQV 110

Query: 150 --GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
              + YLH      I++RD+K  N+LLD+D   ++ DFGFAK +       T  + GT  
Sbjct: 111 VLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPE 163

Query: 208 YLAPEYAML---GKASESCDVYSFGILLLELASGKKP 241
           YLAPE  +    GKA    D ++ GIL+ E+ +G  P
Sbjct: 164 YLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 72/278 (25%), Positives = 118/278 (42%), Gaps = 23/278 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ-IAVKRLKVWSNKAEMEFAV-EVEILARVRHKN 95
           +++     +G G    VY       ++ +A+KR+ +   +  ++    EV+ +++  H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++        G E  +V  Y+   SLL  +         L+      +     +G+ YLH
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK----GTLGYLAP 211
            +     IHRDIKA N+LL  D   ++ADFG +  + DG    T +V+    GT  ++AP
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGTPCWMAP 175

Query: 212 EYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA 270
           E            D++SFGI  +ELA+G  P  K    +K       L L  +     L 
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMK------VLMLTLQNDPPSLE 228

Query: 271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                  + +   K + L    C    P KRPT  E+L
Sbjct: 229 TGADYKKYSKSFRKMISL----CLQKDPSKRPTAEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 50/240 (20%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARV 91
           S   ++    KLGEG FG VY   Q+  G  +A+K++ + + K         E++IL ++
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64

Query: 92  RHKNLLSL-----RGYCAEGQERLIVYDYMP----NLSLLSH---LHGQHSS-EC----L 134
           +H N++ L            ++R  VY   P    +LS L     +    S  +C    L
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 135 LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--- 191
           L             EGI YLH +   HI+HRDIKA+N+L+D     ++ADFG A+     
Sbjct: 125 L-------------EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 192 -------PDGATHVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPI 242
                    G T   T +  T  Y  PE  +LG  + + + D++  G +  E+ +  +PI
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 40/289 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEME-FAVEVEILAR 90
           NN ++   LG G FG V     +  S      ++AVK LK  ++ +E E    E++I++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
           +  H+N+++L G C  G   L++ +Y     LL+ L      E  L     +  +   A+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAK 152

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT---- 205
           G+ +L   A+ + IHRD+ A NVLL      ++ DFG A+ I + + +V   VKG     
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLP 206

Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK--VNSAIKRTITDWALPLAC 262
           + ++APE       +   DV+S+GILL E+ S G  P     V+S   + I +       
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG------ 260

Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                 +A P       E     +  +  TC  + P KRPT  +++ L+
Sbjct: 261 ----YRMAQP-------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 54/304 (17%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK-VWSNKAEMEFAV-EVEILARVRHK 94
           N +     +GEG +G V   +     +I A+K+ K    ++   + A+ EV++L ++RH+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS------A 148
           N+++L+          +V++Y+   +LL  L               +             
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG---------LPPDAVRSYIWQLL 110

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           + I Y H H   +IIHRDIK  N+L+      ++ DFGFA+ +        T    T  Y
Sbjct: 111 QAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY 167

Query: 209 LAPE----YAMLGKASESCDVYSFGILLLELAS------GKKPIEKVNSAIKRTITDWAL 258
            APE        GK     DV++ G ++ EL        G   I+++   I++ +     
Sbjct: 168 RAPELLVGDTNYGKP---VDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLG---- 219

Query: 259 PLACERKFSELADPRLNGNFV-----EEELKRVVLVALT---------CAHSKPEKRPTM 304
           PL    +    ++PR  G         E L+R     ++         C    P++R T 
Sbjct: 220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC 279

Query: 305 LEVL 308
            E+L
Sbjct: 280 DELL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV-----EVEILARV 91
            N+     LG+G FG VY     D G ++AVK++    +  E +  V     E+++L  +
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAE 149
           +H+ ++   G   + +   I  +YMP  S+   L  +G  +      + R++       E
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LE 115

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT--TRVKGTLG 207
           G+ YLH +    I+HRDIK +N+L D+    ++ DFG +K +    +  T    V GT  
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
           +++PE           DV+S G  ++E+ + K P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.0 bits (205), Expect = 5e-18
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 17/211 (8%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG+G +G VY  + L    +IA+K +    ++       E+ + + ++H+N++   G  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 105 EGQERLIVYDYMPNLSLLSHLHGQ----HSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           E     I  + +P  SL + L  +      +E  + +  +  +     EG+ YLH +   
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN--- 127

Query: 161 HIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            I+HRDIK  NVL++      +++DFG +K +  G    T    GTL Y+APE    G  
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 220 --SESCDVYSFGILLLELASGKKPIEKVNSA 248
                 D++S G  ++E+A+GK P  ++   
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.6 bits (206), Expect = 5e-18
 Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 42/270 (15%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           ++G G FG+VY+ + + +   +A+K++      SN+   +   EV  L ++RH N +  R
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 101 G-YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAI---GSAEGIVYLHH 156
           G Y  E    L++   + + S L  +H +   E        ++IA    G+ +G+ YLH 
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--------VEIAAVTHGALQGLAYLHS 133

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
           H   ++IHRD+KA N+LL      ++ DFG A ++      V     GT  ++APE  + 
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185

Query: 217 ---GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR 273
              G+     DV+S GI  +ELA  K P+  +N+            ++     ++   P 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNESPA 233

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPT 303
           L      E  +  V    +C    P+ RPT
Sbjct: 234 LQSGHWSEYFRNFV---DSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.0 bits (206), Expect = 6e-18
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 37/215 (17%)

Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEME---FAV--EVEILARVR 92
            +    KLGEG +  VY       G  +A+K++K+   K   +   F    E+++L  ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE--- 149
           H N++ L           +V+++M      + L      E ++   +   I +  A+   
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-----TDL------EKVI---KDKSIVLTPADIKS 106

Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                  G+ YLH +    I+HRD+K +N+L+ +D   ++ADFG A+        +T +V
Sbjct: 107 YMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163

Query: 203 KGTLGYLAPEYAMLG--KASESCDVYSFGILLLEL 235
             T  Y APE  + G        D++S G +  EL
Sbjct: 164 V-TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.8 bits (204), Expect = 9e-18
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 36/273 (13%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQI-AVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSL 99
           +++G G FG+VY+      +++ AVK++      +N+   +   EV+ L +++H N +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 100 RG-YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           +G Y  E    L++   + + S L  +H +   E  +       I  G+ +G+ YLH H 
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLHSHN 141

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-- 216
              +IHRDIKA N+LL    + ++ADFG A       + V     GT  ++APE  +   
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMD 193

Query: 217 -GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN 275
            G+     DV+S GI  +ELA  K P+  +N+            ++     ++   P L 
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNDSPTLQ 241

Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            N   +  +  V     C    P++RP   E+L
Sbjct: 242 SNEWTDSFRGFVDY---CLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 80/309 (25%), Positives = 142/309 (45%), Gaps = 55/309 (17%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLW-DGSQI--AVKRLKVWSNKAE-MEFAVEVEILARV-R 92
           N+  + + +GEG FG V   ++  DG ++  A+KR+K +++K +  +FA E+E+L ++  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ------------HSSECLLNWNRR 140
           H N+++L G C       +  +Y P+ +LL  L               +S+   L+  + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
           +  A   A G+ YL   +    IHRD+ A N+L+  ++ A++ADFG ++           
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEV 176

Query: 201 RVKGTLG-----YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTIT 254
            VK T+G     ++A E       + + DV+S+G+LL E+ S G  P             
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY------------ 224

Query: 255 DWALPLACERKFSELADPRLNGNFVEEELK---RVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  C    +EL +    G  +E+ L     V  +   C   KP +RP+  ++L  L
Sbjct: 225 -------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277

Query: 312 KGESKEKLT 320
               +E+ T
Sbjct: 278 NRMLEERKT 286

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 41/277 (14%)

Query: 46  LGEGGFGSVYWGQLW--DGSQ--IAVKRLKV-WSNKAEME-FAVEVEILARVRHKNLLSL 99
           LGEG FGSV  GQL   DGSQ  +AVK +K+     +E+E F  E   +    H N++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 100 RGYCAEGQER------LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRM--DIAIGSAEGI 151
            G C E          +++  +M +  L S L              +      +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV-KGTLGYLA 210
            YL   +  + IHRD+ A N +L  D    VADFG +K I  G  +   R+ K  + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E       +   DV++FG+ + E+A+ G+ P   V +                    E+
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------------------HEI 224

Query: 270 ADPRLNGNFV---EEELKRVVLVALTCAHSKPEKRPT 303
            D   +GN +   E+ L  +  +  +C  + P+ RPT
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPT 261

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 43/231 (18%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
            F   N++GEG +G VY  +    G  +A+K++++ + +  +  +   E+ +L  +RH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 96  LLSLR---------------GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRR 140
           ++ L+                YC +    L+  D MP     S +               
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQVKC------------- 112

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
             + +    G+ YLH +    IIHRD+K SN+LL      ++ADFG A+     A  +T 
Sbjct: 113 --LMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167

Query: 201 RVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPIEKVNSAI 249
           +V  TL Y APE  +LG    + + D+++ G +L EL +  KP+    S I
Sbjct: 168 KVV-TLWYRAPEL-LLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEI 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 19/220 (8%)

Query: 46  LGEGGFGSVYWGQL-WDGS--QIAVKRLKVW-SNKAEME-FAVEVEILARVRHKNLLSLR 100
           LGEG FGSV  GQL  D S  ++AVK +K+    ++EME F  E   +    H N++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 101 GYCAEGQER------LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS--AEGIV 152
           G C +  E       +++  +M +  L S L      +C      +M +   +  A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV-KGTLGYLAP 211
           YL   ++   IHRD+ A N +L+ +    VADFG +K I +G  +   R+ K  + ++A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAI 249
           E       +   DV+SFG+ + E+A+ G+ P   V NS I
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 74/288 (25%), Positives = 136/288 (47%), Gaps = 38/288 (13%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEM-EFAVEVEILARVRH---KNLLSLR 100
           +G G +G+VY G  +  G  +A+K + + +   ++ +   EV +L+++R     N+    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV---YLHHH 157
           G   +G    I+ +Y    S+ + +     +E          I++   E +V   Y+H  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE--------KYISVIIREVLVALKYIHKV 120

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRDIKA+N+L+      ++ DFG A L+   ++  +T V GT  ++APE    G
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176

Query: 218 KASES-CDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
           K  ++  D++S GI + E+A+G  P   V++   R +    +P +          PRL  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAF--RAMM--LIPKS--------KPPRLED 224

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL--LKGESKEKLTEL 322
           N   + L+  V     C   +P++R +  E+L    +K  SK  ++ L
Sbjct: 225 NGYSKLLREFV---AACLDEEPKERLSAEELLKSKWIKAHSKTPVSIL 269

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 23/212 (10%)

Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRL-KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G +W  +G  +    A+K L +    KA +EF  E  I+A + H +L+ 
Sbjct: 15  LGSGAFGTVYKG-IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS---SECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C     +L+    MP+  LL ++H       S+ LLNW       +  A+G++YL 
Sbjct: 74  LLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGTLGYLAPEYA 214
                 ++HRD+ A NVL+ +    ++ DFG A+L+  D   +     K  + ++A E  
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
              K +   DV+S+G+ + EL + G KP + +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 18/201 (8%)

Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLLS 98
           LGEG FG V   + +D      G Q+AVK LK  S    + +   E+EIL  + H+N++ 
Sbjct: 12  LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 99  LRGYCAEGQERLI--VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
            +G C E     I  + +++P+ SL  +L    +    +N  +++  A+   +G+ YL  
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYL-- 125

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   +HRD+ A NVL++++ + ++ DFG  K I     + T +  +   + + APE  
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 215 MLGKASESCDVYSFGILLLEL 235
           +  K   + DV+SFG+ L EL
Sbjct: 185 IQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 35/287 (12%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVR 92
             NF  + K+G+G F  VY    L DG  +A+K+++++     KA  +   E+++L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMP--NLS-LLSHLHGQHS--SECLLNWNRRMDIAIGS 147
           H N++       E  E  IV +     +LS ++ H   Q     E  + W   + +    
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLC--- 116

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
              + ++H      I+HRDIK +NV + A    ++ D G  +      T   + V GT  
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERK 265
           Y++PE       +   D++S G LL E+A+ + P   +K+N           L   C +K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LYSLC-KK 219

Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
             +   P L  +   EEL+ +V     C +  PEKRP +  VL + K
Sbjct: 220 IEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRGYCA 104
           LG+G FG VY  Q  +    A  ++    ++ E+E F VE++IL+  +H N++ L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE--- 69

Query: 105 EGQERLIVYDYMPNLSLLSHLHGQHSSECL-------LNWNRRMDIAIGSAEGIVYLHHH 157
                   Y Y   L +L       + + +       L   +   +     E + +LH H
Sbjct: 70  -------AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRD+KA N+LL  D   ++ADFG +           T + GT  ++APE     
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACE 178

Query: 218 KASES-----CDVYSFGILLLELASGKKPIEKVN 246
              ++      D++S GI L+ELA  + P  ++N
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.6 bits (199), Expect = 8e-17
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 38/235 (16%)

Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQH-SSECLLNWNRRMD 142
           E+EIL  V H N++          E  ++ ++M   SL     G H + E  L      D
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLA-----D 172

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           +A     GI YLH     HI+HRDIK SN+L+++    ++ADFG ++++        + V
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229

Query: 203 KGTLGYLAPEY--------AMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT 254
            GT+ Y++PE         A  G A    D++S G+ +LE   G+ P       + R   
Sbjct: 230 -GTIAYMSPERINTDLNHGAYDGYAG---DIWSLGVSILEFYLGRFPF-----GVGRQ-G 279

Query: 255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
           DWA  L C    S+  +          E +  +     C   +P KR + +++L 
Sbjct: 280 DWA-SLMCAICMSQPPEAPAT---ASREFRHFISC---CLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 8e-17
 Identities = 64/233 (27%), Positives = 115/233 (49%), Gaps = 29/233 (12%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEME---------FAVEVEILARVRHKN 95
           +G G FGSVY G     G  +AVK++++ S  A  +          A E+ +L  ++H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           ++   G   +     I  +Y+P  S+ + L  +G      + N+ R++       +G+ Y
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-----VKGTLGY 208
           LH+     IIHRDIK +N+L+D     +++DFG +K +   +    T      ++G++ +
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALP 259
           +APE       +   D++S G L++E+ +GK P        AI + I + A P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGENASP 230

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
            ++G G +G VY  + +  G  +A+K +K+           E+ +L   RH N+++  G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 103 CAEGQERLIVYDYMPNLSL--LSHLHGQHSSECLLNWNRRMDIAIGSAE---GIVYLHHH 157
                +  IV +Y    SL  +  +     SE          IA    E   G+ YLH  
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ--------IAYVCRETLKGLAYLHET 120

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK---GTLGYLAPEYA 214
                IHRDIK +N+LL  D   ++ADFG +  +    T    + K   GT  ++APE A
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVA 173

Query: 215 ---MLGKASESCDVYSFGILLLELASGKKP 241
                G     CD+++ GI  +ELA  + P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 17/213 (7%)

Query: 46  LGEGGFGSV------YWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           LG+GGFG V        G+++   ++  KR+K    K E     E +IL +V  + ++SL
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSL 65

Query: 100 RGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             Y  E ++ L +V   M    L  H++  H  E      R +  A     G+  LH   
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIY--HMGEAGFEEGRAVFYAAEICCGLEDLHQE- 121

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              I++RD+K  N+LLD     +++D G A  +P+G T +  RV GT+GY+APE     +
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER 177

Query: 219 ASESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            + S D ++ G LL E+ +G+ P ++    IKR
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.2 bits (195), Expect = 9e-17
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
            +    K+GEG FG +Y  +   D     +K + +     + + A   EV +LA+++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQH----SSECLLNWNRRMDIAIGSAEGI 151
           +++      E     IV +Y     L+  ++ Q     S + +L+W   + I++G     
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----- 113

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFK-AQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
             L H     I+HRDIK+ N+ L  +   A++ DFG A+ + D      T V GT  YL+
Sbjct: 114 --LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLS 170

Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
           PE       +   D++S G +L EL + K P E  N
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 10/222 (4%)

Query: 45  KLGEGGFGSVYWGQL-WDGSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           ++G G FG V+ G+L  D + +AVK  +       + +F  E  IL +  H N++ L G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
           C + Q   IV + +     L+ L  +      L     + +   +A G+ YL    + H 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLE---SKHC 115

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-LGYLAPEYAMLGKASE 221
           IHRD+ A N L+      +++DFG ++   DG    T  +K   + + APE    G+ S 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 222 SCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLAC 262
             DV+SFGILL E  S G  P   +++   R   +  + L C
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC 217

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 1e-16
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 44/220 (20%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAV----EVEILARVR 92
           +    KLGEG +G VY  +  D   G  +A+K++++  +  E         E+ +L  ++
Sbjct: 1   YEKLEKLGEGTYGVVY--KARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELK 56

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMP-NLSLLSHLHGQHSSEC--------LLNWNRRMDI 143
           H N++ L       ++  +V++Y   +L           S          LL        
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLR------- 109

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL--IPDGATHVTTR 201
                 G+ Y H H    I+HRD+K  N+L++ D   ++ADFG A+   IP      T  
Sbjct: 110 ------GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYTHE 158

Query: 202 VKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
           V  TL Y APE  +LG    S + D++S G +  E+ +GK
Sbjct: 159 VV-TLWYRAPE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 30/208 (14%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLK-----VWSNKAEMEFAVEVEILARVRHKNLLS 98
           K+GEG +G VY  +    G  +A+K++K         K  +    E+++L  + H N++ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR---EIKLLKELNHPNIIK 62

Query: 99  LRGYCAEGQERLIVYDYM-PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
           L        +  +V+++M  +L  L     +   E L+             +G+ + H H
Sbjct: 63  LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLI-----KSYLYQLLQGLAFCHSH 117

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATH-VTTRVKGTLGYLAPEY 213
               I+HRD+K  N+L++ +   ++ADFG A+         TH V TR      Y APE 
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPE- 168

Query: 214 AMLGKA--SESCDVYSFGILLLELASGK 239
            +LG    S   D++S G +  EL S +
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 75/283 (26%), Positives = 130/283 (45%), Gaps = 31/283 (10%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHK 94
           NF  + K+G G F  VY    L DG  +A+K+++++     KA  +   E+++L ++ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNR---RMDIAIGSAEGI 151
           N++       E  E  IV + + +   LS +      +  L   +   +  + + SA   
Sbjct: 63  NVIKYYASFIEDNELNIVLE-LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--- 118

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
             L H  +  ++HRDIK +NV + A    ++ D G  +      T   + V GT  Y++P
Sbjct: 119 --LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKFSEL 269
           E       +   D++S G LL E+A+ + P   +K+N           L   C +K  + 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LYSLC-KKIEQC 223

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
             P L  +   EEL+++V +   C +  PEKRP +  V D+ K
Sbjct: 224 DYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 41/214 (19%)

Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG GGFG V   ++       A+K +K   +     +     E EIL    H  ++ L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 102 -------------YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
                        YC  G+    ++  + +  L      +    C++             
Sbjct: 61  TFKDKKYIYMLMEYCLGGE----LWTILRDRGLFDEYTARFYIACVV------------- 103

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
               YLH+     II+RD+K  N+LLD++   ++ DFGFAK +  G    T    GT  Y
Sbjct: 104 LAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEY 158

Query: 209 LAPEYAMLGKA-SESCDVYSFGILLLELASGKKP 241
           +APE  +L K    S D +S GILL EL +G+ P
Sbjct: 159 VAPE-IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 25/219 (11%)

Query: 40  FNYDNKLGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVR 92
           F     LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V 
Sbjct: 9   FKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS----SECLLNWNRRMDIAIGSA 148
           + ++  L G C     +LI    MP   LL ++  +H     S+ LLNW       +  A
Sbjct: 68  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR-EHKDNIGSQYLLNW------CVQIA 119

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLG 207
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  D   +     K  + 
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           ++A E  +    +   DV+S+G+ + EL + G KP + +
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 13/211 (6%)

Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG+GGFG V   Q+   G   A K+L   ++   K E     E +IL +V  + ++SL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  E ++ L +V   M    L    H  +  E      R +  A     G+ +LH     
Sbjct: 60  YAFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
            I++RD+K  NVLLD     +++D G A  +  G         GT GY+APE        
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYD 172

Query: 221 ESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            S D ++ G  L E+ +G+ P  +    +++
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 24/218 (11%)

Query: 45  KLGEGGFGSVYWGQLW----DGSQ-IAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLLS 98
           +LGE  FG +Y G L+    D +Q +A+K LK  +N  +  EF  E  ++A + H N++ 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSS-----------ECLLNWNRRMDIAI 145
           L G   + Q   ++++Y+    L   L     HS            +  L+    + IAI
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKG 204
             A G+ YL  H     +H+D+ A N+L+      +++D G ++ I     + V  +   
Sbjct: 132 QIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            + ++ PE  M GK S   D++SFG++L E+ S G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 19/153 (12%)

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
                ++HRD+K +N+ LDA+   ++ DFG AK++   ++   T V GT  Y++PE    
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELADPRLN 275
               E  D++S G L+ EL +   P    N   +   I         E KF  +      
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI--------KEGKFRRIPY---- 232

Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                 EL  V+    +  +  P+KRP+  E+L
Sbjct: 233 --RYSSELNEVI---KSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 22/216 (10%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAV-EVEILARVRHKN 95
                 ++LGEG  GSV   +L +   I A+K +    N    +  + E+EI    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 96  LLSLRGYCAEGQERLI--VYDYMPNLSLLSHL-----HGQHSSECLLNWNRRMDIAIGSA 148
           ++   G   +     I    +Y    SL S        G    E +L       IA    
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           +G+ YLH   +  IIHRDIK SN+LL    + ++ DFG + +L+   A   T    GT  
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           Y+APE       S + DV+S G+ LLE+A  + P  
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 68/286 (23%), Positives = 121/286 (42%), Gaps = 37/286 (12%)

Query: 44  NKLGEGGFGSVYWGQLWDG---SQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSL 99
           +++G G FG V  G+   G   +++ VK L+  +    ++ F  EV+    + H N+L  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNR---RMDIAIGSAEGIVYLHH 156
            G C E    L+V ++ P   L ++L         +       RM  A   A G+++LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQ 118

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-LGYLAPEYA- 214
                 IH D+   N  L AD   ++ D+G A        ++T       L +LAPE   
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 215 ------MLGKASESCDVYSFGILLLELAS-GKKPIEKVNS--AIKRTITDWALPLACERK 265
                 +    ++  +++S G+ + EL +   +P   ++    +K+ + +  +       
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI------- 228

Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
             +L  P+L+  + +    R   V   C    PE RPT  EV +LL
Sbjct: 229 --KLPKPQLDLKYSD----RWYEVMQFCWLD-PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 23/223 (10%)

Query: 46  LGEGGFGSV------YWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           LG+GGFG V        G+++   ++  KRLK      E    +E EIL +V    +++L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK--KKSGEKMALLEKEILEKVNSPFIVNL 58

Query: 100 RGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             Y  E +  L +V   M    L  H++  +  E  L   R +  +     GI++LH   
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIY--NVGERGLEMERVIHYSAQITCGILHLH--- 112

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
           +  I++RD+K  NVLLD     +++D G A  + DG T   T+  GT GY+APE      
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEP 170

Query: 219 ASESCDVYSFGILLLELASGKKPI----EKV--NSAIKRTITD 255
            S   D ++ G  + E+ +G+ P     EKV      +RT+ D
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 23/212 (10%)

Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEME----FAVEVEILARVRHKNLLSL 99
           ++G G FG+VY+ +    +++ A+K++  +S K   E       EV  L ++RH N +  
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 100 RG-YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           +G Y  E    L++   + + S +  +H +   E  +       I  G+ +G+ YLH H 
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI-----AAICHGALQGLAYLHSHE 135

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE--YAM- 215
               IHRDIKA N+LL      ++ADFG A L+    + V     GT  ++APE   AM 
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNS 247
            G+     DV+S GI  +ELA  K P+  +N+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 33/216 (15%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAE--------MEFAV--EVEILARVRHK 94
           +G+G +G VY    +  G  +AVK++++ +  A         M  A+  E+E L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 95  NLLSLRGYCAEGQERLIVY-DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA----- 148
           N++   G     +E L ++ +Y+P  S+ S         CL  + R  +  +        
Sbjct: 69  NIVQYLG-FETTEEYLSIFLEYVPGGSIGS---------CLRTYGRFEEQLVRFFTEQVL 118

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG-ATHVTTRVKGTLG 207
           EG+ YLH      I+HRD+KA N+L+DAD   +++DFG +K   D         ++G++ 
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175

Query: 208 YLAPEYAMLGKASESC--DVYSFGILLLELASGKKP 241
           ++APE         S   D++S G ++LE+ +G++P
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 40/236 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYW----GQLWDGSQ--IAVKRLKV-WSNKAEMEFAVEVEILAR 90
           NN  Y   +G+G FG V+     G L       +AVK LK   S   + +F  E  ++A 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-----HGQHSSE------------- 132
             H N++ L G CA G+   ++++YM    L   L       Q S               
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
             L+   ++ IA   A G+ YL   +    +HRD+   N L+  +   ++ADFG ++ I 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI- 180

Query: 193 DGATHVTTRVKGT------LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
               +     K +      + ++ PE     + +   DV+++G++L E+ S G +P
Sbjct: 181 ----YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 66/272 (24%), Positives = 127/272 (46%), Gaps = 37/272 (13%)

Query: 46  LGEGGFGSVYWGQLWDGSQ-IAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRGY 102
           +G G FG V+  +     + + +K++ V     +   A   E ++L  + H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQHSS----ECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             E +  +IV +Y P  +L  ++  + +S    + +L++  ++ +A         LHH  
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---------LHHVH 118

Query: 159 TPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
           T  I+HRD+K  N+LLD      ++ DFG +K++   +   T  V GT  Y++PE     
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGK 176

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACERKFSELADPRLNG 276
             ++  D+++ G +L ELAS K+  E  N  A+   I            F+ ++D     
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--------SGTFAPISDR---- 224

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                +L++++L  L   +  P KRP + +++
Sbjct: 225 --YSPDLRQLILSML---NLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 36/227 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ----------------IAVKRLKVWSNK-AEME 80
                  KLGEG FG V+  +  +G                  +AVK L+    K A  +
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEA-EGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND 63

Query: 81  FAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRR 140
           F  E++I++R+++ N++ L G C       ++ +YM N  L   L  +       + N  
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 141 MDIAIGS--------AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
             ++I +        A G+ YL   A+ + +HRD+   N L+   +  ++ADFG ++ + 
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180

Query: 193 DGATHVTTRVKG----TLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
            G  +   R++G     + ++A E  +LGK + + DV++FG+ L E+
Sbjct: 181 SGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.4 bits (188), Expect = 9e-16
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 45  KLGEGGFG-SVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           K+GEG FG ++      DG Q  +K + +   S K   E   EV +L+ ++H N++  + 
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQH----SSECLLNWNRRMDIAIGSAEGIVYLHHH 157
              E     IV DY     L   ++ Q       + +L+W  ++ +A         L H 
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LKHV 117

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               I+HRDIK+ N+ L  D   ++ DFG A+++        T + GT  YL+PE     
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVN 246
             +   D+++ G +L E+ + K   E  N
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 32/270 (11%)

Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEF-AVEVEILARVRHKNLLSLRGY 102
            +G+G FG VY       +Q+ A+K + +   + E+E    E++ L++ R   +    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE---GIVYLHHHAT 159
             +G +  I+ +Y    S L  L      E          IA    E   G+ YLH    
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDE--------TYIAFILREVLLGLEYLHEEGK 119

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
              IHRDIKA+N+LL  +   ++ADFG +  +    +   T V GT  ++APE       
Sbjct: 120 ---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGY 175

Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
            E  D++S GI  +ELA G+ P+  ++            P+       +   P L GN  
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLH------------PMRVLFLIPKNNPPSLEGNKF 223

Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            +  K  V +   C +  P++RP+  E+L 
Sbjct: 224 SKPFKDFVSL---CLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 77/323 (23%), Positives = 142/323 (43%), Gaps = 82/323 (25%)

Query: 42  YDNKLGEGGFGSVYWGQLWDGSQ------------------IAVKRLKVWSNK-AEMEFA 82
           +  KLGEG FG V+  ++    Q                  +AVK L+  +NK A  +F 
Sbjct: 9   FKEKLGEGQFGEVHLCEV-VNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67

Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL---LSHLH----------GQH 129
            EV+IL+R++  N++ L G C +     ++ +YM N  L   LS  H             
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 130 SSECLL--NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
            + CL   +++  + +A+  A G+ YL   ++ + +HRD+   N L+  +   ++ADFG 
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 188 AKLIPDGATHVTTRVKG----TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           ++ +  G  +   R++G     + ++A E  ++GK + + DV++FG+ L E+        
Sbjct: 185 SRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI-------- 233

Query: 244 KVNSAIKRTITDWALPLACERKFSELADPRL---NGNFVEEELKRVVL------------ 288
                         L L  E+ + EL D ++    G F  ++ ++V L            
Sbjct: 234 --------------LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE 279

Query: 289 VALTCAHSKPEKRPTMLEVLDLL 311
           + L C      +RP+  ++   L
Sbjct: 280 LMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLK--VWSNKAEMEFA-VEVEILARV-RHKNLLSLR 100
           LG+G FG V   +L    ++ AVK LK  V     ++E    E  +LA   +H  L  L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 101 GYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
             C + ++RL  V +Y+    L+ H+          +  R    A     G+ +LH    
Sbjct: 63  S-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERG- 116

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEYAMLGK 218
             II+RD+K  NVLLD++   ++ADFG  K  I  G T  T+   GT  Y+APE      
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQP 172

Query: 219 ASESCDVYSFGILLLELASGKKPIEKVN 246
              + D ++ G+LL E+ +G+ P E  +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 31/284 (10%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G Q+AVK + +   +       EV I+   +H+N++ +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G+E  ++ +++   +L   +     S+  LN  +   +     + + YLH      +I
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG---VI 139

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRDIK+ ++LL  D + +++DFGF   I        + V GT  ++APE           
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEV 198

Query: 224 DVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           D++S GI+++E+  G+ P   +    A+KR + D   P    +   +++ P L  +F+E 
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKL--KNAHKIS-PVLR-DFLER 253

Query: 282 ELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLTEL 322
            L R           +P++R T  E+LD   LL+    E L  L
Sbjct: 254 MLTR-----------EPQERATAQELLDHPFLLQTGLPECLVPL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 32/221 (14%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLW-DGSQI--AVKRLKVWSNKAE-MEFAVEVEILARV-RH 93
           +  +++ +GEG FG V    +  DG ++  A+K LK ++++ +  +FA E+E+L ++  H
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHG------------QHSSECLLNWNRRM 141
            N+++L G C       I  +Y P  +LL  L              +H +   L   + +
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR 201
             A   A G+ YL   +    IHRD+ A NVL+  +  +++ADFG ++            
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVY 172

Query: 202 VKGTLG-----YLAPEYAMLGKASESCDVYSFGILLLELAS 237
           VK T+G     ++A E       +   DV+SFG+LL E+ S
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 74/262 (28%), Positives = 113/262 (43%), Gaps = 23/262 (8%)

Query: 46  LGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           LG+GGFG V        G+L+   ++  KRLK    K      VE  ILA+V  + ++SL
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLK--KRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 100 RGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             Y  + +  L +V   M    L  H++            R          G+ +LH   
Sbjct: 59  -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              II+RD+K  NVLLD D   +++D G A  + DG +  T    GT G++APE     +
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173

Query: 219 ASESCDVYSFGILLLELASGKKPI----EKV-NSAIK-RTITDWALPLACERKFSELADP 272
              S D ++ G+ L E+ + + P     EKV N  +K R + D    +    KFS  +  
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---SVTYPDKFSPASKS 230

Query: 273 RLNGNFVEEELKRVVLVALTCA 294
                  ++  KR+      C 
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCD 252

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 29/207 (14%)

Query: 45  KLGEGGFGSVY-WGQLWDGSQIAVKR--LKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           ++GEG  G V+       G  +A+K+  L+        +   E++ L   +H  ++ L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA--------EGIVY 153
               G   ++V +YMP+  L   L            +    +             +G+ Y
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLR-----------DEERPLPEAQVKSYMRMLLKGVAY 114

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           +H +    I+HRD+K +N+L+ AD   ++ADFG A+L  +    + +    T  Y APE 
Sbjct: 115 MHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Query: 214 AMLG--KASESCDVYSFGILLLELASG 238
            + G  K     D+++ G +  EL +G
Sbjct: 172 -LYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 12/202 (5%)

Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG G FG +  G L   S+    +A+  L+   S+K    F  E   L +  H N++ L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G    G   +IV +YM N +L S L  +H  +  L   + M +  G A G+ YL   +  
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLR-KHEGQ--LVAGQLMGMLPGLASGMKYL---SEM 126

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +H+ + A  VL+++D   +++ F   +     A + T   K  + + APE       S
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 221 ESCDVYSFGILLLELAS-GKKP 241
            + DV+SFGI++ E+ S G++P
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 79/276 (28%), Positives = 125/276 (45%), Gaps = 39/276 (14%)

Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G +W  DG  +    A+K L+   S KA  E   E  ++A V    +  
Sbjct: 15  LGSGAFGTVYKG-IWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C     +L V   MP   LL ++     +  S+ LLNW       +  A+G+ YL 
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGTLGYLAPEYA 214
                 ++HRD+ A NVL+ +    ++ DFG A+L+  D   +     K  + ++A E  
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPR 273
           +  + +   DV+S+G+ + EL + G KP + + +   R I D  L    ER    L  P 
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPD--LLEKGER----LPQPP 234

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
           +           V ++ + C     E RP   E++D
Sbjct: 235 IC-------TIDVYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 69/289 (23%), Positives = 131/289 (45%), Gaps = 46/289 (15%)

Query: 45  KLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNL 96
           +LG+G FG VY G +  G       +++A+K + +  S +  +EF  E  ++      ++
Sbjct: 13  ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHG------QHSSECLLNWNRRMDIAIGSAEG 150
           + L G  ++GQ  L++ + M    L S+L         +  +   +  + + +A   A+G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--Y 208
           + YL+ +     +HRD+ A N ++  DF  ++ DFG  + I +   +     KG L   +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRW 187

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWAL---PLACE 263
           ++PE    G  +   DV+SFG++L E+A+  ++P + + N  + R + +  L   P  C 
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCP 247

Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
               EL                       C    P+ RP+ LE++  +K
Sbjct: 248 DMLFELMR--------------------MCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 74/315 (23%), Positives = 146/315 (46%), Gaps = 74/315 (23%)

Query: 42  YDNKLGEGGFGSVYWGQLWDGSQ------------------IAVKRLKVWSNK-AEMEFA 82
           +  KLGEG FG V+  +  +G +                  +AVK L+  +NK A  +F 
Sbjct: 9   FKEKLGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67

Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL---LSHLHGQHSSE----CLL 135
            E++I++R++  N++ L   C       ++ +YM N  L   LS    Q ++E      +
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
           +++  + +A   A G+ YL   ++ + +HRD+   N L+  ++  ++ADFG ++ +  G 
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 196 THVTTRVKG----TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            +   R++G     + +++ E  +LGK + + DV++FG+ L E+                
Sbjct: 185 YY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI---------------- 225

Query: 252 TITDWALPLACERKFSELADPRL---NGNFVEEELKRVVL------------VALTCAHS 296
                 L L  E+ +S+L+D ++    G F  ++ ++V L            + L+C   
Sbjct: 226 ------LTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279

Query: 297 KPEKRPTMLEVLDLL 311
             ++RP+  E+   L
Sbjct: 280 NAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 13/211 (6%)

Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG+GGFG V   Q+   G   A K+L   ++   K E     E +IL +V  + ++SL  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  E ++ L +V   M    L  H++  +      +  R +  A     G+  LH     
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRE--- 121

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
            I++RD+K  N+LLD     +++D G A  IP+G T +  RV GT+GY+APE     + +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNERYT 179

Query: 221 ESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            S D +  G L+ E+  GK P  +    +KR
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 76/319 (23%), Positives = 129/319 (40%), Gaps = 86/319 (26%)

Query: 45  KLGEGGFGSVYWGQLWDGSQ------------------IAVKRLKVWSNKAEM-EFAVEV 85
           KLGEG FG V+  +  DG Q                  +AVK L+  ++     +F  EV
Sbjct: 12  KLGEGQFGEVHLCEA-DGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL-------------LSHLHGQHSSE 132
           +IL+R+   N+  L G C       ++ +YM N  L             L+      S  
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
            LL       +A   A G+ YL    + + +HRD+   N L+  ++  ++ADFG ++   
Sbjct: 131 TLLY------MATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR--- 178

Query: 193 DGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           +  +    RV+G     + ++A E  +LGK +   DV++FG+ L E+ +           
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----------- 227

Query: 249 IKRTITDWALPLACERKFSELADPRLNGN---FVEEELKRVVL------------VALTC 293
                      L  E+ +  L D ++  N   F  ++ +++ L            + L C
Sbjct: 228 -----------LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLEC 276

Query: 294 AHSKPEKRPTMLEVLDLLK 312
                E RPT  E+   L+
Sbjct: 277 WRRDEEDRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           K+G+G  G+VY    +  G ++A+K++ +   + + E  + E+ ++   +H N+++    
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
              G E  +V +Y+   SL   +     +E  ++  +   +     + + +LH +    +
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QV 136

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           IHRDIK+ N+LL  D   ++ DFGF   I    +  +T V GT  ++APE          
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 38/214 (17%)

Query: 49  GGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFA-------VEVEILARVRHKNLLSLR 100
           G +G V+  +    G   A+K +     KA+M           E +IL++ +   ++ L 
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVI----KKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 101 GYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE---GIVYLHH 156
            Y  +G++ L +V +Y+P   L S L    +   L   +  +   I  AE    + YLH 
Sbjct: 60  -YSFQGKKNLYLVMEYLPGGDLASLLE---NVGSL---DEDV-ARIYIAEIVLALEYLHS 111

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKL--------IPDGATHVTTRVKGTLGY 208
           +    IIHRD+K  N+L+D++   ++ DFG +K+        + D       R+ GT  Y
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDY 167

Query: 209 LAPEYAMLGKA-SESCDVYSFGILLLELASGKKP 241
           +APE  +LG+  S++ D +S G +L E   G  P
Sbjct: 168 IAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 75/239 (31%), Positives = 111/239 (46%), Gaps = 16/239 (6%)

Query: 40  FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKN 95
           F +   LG+GGFG V   Q+   G   A K+L   ++   K E     E  IL +V  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 96  LLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           ++SL  Y  E ++ L +V   M    L  H++   +     +  R +  A     G+  L
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDL 118

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                  I++RD+K  N+LLD     +++D G A  IP+G T V  RV GT+GY+APE  
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVI 173

Query: 215 MLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER---KFSELA 270
              K + S D +  G L+ E+  G+ P  K    +KR   D  +    E    KFSE A
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 32/214 (14%)

Query: 46  LGEGGFGSVYWGQLW-DGSQI--AVKRLKVWSNKAE-MEFAVEVEILARV-RHKNLLSLR 100
           +GEG FG V   ++  DG ++  A+KR+K +++K +  +FA E+E+L ++  H N+++L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHG------------QHSSECLLNWNRRMDIAIGSA 148
           G C       +  +Y P+ +LL  L               +S+   L+  + +  A   A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG- 207
            G+ YL   +    IHRD+ A N+L+  ++ A++ADFG ++            VK T+G 
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 172

Query: 208 ----YLAPEYAMLGKASESCDVYSFGILLLELAS 237
               ++A E       + + DV+S+G+LL E+ S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 54/163 (33%), Positives = 81/163 (49%), Gaps = 13/163 (7%)

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGA-THVTT 200
           IA+   EG+ YL++     I+HRDIK SN+L+++  + ++ DFG + +LI   A T V  
Sbjct: 108 IAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-- 163

Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL 260
              GT  Y++PE    GK +   DV+S GI ++ELA GK P    N           +  
Sbjct: 164 ---GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT 303
             ++   E   PRL  +   E+L+  V     C    P +RPT
Sbjct: 221 LLQQIVQEPP-PRLPSSDFPEDLRDFVDA---CLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 57/284 (20%), Positives = 114/284 (40%), Gaps = 41/284 (14%)

Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG V+  +          + + VK L K      + EF  E+++  ++ HKN++ 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 99  LRGYCAEGQERLIVYDY-----MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           L G C E +   ++ +Y     +      +    +      L+  +++ +    A G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           L   +    +HRD+ A N L+ +  + +V+    +K + +   +        L +LAPE 
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189

Query: 214 AMLGKASESCDVYSFGILLLEL-ASGKKPIEKVN-----SAIKRTITDWALPLACERKFS 267
                 S   DV+SFG+L+ E+   G+ P   ++     + ++    +  +P  C  +  
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249

Query: 268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
           +L                       C    P+ RP+  E++  L
Sbjct: 250 KL--------------------MTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 44/288 (15%)

Query: 45  KLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLL 97
           +LG+G FG VY G   D       +++AVK + +  S +  +EF  E  ++      +++
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHG------QHSSECLLNWNRRMDIAIGSAEGI 151
            L G  ++GQ  L+V + M +  L S+L         +           + +A   A+G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYL 209
            YL+       +HRD+ A N ++  DF  ++ DFG  + I +   +     KG L   ++
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 188

Query: 210 APEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWAL---PLACER 264
           APE    G  + S D++SFG++L E+ S  ++P + + N  + + + D      P  C  
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 248

Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
           + ++L                       C    P+ RPT LE+++LLK
Sbjct: 249 RVTDLMR--------------------MCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 62/305 (20%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAE-MEFAVEVEILARV 91
           N      LGEG FG V     +        + +AVK LK  ++ +E  +   E  +L +V
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSEC------------------ 133
            H +++ L G C++    L++ +Y    SL S L                          
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 134 --LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
              L     +  A   + G+ YL   A   ++HRD+ A NVL+    K +++DFG ++ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 192 PDGATHVTTRVKGTL--GYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
            +  ++V  R KG +   ++A E       +   DV+SFG+LL E+ + G  P   +   
Sbjct: 178 YEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--- 233

Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVE------EELKRVVLVALTCAHSKPEKRP 302
                       A ER F+ L      G  +E      EE+  ++   LTC   +P+KRP
Sbjct: 234 ------------APERLFNLLK----TGYRMERPENCSEEMYNLM---LTCWKQEPDKRP 274

Query: 303 TMLEV 307
           T  ++
Sbjct: 275 TFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 46  LGEGGFGSVYWGQLWDGSQ-IAVKRLK---VWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG V+  +        A+K +    V   K E     E  +L  V H  ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 102 YCAEGQERLI--VYDYMPNLSLLSHLH--GQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +  E  +R +  + +Y+P   L S+L   G+ S+   L +   +  A+       YLH  
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE------YLHSK 120

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               I++RD+K  N+LLD +   ++ DFGFAK + D     T  + GT  YLAPE     
Sbjct: 121 ---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSK 173

Query: 218 KASESCDVYSFGILLLELASGKKP 241
             +++ D ++ GIL+ E+  G  P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 57/296 (19%)

Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEMEFA---VEVEILARV-RHKN 95
           LGEG FG V   +          S +AVK LK   +  E + +    E+E++  + +HKN
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRR------------MDI 143
           +++L G C +     +V +Y  + +L   L  +       + +              +  
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
           A   A G+ +L   A+   IHRD+ A NVL+  D   ++ADFG A+ I     +  TT  
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 203 KGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPL 260
           +  + ++APE A+  +  +   DV+SFG+LL E+ + G  P   +               
Sbjct: 195 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--------------- 238

Query: 261 ACERKFSELA-----DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
             E  F  L      +   N     +EL  ++     C H  P +RPT  ++++ L
Sbjct: 239 PVEELFKLLKEGYRMEKPQN---CTQELYHLM---RDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 68/238 (28%), Positives = 105/238 (44%), Gaps = 37/238 (15%)

Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEMEFAVEV 85
           +  L+ L   T+ +     +G+G +G VY      DGS  AVK L   S+  E E   E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEY 69

Query: 86  EILARV-RHKNLLSLRG------YCAEGQERLIVYDYMPNLSLLSHLHGQHSSEC---LL 135
            IL  +  H N++   G          GQ  L+          L   +G   +E    LL
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV----------LELCNGGSVTELVKGLL 119

Query: 136 NWNRRMDIAI------GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK 189
              +R+D A+      G+  G+ +LH++    IIHRD+K +N+LL  +   ++ DFG + 
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA 176

Query: 190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASES-----CDVYSFGILLLELASGKKPI 242
            +        T V GT  ++APE     +  +      CDV+S GI  +EL  G  P+
Sbjct: 177 QLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 32/269 (11%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G Q+AVK++ +   +       EV I+    H+N++ +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++   +L   +     +   +N  +   + +     + YLH+     +I
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140

Query: 164 HRDIKASNVLLDADFKAQVADFGF----AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
           HRDIK+ ++LL +D + +++DFGF    +K +P   + V     GT  ++APE       
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRLPY 195

Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
               D++S GI+++E+  G+ P    N            PL   R+  +   PR+  +  
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY--FNEP----------PLQAMRRIRDNLPPRVKDSHK 243

Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVL 308
              + R  L  +     +P +R T  E+L
Sbjct: 244 VSSVLRGFLDLMLV--REPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.3 bits (174), Expect = 8e-14
 Identities = 49/199 (24%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+VY    +  G ++A+K++ +     +     E+ ++   ++ N+++     
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+   SL   +     +E  ++  +   +     + + +LH +    +I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HRDIK+ N+LL  D   ++ DFGF A++ P+ +   T  + GT  ++APE          
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195

Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 35/219 (15%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRGYC 103
           +LG+G FG VY  +  +   +A  ++    ++ E+E + VE+EILA   H  ++ L G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD------IAIGSAEGIVYLHHH 157
               +  I+ ++ P         G      +L  +R +       I     E + YLH  
Sbjct: 79  YWDGKLWIMIEFCP---------GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH-- 127

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK-----GTLGYLAPE 212
            +  IIHRD+KA NVLL  D   ++ADFG +      A +V T  +     GT  ++APE
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPE 180

Query: 213 YAMLGKASES-----CDVYSFGILLLELASGKKPIEKVN 246
             M     ++      D++S GI L+E+A  + P  ++N
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 46  LGEGGFGSVYW---------GQLWDGSQIAVKRLKVWSNKAE--MEFAVEVEILARVRHK 94
           LG+G FG V+          GQL+     A+K LK  + K    +   +E +ILA V H 
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLY-----AMKVLKKATLKVRDRVRTKMERDILAEVNHP 58

Query: 95  NLLSLR-GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
            ++ L   +  EG+  LI+ D++    L + L    S E +       D+    AE  + 
Sbjct: 59  FIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRL----SKEVMFT---EEDVKFYLAELALA 110

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           L H  +  II+RD+K  N+LLD +   ++ DFG +K   D          GT+ Y+APE 
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEV 169

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIE 243
                 ++S D +SFG+L+ E+ +G  P +
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 21/215 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV-----EVEILARVR 92
           N+     LG+G FG VY     D G ++AVK+++      E    V     E+++L  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 93  HKNLLSLRGYCAEGQERL--IVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSA 148
           H+ ++   G   +  ER   I  ++MP  S+   L  +G  +      + R++       
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------L 116

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT--TRVKGTL 206
           EG+ YLH   +  I+HRDIK +N+L D+    ++ DFG +K +       T    V GT 
Sbjct: 117 EGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            +++PE           D++S G  ++E+ + K P
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 20/206 (9%)

Query: 45  KLGEGGFGSVYWGQLWDG---SQIAVKRLKVWSNKAE-MEFAVEVEILARVRHKNLLSLR 100
           ++G G FG V  G++  G   +Q+ VK L+V ++  E M+F  E +    ++H NLL   
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSE---CLLNWNRRMDIAIGSAEGIVYLHHH 157
           G C E    L+V ++ P   L  +L     +E         +RM   I  A G+++LH +
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHKN 119

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-RVKGTLGYLAPEYA-- 214
              + IH D+   N LL AD   ++ D+G +        +VT  ++   L ++APE    
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 215 -----MLGKASESCDVYSFGILLLEL 235
                ++   ++  +V+S G+ + EL
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 73/280 (26%), Positives = 114/280 (40%), Gaps = 42/280 (15%)

Query: 46  LGEGGFGSVYWGQLWDGSQ--IAVKRLKVW----------SNKAEMEFAVEVEIL-ARVR 92
           LG G FG VY  +  +  Q  +A+K + V            +K+  +   EV I+  ++R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLH-----GQHSSECLLNWNRRMDIAIGS 147
           H N++       E     IV D +    L  H +      Q  +E  + WN    I +  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WN----IFVQM 122

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
              + YLH      I+HRD+  +N++L  D K  + DFG AK          T V GT+ 
Sbjct: 123 VLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTIL 178

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS 267
           Y  PE        E  DV++FG +L ++ + + P    N           L LA  +   
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----------MLSLAT-KIVE 227

Query: 268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEV 307
            + +P   G + E     V  V  +C     E RP +++V
Sbjct: 228 AVYEPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 29/209 (13%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL----- 99
           LG+G FG V+  +L   +Q  A+K LK   +   M+  VE  ++     K +LSL     
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALK--KDVVLMDDDVECTMV----EKRVLSLAWEHP 56

Query: 100 ---RGYCA-EGQERLI-VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
                YC  + +E L  V +Y+    L+ H+   H      +  R    A     G+ +L
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLAPE 212
           H      I++RD+K  N+LLD D   ++ADFG  K  ++ D  T       GT  Y+APE
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPDYIAPE 166

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKP 241
             +  K + S D +SFG+LL E+  G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 46/232 (19%)

Query: 41  NYD--NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME-FAV----EVEILARVR 92
            Y+  N++ EG +G VY  +    G  +A+K+LK    + E E F +    E+ IL +++
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQ 62

Query: 93  HKNLLSLR----GYCAEGQERL-IVYDYMPN--LSLLSHLHGQHS-SE--CLLNWNRRMD 142
           H N+++++    G      +++ +V +Y+ +   SL+  +      SE  CL+       
Sbjct: 63  HPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM------- 112

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
             +    G+ +LH +    I+HRD+K SN+LL+     ++ DFG A+         T  V
Sbjct: 113 --LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV 167

Query: 203 KGTLGYLAPEYAMLGKA--SESCDVYS----FGILLLE--LASGKKPIEKVN 246
             TL Y APE  +LG    S + D++S    F  LL +  L  GK  I+++N
Sbjct: 168 V-TLWYRAPEL-LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 28/215 (13%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK---------VWSNKAEMEFAVEVEILA 89
           F     LG G FG V   +     ++ A+K LK         V S   E       E   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI---FETAN 57

Query: 90  RVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
             RH  L++L   C + ++ +  V +Y     L+ H+H    SE      R +  A    
Sbjct: 58  SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE-----PRAVFYAACVV 111

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH--VTTRVKGTL 206
            G+ YLH +    I++RD+K  N+LLD +   ++ADFG  K   +G      T+   GT 
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTP 165

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            +LAPE       + + D +  G+L+ E+  G+ P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 29/218 (13%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM-EFAV-EVEILARVRHKNLLSLRG 101
           K+GEG +G VY G+    G  +A+K++++ S +  +   A+ E+ +L  ++H N++ L+ 
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA------EGIVYLH 155
              +     ++++++ ++ L  +L         L   + MD  +  +      +GI++ H
Sbjct: 67  VLMQESRLYLIFEFL-SMDLKKYLDS-------LPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL--IPDGATHVTTRVKGTLGYLAPEY 213
                 ++HRD+K  N+L+D     ++ADFG A+   IP     V T    TL Y APE 
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRVYTHEVVTLWYRAPE- 171

Query: 214 AMLGKASESC--DVYSFGILLLELASGKKPIEKVNSAI 249
            +LG    S   D++S G +  E+A+ KKP+   +S I
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEI 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 58/242 (23%), Positives = 89/242 (36%), Gaps = 58/242 (23%)

Query: 33  LHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILAR 90
           L   T  F     +GEG +G VY  +     Q+    +K+     +   E   E  IL +
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVA--IKIMDIIEDEEEEIKEEYNILRK 58

Query: 91  V-RHKNLLSLRG-------------------YCAEGQERLIVYDYMPNLSLLSHLHGQHS 130
              H N+ +  G                    C  G     V D +  L           
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGL----------- 103

Query: 131 SECLLNWNRRMD------IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD 184
                   +R+       I   +  G+ YLH +    +IHRDIK  N+LL  + + ++ D
Sbjct: 104 ----RKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156

Query: 185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES-----CDVYSFGILLLELASGK 239
           FG +  + D          GT  ++APE     +  ++      DV+S GI  +ELA GK
Sbjct: 157 FGVSAQL-DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Query: 240 KP 241
            P
Sbjct: 216 PP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 65/224 (29%), Positives = 117/224 (52%), Gaps = 28/224 (12%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNL 96
           F+   ++GEG +G VY  +  D G  +A+K++++ + K         E++IL ++ H+N+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 97  LSLRGYCAEGQERL----------IVYDYMPN--LSLLSHLHGQHSSECLLNWNRRMDIA 144
           ++L+    + Q+ L          +V++YM +  + LL       S + + ++ +++   
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL--- 125

Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
               EG+ Y H     + +HRDIK SN+LL+   + ++ADFG A+L     +   T    
Sbjct: 126 ---LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 205 TLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPIEKVN 246
           TL Y  PE  +LG  +   + DV+S G +L EL + KKPI + N
Sbjct: 180 TLWYRPPEL-LLGEERYGPAIDVWSCGCILGELFT-KKPIFQAN 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 13/215 (6%)

Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG+GGFG V   Q+   G   A KRL   ++   K E     E +IL +V  + +++L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  E ++ L +V   M    L  H++   +        R +  A     G+  LH   T 
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHRENT- 123

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             ++RD+K  N+LLD     +++D G A  IP+G + +  RV GT+GY+APE     + +
Sbjct: 124 --VYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYT 179

Query: 221 ESCDVYSFGILLLELASGKKPIEKVNSAIKRTITD 255
            S D +  G L+ E+  G+ P       +KR   D
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 77/274 (28%), Positives = 116/274 (42%), Gaps = 33/274 (12%)

Query: 40  FNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLL 97
           F    ++G+G FG V+ G        +A+K + +   + E+E    E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE---GIVYL 154
              G   +G +  I+ +Y+   S L  L      E          IA    E   G+ YL
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--------FQIATMLKEILKGLDYL 117

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
           H       IHRDIKA+NVLL      ++ADFG A  + D      T V GT  ++APE  
Sbjct: 118 HSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 173

Query: 215 MLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL 274
                    D++S GI  +ELA G+ P    NS +      + +P     K +    P L
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP----NSDMHPMRVLFLIP-----KNNP---PTL 221

Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            G F  +  K  +     C +  P  RPT  E+L
Sbjct: 222 TGEF-SKPFKEFI---DACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 11/205 (5%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAV-EVEILARVRHKNL 96
           NF    KLGEG + +VY G+     +I A+K + + + +     A+ E+ ++  ++H+N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L        + ++V++YM     L      H     L+ N          +GI + H 
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
           +    ++HRD+K  N+L++   + ++ADFG A+         +  V  TL Y AP+  +L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD-VLL 173

Query: 217 GKA--SESCDVYSFGILLLELASGK 239
           G    S S D++S G ++ E+ +G+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 21/214 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +FN+   LG+G FG V   +     ++ A+K LK    +  +  E    VE  +LA    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTM-VEKRVLALSGK 59

Query: 94  KNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLH--GQHSSECLLNWNRRMDIAIGSAEG 150
              L+    C +  +RL  V +Y+    L+  +   G+      + +    +IAIG    
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIG---- 113

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYL 209
           + +LH      II+RD+K  NV+LD++   ++ADFG  K  + DG T  T    GT  Y+
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYI 168

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           APE        +S D ++FG+LL E+ +G+ P E
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 21/215 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLK----VWSNKAEMEFAVEVEILAR 90
           NF     LG G +G V+  +   G       A+K L+    V   K       E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 91  VRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHG-QHSSECLLNWNRRMDIAIGSA 148
           VR    L    Y  + + +L ++ DY+    + +HL+   + SE         ++   S 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED--------EVRFYSG 112

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           E I+ L H     I++RDIK  N+LLD++    + DFG +K         T    GT+ Y
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 209 LAPEYAMLGKA--SESCDVYSFGILLLELASGKKP 241
           +APE  + GK    ++ D +S GIL+ EL +G  P
Sbjct: 173 MAPE-IIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.0 bits (168), Expect = 4e-13
 Identities = 49/199 (24%), Positives = 100/199 (50%), Gaps = 12/199 (6%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+V+    +  G ++A+K++ +     +     E+ ++  +++ N+++     
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+   SL   +     +E  ++  +   +     + + +LH +    +I
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HRDIK+ NVLL  D   ++ DFGF A++ P+ +   T  + GT  ++APE          
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195

Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRGYC 103
           +LG+G FG VY  Q  +   +A  ++    ++ E+E + VE++ILA   H N++ L    
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL---- 67

Query: 104 AEGQERLIVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMD------IAIGSAEGIVYLHH 156
                 L  + Y  NL +L     G      +L   R +       +   + E + YLH 
Sbjct: 68  ------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG---YLAPEY 213
           +    IIHRD+KA N+L   D   ++ADFG    +    T    R    +G   ++APE 
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAPEV 174

Query: 214 AMLGKASE-----SCDVYSFGILLLELASGKKPIEKVN 246
            M   + +       DV+S GI L+E+A  + P  ++N
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.6 bits (167), Expect = 4e-13
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV-----EVEILARVRHKNLLSL 99
           LG+G FG VY     D G ++A K+++      E    V     E+++L  ++H+ ++  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 100 RGYCAEGQERL--IVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
            G   +  E+   I  +YMP  S+   L  +G  +      + R++       EG+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYLH 123

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT--TRVKGTLGYLAPEY 213
            +    I+HRDIK +N+L D+    ++ DFG +K +       T    V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 214 AMLGKASESCDVYSFGILLLELASGKKP 241
                     DV+S G  ++E+ + K P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLK--VWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           LG+G FG V   +L +  ++ AVK LK  V     ++E  + E  IL+  R+   L+   
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 102 YCAEGQERLI-VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG---SAE---GIVYL 154
            C +  +RL  V +++    L+ H+  Q S        RR D A     +AE    +++L
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHI--QKS--------RRFDEARARFYAAEITSALMFL 112

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEY 213
           H      II+RD+K  NVLLD +   ++ADFG  K  I +G T  T+   GT  Y+APE 
Sbjct: 113 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEI 167

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
                   S D ++ G+LL E+  G  P E  N
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 24/218 (11%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEM----EFAVEVEILARVRHKNLL 97
           +LGE  FG VY G L+    G Q     +K   +KAE     EF  E  + +R++H N++
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAE------ 149
            L G   + Q   +++ Y  +  L   L     HS     + ++ +   +  A+      
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 150 ----GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG-FAKLIPDGATHVTTRVKG 204
               G+ +L  H   H++H+D+   NVL+      +++D G F ++       +      
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            + +++PE  M GK S   D++S+G++L E+ S G +P
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.6 bits (167), Expect = 7e-13
 Identities = 47/199 (23%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+VY    +  G ++A++++ +     +     E+ ++   ++ N+++     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+   SL   +     +E  ++  +   +     + + +LH +    +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HRDIK+ N+LL  D   ++ DFGF A++ P+ +    + + GT  ++APE          
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196

Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 34/217 (15%)

Query: 46  LGEGGFGSVYWGQLWDG--------SQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ------------HSSECLLNWNRRMDI 143
           +++L G C +     ++ +Y    +L  +L  +               E  L++   +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+    K
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 198

Query: 204 GTLG-----YLAPEYAMLGKASESCDVYSFGILLLEL 235
            T G     ++APE       +   DV+SFG+LL E+
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 34/217 (15%)

Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLK-VWSNKAEMEFAVEVEILARV-RHKN 95
           LGEG FG V   + +            +AVK LK   ++K   +   E+E++  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLH------------GQHSSECLLNWNRRMDI 143
           +++L G C +     ++ +Y    +L   L                  E  L++   +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
           A   A G+ YL    +   IHRD+ A NVL+  D   ++ADFG A+    G   +    K
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192

Query: 204 GTLG-----YLAPEYAMLGKASESCDVYSFGILLLEL 235
            + G     ++APE       +   DV+SFGIL+ E+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 20/215 (9%)

Query: 39  NFNYDNKLGEGGFGSVYW----GQLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILAR 90
           NF     LG G +G V+     G    G   A+K LK    V   K       E ++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 91  VRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMDIAIGSA 148
           VR    L    Y  +   +L ++ DY+    L +HL   +H +E        + + I   
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE------SEVRVYIA-- 112

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           E ++ L H     II+RDIK  N+LLD++    + DFG +K              GT+ Y
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172

Query: 209 LAPEYAMLGKA--SESCDVYSFGILLLELASGKKP 241
           +APE    G     ++ D +S G+L  EL +G  P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 47/266 (17%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLK---VWSNKAEMEFAVEVEILAR 90
            +F+  + +G G FG V   Q+      G   A+K +K   + + +    F  E +IL+ 
Sbjct: 1   KDFDVKSLVGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 91  VRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS-- 147
                +  L+ Y  + ++ L +V +Y P   LLS L            NR  D       
Sbjct: 58  SNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLL------------NRYEDQFDEDMA 104

Query: 148 ----AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG-FAKLIPDGATHVTTRV 202
               AE ++ +H       +HRDIK  NVL+D     ++ADFG  A+L  +   +    V
Sbjct: 105 QFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164

Query: 203 KGTLGYLAPEYAML------GKASE--SCDVYSFGILLLELASGKKPIEKVNSAIKRTIT 254
            GT  Y+APE  +L      GK +    CD +S G++  E+  G+ P  +  SA  +T  
Sbjct: 165 -GTPDYIAPE--VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KTYN 219

Query: 255 DWALPLACERKFSELADPRLNGNFVE 280
           +    +  +R      DP+++ +F++
Sbjct: 220 NI---MNFQRFLKFPEDPKVSSDFLD 242

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFA-VEVEILARVRHKNLLSLR-GY 102
           +GEG FG     Q  +  Q  A+K +++  + + +E +  E  +LA+++H N+++ +  +
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQH----SSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
            A+G    IV +Y     L+  +  Q       + +L W  +M + +          H  
Sbjct: 68  EADGH-LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV---------QHIH 117

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              ++HRDIK+ N+ L  + K ++ DFG A+L+     +  T V GT  Y+ PE      
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176

Query: 219 ASESCDVYSFGILLLELASGKKPIE 243
            +   D++S G +L EL + K P +
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV-----EVEILARVR 92
           N+     LG G FG VY     D G ++AVK++    +  E    V     E+++L  +R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 93  HKNLLSLRGYCAEGQER--LIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSA 148
           H  ++   G   + +E+   I  +YMP  S+   L  +G  +      + R++       
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------L 116

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT--TRVKGTL 206
           +G+ YLH +    I+HRDIK +N+L D+    ++ DFG +K I       T    V GT 
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            +++PE           DV+S    ++E+ + K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+G FG V   +L    ++ A+K LK    +  +  +     E  ILA       L+  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTM-TEKRILALAAKHPFLTAL 61

Query: 101 GYCAEGQERLI-VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
             C + ++RL  V +Y+    L+  +  Q S +   +  R    A      +++LH H  
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRK--FDEPRSRFYAAEVTLALMFLHRHG- 116

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEYAMLGK 218
             +I+RD+K  N+LLDA+   ++ADFG  K  I +G T  TT   GT  Y+APE     +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172

Query: 219 ASESCDVYSFGILLLELASGKKPIEKVN 246
              S D ++ G+L+ E+ +G+ P E  N
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 70/248 (28%), Positives = 105/248 (42%), Gaps = 50/248 (20%)

Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKV 72
           G+K P      L +L +          LGE G G+   GQ++       G  +AVK+++ 
Sbjct: 7   GQKYPA----DLNDLEN----------LGEIGSGTC--GQVYKMRFKKTGHVMAVKQMRR 50

Query: 73  WSNKAEMEFAVEVEILARVR-----H--KNLLSLRGYCAEGQERLIVYDYMPN-LSLLSH 124
             NK E +      IL  +      H    ++   GY     +  I  + M   L  L  
Sbjct: 51  TGNKEENK-----RILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLK 105

Query: 125 LHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH-IIHRDIKASNVLLDADFKAQVA 183
                  E +L    +M +AI  A     LH+    H +IHRD+K SN+LLDA    ++ 
Sbjct: 106 RIQGPIPEDILG---KMTVAIVKA-----LHYLKEKHGVIHRDVKPSNILLDASGNVKLC 157

Query: 184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES----CDVYSFGILLLELASGK 239
           DFG +  + D      TR  G   Y+APE       +       DV+S GI L+ELA+G+
Sbjct: 158 DFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Query: 240 KPIEKVNS 247
            P +   +
Sbjct: 216 FPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 18/214 (8%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLK----VWSNKAEMEFAVEVEILAR 90
           NF     LG G +G V+  +   G       A+K LK    V   K       E ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 91  VRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
           +R    L    Y  +   +L ++ DY+    L +HL  +          +  ++ I S E
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF-------KEQEVQIYSGE 113

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
            ++ L H     II+RDIK  N+LLD++    + DFG +K   +          GT+ Y+
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 210 APEYAMLGKA--SESCDVYSFGILLLELASGKKP 241
           AP+    G     ++ D +S G+L+ EL +G  P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 18/205 (8%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRL--KVWSNKAEMEFAV-EVEILARVRHKN---LLS 98
           +G+G FG VY  +  D  +I A+K L  K    K E+   + E  IL R        ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L+       +  +V DYM    L  HL  +           R    I  AE ++ L H  
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-----EDRAKFYI--AELVLALEHLH 113

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV-KGTLGYLAPEYAMLG 217
              I++RD+K  N+LLDA     + DFG +K   +   + TT    GT  YLAPE  +  
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 218 KA-SESCDVYSFGILLLELASGKKP 241
           K  ++  D +S G+L+ E+  G  P
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 70/206 (33%), Positives = 98/206 (47%), Gaps = 23/206 (11%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLK--VWSNKAEMEFA-VEVEILARV-RHKNLLSLR 100
           LG+G FG V   +L   ++  A+K LK  V     ++E   VE  +LA    H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61

Query: 101 GYCA-EGQERLI-VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG---SAEGIVYLH 155
            +C  + +E L  V +Y+    L+ H+              R D A     +AE I  L 
Sbjct: 62  -FCTFQTKEHLFFVMEYLNGGDLMFHIQSSG----------RFDEARARFYAAEIICGLQ 110

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
                 II+RD+K  NVLLD D   ++ADFG  K   +G    +T   GT  Y+APE   
Sbjct: 111 FLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILK 169

Query: 216 LGKASESCDVYSFGILLLELASGKKP 241
             K +ES D +SFG+LL E+  G+ P
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 38/97 (39%), Positives = 56/97 (57%), Gaps = 6/97 (6%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTL 206
           A G+ +LH   +  II+RD+K  NV+LDA+   ++ADFG  K  I  G T  T    GT 
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
            Y+APE        +S D ++FG+LL E+ +G+ P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 46  LGEGGFGSVYWGQLW---DGSQIAVKRLKVWSNKAEM-EFAVEVEILAR-------VRHK 94
           +G G FG+V   ++     G+ +AVKR++   ++ E     ++++++ R       V+  
Sbjct: 12  IGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 95  NLLSLRGYCAEGQERLIVYDYMP----NLSLLSHLHG-QHSSECLLNWNRRMDIAIGSAE 149
             L   G C       I  + M           +        E +L       IA+ + +
Sbjct: 70  GALFREGDC------WICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVK 118

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGY 208
            + YL       IIHRD+K SN+LLD +   ++ DFG + +L+   A    TR  G   Y
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPY 173

Query: 209 LAPE----YAMLGKASESCDVYSFGILLLELASGKKPIEKVNS 247
           +APE     A  G    S DV+S GI L E+A+GK P  K NS
Sbjct: 174 MAPERIDPSARDGYDVRS-DVWSLGITLYEVATGKFPYPKWNS 215

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 33/290 (11%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQ--IAVKRLKVWSNKAEME-FAVEVEILARVRHKNL 96
           F    K+G+G FG V+ G + + +Q  +A+K + +   + E+E    E+ +L++     +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
               G   +  +  I+ +Y+   S L  L      E  +    R  +     +G+ YLH 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-----KGLDYLHS 119

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
                 IHRDIKA+NVLL    + ++ADFG A  + D      T V GT  ++APE    
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
                  D++S GI  +ELA G+ P  +++            P+       +   P L G
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELH------------PMKVLFLIPKNNPPTLEG 223

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD----LLKGESKEKLTEL 322
           N+  + LK  V     C + +P  RPT  E+L     +   +    LTEL
Sbjct: 224 NY-SKPLKEFV---EACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTEL 269

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 73/271 (26%), Positives = 116/271 (42%), Gaps = 27/271 (9%)

Query: 40  FNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLL 97
           F    ++G+G FG VY G        +A+K + +   + E+E    E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
              G   +G +  I+ +Y+   S L  L      E  +    R  +     +G+ YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLH-- 118

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
            +   IHRDIKA+NVLL      ++ADFG A  + D      T V GT  ++APE     
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN 277
                 D++S GI  +ELA G+ P   ++            P+       + + P L G 
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLH------------PMRVLFLIPKNSPPTLEGQ 224

Query: 278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           +  +  K  V     C +  P  RPT  E+L
Sbjct: 225 Y-SKPFKEFV---EACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 27/163 (16%)

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK----GTLGYL 209
           +HH  + H+IHRDIK++N+LL ++   ++ DFGF+K+    A  V+  V     GT  Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDDVGRTFCGTPYYV 212

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALPLACERKFS 267
           APE       S+  D++S G+LL EL + K+P +  N    + +T+     PL       
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS---- 268

Query: 268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL 310
                      +  E++ +V   L+   S P++RP+  ++L++
Sbjct: 269 -----------ISPEMQEIVTALLS---SDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 31/283 (10%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHK 94
           NF  + K+G G F  VY    L D   +A+K+++++     KA  +   E+++L ++ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNR---RMDIAIGSAEGI 151
           N++       E  E  IV + + +   LS +      +  L   R   +  + + SA   
Sbjct: 63  NVIKYLDSFIEDNELNIVLE-LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--- 118

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
             + H  +  ++HRDIK +NV + A    ++ D G  +      T   + V GT  Y++P
Sbjct: 119 --VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKFSEL 269
           E       +   D++S G LL E+A+ + P   +K+N           L   C+ K  + 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LFSLCQ-KIEQC 223

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
             P L      E+L+ +V +   C +  P++RP +  V  + K
Sbjct: 224 DYPPLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 39  NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVRHK 94
           +F     LG G FG V   +    G   A+K LK   +   K     A E  IL  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 95  NLLS-LRGYCAEGQERL-IVYDYMPNLSLLSHLH--GQHSSECLLNWNRRMDIA-IGSAE 149
            +++ +  +  + + R+  + +++    L +HL   G+  +          D+A    AE
Sbjct: 79  FIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKAGRFPN----------DVAKFYHAE 126

Query: 150 GIV---YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            ++   YLH   +  II+RD+K  N+LLD     +V DFGFAK +PD     T  + GT 
Sbjct: 127 LVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTP 179

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            YLAPE        ++ D ++ G+LL E  +G  P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)

Query: 43  DNKLGEGGFGSVYWG----QLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLL 97
              +GEG FG VY G       +   +AVK  K  ++ +  E F  E  I+ +  H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYL 154
            L G   E     IV +  P   L S+L           L+ ++ ++  A+       YL
Sbjct: 71  KLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL------AYL 123

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
               +   +HRDI A NVL+ +    ++ DFG ++ + D + +  ++ K  + ++APE  
Sbjct: 124 E---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
              + + + DV+ FG+ + E+   G KP + V
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 74/280 (26%), Positives = 128/280 (45%), Gaps = 50/280 (17%)

Query: 44  NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRG 101
            K+GEG  G V        G Q+AVK++ +    + E+ F  EV I+   +H N++ +  
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYS 83

Query: 102 YCAEGQERLIVYDYMPNLSL---LSHLHGQHSSECLLNWNRRMD------IAIGSAEGIV 152
               G E  +V +++   +L   ++H               RM+      + +   + + 
Sbjct: 84  SYLVGDELWVVMEFLEGGALTDIVTHT--------------RMNEEQIATVCLAVLKALS 129

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           +LH      +IHRDIK+ ++LL +D + +++DFGF   +        + V GT  ++APE
Sbjct: 130 FLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPE 185

Query: 213 Y-AMLGKASESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKFSEL 269
             + L   +E  D++S GI+++E+  G+ P   E    A+KR I D   P   + K    
Sbjct: 186 VISRLPYGTEV-DIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-IRDNLPP---KLKNLHK 240

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
             PRL   F++  L R            P +R T  E+L+
Sbjct: 241 VSPRLRS-FLDRMLVR-----------DPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 16/213 (7%)

Query: 48  EGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAV---EVEILARVRHKNLLSLRG 101
           EG FG +++G L D   G +  V    V  + +E++  +   E  +L  + H+N+L +  
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 102 YCAEGQER-LIVYDYMPNLSLLSHL----HGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
            C E  E   ++Y YM   +L   L     G+ ++   L+  + + +AI  A G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTLGYLAPEYAM 215
                +IH+DI A N ++D + + ++ D   ++ L P     +       + ++A E  +
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 216 LGKASESCDVYSFGILLLELAS-GKKPIEKVNS 247
             + S + DV+SFG+LL EL + G+ P  +++ 
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 24/208 (11%)

Query: 42  YDN--KLGEGGFGSVYWGQLWDGSQI-AVKR-LKVWSNKAEMEFAV-EVEILARVRHKNL 96
           Y+N   +GEG +G V   +  +  QI A+K+ L+   +K   + A+ E+ +L ++RH+NL
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHL----HGQHSSECLLNWNRRMDIAIGSAEGIV 152
           ++L       +   +V++++ + ++L  L    +G       L+ +R          GI 
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG-------LDESRVRKYLFQILRGIE 114

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           + H H   +IIHRDIK  N+L+      ++ DFGFA+ +       T  V  T  Y APE
Sbjct: 115 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPE 170

Query: 213 YAMLG--KASESCDVYSFGILLLELASG 238
             ++G  K   + D+++ G L+ E+ +G
Sbjct: 171 L-LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +FN+   LG+G FG V   +     ++ A+K LK    +  +  E    VE  +LA    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTM-VEKRVLALQDK 59

Query: 94  KNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLH--GQHSSECLLNWNRRMDIAIGSAEG 150
              L+    C +  +RL  V +Y+    L+ H+   G+      + +   + +      G
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------G 113

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRV-KGTLGY 208
           + +LH      II+RD+K  NV+LD++   ++ADFG  K  + DG   VTTR   GT  Y
Sbjct: 114 LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDY 167

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           +APE        +S D +++G+LL E+ +G+ P +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLKVWS--NKAEME-FAVEVEILARVRHKNLLSLRG 101
           +G G FG V   +L +  ++ A+K L  W    +AE   F  E ++L    ++ + +L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 102 YCAEGQERLIVYDYMPN---LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
              +     +V DY      L+LLS    +   +    +   M IAI S   +       
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL------- 121

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYLAPEYAML- 216
             H +HRDIK  N+L+D +   ++ADFG   KL+ DG    +  V GT  Y++PE     
Sbjct: 122 --HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAM 178

Query: 217 ----GKASESCDVYSFGILLLELASGKKP 241
               GK    CD +S G+ + E+  G+ P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 30/236 (12%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAE--MEFAV--EVEILA 89
           +AT+  N + KLGEG + +VY G    +G  +A   LKV S K E  + F    E  +L 
Sbjct: 3   AATSYLNLE-KLGEGSYATVYKGISRINGQLVA---LKVISMKTEEGVPFTAIREASLLK 58

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYM-PNLS--LLSHLHGQHSSECLLNWNRRMDIAIG 146
            ++H N++ L       +    V++YM  +L+  ++ H  G H     L   + +     
Sbjct: 59  GLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL----- 113

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA--KLIPDGATHVTTRVKG 204
              G+ Y+H     HI+HRD+K  N+L+    + ++ADFG A  K IP   T+ +  V  
Sbjct: 114 --RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVV-- 165

Query: 205 TLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWAL 258
           TL Y  P+  +LG    S + D++  G + +E+  G+     V+   ++    W +
Sbjct: 166 TLWYRPPD-VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 32/270 (11%)

Query: 46  LGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFAVEVE--ILARVRHKNLLSLRGY 102
           +G+G +G V       DG Q  +K+L + +       A E E  +L++++H N+++ R  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR-E 66

Query: 103 CAEGQERL--IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
             EG++ L  IV  +     L   L  Q     LL  N+ ++  +  A  + YLH     
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           HI+HRD+K  NV L      +V D G A+++ +     +T + GT  Y++PE       +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYN 180

Query: 221 ESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKFSELADPRLNGNF 278
              DV++ G  + E+A+ K     + +NS + R I     P+   + +S    P L G  
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP--KDYS----PEL-GEL 233

Query: 279 VEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           +   L +           +PEKRP++  +L
Sbjct: 234 IATMLSK-----------RPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 48/198 (24%), Positives = 93/198 (46%), Gaps = 10/198 (5%)

Query: 45  KLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G  +AVK++ +   +       EV I+   +H+N++ +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++   +L   +     +   +N  +   + +   + +  LH      +I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRDIK+ ++LL  D + +++DFGF   +        + V GT  ++APE           
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197

Query: 224 DVYSFGILLLELASGKKP 241
           D++S GI+++E+  G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 76/252 (30%), Positives = 113/252 (44%), Gaps = 27/252 (10%)

Query: 46  LGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEVEILARVRHKNLLSLRG 101
           LG+G FG V    +   G   A+K LK     A+ E A    E  +L   RH  L SL+ 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  + ++RL  V +Y+    L  HL    S E + + +R           + YLH   + 
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLH---SG 114

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            I++RD+K  N++LD D   ++ DFG  K  I D AT  T    GT  YLAPE       
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDY 172

Query: 220 SESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITDWALPLACERKFSELADPRL 274
             + D +  G+++ E+  G+ P      EK+   I   + D   P    R  S  A   L
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDIKFP----RTLSADAKSLL 226

Query: 275 NGNFVEEELKRV 286
           +G  +++  KR+
Sbjct: 227 SGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)

Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK----VWSNKAEMEFAVEVEILARVRHKNLL 97
           LG+GG+G V+  +   G+      A+K LK    V + K       E  IL  V+H  ++
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ----HSSECLLNWNRRMDIAIGSAEGIVY 153
            L      G +  ++ +Y+    L  HL  +      + C              +E  + 
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY-----------LSEISLA 112

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTLGYLAPE 212
           L H     II+RD+K  N+LLDA    ++ DFG  K  I +G   VT    GT+ Y+APE
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPE 170

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
             M     ++ D +S G L+ ++ +G  P    N   K+TI
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--KKTI 209

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 26/213 (12%)

Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKV-WSNKAEMEFAVEVEILARV-RHKN 95
           LGEG FG V   +              +AVK LK   ++K   +   E+E++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSS------------ECLLNWNRRMDI 143
           +++L G C +     ++ +Y    +L  +L  +               E  L +   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ + +   +  TT  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+LL E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 49/218 (22%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEI-----LARVRHKNLL 97
            ++GEG +G+VY  + L  G  +A+K+++V  ++  +  +   EI     L    H N++
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 98  SLRGYCAEGQ-ER----LIVYDYM-------------PNLS--LLSHLHGQHSSECLLNW 137
            L   C   + +R     +V++++             P L    +  L  Q     LL  
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ-----LLR- 118

Query: 138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH 197
                       G+ +LH H    I+HRD+K  N+L+ +D + ++ADFG A++       
Sbjct: 119 ------------GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEM 161

Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
             T V  TL Y APE  +    +   D++S G +  EL
Sbjct: 162 ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)

Query: 45  KLGEGGFGSVYWGQL-WDGSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKNLLSLR 100
           +LG G FG V  G       QI  A+K LK  + K+   E   E EI+ ++ +  ++ + 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G C E +  ++V +      L   L G+     + N    M      + G+ YL      
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV---SMGMKYLEGK--- 114

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT--LGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +    ++   R  G   L + APE     K
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKV 245
            S   DV+S+GI + E  + G+KP +K+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 39/228 (17%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQ---IAVKRLKVWSNKAE---MEFAVEVEILARVRH 93
           +  +  +G G +G VY  +  +G      A+K+ K    +          E+ +L  ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 94  KNLLSLRGYCAEGQERLI--VYDYMP-NLSLLSHLHGQHSSECLLNWNRRMDIAIGSA-- 148
           +N++SL     E  ++ +  ++DY   +L  +   H Q     +      M   + S   
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSM---VKSLLW 115

Query: 149 ---EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ----VADFGFAKLI--PDGATHVT 199
               G+ YLH   +  ++HRD+K +N+L+  +   +    + D G A+L   P       
Sbjct: 116 QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 200 TRVKGTLGYLAPEYAMLG-----KASESCDVYSFGILLLELASGKKPI 242
             V  T+ Y APE  +LG     KA    D+++ G +  EL +  +PI
Sbjct: 173 DPVVVTIWYRAPEL-LLGARHYTKA---IDIWAIGCIFAELLT-LEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 38/215 (17%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV------EVEILARVRHKNLL 97
           K+GEG +G VY  +    G  +A+K++++   + E E  V      E+ +L  + H N++
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRL---ETEDE-GVPSTAIREISLLKELNHPNIV 61

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS-----AEGIV 152
            L        +  +V++++ +L L  ++    S    L+    +   I S      +GI 
Sbjct: 62  RLLDVVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLD--PPL---IKSYLYQLLQGIA 113

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL--IPDGA-THVTTRVKGTLGYL 209
           Y H H    ++HRD+K  N+L+D +   ++ADFG A+   +P    TH       TL Y 
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYR 166

Query: 210 APEYAMLGKA--SESCDVYSFGILLLELASGKKPI 242
           APE  +LG    S   D++S G +  E+ + ++P+
Sbjct: 167 APE-ILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 75/271 (27%), Positives = 116/271 (42%), Gaps = 37/271 (13%)

Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL----- 99
           +G GGFG VY  +  D G   A+K L     + +M+   + E LA +  + +LSL     
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKMK---QGETLA-LNERIMLSLVSTGD 55

Query: 100 ------RGYCAEGQERL-IVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEG 150
                   Y     ++L  + D M    L  HL  HG  S           ++   +AE 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---------EMRFYAAEI 106

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           I+ L H     +++RD+K +N+LLD     +++D G A        H +    GT GY+A
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163

Query: 211 PEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
           PE    G A + S D +S G +L +L  G  P  +  +  K  I    L +A E   S  
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 223

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEK 300
            + R   + +E  L+R V   L C     ++
Sbjct: 224 PELR---SLLEGLLQRDVNRRLGCLGRGAQE 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           +++    ++G G +G VY  + L  G   AVK +K+           E+ ++   +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSL--LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           ++  G     ++  I  +Y    SL  + H+ G   SE  + +  R  +     +G+ YL
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP-LSELQIAYVCRETL-----QGLAYL 122

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG---YLAP 211
           H       +HRDIK +N+LL  +   ++ADFG A  I    T    + K  +G   ++AP
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFIGTPYWMAP 175

Query: 212 EYAML---GKASESCDVYSFGILLLELASGKKPI 242
           E A +   G  ++ CD+++ GI  +ELA  + P+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 69/260 (26%), Positives = 111/260 (42%), Gaps = 29/260 (11%)

Query: 46  LGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN--LL 97
           +G GGFG VY       G+++    +  KR+K+   + E     E  +L+ V   +   +
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFI 59

Query: 98  SLRGYCAEGQERL-IVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
               Y     ++L  + D M    L  HL  HG  S +         ++   + E I+ L
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK---------EMRFYATEIILGL 110

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
            H     +++RD+K +N+LLD     +++D G A        H +    GT GY+APE  
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167

Query: 215 MLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR 273
             G A + S D +S G +L +L  G  P  +  +  K  I    L +  E    +   P 
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE--LPDSFSPE 225

Query: 274 LNGNFVEEELKRVVLVALTC 293
           L  + +E  L+R V   L C
Sbjct: 226 LK-SLLEGLLQRDVSKRLGC 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 26/213 (12%)

Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDI 143
           +++L G C +     ++ +Y    +L  +L  +               +  + +   +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ + +   +  TT  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS--QIAVKRL---KVWSNKAEMEFAVEVEILARVRH 93
           +FN+   LG G FG V      +     +A+KR    K+   K       E +IL  + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG---SAEG 150
              ++L G   +     +V +++      +           L  N+R    +G   +A+ 
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFT----------FLRRNKRFPNDVGCFYAAQI 140

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           ++   +  + +I++RD+K  N+LLD D   ++ DFGFAK++ D  T+      GT  Y+A
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYTLC---GTPEYIA 196

Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKP 241
           PE  +     ++ D ++ GI + E+  G  P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+G FG V   +L   G   AVK LK    +  +  E    VE  +LA       L+  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTM-VEKRVLALAWENPFLT-H 60

Query: 101 GYCA-EGQERLI-VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
            YC  + +E L  V +++    L+ H+  +   +      R    A     G+ +LH   
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY----RATFYAAEIVCGLQFLHSKG 116

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              II+RD+K  NV+LD D   ++ADFG  K    G    +T   GT  Y+APE     K
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLK 172

Query: 219 ASESCDVYSFGILLLELASGKKP 241
            + S D +SFG+LL E+  G+ P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 34/279 (12%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV---EVEILARVRHKN 95
           +F    ++G G +G VY  +  +  ++A   +KV   +   +FAV   E+ ++   +H N
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAA--IKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSL--LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           +++  G      +  I  ++    SL  + H+ G  S   +   +R       + +G+ Y
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE------TLQGLYY 121

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           LH       +HRDIK +N+LL  +   ++ADFG +  I        + + GT  ++APE 
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEV 177

Query: 214 AML---GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA 270
           A +   G  ++ CD+++ GI  +ELA  + P+  ++          AL L  +  F    
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFLMTKSNFQP-- 228

Query: 271 DPRLNGNFV-EEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            P+L             V +ALT     P+KRPT  ++L
Sbjct: 229 -PKLKDKMKWSNSFHHFVKMALT---KNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 27/190 (14%)

Query: 124 HLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA 183
           +  G    E +L       IA+   + + YLH  +   +IHRD+K SNVL++ + + ++ 
Sbjct: 94  YDKGLTIPEDILG-----KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLC 146

Query: 184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEY---AMLGKASE-SCDVYSFGILLLELASGK 239
           DFG +  + D  +   T   G   Y+APE     +  K  +   DV+S GI ++ELA+G+
Sbjct: 147 DFGISGYLVD--SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Query: 240 KPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPE 299
            P +            W  P    ++  E   P+L       E +  V     C     +
Sbjct: 205 FPYDS-----------WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYK 250

Query: 300 KRPTMLEVLD 309
           +RP   E+L 
Sbjct: 251 ERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME----FAV-EVEILARVR 92
           NF    K+GEG +G VY  +    G  +A+K++++     E E     A+ E+ +L  + 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 57

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++ +  L   +     S   L   +     +   +G+ 
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLA 114

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           + H H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 170

Query: 213 YAMLGKA--SESCDVYSFGILLLELASGK 239
             +LG    S + D++S G +  E+ + +
Sbjct: 171 -ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.5 bits (153), Expect = 6e-11
 Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 44/178 (24%)

Query: 84  EVEILARVRHKNLLSLR-----GYCAEGQERLIVYDYMP-NL-------SLLSHLHGQHS 130
           E+++L  +RH+N++ L          +  +  IV + M  +L         L+  H Q+ 
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY- 107

Query: 131 SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
              L    R          G+ YLH   + ++IHRD+K SN+L++++   ++ DFG A+ 
Sbjct: 108 --FLYQILR----------GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152

Query: 191 I-PDGAT------HVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
           + PD         +V TR      Y APE  +L   + +++ D++S G +  EL + K
Sbjct: 153 VDPDEDEKGFLTEYVVTRW-----YRAPE-LLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 37/226 (16%)

Query: 43  DNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKV--WSNKAE----------MEFAV--EVEI 87
              LGEG +G V        G  +A+K++K+   SN             + F    E++I
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS 147
           +  ++H+N++ L     EG    +V D M      S L      +  L  ++   I +  
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMA-----SDLKKVVDRKIRLTESQVKCILLQI 128

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK------LIPDGATHVTTR 201
             G+  LH     + +HRD+  +N+ +++    ++ADFG A+           +   T +
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 202 VKG-------TLGYLAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            +        TL Y APE  M   K   + D++S G +  EL +GK
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 55/225 (24%), Positives = 107/225 (47%), Gaps = 33/225 (14%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQ-IAVKRLKVWSNKAEMEFAV--EVEILARVR---HKNLL 97
           ++GEG +G V+  + L +G + +A+KR++V + +  M  +   EV +L  +    H N++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRM-----------DIAIG 146
            L   C   +      D    L+L+     +H  + L  +  ++           D+   
Sbjct: 68  RLFDVCTVSRT-----DRETKLTLVF----EHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
              G+ +LH H    ++HRD+K  N+L+ +  + ++ADFG A++         T V  TL
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTL 173

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            Y APE  +    +   D++S G +  E+   +KP+ + +S + +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 30/228 (13%)

Query: 29  SLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEME------- 80
            + +L     +F+    +G G FG V   +     Q+ A+K L    +K EM        
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL----SKFEMIKRSDSAF 89

Query: 81  FAVEVEILARVRHKNLLSLRGYCAEGQERLI--VYDYMPNLSLLSHLHGQHSSECLLNWN 138
           F  E +I+A    + ++ L  + A   ++ +  V +YMP   L++ +      E    W 
Sbjct: 90  FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWA 144

Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATH 197
           R       +AE ++ L    +   IHRD+K  N+LLD     ++ADFG   K+  +G   
Sbjct: 145 R-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199

Query: 198 VTTRVKGTLGYLAPEYAML----GKASESCDVYSFGILLLELASGKKP 241
             T V GT  Y++PE        G     CD +S G+ L E+  G  P
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLK---VWSNKAEMEFAVEVEILAR-VRHKNLLSLR 100
           +G+G FG V   +   DGS  AVK L+   +   K +     E  +L + ++H  L+ L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 101 GYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
            Y  +  E+L  V DY+    L  HL  +    C L    R   A   A  I YLH   +
Sbjct: 63  -YSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARF-YAAEVASAIGYLH---S 114

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLAPEYAMLG 217
            +II+RD+K  N+LLD+     + DFG  K  + P+     T+   GT  YLAPE     
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPEVLRKE 171

Query: 218 KASESCDVYSFGILLLELASGKKP 241
               + D +  G +L E+  G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 22/171 (12%)

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           IA+   +G+ YL    +  I+HRD+K SN+L++   + ++ DFG +  +      +    
Sbjct: 100 IAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY 153

Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP---IEKVNSAIKRTITDWALP 259
            GT  Y+APE     +     DV+S GI  +ELA G+ P   I+K   ++        +P
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MP 205

Query: 260 LACERKFSELADPRL-NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
           L   +   +   P L  G F E    + V     C   +P++RP    ++D
Sbjct: 206 LQLLQCIVDEDPPVLPVGQFSE----KFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 46  LGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEVEILARVRHKNLLSLRG 101
           LG+G FG V    +   G   A+K LK     A+ E A    E  +L   RH  L +L+ 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  +  +RL  V +Y     L  HL    S E + + +R           + YLH   + 
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALGYLH---SC 114

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            +++RD+K  N++LD D   ++ DFG  K  I DGAT       GT  YLAPE       
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDY 172

Query: 220 SESCDVYSFGILLLELASGKKP 241
             + D +  G+++ E+  G+ P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 39/220 (17%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARVR 92
            +F    ++G+GG+G V+  +  D  +I A+KR+K       N+       E +IL   +
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR-HVLTERDILTTTK 59

Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMP---------NLSLLSHLHGQ-HSSECLLNWNRRM 141
            + L+ L  Y  +  E L +  +Y+P         NL +LS  H + + +E        M
Sbjct: 60  SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAE--------M 110

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR 201
             A+ +      LH       IHRD+K  N L+DA    ++ DFG +K    G       
Sbjct: 111 FEAVDA------LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANS 157

Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
           V G+  Y+APE         + D +S G +L E   G  P
Sbjct: 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 46  LGEGGFGSVYW-GQLWDGSQIAVK--RLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           LG+G FG V    +   G   A+K  R +V   K E+   V E  +L   RH  L +L+ 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 61

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  +  +RL  V +Y     L  HL    S E +    R           + YLH   + 
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLH---SR 114

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            +++RDIK  N++LD D   ++ DFG  K  I DGAT  T    GT  YLAPE       
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 172

Query: 220 SESCDVYSFGILLLELASGKKP 241
             + D +  G+++ E+  G+ P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 46  LGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEVEILARVRHKNLLSLRG 101
           LG+G FG V    +   G   A+K LK     A+ E A    E  +L   RH  L +L+ 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  +  +RL  V +Y     L  HL    S E + + +R           + YLH  +  
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLH--SEK 115

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
           ++++RD+K  N++LD D   ++ DFG  K  I DGAT  T    GT  YLAPE       
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDY 173

Query: 220 SESCDVYSFGILLLELASGKKP 241
             + D +  G+++ E+  G+ P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 40/234 (17%)

Query: 43  DNKLGEGGFGSVYWGQLW------DGSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRHK 94
           D  +G G FG V     W      DG ++A+K++  V+ N    +    E+++L   +H 
Sbjct: 5   DRPIGYGAFGVV-----WSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHD 59

Query: 95  NLLSLRGYCAEG-----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
           N+LS             +E  +V + M      S LH    S   L+ +           
Sbjct: 60  NVLSALDILQPPHIDPFEEIYVVTELMQ-----SDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGY 208
           G+ YLH   +  I+HRDIK  N+L++++   ++ DFG A++  PD + H+T  V  T  Y
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170

Query: 209 LAPEYAMLGKA-SESCDVYSFGILLLELASGK------KPIEKVNSAIKRTITD 255
            APE  M  +  + + D++S G +  EL   +       PI++++      ITD
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD-----LITD 219

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 7/100 (7%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTL 206
           AE ++ +H     H +HRDIK  NVLLD +   ++ADFG   K+  DG    +  V GT 
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167

Query: 207 GYLAPEY--AM---LGKASESCDVYSFGILLLELASGKKP 241
            Y++PE   AM   +GK    CD +S G+ + E+  G+ P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLKVWS--NKAEME-FAVEVEILARVRHKNLLSLRG 101
           +G G FG V   ++ +  Q+ A+K L  W    +AE   F  E ++L     + + +L  
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH- 67

Query: 102 YCAEGQERL-IVYDYMPN---LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
           Y  + +  L +V DY      L+LLS    +   +    +   M +AI S   + Y    
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY---- 123

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYLAPEY--A 214
                +HRDIK  NVLLD +   ++ADFG   +L+ DG       V GT  Y++PE   A
Sbjct: 124 -----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQA 177

Query: 215 M---LGKASESCDVYSFGILLLELASGKKP 241
           M    G+    CD +S G+ + E+  G+ P
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 21/212 (9%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILAR-VRHKNLLSLR 100
           +G+G FG V   +   +    AVK L+   +   K E     E  +L + V+H  L+ L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 101 GYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGSAEGIVYLHHHA 158
            +  +  ++L  V DY+    L  HL  +    C L    R   A I SA G  YLH   
Sbjct: 63  -FSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALG--YLH--- 113

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLAPEYAML 216
           + +I++RD+K  N+LLD+     + DFG  K  +  +G    T+   GT  YLAPE    
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYLAPEVLHK 170

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSA 248
                + D +  G +L E+  G  P    N+A
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G+G FG V   +   DG   AVK L+    +   + +   A    +L  V+H  L+ L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 101 GYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGSAEGIVYLHHHA 158
            Y  +  ++L  V DY+    L  HL  +           R   A I SA G  YLH   
Sbjct: 63  -YSFQTADKLYFVLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALG--YLH--- 113

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH--VTTRVKGTLGYLAPEYAML 216
           + +II+RD+K  N+LLD+     + DFG  K   +G  H   T+   GT  YLAPE    
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 217 GKASESCDVYSFGILLLELASGKKP 241
                + D +  G +L E+  G  P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 11/103 (10%)

Query: 143 IAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGA-THVT 199
           I+I    G+ YL   H    I+HRD+K SN+L+++  + ++ DFG + +LI   A + V 
Sbjct: 104 ISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160

Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           TR      Y++PE       +   D++S G+ L+E+A G+ PI
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 4e-10
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 30/208 (14%)

Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARV-RHKNLLS 98
           +LG+G FGSVY  +  +  ++ A+K++K     W     +    EV+ L ++  H N++ 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR---EVKSLRKLNEHPNIVK 62

Query: 99  LRGYCAEGQERLIVYDYMP-NL-SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           L+    E  E   V++YM  NL  L+    G+  SE     +    I     +G+ ++H 
Sbjct: 63  LKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSE-----SVIRSIIYQILQGLAHIHK 117

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKGTLGYLAPEY 213
           H      HRD+K  N+L+      ++ADFG A+ I   P    +V+TR      Y APE 
Sbjct: 118 H---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPE- 168

Query: 214 AMLGKASESC--DVYSFGILLLELASGK 239
            +L   S S   D+++ G ++ EL + +
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 62/246 (25%), Positives = 116/246 (47%), Gaps = 17/246 (6%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAV--EVEILARVRHK 94
           N F     +GEG +G V   +  +  +I A+K+ K      E++     E+++L  ++ +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 95  NLLSLRGYCAEGQERLIVYDYMPN--LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           N++ L+       +  +V++Y+    L LL  +      E + ++  ++  AI       
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI------- 113

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
             H      I+HRDIK  N+L+  +   ++ DFGFA+ + +G+    T    T  Y +PE
Sbjct: 114 --HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITDWALPLACERKFSELA 270
             +     ++ D++S G +L EL+ G +P+    S I +  TI     PL  E+     +
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230

Query: 271 DPRLNG 276
           +PR +G
Sbjct: 231 NPRFHG 236

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 45  KLGEGGFGSV---YWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSL 99
           +LG G FG+V    +        +AVK LK  +N   +  E   E  ++ ++ +  ++ +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRM------DIAIGSAEGIVY 153
            G C E +  ++V +    L+ L  L+        L  N+ +      ++    + G+ Y
Sbjct: 62  IGIC-EAESWMLVME----LAELGPLNK------FLQKNKHVTEKNITELVHQVSMGMKY 110

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT--LGYLAP 211
           L      + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + AP
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           E     K S   DV+SFG+L+ E  S G+KP
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 52/214 (24%), Positives = 105/214 (49%), Gaps = 26/214 (12%)

Query: 41  NYDN--KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWS-NKAEMEFAV-EVEILARVRHKN 95
            Y+   K+GEG +G+V+  +  +    +A+KR+++   ++     A+ E+ +L  ++HKN
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA------E 149
           ++ L       ++  +V++Y            Q   +   + N  +D  I  +      +
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYC----------DQDLKKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           G+ + H H   +++HRD+K  N+L++ + + ++ADFG A+         +  V  TL Y 
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYR 166

Query: 210 APEYAMLGKA-SESCDVYSFGILLLELASGKKPI 242
            P+     K  S S D++S G +  ELA+  +P+
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.5 bits (145), Expect = 8e-10
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 20/98 (20%)

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---------PDGATHVTTRVK 203
           Y+H   + ++IHRD+K SN+LL++D + ++ADFG A+ +         P    +V TR  
Sbjct: 122 YIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR-- 176

Query: 204 GTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
               Y APE  +LG  + ++  D++S G +L E+  GK
Sbjct: 177 ---WYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGY-- 102
           +G G +G VY G+     Q+A  ++   +   E E  +E+ +L +   H+N+ +  G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 103 ----CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE---GIVYLH 155
                    +  +V ++    S+   +     +    +W     IA    E   G+ +LH
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-----IAYICREILRGLAHLH 138

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    +IHRDIK  NVLL  + + ++ DFG +  +        T + GT  ++APE   
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194

Query: 216 LGKASESC-----DVYSFGILLLELASGKKPI 242
             +  ++      D++S GI  +E+A G  P+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 21/249 (8%)

Query: 46  LGEGGFGSVYWGQLWDGSQI----AVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G+G FG V   +  D  +I     +++  + S         E  +LA+V    ++ L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           +  +  E+L +V  ++    L  HL      E   + +R       +AE +  L +    
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQ----REGRFDLSRA---RFYTAELLCALENLHKF 112

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           ++I+RD+K  N+LLD      + DFG  KL        T    GT  YLAPE  +LG   
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPEL-LLGHGY 170

Query: 221 ESC-DVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKFSELADPRLNGN 277
               D ++ G+LL E+ +G  P   E VN   ++ + +   PL     F   A   L G 
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---PLRFPDGFDRDAKDLLIGL 227

Query: 278 FVEEELKRV 286
              +  +R+
Sbjct: 228 LSRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 76/292 (26%), Positives = 128/292 (43%), Gaps = 41/292 (14%)

Query: 40  FNYDNKLGEGGFGSVYWGQLW--DGS--QIAVKRLK--VWSNKAEMEFAVEVEILARVRH 93
           F     LG+G FGSV   QL   DGS  ++AVK LK  ++S+    EF  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 94  KNLLSLRGYC--AEGQERL----IVYDYMPNLSLLSHLHGQHSSECLLNWNRR--MDIAI 145
            N++ L G    +  + RL    ++  +M +  L + L      E       +  +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV-KG 204
             A G+ YL   ++ + IHRD+ A N +L+ +    VADFG +K I  G  +      K 
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACE 263
            + +LA E       +   DV++FG+ + E+ + G+ P   V +                
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---------------- 221

Query: 264 RKFSELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
              SE+ +  + GN +++    L+ V  +   C   +P+ RP+   + D L+
Sbjct: 222 ---SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 3/103 (2%)

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGT 205
           SAE  + L+      II+RD+K  NVLLDA+   ++ D+G  K  I  G T  T+   GT
Sbjct: 102 SAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGT 159

Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
             Y+APE         S D ++ G+L+ E+ +G+ P + V  +
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 66/253 (26%), Positives = 98/253 (38%), Gaps = 58/253 (22%)

Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEM-------EFAVEVEILARVRHKNLL 97
           +G G FG V+  +  D  Q+ A+K L+    K++M           E +ILA      ++
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLR----KSDMIKRNQIAHVRAERDILADADSPWIV 64

Query: 98  SLRGYCA-EGQERL-IVYDYMPN---LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
            L  Y + + +E L +V +YMP    ++LL                 R  IA    E ++
Sbjct: 65  KL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIA----ELVL 112

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT---------------- 196
            L        IHRDIK  N+L+DAD   ++ADFG  K +                     
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 197 -------HVTTRVK-----GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEK 244
                  H   RV+     GT  Y+APE          CD +S G++L E+  G  P   
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232

Query: 245 VNSAI-KRTITDW 256
                    I +W
Sbjct: 233 DTLQETYNKIINW 245

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWS-------NKAEMEFA-VEVEILARVRHKNL 96
           +LG+G FG+VY   + D   +A +RLKV         N  E   A  E ++L+++ H  +
Sbjct: 7   RLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           +       E     I+ +Y     L   L     +   L+ N+  +  I    G+ Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
                I+HRD+KA N+ L  +   ++ DFG ++L+  G+  + T   GT  Y++PE A+ 
Sbjct: 125 R---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSPE-ALK 178

Query: 217 GKASES-CDVYSFGILLLEL 235
            +  +S  D++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I    G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 108 VSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 162

Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+ELA G+ PI
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 8/94 (8%)

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           G+  LH      IIHRDIK  N+L+D     ++ DFG ++           +  GT  YL
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYL 160

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           APE  +     +  D +S G ++ E   G  P  
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 28/170 (16%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A G+ +L   A+   IHRD+ A N+LL  +   ++ DFG A+ I   PD     + R+  
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP- 239

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIE--KVNSAIKRTITDWALPLA 261
            L ++APE       +   DV+SFG+LL E+ S G  P    ++N    + + D      
Sbjct: 240 -LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-----G 293

Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              +  E A P +              + L C    P++RPT   ++++L
Sbjct: 294 TRMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 44  NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +KLGEG + +V+ G+     + +A+K +++   +     A+ EV +L  ++H N+++L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
                +   +V++Y+ +  L  +L    +   + N    M        G+ Y H      
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCHKRK--- 123

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGYLAPEYAMLG 217
           I+HRD+K  N+L++   + ++ADFG A+     A  V T+       TL Y  P+  +LG
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEVVTLWYRPPD-VLLG 177

Query: 218 KA--SESCDVYSFGILLLELASGK 239
               S   D++  G +L E+A+G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 28/189 (14%)

Query: 62  GSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVY 113
           G  +AVK+L + + N+   + A  E+ +L  V HKN++SL      +    E Q+  +V 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 114 DYM-PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV 172
           + M  NL  + H+   H     L +            GI +LH   +  IIHRD+K SN+
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNI 154

Query: 173 LLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFG 229
           ++ +D   ++ DFG A+          +V TR      Y APE  +     E+ D++S G
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVG 209

Query: 230 ILLLELASG 238
            ++ EL  G
Sbjct: 210 CIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIA---VKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLR 100
           ++G G FG V   +++  + +A   VK LK  ++ K + EF  + +    ++H N+L   
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           G C E    L+V++Y     L S+L     H     L   +RM   I  A G+ ++H H 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI--AAGVTHMHKH- 118

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADF--GFAKLIPDGATHVTTRVK--GTLGYLAPEYA 214
             + +H D+   N  L +D   +V D+  G ++   D   ++ T       L +LAPE  
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED---YIETEDDKCVPLRWLAPELV 173

Query: 215 -------MLGKASESCDVYSFGILLLEL 235
                  +  + ++  +V++ G+ L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 57/232 (24%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEME-----FAVEVEILARVRHKNL 96
            +G+GG G VY    +D     ++A+K+++   + +E       F  E +I A + H  +
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIR--EDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 97  LSLRGYCAEGQERLIVYDYMPNL----------------SLLSHLHGQHSSECLLNWNRR 140
           + +   C++G     VY  MP +                SL   L  + S    L+    
Sbjct: 65  VPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS---- 117

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--------- 191
             I       I Y+H      ++HRD+K  N+LL    +  + D+G A            
Sbjct: 118 --IFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 192 -----PDGATHVTT---RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
                 +      T   ++ GT  Y+APE  +   ASES D+Y+ G++L ++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 48/223 (21%)

Query: 44  NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV----EVEILARVRHKNLLS 98
           + +GEG +G V        G ++A+K++  + ++    F      E++IL R +H+N++ 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFKHENIIG 67

Query: 99  L------RGYCAEGQERLIVYDYMPN----LSLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
           +        +     +  IV + M      L    HL   H    L    R         
Sbjct: 68  ILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR--------- 117

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-------VTTR 201
            G+ Y+H   + +++HRD+K SN+LL+ +   ++ DFG A++      H       V TR
Sbjct: 118 -GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 202 VKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPI 242
                 Y APE  ML     +++ D++S G +L E+ S  +P+
Sbjct: 174 -----WYRAPE-IMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRL--KVWSNKAEME--FAVEVEILARVRHKNLLSLR 100
           +G+G FG V   +   DG   AVK L  K+  N+ E +   A    +L  V+H  L+ L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 101 GYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGSAEGIVYLHHHA 158
            Y  +  E+L  V D++    L  HL  + S         R   A I SA G  YLH   
Sbjct: 63  -YSFQTTEKLYFVLDFVNGGELFFHLQRERS---FPEPRARFYAAEIASALG--YLH--- 113

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAML 216
           + +I++RD+K  N+LLD+     + DFG  K   +G   +  TT   GT  YLAPE    
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRK 170

Query: 217 GKASESCDVYSFGILLLELASGKKP 241
                + D +  G +L E+  G  P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 31/219 (14%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKV-WSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           K+GEG +G VY  +       IA+K++++   ++     A+ E+ +L  ++H N++ L+ 
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS-----AEGIVYLHH 156
                +   +V++Y+ +L L  H+     S      N R+   I +       GI Y H 
Sbjct: 69  VVHSEKRLYLVFEYL-DLDLKKHM----DSSPDFAKNPRL---IKTYLYQILRGIAYCHS 120

Query: 157 HATPHIIHRDIKASNVLLDADFKA-QVADFGFAKL--IPDGA-THVTTRVKGTLGYLAPE 212
           H    ++HRD+K  N+L+D    A ++ADFG A+   IP    TH       TL Y APE
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPE 173

Query: 213 YAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAI 249
             +LG    S   D++S G +  E+ + +KP+   +S I
Sbjct: 174 -ILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEI 210

Length = 294

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 17/151 (11%)

Query: 103 CAEGQERLI-VYDYMPNLSLLSHLHGQHS--SECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
           C + + RL  V +Y+    L+ H+  Q     E    ++  + +A+       YLH    
Sbjct: 64  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHERG- 116

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLAPEYAMLG 217
             II+RD+K  NVLLD++   ++ D+G  K  L P G T  T+   GT  Y+APE     
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT--TSTFCGTPNYIAPEILRGE 171

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNSA 248
               S D ++ G+L+ E+ +G+ P + V S+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 38/99 (38%), Positives = 57/99 (57%), Gaps = 11/99 (11%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-- 205
           A+G+ +L   A+ + IHRD+ A NVLL     A++ DFG A+ I + + +V   VKG   
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNAR 275

Query: 206 --LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + ++APE       +   DV+S+GILL E+ S GK P
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 30/172 (17%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-- 205
           A+G+ +L   A+ + IHRD+ A N+LL      ++ DFG A+ I + + +V   VKG   
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277

Query: 206 --LGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWALPL 260
             + ++APE       +   DV+S+GILL E   L S   P   V+S   + I +    L
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
           + E   SE+ D                 +  +C  + P KRPT  +++ L++
Sbjct: 338 SPECAPSEMYD-----------------IMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 108 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 162

Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 45  KLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           KLGEG + +VY G+   +G  +A+K +++   +     A+ E  +L  ++H N++ L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 103 CAEGQERLIVYDYMPN---LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
               +   +V++Y+       +  H  G H     L   + +        G+ Y+H    
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIHQR-- 122

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGF--AKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
            +I+HRD+K  N+L+    + ++ADFG   AK +P   +H  +    TL Y  P+  +  
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPDVLLGS 178

Query: 218 KASESC-DVYSFGILLLELASG 238
               +C D++  G + +E+  G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 45/172 (26%), Positives = 85/172 (49%), Gaps = 27/172 (15%)

Query: 84  EVEILARVRHKNLLSLRGYC----AEGQERLIVYDYMP-NLSLLSH----LHGQHSSECL 134
           E++IL   +H N++++R       A+ ++  +V D M  +L  + H    L  +H    L
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL 113

Query: 135 LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--- 191
               R          G+ Y+H   + ++IHRD+K SN+L++ D + ++ DFG A+ +   
Sbjct: 114 YQLLR----------GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160

Query: 192 PDGATHVTTRVKGTLGYLAPEYAM-LGKASESCDVYSFGILLLELASGKKPI 242
           P    +  T    T  Y APE  + L + + + D++S G +  E+  G++ +
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 18/209 (8%)

Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCA 104
           +G G +G VY G+     Q+A  ++   +   E E   E+ +L +   H+N+ +  G   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 105 EGQ------ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           +        +  +V ++    S+   +     +     W   +   I    G+ +LH H 
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI--LRGLSHLHQH- 130

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              +IHRDIK  NVLL  + + ++ DFG +  +        T + GT  ++APE     +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187

Query: 219 ASESC-----DVYSFGILLLELASGKKPI 242
             ++      D++S GI  +E+A G  P+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 27/207 (13%)

Query: 44  NKLGEGGFGSVYWG--QLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLR 100
            KLGEG + +V+ G  +L + + +A+K +++   +     A+ EV +L  ++H N+++L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSEC--LLNWNRRMDIAIGSAEGIVYLHHHA 158
                 +   +V++Y      L     Q+  +C  +++ +           G+ Y H   
Sbjct: 71  DIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR- 123

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGYLAPEYA 214
              ++HRD+K  N+L++   + ++ADFG A+     A  V T+       TL Y  P+  
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLAR-----AKSVPTKTYSNEVVTLWYRPPD-V 175

Query: 215 MLGKA--SESCDVYSFGILLLELASGK 239
           +LG +  S   D++  G +  E+ASG+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 46  LGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEIL-ARVRHKNLLSLRGY- 102
           +G+G +G V+      +GS+ AVK L    +  E E   E  IL A   H N++   G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGMY 84

Query: 103 ----CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD---IAIGSAEGIVYLH 155
                  G +  +V +     S+   + G       L    RM+   IA    E ++ L 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKG------FLKRGERMEEPIIAYILHEALMGLQ 138

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
           H      IHRD+K +N+LL  +   ++ DFG +  +        T V GT  ++APE   
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197

Query: 216 LGKASES-----CDVYSFGILLLELASGKKPI 242
             +  +S     CDV+S GI  +EL  G  P+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 15/166 (9%)

Query: 103 CAEGQERL-IVYDYMPNLSLLSHLHGQHS--SECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
           C +   RL +V +Y+    L+ H+  Q     E    +   + IA+       +LH    
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERG- 116

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPEYAMLGK 218
             II+RD+K  NVLLDAD   ++ D+G  K  +  G T  T+   GT  Y+APE     +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEE 172

Query: 219 ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER 264
              S D ++ G+L+ E+ +G+ P + +         D+   +  E+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 45/195 (23%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV----EVEILARVRHKNLLS 98
            K+G+G FG V+  +       +A+K  KV     +  F +    E++IL  ++H+N+++
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVN 75

Query: 99  LRGYC---AEGQER-----LIVYDYMPN--LSLLSHLHGQHS-SEC------LLNWNRRM 141
           L   C   A    R      +V+++  +    LLS+ + + + SE       LLN     
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN----- 130

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP----DGATH 197
                   G+ Y+H      I+HRD+KA+N+L+  D   ++ADFG A+            
Sbjct: 131 --------GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 198 VTTRVKGTLGYLAPE 212
            T RV  TL Y  PE
Sbjct: 180 YTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 39/222 (17%)

Query: 45  KLGEGGFG---SVYWGQLWDGSQIAVKRL-KVWSNKAEMEFAV-EVEILARVR-HKNLLS 98
           +LG+G +G   S    +  +   +A+K++  V+S K   + A+ E+++L   R HKN+  
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 99  LRGYCAEGQERLIVYDYMPN-LSLLSHLHGQHSSECLLNWNRRMDIAIGSAE-------- 149
           L  Y  +     IV+    N L L   L      E  L+   R    +  A         
Sbjct: 67  L--YDMD-----IVFPGNFNELYLYEEL-----MEADLHQIIRSGQPLTDAHFQSFIYQI 114

Query: 150 --GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--- 204
             G+ Y+H   + +++HRD+K  N+L++AD + ++ DFG A+   +        +     
Sbjct: 115 LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 205 TLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPIEK 244
           T  Y APE  ML     +++ DV+S G +L EL  G+KP+ K
Sbjct: 172 TRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 28/226 (12%)

Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-------FA 82
           +++L     +++    +G G FG V   +     ++   +L    +K EM        F 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL---SKFEMIKRSDSAFFW 91

Query: 83  VEVEILARVRHKNLLSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRR 140
            E +I+A      ++ L  +CA   ++   +V +YMP   L++ +      E    W + 
Sbjct: 92  EERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KWAK- 145

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVT 199
                 +AE ++ L    +  +IHRD+K  N+LLD     ++ADFG   K+   G     
Sbjct: 146 ----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201

Query: 200 TRVKGTLGYLAPEYAML----GKASESCDVYSFGILLLELASGKKP 241
           T V GT  Y++PE        G     CD +S G+ L E+  G  P
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 44  NKLGEGGFGSVYWG--QLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLR 100
           +KLGEG + +VY G  +L D + +A+K +++   +     A+ EV +L  ++H N+++L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSEC--LLNWNRRMDIAIGSAEGIVYLHHHA 158
                 +   +V++Y      L     Q+  +C   +N +           G+ Y H   
Sbjct: 71  DIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR- 123

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGF--AKLIPDGATHVTTRVKGTLGYLAPEYAML 216
              ++HRD+K  N+L++   + ++ADFG   AK IP   T   +    TL Y  P+  +L
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSNEVVTLWYRPPD-ILL 177

Query: 217 GKA--SESCDVYSFGILLLELASGK 239
           G    S   D++  G +  E+++G+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR---HKNLLS 98
           ++G G +G+VY  +    G  +A+K ++V +N+  +  +   EV +L R+    H N++ 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 99  LRGYCAEGQ-----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           L   CA  +     +  +V++++ +  L ++L         L      D+      G+ +
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           LH      I+HRD+K  N+L+ +  + ++ADFG A++         T V  TL Y APE 
Sbjct: 124 LH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEV 178

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPI 242
            +    +   D++S G +  E+   +KP+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 30/207 (14%)

Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKVWS------NKAEMEFAVEVEILARVRHKNLL 97
           K+GEG +G V+  +  +  QI A+K+  V S       K  +    E+ +L +++H NL+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALR---EIRMLKQLKHPNLV 63

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLS----HLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           +L       ++  +V++Y  + ++L+    +  G       +  +    I   + + + +
Sbjct: 64  NLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNF 115

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
            H H   + IHRD+K  N+L+    + ++ DFGFA+++       T  V  T  Y APE 
Sbjct: 116 CHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPEL 171

Query: 214 AMLG--KASESCDVYSFGILLLELASG 238
            ++G  +     DV++ G +  EL +G
Sbjct: 172 -LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 12/93 (12%)

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 181

Query: 209 LAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +GK
Sbjct: 182 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 40/140 (28%), Positives = 61/140 (43%), Gaps = 21/140 (15%)

Query: 110 LIVYDYMPNLSLLSHLHGQHS---SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRD 166
           +++ DY+ +  L   L  +     +E          I     E +  LH H   +IIH D
Sbjct: 85  VLIMDYIKDGDLFDLLKKEGKLSEAEVKK-------IIRQLVEALNDLHKH---NIIHND 134

Query: 167 IKASNVLLDADFKAQV--ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCD 224
           IK  NVL D   K ++   D+G  K+I        +   GTL Y +PE         S D
Sbjct: 135 IKLENVLYD-RAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSPEKIKGHNYDVSFD 188

Query: 225 VYSFGILLLELASGKKPIEK 244
            ++ G+L  EL +GK P ++
Sbjct: 189 WWAVGVLTYELLTGKHPFKE 208

Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVT-TRVKGTLG 207
            + Y+H   T ++ HRD+K  N+L +AD K ++ DFG A++   D  T +  T    T  
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 208 YLAPEY--AMLGKASESCDVYSFGILLLELASGK 239
           Y APE   +   K + + D++S G +  E+ +GK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 49/214 (22%)

Query: 65  IAVKR--LKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLL 122
           +AVK+  L   S +       E+    +++H N+L          E  +V   M      
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA----- 82

Query: 123 SHLHGQHSSECLL--NWNRRM-DIAI-----GSAEGIVYLHHHATPHIIHRDIKASNVLL 174
              +G  S E LL  ++   + ++AI          + Y+H       IHR +KAS++LL
Sbjct: 83  ---YG--SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILL 134

Query: 175 DADFKAQVADF---------GFAKLIPDGATHVTTRVKGTLGYLAPEY---AMLGKASES 222
             D K  ++           G  + +       + +    L +L+PE     + G   +S
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPEVLQQNLQGYNEKS 191

Query: 223 CDVYSFGILLLELASGKKP----------IEKVN 246
            D+YS GI   ELA+G  P          +EKV 
Sbjct: 192 -DIYSVGITACELANGHVPFKDMPATQMLLEKVR 224

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 36/216 (16%)

Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD 142
           +E  +L  V H +++ ++     G    +V   +P+ S  S L+       L   +R + 
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYS--SDLY-----TYLTKRSRPLP 155

Query: 143 IAIGSA------EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT 196
           I           EG+ YLH      IIHRD+K  N+ ++   +  + D G A+  P  A 
Sbjct: 156 IDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAP 211

Query: 197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLEL------------ASGKKPIEK 244
                + GT+   APE     K +   D++S GI+L E+            ++ ++ ++ 
Sbjct: 212 AFLG-LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270

Query: 245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVE 280
            +S + + I+   L +  E +F      RL   F+E
Sbjct: 271 CHSHLLKIIS--TLKVHPE-EFPRDPGSRLVRGFIE 303

Length = 357

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 30/172 (17%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-- 205
           A G+ +L   A+ + +HRD+ A NVLL      ++ DFG A+ I   + +V+   KG+  
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300

Query: 206 --LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK--VNSAIKRTITDWALPL 260
             + ++APE       +   DV+S+GILL E+ S G  P     V+S     I       
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI------- 353

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
              +    +A P       +   + V  + + C +S+PEKRP+ L + D+++
Sbjct: 354 ---KSGYRMAKP-------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 28/202 (13%)

Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104

Query: 117 -PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD 175
             NL  +  +   H     L +            GI +LH   +  IIHRD+K SN+++ 
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVVK 153

Query: 176 ADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+
Sbjct: 154 SDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Query: 236 AS------GKKPIEKVNSAIKR 251
                   G+  I++ N  I++
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 32/215 (14%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRH 93
           TN +     +G G FG V   +    G  +A+K++ K +S     +    E+++L  +RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD------IAIGS 147
           +N++SL           I    + ++  ++ L G      L +  R ++           
Sbjct: 69  ENIISLSD---------IFISPLEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQI 117

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
             G+ Y+H   +  ++HRD+K SN+L++ +   ++ DFG A++  P    +V+TR     
Sbjct: 118 LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY---- 170

Query: 207 GYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            Y APE  ML   K     D++S G +  E+  GK
Sbjct: 171 -YRAPE-IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 10/96 (10%)

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           G+ Y+H   + +++HRD+K SN+LL+A+   ++ DFG A+   +    +T  V  T  Y 
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYR 175

Query: 210 APEYAMLGKASE---SCDVYSFGILLLELASGKKPI 242
           APE  +L   SE   + DV+S G +  EL  G+KP+
Sbjct: 176 APE--LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 66/283 (23%), Positives = 127/283 (44%), Gaps = 45/283 (15%)

Query: 44  NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLLSLRG 101
           ++LG+G +GSVY       G  +A+K +++  ++++  +  +E++IL +     ++    
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF-- 64

Query: 102 YCAEGQERLIVY--DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
           Y A   E  +    +YM   SL   L+    +   +  +    I     +G+ +L     
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
            +IIHRD+K +NVL++ + + ++ DFG +  L+   A+   T + G   Y+APE    G 
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNI-GCQSYMAPERIKSGG 177

Query: 219 ASE------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA-- 270
            ++        DV+S G+ +LE+A G+ P                 P      F++L+  
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYP---------------PETYANIFAQLSAI 222

Query: 271 ----DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                P L   + ++    V      C +  P +RPT  ++L+
Sbjct: 223 VDGDPPTLPSGYSDDAQDFVAK----CLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 28/170 (16%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A+G+ +L   A+   IHRD+ A N+LL  +   ++ DFG A+ I   PD       R+  
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 244

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWALPLA 261
            L ++APE       +   DV+SFG+LL E   L +   P  K++    R + +     A
Sbjct: 245 -LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
            +    E+    L+                 C H +P +RPT  E+++ L
Sbjct: 304 PDYTTPEMYQTMLD-----------------CWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 58/278 (20%), Positives = 117/278 (42%), Gaps = 55/278 (19%)

Query: 53  SVYWGQLWDGSQIAVKRLKVWSN--KAEME-FAVEVEILARVRHKNLLSLRGYCAEGQER 109
           S+Y G  ++  ++ ++  K +    K  ++    E++ L R+   N+L + G+  +    
Sbjct: 35  SIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID---- 89

Query: 110 LIVYDYMPNLSLL------SHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH-HHATPHI 162
             + D +P LSL+       +L      E  L++  ++D+AI   +G+  L+ +   P+ 
Sbjct: 90  --IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY- 146

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML----GK 218
             +++ + + L+  ++K ++   G  K++          V   + Y + +  ML     +
Sbjct: 147 --KNLTSVSFLVTENYKLKIICHGLEKILSSPPFK---NVN-FMVYFSYK--MLNDIFSE 198

Query: 219 ASESCDVYSFGILLLELASGKKPIEKVNS-----AIKRTITDWALPLACERKFSELADPR 273
            +   D+YS G++L E+ +GK P E + +      I        LPL C           
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL--------- 249

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                   E+K +V     C      KRP + E+L  L
Sbjct: 250 --------EIKCIV---EACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 24/197 (12%)

Query: 62  GSQIAVKRLKVWSNKAEMEFA---VEVEILARVRHKNLLSL--RGYCAEGQERLI-VYDY 115
           G ++A+K L+  + + E + A    E  + AR+ H N+++L   G    G   L  V++Y
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEY 60

Query: 116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL- 174
           +P  +L   L    +++  L       + +   + +   H+     I+HRD+K  N+++ 
Sbjct: 61  VPGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS 113

Query: 175 --DADFKAQVADFGFAKLIPD----GATHVT--TRVKGTLGYLAPEYAMLGKASESCDVY 226
                  A+V DFG   L+P         +T  T V GT  Y APE       + + D+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 227 SFGILLLELASGKKPIE 243
           ++G++ LE  +G++ ++
Sbjct: 174 AWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 24/227 (10%)

Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME------ 80
           I  +++L     ++     +G G FG V   +     ++   +L    +K EM       
Sbjct: 32  INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL---LSKFEMIKRSDSA 88

Query: 81  -FAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNR 139
            F  E +I+A      ++ L     + +   +V +YMP   L++ +      E    W R
Sbjct: 89  FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWAR 145

Query: 140 RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHV 198
                  +AE ++ L    +   IHRD+K  N+LLD     ++ADFG   K+  +G    
Sbjct: 146 -----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200

Query: 199 TTRVKGTLGYLAPEYAML----GKASESCDVYSFGILLLELASGKKP 241
            T V GT  Y++PE        G     CD +S G+ L E+  G  P
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 22/185 (11%)

Query: 64  QIAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDY 115
            +A+K+L + + N+   + A  E+ ++  V HKN++ L      +    E Q+  IV + 
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 116 M-PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL 174
           M  NL  +  +   H     L +            GI +LH   +  IIHRD+K SN+++
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159

Query: 175 DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLE 234
            +D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E
Sbjct: 160 KSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 235 LASGK 239
           +  G 
Sbjct: 218 MIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 28/83 (33%), Positives = 48/83 (57%), Gaps = 1/83 (1%)

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKAS 220
           ++HRD+K++N+ L      ++ DFGF+K   D  +  V +   GT  YLAPE     + S
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 221 ESCDVYSFGILLLELASGKKPIE 243
           +  D++S G++L EL +  +P +
Sbjct: 250 KKADMWSLGVILYELLTLHRPFK 272

Length = 478

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 24/168 (14%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A G+ +L   A+   IHRD+ A N+LL  +   ++ DFG A+ I   PD       R+  
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 238

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACE 263
            L ++APE       +   DV+SFG+LL E+ S G  P   V   I            C 
Sbjct: 239 -LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ--IDEEF--------C- 286

Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
           R+  E    R    +   E+  ++   L C H+ PE RPT  E++++L
Sbjct: 287 RRLKEGTRMR-APEYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 13/94 (13%)

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT---HVTTRVKGTL 206
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+          +V TR     
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 207 GYLAPEYAMLGKA-SESCDVYSFGILLLELASGK 239
            Y APE  +LG    E+ D++S G ++ E+  G 
Sbjct: 183 -YRAPE-VILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 20/164 (12%)

Query: 82  AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRM 141
           A E  IL  + H +++ L+G           Y+    L L  +   +    C L   R +
Sbjct: 131 ATEAHILRAINHPSIIQLKG--------TFTYNKFTCLILPRY---KTDLYCYLAAKRNI 179

Query: 142 DI----AIGSA--EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
            I    AI  +    I YLH +    IIHRDIKA N+ ++      + DFG A    D  
Sbjct: 180 AICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236

Query: 196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK 239
            +      GT+   APE         + D++S GI+L E+A+  
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 12/93 (12%)

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SNV ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181

Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL  GK
Sbjct: 182 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLK--VWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           +G G +GSV        G ++AVK+L     S         E+ +L  ++H+N++ L   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHG---QHSSECLLNWNRRMDIAIGSA-EGIVYLHHHA 158
               +      +   ++ L++HL G    +  +C    +  +   I     G+ Y+H   
Sbjct: 85  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 137

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLG 217
           +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y APE  ML 
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE-IMLN 191

Query: 218 --KASESCDVYSFGILLLELASGK 239
               +++ D++S G ++ EL +G+
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 27/205 (13%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           KLGEG + +VY G+    G  +A+K +++   +     A+ E  +L  ++H N+++L   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 103 CAEGQERLIVYDYM-PNLSLLSHLHGQ----HSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
               +   +V++Y+  +L       G     H+    L    R         G+ Y H  
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------GLAYCHQR 122

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGF--AKLIPDGATHVTTRVKGTLGYLAPEYAM 215
               ++HRD+K  N+L+    + ++ADFG   AK +P   +   +    TL Y  P+  +
Sbjct: 123 ---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVVTLWYRPPD-VL 175

Query: 216 LGKA--SESCDVYSFGILLLELASG 238
           LG    S S D++  G +  E+A+G
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 53/220 (24%), Positives = 106/220 (48%), Gaps = 23/220 (10%)

Query: 40  FNYDN-KLGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAVEVEILARVRHKN 95
           F Y+  K+G G +G VY  +  DG    + A+K+++       M    E+ +L  ++H N
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPN 59

Query: 96  LLSLRGYCAEGQERLI--VYDYMPN--LSLLSHLHGQHSSECLLNWNRRM--DIAIGSAE 149
           +++L+       +R +  ++DY  +    ++       +++  +   R M   +     +
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDAD----FKAQVADFGFAKLI--PDGATHVTTRVK 203
           GI YLH +    ++HRD+K +N+L+  +     + ++AD GFA+L   P         V 
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 204 GTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPI 242
            T  Y APE  +  +  +++ D+++ G +  EL +  +PI
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 19/218 (8%)

Query: 40  FNYDN-KLGEGGFGSVYWGQLWDGSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLL 97
           F Y+  K+G G +G VY  +  DG       LK +      M    E+ +L  ++H N++
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVI 61

Query: 98  SLRGYCAEGQERLI--VYDYMPN--LSLLSHLHGQHSSECLLNWNRRM--DIAIGSAEGI 151
           SL+       +R +  ++DY  +    ++       +++  +   R M   +     +GI
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 152 VYLHHHATPHIIHRDIKASNVLLDAD----FKAQVADFGFAKLI--PDGATHVTTRVKGT 205
            YLH +    ++HRD+K +N+L+  +     + ++AD GFA+L   P         V  T
Sbjct: 122 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 206 LGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPI 242
             Y APE  +  +  +++ D+++ G +  EL +  +PI
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 17/163 (10%)

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS--SECLLNWNRRMDIAIGSAEGIV 152
           N++ L  Y        +V  +     L SH+    +   EC+  W   M +A+ +     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFG-FAKLIPDGATHVTTRVKGTLGYLAP 211
            LH      I+ RD+  +N+LLD     Q+  F  ++++           +     Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT 254
           E   + + +E+CD +S G +L EL +GK  +E   S I    T
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTT 194

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 44/214 (20%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLK-VWSNKAEMEFAVEVEILARVR-HKNLLSLR 100
            K+GEG F  V   Q    G   A+K +K  + +  ++    E++ L R+  H N+L L 
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 101 GYCAEGQERLIVYDYMPN-LSLLSHL-----------HGQHSSECLLNWNRRMDIAIGSA 148
                     +++D     L+L+  L             +   E      R         
Sbjct: 65  E---------VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPE-----KRVKSYMYQLL 110

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKGT 205
           + + ++H +    I HRDIK  N+L+  D   ++ADFG  + I   P    +++TR    
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR---- 162

Query: 206 LGYLAPEYAML--GKASESCDVYSFGILLLELAS 237
             Y APE  +L  G      D+++ G +  E+ S
Sbjct: 163 -WYRAPE-CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.6 bits (115), Expect = 4e-06
 Identities = 52/250 (20%), Positives = 103/250 (41%), Gaps = 48/250 (19%)

Query: 35  SATNNFNYDNKLGEGGFGSVYW------GQLWDGSQIAVKRLKVWSNKAEMEFAVEVEIL 88
           S  N +    K+G G FG V+        + +    I+ + LK    + + +  +EV ++
Sbjct: 10  SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK---EREKSQLVIEVNVM 66

Query: 89  ARVRHKNLLS-LRGYCAEGQERLIVY-------DYMPNLSLLSHLHGQHSSECLLNWNRR 140
             ++HKN++  +  +  +  ++L +        D   N+     + G+     +++  R+
Sbjct: 67  RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126

Query: 141 MDIAIGSAEGIVYLHHHAT----PHIIHRDIKASNVLLDADFK----------------- 179
           +         + Y H+         ++HRD+K  N+ L    +                 
Sbjct: 127 L------LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS--ESCDVYSFGILLLELAS 237
           A++ DFG +K I  G   +     GT  Y +PE  +    S  +  D+++ G ++ EL S
Sbjct: 181 AKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 238 GKKPIEKVNS 247
           GK P  K N+
Sbjct: 239 GKTPFHKANN 248

Length = 1021

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 17/115 (14%)

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-- 205
           A G+ +L   A+ + +HRD+ A NVL+      ++ DFG A+ I   + +++   KG+  
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGSTF 302

Query: 206 --LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPI------EKVNSAIKR 251
             L ++APE       +   DV+SFGILL E+ + G  P       E+  +AIKR
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 6/103 (5%)

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E + YLH      IIHRD+K  N+ LD    A + DFG A KL     T       GTL 
Sbjct: 196 EALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPI--EKVNSA 248
             +PE   L       D++S G++L E++     +  ++V S+
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295

Length = 392

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRL------KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +G G +GSV        G ++A+K+L      ++++ +A  E    + +L  ++H+N++ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRE----LTLLKHMQHENVIG 78

Query: 99  LRGYCAEGQERLIVYDY---MPNLSL-LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           L              D+   MP +   L  + G   SE  + +     +      G+ Y+
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYI 133

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEY 213
           H      IIHRD+K  N+ ++ D + ++ DFG A+      T +V TR      Y APE 
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185

Query: 214 AM-LGKASESCDVYSFGILLLELASGK 239
            +     +++ D++S G ++ E+ +GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 14/95 (14%)

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAK--LIPDGA-THVTTRVKGT 205
           G+ + H H    ++HRD+K  N+L+D      ++AD G  +   IP  + TH       T
Sbjct: 122 GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----T 174

Query: 206 LGYLAPEYAMLGKA--SESCDVYSFGILLLELASG 238
           L Y APE  +LG    S   D++S G +  E++  
Sbjct: 175 LWYRAPE-VLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 63/239 (26%), Positives = 111/239 (46%), Gaps = 22/239 (9%)

Query: 46  LGEGGFGSVYWG---QLWDGSQIAVKR--LKVW--SNKAEME-FAVEVEILARVRHKNLL 97
           LG+G F  ++ G   ++ D  ++      LKV   S++   E F     +++++ HK+L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
              G C  G E ++V +Y+   SL ++L    +   L+N + ++++A   A     LH  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWA---LHFL 116

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL----GYLAPEY 213
               + H ++ A NVLL  +   +  +  F KL  D    +T   K  L     ++ PE 
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL-SDPGISITVLPKEILLERIPWVPPEC 175

Query: 214 AMLGKA-SESCDVYSFGILLLELASG-KKPIEKVNSAIKRTITDWALPLACERKFSELA 270
               +  S + D +SFG  L E+ SG  KP+  ++S  K    +    L    K++ELA
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAP-KWTELA 233

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 17/103 (16%)

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL--------IPDGATHVTTR--- 201
           YLH++    I+HRD+K  N+L+ +    ++ DFG +K+        + +G     TR   
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 202 ---VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
              V GT  Y+APE  +     +  D ++ GI+L E   G  P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 35/222 (15%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRL---KVWSNKAEMEFAVEVEILAR 90
           S   ++   N +G G FG VY     D S ++A+K++     + N+       E+ I+  
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKN 115

Query: 91  VRHKNLLSLRGY----CAEGQERLI----VYDYMPNLSLLSHLHGQHSSECLLNWNRRMD 142
           + H N++ L+ Y    C +  E+ I    V +++P        H   ++  L  +  ++ 
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL- 174

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHV 198
            +      + Y+H   +  I HRD+K  N+L+D +    ++ DFG AK +  G    +++
Sbjct: 175 YSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 199 TTRVKGTLGYLAPEYAMLGKASESC--DVYSFGILLLELASG 238
            +R      Y APE  MLG  + +   D++S G ++ E+  G
Sbjct: 232 CSRF-----YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 23/152 (15%)

Query: 49  GGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEM-------EFAVEVEILARVRHKNLLSLR 100
           G FG VY G+  + S++ AVK +K    KA+M       +   E + LA  +   ++ L 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVK----KADMINKNMVHQVQAERDALALSKSPFIVHLY 70

Query: 101 GYCAEGQERLIVYDYM--PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
                     +V +Y+   ++  L H++G    E  + +   + +A+       YLH H 
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHRHG 124

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
              IIHRD+K  N+L+  +   ++ DFG +K+
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 31/201 (15%)

Query: 68  KRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE--RLIVYDYMP----NLSL 121
           KR+K  S +A ++   E+  L R+ H+N+L +       +E  R     YM     +  L
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI-------EEILRSEANTYMITQKYDFDL 249

Query: 122 LSHLHG---QHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF 178
            S ++          LL   R +   +  A  + Y+H      +IHRDIK  N+ L+ D 
Sbjct: 250 YSFMYDEAFDWKDRPLLKQTRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIFLNCDG 304

Query: 179 KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS- 237
           K  + DFG A               GT+   +PE        E  D++S G++LL++ S 
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Query: 238 --------GKKPIEKVNSAIK 250
                   G KP +++   I 
Sbjct: 365 DFCPIGDGGGKPGKQLLKIID 385

Length = 501

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 41/205 (20%)

Query: 62  GSQIAVKRLKVWSNKAEMEFAVEVEILAR--VRHKNLLSLRGYCAEGQERLIVYDYMPNL 119
           G+ + V+   + +   E   A++ E++     RH N+++       G    ++  +M   
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 120 S---LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
           S   LL     +  SE L+      +I  G+  G+ YLH +     IHR+IKAS++L+  
Sbjct: 85  SANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHILISG 136

Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVK----------------GTLGYLAPEYAM--LGK 218
           D        G   L   G +H+ + V+                  L +L+PE     L  
Sbjct: 137 D--------GLVSL--SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG 186

Query: 219 ASESCDVYSFGILLLELASGKKPIE 243
            +   D+YS GI   ELA+G+ P +
Sbjct: 187 YNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 10/93 (10%)

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLG 207
           +G+ Y+H      IIHRD+K  N+ ++ D + ++ DFG A+      T +V TR      
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180

Query: 208 YLAPEYAM-LGKASESCDVYSFGILLLELASGK 239
           Y APE  +     +++ D++S G ++ E+ +GK
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 60/236 (25%), Positives = 87/236 (36%), Gaps = 51/236 (21%)

Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEME-------FAVEVEILARVRHKNL 96
            LG+G  G V+  +L    ++ A+K L    +K EM           E EILA + H  L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVL----DKKEMIKRNKVKRVLTEQEILATLDHPFL 63

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV---Y 153
            +L           +V DY P   L   L  Q   +CL            +AE ++   Y
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQ-PGKCL----SEEVARFYAAEVLLALEY 118

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV--------------- 198
           LH      I++RD+K  N+LL       ++DF  +K        V               
Sbjct: 119 LH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 199 ----------TTRVK---GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
                     + R     GT  Y+APE         + D ++ GILL E+  G  P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 54/239 (22%), Positives = 94/239 (39%), Gaps = 48/239 (20%)

Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN--KAEMEFAVEVEIL 88
           +++  +T  F   + LGEG FG V   + WD  +     +K+  N  K   +  +E++ +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVV--EAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFM 179

Query: 89  ARVRHKN------LLSLRGYCAE--GQERLIVYDYMPNLSLLSHLHGQHSSECLLNW--- 137
            +VR  +      L+ ++ Y     G   +++  Y P               CLL+W   
Sbjct: 180 EKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGP---------------CLLDWIMK 224

Query: 138 ----NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD 193
               + R    I    G+   + H   H++H D+K  N+L++      V       L PD
Sbjct: 225 HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETS-DTVVDPVTNRALPPD 283

Query: 194 -------------GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK 239
                           H  T +  T  Y +PE  +      S D++S G ++ EL +GK
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 30/118 (25%), Positives = 44/118 (37%), Gaps = 41/118 (34%)

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT---------------------- 200
           IHRDIK  N+LLDA    +++DFG         +H T                       
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 201 ------------RVK-----GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
                       R       GT  Y+APE  +    ++ CD +S G+++ E+  G  P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 58/249 (23%), Positives = 93/249 (37%), Gaps = 63/249 (25%)

Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRLK---VWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG G FG V      D  +  A+K L+   V +         E +ILA   ++ ++ L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67

Query: 102 YCAEGQERL-IVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           Y  + ++ L  V DY+P   ++S L             +   + +AI S   + +     
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF----- 122

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFA------------------------------ 188
               IHRDIK  N+L+D D   ++ DFG                                
Sbjct: 123 ----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 189 -----------KLIPDGATHVTTR-----VKGTLGYLAPEYAMLGKASESCDVYSFGILL 232
                      K +   AT    R     + GT  Y+APE  +    ++ CD +S G++L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 233 LELASGKKP 241
            E+  G+ P
Sbjct: 239 FEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 4/87 (4%)

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG-ATHVTTRVKGTLGYL 209
           I Y+H      IIHRDIK  NVL++      + DFG A       +T     + GT+   
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 210 APEYAMLGKASESCDVYSFGILLLELA 236
           APE       + S D++S G+++ E A
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 30/121 (24%), Positives = 44/121 (36%), Gaps = 42/121 (34%)

Query: 163 IHRDIKASNVLLDADFKAQVADFGF----------------------------------- 187
           IHRDIK  N+L+D D   ++ DFG                                    
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 188 AKLIPDGATHVT--TRVK-----GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
            +L P          R       GT  Y+APE  +    ++ CD +S G++L E+  G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 241 P 241
           P
Sbjct: 243 P 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 31/129 (24%), Positives = 48/129 (37%), Gaps = 35/129 (27%)

Query: 163 IHRDIKASNVLLDADFKAQVADFGF----------------------------------A 188
           IHRDIK  N+LLDA    +++DFG                                   A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-EKVNS 247
           +        +     GT  Y+APE  M    ++ CD +S G+++ E+  G  P   +   
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 248 AIKRTITDW 256
              R + +W
Sbjct: 243 ETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 21/114 (18%)

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF----------GFAKLIP 192
           I  G  + + Y+HH      +HR +KAS++L+  D K  ++               +++ 
Sbjct: 106 ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162

Query: 193 DGATHVTTRVKGTLGYLAPEYA---MLGKASESCDVYSFGILLLELASGKKPIE 243
           D   + + +V   L +L+PE     + G  ++S D+YS GI   ELA+G  P +
Sbjct: 163 DFPKY-SVKV---LPWLSPEVLQQNLQGYDAKS-DIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 31/129 (24%), Positives = 49/129 (37%), Gaps = 35/129 (27%)

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAK----------------LIPDGATHVTTRVK--- 203
           IHRDIK  N+LLD+    +++DFG                    +P   T      K   
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 204 ---------------GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-EKVNS 247
                          GT  Y+APE  M    ++ CD +S G+++ E+  G  P   +   
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 248 AIKRTITDW 256
              + + +W
Sbjct: 243 ETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 10/107 (9%)

Query: 38  NNFNYDNKLGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           +N  +   LG G FG V        G+  +  ++AVK LK  ++  E E    E++IL+ 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLN 136
           + +HKN+++L G C  G   L++ +Y     LL+ L  +  +E  LN
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RKKAETFLN 142

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	400
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
smart00090	237	RIO RIO-like kinase.	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG1243	690	consensus Protein kinase [General function predict	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.24
COG4248	637	Uncharacterized protein with protein kinase and he	99.21
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.98
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.76
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.74
PRK09902	216	hypothetical protein; Provisional	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.71
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.62
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.43
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.42
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.3
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.23
PLN02876	822	acyl-CoA dehydrogenase	98.2
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.16
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.13
PRK10593	297	hypothetical protein; Provisional	98.12
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.1
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.08
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.96
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
PRK05231	319	homoserine kinase; Provisional	97.88
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.73
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.71
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.42
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.33
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.29
PLN02236	344	choline kinase	97.28
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.25
PLN02756	418	S-methyl-5-thioribose kinase	97.22
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.17
KOG2270	520	consensus Serine/threonine protein kinase involved	97.05
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.02
PRK12396	409	5-methylribose kinase; Reviewed	96.93
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.93
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.81
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.73
PRK11768	325	serine/threonine protein kinase; Provisional	96.72
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.6
COG2334	331	Putative homoserine kinase type II (protein kinase	96.48
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.41
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.14
PTZ00384	383	choline kinase; Provisional	95.77
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.58
PRK06148	1013	hypothetical protein; Provisional	95.4
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.44

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-55  Score=415.06  Aligned_cols=288  Identities=51%  Similarity=0.882  Sum_probs=251.3

Q ss_pred             CcccccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           24 TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        24 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      +.+.|+++++..||++|.-...||+|+||.||+|...++..||||++.........+|..|+.++..++|||+|+++|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            78899999999999999999999999999999998888899999988764443144599999999999999999999999


Q ss_pred             EeCC-eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEE
Q 015797          104 AEGQ-ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV  182 (400)
Q Consensus       104 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl  182 (400)
                      .+.+ ..+||+||+++|+|.++|......  .++|..++.|+.++|+||+|||....|+||||||||+|||+|+++..||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9999 599999999999999999876543  6899999999999999999999988888999999999999999999999


Q ss_pred             EecCCccccCC-CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchh
Q 015797          183 ADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLA  261 (400)
Q Consensus       183 ~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~  261 (400)
                      +|||+++.... ........ .||.+|+|||++..+..+.|+||||||++|.||+||+.|.+.........+..|..+..
T Consensus       219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999976543 22221111 69999999999999999999999999999999999999987654333344777777777


Q ss_pred             cccccccccCccCC-CCCcH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          262 CERKFSELADPRLN-GNFVE-EELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       262 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ....+.+++|+.+. +.+.. .....+..++..|++.+|..||+|.+|++.|+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            77789999999987 55554 6888899999999999999999999999988543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-51  Score=370.95  Aligned_cols=252  Identities=26%  Similarity=0.350  Sum_probs=205.4

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec-CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe-EEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE-RLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~e~  115 (400)
                      +.+..+.||+|..|+||++.+ .+++.+|+|++.. .......++.+|+++++..+||+||++||.|..++. ++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            455678999999999999965 5688999999964 344556789999999999999999999999999995 9999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |++|||.+++...+    .+++...-.++.++++||.|||+ ++   ||||||||+||||++.|.+||||||.+..+.+.
T Consensus       160 MDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999987543    38889999999999999999996 65   999999999999999999999999999987654


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                         ...+.+||..|||||.+++..|+.++||||||++++|+++|+.||......       +..+......+-.-..|.+
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-------~~~~~~Ll~~Iv~~ppP~l  302 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-------YLDIFELLCAIVDEPPPRL  302 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-------CCCHHHHHHHHhcCCCCCC
Confidence               445667999999999999999999999999999999999999999764110       0000000000111112222


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +..   ....++..++..||++||.+|||+.++++.
T Consensus       303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            222   234478888899999999999999999973

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-51  Score=387.15  Aligned_cols=255  Identities=32%  Similarity=0.499  Sum_probs=205.8

Q ss_pred             CcCCcccccCceEEEEEEEcCCCE-EEEEEEecCChHH--HHHHHHHHHHHhcCCCCccceeeeEEEeCC-eEEEEEEcc
Q 015797           41 NYDNKLGEGGFGSVYWGQLWDGSQ-IAVKRLKVWSNKA--EMEFAVEVEILARVRHKNLLSLRGYCAEGQ-ERLIVYDYM  116 (400)
Q Consensus        41 ~~~~~LG~G~~g~Vy~a~~~~~~~-vavK~l~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~  116 (400)
                      .+.+.||.|+||+||+|.+ .|+. ||+|++.......  ...|.+|+.+|+.|+|||||+|+|+|.+.. ..++||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3455699999999999985 4555 9999997543322  458999999999999999999999999988 799999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCccccCCCC
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGA  195 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~~~~~~~  195 (400)
                      ++|+|.+++...  ....+++..++.|+.||+.||.|||+.+.  ||||||||+||||+.++ ++||+|||+++......
T Consensus       123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999864  23359999999999999999999999862  99999999999999998 99999999998765432


Q ss_pred             ceeeeecccccCcCChhhhc--cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAM--LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                       ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.||...........           .......+ 
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~-----------v~~~~~Rp-  265 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA-----------VVVGGLRP-  265 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH-----------HHhcCCCC-
Confidence             2222356999999999999  56999999999999999999999999987664110000           00000111 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         .........+..+|..||+.||..||++.+++..|..+..
T Consensus       266 ---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  266 ---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             ---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence               1112244578888899999999999999999999876544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-50  Score=383.72  Aligned_cols=244  Identities=25%  Similarity=0.407  Sum_probs=207.8

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec---CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      .+|...+.||+|||+.||.+++ .+|+.||+|++..   ........+.+|+++.+.|+|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999976 7899999999974   34455667899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |+|.+++|..++.++.    ++++.++..+++||+.||.|||+++   |+|||||..|+|++++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999887433    4999999999999999999999998   99999999999999999999999999998864


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhh--hccccchhccccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTI--TDWALPLACERKFSELA  270 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~  270 (400)
                      ... ...+.+|||.|+|||++.....+..+||||+||+||.||+|++||+...-. ....+  .++..|           
T Consensus       171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P-----------  238 (592)
T KOG0575|consen  171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP-----------  238 (592)
T ss_pred             ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-----------
Confidence            322 344678999999999999999999999999999999999999999865321 11111  111111           


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                            ...   ...-.+||.++|+.||.+|||+.+|+.
T Consensus       239 ------~~l---s~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  239 ------SHL---SAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------ccc---CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  111   234456778999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-52  Score=360.85  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=209.0

Q ss_pred             ccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEec--CChHHHHHHHHHHHHHhcCCCCccceeee-EEEeCCe-EEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLRG-YCAEGQE-RLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~~-~~l  111 (400)
                      ..+|++.+.||.|+||.||++ ...+|..+|.|.++.  ........+..|+.+|++|+|||||++++ .|.+++. ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            356889999999999999999 567899999998873  33444556888999999999999999999 5666666 899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA-TPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      |||||.+|+|.+.+..-......+++..+|.++.|++.||..+|+.- ...|+||||||.||+++.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999998755555567999999999999999999999831 12399999999999999999999999999998


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhh-hhhhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS-AIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      +.+... ...+.+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.+.+- .+...+.+...           
T Consensus       178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-----------  245 (375)
T KOG0591|consen  178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-----------  245 (375)
T ss_pred             hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-----------
Confidence            765443 34556799999999999999999999999999999999999999987642 12222221111           


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                        +.++   ..-...++..+|.-|+..||+.||+...++..+.
T Consensus       246 --~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  246 --PPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             --CCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence              1111   1233457788889999999999999666665543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=363.77  Aligned_cols=203  Identities=26%  Similarity=0.449  Sum_probs=182.6

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ...++|.+.+.||.|+||+||+|+. .++..||||.+...  .....+.+..|+.+|+.++|||||.+++++..++.+|+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            3457899999999999999999964 56899999999765  55556678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC------CcEEEEec
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD------FKAQVADF  185 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~------~~~kl~Df  185 (400)
                      |||||+||+|.++|+.+.    .+++..+..++.||+.||++||+++   ||||||||.|||++..      -.+||+||
T Consensus        87 VMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            999999999999998765    3899999999999999999999998   9999999999999865      46899999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      |+++.+...  ....+.+|+|.|||||+++.+.|+.|+|+||+|+|||+|++|+.||...+
T Consensus       160 GfAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  160 GFARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             chhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            999988643  33456789999999999999999999999999999999999999998554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-50  Score=378.49  Aligned_cols=254  Identities=34%  Similarity=0.530  Sum_probs=211.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      ..+++++.||+|-||.||.|.+.....||+|.++... .....|.+|+++|+.|+|+|||+++++|..+..+||||||++
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            4446789999999999999998777799999998643 234568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      .|+|.++|....  ...++..+.+.++.|||+||+||++++   +|||||-.+||||++++.+||+|||+++...++...
T Consensus       285 ~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  285 KGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             cCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            999999998633  234888999999999999999999998   999999999999999999999999999966555444


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hh-hhccccchhcccccccccCccC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RT-ITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      ......-+..|+|||.+..+.+|.|||||||||+||||+| |+.||........ .. -..+.+|               
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp---------------  424 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP---------------  424 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC---------------
Confidence            4443445678999999999999999999999999999999 9999987664321 11 1222222               


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                         ....++..+.++|..||..+|++||||..+...|....
T Consensus       425 ---~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  425 ---RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             ---CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence               11223457888999999999999999999998886654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-50  Score=366.72  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=203.8

Q ss_pred             HccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChH-------HHHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNK-------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  107 (400)
                      ..+.|.+.+.||+|+||.|-+| ...+|+.||||+++.....       ......+|+++|+.|+|||||+++++|+...
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            5577899999999999999999 5578999999999742221       2234578999999999999999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC---CcEEEEe
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD---FKAQVAD  184 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~---~~~kl~D  184 (400)
                      ..|+||||+.||+|.+.+..+..    +.+..-..++.|++.|+.|||++|   |+||||||+|||++.+   -.+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999999976543    666677889999999999999999   9999999999999876   6799999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCC---CCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALP  259 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~  259 (400)
                      ||+++...  ....+.+.+|||.|.|||++.+..+   ..+.||||+||+||-+++|.+||......  ..+++.....+
T Consensus       323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            99999765  4455667899999999999987654   34779999999999999999999764322  22222221111


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +. +             ..-.....+..++|.+||..||++|||+.|+|+.
T Consensus       401 f~-p-------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  401 FG-P-------------LQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cc-C-------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            10 0             0112234567788899999999999999999974

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-48  Score=348.11  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=203.3

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ...++|++.+.||+|+||.||.++. .+++.+|+|+++..   ...+......|..+|..++||.||+++-.|++...+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            3457889999999999999999954 56999999999753   2344567888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|+||++||.|...|.+..    .+++..+.-++..|+.||.|||+++   ||||||||+|||+|.+|+++|+|||+|+.
T Consensus       102 lVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence            9999999999999997544    3899999999999999999999999   99999999999999999999999999985


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .... ...+.+.+||+.|||||++.+..|+.++|+||||+++|+|++|.+||...+.. ..+.+.....+          
T Consensus       175 ~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~----------  243 (357)
T KOG0598|consen  175 DLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP----------  243 (357)
T ss_pred             cccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC----------
Confidence            4332 22344578999999999999999999999999999999999999999876532 11221111100          


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP----TMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~ell~  309 (400)
                          ..+...   .....+++.+.|..||.+|.    ++.+|.+
T Consensus       244 ----~~p~~l---s~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  244 ----LPPGYL---SEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             ----CCCccC---CHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence                001112   23566677888999999996    4555543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-47  Score=347.47  Aligned_cols=265  Identities=25%  Similarity=0.341  Sum_probs=213.8

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH-HHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA-EMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..+......|++.+.||.|..++||+|+. ..+..||||+++...... ...+.+|++.|+.++||||++++..|..+..
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            33455678899999999999999999954 568999999998654443 4789999999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      +++||+||.+||+.+.+.......  +++..+..+++++++||.|||.+|   .||||||+.||||+++|.|||+|||.+
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence            999999999999999998766554  899999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCceee---eecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchh
Q 015797          189 KLIPDGATHVT---TRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLA  261 (400)
Q Consensus       189 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~  261 (400)
                      ..+........   .+.+||++|||||++..  ..|+.|+|||||||+..||++|..||......  +...+.+. .|..
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~-pp~~  252 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND-PPTL  252 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-CCCc
Confidence            76544322211   34579999999999643  57999999999999999999999999876532  11111110 0100


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                              .-..+..+......+.+..++..||.+||.+|||++++++
T Consensus       253 --------~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 --------LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             --------ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                    0011111222233457888999999999999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=349.94  Aligned_cols=255  Identities=29%  Similarity=0.437  Sum_probs=201.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC--eEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ--ERLIVY  113 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~  113 (400)
                      ..+|..++.||+|+||.||++.+ .+|+..|||.+..........+..|+.+|++|+|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            56788999999999999999965 448999999987654333566889999999999999999999755444  689999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecCCccccC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIP  192 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~~~~~  192 (400)
                      ||+++|+|.+++.+...   .+++..+..+.+|+++||.|||+++   ++||||||+||||+. ++.+||+|||++....
T Consensus        96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            99999999999986553   3899999999999999999999999   999999999999999 7999999999998765


Q ss_pred             C--CCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhh-hhhhhhhhhccccchhccccccc
Q 015797          193 D--GATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKV-NSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       193 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      .  ..........||+.|||||++.++ ....++|||||||++.||+||..||... .... ..+.     .....    
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-~~~~-----ig~~~----  239 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-ALLL-----IGRED----  239 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-HHHH-----HhccC----
Confidence            3  222223346799999999999964 3345999999999999999999999863 1110 0000     00000    


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                       ..|.+    .........+++.+|+..||+.|||+.++|+...
T Consensus       240 -~~P~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 -SLPEI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             -CCCCC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence             01111    1122345667789999999999999999998653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-47  Score=335.53  Aligned_cols=264  Identities=20%  Similarity=0.297  Sum_probs=206.2

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|+.+.++|+|+||+||+.++ .+|+.||||++.....  ....-.++|+++|++|+|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688889999999999999965 5699999999865332  233457889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      ||+. ++.+-|....+.   ++...+.+++.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|+.+.. 
T Consensus        82 ~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            9986 666667655543   888999999999999999999998   99999999999999999999999999998864 


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhcc----ccc-----hhccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW----ALP-----LACER  264 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~----~~~-----~~~~~  264 (400)
                      .....+.++.|..|.|||++.+ -+|+.+.||||+||++.||++|.+-|.+.++...-.....    ..|     +...+
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            3334556678999999999988 6899999999999999999999999876543211110000    000     00011


Q ss_pred             cccccc-----CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELA-----DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .+..+.     .+..-..-.+....-+++++.+||..||.+|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111111     111111123334457889999999999999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=358.97  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=212.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .+....|.....||+|+.|.||.| +..+++.||||++.........-+.+|+.+|+.++|+|||++++.|..++.+++|
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            345678888999999999999999 4567899999999876666667789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||++||+|.+.+....     +++.++..+++.+++||+|||.++   |+|||||.+|||++.+|.+||+|||+|..+.
T Consensus       349 MEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             EeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            99999999999886443     889999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhccccccccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ..... ..+.+|||.|||||++....|++|.||||||+++.||+-|.+||-..+.-  +....... .            
T Consensus       421 ~~~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~------------  486 (550)
T KOG0578|consen  421 EEQSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-T------------  486 (550)
T ss_pred             cccCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-C------------
Confidence            54443 33467999999999999999999999999999999999999999754321  11111110 0            


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       +.+  .........+.+++.+||..||.+|+++.|||+.
T Consensus       487 -P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 -PKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -CCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence             111  1122334577788899999999999999999983

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=351.12  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=212.1

Q ss_pred             HHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .....|+..+.||+|+||.||+| ...+++.||+|++..... .+..++.+|+.+|.+++++||.++|+.+..+..++++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            44566788899999999999999 456799999999986544 3456799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||.||++.+.+....    .+++..+.-++++++.||.|||..+   .+|||||+.|||+..+|.+||+|||.+..+.
T Consensus        90 Mey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeee
Confidence            99999999999987543    2466777778999999999999998   9999999999999999999999999998877


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...... .+.+|||.|||||++.+..|+.|+||||||++.+||++|.+|+.....            +-..-.+.+-.+|
T Consensus       163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------mrvlflIpk~~PP  229 (467)
T KOG0201|consen  163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------MRVLFLIPKSAPP  229 (467)
T ss_pred             chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------ceEEEeccCCCCC
Confidence            655444 566799999999999988999999999999999999999999976653            1112223333444


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+.+.+    ...+.+++..||.+||+.||++.++++.
T Consensus       230 ~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            454433    3367778899999999999999999973

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=352.80  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=206.5

Q ss_pred             HHHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  108 (400)
                      ....++|.+++.||.|+|++|++|+ ..+++.+|||++....   ..-..-+..|-.+|..| .||.|+++|-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4456899999999999999999994 4679999999986422   12223456788999999 89999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      +|+|+||+++|+|.++|...+    .+++.....++.+|+.||.|||++|   ||||||||+|||+|.||++||+|||.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence            999999999999999998664    3999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCce------------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhc
Q 015797          189 KLIPDGATH------------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITD  255 (400)
Q Consensus       189 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~  255 (400)
                      ..+......            .....+||..|.+||++..+..++.+|||+||||||+|+.|.+||...+.-. .+.+..
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            987542221            1134679999999999999999999999999999999999999998776421 111111


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..      -        .+...+.    ....+|+.+.|-.||.+|+|+.+|.+.
T Consensus       302 l~------y--------~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 LD------Y--------EFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             hc------c--------cCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence            00      0        0111122    356667788888999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-46  Score=353.02  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=205.4

Q ss_pred             HHHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecC----Ch-HHHHHHHHHHHHHhcCC-CCccceeeeEEEeC
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW----SN-KAEMEFAVEVEILARVR-HKNLLSLRGYCAEG  106 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  106 (400)
                      ....++|.+++.||+|+||+|+.|. ..+++.||+|++...    .. .....+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            4567899999999999999999994 467899999977643    12 23445778999999998 99999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-CcEEEEec
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADF  185 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~~kl~Df  185 (400)
                      ..+|+|||||.||+|.+++....    .+.+..+..++.|++.|++|||+++   |+||||||+|||++.+ +.+||+||
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence            99999999999999999998633    3788999999999999999999999   9999999999999999 99999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCC-CC-CccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK-AS-ESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLAC  262 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~  262 (400)
                      |++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+.. ....+....     
T Consensus       166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-----  239 (370)
T KOG0583|consen  166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-----  239 (370)
T ss_pred             ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-----
Confidence            9999764 2233345668999999999999877 85 7899999999999999999999874421 111111000     


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       -.+..        ...   ...+..++.+||..||.+|+|+.+++.
T Consensus       240 -~~~p~--------~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 -FKIPS--------YLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -ccCCC--------CcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             00000        110   346777889999999999999999995

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-45  Score=353.21  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=201.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC-
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG-  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-  106 (400)
                      ..++|++.+.||+|+||.||+|..      ..++.||+|++.... ......+..|+.++..+ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            457899999999999999999953      235689999987533 33345688999999999 899999999988764 


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCc-------------------------------------------------------
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSS-------------------------------------------------------  131 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  131 (400)
                      ...++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4578999999999999998643210                                                       


Q ss_pred             ---ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce-eeeecccccC
Q 015797          132 ---ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLG  207 (400)
Q Consensus       132 ---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~  207 (400)
                         ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ ......+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               123778888999999999999999998   999999999999999999999999999865332221 1122346788


Q ss_pred             cCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--hhhhhhccccchhcccccccccCccCCCCCcHHHHH
Q 015797          208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--IKRTITDWALPLACERKFSELADPRLNGNFVEEELK  284 (400)
Q Consensus       208 y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (400)
                      |+|||++.+..++.++|||||||++|||++ |..||......  ....+....             ....    ......
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------------~~~~----~~~~~~  304 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-------------RMRA----PENATP  304 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-------------CCCC----CCCCCH
Confidence            999999999999999999999999999997 99999754321  111111000             0000    111234


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          285 RVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       285 ~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6788999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-45  Score=317.90  Aligned_cols=265  Identities=21%  Similarity=0.333  Sum_probs=209.9

Q ss_pred             cCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .+|...+.||+|.||.||+| +..+|+.||||.++.....  ......+|++.|+.++||||+.++++|....++.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            57888999999999999999 4578999999999865433  24568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |++. +|..++....   ..+....+..|+.++++|++|||.+.   |+||||||.|+||+++|.+||+|||+++.+...
T Consensus        82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9974 9999887543   35888999999999999999999998   999999999999999999999999999998765


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccch--hcc-----c
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPL--ACE-----R  264 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~--~~~-----~  264 (400)
                      ....... +-|..|.|||++.| ..|+...||||.|||+.||+-|.+-|.+.++-  ....+.....|.  .++     .
T Consensus       155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            5544433 58999999999986 57999999999999999999988777654432  111121111111  111     1


Q ss_pred             ccccc--cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSEL--ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...++  .+....+...+....+.++++.++|..||.+|+|+.|.+++
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11111  11122222445556677999999999999999999999974

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-45  Score=342.38  Aligned_cols=268  Identities=24%  Similarity=0.319  Sum_probs=207.5

Q ss_pred             HHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QER  109 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~  109 (400)
                      .-.+.|+.+++||+|.||.||+|+ ..+|+.||+|++....  .....-..+|+.+|++|+||||+++.+...+.  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            334567888999999999999995 5679999999998655  33345577899999999999999999998876  789


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+|+|||+. +|.-++...   ...|+..++..++.||+.||.|||.++   |+|||||.+|||||.+|.+||+||||++
T Consensus       194 YlVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             EEEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence            999999985 888887643   345999999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc-
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS-  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  267 (400)
                      .+........+..+-|..|.|||++.|. .|+.+.|+||.||||.||++|++.|.+......-...-.....+.+..|. 
T Consensus       267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence            8776655556666789999999999874 79999999999999999999999997665432211110000001111111 


Q ss_pred             ------cccCccCC-CC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ------ELADPRLN-GN----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ------~~~~~~~~-~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                            ..+.+.-. ..    .........++|+..+|..||.+|.|+.+.|+
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                  11111000 00    01112346677889999999999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-45  Score=348.06  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=208.4

Q ss_pred             cCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEec--CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|.+.+.||+|+||.||+| +.++.+.||+|.+..  ....+...+.+|+++++.|+||||+.+++.|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57999999999999999999 567899999999864  334456678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      ||.| +|..+|....    .++++.+..++.|++.||.|||+.+   |+|||+||.|||++..|.+|++|||+++.+.. 
T Consensus        82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9986 9999997654    3999999999999999999999998   99999999999999999999999999998765 


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhh-hhhhhhhccccchhcccccccccCcc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS-AIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      .+...+.+.|||.|||||++.++.|+..+|+||+|||+|||++|++||....- .....+..            +...  
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~------------d~v~--  218 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK------------DPVK--  218 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc------------CCCC--
Confidence            34445567899999999999999999999999999999999999999975431 11111110            0000  


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          ..+.....+..++...|.+||.+|.|-.+++..
T Consensus       219 ----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 ----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ----CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                112334578888899999999999999999874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=346.47  Aligned_cols=267  Identities=22%  Similarity=0.333  Sum_probs=209.4

Q ss_pred             HHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCC-eEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQ-ERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~~  110 (400)
                      ..-++|.++++||.|+||.||+|+ ..++..||||.++..- ..++..-.+|+..|++|+ ||||+++.+++.+.. .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            455789999999999999999995 4679999999987533 333445568999999998 999999999999888 999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|||||+ .+|.+++..+.   ..+++..+..|+.||++||+|+|.+|   +.|||+||+||||.....+||+|||+|+.
T Consensus        87 fVfE~Md-~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeHHhhh-hhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            9999996 69999998763   35999999999999999999999999   99999999999999888999999999998


Q ss_pred             cCCCCceeeeecccccCcCChhhhc-cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccc---
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAM-LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF---  266 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---  266 (400)
                      +.+...  .+.++.|..|.|||++. .+.|+.+.|||++|||++|+.+-++-|.+.+....-.........+....+   
T Consensus       160 v~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  160 VRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             cccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            764433  45667999999999875 678999999999999999999999998765532111110000000000011   


Q ss_pred             ---ccccC---ccCC----CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          267 ---SELAD---PRLN----GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       267 ---~~~~~---~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ...+.   +...    ....+....+.+.+|.+|++.||.+|||+.+.++.
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               10110   1111    12233456688889999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=346.77  Aligned_cols=251  Identities=27%  Similarity=0.493  Sum_probs=205.4

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG  106 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  106 (400)
                      .+++++|..       ++-||.|+-|.||+|+. .++.||||.++....       .+++.|+.|+||||+.|.|+|...
T Consensus       120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  120 EIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             cCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCC
Confidence            466777764       46899999999999984 789999998764322       467889999999999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      .-+|||||||..|-|..+|....    .+.......|..+||.||.|||.+.   |||||||+-||||+.+..|||+|||
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecccc
Confidence            99999999999999999997544    3778889999999999999999997   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF  266 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  266 (400)
                      -++...+.  .......||..|||||++++.+.++|.|||||||+|||||||..||.+.....    .-|...   ...+
T Consensus       258 TS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVG---sNsL  328 (904)
T KOG4721|consen  258 TSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVG---SNSL  328 (904)
T ss_pred             chHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEecc---CCcc
Confidence            99876543  22334679999999999999999999999999999999999999997654310    111110   0111


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .-        ...+.++..+.-||.+||+..|..||+|++++..|.....
T Consensus       329 ~L--------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  329 HL--------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             cc--------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            11        1223345577888999999999999999999998865433

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.6e-44  Score=335.21  Aligned_cols=243  Identities=18%  Similarity=0.292  Sum_probs=195.1

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHH---HHHHHHHHHHHhcCCCCccceeeeEEEe----CCeEEEEEEcc
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA---EMEFAVEVEILARVRHKNLLSLRGYCAE----GQERLIVYDYM  116 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~  116 (400)
                      ..||+|++|.||+|.. +|+.||+|.+.......   ...+.+|+.+|+.++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999975 78999999987543222   3567899999999999999999999877    45789999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      ++|+|.+++....    .+++...+.++.|++.||.|||.. +   ++||||||+||+++.++.+||+|||++.......
T Consensus       105 ~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        105 TRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            9999999987542    388899999999999999999984 5   7899999999999999999999999998654322


Q ss_pred             ceeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          196 THVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                          ....|++.|+|||++.+  ..++.++|||||||++|||+||..||....... ...+....            ...
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~------------~~~  241 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN------------NSL  241 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------------CCC
Confidence                12358999999999976  689999999999999999999999998654221 11110000            000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ...    ......+.+++.+||+.||++|||+.++++.|+..
T Consensus       242 ~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        242 KLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            011    11234677888999999999999999999988643

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.9e-45  Score=364.00  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=212.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ..+-.+.+.||+|+||.||+|...      ....||||.++..... ...+|++|+.+|..|+|||||+++|+|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345566789999999999999642      3567999999976655 677899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCc----------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSS----------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      |+|+|||..|+|.++|..+...          ..+++..+.+.|+.|||.||.||-++.   +|||||-.+||||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            9999999999999999654322          223788899999999999999999997   999999999999999999


Q ss_pred             EEEEecCCccccCCCCceeee-ecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhh-hhhcc
Q 015797          180 AQVADFGFAKLIPDGATHVTT-RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKR-TITDW  256 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~-~~~~~  256 (400)
                      |||+|||+++..-+....... ...-...|||||.+..++||++||||||||+|||+++ |+.||.+......- .+...
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g  721 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG  721 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence            999999999976554433322 3335779999999999999999999999999999998 99999877643221 11111


Q ss_pred             ccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                              .+  +       .....++..+..||..||+.+|.+||+|+||-..|+..
T Consensus       722 --------~l--L-------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  722 --------QL--L-------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             --------Cc--c-------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                    11  0       12233456889999999999999999999999998754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=340.08  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=203.8

Q ss_pred             HHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ...++|.+++.||+|+||.||+|+ ..+|..+|+|+++..   ........+.|-.+|....+|+||++|-.|++..++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            357899999999999999999995 457999999999753   2333456788999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      |||||++||++..+|.+..    .+++..+..++.+.+.|+..||..|   +|||||||+|+|||..|++||+|||||.-
T Consensus       218 LiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999997654    4899999999999999999999999   99999999999999999999999999854


Q ss_pred             cCCC-----------------------Cc-----ee------------------eeecccccCcCChhhhccCCCCCccc
Q 015797          191 IPDG-----------------------AT-----HV------------------TTRVKGTLGYLAPEYAMLGKASESCD  224 (400)
Q Consensus       191 ~~~~-----------------------~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~s~ksD  224 (400)
                      +...                       ..     ..                  ....+|||.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            3110                       00     00                  01246999999999999999999999


Q ss_pred             eehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 015797          225 VYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT  303 (400)
Q Consensus       225 IwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  303 (400)
                      +||||||+||||.|.+||...... ..+.+..|......+..           ...+   .+..+||.+|+. ||.+|..
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-----------~~~s---~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-----------VDLS---DEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-----------Cccc---HHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999999876543 33344444322111110           0111   355667789888 9999965


Q ss_pred             ---HHHHHH
Q 015797          304 ---MLEVLD  309 (400)
Q Consensus       304 ---~~ell~  309 (400)
                         +.||.+
T Consensus       436 ~~G~~EIK~  444 (550)
T KOG0605|consen  436 SKGAEEIKK  444 (550)
T ss_pred             cccHHHHhc
Confidence               777776

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-44  Score=336.19  Aligned_cols=244  Identities=23%  Similarity=0.251  Sum_probs=199.3

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            4799999999999999999965 468999999986432   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++....    .+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999986543    3788899999999999999999998   99999999999999999999999999986543


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..    ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+....              .
T Consensus       154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--------------~  215 (291)
T cd05612         154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--------------L  215 (291)
T ss_pred             Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------c
Confidence            22    22459999999999999999999999999999999999999997654221 11111000              0


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~  310 (400)
                      .+.    ......+.+++.+||+.||.+||+     +.++++.
T Consensus       216 ~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 EFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            001    111236778889999999999995     8888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-45  Score=343.44  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=210.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe-EEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE-RLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv  112 (400)
                      -++|.+++.+|+|+||.++.++. .++..+|+|.+....  ........+|+.+++++.|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            36899999999999999999953 567899999987533  3444568899999999999999999999999888 9999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |+||+||++.+.+....  ...+++..++.|+.|++.|+.|||+..   |+|||||+.|||++.++.|||+|||+++.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999997654  346999999999999999999999887   9999999999999999999999999999887


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ... ....++.|||.||+||++.+.+|+.|+|||||||++|||++-+++|...+...           ........... 
T Consensus       158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----------Li~ki~~~~~~-  224 (426)
T KOG0589|consen  158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----------LILKINRGLYS-  224 (426)
T ss_pred             Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----------HHHHHhhccCC-
Confidence            644 23456779999999999999999999999999999999999999998655321           00111111111 


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          .....+...+..++..|+..+|..||++.+||..
T Consensus       225 ----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 ----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1223334578888899999999999999999985

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8e-45  Score=345.94  Aligned_cols=269  Identities=30%  Similarity=0.455  Sum_probs=212.7

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEE
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCA  104 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  104 (400)
                      ..+.+++....+...+...||+|.||+||+|.+.  ..||||+++...  ......|+.|+.++++-+|.||+-|.|+|.
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            3444667777788889999999999999999753  468999998643  344567999999999999999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                      .++. .||+.+|.|-+|..+|+-..   ..++....+.|+.|+++||.|||.++   |||||||+.|||+.+++.|||+|
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEec
Confidence            8887 99999999999999997543   35899999999999999999999998   99999999999999999999999


Q ss_pred             cCCccccCCCC-ceeeeecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccch
Q 015797          185 FGFAKLIPDGA-THVTTRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL  260 (400)
Q Consensus       185 fgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~  260 (400)
                      ||++....... ........|...|||||+++.   .+|++.||||||||++|||+||..||...+....-....     
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-----  606 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-----  606 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-----
Confidence            99997543221 111223458899999999974   578999999999999999999999998333211000000     


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                        ++.+    .+.+ ........+.|.+|+..||..++++||++.+|+..|..+..
T Consensus       607 --rG~l----~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 --RGYL----MPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --cccc----Cccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              0100    0000 01233456688888899999999999999999997766544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.9e-44  Score=331.92  Aligned_cols=250  Identities=26%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+....   ......+..|+.+++.++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999954 579999999986432   2223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++......
T Consensus        81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999988754322  24888999999999999999999998   999999999999999999999999999865432


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhcccccccccCcc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLACERKFSELADPR  273 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+...         +.   .. 
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---------~~---~~-  220 (285)
T cd05631         156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR---------VK---ED-  220 (285)
T ss_pred             Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH---------hh---cc-
Confidence            22  22345899999999999999999999999999999999999999754321100 00000         00   00 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                       ...+.......+.+++.+||+.||.+||+     +.++++
T Consensus       221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence             00011112346778889999999999997     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-43  Score=334.22  Aligned_cols=263  Identities=24%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcC-----------------CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccce
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWD-----------------GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLS   98 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~   98 (400)
                      .++|++.+.||+|+||.||++.+.+                 +..||+|.+.... ......+..|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999996422                 3369999987543 333457889999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEccCCCChhhhhhcCCCc---------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 015797           99 LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSS---------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHII  163 (400)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  163 (400)
                      +++++.+.+..++||||+.+|+|.+++......               ...+++..++.++.|++.||.|||+.+   ++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            999999999999999999999999988643211               124678889999999999999999998   99


Q ss_pred             ecCCCCCCeEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh--CCC
Q 015797          164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS--GKK  240 (400)
Q Consensus       164 H~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt--g~~  240 (400)
                      ||||||+|||++.++.+||+|||++......... ......++..|+|||++.++.++.++|||||||++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865433221 1222346788999999999999999999999999999987  567


Q ss_pred             Chhhhhhhh-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          241 PIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       241 Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ||....... ..........   .......       ...+.....+.+++.+||+.||.+|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~---~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRD---QGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhh---ccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776543211 1110000000   0000000       001122347888999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.9e-44  Score=330.25  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=201.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|++.+.||+|+||.||+|..    ..+..||+|.++... ......+..|+.+++.++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            46789999999999999999954    236689999987543 3334568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999875432   4889999999999999999999998   999999999999999999999999987653


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ............++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...+.+..            
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------------  225 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------------  225 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------
Confidence            2221111112235678999999999999999999999999999775 999997654321 11111000            


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                       ...    ........+.+++.+||+.+|.+||++.+|++.|..
T Consensus       226 -~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 -RLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -CCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence             000    011123467788899999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-44  Score=339.31  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=202.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+..|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999654 58999999987432   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999986543    3788899999999999999999998   99999999999999999999999999986543


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+..+...      +.   .+
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------~~---~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET------LQ---RP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc------cc---CC
Confidence                2233469999999999999999999999999999999999999997644321 1111111100      00   00


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ... .........+.+++.+||..+|.+||++.++++.
T Consensus       221 ~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000 0001223467788899999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-43  Score=335.85  Aligned_cols=265  Identities=22%  Similarity=0.268  Sum_probs=203.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++.+.||+|+||.||++.. .++..+|+|.+.... ......+..|+++++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            47899999999999999999965 468889999987542 3344578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+.+  .++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999986533    3788899999999999999999853  2999999999999999999999999998765432


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhcccc------------chhc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWAL------------PLAC  262 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~------------~~~~  262 (400)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|+||+.||................            +...
T Consensus       158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            2   223459999999999999999999999999999999999999996543211111000000            0000


Q ss_pred             c--cc-----------------cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          263 E--RK-----------------FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       263 ~--~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .  ..                 ...+................+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0  00                 000000000000011233568889999999999999999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.6e-44  Score=337.67  Aligned_cols=241  Identities=22%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.||+|+||.||+|.. .+++.+|+|++....   ......+..|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 578999999987422   223346778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceee
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT  199 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~  199 (400)
                      +|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  152 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence            9999886533    3888999999999999999999998   99999999999999999999999999875322111 12


Q ss_pred             eecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCCC
Q 015797          200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGNF  278 (400)
Q Consensus       200 ~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (400)
                      ....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ...+..        ..      ..+    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------~~------~~~----  214 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------EE------IRF----  214 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------CC------CCC----
Confidence            23469999999999999999999999999999999999999997543211 111100        00      001    


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          279 VEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       279 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                      .......+.+++.+||+.||.+||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            111234677888999999999999     79999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.4e-44  Score=339.27  Aligned_cols=245  Identities=26%  Similarity=0.323  Sum_probs=199.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.+++.++||||+++++++.+++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            36789999999999999999965 468999999987422   22334678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++....
T Consensus        97 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999987543    3788888899999999999999998   9999999999999999999999999998654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ...    ....||+.|+|||++.+..++.++|||||||++|+|+||..||...... ....+.....      .      
T Consensus       170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------~------  233 (329)
T PTZ00263        170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL------K------  233 (329)
T ss_pred             CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc------C------
Confidence            322    2345999999999999999999999999999999999999999754321 1111111000      0      


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~  310 (400)
                        +...    ....+.+++.+||+.||.+||+     +.+++..
T Consensus       234 --~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 --FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              0001    1235678889999999999997     6777753

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=315.61  Aligned_cols=200  Identities=30%  Similarity=0.392  Sum_probs=179.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||.|+||.|.+++. .+|..+|+|+++...   .........|..+|+.+.||.++++++.|.+..++|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            35788899999999999999965 458889999997432   23344567799999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||++||.|..++++.+.    +++..+..++.+|+.||+|||+.+   |++|||||+|||+|.+|++||+|||++..+.
T Consensus       123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999976543    889999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhh
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS  247 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~  247 (400)
                      ..    +.+.+|||.|+|||+++...|+.++|.|||||++|||+.|.+||...+.
T Consensus       196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            43    4567899999999999999999999999999999999999999986553

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=333.23  Aligned_cols=263  Identities=23%  Similarity=0.299  Sum_probs=204.7

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--------------HHHHHHHHHHHHHhcCC
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--------------KAEMEFAVEVEILARVR   92 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~   92 (400)
                      +.-.+=....++|++.+.||+|.||.|-+|++ .+++.||||++....-              ...+...+|+.+|+.|+
T Consensus        87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            33444456679999999999999999999954 5799999999963211              12246788999999999


Q ss_pred             CCccceeeeEEEeC--CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 015797           93 HKNLLSLRGYCAEG--QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKAS  170 (400)
Q Consensus        93 hpnIv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~  170 (400)
                      |||||+++++..+.  ..+|+|+|||..|.+...-.    ....+.+.+++.++++++.||.|||.++   ||||||||+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs  239 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS  239 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence            99999999998764  67899999999998876432    2222889999999999999999999999   999999999


Q ss_pred             CeEECCCCcEEEEecCCccccCCCCc----eeeeecccccCcCChhhhccCC----CCCccceehhhHHHHHHHhCCCCh
Q 015797          171 NVLLDADFKAQVADFGFAKLIPDGAT----HVTTRVKGTLGYLAPEYAMLGK----ASESCDVYSFGILLLELASGKKPI  242 (400)
Q Consensus       171 NIlv~~~~~~kl~Dfgl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~ksDIwSlGiil~elltg~~Pf  242 (400)
                      |+||+++|++||+|||.+..+..+..    .......|||.|+|||.+.++.    .+.+.||||+||+||-|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            99999999999999999987643211    1112356999999999998743    357899999999999999999999


Q ss_pred             hhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          243 EKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ......               .....+.+..+.-...++....+.+||.++|.+||++|.+..+|.....
T Consensus       320 ~~~~~~---------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  320 FDDFEL---------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             ccchHH---------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            754421               0111222222222222344557788889999999999999999987643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-44  Score=344.17  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=206.7

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..+-|++++.||.|+.|.|-+|++ .+|+.+|||++....   ......+.+|+-+|+.+.|||++++|+++.+...+|+
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            346789999999999999999954 679999999997542   2334567889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |.||++||.|.+++..++.    +.+.++..++.||+.|+.|+|..+   |+||||||+|+|++..+.+||+|||.|.+-
T Consensus        90 vlEyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEEecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc
Confidence            9999999999999986653    889999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ..+.  ...+.||+|+|.|||++.|.+| +.++||||+|||||.||||+.||++.+.. +-..+..        +.+.- 
T Consensus       163 ~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--------G~f~M-  231 (786)
T KOG0588|consen  163 VPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--------GVFEM-  231 (786)
T ss_pred             cCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--------CcccC-
Confidence            4333  3455689999999999999998 57999999999999999999999966532 1111111        11110 


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           + .+.+   .+..+|+.+|+..||++|.|+.+|++.
T Consensus       232 -----P-s~Is---~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  232 -----P-SNIS---SEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -----C-CcCC---HHHHHHHHHHhccCccccccHHHHhhC
Confidence                 0 1222   355667789999999999999999985

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.1e-44  Score=331.90  Aligned_cols=265  Identities=21%  Similarity=0.284  Sum_probs=199.9

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++.+.||+|+||.||+|.. .+++.+|+|++....  ......+..|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            5799999999999999999965 468899999987532  2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+.++.+..+.. ..   ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~-~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEE-MP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHh-cC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999876655433 22   13888999999999999999999998   999999999999999999999999999876443


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchh--------cccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLA--------CERK  265 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~--------~~~~  265 (400)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ........+..        ....
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            32223335689999999999999999999999999999999999999975432110 00000000000        0000


Q ss_pred             cccccCccCCC------CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELADPRLNG------NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ......+....      .........+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000      001112346888999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.7e-44  Score=344.91  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=201.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  107 (400)
                      ..++|++.+.||+|+||.||+|..      .++..||+|+++... ......+..|+.+|+.+ +||||++++++|.+..
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345799999999999999999953      235689999987432 33445688899999999 8999999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCC---------------------------------------------------------
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHS---------------------------------------------------------  130 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  130 (400)
                      ..++|||||++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999999864321                                                         


Q ss_pred             --------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          131 --------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       131 --------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                                    ....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                          0124788899999999999999999998   99999999999999999999999999986543222


Q ss_pred             e-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--hhhhhhccccchhcccccccccCc
Q 015797          197 H-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--IKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       197 ~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      . ......++..|+|||++.+..++.++|||||||++|+|++ |..||......  ....+...         ... ..+
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---------~~~-~~~  339 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---------YRM-LSP  339 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC---------ccC-CCC
Confidence            1 1112335678999999999999999999999999999998 89998654321  11111100         000 000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                          ..   ....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       340 ----~~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         340 ----EC---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----CC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                11   12467888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-43  Score=325.30  Aligned_cols=250  Identities=29%  Similarity=0.492  Sum_probs=201.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      ++|++.+.||+|+||.||+|...++..+|+|.+.... .....+..|+.+++.++||||+++++++.++...++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            5688899999999999999987777889999876432 234568889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.........
T Consensus        83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          83 NGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            9999998864332   3889999999999999999999998   999999999999999999999999999865433222


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccccccCccCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ....+.....          ...+.  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~----------~~~~~--  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR----------LYRPK--  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------CCCCC--
Confidence            2222235678999999998899999999999999999999 99999755421 1111111000          00010  


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                        .   ....+.+++.+||+.+|.+||++.++++.|
T Consensus       225 --~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 --L---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --C---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              1   124678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-43  Score=325.29  Aligned_cols=254  Identities=29%  Similarity=0.469  Sum_probs=204.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||+|++|.||+|...++..||+|.+..... ....+..|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            467899999999999999999877788899998765332 3457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....  ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999865432  24788889999999999999999988   99999999999999999999999999987654322


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......++..|+|||.+.++.++.++|||||||++|+|+| |..||....... ...+...         .   ..+. 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------~---~~~~-  225 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG---------Y---RMPR-  225 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---------C---CCCC-
Confidence            22222336678999999999999999999999999999998 999996543211 1111100         0   0000 


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                          .......+.+++.+||+.+|++||++.++++.|+.
T Consensus       226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                01122467788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.5e-43  Score=330.99  Aligned_cols=265  Identities=19%  Similarity=0.275  Sum_probs=198.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|.+.+.||.|+||.||+|.. .+++.||+|.+.... ......+..|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            46799999999999999999954 468999999986432 2223467789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+. |+|.+++.....   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            997 499998865432   3788899999999999999999998   999999999999999999999999999765332


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh--hhhcccc--chhcc-----c
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITDWAL--PLACE-----R  264 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~--~~~~~~~--~~~~~-----~  264 (400)
                      ... .....+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.........  .......  +..+.     .
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         157 TKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             Ccc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            221 223358999999999875 56899999999999999999999999754322110  0000000  00000     0


Q ss_pred             ccccccCccCCCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELADPRLNGN----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .+.....+.....    ..+.......+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0001110100000    00112346778999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=353.82  Aligned_cols=253  Identities=19%  Similarity=0.249  Sum_probs=203.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cC-CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ...|.+.+.||+|++|.||+|.. .+ +..||+|.+..........+..|+.+|+.++||||+++++++..++..|+|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            34599999999999999999954 34 67888887765555555667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++.........+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999988654333445888899999999999999999998   999999999999999999999999999876443


Q ss_pred             Cc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          195 AT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       195 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ......        ....    +
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~----~  290 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--------GKYD----P  290 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCCC----C
Confidence            22 12234569999999999999999999999999999999999999997543211 010000        0000    0


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                           ........+.++|.+||+.||.+||++.+++.
T Consensus       291 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                 00112246788889999999999999999975

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=332.20  Aligned_cols=238  Identities=24%  Similarity=0.299  Sum_probs=190.9

Q ss_pred             ccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           46 LGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        46 LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ||+|+||.||+|.+ .+++.||+|++...   .......+..|+.+++.++||||+++++++.+.+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999965 46889999998742   233345677899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeee
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR  201 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~  201 (400)
                      .+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........ ....
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  152 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT  152 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence            99986533    3888999999999999999999998   99999999999999999999999999875432221 2233


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCCCcH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGNFVE  280 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (400)
                      ..||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ......        ..      ..    +..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~--------~~------~~----~~~  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ--------EP------LR----FPD  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc--------CC------CC----CCC
Confidence            569999999999999999999999999999999999999997543211 011000        00      00    111


Q ss_pred             HHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 015797          281 EELKRVVLVALTCAHSKPEKRPT---MLEVLD  309 (400)
Q Consensus       281 ~~~~~l~~li~~cl~~dP~~Rps---~~ell~  309 (400)
                      .....+.+++.+||+.||.+||+   +.+++.
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            12246778889999999999985   566665

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-43  Score=342.66  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=201.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  107 (400)
                      ..++|.+.+.||+|+||.||+|...      ++..||+|.+.... ......+..|+.+++.+ +||||++++++|.+.+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457899999999999999998532      23579999987533 33345688899999999 8999999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCC---------------------------------------------------------
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHS---------------------------------------------------------  130 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  130 (400)
                      ..++|||||++|+|.+++.....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999998854210                                                         


Q ss_pred             ---------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce-eee
Q 015797          131 ---------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTT  200 (400)
Q Consensus       131 ---------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~  200 (400)
                               ....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++......... ...
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                     0123788889999999999999999998   999999999999999999999999999765433221 111


Q ss_pred             ecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCC
Q 015797          201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNF  278 (400)
Q Consensus       201 ~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (400)
                      ...+++.|+|||++.+..++.++|||||||++|+|++ |+.||........ ......        ..    ..... ..
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~--------~~----~~~~~-~~  339 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR--------GY----QMSRP-DF  339 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc--------cc----CccCC-CC
Confidence            2235678999999999999999999999999999997 9999975432110 000000        00    00000 01


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          279 VEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       279 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                         ....+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       340 ---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 ---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               124678888999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-43  Score=326.07  Aligned_cols=255  Identities=33%  Similarity=0.496  Sum_probs=209.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ...+|++.+.||.|+||.||+|....+..+++|.+..........+..|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45679999999999999999998777999999998876665566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999975432  24889999999999999999999998   9999999999999999999999999998664332


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ... ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .......         .    .. 
T Consensus       159 ~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---------~----~~-  223 (261)
T cd05148         159 YLS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG---------Y----RM-  223 (261)
T ss_pred             ccc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC---------C----cC-
Confidence            221 12336778999999998899999999999999999998 899997544211 1111100         0    00 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                         .........+.+++.+||+.||.+|||+.++++.|+.
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 ---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               0111223467889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.6e-43  Score=333.05  Aligned_cols=241  Identities=24%  Similarity=0.295  Sum_probs=194.2

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.||+|+||.||++.. .+++.||+|++...   .......+..|+.+++.++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 56899999998742   2233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceee
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT  199 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~  199 (400)
                      +|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  152 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM  152 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence            9998886432    3888999999999999999999998   99999999999999999999999999875332211 12


Q ss_pred             eecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCC
Q 015797          200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNF  278 (400)
Q Consensus       200 ~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (400)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..+..        .      ...+..  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------~------~~~~p~--  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------E------DIKFPR--  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--------C------CccCCC--
Confidence            234699999999999999999999999999999999999999975432111 11100        0      000111  


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          279 VEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       279 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                        .....+.+++.+||..||.+||     ++.++++.
T Consensus       217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 --TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              1224677888999999999997     89999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.3e-43  Score=335.21  Aligned_cols=246  Identities=22%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcC--CCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWD--GSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..++|.+.+.||+|+||.||+|....  +..||+|.+...   .......+..|+.+++.++||||+++++++.+.+..|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            44679999999999999999996433  368999998642   2233456788999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999986543    3888899999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .....    ....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+..        ...   
T Consensus       181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--------~~~---  245 (340)
T PTZ00426        181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--------GII---  245 (340)
T ss_pred             cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--------CCC---
Confidence            54321    23469999999999999999999999999999999999999997654321 111110        000   


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                         .... ..   ...+.+++.+||+.||.+|+     ++.++++.
T Consensus       246 ---~~p~-~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ---YFPK-FL---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---CCCC-CC---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               0001 11   23567788999999999995     88888874

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=339.68  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=202.3

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4799999999999999999965 469999999987422   233456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++....    .+++..++.++.|++.||.|||..+   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999987542    3888999999999999999999998   99999999999999999999999999986644


Q ss_pred             CC----------------------------ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          194 GA----------------------------THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       194 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            33                            11122345999999999999999999999999999999999999999765


Q ss_pred             hhhh-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 015797          246 NSAI-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-MLEVLDL  310 (400)
Q Consensus       246 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~ell~~  310 (400)
                      .... ...+..+...      .   ..+..     ......+.+++.+||. ||.+||+ +.++++.
T Consensus       234 ~~~~~~~~i~~~~~~------~---~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQETYNKIINWKES------L---RFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHHHHHHHHhccCCc------c---cCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            4221 1111111000      0   00000     0023467778899997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5e-43  Score=326.14  Aligned_cols=256  Identities=28%  Similarity=0.518  Sum_probs=203.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcC-C-----CEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWD-G-----SQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~-~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ++|++.+.||+|+||.||+|.... +     ..+++|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            578899999999999999996432 2     578999886433 233456889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCc------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          111 IVYDYMPNLSLLSHLHGQHSS------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      ++|||+++|+|.+++......            ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            999999999999998654211            134788899999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhc
Q 015797          179 KAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITD  255 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~  255 (400)
                      .++|+|||++........ .......+++.|+|||.+.++.++.++|||||||++|||++ |..||...... ....+..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976533221 11222346889999999998999999999999999999998 99998754422 1111110


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                              ....         .........+.+++.+||+.||.+||++.+|++.|+.
T Consensus       242 --------~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         242 --------RQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --------CCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                    0000         0112234578889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.7e-43  Score=332.10  Aligned_cols=201  Identities=24%  Similarity=0.348  Sum_probs=174.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+..|+++++.++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999654 6888999988754 33344568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+.+  .++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999986533    3788889999999999999999742  2999999999999999999999999998765332


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      .   .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            1   123458999999999999899999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.6e-43  Score=322.50  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .+|.+.+.||+|++|.||+|.. ..+..+|+|.+... ......+..|+++++.++||||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            4578889999999999999954 46889999988643 333456888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++++|.+++.....  ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        85 ~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999865432  24888999999999999999999998   99999999999999999999999999987654322


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ ..+...             .... 
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-------------~~~~-  225 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-------------YRME-  225 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------------CCCC-
Confidence            22222234678999999999999999999999999999998 9999865432111 111100             0000 


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                         ........+.+++.+||+.+|++|||+.++++.|+.
T Consensus       226 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         226 ---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence               111123467788899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.1e-43  Score=333.27  Aligned_cols=241  Identities=23%  Similarity=0.301  Sum_probs=193.4

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.||+|+||.||++.. .++..||+|++...   .......+..|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999964 56899999998743   2223445778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceee
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT  199 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~  199 (400)
                      +|..++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  152 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence            9998886433    3888999999999999999999998   99999999999999999999999999875322211 12


Q ss_pred             eecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCC
Q 015797          200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNF  278 (400)
Q Consensus       200 ~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (400)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....        ...      .+..  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------~~~------~~p~--  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------EEI------RFPR--  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------CCC------CCCC--
Confidence            234599999999999999999999999999999999999999975432211 11100        000      0111  


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          279 VEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       279 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                        .....+.+++.+||..||.+||     ++.++++.
T Consensus       217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              1124667888999999999998     88888863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-43  Score=322.29  Aligned_cols=250  Identities=28%  Similarity=0.481  Sum_probs=201.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      ++|++.+.||+|+||.||.|....+..+|+|.+..... ....+..|+.+++.++||||+++++++.+....+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            56889999999999999999776677799998874332 34568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.........
T Consensus        83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            9999999865332   3889999999999999999999998   999999999999999999999999998865443222


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccccccCccCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      ......++..|+|||.+.+..++.++|||||||++|+|+| |..||...... ....+.....+             ...
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~  223 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-------------YRP  223 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-------------CCC
Confidence            2222235678999999998899999999999999999999 99999754432 11111110000             000


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                          ......+.+++.+||+.+|.+||++.+|++.|
T Consensus       224 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         224 ----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             ----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                01135778899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.3e-43  Score=332.86  Aligned_cols=251  Identities=23%  Similarity=0.294  Sum_probs=196.5

Q ss_pred             CCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecC----ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVW----SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  109 (400)
                      +|++.+.||+|+||.||++..    .+++.||+|++...    .......+..|+.++..+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588999999999999999864    35889999998642    122334577899999999 589999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999986543    3888999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      ..............||+.|+|||++.+. .++.++|||||||++|+|+||..||........ ..+..         .+.
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---------~~~  224 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---------RIL  224 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---------HHh
Confidence            6544333333345699999999999865 478999999999999999999999964321100 00000         000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                      . .++.+.    ......+.+++.+||+.||.+||     ++.++++.
T Consensus       225 ~-~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 K-CDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             c-CCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0 001111    11223567788999999999999     67788864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=351.13  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=211.3

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCC-CEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeE-EEe-----
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDG-SQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGY-CAE-----  105 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-~~~-----  105 (400)
                      .....++++.+.|.+|||+.||.|.+..+ ..+|+|++-.........+.+|+.+|+.|+ |+|||.|++. ...     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            45556679999999999999999976655 999999998878888888999999999996 9999999993 211     


Q ss_pred             -CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          106 -GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       106 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                       .-+++|.||||.||+|.+++..+....  |++.++++|+.|+++|+++||... |+|||||||-+||||+.+|.+||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence             134679999999999999998765544  999999999999999999999995 7799999999999999999999999


Q ss_pred             cCCccccCCCCceee--------eecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhh
Q 015797          185 FGFAKLIPDGATHVT--------TRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI  253 (400)
Q Consensus       185 fgl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~  253 (400)
                      ||.+.-.........        ....-|+.|.|||++.   +...++|+|||+|||+||-|+....||+.....     
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----  264 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----  264 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence            999875432221110        0123689999999874   678899999999999999999999999865321     


Q ss_pred             hccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          254 TDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                    .+++....-.-.+.+...|.+||..||+.||.+||++.+++..+..+..
T Consensus       265 --------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 --------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                          1111111111235567789999999999999999999999998765543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=342.20  Aligned_cols=259  Identities=28%  Similarity=0.413  Sum_probs=208.0

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEcC--C---CEEEEEEEec---CChHHHHHHHHHHHHHhcCCCCccceeeeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLWD--G---SQIAVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLRGYCA  104 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~--~---~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  104 (400)
                      ++-..++-.+.+.||+|+||.||+|....  +   ..||+|..+.   .......++..|+++|++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            44455666777999999999999996432  2   2389999875   33555678999999999999999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                      ....+++|||+|+||+|.++|.....   .++..+++.++.+.+.||+|||.++   +|||||-.+|||++.++.+||+|
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence            99999999999999999999986654   3889999999999999999999998   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhh-h-h-ccccch
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRT-I-T-DWALPL  260 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~-~-~-~~~~~~  260 (400)
                      ||+++.-...... .....-...|+|||.+..+.|++++|||||||++||+++ |..||.......... + . .+..+ 
T Consensus       306 FGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~-  383 (474)
T KOG0194|consen  306 FGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP-  383 (474)
T ss_pred             cccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC-
Confidence            9998854311111 101235678999999999999999999999999999999 899998776432211 1 1 11111 


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                       .....+..+..++.+||..+|++||||.++.+.|.....
T Consensus       384 -----------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  384 -----------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             -----------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                             111224466777889999999999999999999876543

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-42  Score=336.33  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=195.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      +.|.+++.||+|+||+||+|.. .+++.+|+|++....   ......+..|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            3688999999999999999954 568899999997532   233456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||..+   |+||||||+||||+.++.+||+|||++..+..
T Consensus        81 E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          81 DYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            9999999999986543    3788888999999999999999998   99999999999999999999999999754311


Q ss_pred             CCc----------------------------------------------eeeeecccccCcCChhhhccCCCCCccceeh
Q 015797          194 GAT----------------------------------------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYS  227 (400)
Q Consensus       194 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwS  227 (400)
                      ...                                              ......+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            000                                              0012346999999999999999999999999


Q ss_pred             hhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHh--ccccCCCCCCCH
Q 015797          228 FGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT--CAHSKPEKRPTM  304 (400)
Q Consensus       228 lGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~  304 (400)
                      |||++|||+||..||........ ..+..+...      ..  ...   ....+   ..+.+++.+  |+..+|..||++
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~--~~~---~~~~s---~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENT------LH--IPP---QVKLS---PEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc------cC--CCC---CCCCC---HHHHHHHHHHccCcccccCCCCH
Confidence            99999999999999976443211 111111100      00  000   00112   245555655  666777779999


Q ss_pred             HHHHHH
Q 015797          305 LEVLDL  310 (400)
Q Consensus       305 ~ell~~  310 (400)
                      .+++..
T Consensus       300 ~~~l~h  305 (381)
T cd05626         300 DDIKAH  305 (381)
T ss_pred             HHHhcC
Confidence            999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-43  Score=322.78  Aligned_cols=248  Identities=33%  Similarity=0.541  Sum_probs=192.5

Q ss_pred             cCCcccccCceEEEEEEEc-----CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           42 YDNKLGEGGFGSVYWGQLW-----DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +.+.||.|.||.||+|...     .+..|+||.++... ......+..|++.++.++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999755     36789999997543 34467899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      |++|+|.++|.....  ..+++..++.|+.|++.||.|||+.+   ++|+||+++||+++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            999999999987622  24899999999999999999999998   9999999999999999999999999998763322


Q ss_pred             ce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          196 TH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .. ......+...|+|||.+.+..++.++||||||+++|||+| |+.||....... ...+.....+             
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~-------------  224 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL-------------  224 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------------
Confidence            21 2222347788999999999999999999999999999999 789987654321 1111111000             


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                          .........+.+++.+||+.+|.+|||+.+|++.|
T Consensus       225 ----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                01111234677889999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.5e-43  Score=339.69  Aligned_cols=255  Identities=20%  Similarity=0.257  Sum_probs=200.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ....++|++.+.||+|+||.||+|.. .++..+|+|++...   .......+..|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            34567899999999999999999965 46889999998642   122334577899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+||||+++|+|.+++...     .++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999988643     2677888889999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccC----CCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLG----KASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACER  264 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~  264 (400)
                      ..............||+.|+|||++.+.    .++.++|||||||++|+|++|+.||...... ....+....      .
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------~  264 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK------N  264 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC------C
Confidence            6543322222345699999999998753    4789999999999999999999999765421 111111000      0


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK--RPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~  310 (400)
                      .+   .   ...  .......+.+++.+||+.+|.+  |||+.++++.
T Consensus       265 ~~---~---~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 SL---T---FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cC---C---CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00   0   000  0012346677889999999988  9999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.3e-43  Score=324.82  Aligned_cols=256  Identities=27%  Similarity=0.493  Sum_probs=204.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+...... ....+..|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            457889999999999999999653      2478999998765444 456789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCC----------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHS----------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      ++||||+++|+|.+++.....          ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            999999999999999975421          2234788899999999999999999998   999999999999999999


Q ss_pred             EEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhcc
Q 015797          180 AQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDW  256 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~  256 (400)
                      ++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... 
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~-  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ-  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence            99999999975433221 11122336788999999999999999999999999999998 999986544321 111110 


Q ss_pred             ccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                             +....         ........+.+++.+||+.||++||++.|+++.|+
T Consensus       240 -------~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 -------GRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------CCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                   00000         01112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-42  Score=320.62  Aligned_cols=260  Identities=22%  Similarity=0.340  Sum_probs=206.4

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+...   .......+..|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            6899999999999999999964 57899999987642   2333456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++.........+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988643333334788899999999999999999998   99999999999999999999999999886643


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCcc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      .... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||............          .+.....+.
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~----------~~~~~~~~~  227 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ----------KIEQCDYPP  227 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH----------HHhcCCCCC
Confidence            2221 12235889999999999888999999999999999999999998643321111000          000000000


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                         .........+.+++.+||..+|++||++.++++.++++
T Consensus       228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence               01122335688889999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.6e-44  Score=323.67  Aligned_cols=247  Identities=21%  Similarity=0.362  Sum_probs=206.7

Q ss_pred             ccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ..+|++.+.||+|.||.|-+|. ...|+.||||.+...   ...+...+++|+++|+.|+||||+.+|++|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4689999999999999999994 478999999998753   344556788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||..+|.|.+++..+..    +++.++..+++||+.|+.|+|.++   ++|||||.+|||+|.++++||+|||++-.+.
T Consensus       132 MEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999987653    899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhccccccccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ...  ...+.+|+|.|.+||++.+.+| ++..|-||||++||.|+.|.+||++.... ..+++..        +.+.+..
T Consensus       205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~--------GaYrEP~  274 (668)
T KOG0611|consen  205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR--------GAYREPE  274 (668)
T ss_pred             ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--------ccccCCC
Confidence            433  3456789999999999999888 58899999999999999999999876532 1122211        1111111


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                      .           +.+..-||.+||-.||++|.|+.+|...-
T Consensus       275 ~-----------PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  275 T-----------PSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             C-----------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            1           11333467899999999999999998753

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-43  Score=335.08  Aligned_cols=264  Identities=21%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----CeEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----QERL  110 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~  110 (400)
                      +|++.+.||+|+||.||+|.. .++..||+|.+...  .......+..|+.+++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            689999999999999999964 56899999998642  223345688999999999999999999988543     3579


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|||||. ++|.+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 68999886433    3889999999999999999999998   99999999999999999999999999975


Q ss_pred             cCCCCc--eeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhc---cccchh-
Q 015797          191 IPDGAT--HVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITD---WALPLA-  261 (400)
Q Consensus       191 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~---~~~~~~-  261 (400)
                      ......  .......||+.|+|||++.+  ..++.++|||||||++|+|+||+.||......... .+..   ...+.. 
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432211  11223469999999999876  67899999999999999999999999654321100 0000   000000 


Q ss_pred             ---cccccccc---cCccCCCCC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 ---CERKFSEL---ADPRLNGNF---VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ---~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ........   .........   .+.....+.+++.+||+.||++|||+.++++.
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence               00000000   000000000   01123467789999999999999999999973

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=336.04  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=197.6

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.++..++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4799999999999999999965 468999999997422   223345778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999986543    3888999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCce-------------------------------------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHH
Q 015797          194 GATH-------------------------------------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA  236 (400)
Q Consensus       194 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ell  236 (400)
                      ....                                     .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011235999999999999999999999999999999999


Q ss_pred             hCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 015797          237 SGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT---MLEVLDL  310 (400)
Q Consensus       237 tg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ell~~  310 (400)
                      +|..||....... ...+..+...      +.      ....  ......+.+++.+|+. +|.+|++   +.++++.
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~~~------~~------~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWKET------LQ------FPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCc------cC------CCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999997654321 1111111100      00      0000  0112356667788886 9999998   8888873

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.5e-43  Score=325.51  Aligned_cols=264  Identities=22%  Similarity=0.349  Sum_probs=193.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE--cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcC---CCCccceeeeEEE-----e
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL--WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARV---RHKNLLSLRGYCA-----E  105 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~--~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~-----~  105 (400)
                      .+|++.+.||+|+||.||+|..  .+++.||+|.+.....  .....+..|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4799999999999999999965  2467899998874322  1223455677666655   7999999999985     3


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      ....++||||+. ++|.+++......  .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999997 6999988654322  3788999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhcccc--chh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWAL--PLA  261 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~--~~~  261 (400)
                      |++......  .......||+.|+|||++.+..++.++|||||||++|+|++|++||......  ....+.....  +..
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            999765432  1223345899999999999999999999999999999999999999764421  1111100000  000


Q ss_pred             ccccc---ccccCccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          262 CERKF---SELADPRLN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       262 ~~~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +....   .....+...   ....+.....+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000   000000000   0011122345678899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-43  Score=321.02  Aligned_cols=255  Identities=30%  Similarity=0.451  Sum_probs=204.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..++|++.+.||+|++|.||+|....+..||+|.+.... .....+..|+.+++.++||||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346799999999999999999976677889999986533 2345688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            99999999987543  224889999999999999999999998   9999999999999999999999999998765322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      .........+..|+|||.+.+..++.++||||||+++|+|+| |+.||....... ......         ...    . 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------~~~----~-  223 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ---------GYR----M-  223 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------CCC----C-
Confidence            211111223457999999999999999999999999999999 999997543221 111100         000    0 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                         .........+.+++.+||+.+|.+||++.++++.|+.
T Consensus       224 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 ---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               0011123467888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.3e-43  Score=336.55  Aligned_cols=256  Identities=20%  Similarity=0.252  Sum_probs=198.4

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      +....++|++.+.||+|+||.||++.. .+++.+|+|++...   .......+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            444568999999999999999999965 46889999998642   22233457789999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .|+|||||++|+|.+++...     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999988643     2778889999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccC----CCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLG----KASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACE  263 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~  263 (400)
                      ...............||+.|+|||++.+.    .++.++|||||||++|+|++|+.||....... ...+....      
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~------  263 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK------  263 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Confidence            87643332223345699999999999764    37899999999999999999999997544211 01110000      


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK--RPTMLEVLDL  310 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~  310 (400)
                      ..+      ....  .......+.+++..|+..+|.+  |+++.++++.
T Consensus       264 ~~~------~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NSL------NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ccc------CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            000      0000  0111235566778888755544  8899999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.3e-43  Score=350.28  Aligned_cols=261  Identities=23%  Similarity=0.310  Sum_probs=207.2

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG  106 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  106 (400)
                      .+......++|++.+.||+|+||+||+|. ..+++.||+|++...  .......+..|+.++..++|+||+++++.+...
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            34556677899999999999999999995 457999999998753  334455688899999999999999998877543


Q ss_pred             C--------eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          107 Q--------ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       107 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      .        .+++||||+++|+|.+++..+......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence            2        367999999999999998755444445888999999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhcc
Q 015797          179 KAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDW  256 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~  256 (400)
                      .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... 
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-  259 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-  259 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-
Confidence            999999999986543221 12234569999999999999999999999999999999999999997543211 000000 


Q ss_pred             ccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                             ..    ..+ +    .......+.+++.+||+.||.+||++.++++.
T Consensus       260 -------~~----~~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 -------GR----YDP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -------CC----CCC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                   00    000 1    11123467888999999999999999999874

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=303.55  Aligned_cols=268  Identities=22%  Similarity=0.301  Sum_probs=213.6

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC----
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG----  106 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----  106 (400)
                      .+-...++|++.+.||+|||+-||++. ..++..+|+|++...+.++.+..++|+...+.++|||+++++++...+    
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            345677899999999999999999995 457899999999988888888899999999999999999998876443    


Q ss_pred             -CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 -QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       ...||+++|+..|||.+.+......+..+++.+.+.|+.++++||.+||+.. +++.||||||.|||+++++.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence             4589999999999999999877666667999999999999999999999985 56999999999999999999999999


Q ss_pred             CCccccCCCCceee--------eecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhh
Q 015797          186 GFAKLIPDGATHVT--------TRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT  254 (400)
Q Consensus       186 gl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~  254 (400)
                      |.++...-......        ..-..|..|.|||++.-   ...+++.|||||||+||.|+.|.-||+..-..-. .+ 
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sl-  251 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SL-  251 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eE-
Confidence            99986532111110        01236899999999864   4568999999999999999999999975432100 00 


Q ss_pred             ccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                                 .-.+.+..+.-...+...+.+..++..|++.||.+||++.+++..+..
T Consensus       252 -----------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  252 -----------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             -----------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                       000111111111122245688889999999999999999999987653

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-42  Score=330.29  Aligned_cols=244  Identities=25%  Similarity=0.335  Sum_probs=192.2

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHH---hcCCCCccceeeeEEEeCCeEEEE
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEIL---ARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      |++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67889999999999999964 468999999987422   22234566666554   567899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|...+...     .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999999887532     3889999999999999999999998   9999999999999999999999999987533


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+..        ..      
T Consensus       153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--------~~------  217 (324)
T cd05589         153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--------DE------  217 (324)
T ss_pred             CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC------
Confidence            2221 2233569999999999999999999999999999999999999997543221 111100        00      


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                      ....    ......+.+++.+||+.||.+||     ++.++++.
T Consensus       218 ~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 VRYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            0000    11124667888999999999999     57777663

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.4e-43  Score=331.14  Aligned_cols=241  Identities=22%  Similarity=0.280  Sum_probs=192.9

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.||+|+||.||++.. .++..||+|++...   .......+..|++++..++||||+++++++......|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 57899999998742   2223345678999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      +|.+++....    .+++..+..++.|++.||.|||+ .+   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~  152 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T  152 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence            9999886433    38899999999999999999997 67   99999999999999999999999999875332221 1


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|+||..||........ ..+....              ..+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--------------~~~p~~  218 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------------IRFPRT  218 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--------------CCCCCC
Confidence            2234699999999999999999999999999999999999999975442211 1110000              001111


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                          ....+.+++.+||+.||.+|+     ++.++++.
T Consensus       219 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 ----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                123677788999999999996     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.3e-43  Score=332.20  Aligned_cols=252  Identities=23%  Similarity=0.273  Sum_probs=200.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|.+.+.||+|+||.||++.. .+++.+|+|++....   ......+..|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4799999999999999999954 578999999997532   223445788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999875422   3888999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhc------cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAM------LGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      ..........||+.|+|||++.      ...++.++|||||||++|+|++|+.||....... ...+....       ..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-------~~  227 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ-------RF  227 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC-------Cc
Confidence            4333333346999999999987      4567899999999999999999999997543211 11111100       00


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ....       ........+.+++..||. +|.+|||+.+++..
T Consensus       228 ~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 LKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             cCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0000       001123457778889997 99999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-42  Score=328.66  Aligned_cols=242  Identities=26%  Similarity=0.340  Sum_probs=193.0

Q ss_pred             CCcccccCceEEEEEEE----cCCCEEEEEEEecCC----hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           43 DNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS----NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .+.||+|+||.||++..    ..++.||+|++....    ......+..|+.+|+.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999964    357899999987421    2223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++....    .+.+..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          81 YLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            999999999986543    3777888889999999999999998   999999999999999999999999998754322


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCcc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..+..        ...      .
T Consensus       154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--------~~~------~  218 (323)
T cd05584         154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--------GKL------N  218 (323)
T ss_pred             CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------CCC------C
Confidence            21 12234699999999999998999999999999999999999999975442110 00000        000      0


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                      +.    ......+.+++.+||+.||++||     ++.++++.
T Consensus       219 ~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         219 LP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            00    11123677888999999999999     78888864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.7e-43  Score=328.07  Aligned_cols=266  Identities=19%  Similarity=0.313  Sum_probs=197.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            4578999999999999999999654 689999999875332 22345778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+. ++|.+++.....   .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          83 EYVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             ECCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9996 688888765432   3788889999999999999999998   99999999999999999999999999875432


Q ss_pred             CCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhh---hhhhhhccccch--hccc--c
Q 015797          194 GATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSA---IKRTITDWALPL--ACER--K  265 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~---~~~~~~~~~~~~--~~~~--~  265 (400)
                      ... ......||+.|+|||++.+ ..++.++|||||||++|+|+||..||......   ..........+.  .+..  .
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         156 PSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            221 1223458999999999875 45889999999999999999999999754321   111100000000  0000  0


Q ss_pred             cccccCccC---CCCCcH------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELADPRL---NGNFVE------EELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~~~~~---~~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .........   ......      .....+.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000000   000000      01235678889999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-42  Score=337.29  Aligned_cols=259  Identities=21%  Similarity=0.259  Sum_probs=196.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|.+.+.||+|+||.||++.+ .+++.||+|...      ...+..|+++|+.|+||||+++++++..+...++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            46899999999999999999954 578999999643      23467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +. ++|..++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       165 ~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            95 68988886543    3788999999999999999999998   9999999999999999999999999997543322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhh---------hhhhhhhccc-cc----hh
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS---------AIKRTITDWA-LP----LA  261 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~---------~~~~~~~~~~-~~----~~  261 (400)
                      ........||+.|+|||++.+..++.++|||||||++|+|+||..||.....         .....+.... .|    ..
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            2223345699999999999999999999999999999999999988753211         0000000000 00    00


Q ss_pred             ccccccccc---------CccCCC--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          262 CERKFSELA---------DPRLNG--NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       262 ~~~~~~~~~---------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....+....         .+....  .........+.+++.+||+.||.+|||+.|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000         000000  001123457888999999999999999999996

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-42  Score=324.21  Aligned_cols=259  Identities=28%  Similarity=0.468  Sum_probs=205.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+..........+..|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57899999999999999999632      245688998876655556678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC---------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEE
Q 015797          112 VYDYMPNLSLLSHLHGQHS---------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV  182 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl  182 (400)
                      ||||+++++|.+++.....         ....+++..++.++.|++.||+|||+++   ++||||||+||+++.++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            9999999999999864431         1224899999999999999999999998   999999999999999999999


Q ss_pred             EecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccc
Q 015797          183 ADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALP  259 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~  259 (400)
                      +|||++......... ......+++.|+|||++.+..++.++|||||||++|+|+| |..||....... ...+...   
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~---  238 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG---  238 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence            999999865432221 1122335778999999999999999999999999999998 999986544211 1111100   


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                           ...     .....    ....+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       239 -----~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         239 -----RVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             -----CcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                 000     00011    12367889999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-42  Score=328.78  Aligned_cols=245  Identities=27%  Similarity=0.340  Sum_probs=194.2

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCC-ccceeeeEEEeCCeEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHK-NLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~  113 (400)
                      +|++.+.||+|+||.||+|.. .+++.||+|++...   .......+..|..++..+.|+ +|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            588999999999999999964 45789999998742   223345677899999999764 6888999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++....    .+++..++.++.|++.||.|||.++   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999886543    3788999999999999999999998   99999999999999999999999999875322


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ...+....              .
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------------~  218 (324)
T cd05587         154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------------V  218 (324)
T ss_pred             CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------C
Confidence            121 1233469999999999999999999999999999999999999997544221 11111000              0


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTM-----LEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~  309 (400)
                      ...    ......+.+++.+||..||.+|++.     .++++
T Consensus       219 ~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         219 SYP----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             CCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            000    1122467788899999999999986     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=318.72  Aligned_cols=250  Identities=28%  Similarity=0.466  Sum_probs=199.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      .+|++.+.||+|+||.||+|.+..+..+|+|.+..... ....+..|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            45889999999999999999776777899998764322 23467889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +++|.+++.....   .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...+....
T Consensus        83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            9999999875432   4889999999999999999999998   999999999999999999999999999765432221


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      ......++..|+|||.+.+..++.++||||||+++|+|+| |..||....... ......             .....  
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------~~~~~--  221 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-------------GYRLY--  221 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-------------CCcCC--
Confidence            1111224457999999999999999999999999999999 899986543211 111100             00000  


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                        ........+.+++.+||..+|++|||+.++++.|
T Consensus       222 --~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 --RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              0011234788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-42  Score=336.26  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=194.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.+|+.++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4799999999999999999964 568999999986422   222345778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999986543    3788888899999999999999998   99999999999999999999999999753210


Q ss_pred             CC------------------------------------------ceeeeecccccCcCChhhhccCCCCCccceehhhHH
Q 015797          194 GA------------------------------------------THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGIL  231 (400)
Q Consensus       194 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGii  231 (400)
                      ..                                          ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000112469999999999999999999999999999


Q ss_pred             HHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC---CHHHH
Q 015797          232 LLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP---TMLEV  307 (400)
Q Consensus       232 l~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~el  307 (400)
                      +|+|++|+.||........ ..+..+...      .   ..+ .....    ...+.+++.+|+ .+|.+|+   ++.++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~------~---~~~-~~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKVINWETT------L---HIP-SQAKL----SREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHHhccCcc------c---cCC-CCCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            9999999999976543211 111111100      0   000 00011    224455556665 4999999   89999


Q ss_pred             HHH
Q 015797          308 LDL  310 (400)
Q Consensus       308 l~~  310 (400)
                      ++.
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.5e-42  Score=314.78  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=207.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|++|.||+|... +++.+|+|.++..   .......+..|+.+++.++|+||+++++++.+++..++|
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            368999999999999999999654 7999999988642   223355788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++.........+++..++.++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999999988654333445889999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...............     ...    ..+
T Consensus       158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~----~~~  227 (267)
T cd08224         158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-----KCD----YPP  227 (267)
T ss_pred             CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-----cCC----CCC
Confidence            33221 12235889999999999989999999999999999999999998643321111100000     000    000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                       .   ........+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       228 -~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 -L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             -C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence             0   0112334677889999999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-42  Score=328.43  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=200.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCC----EEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGS----QIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..+|++.+.||+|+||.||+|.+. ++.    .||+|.+.... ......+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            357999999999999999999643 333    38999986433 34456788999999999999999999998764 578


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ++++|+++|+|.+++.....   .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999999875432   3788899999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCceee-eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          191 IPDGATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||................      .+  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~--  230 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------RL--  230 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC------CC--
Confidence            654332211 12234678999999999999999999999999999998 999997644321111100000      00  


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                       ..       .......+..++.+||..+|.+||++.+++..|....
T Consensus       231 -~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         231 -PQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             -CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             00       0011236778899999999999999999999886554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.2e-42  Score=318.44  Aligned_cols=254  Identities=30%  Similarity=0.478  Sum_probs=202.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||+|+||.||+|.+.++..||+|.+..... ....+..|+++++.++||||+++++.+.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            467999999999999999999766667899999874322 23468889999999999999999998754 5679999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....  ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||.+........
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999975322  24788999999999999999999998   99999999999999999999999999986644332


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......++..|+|||+..+..++.++|||||||++|+|+| |..||........ ..... .            ...  
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~------------~~~--  222 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-G------------YRM--  222 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-C------------CCC--
Confidence            22222346778999999998999999999999999999999 8889865432111 10000 0            000  


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                        .........+.+++.+||+.+|.+||++.++++.|+..
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              01122345788899999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.8e-42  Score=317.47  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=201.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++.+.||+|+||.||+|.. .+++.+|+|++..........+..|+.+++.++||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            46799999999999999999964 56889999998765545556688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999999886432    3788999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          196 THVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .. .....|++.|+|||.+.   ...++.++|||||||++|+|++|..||..........  ....        .....+
T Consensus       161 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~--------~~~~~~  229 (267)
T cd06646         161 AK-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSK--------SNFQPP  229 (267)
T ss_pred             cc-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeec--------CCCCCC
Confidence            11 12235889999999884   3457889999999999999999999986543211100  0000        000000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                      ...  ........+.+++.+||+.+|++|||+.++++.|
T Consensus       230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000  0112235778899999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5e-42  Score=331.05  Aligned_cols=202  Identities=23%  Similarity=0.342  Sum_probs=174.2

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++....   ......+..|+.++..++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4799999999999999999954 568999999987422   222346778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999987543    3888999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCc----------------------------------eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCC
Q 015797          194 GAT----------------------------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK  239 (400)
Q Consensus       194 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~  239 (400)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012346999999999999999999999999999999999999


Q ss_pred             CChhhhh
Q 015797          240 KPIEKVN  246 (400)
Q Consensus       240 ~Pf~~~~  246 (400)
                      .||....
T Consensus       234 ~Pf~~~~  240 (363)
T cd05628         234 PPFCSET  240 (363)
T ss_pred             CCCCCCC
Confidence            9997544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-42  Score=317.45  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=201.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||+|+||.||+|....+..+|+|.+..... ....+..|+.+++.++|||++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457899999999999999999877788899999875333 2456889999999999999999999875 45689999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          83 SKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999875332  23788999999999999999999998   99999999999999999999999999986543322


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...+...             ...  
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-------------~~~--  222 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-------------YRM--  222 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------CCC--
Confidence            22222235668999999998899999999999999999999 899996543211 1111000             000  


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                        .........+.+++.+||..+|++|||+.++.+.|+.
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              0111223468889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-42  Score=317.86  Aligned_cols=254  Identities=26%  Similarity=0.459  Sum_probs=202.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|++.+.||+|+||.||+|.+.    +...||+|.+.... ......+..|+.+++.++||||+++++.+.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            367999999999999999999653    24578999887543 3334568889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      +|||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999865432   4889999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhccccccc
Q 015797          192 PDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFSE  268 (400)
Q Consensus       192 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....+.....          
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  226 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR----------  226 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            522221 1112235678999999999999999999999999999998 99999654322 1111111000          


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                        .+     ........+.+++.+||+.+|++||++.+|++.|..
T Consensus       227 --~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         227 --LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             --CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence              00     001123467889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.5e-42  Score=316.85  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=206.6

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||.|++|.||+|.. .++..+++|.+....   ......+..|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5789999999999999999964 578999999876432   233456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988643333345889999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCcc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      .... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||............          .+.....+.
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~~~~  227 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----------KIEQCDYPP  227 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh----------hhhcCCCCC
Confidence            3221 22345899999999999999999999999999999999999999643321111100          000001111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ...   ......+.+++.+||..||++|||+.+|++.+++.
T Consensus       228 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 LPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            111   12334677888999999999999999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-42  Score=333.71  Aligned_cols=260  Identities=20%  Similarity=0.246  Sum_probs=200.6

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      ..++....++|++.+.||+|+||.||++.. .+++.+|+|++...   .......+..|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            445666779999999999999999999965 46889999998642   22233457789999999999999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      +...|+||||+++|+|.+++...     .++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999988643     2777888889999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccC----CCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccch
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG----KASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPL  260 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~  260 (400)
                      |++...............||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+... ...+....   
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---  263 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---  263 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---
Confidence            99987654332223345699999999999754    37899999999999999999999997544211 01110000   


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHh
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK--RPTMLEVLDLL  311 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~L  311 (400)
                         ..+. +.       ........+.+++.+|+..++.+  ||++.++++..
T Consensus       264 ---~~~~-~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 ---NSLT-FP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---Cccc-CC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               0000 00       00112335666778899844433  78999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-43  Score=336.95  Aligned_cols=244  Identities=26%  Similarity=0.372  Sum_probs=199.8

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec---CChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV---WSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  108 (400)
                      .....+|++.++||+|.||+|++|.. .+++.+|||+++.   ...++.+..+.|.+++... +||.+++++..|.+..+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            44567899999999999999999954 5688999999985   3345556688899988877 59999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      +|+||||++||++..+.+..     .+++..+.-++..++.||.|||+++   |||||||.+|||+|.+|++||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence            99999999999955544322     3899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~  267 (400)
                      +.-.. ....+.+.+|||.|||||++.+..|+.+.|+|||||+||||++|..||.+.+.. ....+..           .
T Consensus       516 Ke~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-----------d  583 (694)
T KOG0694|consen  516 KEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-----------D  583 (694)
T ss_pred             cccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----------C
Confidence            85432 233566789999999999999999999999999999999999999999865532 1111111           0


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM  304 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  304 (400)
                      +..       +..-...+.+.+|.+.|.++|++|.-+
T Consensus       584 ~~~-------yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 EVR-------YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCC-------CCCcccHHHHHHHHHHhccCcccccCC
Confidence            000       111123467778899999999999765

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-42  Score=334.05  Aligned_cols=202  Identities=24%  Similarity=0.334  Sum_probs=172.2

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++++.||+|+||.||+|.. .+++.+|+|++....   ......+..|+.+++.++||||+++++.+.+++..|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            3689999999999999999964 568899999987422   223446788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.+|.+||+|||++..+..
T Consensus        81 E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          81 DYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            9999999999986542    3788888999999999999999998   99999999999999999999999999753210


Q ss_pred             CC----------------------------------------------ceeeeecccccCcCChhhhccCCCCCccceeh
Q 015797          194 GA----------------------------------------------THVTTRVKGTLGYLAPEYAMLGKASESCDVYS  227 (400)
Q Consensus       194 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwS  227 (400)
                      ..                                              ........||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            00                                              00011246999999999999999999999999


Q ss_pred             hhHHHHHHHhCCCChhhhh
Q 015797          228 FGILLLELASGKKPIEKVN  246 (400)
Q Consensus       228 lGiil~elltg~~Pf~~~~  246 (400)
                      |||++|||++|+.||....
T Consensus       234 lGvil~elltG~~Pf~~~~  252 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQT  252 (382)
T ss_pred             chHHHHHHHhCCCCCCCCC
Confidence            9999999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.8e-42  Score=325.66  Aligned_cols=240  Identities=28%  Similarity=0.340  Sum_probs=188.1

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhc-CCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILAR-VRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.||+|++....   ......+..|..++.. .+||||+++++++..+...|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 468899999987422   2223345566667764 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            99999886543    3888899999999999999999998   9999999999999999999999999997543322 22


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+.. .             .+...  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~-------------~~~~~--  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-D-------------RPHFP--  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-C-------------CCCCC--
Confidence            233569999999999999999999999999999999999999997554321 111100 0             00011  


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTML-EVLD  309 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~  309 (400)
                        ......+.+++.+||+.||.+||++. ++++
T Consensus       217 --~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 --RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence              11123567788999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=333.35  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=194.7

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||.|+||.||++.. .+++.||+|++....   ......+..|+++++.++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4799999999999999999954 578999999986422   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999986532    3788889999999999999999998   99999999999999999999999999863321


Q ss_pred             CCc------------e----------------------------------eeeecccccCcCChhhhccCCCCCccceeh
Q 015797          194 GAT------------H----------------------------------VTTRVKGTLGYLAPEYAMLGKASESCDVYS  227 (400)
Q Consensus       194 ~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwS  227 (400)
                      ...            .                                  ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000            0                                  001245999999999999999999999999


Q ss_pred             hhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCC---CC
Q 015797          228 FGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR---PT  303 (400)
Q Consensus       228 lGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps  303 (400)
                      |||++|||+||..||....... ...+..+...      +.      +...  ......+.+++.+|+. +|.+|   ++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~------~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHETYRKIINWRET------LY------FPDD--IHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc------cC------CCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999997544211 1111111100      00      0000  0112356677788887 67665   59


Q ss_pred             HHHHHHH
Q 015797          304 MLEVLDL  310 (400)
Q Consensus       304 ~~ell~~  310 (400)
                      +.+++..
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.5e-42  Score=336.03  Aligned_cols=261  Identities=25%  Similarity=0.369  Sum_probs=203.6

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcC------CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCC-CCccceeeeEEEe
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWS-NKAEMEFAVEVEILARVR-HKNLLSLRGYCAE  105 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  105 (400)
                      ....++|.+++.||+|+||.||+|....      +..||+|++.... ......+..|+.+|+.+. ||||+++++++.+
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3446789999999999999999996421      3469999987533 333456889999999996 9999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCC-------------------------------------------------------
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHS-------------------------------------------------------  130 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  130 (400)
                      .+..|+|||||++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999998864311                                                       


Q ss_pred             -------------------------------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 015797          131 -------------------------------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL  173 (400)
Q Consensus       131 -------------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIl  173 (400)
                                                           ....+++..++.++.|++.||.|||+.+   ++||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence                                                 0123778888999999999999999998   999999999999


Q ss_pred             ECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--h
Q 015797          174 LDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--I  249 (400)
Q Consensus       174 v~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--~  249 (400)
                      ++.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......  .
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            999999999999999865432221 1122346788999999999999999999999999999997 99998754321  1


Q ss_pred             hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ...+...             ....    ........+.+++.+||+.||++|||+.+|.+.|...
T Consensus       350 ~~~~~~~-------------~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         350 YNKIKSG-------------YRMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HHHHhcC-------------CCCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            1111000             0000    1112234678899999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.1e-42  Score=326.22  Aligned_cols=241  Identities=26%  Similarity=0.315  Sum_probs=191.8

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.||+|++...   .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999965 45889999998742   223334567788888865 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|...+....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~  152 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T  152 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence            99999886443    3788899999999999999999998   99999999999999999999999999875432222 1


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.... ..+..        ..   ..   ..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--------~~---~~---~p--  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--------DD---VL---YP--  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--------CC---CC---CC--
Confidence            2234599999999999999999999999999999999999999976543211 11100        00   00   00  


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRP-------TMLEVLDL  310 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~ell~~  310 (400)
                        ......+.+++.+||+.||.+||       ++.++++.
T Consensus       217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence              01124677888999999999999       78888764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-42  Score=319.81  Aligned_cols=268  Identities=28%  Similarity=0.385  Sum_probs=200.5

Q ss_pred             cCC-CcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeC--Ce
Q 015797           38 NNF-NYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QE  108 (400)
Q Consensus        38 ~~y-~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~  108 (400)
                      ++| .+.+.||+|+||+||++..     .++..||+|.+..... .....+..|+++++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            456 8899999999999987632     3577899999875432 3455688899999999999999999988653  46


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .+++|||+++|+|.+++...     .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence            78999999999999998643     2899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccc
Q 015797          189 KLIPDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF  266 (400)
Q Consensus       189 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  266 (400)
                      ..........  .....++..|+|||.+.+..++.++||||||+++|+|+||..||............. .........+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~  233 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-KQGQMTVVRL  233 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc-cccccchhhh
Confidence            8664322211  112235677999999998899999999999999999999999986543221111100 0000000001


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ...................+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            111111111111112235788899999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.7e-42  Score=326.31  Aligned_cols=235  Identities=26%  Similarity=0.300  Sum_probs=187.5

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.||+|++...   .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 46889999998742   222344567788888766 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~  152 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T  152 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence            99999886543    3888999999999999999999998   99999999999999999999999999875422211 1


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+...        .   ..   .   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------~---~~---~---  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--------E---VV---Y---  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--------C---CC---C---
Confidence            223469999999999999999999999999999999999999997654321 1111100        0   00   0   


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTM  304 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~  304 (400)
                       .......+.+++.+||+.||.+||++
T Consensus       216 -~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 -PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence             01112467788899999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-42  Score=322.94  Aligned_cols=259  Identities=27%  Similarity=0.480  Sum_probs=206.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            56888899999999999999632      345688898876666666778899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          112 VYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      ||||+++++|.+++.....            ....+++..++.++.|++.||+|||+++   ++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999865431            1224789999999999999999999998   999999999999999999


Q ss_pred             EEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhcc
Q 015797          180 AQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDW  256 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~  256 (400)
                      ++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|+| |..||....... ...... 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-  240 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-  240 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC-
Confidence            99999999976543221 11223446788999999999999999999999999999999 999986544321 111100 


Q ss_pred             ccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                             .....         ........+.+++.+||+.+|++|||+.++++.|....+
T Consensus       241 -------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         241 -------GRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -------CCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                   00000         001123467889999999999999999999999977644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-42  Score=321.09  Aligned_cols=257  Identities=23%  Similarity=0.412  Sum_probs=201.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      +.++|++.+.||+|+||.||+|...      .+..+|+|.+.... ......+..|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            5678999999999999999998532      35679999886432 2344568899999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCc------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEE
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSS------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV  182 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl  182 (400)
                      .++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            99999999999999998653211      123577888999999999999999988   999999999999999999999


Q ss_pred             EecCCccccCCCCceee-eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccc
Q 015797          183 ADFGFAKLIPDGATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALP  259 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~  259 (400)
                      +|||++........... ....+++.|+|||++.++.++.++|||||||++|+|++ |..||........ ......   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---  237 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG---  237 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence            99999876543222111 12235788999999999999999999999999999999 7889865442211 111000   


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                           ...     ..    .......+.+++.+||+.||++|||+.++++.|+
T Consensus       238 -----~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         238 -----GLL-----DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----CcC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                 000     00    0112246788899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.1e-42  Score=319.64  Aligned_cols=271  Identities=23%  Similarity=0.367  Sum_probs=201.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~  109 (400)
                      ..+|++.+.||+|+||.||++..     .++..||+|.+..........+..|+++++.++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35789999999999999999853     3578999999887666666778999999999999999999998754  3568


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            899999999999999864322   3889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      ..........  ....++..|+|||.+.+..++.++|||||||++|||++|..|+.......................+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            7654322111  11223456999999999999999999999999999999887764332211111000000000000000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      ..................+.+++.+||+.+|++|||+.+|++.|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            0000000000111123468889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.9e-42  Score=319.39  Aligned_cols=246  Identities=25%  Similarity=0.317  Sum_probs=192.9

Q ss_pred             ccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           46 LGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        46 LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ||+|+||+||++.. .+++.+|+|.+.....   .....+..|+.+++.++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999954 5789999999864322   2234567899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeee
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR  201 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~  201 (400)
                      .+.+.........+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            9887543333335889999999999999999999998   999999999999999999999999999765443221 223


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCCcH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNFVE  280 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (400)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ......            ......  ....
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~------------~~~~~~--~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR------------ILNDSV--TYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh------------hcccCC--CCcc
Confidence            4589999999999999999999999999999999999999975432110 000000            000000  0111


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015797          281 EELKRVVLVALTCAHSKPEKRP-----TMLEVLD  309 (400)
Q Consensus       281 ~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  309 (400)
                      .....+.+++.+||+.||.+||     ++.++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2334677888999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-43  Score=301.06  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=204.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++++.||+|-||.||.|+. .++..||+|++...   ......++.+|+++-+.|+||||+++|++|.+...+|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46778999999999999999954 56888999998642   223345688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      +||.++|+|...|......  .+++.....++.|+|.||.|+|..+   ||||||||+|+|++..|.+|++|||-+...+
T Consensus       101 lEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999754433  3888899999999999999999988   9999999999999999999999999987644


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                         .....+.+||..|.|||...+..++.+.|+|++|++.||++.|.+||...... ....+..          . .+. 
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----------~-~~~-  240 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----------V-DLK-  240 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----------c-ccc-
Confidence               22334567999999999999999999999999999999999999999866521 1111111          0 011 


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            +.+.......++|.+|+..+|.+|.+..|++..
T Consensus       241 ------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  241 ------FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  111223456678899999999999999999874

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-42  Score=316.33  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=203.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..++|++.+.||+|+||.||+|...+++.+|+|.+..... ....+..|+.+++.++||||+++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3468999999999999999999877889999999875433 2456888999999999999999999874 5678999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +.+|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999998865432  24888999999999999999999998   9999999999999999999999999997665322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ....+...             ....
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------------~~~~  223 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-------------YRMP  223 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-------------CCCC
Confidence            222222336678999999998999999999999999999999 99999754421 11111100             0000


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      ..    ......+.+++.+||+.+|++||+++++++.|+.
T Consensus       224 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RP----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            00    1122468889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-42  Score=315.15  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=199.8

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-----HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-----KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ++|.+.+.||+|++|.||.|.. .+++.+|+|.+.....     .....+..|+.+++.++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999954 5689999998864321     123457889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++...
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999886543    3788889999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccccc
Q 015797          192 PDGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSE  268 (400)
Q Consensus       192 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  268 (400)
                      ........  ....|+..|+|||++.+..++.++||||||+++|+|++|+.||........ .......           
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------  223 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-----------  223 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-----------
Confidence            43221111  224578899999999999999999999999999999999999975432111 0000000           


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ....    ........+.+++.+||..+|.+|||+.++++.
T Consensus       224 -~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 -TNPQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             0000    111223467788899999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.6e-42  Score=323.99  Aligned_cols=240  Identities=27%  Similarity=0.362  Sum_probs=189.1

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhc-CCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILAR-VRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.||+|++....   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 458899999987531   2233445667777775 5999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence            99999986532    3788899999999999999999998   99999999999999999999999999875322221 1


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..+.. .             .+.... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~-------------~~~~~~-  217 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-D-------------NPCYPR-  217 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-C-------------CCCCCc-
Confidence            2234699999999999999999999999999999999999999975442211 11100 0             000000 


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTML-EVLD  309 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~  309 (400)
                         .....+.+++.+||+.||.+||++. ++++
T Consensus       218 ---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         218 ---WLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ---cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence               1123567788999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.8e-42  Score=325.98  Aligned_cols=245  Identities=26%  Similarity=0.338  Sum_probs=193.8

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      +|.+.+.||+|+||.||+|.. .++..+|+|++....   ......+..|..++..+ +||+|+++++++.+.+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            588999999999999999965 457899999987432   22233466688888777 6899999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+.+....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999999886543    3788999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ...+...        ..      
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------~~------  218 (323)
T cd05616         154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------NV------  218 (323)
T ss_pred             CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------CC------
Confidence            111 2233569999999999999999999999999999999999999997654321 1111100        00      


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTM-----LEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~  309 (400)
                      .    +.......+.+++.+||+.||.+|++.     .++++
T Consensus       219 ~----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         219 A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             C----CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence            0    011123467788899999999999984     56554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=331.18  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=192.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|...+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            45678889999999999999965 4689999999865432 334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+.+|+|.+..        ...+..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++......
T Consensus       153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999986532        1455677889999999999999998   999999999999999999999999999865432


Q ss_pred             CceeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .. ......||..|+|||++..     ...+.++|||||||++|+|++|+.||..........+..         .....
T Consensus       222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---------~~~~~  291 (353)
T PLN00034        222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---------AICMS  291 (353)
T ss_pred             cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---------HHhcc
Confidence            21 1223469999999998743     234569999999999999999999997322110000000         00000


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..+    .........+.++|.+||+.||++|||+.++++.
T Consensus       292 ~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 QPP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000    0111223467888999999999999999999974

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-42  Score=319.28  Aligned_cols=251  Identities=27%  Similarity=0.317  Sum_probs=199.0

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .|++.+.||+|+||.||++.. .+++.||+|.+.....   .....+..|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            488899999999999999964 4689999999864322   223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+.+|+|.+++.....  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999988864332  23889999999999999999999998   999999999999999999999999999865432


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCcc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ..  .....|++.|+|||++.+..++.++|||||||++|+|++|..||........ ..+...         +...    
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---------~~~~----  220 (285)
T cd05605         156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---------VKED----  220 (285)
T ss_pred             Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---------hhhc----
Confidence            22  1234589999999999999999999999999999999999999975432110 000000         0000    


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                       ...........+.+++.+||..||.+||     ++.++++.
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             0011122334677889999999999999     78888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-42  Score=330.30  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=201.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEe-C
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAE-G  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-~  106 (400)
                      ..++|++.+.||+|+||.||+|...      +++.||+|++.... ......+..|+.++..+ +||||++++++|.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3458999999999999999999532      24789999987533 23345678899999999 89999999998864 4


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCc-------------------------------------------------------
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSS-------------------------------------------------------  131 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  131 (400)
                      ...+++|||+++|+|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            6688999999999999988543210                                                       


Q ss_pred             --ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce-eeeecccccCc
Q 015797          132 --ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGY  208 (400)
Q Consensus       132 --~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y  208 (400)
                        ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..+...... ......++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              125789999999999999999999998   999999999999999999999999999875432221 12223467789


Q ss_pred             CChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--hhhhhhccccchhcccccccccCccCCCCCcHHHHHH
Q 015797          209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--IKRTITDWALPLACERKFSELADPRLNGNFVEEELKR  285 (400)
Q Consensus       209 ~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (400)
                      +|||++.+..++.++|||||||++|+|++ |..||......  ....+....             ...    ........
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------~~~----~~~~~~~~  304 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-------------RMR----APEYATPE  304 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-------------CCC----CCccCCHH
Confidence            99999999999999999999999999998 99999643211  111111000             000    01112346


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          286 VVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       286 l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      +.+++.+||+.+|++||++.+|++.|....
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            888999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-42  Score=326.69  Aligned_cols=237  Identities=24%  Similarity=0.312  Sum_probs=190.2

Q ss_pred             CcccccCceEEEEEEE----cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           44 NKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      +.||+|+||.||++..    .+++.+|+|++....  ......+..|+++++.++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999854    357899999987532  2233456789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            999999986432    3889999999999999999999998   99999999999999999999999999876543322 


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                      ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ..+..        ...      .   
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~--------~~~------~---  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--------AKL------G---  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc--------CCC------C---
Confidence            22335699999999999998999999999999999999999999975432110 00100        000      0   


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRPTMLE  306 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  306 (400)
                       ........+.+++.+||+.||.+||++.+
T Consensus       217 -~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 -MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             00111246677889999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-43  Score=356.48  Aligned_cols=259  Identities=30%  Similarity=0.451  Sum_probs=206.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEc--CCC----EEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW--DGS----QIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~--~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .+-++...||+|.||.||.|...  .+.    .||+|.+... +.....+|.+|+.+|+.++||||++++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            44566788999999999999543  343    4889988754 4566778999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCc---ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          111 IVYDYMPNLSLLSHLHGQHSS---ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      |++|||.+|+|..+|+.....   ...+.....+.++.|||+|+.||++++   +|||||..+||||+....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999765111   234888899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeee-ecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhh-hhccccchhccc
Q 015797          188 AKLIPDGATHVTT-RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRT-ITDWALPLACER  264 (400)
Q Consensus       188 ~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~-~~~~~~~~~~~~  264 (400)
                      |+.+......... ...-...|||||.+..+.++.|+|||||||+|||++| |..||.......... +..       .+
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-------gg  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-------GG  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-------CC
Confidence            9955433322221 1234578999999999999999999999999999999 999998766432211 110       00


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                              ++  +....++..+.++|.+||+.+|++||+|..|++.+..+..
T Consensus       922 --------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 --------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             --------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                    00  1122234477789999999999999999999997765543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.5e-42  Score=311.96  Aligned_cols=247  Identities=30%  Similarity=0.449  Sum_probs=197.1

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChh
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLL  122 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~  122 (400)
                      +.||+|+||.||+|...++..+|+|.+.... ......+..|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999987788999999887543 333456889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeec
Q 015797          123 SHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV  202 (400)
Q Consensus       123 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  202 (400)
                      +++.....   .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            98865432   3789999999999999999999998   99999999999999999999999999875433222111122


Q ss_pred             ccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHH
Q 015797          203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE  281 (400)
Q Consensus       203 ~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (400)
                      .+++.|+|||++.++.++.++||||||+++|+|++ |..||..............        ..    ...    ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~--------~~----~~~----~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK--------GY----RMS----CPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------CC----CCC----CCCC
Confidence            34677999999999999999999999999999998 9999975432211110000        00    000    0111


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          282 ELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       282 ~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ....+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2357888999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.2e-42  Score=324.23  Aligned_cols=240  Identities=27%  Similarity=0.324  Sum_probs=189.2

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhc-CCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILAR-VRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .++..||+|.+....   ......+..|..++.. ++||||+++++++.+++..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999965 468899999987422   2233456667778775 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.++|+|||++........ .
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence            99999886532    3788899999999999999999998   99999999999999999999999999874322221 2


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+.. .             .+.... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-~-------------~~~~~~-  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-D-------------TPHYPR-  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-C-------------CCCCCC-
Confidence            234569999999999999999999999999999999999999997544321 111100 0             000111 


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTML-EVLD  309 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~  309 (400)
                         .....+.+++.+||+.||.+||++. ++++
T Consensus       218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         218 ---WITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence               1123667788999999999999984 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.7e-42  Score=319.94  Aligned_cols=253  Identities=22%  Similarity=0.326  Sum_probs=204.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ....+|++.+.||+|++|.||+|.. .+++.+++|.+..........+..|+.+++.++||||+++++.+..+...|+||
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            4457899999999999999999964 568999999988655555667889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++...     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        97 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            999999999988643     2788899999999999999999998   99999999999999999999999999876543


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCcc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      .... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... .....+      .     +.
T Consensus       169 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-~~~~~~------~-----~~  235 (296)
T cd06654         169 EQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNG------T-----PE  235 (296)
T ss_pred             cccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-HHhcCC------C-----CC
Confidence            2211 122358899999999998889999999999999999999999997544211000 000000      0     00


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .  .........+.+++.+||..+|++|||+.++++.
T Consensus       236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0  0111223467788899999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.1e-42  Score=312.97  Aligned_cols=247  Identities=28%  Similarity=0.423  Sum_probs=195.0

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      +.||+|+||.||+|.. .+++.+|+|.+... .......+..|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4799999999999965 47889999987643 234456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeee-
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-  200 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~-  200 (400)
                      .+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++............ 
T Consensus        81 ~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            999864332   3788999999999999999999998   999999999999999999999999998764432111111 


Q ss_pred             ecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCc
Q 015797          201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV  279 (400)
Q Consensus       201 ~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (400)
                      ...++..|+|||.+.++.++.++||||||+++|+|++ |..||................+            .    ...
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~------------~----~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------------L----PCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------------C----CCc
Confidence            1123456999999999999999999999999999998 9999875443211111100000            0    011


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          280 EEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       280 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ......+.+++.+||+.+|++|||+.++++.|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            112346788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.3e-42  Score=320.93  Aligned_cols=262  Identities=26%  Similarity=0.394  Sum_probs=205.5

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVW-SNKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      +....++|++.+.||+|+||.||++...      ....+|+|.+... .......+..|+.++..+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3455678999999999999999999643      2367899988753 233445688899999999 8999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCC------------CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQH------------SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                      .++..+++|||+++|+|.+++....            .....+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            9999999999999999999986432            12335889999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-  249 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-  249 (400)
                      +++.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            99999999999999998764432211 112235678999999999999999999999999999998 999987543221 


Q ss_pred             hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ...+.....       .          .........+.+++.+||..||++|||+.++++.|..+
T Consensus       244 ~~~~~~~~~-------~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 FKLLKEGYR-------M----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHcCCc-------C----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            111110000       0          01111234688899999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.1e-42  Score=318.16  Aligned_cols=256  Identities=25%  Similarity=0.450  Sum_probs=200.9

Q ss_pred             cCCCcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .+|++.+.||+|+||.||+|..     ..+..+++|.+.... ......+..|+.+++.++||||+++++++..+...|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999963     245789999987433 3334568889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC-------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          112 VYDYMPNLSLLSHLHGQHS-------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      ||||+++|+|.+++.....             ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853321             1124788889999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhc
Q 015797          179 KAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITD  255 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~  255 (400)
                      .+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ....+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986543221 11222336778999999998899999999999999999998 99998654321 1111111


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      ...+             ...    ......+.+++.+||+.||.+||++.+|++.|+.
T Consensus       242 ~~~~-------------~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 RQLL-------------PCS----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCcC-------------CCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            0000             000    1112467778899999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.8e-41  Score=315.15  Aligned_cols=246  Identities=26%  Similarity=0.323  Sum_probs=191.7

Q ss_pred             ccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           46 LGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        46 LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ||+|+||.||++.. .+|+.+|+|.+....   ......+..|+++++.++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999964 568999999986321   12233456799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeee
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR  201 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~  201 (400)
                      .+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~  153 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ  153 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence            988864432  23888999999999999999999998   99999999999999999999999999876643322  223


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCCcH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNFVE  280 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (400)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ..+..        .........  .   ..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~--~---~~  220 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR--------RTLEDEVKF--E---HQ  220 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH--------Hhhcccccc--c---cc
Confidence            4589999999999999999999999999999999999999965322110 00000        000000000  0   01


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          281 EELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       281 ~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                      .....+.+++.+||+.||.+||++.|+++.+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            1234678888999999999999997776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-41  Score=323.20  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=189.7

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.+|+|++...   .......+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999964 46889999998743   223344577888888776 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|..++....    .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~  152 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T  152 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence            99998886432    3888999999999999999999998   99999999999999999999999999875322111 1


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhcccccccccCccCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.......  ......+.........      ..+. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p-  225 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCC-
Confidence            223569999999999999999999999999999999999999996322110  0000000000000000      0011 


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRPTM------LEVLD  309 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rps~------~ell~  309 (400)
                         ......+.+++.+||+.||.+||++      .++++
T Consensus       226 ---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         226 ---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             ---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence               1122456788899999999999984      56664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-41  Score=311.20  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=202.8

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|.+.+.||+|++|.||+|.. .++..+++|.+...  .......+..|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999964 46899999998642  344556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999875422  24888999999999999999999998   9999999999999999999999999988665432


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||........ .....            ... +  
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~-~--  219 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR------------GVF-P--  219 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------------CCC-C--
Confidence            21 2234588999999999999999999999999999999999999975542110 00000            000 0  


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        .........+.+++.+||+.+|++||++.++++.
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 --PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence              0111233578889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-41  Score=312.23  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=200.8

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      +|++.+.||.|+||.||++.. .++..+|+|.+... .......+..|+.+++.++||||+++++.+.+++..|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            588999999999999999954 46899999998643 3344566888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....  ..++...++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999998864322  23788899999999999999999998   99999999999999999999999999976543222


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                       ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ..+..        ....     .+ 
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~-----~~-  220 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------GSYK-----PL-  220 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--------CCCC-----CC-
Confidence             12234589999999999998999999999999999999999999975432110 00000        0000     00 


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         .......+.+++.+||+.||++|||+.+++..
T Consensus       221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               11122457788899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-41  Score=313.35  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=200.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|.+...||.|++|.||+|.+..+..+|+|.+.... .....+..|+++++.++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            36789999999999999999977667789999876433 23456888999999999999999999875 45688999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      .+|+|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          83 GKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999875432  24788999999999999999999998   99999999999999999999999999976543322


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......++..|+|||.+.+..++.++||||||+++|+|+| |..||....... .......         .    ..  
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---------~----~~--  222 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG---------Y----RM--  222 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------C----CC--
Confidence            22222336778999999998999999999999999999999 999997543221 1111100         0    00  


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                        .........+.+++.+||..||++||++.++++.|+.
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              0111223567888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.6e-42  Score=323.24  Aligned_cols=241  Identities=27%  Similarity=0.334  Sum_probs=192.2

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.||+|++....   ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 458899999987432   23344567788888877 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  152 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T  152 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence            99999886543    3889999999999999999999998   99999999999999999999999999875322111 1


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..+...        .      ...   
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--------~------~~~---  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--------E------VRY---  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--------C------CCC---
Confidence            2234589999999999999999999999999999999999999975442211 111000        0      000   


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTM-----LEVLDL  310 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~~  310 (400)
                       .......+.+++.+||..||.+||++     .++++.
T Consensus       216 -~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 -PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             01123467788899999999999999     888763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=323.28  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=190.8

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.||+|+++...   ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999965 468899999997532   22334577899999888 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~  152 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T  152 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence            99998886432    3889999999999999999999998   99999999999999999999999999874322111 2


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhcccccccccCccCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.......  ......+.........      ..+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~  226 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCC
Confidence            233569999999999999999999999999999999999999996432110  0000000000000000      00111


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRPT------MLEVLD  309 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rps------~~ell~  309 (400)
                      .    ....+.+++.+||+.||.+||+      +.++++
T Consensus       227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            1    1235677889999999999997      667775

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.4e-42  Score=317.60  Aligned_cols=253  Identities=26%  Similarity=0.415  Sum_probs=196.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCC----EEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGS----QIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+..... .....+..|+..++.++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            57888999999999999999653 344    467777654322 23356778888999999999999999875 456789


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ++||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            9999999999999975432   3889999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhh-hhccccchhccccccc
Q 015797          192 PDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRT-ITDWALPLACERKFSE  268 (400)
Q Consensus       192 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~  268 (400)
                      ..... .......++..|+|||.+.++.++.++|||||||++|||++ |..||.......... +.....+         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL---------  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC---------
Confidence            43322 11223447788999999999999999999999999999998 999997654321111 1100000         


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                       ..+    ..   ....+..++.+||..||.+|||+.++++.|...
T Consensus       231 -~~~----~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 -AQP----QI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             -CCC----CC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             000    01   123567788999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-41  Score=314.98  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=202.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .+|.+.+.||+|+||.||++...      ++..+++|.+..........+..|+++++.++||||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46788899999999999999532      356788998876666666789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCc-----------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcE
Q 015797          112 VYDYMPNLSLLSHLHGQHSS-----------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA  180 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~  180 (400)
                      +|||+++|+|.+++......           ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            99999999999998654311           124788999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccc
Q 015797          181 QVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWA  257 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~  257 (400)
                      ||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ .......
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            99999999765432211 1122335788999999999999999999999999999998 9999865443211 1111000


Q ss_pred             cchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                       +            ...    .......+.+++.+||+.||.+||++.+|++.|+
T Consensus       242 -~------------~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         242 -E------------LER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -c------------CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             0            000    0111245778889999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-41  Score=323.63  Aligned_cols=236  Identities=27%  Similarity=0.313  Sum_probs=185.7

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHH-HHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVE-ILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.||+|++....   ......+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4799999999999965 468999999987422   122234445544 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-T  152 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-c
Confidence            99999886533    3788899999999999999999998   99999999999999999999999999875322221 2


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+...        .      ..+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--------~------~~~~~~  218 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--------P------LRLKPN  218 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--------C------CCCCCC
Confidence            233469999999999999999999999999999999999999997543211 1111100        0      001111


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTML  305 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~  305 (400)
                          ....+.+++.+||+.||.+||++.
T Consensus       219 ----~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ----ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence                134677888999999999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=313.45  Aligned_cols=255  Identities=31%  Similarity=0.499  Sum_probs=204.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..++|++.+.||.|++|.||+|...++..+|+|.+..... ....+..|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4578999999999999999999877788899998875332 345688999999999999999999999998999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999975432  24889999999999999999999998   9999999999999999999999999998664322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ........++..|+|||.+.+..++.++||||||+++|+|+| |+.||....... ......         ..    ...
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---------~~----~~~  224 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---------GY----RMP  224 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------CC----CCC
Confidence            211112235678999999998899999999999999999998 999996543211 011000         00    000


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      ....    ....+.+++.+||+.+|++||++.++++.|+.
T Consensus       225 ~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPPN----CPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0001    13467888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.5e-42  Score=318.72  Aligned_cols=256  Identities=24%  Similarity=0.416  Sum_probs=200.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .+|++.+.||+|+||.||+|...      .+..||+|.+...... ....+..|+.++..++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            45788899999999999999643      2478999998754332 3456888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC------------CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          111 IVYDYMPNLSLLSHLHGQH------------SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      +++||+.+++|.+++....            .....+++..++.++.|++.||.|||+++   ++||||||+||+++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999999985321            11224788889999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhc
Q 015797          179 KAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITD  255 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~  255 (400)
                      .+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||...... ....+..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999886543222 11223346789999999998999999999999999999998 88888654321 1111110


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                              ...     ..    ........+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       242 --------~~~-----~~----~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 --------RQV-----LP----CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --------CCc-----CC----CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                    000     00    111123467788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-41  Score=318.53  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=201.1

Q ss_pred             CCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+..|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            5889999999999999999642      234688888765432 334568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC--------------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797          112 VYDYMPNLSLLSHLHGQHS--------------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      +|||+.+|+|.+++.....                    ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            9999999999998764211                    1124788999999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI  249 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~  249 (400)
                      ||+++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|+| |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999999765332221 1122335678999999998899999999999999999999 999996543211


Q ss_pred             hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ......        ...    ..    .........+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       238 ~~~~~~--------~~~----~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 LFNLLK--------TGY----RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHh--------CCC----CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            100000        000    00    001112346788999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.2e-42  Score=338.34  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=193.6

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC------
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG------  106 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------  106 (400)
                      .....+|++.+.||+|+||.||+|.. .+++.||+|.+....    .....|+.+|+.++||||+++++++...      
T Consensus        62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            34557899999999999999999965 568999999885432    2244699999999999999998876432      


Q ss_pred             --CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEE
Q 015797          107 --QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVA  183 (400)
Q Consensus       107 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~  183 (400)
                        ..+++||||++ ++|.+++.........+++..++.++.|++.||.|||+.+   |+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence              24679999997 4787776543233335888999999999999999999998   99999999999999665 69999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccch
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPL  260 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~  260 (400)
                      |||+++.+.....  .....||+.|+|||++.+. .++.++|||||||++|+|+||.+||......  ..........|.
T Consensus       214 DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        214 DFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             ccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9999986643322  2234589999999998764 6899999999999999999999999764321  111110000000


Q ss_pred             h-----cccccccccCccCC-----CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 A-----CERKFSELADPRLN-----GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 ~-----~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .     ....+..+.-+...     ..+.......+.+|+.+||..||.+|||+.++++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0     00000000000000     00111123467889999999999999999999963

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=323.67  Aligned_cols=255  Identities=23%  Similarity=0.309  Sum_probs=209.8

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH---HHHHHHHHHHHHhcCC-CCccceeeeEEEeCC
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK---AEMEFAVEVEILARVR-HKNLLSLRGYCAEGQ  107 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  107 (400)
                      -......|.+.+.||.|.||.||++.. .+|+.+|+|.+......   ....+..|+.+|++++ ||||+.++++|++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            355667899999999999999999965 45999999999754332   3357889999999998 999999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC----CcEEEE
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD----FKAQVA  183 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~----~~~kl~  183 (400)
                      ..++|||+|.||.|.+.+...     .+++..+..++.|++.|+.|||+.|   ++||||||+|+|+...    +.+|++
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEe
Confidence            999999999999999999765     2888999999999999999999998   9999999999999643    579999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE  263 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  263 (400)
                      |||++.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.............       .
T Consensus       182 DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------~  252 (382)
T KOG0032|consen  182 DFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------R  252 (382)
T ss_pred             eCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------c
Confidence            9999998765  334556789999999999999999999999999999999999999998766432211100       1


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..+      .+....-+......-+++..|+..||.+|+|+.++|+.
T Consensus       253 ~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  253 GDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            111      11111112223456667799999999999999999985

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-41  Score=312.58  Aligned_cols=254  Identities=26%  Similarity=0.479  Sum_probs=203.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..++|++.+.||+|+||.||+|....+..+++|.+... ......+..|+.+++.++|+||+++++++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            45789999999999999999998777788999987643 2234568889999999999999999999887 778999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999875432  24788899999999999999999998   9999999999999999999999999997654332


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ........++..|+|||.+.++.++.++|||||||++|+|+| |..||...... ....+...         .   ..  
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------~---~~--  222 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---------Y---RM--  222 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---------C---CC--
Confidence            222222335678999999998899999999999999999999 99999754322 11111100         0   00  


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                         .........+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               0011223468888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-41  Score=316.37  Aligned_cols=257  Identities=28%  Similarity=0.393  Sum_probs=201.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|.+.+.||+|++|.||+|...      .+..|++|.+.... ......+..|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567899999999999999999653      45678999876443 3344568899999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCC---cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC---cEEE
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHS---SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF---KAQV  182 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~---~~kl  182 (400)
                      .++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999865432   1124889999999999999999999998   99999999999998765   5999


Q ss_pred             EecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccc
Q 015797          183 ADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALP  259 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~  259 (400)
                      +|||++.......... ......++.|+|||++.+..++.++|||||||++|+|++ |..||....... ...+....  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--  238 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG--  238 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence            9999998663322111 111224568999999999999999999999999999997 999997543221 11111000  


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                           ..          .........+.+++.+||+.+|++|||+.+|++.|.
T Consensus       239 -----~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 -----RL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----cC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                 00          001112346778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.8e-42  Score=309.10  Aligned_cols=269  Identities=20%  Similarity=0.269  Sum_probs=202.9

Q ss_pred             ccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCc-cceeeeEEEeCC-----
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKN-LLSLRGYCAEGQ-----  107 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~-----  107 (400)
                      ...|...++||+|+||+||+|+ ..+|+.||+|.+......  ......+|+.+|+.|+|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3457777889999999999995 467899999999865442  3456788999999999999 999999998877     


Q ss_pred             -eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          108 -ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       108 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                       ..++|+||+. -+|..++.........++...+..++.||+.||+|||+++   |+||||||.||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             8899999997 5999999766532233666789999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccc--hh
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALP--LA  261 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~--~~  261 (400)
                      +++...-.... .+..++|..|.|||++.+. .|++..||||+|||++||++++.-|.+....  ....+.-...|  ..
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            99965433322 3344589999999999886 7999999999999999999999888765532  11111111111  11


Q ss_pred             ccc-----ccccccCccC-CCCCcH---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CER-----KFSELADPRL-NGNFVE---EELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~~-----~~~~~~~~~~-~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +++     .+.......- ......   ....+..+++.+|++.+|.+|.|+...+..
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111     0110001110 001111   111367788899999999999999999874

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-42  Score=316.49  Aligned_cols=257  Identities=24%  Similarity=0.401  Sum_probs=202.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .++|++.+.||+|+||.||+|...      .+..+|+|.+.... ......+..|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            468899999999999999999643      23689999986443 33445688999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCc------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSS------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                      ++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            9999999999999998654321      123688899999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchh
Q 015797          184 DFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLA  261 (400)
Q Consensus       184 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  261 (400)
                      |||+++........ ......++..|+|||.+.++.++.++|||||||++|+|+| |..||.............      
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence            99998765432221 1122346789999999998899999999999999999998 999986544221111000      


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                       ....     ....    ......+.+++.+||+.+|++|||+.++++.|+
T Consensus       236 -~~~~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 -DGGH-----LDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -cCCC-----CCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             0000     0001    111357788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-42  Score=306.93  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=201.6

Q ss_pred             ccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCChHH--HHHHHHHHHHHhcCCCCccceeeeEEEe--CCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKA--EMEFAVEVEILARVRHKNLLSLRGYCAE--GQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l  111 (400)
                      .+.|+.+..|++|+||.||+|+ ..+++.||+|+++......  ...-.+|+.+|...+|||||.+-.+...  -+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            3567888999999999999995 4679999999998644322  3456789999999999999999998754  356999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |||||+. +|..++.....   .+...++.-+..|+++|++|||.+.   |+|||||++|+|++..|.+||+|||+|+.+
T Consensus       155 VMe~~Eh-DLksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            9999985 99998886653   4888899999999999999999998   999999999999999999999999999988


Q ss_pred             CCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERKFSE  268 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  268 (400)
                      .+... ..+..+-|..|.|||++.+ ..|+++.|+||+|||+.||+++++-|.+....  +...+.-...|  .+..|..
T Consensus       228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP--te~iwpg  304 (419)
T KOG0663|consen  228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP--SEAIWPG  304 (419)
T ss_pred             cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC--ccccCCC
Confidence            76533 3445568999999999987 47999999999999999999999998765432  22221111111  0111111


Q ss_pred             ccC--------------ccCCCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          269 LAD--------------PRLNGNFVEE-ELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       269 ~~~--------------~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +..              ..+...|... ....-.+|+...|..||.+|.|+.+.|+
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            111              1111111111 2245566778899999999999999986

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=322.30  Aligned_cols=203  Identities=26%  Similarity=0.364  Sum_probs=173.2

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||++.. .+++.||+|++...   .......+..|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999964 46899999998742   2223345788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999865322   3788899999999999999999998   99999999999999999999999999876544


Q ss_pred             CCceeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          194 GATHVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      ..........||+.|+|||++..     +.++.++|||||||++|+|++|+.||....
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            33222223459999999999873     457889999999999999999999997543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-41  Score=315.28  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC-----
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG-----  106 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-----  106 (400)
                      .++++.|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            45788999999999999999999964 468899999986543 3345688899999998 799999999998753     


Q ss_pred             -CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 -QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       ...+++|||+.+|+|.+++.....  ..+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence             468999999999999999875332  24888999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccch
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL  260 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~  260 (400)
                      |++........ ......|++.|+|||++.     +..++.++|||||||++|+|++|..||............    + 
T Consensus       156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~-  229 (272)
T cd06637         156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----P-  229 (272)
T ss_pred             CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----h-
Confidence            99976543222 122345899999999986     345788999999999999999999999654322111100    0 


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ....     ....   .......+.+++.+||..+|.+|||+.++++
T Consensus       230 --~~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 --RNPA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --cCCC-----CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              0000     0000   0112246788899999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-41  Score=316.51  Aligned_cols=266  Identities=23%  Similarity=0.332  Sum_probs=205.5

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      .++++.+..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            466788888999999999999999999999954 568899999876432 2235677899999999 6999999999874


Q ss_pred             -----eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          105 -----EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       105 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                           .++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence                 346789999999999999987643333335888899999999999999999998   999999999999999999


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhh
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT  254 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~  254 (400)
                      ++|+|||++........ ......|++.|+|||++..     ..++.++|||||||++|+|++|+.||........  ..
T Consensus       163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~  239 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF  239 (286)
T ss_pred             EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh
Confidence            99999999876543221 1223458999999998853     4578999999999999999999999875432110  00


Q ss_pred             ccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                      ...     .........+       ......+.+++.+||+.||++|||+.++++.+
T Consensus       240 ~~~-----~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KIP-----RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hcc-----ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            000     0000000000       01124678889999999999999999999753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-41  Score=312.86  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=196.4

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||+|+||.||+|.+ .+++.+|+|.+... .......+..|+.+++.++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3688899999999999999954 57899999998654 233445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|..+.        .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            9999986542        2677888899999999999999998   9999999999999999999999999997654322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                         .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...........     +......+.....+...
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  221 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-----PLQLLQCIVDEDPPVLP  221 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-----hHHHHHHHhccCCCCCC
Confidence               2234589999999999999999999999999999999999999975332110000     00000000000001110


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .   ......+.+++.+||+.+|.+||++.++++.
T Consensus       222 ~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 V---GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0   1122467788899999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.8e-41  Score=311.72  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=199.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|.+.+.||+|+||.||+|.. .+++.+|+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            45888999999999999999954 56889999998765555555678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999999886443    3888999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          196 THVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      . ......|++.|+|||.+.   .+.++.++|||||||++|+|++|..||..............       .   ....+
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-------~---~~~~~  229 (267)
T cd06645         161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-------S---NFQPP  229 (267)
T ss_pred             c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-------c---CCCCC
Confidence            1 122345899999999874   45688999999999999999999999864432111000000       0   00000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....  .......+.+++.+||+.+|++||++.+|++
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000  0011235778899999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-41  Score=321.37  Aligned_cols=264  Identities=19%  Similarity=0.309  Sum_probs=196.9

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+..|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            6799999999999999999964 4688899999875332 2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +.+ +|.+++.....   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            974 88888764432   3788889999999999999999998   9999999999999999999999999987643322


Q ss_pred             ceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccc--hhccc-----c
Q 015797          196 THVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP--LACER-----K  265 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~--~~~~~-----~  265 (400)
                      .. .....+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||........  ........|  ..++.     .
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            21 122357899999998865 4689999999999999999999999965432111  000000000  00000     0


Q ss_pred             cccccCccCCC----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELADPRLNG----NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ......+....    ...+.....+.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000000    001112346678899999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.5e-41  Score=308.00  Aligned_cols=250  Identities=28%  Similarity=0.388  Sum_probs=202.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++.+.||.|++|.||+|... ++..+++|.+.....  ...+..|+.+++.++||||+++++.+.++...|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            478999999999999999999654 488999999875432  56788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            99999999986433   24899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      . ......++..|+|||++.+..++.++||||||+++|+|++|+.||............            .....+.. 
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~-  219 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------PNKPPPTL-  219 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------------ccCCCCCC-
Confidence            2 122344889999999999999999999999999999999999999754321100000            00000000 


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       .........+.+++.+||+.||++|||+.++++
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             011222356788899999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=310.38  Aligned_cols=249  Identities=32%  Similarity=0.482  Sum_probs=203.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||.|++|.||+|.. .++.||+|.+..... ....+..|+.+++.++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            46889999999999999999974 589999999876544 4567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||..+   ++|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          83 AKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999999875432  24899999999999999999999998   99999999999999999999999999986633222


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                          ...++..|+|||.+.++.++.++||||||+++|+|++ |..||........ ..+...         ..    .  
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------~~----~--  218 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------YR----M--  218 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------CC----C--
Confidence                2235678999999998899999999999999999997 9999865532211 111000         00    0  


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                        .........+.+++.+||..+|++|||+.++++.|+.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 --EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              0011123467888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-41  Score=315.55  Aligned_cols=253  Identities=27%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ...++|++.+.||.|+||.||+|.. .++..+++|.+..........+..|+.+++.++||||+++++.+..++..++||
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            3457899999999999999999965 458899999998766666777889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|..++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          89 EFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             ecCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999888754322   3889999999999999999999998   99999999999999999999999999875433


Q ss_pred             CCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ... ......+++.|+|||++.     ...++.++|||||||++|+|++|..||....... .........         
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------  232 (292)
T cd06644         163 TLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---------  232 (292)
T ss_pred             ccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC---------
Confidence            221 122345889999999885     3456889999999999999999999997543210 000000000         


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                          +..  .........+.+++.+||..+|++||++.++++
T Consensus       233 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 ----PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                000  001122346778899999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-41  Score=314.25  Aligned_cols=268  Identities=24%  Similarity=0.374  Sum_probs=199.5

Q ss_pred             CCCcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERL  110 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~  110 (400)
                      -|++.+.||+|+||.||.+..     .++..||+|.+.... ......+..|+.+++.++||||+++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            468899999999999999963     357889999987543 33345788999999999999999999998775  5688


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++++|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            99999999999999864432   3889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCce--eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          191 IPDGATH--VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      .......  ......++..|+|||.+.+..++.++|||||||++|+|+|++.|+..................... ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  237 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLVR  237 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHHH
Confidence            6433221  112344677899999999889999999999999999999988775432111100000000000000 0000


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      .................+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            000000000011123578889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-41  Score=311.52  Aligned_cols=255  Identities=27%  Similarity=0.396  Sum_probs=198.1

Q ss_pred             CCcCCcccccCceEEEEEEEcC----CCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe-----
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE-----  108 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----  108 (400)
                      |.+.+.||+|+||.||+|....    +..||+|.+....  ......+..|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999996432    3679999987532  3334578899999999999999999998866554     


Q ss_pred             -EEEEEEccCCCChhhhhhcCC--CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          109 -RLIVYDYMPNLSLLSHLHGQH--SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       109 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       .+++|||+++|+|..++....  .....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999885432  12235888999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhc
Q 015797          186 GFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLAC  262 (400)
Q Consensus       186 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~  262 (400)
                      |+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+.....    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----  233 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR----  233 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            9998654332211 111235678999999988899999999999999999999 88998654321 1111110000    


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                               ..    ........+.+++.+||+.||.+|||+.++++.|..+
T Consensus       234 ---------~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 ---------LK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------CC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     00    0111234788888999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-41  Score=322.38  Aligned_cols=240  Identities=25%  Similarity=0.297  Sum_probs=186.5

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHH-HHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEV-EILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.+|+|++....   ......+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999965 467889999987422   12223344444 456789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+....+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~  152 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T  152 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence            99999886533    3777888889999999999999998   99999999999999999999999999875432221 2


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+...  +      .      .    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~------~------~----  214 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--P------L------Q----  214 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--C------c------C----
Confidence            234569999999999999999999999999999999999999997544221 1111100  0      0      0    


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..+.....+.+++.+||+.||.+||++.+.+.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            01112346777889999999999999774443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.6e-42  Score=330.91  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=196.6

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC-----eEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ-----ERL  110 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~  110 (400)
                      +|++.+.||+|+||.||+|.. .+++.||+|.+...  .......+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999964 57899999988642  2233456888999999999999999999998776     789


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+. ++|.+.+....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 58888775432    3889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhcc-ccchh------
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDW-ALPLA------  261 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~-~~~~~------  261 (400)
                      .............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ..+... ..+..      
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            543322222334589999999999874 579999999999999999999999975432110 000000 00000      


Q ss_pred             cccc----cccccCc-cCCC--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CERK----FSELADP-RLNG--NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~~~----~~~~~~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ....    ......+ ....  .........+.+++.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000    0000000 0000  0011123467789999999999999999999974

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.9e-41  Score=321.68  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|.+.+.||+|+||.||++.. .+++.||+|++...   .......+..|..++..++||||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5799999999999999999965 46889999998642   2222345778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999975322   3788889999999999999999998   99999999999999999999999999986654


Q ss_pred             CCceeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ..........||+.|+|||++.+     +.++.++|||||||++|+|++|+.||....... ...+.....      .+.
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------~~~  228 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE------RFQ  228 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC------ccc
Confidence            33322333469999999999876     568899999999999999999999997543211 011100000      000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEK--RPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~  310 (400)
                        ..     .........+.+++.+|+..++.+  |+++.++++.
T Consensus       229 --~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 --FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              00     011112345667778888765544  4688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-41  Score=311.75  Aligned_cols=251  Identities=31%  Similarity=0.429  Sum_probs=198.8

Q ss_pred             CCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHH--HHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           40 FNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      |++.+.||+|+||+||++... +++.+|+|.+.........  ....|+.+++.++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678899999999999999654 4668999999876554443  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      .+++|.+++...    ..+++..++.++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||++...... .
T Consensus        81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N  152 (260)
T ss_dssp             TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred             cccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-c
Confidence            999999999722    23889999999999999999999998   999999999999999999999999999764222 2


Q ss_pred             eeeeecccccCcCChhhhc-cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAM-LGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......+++.|+|||++. +..++.++||||||+++|+|++|..||....... .........+..... ..       
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~-------  224 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-SQ-------  224 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-TT-------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc-cc-------
Confidence            2233456899999999998 8899999999999999999999999998652111 011100000000000 00       


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         ........+.+++.+||+.||++|||+.++++
T Consensus       225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00000157888999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-41  Score=319.54  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=199.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCC--EEEEEEEecC-ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGS--QIAVKRLKVW-SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|++.+.||+|+||.||+|.+. ++.  .+++|.+... .......+..|+.++..+ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357899999999999999999653 454  4577766543 233445788899999999 89999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          112 VYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      ||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            9999999999999864421            1124788999999999999999999998   999999999999999999


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccc
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWA  257 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~  257 (400)
                      +||+|||++........  .....++..|+|||.+.+..++.++|||||||++|+|+| |..||....... ......  
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--  238 (303)
T cd05088         163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--  238 (303)
T ss_pred             EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence            99999999864321111  111124667999999988889999999999999999998 999996543211 111100  


Q ss_pred             cchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         .        .....    .......+.+++.+||+.+|++||++.+++..|.....
T Consensus       239 ---~--------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         239 ---G--------YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             ---C--------CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               0        00000    01112367788999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-41  Score=318.35  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=198.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCC--EEEEEEEecC-ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGS--QIAVKRLKVW-SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.++.. .......+..|+.++.++ +||||+++++++.+.+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57899999999999999999653 333  4688887643 333455788999999999 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcE
Q 015797          113 YDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA  180 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~  180 (400)
                      |||+++|+|.+++.....            ....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            999999999999865321            1124788899999999999999999998   9999999999999999999


Q ss_pred             EEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhcccc
Q 015797          181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWAL  258 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~  258 (400)
                      ||+|||++........  ......+..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...+..   
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~---  233 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---  233 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---
Confidence            9999999864321111  111123557999999998899999999999999999997 999997544221 000000   


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                            ..    ....    .......+.+++.+||+.+|.+|||+.++++.|....
T Consensus       234 ------~~----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         234 ------GY----RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             ------CC----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  00    0000    0112246778899999999999999999999886554

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-40  Score=314.37  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=199.7

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||+|+||.||++.. .++..+|+|.+... .......+..|+++++.++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4789999999999999999964 46788899988653 233345688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      +++++|.+++....    .+++..+..++.|++.||.|||+ .+   ++|+||||+|||++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999986542    37888999999999999999997 46   999999999999999999999999998755332


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccc-hhcccc--------
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALP-LACERK--------  265 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~--------  265 (400)
                      .   .....|++.|+|||.+.+..++.++|||||||++|+|+||+.||................. ......        
T Consensus       154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            1   1234589999999999888899999999999999999999999864432111111000000 000000        


Q ss_pred             ------------ccccc---CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          266 ------------FSELA---DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       266 ------------~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                  .....   .+.....   .....+.+++.+||..+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        00000   0000000   123457889999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-41  Score=318.65  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=202.9

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  106 (400)
                      ...++|.+.+.||+|+||.||+|...      .+..+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            44467999999999999999999632      24578999887543 33345688999999999 799999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      +..+++|||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            999999999999999999865332  23789999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh--hhhhccccchhc
Q 015797          187 FAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK--RTITDWALPLAC  262 (400)
Q Consensus       187 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~--~~~~~~~~~~~~  262 (400)
                      ++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||........  .....       
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-------  259 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-------  259 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-------
Confidence            99865433221 1122346788999999999999999999999999999998 9999875432110  00000       


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                        ..    ...    ........+.+++.+||+.+|++|||+.++++.|..
T Consensus       260 --~~----~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         260 --GY----RMA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             --CC----cCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence              00    000    001112467889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=316.20  Aligned_cols=263  Identities=23%  Similarity=0.380  Sum_probs=199.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcC---------------CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceee
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWD---------------GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLR  100 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~  100 (400)
                      .++|++.+.||+|+||.||++....               ...||+|.+.... ......+..|+++++.++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999985421               2358999887542 33345688999999999999999999


Q ss_pred             eEEEeCCeEEEEEEccCCCChhhhhhcCCC--------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797          101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHS--------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                      +++...+..++||||+.+++|.+++.....        ....+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999999864321        1123678889999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh--CCCChhhhhhhh
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS--GKKPIEKVNSAI  249 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt--g~~Pf~~~~~~~  249 (400)
                      +++.++.+||+|||++......... ......+++.|+|||.+.++.++.++|||||||++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999999765432221 1122335778999999999999999999999999999998  667876543211


Q ss_pred             -hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          250 -KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                       ............   ......       ........+.+++.+||+.||++|||+.+|++.|+
T Consensus       241 ~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQG---RQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhcc---ccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             111100000000   000000       00112347888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-41  Score=315.42  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcC-----CCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe-CCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWD-----GSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE-GQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~  108 (400)
                      ..++|++.+.||+|+||.||+|....     +..|++|.+... .......+..|+.+++.++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35789999999999999999996554     678899988643 33445668889999999999999999998766 567


Q ss_pred             EEEEEEccCCCChhhhhhcCCCc----ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSS----ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                      .+++++|+++|+|.+++......    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999998654221    135889999999999999999999998   99999999999999999999999


Q ss_pred             cCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchh
Q 015797          185 FGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLA  261 (400)
Q Consensus       185 fgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~  261 (400)
                      ||+++.+....... .....++..|+|||++.+..++.++|||||||++|++++ |+.||....... ...+...     
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----  235 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-----  235 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-----
Confidence            99998654332221 122336778999999998899999999999999999999 999997543211 1111000     


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                              ....    ........+.+++.+||..||++|||+.++++.|..+.
T Consensus       236 --------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         236 --------YRLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             --------CCCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                    0000    01112246788999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-41  Score=323.24  Aligned_cols=237  Identities=26%  Similarity=0.297  Sum_probs=186.0

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHH-HHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVE-ILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.+|+|++...   .......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999954 56899999998642   1222334555554 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|..++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  152 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T  152 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence            99998886433    3888999999999999999999998   99999999999999999999999999875322221 1


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......        ..      .... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--------~~------~~~~-  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--------PL------VLRP-  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--------Cc------cCCC-
Confidence            233469999999999999999999999999999999999999997543211 1111100        00      0001 


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTMLE  306 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~e  306 (400)
                         .....+.+++.+||+.||.+||++.+
T Consensus       218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         218 ---GASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ---CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence               11235677889999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-41  Score=316.45  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=204.2

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .....+|++.+.||.|++|.||+|.. .+++.||+|.+..........+..|+.+++.++||||+++++++..+...++|
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            34558899999999999999999964 57999999999765555566788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++++|.+++...     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        95 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          95 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             ecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            9999999999988643     2788899999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||....... ........      .     .+
T Consensus       167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-~~~~~~~~------~-----~~  233 (297)
T cd06656         167 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATN------G-----TP  233 (297)
T ss_pred             CCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-heeeeccC------C-----CC
Confidence            32221 122358899999999999999999999999999999999999996543210 00000000      0     00


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..  .........+.+++.+||..+|.+||++.++++
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 EL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  011122345677889999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.6e-41  Score=314.13  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=199.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCC----EEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGS----QIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..+|++.+.||+|+||+||+|.+ .++.    .||+|++... .......+..|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            46788999999999999999964 3444    4799988753 33345678899999999999999999999875 4578


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ++|+|+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence            99999999999999875432   3888999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          191 IPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       191 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ...+.....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------  229 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER---------  229 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc---------
Confidence            64332211 111235678999999999999999999999999999998 999987543221 111111000         


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                          ..    ........+.+++.+||..||++||++.++++.|....
T Consensus       230 ----~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         230 ----LP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             ----CC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                00    01112346778899999999999999999999886543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.3e-41  Score=309.06  Aligned_cols=246  Identities=26%  Similarity=0.375  Sum_probs=192.4

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCC
Q 015797           45 KLGEGGFGSVYWGQLW---DGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLS  120 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gs  120 (400)
                      .||+|+||.||+|.+.   .+..||+|++..... .....+..|+.+++.++||||+++++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999543   355689998875433 33456889999999999999999999885 457899999999999


Q ss_pred             hhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeee
Q 015797          121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT  200 (400)
Q Consensus       121 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~  200 (400)
                      |.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++............
T Consensus        81 L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9999864332   4889999999999999999999998   999999999999999999999999999765433222111


Q ss_pred             e--cccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccCCC
Q 015797          201 R--VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       201 ~--~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                      .  ..+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ ..+....             ..    
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------~~----  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-------------RL----  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-------------CC----
Confidence            1  123578999999998899999999999999999996 9999976543211 1111100             00    


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      .........+.+++.+||..+|++||++.+|.+.|+..
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            01111234677889999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-41  Score=320.17  Aligned_cols=260  Identities=27%  Similarity=0.395  Sum_probs=203.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG  106 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  106 (400)
                      .++|.+.+.||+|+||.||+|...        ....+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            468999999999999999999642        23469999887532 33445688899999999 799999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999975432            1224888999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hh
Q 015797          175 DADFKAQVADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KR  251 (400)
Q Consensus       175 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~  251 (400)
                      +.++.+||+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... ..
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            999999999999987654322111 111224578999999999999999999999999999998 888986543211 11


Q ss_pred             hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          252 TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .+....             ..    .........+.+++.+||..+|.+|||+.++++.|..+..
T Consensus       254 ~~~~~~-------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         254 LLKEGH-------------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             HHHcCC-------------CC----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            111000             00    0111123467788899999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-41  Score=311.57  Aligned_cols=254  Identities=26%  Similarity=0.442  Sum_probs=201.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-C---CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-D---GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|++.+.||+|+||.||+|... +   +..+|+|.+.... ......+..|+.+++.++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            367899999999999999999643 2   3368999886433 3334578889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999999875432   3788999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeee--cccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccc
Q 015797          192 PDGATHVTTR--VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~  267 (400)
                      ..........  ..++..|+|||.+.+..++.++|||||||++|++++ |..||...... ....+.....         
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---------  227 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---------  227 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---------
Confidence            5433222111  123568999999999999999999999999999886 99999754321 1111111000         


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                         .+     .....+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       228 ---~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 ---LP-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ---CC-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence               00     011123467788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.2e-41  Score=313.26  Aligned_cols=263  Identities=26%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcC-----------------CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccce
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWD-----------------GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLS   98 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~   98 (400)
                      .++|++.+.||+|+||.||+|....                 +..||+|.+.... ......+..|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999985432                 2458999887543 334557889999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEccCCCChhhhhhcCCC-------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797           99 LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS-------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      +++++..+...+++|||+++++|.+++.....       ....+++..++.++.|++.||.|||+++   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999999999999999999999999865431       1124889999999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh--CCCChhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS--GKKPIEKVNSA  248 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt--g~~Pf~~~~~~  248 (400)
                      |+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999976543221 11223346788999999998899999999999999999998  77888654321


Q ss_pred             h-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          249 I-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       249 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      . ..........    .......      .........+.+++.+||+.||.+|||+.+|++.|+
T Consensus       241 ~~~~~~~~~~~~----~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVIENAGHFFRD----DGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHhcccc----ccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1 1111110000    0000000      011112357888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.7e-41  Score=311.62  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=195.3

Q ss_pred             CCcCCcccccCceEEEEEEEcC-CC--EEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC------Ce
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWD-GS--QIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG------QE  108 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~-~~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~  108 (400)
                      |.+++.||+|+||.||+|.... +.  .+|+|.++..  .......+..|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678899999999999996543 33  5899987643  334456788899999999999999999987432      24


Q ss_pred             EEEEEEccCCCChhhhhhcCC--CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          109 RLIVYDYMPNLSLLSHLHGQH--SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      .+++|||+.+|+|.+++....  .....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874321  12234889999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCceee-eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcc
Q 015797          187 FAKLIPDGATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACE  263 (400)
Q Consensus       187 l~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~  263 (400)
                      ++........... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ....+.....+    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----  233 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL----  233 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9987644322111 12236778999999999999999999999999999999 88998654321 11111110000    


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                               .    ........+.+++.+||+.||++|||+.+|++.|..
T Consensus       234 ---------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         234 ---------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             ---------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                     0    011123467888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.9e-41  Score=325.44  Aligned_cols=202  Identities=23%  Similarity=0.355  Sum_probs=173.7

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++...   .......+..|+.++..++||||+++++.+.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4789999999999999999954 56899999998742   2223456778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999986543    3888999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCc----------------------------------eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCC
Q 015797          194 GAT----------------------------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK  239 (400)
Q Consensus       194 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~  239 (400)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|+|+||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0011246999999999999999999999999999999999999


Q ss_pred             CChhhhh
Q 015797          240 KPIEKVN  246 (400)
Q Consensus       240 ~Pf~~~~  246 (400)
                      .||....
T Consensus       234 ~Pf~~~~  240 (360)
T cd05627         234 PPFCSET  240 (360)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.5e-41  Score=308.76  Aligned_cols=244  Identities=24%  Similarity=0.332  Sum_probs=192.6

Q ss_pred             cccccCceEEEEEEE---cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           45 KLGEGGFGSVYWGQL---WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      .||+|+||.||+|..   .++..+|+|++....  ......+..|+.+++.++||||+++++++. ....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999953   357889999886433  233457889999999999999999999875 45678999999999


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceee
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT  199 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~  199 (400)
                      +|.+++....    .+++..++.++.|++.||.|||+++   ++||||||.||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999986432    3888999999999999999999998   99999999999999999999999999987654332211


Q ss_pred             --eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccCC
Q 015797          200 --TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       200 --~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                        ....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ...+.....             +...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-------------~~~~  220 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-------------MECP  220 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-------------CCCC
Confidence              11224578999999988889999999999999999998 999997644321 111111000             0011


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                          ......+.++|.+||+.||++||++.+|.+.|.+
T Consensus       221 ----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 ----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                1122467788999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.4e-41  Score=312.47  Aligned_cols=249  Identities=26%  Similarity=0.312  Sum_probs=197.8

Q ss_pred             CCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           40 FNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      |++.+.||.|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            678899999999999999654 5778899988766656666788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      ++|..++....   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........ .
T Consensus        87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~  159 (282)
T cd06643          87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  159 (282)
T ss_pred             CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence            99998876432   24889999999999999999999998   99999999999999999999999999876533221 1


Q ss_pred             eeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCc
Q 015797          199 TTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADP  272 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .....+++.|+|||++.     +..++.++|||||||++|+|++|..||........ ........+        ...  
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~--  229 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--------TLA--  229 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--------CCC--
Confidence            22345899999999984     34578899999999999999999999975442110 000000000        000  


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           ........+.+++.+||+.||.+||++.++++.
T Consensus       230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 001123467888899999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.2e-41  Score=320.89  Aligned_cols=248  Identities=22%  Similarity=0.294  Sum_probs=189.9

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.+|+|++....   ......+..|+.++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999964 568899999997532   22334577899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  152 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T  152 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence            99998886432    3889999999999999999999998   99999999999999999999999999875322111 2


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNF  278 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|+||..||.......................      ..+..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~--  224 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPR--  224 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCC--
Confidence            2345699999999999999999999999999999999999999964321100000000000000000      00111  


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 015797          279 VEEELKRVVLVALTCAHSKPEKRPTM------LEVLD  309 (400)
Q Consensus       279 ~~~~~~~l~~li~~cl~~dP~~Rps~------~ell~  309 (400)
                        .....+.+++.+||+.||.+|+++      .++++
T Consensus       225 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  259 (327)
T cd05617         225 --FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS  259 (327)
T ss_pred             --CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence              112356778899999999999984      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.3e-41  Score=309.41  Aligned_cols=247  Identities=29%  Similarity=0.431  Sum_probs=197.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEE-eCCeEEEEEEcc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA-EGQERLIVYDYM  116 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~  116 (400)
                      .+|.+.+.||+|+||.||++.. .+..+++|.+....  ....+..|+.+++.++|||++++++++. +++..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4788999999999999999964 58889999886432  3456889999999999999999999764 556789999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....  ..+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  157 (256)
T cd05082          83 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  157 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence            99999999875432  23788999999999999999999998   99999999999999999999999999875433221


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                          ...++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ...+..        . .    .+. 
T Consensus       158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~--------~-~----~~~-  219 (256)
T cd05082         158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------G-Y----KMD-  219 (256)
T ss_pred             ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--------C-C----CCC-
Confidence                2235678999999999999999999999999999998 999986543211 111100        0 0    000 


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                         ........+.+++.+||+.+|++|||+.++++.|..
T Consensus       220 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 ---APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence               111123467788899999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-41  Score=309.70  Aligned_cols=239  Identities=21%  Similarity=0.355  Sum_probs=187.5

Q ss_pred             CcccccCceEEEEEEEcC-------------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           44 NKLGEGGFGSVYWGQLWD-------------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      +.||+|+||.||+|....             ...+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999996321             2257888876554455567888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc-------EEEE
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK-------AQVA  183 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~-------~kl~  183 (400)
                      +||||+++|+|..++.....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999888764322   3888999999999999999999998   999999999999987664       8999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhc-cCCCCCccceehhhHHHHHHH-hCCCChhhhhhhhhhhhhccccchh
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM-LGKASESCDVYSFGILLLELA-SGKKPIEKVNSAIKRTITDWALPLA  261 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDIwSlGiil~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~  261 (400)
                      |||++......     ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||..........+..      
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~------  223 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE------  223 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh------
Confidence            99998754322     1234788999999887 467899999999999999998 5888886543211111100      


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                        ... ..         .......+.++|.+||+.||.+||++.+|++.+
T Consensus       224 --~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 --GQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --cCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              000 00         011134677889999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.7e-41  Score=319.90  Aligned_cols=240  Identities=25%  Similarity=0.344  Sum_probs=190.5

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      +|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|..++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999954 568999999987422   223345677888888885 577889999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999886543    3889999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ...+..        ...      
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--------~~~------  218 (323)
T cd05615         154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--------HNV------  218 (323)
T ss_pred             CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCC------
Confidence            211 1223459999999999999999999999999999999999999997654321 111110        000      


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTM  304 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  304 (400)
                      .    ........+.+++.+||+.+|.+|++.
T Consensus       219 ~----~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 S----YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             C----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            0    001112466778899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-41  Score=307.82  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=204.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++.+.||.|++|.||+|.. .++..+++|.+..........+..|+.+++.++||||+++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            46899999999999999999965 45788999999866555667788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++....   ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            99999999886542   23888999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ceeeeecccccCcCChhhhccC---CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG---KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      . ......++..|+|||.+.+.   .++.++||||||+++|+|+||..||.............       .   .....+
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-------~---~~~~~~  224 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-------K---SNFPPP  224 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------h---ccCCCc
Confidence            1 12234588899999999876   88999999999999999999999997544221111000       0   000000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..  .........+.+++.+||..+|..|||+.+++.
T Consensus       225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00  112234457888999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-42  Score=312.49  Aligned_cols=262  Identities=25%  Similarity=0.339  Sum_probs=195.7

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC---eE--EE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ---ER--LI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~--~l  111 (400)
                      =.|.-.+++|.|+||.||.|.. .++..||||.+-....    --..|+++|+.++|||||++.-+|....   ..  .+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3467778999999999999954 4579999998764332    2336899999999999999988875432   23  48


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-CcEEEEecCCccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAKL  190 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~~kl~Dfgl~~~  190 (400)
                      ||||++. +|.++++........++...+..+..||.+||+|||+.+   |+||||||.|+|||.+ |.+||+|||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999985 999988743222334777788889999999999999998   9999999999999976 9999999999998


Q ss_pred             cCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh--hhcccc---------
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT--ITDWAL---------  258 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~--~~~~~~---------  258 (400)
                      +..+....  .+..|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+....-.  +.-...         
T Consensus       176 L~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  176 LVKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            87666543  3457899999999986 579999999999999999999999998755331111  110011         


Q ss_pred             -chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          259 -PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       259 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       |.........+.......-+......+.++++.++|..+|.+|.++.+++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence             110011111111111111122334457888999999999999999999986

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.1e-41  Score=311.96  Aligned_cols=251  Identities=26%  Similarity=0.311  Sum_probs=197.2

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .|+..+.||+|+||+||+|.. .+++.+|+|.+.....   .....+..|+++++.++|+||+++++.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            367788999999999999954 5688999999865322   223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+.+|+|.+++.....  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999988864332  24899999999999999999999998   999999999999999999999999999765432


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      ..  .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.................   ..  .    .  
T Consensus       156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~---~~--~----~--  222 (285)
T cd05632         156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL---ET--E----E--  222 (285)
T ss_pred             Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh---cc--c----c--
Confidence            21  2234589999999999999999999999999999999999999975433211110000000   00  0    0  


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                        .+.......+.+++..||+.||.+||+     +.+++.
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 --VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              011112235677889999999999999     667775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.9e-41  Score=313.66  Aligned_cols=263  Identities=22%  Similarity=0.395  Sum_probs=200.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-----------------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccce
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-----------------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLS   98 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~   98 (400)
                      .++|++.+.||+|+||.||++...                 +...+|+|.+.... ......+..|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            367999999999999999998432                 23468999887543 334567889999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEccCCCChhhhhhcCCCc-------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797           99 LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSS-------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      +++++..+...++||||+++|+|.+++......       ...+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            999999999999999999999999998754321       123677889999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh--CCCChhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS--GKKPIEKVNSA  248 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt--g~~Pf~~~~~~  248 (400)
                      |+++.++.++|+|||++..+...... ......+++.|+|||...++.++.++|||||||++|||+|  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999865432221 1122234678999999988899999999999999999998  77888654321


Q ss_pred             h-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          249 I-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       249 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      . ......+...     .......+     ........+.+++.+||+.||.+||++.+|++.|+
T Consensus       241 ~~~~~~~~~~~~-----~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEFFRD-----QGRQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHhh-----ccccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1 0000000000     00000000     00112257788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=306.88  Aligned_cols=271  Identities=22%  Similarity=0.304  Sum_probs=205.8

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEe--cCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe---
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK--VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE---  105 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  105 (400)
                      +......+|...+.||.|+||.|+.| ...+|..||||.+.  ........+..+|+++|+.++|+||+.+++++..   
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            45566778888899999999999999 45679999999987  4555566778899999999999999999999865   


Q ss_pred             --CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          106 --GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       106 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                        -+.+|+|+|+|. .+|.+.+....    .++...+..++.|++.||.|+|+.+   |+||||||+|+|++.+..+||+
T Consensus        96 ~~f~DvYiV~elMe-tDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   96 DKFNDVYLVFELME-TDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             cccceeEEehhHHh-hHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence              456899999994 68888886543    2778888899999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCC-CceeeeecccccCcCChhhhc-cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchh
Q 015797          184 DFGFAKLIPDG-ATHVTTRVKGTLGYLAPEYAM-LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLA  261 (400)
Q Consensus       184 Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~  261 (400)
                      |||+++..... .....+..+-|..|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+....-.+.-...+.+
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            99999987542 122234566899999999886 4689999999999999999999999987654321111111111111


Q ss_pred             cccccccccC-----------ccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CERKFSELAD-----------PRLNGN---FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~~~~~~~~~-----------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+..+..+.+           ......   ..+......++|+.+||..||.+|+|++|.|+.
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1111111110           000000   111223466788899999999999999999974

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.5e-41  Score=319.96  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=193.7

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||++.. .+++.+|+|++...   .......+..|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4799999999999999999965 45788999998642   1222335778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999975322   3788889999999999999999998   99999999999999999999999999876543


Q ss_pred             CCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ..........||+.|+|||++.     ...++.++|||||||++|+|++|+.||....... ...+....      ....
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------~~~~  228 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------ERFQ  228 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC------cccc
Confidence            3332233346999999999986     3468899999999999999999999997543211 11110000      0000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEK--RPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~  310 (400)
                        . +    .........+.+++.+|+..+|.+  |+++.++++.
T Consensus       229 --~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 --F-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --C-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              0 0    001112235666677777554444  6899999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.9e-41  Score=309.58  Aligned_cols=250  Identities=28%  Similarity=0.510  Sum_probs=200.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      .+|++.+.||.|+||.||+|.+..+..+|+|.+..... ....+..|+++++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            57889999999999999999766788999998864332 23468889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          83 HGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            9999999865432   3788999999999999999999998   999999999999999999999999998765432221


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      ......++..|+|||.+.++.++.++||||||+++|+|++ |..||....... ...+..         .. ....+.  
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---------~~-~~~~~~--  224 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA---------GF-RLYKPR--  224 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC---------CC-CCCCCC--
Confidence            1112235678999999998999999999999999999998 999997543211 111100         00 000011  


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                        .   ....+.+++.+||+.+|++|||+.++++.|
T Consensus       225 --~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 --L---ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --C---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              1   124688899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.2e-41  Score=312.35  Aligned_cols=250  Identities=27%  Similarity=0.346  Sum_probs=197.2

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .|++.+.||+|+||.||++.. .+++.+|+|.+....   ......+..|+.+++.++|+||+++++.+.+++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377888999999999999954 568999999886432   2223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999998864332  23888999999999999999999998   999999999999999999999999998765432


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhcccccccccCcc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLACERKFSELADPR  273 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ..  .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......... ......      ....    ..
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~------~~~~----~~  223 (285)
T cd05630         156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV------KEVQ----EE  223 (285)
T ss_pred             cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh------hhhh----hh
Confidence            22  12235899999999999999999999999999999999999999753321100 000000      0000    00


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                      .    .......+.+++.+||+.||.+|||     +.++++
T Consensus       224 ~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 Y----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             c----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1    1112245778889999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.5e-41  Score=310.48  Aligned_cols=254  Identities=27%  Similarity=0.482  Sum_probs=200.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCC---EEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGS---QIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|+..+.||+|+||.||+|... ++.   .+++|.+... .......+..|+++++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999653 333   6889988654 23445678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999865332   3888999999999999999999998   999999999999999999999999999866


Q ss_pred             CCCCceeeee--cccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccc
Q 015797          192 PDGATHVTTR--VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~  267 (400)
                      ..........  ...++.|+|||++.+..++.++|||||||++|+|++ |..||...... ....+... .         
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~---------  227 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-F---------  227 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-C---------
Confidence            4332211111  123457999999998899999999999999999998 99999654321 11111100 0         


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                        ..+     ........+.+++.+||+.+|++||++.++++.|.+
T Consensus       228 --~~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         228 --RLP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             --CCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence              000     011123467889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-41  Score=317.85  Aligned_cols=261  Identities=24%  Similarity=0.398  Sum_probs=204.1

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      ....+|.+.+.||+|+||.||+|...        ++..+|+|.+.... ......+..|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34577899999999999999999531        24478999886432 33456788999999999 8999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCc------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSS------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                      .....++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+++   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            999999999999999999998754221            224788889999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-  249 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-  249 (400)
                      +++.++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... 
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999998764322211 122335678999999999899999999999999999998 788886543211 


Q ss_pred             hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ...+....       ..          .........+..++.+||+.+|.+|||+.++++.|..+.
T Consensus       249 ~~~~~~~~-------~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         249 FKLLKEGH-------RM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHHHcCC-------cC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            11111000       00          001122346778889999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.9e-41  Score=319.51  Aligned_cols=236  Identities=26%  Similarity=0.319  Sum_probs=184.7

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHH-HHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEV-EILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. .+++.+|+|++....   ......+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999965 468899999987422   12233444554 467889999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|...+....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T  152 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence            99998886432    3778888899999999999999998   99999999999999999999999999875322221 2


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ...+...  +            ..    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~------------~~----  214 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--P------------LQ----  214 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--C------------CC----
Confidence            233469999999999999999999999999999999999999997543211 1111000  0            00    


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTML  305 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~  305 (400)
                      ........+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            0111234677888999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-41  Score=310.10  Aligned_cols=261  Identities=24%  Similarity=0.271  Sum_probs=207.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++++.||.|.-|+||+++.. ++...|+|++....   .....+...|..+|+.++||-++.+|..|+.++..|++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            357888899999999999999754 46889999997533   22334577799999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||+||+|..+++.+...  -+++..+..++..++-||+|||..|   ||+|||||+||||-++|++.|+||.|+....
T Consensus       156 meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            9999999999988766544  4899999999999999999999999   9999999999999999999999999975432


Q ss_pred             CC----------------------------------Cc---------------------eeeeecccccCcCChhhhccC
Q 015797          193 DG----------------------------------AT---------------------HVTTRVKGTLGYLAPEYAMLG  217 (400)
Q Consensus       193 ~~----------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~  217 (400)
                      ..                                  ..                     ......+||-.|+|||++.|.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            10                                  00                     001224699999999999999


Q ss_pred             CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccC
Q 015797          218 KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSK  297 (400)
Q Consensus       218 ~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  297 (400)
                      ..+.+.|+|+|||.||||+.|..||.+.+....  +.             .++...+.-...+.......+||.+.|.+|
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LR-------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HH-------------HHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence            999999999999999999999999987764311  11             111111110111133456778889999999


Q ss_pred             CCCCCC----HHHHHH--Hhcccchh
Q 015797          298 PEKRPT----MLEVLD--LLKGESKE  317 (400)
Q Consensus       298 P~~Rps----~~ell~--~L~~~~~~  317 (400)
                      |.+|..    +.||.+  ++++....
T Consensus       376 P~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hhhhhccccchHHhhcCccccCCChh
Confidence            999998    888887  45555544

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-41  Score=312.33  Aligned_cols=239  Identities=22%  Similarity=0.354  Sum_probs=186.2

Q ss_pred             cccccCceEEEEEEEcC-------------------------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcccee
Q 015797           45 KLGEGGFGSVYWGQLWD-------------------------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL   99 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~   99 (400)
                      .||+|+||.||+|....                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999985311                         23578888865444445678889999999999999999


Q ss_pred             eeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-
Q 015797          100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-  178 (400)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-  178 (400)
                      ++++.++...++||||+++|+|..++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998864322   3788999999999999999999998   99999999999997643 


Q ss_pred             ------cEEEEecCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHH-hCCCChhhhhhhhh
Q 015797          179 ------KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELA-SGKKPIEKVNSAIK  250 (400)
Q Consensus       179 ------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~ell-tg~~Pf~~~~~~~~  250 (400)
                            .++++|||++.......     ...+++.|+|||.+.+ ..++.++|||||||++|+|+ +|..||........
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             ccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                  38999999986443221     1247888999998875 56899999999999999995 69999875432211


Q ss_pred             hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          251 RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      .......              ......    ....+.++|.+||+.+|++|||+.++++.|.
T Consensus       231 ~~~~~~~--------------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERFYEKK--------------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHhc--------------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1110000              000001    1236788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=310.77  Aligned_cols=248  Identities=26%  Similarity=0.386  Sum_probs=201.6

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||.|++|.||+|.. .+++.+|+|.+.... ......+..|+++++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            4789999999999999999964 468899999987543 33445688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999998753     3889999999999999999999998   9999999999999999999999999998765432


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      .. .....+++.|+|||.+.+..++.++||||||+++|+|+||..||...........            +.....+.+.
T Consensus       153 ~~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~------------~~~~~~~~~~  219 (274)
T cd06609         153 SK-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL------------IPKNNPPSLE  219 (274)
T ss_pred             cc-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH------------hhhcCCCCCc
Confidence            21 2234588899999999998999999999999999999999999975432110000            0000011111


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..   .....+.+++.+||..+|++|||+.++++
T Consensus       220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11   02346778889999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.5e-41  Score=316.79  Aligned_cols=265  Identities=19%  Similarity=0.278  Sum_probs=197.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|.+.+.||.|+||.||+|.. .++..||+|.+.... ......+..|+.+++.++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            36799999999999999999965 468899999987433 2233457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+. ++|.+++.....   .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        85 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             ccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            997 599888865432   3788899999999999999999998   999999999999999999999999999764332


Q ss_pred             CceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhc---cccchhccc-----
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITD---WALPLACER-----  264 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~---~~~~~~~~~-----  264 (400)
                      ... .....+++.|+|||++.+. .++.++|||||||++|+|+||+.||......... .+..   ......+..     
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            221 1223478999999998754 5789999999999999999999999754321110 0000   000000000     


Q ss_pred             ccccccCccCCCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELADPRLNGNF----VEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .+.....+......    .......+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000001100000    0112345678899999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.9e-41  Score=308.65  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..+|.+.+.||+|+||.||+|...+    ...+++|...... ......+..|+.+++.++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568899999999999999996432    3468889876544 4445678899999999999999999998875 55789


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999875432   3889999999999999999999998   999999999999999999999999999866


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  269 (400)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ..+..        ..    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~--------~~----  225 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN--------GE----  225 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------CC----
Confidence            4432222222234568999999988899999999999999999996 9999976543211 11100        00    


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                       .....    ......+.+++.+||..+|.+|||+.++++.|....
T Consensus       226 -~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         226 -RLPMP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -cCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             00001    112346778889999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-41  Score=313.61  Aligned_cols=263  Identities=25%  Similarity=0.357  Sum_probs=191.6

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcC---CCCccceeeeEEEe-----CC
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARV---RHKNLLSLRGYCAE-----GQ  107 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~~  107 (400)
                      +|++.+.||+|+||.||+|.. .+++.||+|.+......  ....+..|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588999999999999999955 46899999998743221  123455666666655   79999999998864     34


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..+++|||+. ++|.+++......  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPP--GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence            5789999998 5898888654322  3889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhcc-ccc--hhcc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDW-ALP--LACE  263 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~-~~~--~~~~  263 (400)
                      +........  .....||+.|+|||++.+..++.++|||||||++|+|++|++||........ ..+... ..+  ....
T Consensus       155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            986543221  2234589999999999999999999999999999999999999965432110 000000 000  0000


Q ss_pred             cccc---cccCcc---CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          264 RKFS---ELADPR---LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       264 ~~~~---~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....   ....+.   ......+.....+.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000   000000   000111123346778899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-41  Score=312.17  Aligned_cols=253  Identities=26%  Similarity=0.346  Sum_probs=202.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ..++|++.+.||.|++|.||+|.. .++..+|+|.+..........+..|+.+++.++||||+++++.+..+...++|||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356799999999999999999965 4688999999987666666778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            9999999998865332   3889999999999999999999998   999999999999999999999999998765432


Q ss_pred             CceeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSE  268 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  268 (400)
                      ... .....+++.|+|||.+..     ..++.++||||||+++|+|++|+.||....... .........+        .
T Consensus       157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~  227 (280)
T cd06611         157 LQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP--------T  227 (280)
T ss_pred             ccc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC--------C
Confidence            221 223458999999999853     456789999999999999999999997543211 0001000000        0


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +.       ........+.+++.+||+.+|.+||++.++++.
T Consensus       228 ~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 LD-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cC-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            00       001122367778899999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.6e-41  Score=324.19  Aligned_cols=264  Identities=22%  Similarity=0.257  Sum_probs=196.9

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----  106 (400)
                      ...++|++.+.||+|+||.||++.+ ..++.+|+|.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4568999999999999999999954 56899999998643  233345677899999999999999999988643     


Q ss_pred             -CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 -QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       ...|+||||+.+ +|.+.+..      .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence             357999999974 77776642      2778889999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchh--
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLA--  261 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~--  261 (400)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ..+.....+..  
T Consensus       164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998654322  12234589999999999999999999999999999999999999965432100  00000000000  


Q ss_pred             -------------cccccc-----cccCccC---CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 -------------CERKFS-----ELADPRL---NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 -------------~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                   ......     .......   ...........+.+++.+||..||.+|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                         000000     0000000   000111123467889999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.8e-41  Score=322.75  Aligned_cols=264  Identities=24%  Similarity=0.261  Sum_probs=196.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----  107 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----  107 (400)
                      ...++|++.+.||+|+||.||++.+ .++..||+|.+...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4568999999999999999999954 56899999998642  2334456788999999999999999999986543    


Q ss_pred             --eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          108 --ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       108 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                        ..|+||||+.+ +|.+.+..      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence              57999999974 67666642      2677888899999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhcccc-----
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWAL-----  258 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~-----  258 (400)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........  ........     
T Consensus       168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            9997543221  12234589999999999999999999999999999999999999975432100  00000000     


Q ss_pred             ---------------chhcccccccccCccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          259 ---------------PLACERKFSELADPRLN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       259 ---------------~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                     +......+.+.......   ..........+.+++.+||..||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                           00000000000000000   00011123467788999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.2e-41  Score=306.72  Aligned_cols=247  Identities=29%  Similarity=0.452  Sum_probs=196.9

Q ss_pred             CcccccCceEEEEEEEcC--CC--EEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQLWD--GS--QIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~--~~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|++|.||+|.+..  +.  .+|+|.+..... .....+..|+.+++.++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999996533  33  689999876555 456678899999999999999999999988 889999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999876542  24899999999999999999999998   9999999999999999999999999998764422211


Q ss_pred             --eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          199 --TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       199 --~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                        .....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ......   .   ...+   .    
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~---~~~~---~----  221 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---E---GERL---E----  221 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---c---CCcC---C----
Confidence              112347789999999999999999999999999999999 999996543221 111100   0   0000   0    


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                         ........+.+++.+||+.+|.+|||+.++++.|.
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               00112346888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-41  Score=328.38  Aligned_cols=261  Identities=24%  Similarity=0.361  Sum_probs=202.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCC-CCccceeeeEEEe
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSN-KAEMEFAVEVEILARVR-HKNLLSLRGYCAE  105 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  105 (400)
                      ....++|.+.+.||+|+||.||+|.+.      .+..||+|++..... .....+..|+.+|..+. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344456788999999999999999642      346799999975433 23346888999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCC-------------------------------------------------------
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHS-------------------------------------------------------  130 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  130 (400)
                      .+..++|||||++|+|.+++.....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999864321                                                       


Q ss_pred             ---------------------------------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797          131 ---------------------------------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus       131 ---------------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                                                             ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence                                                   1123677788899999999999999988   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI  249 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~  249 (400)
                      ||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999976432211 11122347788999999998899999999999999999998 899986533211


Q ss_pred             --hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          250 --KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       250 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                        ...+...         .    ....    .......+.+++.+||..+|.+||++.+|++.|+..
T Consensus       350 ~~~~~~~~~---------~----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 QFYNAIKRG---------Y----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHHHcC---------C----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              0001000         0    0000    011134678888999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-41  Score=315.17  Aligned_cols=260  Identities=25%  Similarity=0.429  Sum_probs=202.0

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  107 (400)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+..|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45688999999999999999998532      24579999876433 333456788999999999999999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCC------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHS------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                      ..++||||+++|+|.+++.....      ....+.+..++.++.|++.||.|||+++   ++||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999965321      1123566778899999999999999998   99999999999999999999


Q ss_pred             EEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhcccc
Q 015797          182 VADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWAL  258 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~  258 (400)
                      |+|||+++......... .....++..|+|||.+.++.++.++|||||||++|+|++ |..||....... ...+..   
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---  236 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---  236 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence            99999988654322211 112235678999999999999999999999999999998 788986543211 111100   


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                           ....     .    ........+.+++.+||+.||.+|||+.++++.|+..
T Consensus       237 -----~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         237 -----GGYL-----D----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -----CCCC-----C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                 0000     0    0011124788889999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=305.92  Aligned_cols=249  Identities=30%  Similarity=0.476  Sum_probs=200.3

Q ss_pred             CcccccCceEEEEEEEcC----CCEEEEEEEecCChHH-HHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWSNKA-EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|....    +..+++|.+....... ...+..|+..++.++||||+++++++.++...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999996543    8889999987644433 56788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCc-----ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          119 LSLLSHLHGQHSS-----ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       119 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ++|.+++......     ...+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998765211     235899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhccccccccc
Q 015797          194 GAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELA  270 (400)
Q Consensus       194 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ... .......+++.|+|||.+....++.++||||||+++|+|++ |..||........ .....             ..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------~~  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-------------GY  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------CC
Confidence            321 11223447889999999998899999999999999999999 6999976532211 11110             00


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ..    .........+.+++.+||..+|.+|||+.++++.|+
T Consensus       225 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 RL----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CC----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00    011112357888999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-40  Score=308.55  Aligned_cols=249  Identities=25%  Similarity=0.344  Sum_probs=202.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ...|+..+.||.|+||.||+|.+ .++..+|+|.+.... ......+..|+.+++.+.||||+++++++.+++..++|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            35688889999999999999965 468899999987543 3445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++...     .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          83 YLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999999988643     2788889999999999999999988   999999999999999999999999999765432


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .. ......++..|+|||++.+..++.++|+|||||++|+|+||..||............            .    ...
T Consensus       155 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------~----~~~  217 (277)
T cd06640         155 QI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------------P----KNN  217 (277)
T ss_pred             cc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------------h----cCC
Confidence            21 122235788999999999889999999999999999999999999754321100000            0    000


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...........+.+++.+||+.+|.+||++.+++..
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            111223345678889999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.4e-41  Score=307.84  Aligned_cols=250  Identities=25%  Similarity=0.411  Sum_probs=199.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh------HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN------KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +|++.+.||.|+||.||+|...+++.+|+|.+.....      .....+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            5889999999999999999777899999998864321      1224578899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999986543    3788899999999999999999998   9999999999999999999999999987653


Q ss_pred             CCC-----ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          193 DGA-----THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       193 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      ...     ........|++.|+|||.+.+..++.++||||||+++|+|++|..||...............     ...  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~--  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-----RGL--  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-----cCC--
Confidence            211     11122345899999999999989999999999999999999999999754322111000000     000  


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         .+.+    .......+.+++.+||+.+|.+||++.+++.
T Consensus       227 ---~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ---MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               0011    1112346788889999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=304.42  Aligned_cols=247  Identities=29%  Similarity=0.462  Sum_probs=196.8

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChh
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLL  122 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~  122 (400)
                      +.||+|++|.||++....++.|++|.+...... ....+..|+++++.++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999997656999999988754443 4567889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceee-ee
Q 015797          123 SHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT-TR  201 (400)
Q Consensus       123 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~-~~  201 (400)
                      +++.....   .+++..++.++.+++.||.|||+++   ++||||+|+||+++.++.++|+|||++........... ..
T Consensus        81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            99865432   3788899999999999999999998   99999999999999999999999999976543221111 11


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVE  280 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (400)
                      ..++..|+|||.+.++.++.++||||||+++|+|+| |..||................            ..    ....
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------------~~----~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------------RM----PAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------------CC----CCCc
Confidence            224567999999998999999999999999999999 888986544221111100000            00    0011


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          281 EELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       281 ~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      .....+.+++.+||..+|.+|||+.++++.|.
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            12346888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-41  Score=310.82  Aligned_cols=256  Identities=23%  Similarity=0.366  Sum_probs=201.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .+|++.+.||.|+||.||+|...      ....+++|.+...... ....+..|+++++.++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            67889999999999999999643      3467899988654433 4567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCc-----ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          111 IVYDYMPNLSLLSHLHGQHSS-----ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      +||||+++|+|.+++......     ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998754311     114899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACE  263 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~  263 (400)
                      |++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ......        
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--------  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--------  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc--------
Confidence            9987543322222223346788999999998889999999999999999999 888986543211 011100        


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ..+...        ........+.+++.+||+.+|.+|||+.+++..|.
T Consensus       234 ~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            000000        00112246788899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.9e-41  Score=323.78  Aligned_cols=265  Identities=22%  Similarity=0.240  Sum_probs=197.2

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC----
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG----  106 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----  106 (400)
                      ....++|.+.+.||+|+||.||++.+ ..++.||+|++...  .......+.+|+.+++.++||||+++++++...    
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            34568999999999999999999954 56889999998643  233345678899999999999999999987543    


Q ss_pred             --CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          107 --QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       107 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                        ...|+||||+. ++|.+.+..      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEe
Confidence              35799999997 477777642      2777888999999999999999998   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccch--
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPL--  260 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~--  260 (400)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ..+.....|.  
T Consensus       170 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         170 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             CCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            99998654322  12234589999999999999999999999999999999999999965432110  0000000000  


Q ss_pred             ------------------hcccccccccCccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 ------------------ACERKFSELADPRLN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 ------------------~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                        ...............   ..........+.+++.+||+.||.+|||+.++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                              000000000000000   00011123467889999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.5e-41  Score=316.95  Aligned_cols=260  Identities=26%  Similarity=0.411  Sum_probs=202.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAE  105 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  105 (400)
                      ..++|.+.+.||+|+||.||+|...        ....+|+|.+.... ......+..|+.+++.+ +||||+++++++.+
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467889999999999999999632        24568999887433 33455688899999999 69999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL  173 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIl  173 (400)
                      .+..+++|||+++|+|.+++.....            ....+++..+..++.|++.||.|||+++   ++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            9999999999999999999865321            1234888999999999999999999998   999999999999


Q ss_pred             ECCCCcEEEEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-h
Q 015797          174 LDADFKAQVADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-K  250 (400)
Q Consensus       174 v~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~  250 (400)
                      ++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... .
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999998654322111 111224568999999999999999999999999999999 899986543211 1


Q ss_pred             hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          251 RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..+...        ..     .    .........+.+++.+||..+|.+|||+.++++.|....
T Consensus       247 ~~~~~~--------~~-----~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         247 KLLREG--------HR-----M----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHHcC--------CC-----C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            111100        00     0    001112346778899999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.8e-41  Score=310.00  Aligned_cols=253  Identities=25%  Similarity=0.439  Sum_probs=199.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CC---CEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DG---SQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +.|++.+.||+|+||.||+|... ++   ..||+|.+... .......+..|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            46889999999999999999643 33   36999998754 344456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999999875432   3888999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCcee--eeecc--cccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhccccc
Q 015797          193 DGATHV--TTRVK--GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKF  266 (400)
Q Consensus       193 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~  266 (400)
                      ......  .....  .+..|+|||.+.+..++.++|||||||++|||++ |..||........ ..+..         ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~---------~~  228 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---------DY  228 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---------CC
Confidence            322211  11111  2457999999999999999999999999999886 9999975442211 11100         00


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                          ...    ........+.+++.+||+.+|.+||++.+++..|..
T Consensus       229 ----~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         229 ----RLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ----cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                000    001122457788899999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.4e-41  Score=312.58  Aligned_cols=266  Identities=25%  Similarity=0.347  Sum_probs=206.4

Q ss_pred             cccccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeE
Q 015797           25 WRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGY  102 (400)
Q Consensus        25 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  102 (400)
                      ...+.+..+..++++|.+.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++..+ +|||+++++++
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639           9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hhhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            34567788888999999999999999999999965 568899999886432 2234577899999998 89999999999


Q ss_pred             EEeC-----CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC
Q 015797          103 CAEG-----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD  177 (400)
Q Consensus       103 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~  177 (400)
                      +...     ...++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC
Confidence            8754     3589999999999999988643223335889999999999999999999998   9999999999999999


Q ss_pred             CcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC-----CCCCccceehhhHHHHHHHhCCCChhhhhhhhh-h
Q 015797          178 FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-----KASESCDVYSFGILLLELASGKKPIEKVNSAIK-R  251 (400)
Q Consensus       178 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~  251 (400)
                      +.+||+|||++......... .....|+..|+|||.+...     .++.++|||||||++|+|++|+.||........ .
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~  243 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF  243 (291)
T ss_pred             CCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence            99999999998865432221 1223588999999998654     368999999999999999999999975432110 0


Q ss_pred             hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          252 TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ......        ...+.       ........+.+++.+||+.+|++||++.++++.
T Consensus       244 ~~~~~~--------~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KIPRNP--------PPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHhcCC--------CCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            000000        00000       011223468889999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.5e-41  Score=314.84  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=202.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..+|++.+.||.|++|.||+|.. .+++.|++|.+..........+..|+.+++.++||||+++++.+......++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            34699999999999999999954 57899999998765555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            9999999988643     3788999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      .. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||............. .      .....+.     
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~------~~~~~~~-----  236 (296)
T cd06655         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T------NGTPELQ-----  236 (296)
T ss_pred             cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h------cCCcccC-----
Confidence            21 222358899999999998889999999999999999999999997654321111000 0      0000000     


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ........+.++|.+||..||.+||++.+++.
T Consensus       237 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 --NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             --CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              01112236777889999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=303.48  Aligned_cols=246  Identities=30%  Similarity=0.467  Sum_probs=193.9

Q ss_pred             CcccccCceEEEEEEE-cC---CCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WD---GSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.. ..   +..+|+|.+..... .....+..|+++++.++||||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            4799999999999953 22   26899999875443 34557889999999999999999999876 4567999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..++.++.|++.||.|||..+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999997544    3889999999999999999999998   9999999999999999999999999998664433221


Q ss_pred             eee--cccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          199 TTR--VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       199 ~~~--~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      ...  ..++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..+.. ..+         .   . 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~---------~---~-  218 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GER---------L---P-  218 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCc---------C---C-
Confidence            111  123567999999999999999999999999999998 9999976543211 11110 000         0   0 


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                         ........+.+++.+||..+|.+||++.+|++.|...
T Consensus       219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence               0011124677889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.6e-41  Score=321.90  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=199.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC-
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG-  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-  106 (400)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|++.... ......+..|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346899999999999999999953      346789999997533 33345688899999999 689999999988654 


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCC--------------------------------------------------------
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHS--------------------------------------------------------  130 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  130 (400)
                      ...+++||||++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            567899999999999999864321                                                        


Q ss_pred             -------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce-eeeec
Q 015797          131 -------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV  202 (400)
Q Consensus       131 -------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~  202 (400)
                             ....+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++......... .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                   0123678888999999999999999998   999999999999999999999999999765332211 11123


Q ss_pred             ccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--hhhhhhccccchhcccccccccCccCCCCCc
Q 015797          203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--IKRTITDWALPLACERKFSELADPRLNGNFV  279 (400)
Q Consensus       203 ~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (400)
                      .+++.|+|||.+.+..++.++||||||+++|+|++ |..||......  ....+....             ...... . 
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------~~~~~~-~-  306 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-------------RMRAPD-Y-  306 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-------------CCCCCC-C-
Confidence            35678999999999999999999999999999997 99998653211  000010000             000000 1 


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          280 EEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       280 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                        ....+.+++.+||+.+|.+|||+.+|++.|....
T Consensus       307 --~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         307 --TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             --CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              1236788889999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-41  Score=310.18  Aligned_cols=240  Identities=23%  Similarity=0.351  Sum_probs=188.6

Q ss_pred             CcccccCceEEEEEEEc-C-------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           44 NKLGEGGFGSVYWGQLW-D-------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~-~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +.||.|+||.||+|... .       ...+++|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999999542 2       234788887654444556788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc--------EEEEecCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK--------AQVADFGF  187 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~--------~kl~Dfgl  187 (400)
                      +++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            999999999875433   4788999999999999999999998   999999999999987765        69999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCC-CChhhhhhhhhhhhhccccchhcccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGK-KPIEKVNSAIKRTITDWALPLACERK  265 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~  265 (400)
                      +......     ....+++.|+|||++.+ ..++.++|||||||++|+|++|. .||..........+...      .  
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------~--  221 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------R--  221 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------c--
Confidence            8754322     12348889999999986 45799999999999999999984 66654433211111100      0  


Q ss_pred             cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                            ..+.    ......+.+++.+||+.||++|||+.++++.|+
T Consensus       222 ------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  0000    111246788899999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-42  Score=327.15  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=203.1

Q ss_pred             HHccCC-CcCCcccccCceEEEEE-EEcCCCEEEEEEEec----CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           35 SATNNF-NYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKV----WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        35 ~~~~~y-~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      +.+++| ++...||+|+|-+||+| +..+|-.||.-.++.    .......+|..|+.+|+.|+||||++||.++.+..+
T Consensus        36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence            455666 66689999999999999 445688887654432    344555789999999999999999999999988766


Q ss_pred             --EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEec
Q 015797          109 --RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADF  185 (400)
Q Consensus       109 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Df  185 (400)
                        +.+|+|.+..|+|..++.+...    ++...+..|++||++||.|||++ .|+|||||||.+||||+. .|.|||+|+
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence              7789999999999999976553    77889999999999999999999 478999999999999985 589999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhh--hhhhhhhccccchhcc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS--AIKRTITDWALPLACE  263 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~  263 (400)
                      |||........   ..++|||.|||||+.. ..|++..||||||+.+.||+|+..||.....  .+...+.....|    
T Consensus       191 GLAtl~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP----  262 (632)
T KOG0584|consen  191 GLATLLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP----  262 (632)
T ss_pred             hHHHHhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH----
Confidence            99998754332   2367999999999776 8999999999999999999999999986543  244444443333    


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..+..+-+            ..+..+|.+|+.. ...|||+.|||.
T Consensus       263 ~sl~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  263 AALSKVKD------------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHhhccCC------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            22333333            2677788999998 999999999997

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8e-41  Score=311.23  Aligned_cols=260  Identities=23%  Similarity=0.365  Sum_probs=202.7

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEe
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAE  105 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  105 (400)
                      .++..+..+.+.|++.+.||.|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            46777778889999999999999999999965 568899999886543 3345678899999988 79999999999853


Q ss_pred             ------CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          106 ------GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       106 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                            ....|++|||+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence                  4678999999999999998865332  23778888999999999999999998   999999999999999999


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhh
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT  254 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~  254 (400)
                      ++|+|||++........ ......|++.|+|||.+.     ...++.++|||||||++|+|++|..||............
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            99999999876532211 122345899999999886     346788999999999999999999999654321110000


Q ss_pred             ccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .            ....+...   .......+.++|.+||+.||.+|||+.+|++
T Consensus       239 ~------------~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 P------------RNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h------------hCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0            00000000   1112346888999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-41  Score=319.06  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=202.0

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEec--CChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  110 (400)
                      ......|++++.||.||.+.||++...+.+.+|+|.+..  .......-+..|+..|..| .|.+|+++|+|-..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            344567999999999999999999877788899888764  3444456799999999999 5899999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||-+ .+|..+|..+...  ...| .+..+..|++.|+.++|.+|   |||.||||.|+|+ -.|.+||+|||++..
T Consensus       437 mvmE~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             EEeeccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            9999864 6999999866543  2334 77889999999999999999   9999999999998 567999999999998


Q ss_pred             cCCCCceee-eecccccCcCChhhhccCC-----------CCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhcccc
Q 015797          191 IPDGATHVT-TRVKGTLGYLAPEYAMLGK-----------ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWAL  258 (400)
Q Consensus       191 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~-----------~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~  258 (400)
                      +...+.... ...+||+.||+||.+....           .+++|||||||||||+|+.|+.||........        
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a--------  580 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA--------  580 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH--------
Confidence            876655433 3467999999999986432           46899999999999999999999986553211        


Q ss_pred             chhcccccccccCccCCCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          259 PLACERKFSELADPRLNGNFVEE-ELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            ++..+.+|....+|..- ....++++|..||+.||.+|||+.+||+.
T Consensus       581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  22222332111111100 01138899999999999999999999973

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-40  Score=304.89  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=202.7

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||.|+||.||.++. .++..+++|.+...  .......+..|+.+++.++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            689999999999999999954 56889999998753  344456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++|+|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999987543  224888999999999999999999998   9999999999999999999999999998664433


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      . ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ......        +....      
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------~~~~~------  220 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------GNYTP------  220 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--------CCCCC------
Confidence            2 2223458999999999988889999999999999999999999997543211 000000        00000      


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                         ........+.+++.+||..+|.+||++.++++.+
T Consensus       221 ---~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 ---VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ---CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence               0012234677888999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.7e-41  Score=312.37  Aligned_cols=256  Identities=23%  Similarity=0.412  Sum_probs=201.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .++|++.+.||+|+||.||+|...      ++..+|+|.+.... ......+..|+.+++.++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            468999999999999999999642      46789999887533 33345688899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCC------------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797          110 LIVYDYMPNLSLLSHLHGQHS------------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      +++|||+++|+|.+++.....                  ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999864321                  1124778889999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI  249 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~  249 (400)
                      |+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765332211 1112235677999999999999999999999999999998 888986543221


Q ss_pred             h-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          250 K-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       250 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      . ..+..        ....     .    ........+.+++.+||+.+|.+|||+.|+++.|+
T Consensus       241 ~~~~~~~--------~~~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYYVRD--------GNVL-----S----CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHhc--------CCCC-----C----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1 11100        0000     0    00112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=327.87  Aligned_cols=247  Identities=27%  Similarity=0.393  Sum_probs=202.8

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChhh
Q 015797           45 KLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLS  123 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~  123 (400)
                      +||+|.||+||.|++. +...+|||.+..........+.+|+.+.+.|+|.|||++.|.+.+++.+-|.||.++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999754 456789999987777777789999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-CCCcEEEEecCCccccCCCCceeeeec
Q 015797          124 HLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-ADFKAQVADFGFAKLIPDGATHVTTRV  202 (400)
Q Consensus       124 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~  202 (400)
                      +|+..... ..-++..+-.+..||++||.|||++.   |||||||-+|+||+ -.|.+||+|||-++.+..-.. .+.+.
T Consensus       662 LLrskWGP-lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGP-LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF  736 (1226)
T ss_pred             HHHhccCC-CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence            99877643 11277788889999999999999998   99999999999996 578999999999987754333 34556


Q ss_pred             ccccCcCChhhhccC--CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcH
Q 015797          203 KGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVE  280 (400)
Q Consensus       203 ~gt~~y~aPE~~~~~--~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (400)
                      .||.-|||||++..+  .|+.++|||||||++.||.||++||..........+.-        +.+.      .-+....
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--------GmyK------vHP~iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--------GMYK------VHPPIPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--------ccee------cCCCCcH
Confidence            799999999999865  58899999999999999999999998765432111110        0000      0112344


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          281 EELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       281 ~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +..++...+|++|+..||.+||++.++|..
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            556677888999999999999999999973

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.9e-41  Score=343.97  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=199.6

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++....   .....++.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            6899999999999999999965 468999999986422   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCC-------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          114 DYMPNLSLLSHLHGQHS-------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      ||++||+|.+++.....       ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211       1123566778899999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCc-----------------eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh
Q 015797          187 FAKLIPDGAT-----------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI  249 (400)
Q Consensus       187 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~  249 (400)
                      ++........                 .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521100                 00112469999999999999999999999999999999999999997533210


Q ss_pred             hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccc
Q 015797          250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-TMLEVLDLLKGE  314 (400)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~~  314 (400)
                      .........|.    ..    .+      .......+.+++.+||+.||.+|| ++.++++.|...
T Consensus       239 i~~~~~i~~P~----~~----~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 ISYRDVILSPI----EV----AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hhhhhhccChh----hc----cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00000000000    00    00      011234577788999999999996 566676666543

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6e-41  Score=311.36  Aligned_cols=248  Identities=26%  Similarity=0.361  Sum_probs=198.9

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..|+..+.||+|+||.||+|.+ .++..||+|.+.... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            3466778999999999999954 467889999887433 33445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999988542     3788999999999999999999988   9999999999999999999999999997654322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      . ......|+..|+|||++.+..++.++|||||||++|+|+||..||...........            +.....+.  
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------------~~~~~~~~--  220 (277)
T cd06642         156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPT--  220 (277)
T ss_pred             h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh------------hhcCCCCC--
Confidence            1 11223488899999999999999999999999999999999999865432110000            00000011  


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ........+.+++.+||+.+|++||++.++++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 --LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              111223467888899999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-40  Score=307.33  Aligned_cols=248  Identities=26%  Similarity=0.411  Sum_probs=197.9

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH---------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK---------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      +|.+...||.|++|.||+|.. .++..+|+|.+......         ....+..|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588899999999999999954 46889999988643221         12457789999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .+++|||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999986542    3788889999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCce-----eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcc
Q 015797          189 KLIPDGATH-----VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE  263 (400)
Q Consensus       189 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  263 (400)
                      .........     ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........  ...        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~--------  223 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IFK--------  223 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HHH--------
Confidence            866421110     11123488999999999998999999999999999999999999975432110  000        


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ......+.    ........+.+++.+||+.||.+||++.++++
T Consensus       224 --~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 --IGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --HhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              00001111    11122356778889999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=325.17  Aligned_cols=246  Identities=29%  Similarity=0.430  Sum_probs=200.2

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec---CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..|.-++.||.|+||.||.|++ .+.+.||||.++-   .+...+.++..|+..|+.+.|||++.+.|+|..+...++||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3455678999999999999954 6788999999863   34455678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||- ||-.|++.-..   .++-+..+..|..+.+.||+|||+++   .||||||..|||+++.|.|||+|||.+.....
T Consensus       106 EYCl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHHh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            9996 58777765332   24788889999999999999999998   99999999999999999999999999986543


Q ss_pred             CCceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                           ....+|||.|||||++.   .+.|+-+.|||||||++.||..+++|+..++....-.            .+...-
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------------HIAQNe  241 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNE  241 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------------HHHhcC
Confidence                 23456999999999885   5899999999999999999999999988776421100            000001


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .|.+.   ..+....+..++..||++-|.+|||..+++..
T Consensus       242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            11111   23345578889999999999999999999874

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.4e-40  Score=305.06  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=198.6

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEe-CCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAE-GQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e  114 (400)
                      +|++.+.||.|++|.||++.+ .+++.+|+|.+....  ......+..|+.+++.++|||++++++.+.. +...|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            589999999999999999954 457899999986432  3344568889999999999999999998764 456899999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++++|.+++.....  ..+++..++.++.+++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999875322  24889999999999999999999998   999999999999999999999999999866432


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCcc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      .. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||........ .....        ...     + 
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------~~~-----~-  220 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------GKL-----P-  220 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------cCC-----C-
Confidence            22 22234589999999999999999999999999999999999999975432110 00100        000     0 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         .........+.+++.+||+.+|++|||+.++++.
T Consensus       221 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 ---PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ---CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               0111233467889999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.3e-40  Score=306.09  Aligned_cols=254  Identities=28%  Similarity=0.385  Sum_probs=189.6

Q ss_pred             CcccccCceEEEEEEEc---CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.||+|+||.||+|...   .+..+|+|.+.... ......+..|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46899999999999643   34578999886543 233457888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCC-cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          120 SLLSHLHGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       120 sL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      +|.+++..... .....++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999865322 2224567778889999999999999998   9999999999999999999999999987543322211


Q ss_pred             -eeecccccCcCChhhhccC-------CCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          199 -TTRVKGTLGYLAPEYAMLG-------KASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       199 -~~~~~gt~~y~aPE~~~~~-------~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                       .....+++.|+|||++.+.       .++.++||||||+++|+|++ |..||.............       ......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-------REQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-------hcccCCC
Confidence             1223477889999998642       35789999999999999996 999997544321111000       0000111


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ..+.+..    .....+.+++..|| .+|++|||+.+|+..|.
T Consensus       231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111111    11235667889999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.4e-41  Score=346.38  Aligned_cols=258  Identities=22%  Similarity=0.377  Sum_probs=197.9

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCe
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQE  108 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~  108 (400)
                      ....++|.+.+.||.|+||+||+|.. ..+..+|+|.+...  .......+..|+.+|+.|+||||++++++|.+  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            45568999999999999999999965 45778899988643  33345678899999999999999999998854  456


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCeEECC--------
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT----PHIIHRDIKASNVLLDA--------  176 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~----~~iiH~dikp~NIlv~~--------  176 (400)
                      +||||||+++|+|.++|.........+++..++.|+.||+.||.|||..+.    ..||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999987543323358999999999999999999998531    23999999999999964        


Q ss_pred             ---------CCcEEEEecCCccccCCCCceeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          177 ---------DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       177 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                               .+.+||+|||++..+....  ......||+.|+|||++.+  ..++.++||||||||||+|+||..||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     2348999999998654322  1233469999999999864  45899999999999999999999999754


Q ss_pred             hhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          246 NSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .... ..+..          +...  +.+.   .......+.+||..||+.+|.+||++.+++.
T Consensus       247 ~~~~-qli~~----------lk~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFS-QLISE----------LKRG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHH-HHHHH----------HhcC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3211 00000          0000  0000   0011246778899999999999999999995

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=307.42  Aligned_cols=249  Identities=27%  Similarity=0.440  Sum_probs=192.5

Q ss_pred             CcccccCceEEEEEEEc-CCC--EEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQLW-DGS--QIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|... ++.  .+++|.+.... ......+..|+.++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46899999999999653 343  46888876433 34456788999999999 899999999999999999999999999


Q ss_pred             CChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          119 LSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       119 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      |+|.+++.....            ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999865321            1124788999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhccc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACER  264 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~  264 (400)
                      ++........  ......++.|+|||++.+..++.++|||||||++|+|++ |..||....... ...+..        .
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~--------~  227 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--------G  227 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--------C
Confidence            9863221111  111124567999999998899999999999999999997 999996543211 111100        0


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                       .    ...    ........+.+++.+||..+|.+|||+.+++..|..+
T Consensus       228 -~----~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 -Y----RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -C----CCC----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence             0    000    0011224677899999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.2e-40  Score=304.64  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=193.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-----hHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-----NKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQER  109 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~  109 (400)
                      .+|.+.+.||+|+||.||+|.. .++..+++|.+....     ......+..|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            5799999999999999999954 568999999886432     1223467889999999999999999998875  3678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +++|||+++++|.+++....    .+++...+.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            89999999999999986543    3788889999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCc--eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGAT--HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .......  .......++..|+|||.+.+..++.++|||||||++|+|++|+.||............           ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~-----------~~  223 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-----------AT  223 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH-----------hc
Confidence            6532111  1112234888999999999989999999999999999999999999754321100000           00


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....+    .........+..++ +||..+|++||++.+|++
T Consensus       224 ~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 QPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            00011    11112223445555 788899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=326.00  Aligned_cols=264  Identities=26%  Similarity=0.378  Sum_probs=213.1

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEcC-CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ++++---.+..+..+||.|.||.||.|.++. .-.||||.++... -...+|+.|+.+|+.++|||+|+++|+|.....+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3344434455667899999999999997644 7789999987533 3456799999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |||+|||..|+|+++|+......  ++....+.++.||+.||.||..++   +|||||-.+||||.++..+|++|||+++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999998776554  777888899999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      .+...+........-..-|+|||-+..+.++.|||||+||++|||+.| |--||.+......                ..
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV----------------Y~  477 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YG  477 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH----------------HH
Confidence            987655444333345678999999999999999999999999999998 8889876543210                01


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ++....+-+....++..+..||++||+.+|.+||++.|+-+.+..+..
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            111111111122234578889999999999999999999998765543

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=308.40  Aligned_cols=257  Identities=26%  Similarity=0.372  Sum_probs=200.2

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCC----
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQ----  107 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~----  107 (400)
                      ..++++|++.+.||.|++|.||+|.. .+++.+++|.+..... ....+..|+.+++.+ .||||+++++++.+..    
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            35679999999999999999999965 4678899998875443 345688999999999 7999999999997644    


Q ss_pred             --eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          108 --ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       108 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                        ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence              489999999999999988654322235889999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccch
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL  260 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~  260 (400)
                      |++......... .....|++.|+|||.+..     ..++.++|||||||++|+|++|..||..........  ..    
T Consensus       158 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~----  230 (275)
T cd06608         158 GVSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--KI----  230 (275)
T ss_pred             ccceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--Hh----
Confidence            998765432221 223458999999998864     346789999999999999999999997543211000  00    


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                           ... ..+..  .........+.+++.+||..||++|||+.++++
T Consensus       231 -----~~~-~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 -----PRN-PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----hcc-CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 000 00000  011123457788999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.4e-40  Score=305.74  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=199.3

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +.++++......||+|+||.||+|.+ .++..|++|.+..........+..|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            34455566667899999999999964 46788999998876666667889999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecCCcccc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLI  191 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~~~~  191 (400)
                      +||+++++|.+++...... ...++..+..++.|++.||+|||+.+   ++||||||+||+++. ++.++|+|||++...
T Consensus        84 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999998754221 11277888899999999999999998   999999999999976 678999999998765


Q ss_pred             CCCCceeeeecccccCcCChhhhccCC--CCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ...... .....|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||............   ..      ... 
T Consensus       160 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~------~~~-  228 (268)
T cd06624         160 AGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VG------MFK-  228 (268)
T ss_pred             ccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hh------hhc-
Confidence            432221 22234889999999987644  789999999999999999999999643321100000   00      000 


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..+.    ........+.+++.+||+.+|.+|||+.+++..
T Consensus       229 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 IHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             cCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0001    111223467788999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-40  Score=309.64  Aligned_cols=270  Identities=26%  Similarity=0.405  Sum_probs=203.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-----CCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-----DGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAE--GQER  109 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~  109 (400)
                      .+|++.+.||+|+||.||+|...     .+..+|+|.+...... ....+..|+.+++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999642     3678999998765443 45678999999999999999999999877  5678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +++|||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            999999999999999975432   3889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      ..........  ....++..|+|||.+.+..++.++||||||+++|+|+||..|+............... .......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ-GQMIVTRLL  236 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc-ccccHHHHH
Confidence            7653222111  1123556799999999889999999999999999999999998653321111000000 000000000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ..................+.+++.+||+.+|.+|||+.+|++.|..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00000000011112235788899999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-40  Score=314.32  Aligned_cols=263  Identities=19%  Similarity=0.262  Sum_probs=193.1

Q ss_pred             cCCccccc--CceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           42 YDNKLGEG--GFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        42 ~~~~LG~G--~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      ++++||+|  +|++||++.. .+++.||+|.+....  ......+..|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7889999954 678999999987532  233456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++......  .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999998654322  3888999999999999999999998   99999999999999999999999987543321111


Q ss_pred             e------eeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhc-----
Q 015797          197 H------VTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLAC-----  262 (400)
Q Consensus       197 ~------~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~-----  262 (400)
                      .      ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||......... .......+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            0      0112246788999999976  46899999999999999999999999754321100 00000000000     


Q ss_pred             -ccc-------------cccc-----cCc----cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 -ERK-------------FSEL-----ADP----RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 -~~~-------------~~~~-----~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       ...             +...     ..+    .............+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence             000             0000     000    0000111123357788999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-40  Score=304.66  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=200.9

Q ss_pred             CCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQERLIVY  113 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~  113 (400)
                      +|++.+.||.|+||.||+|. ..++..+|+|.+...  .......+..|+++++.++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58899999999999999995 457889999998642  33445568889999999999999999998754  45678999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH-----HHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-----~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      ||+++++|.+++.........+++..++.++.|++.||.|||     +.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998754333345899999999999999999999     666   999999999999999999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ......... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...+..        ... 
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~-  227 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE--------GKF-  227 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------CCC-
Confidence            876543321 223458999999999998889999999999999999999999997654211 111110        000 


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          +    .........+.+++.+||+.+|.+||++.+|++.
T Consensus       228 ----~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ----R----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----C----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                0    1112234578889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-40  Score=310.12  Aligned_cols=265  Identities=21%  Similarity=0.315  Sum_probs=196.2

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||.|++|.||+|.. .++..||+|.+....  ......+..|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            588999999999999999965 468999999986432  22235678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +. ++|.+++..... ...+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 689888764332 234889999999999999999999998   9999999999999999999999999997654322


Q ss_pred             ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccch-------hcccc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPL-------ACERK  265 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~-------~~~~~  265 (400)
                      .. .....+++.|+|||.+.+. .++.++|||||||++|+|+||+.||......  ....+.....+.       .....
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 RV-YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cc-ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            11 1223478999999988754 5789999999999999999999999754321  000000000000       00000


Q ss_pred             cccccCccCCC---CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELADPRLNG---NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .....+.....   .........+.+++.+||..||.+|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000000   000112346678899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-40  Score=320.11  Aligned_cols=193  Identities=23%  Similarity=0.301  Sum_probs=164.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ....+|++.+.||+|+||.||+|.. .++..||+|.....      ....|+.+++.++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            4456899999999999999999965 45788999974322      2356899999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+. ++|.+++.....   .+++..++.++.|++.||.|||.++   |+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EccC-CcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            9995 688888864332   4889999999999999999999998   99999999999999999999999999975322


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCCh
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI  242 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf  242 (400)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            11  122345999999999999999999999999999999999865554

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5e-40  Score=302.80  Aligned_cols=256  Identities=27%  Similarity=0.376  Sum_probs=203.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||.|++|+||+|.. .++..+++|++.... ......+..|+.+++.++||||+++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4799999999999999999964 468899999986433 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++..... ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999875432 124888999999999999999999998   9999999999999999999999999997665432


Q ss_pred             ce---eeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          196 TH---VTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       196 ~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ..   ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||.......  ........          ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~----------~~  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN----------DP  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC----------CC
Confidence            22   12234589999999999877 78999999999999999999999997544211  00000000          00


Q ss_pred             ccCCCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGN-FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +..... ........+.+++.+||..||++||++.+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000000 01123456788999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=334.49  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=212.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +.-.+.++||.|.||.||+|+.+    ....||||.++... .....+|+.|+.+|-+++||||+++.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            34466789999999999999753    35679999999644 45567899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      +|||++|+|..+|+.+..   .+.+.++..+++.|+.||.||-+.+   +|||||-.+||||+++..+|++|||+++.+.
T Consensus       709 TEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             hhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence            999999999999986543   4999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCceeeeecc--cccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--hhhhhhccccchhcccccc
Q 015797          193 DGATHVTTRVK--GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--IKRTITDWALPLACERKFS  267 (400)
Q Consensus       193 ~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~  267 (400)
                      +......++.-  -...|+|||.+...+++.+||||||||+|||.++ |..||.++.+.  +.....++..|        
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP--------  854 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP--------  854 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC--------
Confidence            55433333222  3578999999999999999999999999999876 99999877643  22222222222        


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                -..+++..|..||+.||++|-.+||.|.+|+..|.++..
T Consensus       855 ----------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  855 ----------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ----------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                      112335688899999999999999999999999876543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-40  Score=309.19  Aligned_cols=256  Identities=26%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++.+.||+|+||+||++.. .++..+|+|++.... ......+..|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            46789999999999999999964 468899999886533 3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |+++++|.+++....    .+++..+..++.+++.||.|||+ .+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            999999999886532    37889999999999999999997 45   99999999999999999999999999875432


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-----hhhhccccchhccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-----RTITDWALPLACERKFSE  268 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~  268 (400)
                      ...   ....|+..|+|||++.++.++.++|||||||++|+|+||..||........     ..+......     ....
T Consensus       157 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  228 (284)
T cd06620         157 SIA---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-----IVQE  228 (284)
T ss_pred             hcc---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-----Hhhc
Confidence            221   234589999999999888999999999999999999999999975432100     000000000     0000


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                       ..+.+.   .......+.+++.+||+.||.+|||+.++++..
T Consensus       229 -~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         229 -PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence             000110   011334678889999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.2e-40  Score=302.38  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=199.4

Q ss_pred             CCcCCcccccCceEEEEEEEcC-----CCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      +++.+.||.|+||.||++....     +..+|+|.+...... ....+..|+..++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3577899999999999996543     388999998754433 4567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++......  .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999998754321  2789999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........        .     
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~-----  222 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY--------R-----  222 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------C-----
Confidence            32222212237789999999988899999999999999999998 888886533211 11111000        0     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                      ..    ........+.+++.+||..||++|||+.++++.|
T Consensus       223 ~~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LP----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CC----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            00    0111234678889999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=312.70  Aligned_cols=251  Identities=24%  Similarity=0.256  Sum_probs=199.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChH---HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNK---AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      .+|++.+.||+|++|.||+|... ++..+|+|.+......   ....+..|+++++.++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47899999999999999999654 5899999998754322   3456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+.+++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999998865432  24888999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCce----------------------------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          194 GATH----------------------------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       194 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      ....                            ......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                            011235788999999999989999999999999999999999999754


Q ss_pred             hhhhhh-hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 015797          246 NSAIKR-TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT----MLEVLD  309 (400)
Q Consensus       246 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~  309 (400)
                      ...... ....        ...      ..  .........+.+++.+||..||.+|||    +.+++.
T Consensus       236 ~~~~~~~~~~~--------~~~------~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDETFSNILK--------KEV------TF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHHHHHHHhc--------CCc------cC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            422110 0000        000      00  001113457888999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-40  Score=304.52  Aligned_cols=246  Identities=28%  Similarity=0.472  Sum_probs=196.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      ++|++.+.||+|+||.||++. ..+..+|+|.+....  ....+..|+.+++.++||||+++++++..+ ..+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEecc-cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            578999999999999999996 478889999886532  235688899999999999999999998664 4799999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          82 KGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            9999999875432  24788899999999999999999998   9999999999999999999999999987543221  


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccccccccCccCCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                        .....+..|+|||.+.++.++.++|||||||++|+|++ |+.||..............        ..    ...   
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------~~----~~~---  217 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK--------GY----RME---  217 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC--------CC----CCC---
Confidence              11234678999999998999999999999999999998 9999975543211110000        00    000   


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                       ........+.+++.+||+.+|..||++.+|++.|+
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence             01112346778889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.9e-40  Score=302.88  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=200.2

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||+|+||.||.+.. .+++.+|+|.+...  .......+..|+.+++.++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588999999999999999954 56899999998743  233445788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +.+++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999998865322  23788899999999999999999998   9999999999999999999999999997654322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|..||....... ......        +..     +. 
T Consensus       156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------~~~-----~~-  220 (256)
T cd08218         156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------GSY-----PP-  220 (256)
T ss_pred             hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--------CCC-----CC-
Confidence            11 122358899999999999999999999999999999999999986543211 000000        000     00 


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         ........+.+++.+||+.+|.+||++.++++
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 ---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               11122346788999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-40  Score=319.11  Aligned_cols=264  Identities=22%  Similarity=0.279  Sum_probs=194.7

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC----
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG----  106 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----  106 (400)
                      ....++|++.+.||.|+||.||+|.+ .++..||+|.+....  ......+..|+.+++.++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34568999999999999999999954 568899999986432  22334577899999999999999999987543    


Q ss_pred             --CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          107 --QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       107 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                        ...|++++++ +++|.+++...     .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence              4568999988 67998877532     3888999999999999999999998   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhh--ccccc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTIT--DWALP  259 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~--~~~~~  259 (400)
                      ||++.......    ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......  ......  ....+
T Consensus       162 fg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         162 FGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             CccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998654322    23458999999999877 57899999999999999999999999653321  000000  00000


Q ss_pred             hhcc----cccccccC--ccCCCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LACE----RKFSELAD--PRLNGN----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~~----~~~~~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ....    ........  +.....    ........+.+++.+||..||.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000    00000000  000000    000112346788999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-40  Score=302.12  Aligned_cols=247  Identities=27%  Similarity=0.410  Sum_probs=198.9

Q ss_pred             CCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-----hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-----NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     ......+..|+.+++.++||||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5888899999999999999654 78999999986533     22445788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999986542    3788999999999999999999998   9999999999999999999999999988654


Q ss_pred             CCCceeeeecccccCcCChhhhccCC-CCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ...  ......|++.|+|||.+.... ++.++|+||||+++|+|++|..||..............      ....     
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------~~~~-----  220 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR------SKEL-----  220 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh------cccC-----
Confidence            332  123345899999999998776 89999999999999999999999975432110000000      0000     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +.    ........+.+++.+||+.+|.+||++.+++.
T Consensus       221 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CC----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00    11112346777889999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=306.95  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=201.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCC----EEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGS----QIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..+|++.+.||+|+||.||+|.+. ++.    .+|+|.+..... .....+..|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            367889999999999999999643 333    588888765443 344578899999999999999999999887 7889


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999999875432   3889999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCceee-eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          191 IPDGATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       191 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ......... ....++..|+|||.+....++.++||||||+++|+|++ |..||....... ...+... .+        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~--------  229 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ER--------  229 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CC--------
Confidence            653322111 11224568999999988899999999999999999999 999997654321 1111100 00        


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                       ...+       ......+..++.+||..+|..||++.++++.|....+
T Consensus       230 -~~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 -LPQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -CCCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             0000       0112357778899999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.9e-40  Score=302.34  Aligned_cols=237  Identities=24%  Similarity=0.412  Sum_probs=187.5

Q ss_pred             CcccccCceEEEEEEEcC-C----------CEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           44 NKLGEGGFGSVYWGQLWD-G----------SQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~-~----------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +.||+|+||.||+|.... +          ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999996543 3          24777776543332 5678899999999999999999999988 778999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-------cEEEEec
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-------KAQVADF  185 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-------~~kl~Df  185 (400)
                      |||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++       .+||+||
T Consensus        79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            999999999999875432   4888999999999999999999998   99999999999999888       7999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccC--CCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLAC  262 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  262 (400)
                      |++.....     .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.............  .+   
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--~~---  222 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--DQ---  222 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--cC---
Confidence            99986543     1123477889999999876  78999999999999999999 577876553211111000  00   


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                       .   ....+         ....+.+++.+||..+|.+|||+.++++.|
T Consensus       223 -~---~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 -H---RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -C---CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             0   00000         015788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=316.52  Aligned_cols=239  Identities=26%  Similarity=0.298  Sum_probs=184.1

Q ss_pred             ccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcC---CCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           46 LGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARV---RHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        46 LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      ||+|+||+||+|.+ .+++.||+|++.....   .....+..|..++..+   .||||+++++.+.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999964 5689999999864221   1223345566666654   799999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++........ .
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~  152 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T  152 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence            99999886433    3888999999999999999999998   99999999999999999999999999875432221 1


Q ss_pred             eeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCccCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                      .....||+.|+|||++.+. .++.++|||||||++|+|+||..||....... ...+..        ..      ..+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~--------~~------~~~~~  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF--------GK------VRFPK  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------CC------CCCCC
Confidence            2335699999999998765 48999999999999999999999997543211 111100        00      00010


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRP----TMLEVLD  309 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~ell~  309 (400)
                      ..   ....+.+++.+||+.||.+||    ++.++++
T Consensus       219 ~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 NV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            11   123566788999999999998    5667665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-40  Score=317.53  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=203.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      ....+|++++.||+|+||.||+|...        .+..+|+|.+.... ......+..|+++++.+ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            34457999999999999999999532        12368999877433 33356788999999999 8999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                      .++..+++|||+++|+|.+++.....            ....+++..++.++.|++.||.|||+++   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence            99999999999999999999865321            2234788899999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK  250 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~  250 (400)
                      +++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999997654322111 111234567999999999999999999999999999998 8899865432211


Q ss_pred             -hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          251 -RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       251 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                       ..+....            . .    .........+.+++.+||+.+|.+|||+.++++.|....
T Consensus       246 ~~~~~~~~------------~-~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         246 FKLLKEGH------------R-M----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHcCC------------C-C----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence             1111000            0 0    001112346778899999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.7e-40  Score=304.52  Aligned_cols=253  Identities=26%  Similarity=0.415  Sum_probs=198.6

Q ss_pred             CCCcCCcccccCceEEEEEEEc--CCCEEEEEEEecC----------ChHHHHHHHHHHHHHhc-CCCCccceeeeEEEe
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW--DGSQIAVKRLKVW----------SNKAEMEFAVEVEILAR-VRHKNLLSLRGYCAE  105 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~  105 (400)
                      .|++.+.||+|+||.||+|...  .+..+|+|.+...          .......+..|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4889999999999999999654  3788999987532          12233456778888875 799999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                      ++..+++|||+++++|.+++.........+++..++.++.|++.||.|||. .+   ++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999875432223358889999999999999999996 55   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACE  263 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~  263 (400)
                      ||++.......  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ...+..        
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------  227 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE--------  227 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--------
Confidence            99998654432  2233458999999999999889999999999999999999999996543211 011110        


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ...    .+....    .....+.+++.+||+.||++||++.++..++.
T Consensus       228 ~~~----~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AVY----EPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccC----CcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            000    000000    11246778889999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-40  Score=304.17  Aligned_cols=248  Identities=30%  Similarity=0.409  Sum_probs=189.4

Q ss_pred             CcccccCceEEEEEEEc----CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEE-eCCeEEEEEEccC
Q 015797           44 NKLGEGGFGSVYWGQLW----DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCA-EGQERLIVYDYMP  117 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~  117 (400)
                      +.||+|+||.||+|...    ....+|+|.+... .......+..|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999643    2357899987543 3344567888999999999999999999875 4556889999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++.....   ...+..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999875432   2567778899999999999999998   999999999999999999999999999765432111


Q ss_pred             ---eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhC-CCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          198 ---VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASG-KKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       198 ---~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg-~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                         ......+++.|+|||.+.+..++.++|||||||++|+|++| .+||....... ...+....             ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-------------~~  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-------------RL  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-------------CC
Confidence               11123467789999999989999999999999999999995 56665433211 01110000             00


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ... .   ..+..+.+++.+||..+|++||++.++++.|+..
T Consensus       222 ~~~-~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         222 LQP-E---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCC-C---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            000 0   1123677899999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-40  Score=323.59  Aligned_cols=194  Identities=24%  Similarity=0.263  Sum_probs=166.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..+|.+.+.||+|+||.||+|.+ ..++.||+|....      ..+..|+++|+.++||||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            44799999999999999999965 4588899996432      2356799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +. ++|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       242 ~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 789888864332   4899999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChh
Q 015797          196 TH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE  243 (400)
Q Consensus       196 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~  243 (400)
                      .. ......||+.|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            11 1223469999999999999999999999999999999999887653

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.6e-40  Score=309.64  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=197.5

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      |.....||+|+||.||++.. .++..||+|.+..........+..|+.+++.++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            34456799999999999964 46889999998765555566788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      ++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......... 
T Consensus       104 ~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-  174 (292)
T cd06658         104 GALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-  174 (292)
T ss_pred             CcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence            9999987532     2788999999999999999999998   999999999999999999999999998765432221 


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ..+..             ...+.... 
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------~~~~~~~~-  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-------------NLPPRVKD-  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------cCCCcccc-
Confidence            2234589999999999988999999999999999999999999975432110 00000             00011000 


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       .......+..++.+||..||.+|||+.++++.
T Consensus       241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             01122356678899999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=304.20  Aligned_cols=248  Identities=28%  Similarity=0.386  Sum_probs=205.1

Q ss_pred             CCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           40 FNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      |.++.+||+|+||.||+| ....|+.+|||.+...  .+..++..|+.+|.+...|++|++||.+.....++||||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            457889999999999999 4467999999998753  3466788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |++.+.++.+..   ++.+.++..++++-++||.|||...   -||||||..|||++.+|..||+|||.+-.+.+... .
T Consensus       113 GSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K  185 (502)
T KOG0574|consen  113 GSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K  185 (502)
T ss_pred             CcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence            999999875543   5999999999999999999999987   89999999999999999999999999987654322 2


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNF  278 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (400)
                      ..++.|||.|||||++..-.|+.++||||||++..||..|++||.+....-.-.    ..|...+        |-+  .-
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----MIPT~PP--------PTF--~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----MIPTKPP--------PTF--KK  251 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----eccCCCC--------CCC--CC
Confidence            345679999999999999999999999999999999999999997654311000    0011001        100  11


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          279 VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       279 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ......++.+++.+||-++|++|.|+.++++.
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            22335678899999999999999999999975

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.5e-40  Score=304.12  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=186.2

Q ss_pred             CcccccCceEEEEEEEcCCC---EEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQLWDGS---QIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.||+|+||.||+|...++.   .+++|.+.... ......+.+|+.+++.++||||+++++.+.+....|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999644433   45566665433 334567899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC-cee
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA-THV  198 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~-~~~  198 (400)
                      +|.+++..........++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999998754322233666778889999999999999998   9999999999999999999999999986432211 111


Q ss_pred             eeecccccCcCChhhhcc-------CCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccccc
Q 015797          199 TTRVKGTLGYLAPEYAML-------GKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .....+++.|+|||++..       ..++.++|||||||++|+|++ |..||...... ......        ......+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--------~~~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI--------KDQQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------hhccccc
Confidence            123457889999998753       245789999999999999997 57788644321 111100        0011111


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      .++.+...+    ...+.+++..|| .+|++||++.+|++.|.
T Consensus       230 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222222122    235666778999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=296.44  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=201.9

Q ss_pred             HccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEec--CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++.|.+.+.||+|.|+.||+. ...+|+.+|+|+++.  .+.....++.+|+++-+.|+||||+++.+.+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4578899999999999999998 456799999998864  3444567789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEEecCCcc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~Dfgl~~  189 (400)
                      +|++.|++|..-+-.+    ..+++..+-..++||++||.|+|.++   |||||+||.|+++-+   ..-+||+|||++.
T Consensus        89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence            9999999997766544    23677777789999999999999998   999999999999953   3459999999999


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhh-hhhhhhhhhccccchhccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV-NSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      .+.++.  .-....|||.|||||+++..+|+..+|||+.|+|||-|+.|++||.+. ...+.+.+........ .+.|  
T Consensus       162 ~l~~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~-~~~w--  236 (355)
T KOG0033|consen  162 EVNDGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP-SPEW--  236 (355)
T ss_pred             EeCCcc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC-Cccc--
Confidence            887322  223346999999999999999999999999999999999999999873 3334333322111100 0011  


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                              +..+   ++..+|+.+||..||.+|.|+.|.|+.
T Consensus       237 --------~~is---~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  237 --------DTVT---PEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             --------CcCC---HHHHHHHHHHhccChhhhccHHHHhCC
Confidence                    1122   244556689999999999999999874

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.9e-40  Score=307.96  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=202.8

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ..++|.+.+.||+|+||.||++.. .++..+++|.+..........+..|+.+++.++||||+++++.+...+..|+|+|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            347899999999999999999954 4688999999875555555678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          97 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             cCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            99999999998643     2778889999999999999999998   999999999999999999999999998765433


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      ... .....|++.|+|||.+.++.++.++||||||+++|+|++|+.||........  +.....    ..      .+..
T Consensus       169 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~~~----~~------~~~~  235 (293)
T cd06647         169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIAT----NG------TPEL  235 (293)
T ss_pred             ccc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeehhc----CC------CCCC
Confidence            221 1223588999999999988899999999999999999999999975432110  000000    00      0000


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        .........+.+++.+||..+|++||++.+++..
T Consensus       236 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0111123467788899999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.2e-40  Score=303.15  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=186.3

Q ss_pred             CcccccCceEEEEEEEcC---CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.||+|+||.||+|....   ...+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999995433   3467888765433 233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCc-ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce-
Q 015797          120 SLLSHLHGQHSS-ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-  197 (400)
Q Consensus       120 sL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-  197 (400)
                      +|.+++...... ....++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999998754321 123467788899999999999999998   999999999999999999999999998654322111 


Q ss_pred             eeeecccccCcCChhhhcc-------CCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhccccccc
Q 015797          198 VTTRVKGTLGYLAPEYAML-------GKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSE  268 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  268 (400)
                      ......+++.|+|||++..       ..++.++|||||||++|+|++ |..||....... .......        ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--------~~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE--------QDIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc--------cCcc
Confidence            1122335678999998753       356889999999999999999 788886543211 0000000        0001


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      +..+...    ......+..++..|| .||++|||+.+|++.|.
T Consensus       230 ~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111111    112235556778888 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.2e-40  Score=329.80  Aligned_cols=266  Identities=20%  Similarity=0.235  Sum_probs=191.0

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC------CCccceeeeEE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR------HKNLLSLRGYC  103 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~  103 (400)
                      +++....++|++.+.||+|+||+||+|.+ ..++.||||++.... .....+..|+++++.++      |++++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            34455678999999999999999999964 468899999986432 22234455666666654      45688899888


Q ss_pred             EeC-CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCC---
Q 015797          104 AEG-QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADF---  178 (400)
Q Consensus       104 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~---  178 (400)
                      ... ...|+||+++ +++|.+++....    .+++..+..++.|++.||.|||. .+   ||||||||+|||++.++   
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence            764 5788999988 678999886542    38889999999999999999997 47   99999999999998765   


Q ss_pred             -------------cEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          179 -------------KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       179 -------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                                   .+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         4999999988643221    22356999999999999999999999999999999999999999754


Q ss_pred             hhhhhhh-hhccc--cchhcccc-----ccccc------CccCCC---------CCc--HHHHHHHHHHHHhccccCCCC
Q 015797          246 NSAIKRT-ITDWA--LPLACERK-----FSELA------DPRLNG---------NFV--EEELKRVVLVALTCAHSKPEK  300 (400)
Q Consensus       246 ~~~~~~~-~~~~~--~~~~~~~~-----~~~~~------~~~~~~---------~~~--~~~~~~l~~li~~cl~~dP~~  300 (400)
                      ....... +....  .|......     ...+.      .+....         ...  ......+.+||.+||..||.+
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            4221100 00000  00000000     00000      000000         000  001245778999999999999


Q ss_pred             CCCHHHHHH
Q 015797          301 RPTMLEVLD  309 (400)
Q Consensus       301 Rps~~ell~  309 (400)
                      |||+.|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999997

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.3e-40  Score=305.99  Aligned_cols=264  Identities=21%  Similarity=0.298  Sum_probs=197.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++.+.||+|++|.||+|... +++.||+|++....  ......+..|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47999999999999999999654 58999999886432  2223457889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++++|..++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999888877664322    3889999999999999999999998   999999999999999999999999999876543


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-----hhhccccch---hcccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-----TITDWALPL---ACERK  265 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-----~~~~~~~~~---~~~~~  265 (400)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.........     .......+.   .....
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            22 1222347889999999876 56789999999999999999999999754321110     000000000   00000


Q ss_pred             -cccccCccCCCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 -FSELADPRLNGN-----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 -~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       ......+.....     ..+.....+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             000000000000     01112356788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-40  Score=303.29  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=197.3

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH----------HHHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK----------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  107 (400)
                      +|.+.+.||.|++|.||+|.. .+++.+|+|.+......          ....+..|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588899999999999999954 56899999987632111          1235778999999999999999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence            9999999999999999987542    4888899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCce-eeeecccccCcCChhhhccCC--CCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          188 AKLIPDGATH-VTTRVKGTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       188 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      +......... ......|+..|+|||.+....  ++.++|+||||+++|+|++|..||.............       ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~  227 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG-------NK  227 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh-------cc
Confidence            9765432111 122345889999999988655  8999999999999999999999996433211000000       00


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .    ....+...........+.+++.+||..+|.+|||+.++++.
T Consensus       228 ~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         228 R----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             c----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0    00001111112234577888899999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.2e-41  Score=292.38  Aligned_cols=257  Identities=26%  Similarity=0.360  Sum_probs=204.9

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCCh----HHH----HHHHHHHHHHhcC-CCCccceeee
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSN----KAE----MEFAVEVEILARV-RHKNLLSLRG  101 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~----~~~----~~~~~E~~~l~~l-~hpnIv~~~~  101 (400)
                      .-...-++|.-.+.||.|..++|-+. ...+|...|+|++.....    ...    +.-..|+.+|+++ .||+|+++.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            33555678888899999999999888 456789999998864211    112    2345699999998 6999999999


Q ss_pred             EEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       102 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                      +++.+...++|+|.|+.|.|.|+|...    ..+++.....|++|+.+|+.|||.++   ||||||||+|||++++.++|
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence            999999999999999999999999654    35899999999999999999999998   99999999999999999999


Q ss_pred             EEecCCccccCCCCceeeeecccccCcCChhhhcc------CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhc
Q 015797          182 VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML------GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITD  255 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~  255 (400)
                      |+|||+++.+..+..  ....+|||+|+|||.+..      ..|+...|+|++|+|+|.|+.|.+||.+......-....
T Consensus       164 isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im  241 (411)
T KOG0599|consen  164 ISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM  241 (411)
T ss_pred             EeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence            999999998876654  345789999999999874      467889999999999999999999998765432222111


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                             .+++. +.++     .-.+.....-+||.+||+.||.+|.|++|.|..
T Consensus       242 -------eGkyq-F~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  242 -------EGKYQ-FRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             -------hcccc-cCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                   11110 0011     011223456678899999999999999999973

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=316.11  Aligned_cols=264  Identities=25%  Similarity=0.408  Sum_probs=212.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHH-HHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAE-MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      +.....+.++||+|-||.|.+.....+..||+|.++.....+. .+|..|+++|.+|+||||+.++|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            3466778899999999999999877789999999987666555 789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++|+|.+++..+....  +.-...++|+.||+.||+||.+.+   +|||||.+.|||++.++++||+|||.++.+-.+
T Consensus       616 YmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999998764332  445667789999999999999988   999999999999999999999999999977655


Q ss_pred             Cceee-eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh--CCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          195 ATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS--GKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       195 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ..... ...+-...|||||.+..++++++||+|+||+++||+++  ...||..........-.....+..  +...-+..
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~--~~~~~l~~  768 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ--GRQVVLSR  768 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC--CcceeccC
Confidence            54332 33456789999999999999999999999999999865  889998776432111111111100  00011111


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      |       .-+...+.++|+.||..+-.+|||+++|...|.+
T Consensus       769 P-------~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  769 P-------PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             C-------CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            1       1223477789999999999999999999988754

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7e-40  Score=305.51  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=198.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+..|+.+++.++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46899999999999999999654 7899999988753 333345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      +++++|..++.... ....+++..+..++.|++.||.|||+. +   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999998886531 122488999999999999999999974 6   999999999999999999999999998765332


Q ss_pred             CceeeeecccccCcCChhhhccCC------CCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGK------ASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      .   .....+++.|+|||.+.+..      ++.++|||||||++|+|++|..||....... ...+..          ..
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~----------~~  223 (286)
T cd06622         157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA----------IV  223 (286)
T ss_pred             c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH----------Hh
Confidence            2   12234888999999986543      4889999999999999999999996433211 000000          00


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ....+    .........+.+++.+||+.+|.+||++.+++..
T Consensus       224 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 DGDPP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hcCCC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            00001    1122234567888999999999999999999963

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.8e-40  Score=301.79  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=194.7

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-----hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-----NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QER  109 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~  109 (400)
                      .+|++.+.||+|+||.||.|.. .++..||+|.+....     ......+..|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5789999999999999999964 568999999886321     12335678899999999999999999988764  567


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +++|||+++++|.+++....    .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999999986442    2778888999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCc--eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGAT--HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .......  .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..........  ...         .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--~~~---------~  223 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF--KIA---------T  223 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH--HHh---------c
Confidence            6532111  11222458899999999998889999999999999999999999997543211100  000         0


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ....+    .........+.+++.+||. +|.+||++.+|++.
T Consensus       224 ~~~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         224 QPTNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CCCCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            00001    1122333467778889985 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.8e-40  Score=308.07  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=197.4

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      |.....||+|+||.||+|.. .+++.||+|.+..........+..|+.+++.++||||+++++++..++..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            44456899999999999964 46899999998765444556688899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      ++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......... 
T Consensus       103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-  173 (297)
T cd06659         103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-  173 (297)
T ss_pred             CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence            9999877532     2788999999999999999999998   999999999999999999999999998755432221 


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... .+.....+     .+   .       
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~---~-------  238 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-----KL---K-------  238 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-----Cc---c-------
Confidence            22345899999999999889999999999999999999999999754321111 11000000     00   0       


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            001112357788899999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.3e-40  Score=306.64  Aligned_cols=243  Identities=27%  Similarity=0.338  Sum_probs=198.5

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|++|.||++.. .+++.+|+|.+....   ......+..|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4799999999999999999965 468999999986422   233456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999999986542    3888999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .    .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ........              .
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~  215 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK--------------V  215 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------c
Confidence            3    223458999999999988889999999999999999999999997544211 11111000              0


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  309 (400)
                      .+.    ......+.+++.+||..||.+|+     ++.++++
T Consensus       216 ~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 RFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cCC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            001    11134677888999999999999     7777775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-40  Score=320.97  Aligned_cols=260  Identities=22%  Similarity=0.280  Sum_probs=195.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc---CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     ....+|+.+|+.++||||+++++++......|++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            467999999999999999999532   3577899987542     23457999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |++. ++|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++.....
T Consensus       166 e~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9996 68888884322    3899999999999999999999998   99999999999999999999999999976543


Q ss_pred             CCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-----hhhhhhccc-cchhccc--
Q 015797          194 GATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-----IKRTITDWA-LPLACER--  264 (400)
Q Consensus       194 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-----~~~~~~~~~-~~~~~~~--  264 (400)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ....+.... .+.....  
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            3221 222356999999999999999999999999999999999999999653211     000000000 0000000  


Q ss_pred             ------ccccccCccCCCCC-cH------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 ------KFSELADPRLNGNF-VE------EELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ------~~~~~~~~~~~~~~-~~------~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            .+..... .....+ .+      .....+.++|.+||..||++|||+.+++..
T Consensus       318 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAI-VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcc-cccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  0000000 000000 00      112356778899999999999999999974

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.7e-40  Score=302.02  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=199.1

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh------HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN------KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +|+..+.||+|++|.||+|.. .+++.+|+|.+.....      .....+..|+.+++.++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588899999999999999954 5689999999874331      124568889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKL  190 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~~  190 (400)
                      ||||+++++|.+++....    .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999986432    3788999999999999999999998   99999999999998776 599999999976


Q ss_pred             cCCCCce---eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          191 IPDGATH---VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       191 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...........            +.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------------~~  221 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------------IF  221 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH------------HH
Confidence            6433211   11234588999999999888999999999999999999999999964321100000            00


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..................+.+++.+||..+|.+||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000000011122233457888999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5e-40  Score=305.85  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=193.5

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHH-HhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEI-LARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+..|+.. ++.++||||+++++++..++..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4789999999999999999965 469999999987543 2333455556654 667799999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |++ |+|.+++.........+++..++.++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 688888765433334689999999999999999999987 6   99999999999999999999999999986543


Q ss_pred             CCceeeeecccccCcCChhhhcc----CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAML----GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ...  .....|+..|+|||.+.+    ..++.++|||||||++|+|++|+.||......... +...         . ..
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~---------~-~~  223 (283)
T cd06617         157 SVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-LKQV---------V-EE  223 (283)
T ss_pred             ccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-HHHH---------H-hc
Confidence            221  122348899999998865    45689999999999999999999999643211000 0000         0 00


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..+....   ......+.+++.+||..+|.+||++.++++
T Consensus       224 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011110   112346788999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.1e-40  Score=306.10  Aligned_cols=265  Identities=21%  Similarity=0.308  Sum_probs=201.3

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||.|++|.||+|.+ .++..+|+|++....  ......+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            588999999999999999965 468999999987543  33345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      + +++|.+++....   ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999886543   24899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchh--c-----ccc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLA--C-----ERK  265 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~--~-----~~~  265 (400)
                      ........|+..|+|||.+.+. .++.++||||||+++|+|+||.+||.......  .........+..  +     ...
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            2222334589999999988754 46899999999999999999988886443211  011110000000  0     000


Q ss_pred             cccccCccCC----CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          266 FSELADPRLN----GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       266 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +..+..+...    ....++....+.+++.+||+.+|++|||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000    00111223678889999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-40  Score=310.76  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=198.1

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCC----EEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGS----QIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .++|+..+.||+|+||.||+|.+ .++.    .+|+|.+..... .....+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            46788899999999999999964 3444    468888765332 3334688899999999999999999998754 467


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +++||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence            99999999999999875432   3788899999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          191 IPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||................      ..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~--  230 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE------RL--  230 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC------CC--
Confidence            64332211 112335778999999999999999999999999999997 999996543221111110000      00  


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                       .   .    .......+..++.+||..+|++||++.++++.|....
T Consensus       231 -~---~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         231 -P---Q----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -C---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             0   0    0011236778899999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-39  Score=299.45  Aligned_cols=251  Identities=29%  Similarity=0.456  Sum_probs=199.7

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|.+.+.||+|+||.||+|.. .+++.+++|.+.....  .....+..|+.+++.++||||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            688999999999999999964 4789999999876444  3566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++....    .+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999986532    3778889999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeee---ecccccCcCChhhhccCC---CCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          196 THVTT---RVKGTLGYLAPEYAMLGK---ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       196 ~~~~~---~~~gt~~y~aPE~~~~~~---~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .....   ...+++.|+|||.+.+..   ++.++||||||+++|+|++|+.||.............   .   .     .
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~---~---~-----~  222 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV---G---A-----G  222 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH---h---c-----C
Confidence            22111   245789999999998766   8899999999999999999999997542211100000   0   0     0


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..+.+..  .......+.+++.+||+.+|.+|||+.+++.
T Consensus       223 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000  0011345678889999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.4e-40  Score=310.98  Aligned_cols=197  Identities=24%  Similarity=0.377  Sum_probs=159.8

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeEEEEEEccC
Q 015797           43 DNKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQERLIVYDYMP  117 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~  117 (400)
                      ++.||+|+||.||+|...   +++.+|+|.+.....  ...+.+|+.+++.++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999643   467899998864322  3346789999999999999999998854  456889999986


Q ss_pred             CCChhhhhhcCC-----CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----CCCCcEEEEecCCc
Q 015797          118 NLSLLSHLHGQH-----SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGFA  188 (400)
Q Consensus       118 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv----~~~~~~kl~Dfgl~  188 (400)
                       ++|.+++....     .....+++..+..++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888765321     11224788899999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCCce--eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          189 KLIPDGATH--VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       189 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      .........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433221  1223568999999999987 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=324.48  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=205.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      +.|.++..||.|+||.||+|.+. ++-..|.|++...+.....++..|+.+|....||+|+++++.|...++++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45678889999999999999654 45556789888888888899999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      .||.+...+.....   .+.+.++..++.|++.||.|||++.   |||||||..|||++-+|.++|+|||.+...... .
T Consensus       112 ~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R  184 (1187)
T ss_pred             CCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence            99999998865443   4899999999999999999999998   999999999999999999999999998754322 2


Q ss_pred             eeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          197 HVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .......|||+|||||++.+     .+|+.++|||||||+|.||..+.+|-...+..  +.+......     ....++ 
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKiaKS-----ePPTLl-  256 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS-----EPPTLL-  256 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHHhhc-----CCCccc-
Confidence            22334679999999998864     58999999999999999999999998766532  111111110     000111 


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            ..+.....+.+++.+||.+||..||++.+|++.
T Consensus       257 ------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  257 ------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                  123334578889999999999999999999974

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-40  Score=308.58  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=194.3

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||.|+||.||+|.. .+|..+|+|.+.....  .....+..|+.+++.++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            588999999999999999965 4689999999864322  2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +. ++|.+++.....   .+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            97 588887764322   3889999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh--hh-hccccch-hccccccccc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TI-TDWALPL-ACERKFSELA  270 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~--~~-~~~~~~~-~~~~~~~~~~  270 (400)
                      .. .....+++.|+|||++.+. .++.++|||||||++|+|+||..|+.........  .+ .....+. .....+....
T Consensus       154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            21 1223478999999998764 4799999999999999999999986433221100  00 0000000 0000000000


Q ss_pred             C----ccCCC-----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 D----PRLNG-----NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~----~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +    +....     ...+.....+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0    00000     011123456778899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=317.69  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEc---CC--CEEEEEEEec-CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLW---DG--SQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~--~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  107 (400)
                      ...-..-...+.||.|.||.||.|...   .|  -.||||..+. -..+..+.|..|+-+|++++||||++++|+|.+. 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            333334455678999999999999532   23  3578898876 3445567899999999999999999999999875 


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..+||||.++-|.|..+|..+...   ++......++.||+.||+|||+..   +|||||-.+||||.+..-+||+|||+
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence            468999999999999999866543   888889999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF  266 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  266 (400)
                      ++.+.+..........-..-|||||.+....++.+||||-||+.+||++. |..||.......                +
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------V  601 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------V  601 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------e
Confidence            99987766554444445678999999999999999999999999999987 999997654210                0


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ...+...-+-...+.++..|..||.+||+.+|.+||.+.+|...|.....
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            00000111111233445578889999999999999999999988765543

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.8e-40  Score=303.68  Aligned_cols=250  Identities=28%  Similarity=0.454  Sum_probs=193.9

Q ss_pred             CcccccCceEEEEEEEcC-------CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           44 NKLGEGGFGSVYWGQLWD-------GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +.||+|+||.||+|...+       +..+++|.+.... ......+..|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999996432       2578999876432 23455788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCC---cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-----cEEEEecCC
Q 015797          116 MPNLSLLSHLHGQHS---SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-----KAQVADFGF  187 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-----~~kl~Dfgl  187 (400)
                      +++|+|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999865321   1234788999999999999999999988   99999999999999887     899999999


Q ss_pred             ccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccc
Q 015797          188 AKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERK  265 (400)
Q Consensus       188 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  265 (400)
                      +......... ......++..|+|||.+.++.++.++|||||||++|+|+| |..||..............      ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------~~~  231 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA------GGR  231 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc------CCc
Confidence            9765432211 1112235788999999999999999999999999999998 9999865432111100000      000


Q ss_pred             cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      .          .........+.+++.+||..+|.+||++.++++.|.
T Consensus       232 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         232 L----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             c----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0          011122346778999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.5e-40  Score=302.51  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=200.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||.|++|.||++... +++.+++|.+.... ......+..|+++++.++||||+++++.+..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888999999999999999654 68999999987643 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      +++++|.+++....   ..+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999987542   248888999999999999999999 77   999999999999999999999999998765332


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh---hhhhhhccccchhcccccccccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA---IKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ...   ...++..|+|||.+.+..++.++||||||+++|+|++|..||......   ....+..          +.....
T Consensus       155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~  221 (265)
T cd06605         155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY----------IVNEPP  221 (265)
T ss_pred             Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH----------HhcCCC
Confidence            211   145889999999999999999999999999999999999999654210   0000000          000000


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +.+...   .....+.++|.+||..||.+|||+.+++.
T Consensus       222 ~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 PRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111101   13446788899999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-39  Score=303.94  Aligned_cols=260  Identities=25%  Similarity=0.286  Sum_probs=199.2

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~  113 (400)
                      ++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688889999999999999965 4688999999875333 3456788999999999999999999988653  4689999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887543223334788899999999999999999998   99999999999999999999999999875433


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhcccccccccC
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ...   ....++..|+|||.+.+..++.++|||||||++|+|++|..||......  .......+...    .....+..
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  230 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD  230 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc
Confidence            221   1234788999999999999999999999999999999999999754210  00000000000    00000000


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      . ..  ........+.+++.+||..+|.+|||+.|+++.
T Consensus       231 ~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         231 E-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             C-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            0 00  001124567889999999999999999999973

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.3e-39  Score=302.38  Aligned_cols=247  Identities=26%  Similarity=0.358  Sum_probs=198.7

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      -|++.+.||.|+||.||+|.+ .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            467888999999999999954 568899999876433 233456888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++++|.+++...     .+++..+..++.|++.|+.|||..+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999988642     3788999999999999999999998   99999999999999999999999999876543221


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|..||.............    ..        ..+.   
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~--------~~~~---  220 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP----KN--------NPPT---  220 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh----cC--------CCCC---
Confidence             1222358889999999998889999999999999999999999997543211110000    00        0000   


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ........+.+++.+||+.+|.+||++.++++.
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             111223467788899999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-39  Score=298.89  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=198.6

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||+|++|.||++.. .+++.+|+|.+...  .......+..|+++++.++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588999999999999999954 57889999998753  233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-CcEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~~kl~Dfgl~~~~~~~  194 (400)
                      +++++|.+++.....  ..+++..++.++.+++.||.|||+++   ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999975432  23788999999999999999999998   9999999999999865 45899999999876433


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      ..  .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........  .....     ......      
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~-----~~~~~~------  220 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKIM-----SGTFAP------  220 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHHH-----hcCCCC------
Confidence            22  1224588999999999988899999999999999999999999975432110  00000     000000      


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         ........+.+++.+||+.+|.+|||+.+++.
T Consensus       221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               01112346778889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.7e-39  Score=306.27  Aligned_cols=249  Identities=28%  Similarity=0.410  Sum_probs=197.0

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      +...+|.+.+.||+|+||.||+|.. .+++.||+|.+....   ......+..|+.+++.++||||+++++++.+++..+
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            3456799999999999999999965 468999999886432   233356888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+. |+|.+.+.....   .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        92 lv~e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~  164 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL  164 (307)
T ss_pred             EEHHhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCccee
Confidence            9999997 688777754322   3889999999999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .....     ...+++.|+|||++.   .+.++.++||||||+++|+|+||..||...............       .  
T Consensus       165 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~--  230 (307)
T cd06607         165 VSPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------D--  230 (307)
T ss_pred             cCCCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-------C--
Confidence            43221     234888999999874   456889999999999999999999999754422110000000       0  


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         .+..   ........+.+++.+||+.+|++||++.+++..
T Consensus       231 ---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 ---SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0000   011233568889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=306.04  Aligned_cols=265  Identities=23%  Similarity=0.336  Sum_probs=199.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++.+.||+|++|.||+|.+. +++.|++|.+....  ......+..|+++++.++||||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999654 58899999886432  2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+.++.+..+.... .   .+++..++.++.|++.||.|||..+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~-~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP-G---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC-C---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99976665544322 1   3788999999999999999999998   999999999999999999999999999876554


Q ss_pred             CceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhcc---ccc-----hhccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDW---ALP-----LACER  264 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~---~~~-----~~~~~  264 (400)
                      .........++..|+|||++.+. .++.++||||||+++|+|++|+.||.......... ....   ..+     .....
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            33223334588999999999888 88999999999999999999999997543211000 0000   000     00000


Q ss_pred             cccc--ccCccC----CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSE--LADPRL----NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~--~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....  ......    ...+.......+.+++.+||..+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000  000000    00011112467888999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=301.77  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=198.3

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCC---CCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +.|++.+.||.|+||.||+|.+ .++..+|+|.+... .......+..|+.+++.++   |||++++++++.++...++|
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            3588899999999999999964 57899999998653 2334456888999999986   99999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++++|.+++...     .+++..++.++.|++.||.|||..+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          81 MEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            9999999999988643     3889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ..... .....|+..|+|||.+.++ .++.++||||||+++|+|++|..||...........            ......
T Consensus       153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~------------~~~~~~  219 (277)
T cd06917         153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------------IPKSKP  219 (277)
T ss_pred             CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc------------cccCCC
Confidence            43322 2233589999999998754 468999999999999999999999975432110000            000011


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +.+...   .....+.+++.+||+.||++||++.+++.
T Consensus       220 ~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         220 PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111111   12346788899999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-39  Score=305.55  Aligned_cols=264  Identities=21%  Similarity=0.303  Sum_probs=198.4

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH-----HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK-----AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +|.+.+.||.|++|.||+|.. .+++.|++|.+......     ....+..|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588899999999999999964 46899999998754322     234567899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+ +|+|.+++....   ..+++..++.++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999986543   24899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchh--c--ccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLA--C--ERK  265 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~--~--~~~  265 (400)
                      ..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||......  ..........+..  .  ...
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            43222 122346888999998865 46789999999999999999998877643321  0011000000000  0  000


Q ss_pred             cccccCccCC-----CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          266 FSELADPRLN-----GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       266 ~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..........     ..........+.+++.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000     00112234578889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.9e-40  Score=316.54  Aligned_cols=200  Identities=24%  Similarity=0.317  Sum_probs=172.4

Q ss_pred             HccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-C-----CccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-H-----KNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~~~  108 (400)
                      ...+|.+.+.||+|+||.|.+| +..+++.||||+++... .-..+...|+.+|..|+ |     -|+|+++++|...++
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            3348899999999999999999 55679999999997533 33456778999999996 4     389999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC--cEEEEecC
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF--KAQVADFG  186 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~--~~kl~Dfg  186 (400)
                      .|||+|.+. -+|.+++..+....  ++...+..++.||+.||..||..+   |||+||||+||||...+  .+||+|||
T Consensus       263 lciVfELL~-~NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence            999999996 69999998776654  889999999999999999999998   99999999999997544  59999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      +++.......    +.+-+..|.|||++.|.+|+.+.||||||||++||++|.+-|.+.+
T Consensus       337 SSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  337 SSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            9987543222    4567889999999999999999999999999999999987775443

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=303.97  Aligned_cols=265  Identities=21%  Similarity=0.316  Sum_probs=195.1

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++.+.||.|++|.||+|.. .+++.||+|.+...... ....+..|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            47899999999999999999965 46899999998653322 22346789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+. ++|.+++.....   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            998 499998865432   4788999999999999999999998   999999999999999999999999998754322


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh--hhhc---cccchhccc----
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITD---WALPLACER----  264 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~--~~~~---~~~~~~~~~----  264 (400)
                      ... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.........  ....   ...+.....    
T Consensus       157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            111 112246889999999875 45889999999999999999999999644311000  0000   000000000    


Q ss_pred             ------ccccccCccCCCCC-cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 ------KFSELADPRLNGNF-VEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                            .........+.... .......+.+++.+||+.+|.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                  00000000000000 0001246678899999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=307.92  Aligned_cols=250  Identities=21%  Similarity=0.331  Sum_probs=210.5

Q ss_pred             HccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCChHH--HHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKA--EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +.+=|.+.+.||+|-|+.|-+|+ ..+|..||||++....-+.  ...+.+|++.|+..+|||||++|++......+|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            45678999999999999999995 4689999999998654443  45789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-CCCcEEEEecCCcccc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-ADFKAQVADFGFAKLI  191 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-~~~~~kl~Dfgl~~~~  191 (400)
                      +|.-.+|+|.++|..+..   .+++..+.+++.||+.|+.|+|...   +|||||||+|+++. .-|-+||+|||++-.+
T Consensus        96 LELGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence            999999999999986543   3899999999999999999999987   99999999999886 5688999999999887


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCC-CccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKAS-ESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ..+..  ..+.+|+..|-|||++.+..|+ ++.||||||+|||-|++|++||...+....               +..++
T Consensus       170 ~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmIm  232 (864)
T KOG4717|consen  170 QPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIM  232 (864)
T ss_pred             CCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhh
Confidence            66544  3456799999999999999996 688999999999999999999987664321               11122


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +-..  ...+....+..+||..||..||.+|.+.++|...
T Consensus       233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            2111  1234455678889999999999999999999863

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.2e-40  Score=306.83  Aligned_cols=264  Identities=22%  Similarity=0.321  Sum_probs=196.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+.....  .....+..|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47899999999999999999654 589999998754222  234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+++++|.++.....    .+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999988887664322    3889999999999999999999998   999999999999999999999999998865443


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhh----cccc---chhcc-c
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTIT----DWAL---PLACE-R  264 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~----~~~~---~~~~~-~  264 (400)
                      ... .....++..|+|||.+.+ ..++.++||||||+++|+|++|++||........ ....    ....   ..... .
T Consensus       154 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         154 GEV-YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             ccc-cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            321 223458899999999875 4578899999999999999999999864332100 0000    0000   00000 0


Q ss_pred             ccccccCccCCC-----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELADPRLNG-----NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .......+....     ...+.....+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000000     001122457888999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.6e-39  Score=300.12  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=199.4

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      +|...+.||+|++|.||++.. .+++.+++|.+..........+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455567999999999999964 5688999999876555556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +++|.+++...     .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.........
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            99999988652     3788999999999999999999998   999999999999999999999999988765433221


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                       .....|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..+...             ..+... 
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-------------~~~~~~-  236 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-------------LPPKLK-  236 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-------------CCCCCc-
Confidence             1224589999999999988899999999999999999999999865432111 111100             000000 


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       ........+.+++.+||+.+|++|||+.++++
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             00112346888999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-39  Score=299.11  Aligned_cols=247  Identities=25%  Similarity=0.291  Sum_probs=199.9

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      +|++.+.||.|+||.||+|.. .++..+|+|.+....   ......+..|+++++.++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            588999999999999999965 468999999987432   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+.+++|.+++...    ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998654    24888999999999999999999998   999999999999999999999999999876443


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      ..  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+....         .. ..+  
T Consensus       154 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------~~-~~~--  219 (258)
T cd05578         154 TL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ---------ET-ADV--  219 (258)
T ss_pred             cc--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh---------cc-ccc--
Confidence            21  22345889999999999888999999999999999999999999865421111111000         00 000  


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTM--LEVL  308 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~ell  308 (400)
                        .........+.+++.+||+.||.+||++  .+++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              1111123578889999999999999999  6665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-39  Score=305.88  Aligned_cols=197  Identities=23%  Similarity=0.378  Sum_probs=159.1

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeEEEEEEccC
Q 015797           43 DNKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQERLIVYDYMP  117 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~  117 (400)
                      +..||+|+||.||+|...   ++..+|+|.+....  ....+.+|+.+++.++||||+++++++..  +...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999653   45789999886432  23457789999999999999999998853  567899999987


Q ss_pred             CCChhhhhhcCC-----CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----CCCCcEEEEecCCc
Q 015797          118 NLSLLSHLHGQH-----SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGFA  188 (400)
Q Consensus       118 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv----~~~~~~kl~Dfgl~  188 (400)
                       ++|.+++....     .....+++..++.++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             57877764321     11234788889999999999999999998   9999999999999    56678999999999


Q ss_pred             cccCCCCce--eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          189 KLIPDGATH--VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       189 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|+|+||..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876443221  1223458999999999876 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-39  Score=305.84  Aligned_cols=253  Identities=19%  Similarity=0.237  Sum_probs=196.3

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|.+.+.||+|+||.||++.. ..++.|++|.+.....   .....+..|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4789999999999999999964 4588999998875432   23346778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999986543    3788899999999999999999998   99999999999999999999999999863211


Q ss_pred             CCc--------------eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhcccc
Q 015797          194 GAT--------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWAL  258 (400)
Q Consensus       194 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~  258 (400)
                      ...              .......++..|+|||.+.+..++.++|||||||++|+|++|..||...... ........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~--  231 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD--  231 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence            000              0011234788999999999889999999999999999999999999754321 11110000  


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                            .   ...+..    .......+.+++.+||+.||++||++.++.+.|.
T Consensus       232 ------~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         232 ------D---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ------c---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                  0   000000    0012346788899999999999999655555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.4e-39  Score=300.24  Aligned_cols=255  Identities=26%  Similarity=0.387  Sum_probs=205.3

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ....+.|.+.+.||+|++|.||+|... ++..+++|++..... ....+..|+.+++.++||||+++++.+......+++
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            467788999999999999999999654 688999999876444 455688899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      +||+++++|.+++....   ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999997643   24899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.............       ........  
T Consensus       168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~--  237 (286)
T cd06614         168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT-------TKGIPPLK--  237 (286)
T ss_pred             cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hcCCCCCc--
Confidence            3222 1122347889999999998889999999999999999999999987543221100000       00000000  


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           ........+.+++.+||+.+|.+|||+.++++.
T Consensus       238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 011123467788999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3e-39  Score=302.07  Aligned_cols=266  Identities=21%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++++|++.+.||+|+||.||+|.. .++..+|+|.+..... .....+..|+.+++.++|+||+++++++..+...|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            568999999999999999999954 5689999999864332 22335678999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+. ++|.+++.....   .+.+..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 688777754322   3677888899999999999999998   99999999999999999999999999875433


Q ss_pred             CCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhcc---ccchhc-------
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW---ALPLAC-------  262 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~-------  262 (400)
                      .... .....+++.|+|||.+.+. .++.++||||||+++|+|+||..||.............+   ..|...       
T Consensus       156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            2211 1223478999999998764 578999999999999999999999975443211100000   000000       


Q ss_pred             ccc-cccccCccCCCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 ERK-FSELADPRLNGNF-----VEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 ~~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ... .............     .......+.+++.+|+..||.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000 0000000000000     0001346677889999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-39  Score=296.47  Aligned_cols=252  Identities=27%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||.|++|.||+|... ++..+++|.+..... .....+..|+..+..++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            47889999999999999999654 599999999876543 4456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+ .+   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999998754    248889999999999999999999 88   999999999999999999999999999876443


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      ... .....++..|+|||.+.+..++.++||||||+++|+|+||..||...............        . ....+. 
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------~-~~~~~~-  222 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI--------C-DGPPPS-  222 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH--------h-cCCCCC-
Confidence            322 12345889999999999999999999999999999999999999765420000000000        0 000000 


Q ss_pred             CCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEE-ELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         .... ....+.+++.+||..+|++||++.++++.
T Consensus       223 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 ---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               1111 33578888899999999999999999973

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3e-39  Score=302.40  Aligned_cols=264  Identities=23%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv  112 (400)
                      ++|++.+.||.|+||.||+|... +++.+++|.++.....  ....+..|+.+++.++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57999999999999999999654 5889999998754322  223567899999999999999999998877  889999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+. ++|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99997 599988865432   4899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccc----------
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALP----------  259 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~----------  259 (400)
                      ..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||.......  .........|          
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            43221 2223478899999998764 46899999999999999999999997543211  0000000000          


Q ss_pred             --hhcccccccccCccCCCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          260 --LACERKFSELADPRLNGNFVEE-ELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       260 --~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ......+.......+...+... ....+.+++.+||+.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              0000000000011111111111 2456778889999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-39  Score=297.70  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|.+.+.||.|+||.||+|.. .++..+|+|.+....  ......+..|+.+++.++||||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            588899999999999999954 468899999986532  23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc-EEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK-AQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~-~kl~Dfgl~~~~~~~  194 (400)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++. ++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999865432  24789999999999999999999998   999999999999998864 699999999876443


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......  ......     ......      
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~-----~~~~~~------  221 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ--LVLKIC-----QGYFAP------  221 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHh-----cccCCC------
Confidence            22 1222358999999999988889999999999999999999999997543211  000000     000000      


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ..+.....+.+++.+||..+|++|||+.++++.
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               011122467888899999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3e-39  Score=298.96  Aligned_cols=255  Identities=26%  Similarity=0.362  Sum_probs=196.4

Q ss_pred             CCcCCcccccCceEEEEEEEc----CCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 015797           40 FNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ------  107 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------  107 (400)
                      |.+.+.||+|+||.||+|...    ++..+|+|++...  .......+..|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999542    3688999998653  3334567889999999999999999999886532      


Q ss_pred             eEEEEEEccCCCChhhhhhcCC--CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQH--SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      ..+++++|+.+|+|.+++....  .....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999998875322  11224788889999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhc
Q 015797          186 GFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLAC  262 (400)
Q Consensus       186 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~  262 (400)
                      |+++........ ......+++.|++||.+....++.++|||||||++|+|++ |..||....... ........     
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-----  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            999865432211 1112335678999999998899999999999999999999 889986543211 11111100     


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                        ..      .    ........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       233 --~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 --RL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --cC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              00      0    0011234788899999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.1e-39  Score=295.69  Aligned_cols=249  Identities=27%  Similarity=0.364  Sum_probs=202.9

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||.|++|.||++.. .++..+++|.+...  .......+..|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            588999999999999999954 56889999998743  233445678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999998653332345888999999999999999999998   9999999999999999999999999998765431


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                         .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........ .....        ....       
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~-------  219 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--------GKYP-------  219 (256)
T ss_pred             ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------CCCC-------
Confidence               2223588999999999999999999999999999999999999975443211 11100        0000       


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        .........+.+++.+||+.+|++|||+.++++.
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              1112334578889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-38  Score=290.23  Aligned_cols=249  Identities=29%  Similarity=0.420  Sum_probs=203.0

Q ss_pred             CCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      +|++.+.||.|++|.||++... ++..+++|++..........+..|+.+++.++|||++++++.+..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4888899999999999999654 688999999976555556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +++|.+++....   ..+++..+..++.|++.||.|||..+   ++||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999987543   24899999999999999999999988   99999999999999999999999999987654432 


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|..||..............       ........      
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~------  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-------NGPPGLRN------  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-------cCCCCcCc------
Confidence             2234588999999999988899999999999999999999999976532111100000       00000000      


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       .......+.+++.+||+.||.+|||+.++++
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0001346888899999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=317.07  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=203.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEc--CCC--EEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW--DGS--QIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++.++.++||+|.||.|++|.|.  .|.  .||||.+...... ...+|.+|+.+|..|+|||++++||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            34456789999999999999653  344  5799999865554 56789999999999999999999999887 777899


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||.++.|||++.|+..  ....+-......++.|||.||.||..++   +|||||-.+|+|+-..-.|||+||||.+.+.
T Consensus       189 ~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence            9999999999999872  3345888889999999999999999998   9999999999999999999999999999886


Q ss_pred             CCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          193 DGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       193 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .......  ....-...|+|||.++...++.+||||+|||+||||+| |..||.+.........                
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----------------  327 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----------------  327 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----------------
Confidence            5444322  12334668999999999999999999999999999999 8999987653211111                


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ++....-.....+.+++.++|.+||..+|.+||||..|.+.
T Consensus       328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            11111111223345788999999999999999999999753

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-39  Score=302.67  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=194.9

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|+..+.||.|++|.||+|.. .++..+|+|.+....  ......+..|+++++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            588999999999999999965 468999999886432  22234688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +. ++|.+++......  .+++..++.++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASPLS--GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 6898888654322  4889999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ceeeeecccccCcCChhhhccCC-CCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchh--c--------
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLA--C--------  262 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~--~--------  262 (400)
                      .. .....+++.|+|||++.+.. ++.++||||||+++|+|+||+.||......  ..........+..  .        
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            21 12234788999999887644 588999999999999999999999643321  0000000000000  0        


Q ss_pred             -ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 -ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       ...........+. ...+.....+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             0000000000000 000112245678899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-38  Score=302.21  Aligned_cols=246  Identities=30%  Similarity=0.433  Sum_probs=194.4

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .|...+.||+|+||.||+|.. .++..+|+|.+...   .......+..|+++++.++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            367888999999999999964 46889999998643   22334568889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+. |+|.+.+.....   .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~-g~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            997 588887754322   3889999999999999999999998   999999999999999999999999998754322


Q ss_pred             CceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccccccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELA  270 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  270 (400)
                           ....|++.|+|||.+.   .+.++.++|||||||++|+|++|..||........ ........            
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------------  241 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------  241 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC------------
Confidence                 1235889999999874   45789999999999999999999999865432110 00000000            


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                       +..   ........+.+++.+||+.+|.+||++.++++.+.
T Consensus       242 -~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 -PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             -CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence             000   01112346778889999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=310.56  Aligned_cols=265  Identities=21%  Similarity=0.308  Sum_probs=195.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----Ce
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----QE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~  108 (400)
                      .+++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+.+++.++||||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            467999999999999999999954 578999999986432 22345678899999999999999999987654     35


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .|+++||+. ++|.+.+...     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence            799999997 5888877543     3888999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCce--eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhccccchhccc
Q 015797          189 KLIPDGATH--VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDWALPLACER  264 (400)
Q Consensus       189 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~  264 (400)
                      .........  ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... ..... ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~-~~~~~~  232 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL-GTPSQE  232 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc-CCCCHH
Confidence            765432211  1122458999999998764 568999999999999999999999996433211000 00000 000000


Q ss_pred             ccccccCcc-----------CC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSELADPR-----------LN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~-----------~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+..+....           ..   ....+.....+.+++.+||+.+|++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000           00   00011124568889999999999999999999975

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.5e-39  Score=293.37  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=203.6

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|.+.+.||.|++|.||++.+ .++..+++|.+.....  .....+..|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            588999999999999999965 4689999999875433  4556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++.........+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998765322345899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccCccC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      . ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .......        ....     .+
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~-----~~  223 (258)
T cd08215         158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--------GQYP-----PI  223 (258)
T ss_pred             c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc--------CCCC-----CC
Confidence            1 222345899999999999889999999999999999999999999654321 1111100        0000     01


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .    ......+.+++.+||..+|++|||+.++++
T Consensus       224 ~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 P----SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             C----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1    112346788899999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.4e-39  Score=294.31  Aligned_cols=242  Identities=26%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             ccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           46 LGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        46 LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ||.|++|.||+|.. .+++.+|+|.+....   ......+..|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999965 358999999986432   23345688999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeee
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR  201 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~  201 (400)
                      .+++....    .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            99987543    2788899999999999999999998   9999999999999999999999999998765432  1223


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE  281 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (400)
                      ..|++.|+|||.+.+..++.++|+||||+++|+|++|..||.............             .........+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-------------ILKGNGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH-------------HhccCCCCCCCcc
Confidence            458999999999988889999999999999999999999997554211111000             0000000011111


Q ss_pred             HHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          282 ELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       282 ~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                      ....+.+++.+||+.+|.+||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1457888999999999999999     788876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.7e-39  Score=300.65  Aligned_cols=267  Identities=19%  Similarity=0.258  Sum_probs=194.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCe-----
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQE-----  108 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~-----  108 (400)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+.....  .....+..|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999965 4689999998764322  22346788999999995 6999999999887665     


Q ss_pred             EEEEEEccCCCChhhhhhcCCCc-ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecC
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSS-ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFG  186 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfg  186 (400)
                      .|+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 898887644322 235899999999999999999999998   999999999999998 8899999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchh-c
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLA-C  262 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~-~  262 (400)
                      ++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........  ........|.. .
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            98765332211 112247889999998865 4579999999999999999999999965432110  00000000000 0


Q ss_pred             ccccccccC----ccCC----CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 ERKFSELAD----PRLN----GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 ~~~~~~~~~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .........    +...    ....+.....+.++|.+||..||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000000    0000    0001123456788999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.9e-39  Score=302.79  Aligned_cols=267  Identities=24%  Similarity=0.305  Sum_probs=196.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~  110 (400)
                      ..++|++.+.||.|+||.||+|.. .+++.||+|.+......  ....+..|+.+++.++||||+++++++.+.  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            357899999999999999999965 56899999998753322  123466799999999999999999998765  5689


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+. ++|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence            9999997 58888876432   24889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhc-cccchh------
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITD-WALPLA------  261 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~-~~~~~~------  261 (400)
                      ....... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ..+.. ...+..      
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            6543221 122236788999999875 4679999999999999999999999975443211 00100 000000      


Q ss_pred             c-ccccccccCccCCCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 C-ERKFSELADPRLNGNF----VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~-~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      . .........+......    .......+.++|.+||+.||++|||+.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 0000000000000000    01124566789999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=293.28  Aligned_cols=249  Identities=25%  Similarity=0.340  Sum_probs=194.7

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-----ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-----SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QER  109 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~  109 (400)
                      .+|++.+.||+|+||.||+|.+ .++..+|+|.+...     .......+..|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999954 56899999987532     123345688899999999999999999998764  568


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +++|||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999999986432    3778889999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCc--eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGAT--HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .......  .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........  +....         .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~---------~  223 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFKIA---------T  223 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHHHH---------c
Confidence            6532111  111234588999999999988899999999999999999999999975432110  00000         0


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....+    .........+.+++.+||. +|..||++.+++.
T Consensus       224 ~~~~~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         224 QPTKP----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCC----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            00001    1112223467778899999 6799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-38  Score=305.78  Aligned_cols=264  Identities=23%  Similarity=0.270  Sum_probs=197.6

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----  106 (400)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|.+...  .......+..|+.+++.++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4568999999999999999999964 57899999998642  233345677899999999999999999988644     


Q ss_pred             -CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 -QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       ...|+||||+. ++|.+.+...      ++...+..++.|++.||.|||..+   ++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence             35799999996 5888877532      677888999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccch---
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPL---  260 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~---  260 (400)
                      |++........  .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....  ........|.   
T Consensus       163 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         163 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             ccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99986543222  2233588999999999999999999999999999999999999964432100  0000000000   


Q ss_pred             -----------------hcccccccccCccC----CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 -----------------ACERKFSELADPRL----NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 -----------------~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                       .....+........    ...........+.+++.+||+.||.+|||+.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                             00000001111000    000011234567889999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-39  Score=298.15  Aligned_cols=263  Identities=25%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             CCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEEEEEE
Q 015797           40 FNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERLIVYD  114 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e  114 (400)
                      |++.+.||.|++|.||+|... +++.+|+|.+....  ......+..|+.+++.++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999654 58899999997643  33345678899999999999999999999888  89999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |++ ++|.+++....   ..+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            997 48988886542   24889999999999999999999998   999999999999999999999999999876544


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhcc-ccchh-cccccccc-
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDW-ALPLA-CERKFSEL-  269 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~-~~~~~-~~~~~~~~-  269 (400)
                      .........++..|+|||.+.+ ..++.++||||||+++|+|+||+.||........ ..+... ..+.. ....+... 
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            3222223347889999998765 4578999999999999999999999975442110 011000 00000 00000000 


Q ss_pred             ----c-C-----ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ----A-D-----PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ----~-~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                          . .     ..+...+.......+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                0 0     00000000012457888999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.5e-39  Score=298.86  Aligned_cols=255  Identities=27%  Similarity=0.356  Sum_probs=192.1

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|...+.||+|+||.||++.. .+++.+|+|.+.... ......+..|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            556678999999999999954 568999999987533 234556888999999996 99999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          116 MPNLSLLSHLHGQ-HSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       116 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      +. +++.++.... ......+++..+..++.+++.||+|||+. +   ++||||||+||+++.++.++|+|||++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            86 4655543211 01112488899999999999999999974 6   99999999999999999999999999976543


Q ss_pred             CCceeeeecccccCcCChhhhccC---CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLG---KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ...  .....|++.|+|||++.+.   .++.++|||||||++|+|++|+.||....... ..+.....          ..
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~----------~~  227 (288)
T cd06616         161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLTQVVK----------GD  227 (288)
T ss_pred             CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHhhhcC----------CC
Confidence            222  1223488999999999876   68999999999999999999999997543211 11100000          00


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+.+...........+.+++.+||+.+|++|||+.+|+..
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111111111234468889999999999999999999973

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-38  Score=297.45  Aligned_cols=244  Identities=23%  Similarity=0.358  Sum_probs=195.4

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           43 DNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ...||+|+||.||++.. .++..+|+|.+..........+..|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35799999999999965 56899999998765555566788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeee
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR  201 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~  201 (400)
                      .+++...     .+++..++.++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++......... ...
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~  175 (292)
T cd06657         105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKS  175 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc-ccc
Confidence            9987532     2788999999999999999999998   999999999999999999999999998765432221 222


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE  281 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (400)
                      ..|++.|+|||.+.+..++.++||||||+++|+|++|..||................+            +.+.  ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~------------~~~~--~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------PKLK--NLHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC------------cccC--Cccc
Confidence            4588999999999888899999999999999999999999875432111000000000            0000  0111


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          282 ELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       282 ~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            2335677889999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.8e-39  Score=300.02  Aligned_cols=266  Identities=25%  Similarity=0.342  Sum_probs=196.9

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----  107 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----  107 (400)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|.+....  ......+..|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            4568899999999999999999965 458899999987533  222346778999999999999999999987655    


Q ss_pred             ------eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          108 ------ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       108 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                            ..++|+||+++ ++.+.+....   ..+++..++.++.|++.||+|||+.+   ++||||+|+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                  78999999985 7777776432   24899999999999999999999998   99999999999999999999


Q ss_pred             EEecCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhc---c
Q 015797          182 VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITD---W  256 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~---~  256 (400)
                      |+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .+..   .
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999998765433222222346788999998865 35789999999999999999999999754321100 0000   0


Q ss_pred             ccchhcccccccc-----cC------ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          257 ALPLACERKFSEL-----AD------PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       257 ~~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..+...+ .+...     .+      ..... ........+.+++.+||+.||.+||++.+++.
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWP-DVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcc-cccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000 00000     00      00000 00012356788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-39  Score=302.85  Aligned_cols=204  Identities=22%  Similarity=0.359  Sum_probs=168.3

Q ss_pred             CCCcCCcccccCceEEEEEEEc---CCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERL  110 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~  110 (400)
                      +|.+.+.||+|++|.||+|...   .+..||+|.+....   ......+..|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            5888999999999999999653   57899999987632   23335677899999999999999999999988  8899


Q ss_pred             EEEEccCCCChhhhhhcCCCcc-cccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC----CCcEEEEec
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSE-CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA----DFKAQVADF  185 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~----~~~~kl~Df  185 (400)
                      +||||+.+ +|.+.+....... ..++...++.++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999974 7777664332221 25788899999999999999999998   999999999999999    999999999


Q ss_pred             CCccccCCCCc--eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          186 GFAKLIPDGAT--HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       186 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      |++........  .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99986543222  112234578999999988764 57999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-38  Score=295.29  Aligned_cols=260  Identities=22%  Similarity=0.268  Sum_probs=192.1

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCC-CCccceeeeEEEeC--CeEEEEEE
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVR-HKNLLSLRGYCAEG--QERLIVYD  114 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~e  114 (400)
                      |++.+.||+|+||.||+|.. .++..+|+|.+.... .........|+.++..+. ||||+++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            67889999999999999954 568899999886432 222334557888898885 99999999999987  88999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+. |+|.+.+.....   .+++..++.++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 588888765332   4899999999999999999999998   999999999999999 99999999999866432


Q ss_pred             CceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccc---cc----hhcccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWA---LP----LACERK  265 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~---~~----~~~~~~  265 (400)
                      ..  .....+++.|+|||.+.. +.++.++|||||||++|+|++|..||...+.... .......   .+    ......
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            22  122357899999997754 5678999999999999999999999965432110 0000000   00    000000


Q ss_pred             cccccCccCCC----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELADPRLNG----NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ......+....    .........+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000    011223568889999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.5e-39  Score=299.14  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=194.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++.+.||.|++|.||+|.. .+++.||+|.+.....  .....+..|+++++.++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5799999999999999999965 4688999998864322  223567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecCCccccCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPD  193 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~~~~~~  193 (400)
                      |++ ++|.+.+.....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 588887754332  23677888899999999999999998   999999999999985 56799999999976533


Q ss_pred             CCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchh-------cc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLA-------CE  263 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~-------~~  263 (400)
                      .... .....+++.|+|||.+.+. .++.++|||||||++|+|+||..||......  ....+.....|..       ..
T Consensus       156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        156 PVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             Cccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            2211 1223478999999988764 5789999999999999999999999654321  1111110000000       00


Q ss_pred             cccccccCccCCC----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          264 RKFSELADPRLNG----NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       264 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..+.... +....    ...+.....+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAF-PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhc-ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000 00000    011122345778899999999999999999986

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-38  Score=296.87  Aligned_cols=265  Identities=21%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      +|++.+.||.|++|.||+|.+ .++..||+|.+...... ....+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            588999999999999999965 46889999998754322 2345778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++ +|.+++..... ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            84 89888765432 234899999999999999999999998   99999999999999999999999999976543221


Q ss_pred             eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchh-------ccccc
Q 015797          197 HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLA-------CERKF  266 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~-------~~~~~  266 (400)
                      . .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||.......  .........|..       ....+
T Consensus       156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            1 1223478899999988764 57899999999999999999999997544211  000100000000       00000


Q ss_pred             ccccCcc---CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          267 SELADPR---LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .......   ......+.....+.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000   000011122456778999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-39  Score=298.25  Aligned_cols=262  Identities=22%  Similarity=0.319  Sum_probs=195.4

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      |++.+.||.|++|.||+|.. .+|..||+|++.....  .....+..|+.+++.++||||+++++++.+++..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67889999999999999954 5799999999875332  22346788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      + ++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 699998865432  24889999999999999999999988   99999999999999999999999999976533221


Q ss_pred             eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccch--hc---------
Q 015797          197 HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPL--AC---------  262 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~--~~---------  262 (400)
                      . .....+++.|+|||++.+. .++.++||||||+++|+|++|..||........  ........|.  ..         
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            1 1122468899999988654 578999999999999999999999965432110  0000000000  00         


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ............ ....+.....+.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000 0011122356788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=296.81  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=199.0

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      |.+.+.||.|++|.||+|.. .+++.+++|.+.....  .....+..|+.+++.++||||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999965 4688999999875332  23456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++ +|.+++....   ..+++..++.++.|++.||.|||..+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            75 8888886543   24899999999999999999999998   99999999999999999999999999987654331


Q ss_pred             eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchhcccccccccC--
Q 015797          197 HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLACERKFSELAD--  271 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~--  271 (400)
                       ......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+....  ........+.  ...+.....  
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  230 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD--PEVWPKFTSLA  230 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc--hHhcccchhhh
Confidence             12223478899999999876 789999999999999999999999965442110  0000000000  000000000  


Q ss_pred             -------c----cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 -------P----RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 -------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                             +    .......+.....+.++|.+||+.||.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   0    0000112234567889999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.7e-38  Score=289.17  Aligned_cols=250  Identities=29%  Similarity=0.402  Sum_probs=202.6

Q ss_pred             CCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERLIVY  113 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~  113 (400)
                      +|...+.||+|++|.||+|... ++..+++|++.....  .....+..|+.+++.++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5788899999999999999654 689999999875443  4456788999999999999999999999988  8999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999987543    4899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          194 GATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ..             +...
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~-------------~~~~  219 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL-YK-------------IGSS  219 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-Hh-------------cccc
Confidence            4321 1223458899999999998889999999999999999999999997654111000 00             0000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .............+.+++.+||+.+|.+||++.+++.
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            0000111122457888889999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-38  Score=343.21  Aligned_cols=262  Identities=25%  Similarity=0.497  Sum_probs=201.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ...|.....||+|+||.||+|.. .++..||+|.+......    ...|++.++.++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677788999999999999965 57899999988643321    23458889999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++|+|.+++..       ++|..+..++.|++.||+|||....++++||||||+||+++.++..++. ||........ 
T Consensus       765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            999999999852       7899999999999999999996544559999999999999998887775 6655432211 


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                          ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......|............+.++.+.
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcccc
Confidence                1224889999999999999999999999999999999999998543211 11111111111111122233333332


Q ss_pred             C--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          276 G--NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       276 ~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .  .........+.+++.+||+.||++|||+.++++.|....+
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            2  2344566788899999999999999999999999976543

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-38  Score=293.92  Aligned_cols=243  Identities=26%  Similarity=0.310  Sum_probs=190.2

Q ss_pred             ccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           46 LGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        46 LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ||+|+||+||++.. .+++.+|+|.+....   ......+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999954 568999999986432   22234567899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeee
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR  201 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~  201 (400)
                      .+++.....  ..+++..++.++.|++.||.|||..+   ++||||+|+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~  153 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG  153 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence            999875432  24888999999999999999999998   99999999999999999999999999876543221  222


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccCccCCCCCcH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELADPRLNGNFVE  280 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (400)
                      ..++..|+|||.+.++.++.++||||||+++|+|++|+.||...... ....+....        ..  ...    ....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~--~~~----~~~~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--------LE--MAV----EYPD  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--------cc--ccc----cCCc
Confidence            34788999999999888999999999999999999999999654321 000000000        00  000    0111


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015797          281 EELKRVVLVALTCAHSKPEKRP-----TMLEVLD  309 (400)
Q Consensus       281 ~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  309 (400)
                      .....+.+++.+||+.||.+||     ++.+++.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            1234677889999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.1e-39  Score=306.64  Aligned_cols=266  Identities=20%  Similarity=0.307  Sum_probs=196.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEE----eCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCA----EGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~  109 (400)
                      ..+|++.+.||.|++|.||+|.. .++..||+|++....  ......+..|+.+++.++||||+++++++.    .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            47899999999999999999954 569999999987532  223456778999999999999999999875    34568


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+. |+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999996 68998886432    3889999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCce---eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhh--hccccch--h
Q 015797          190 LIPDGATH---VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI--TDWALPL--A  261 (400)
Q Consensus       190 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~--~~~~~~~--~  261 (400)
                      ........   ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........  .....|.  .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            65432211   1123458899999998865 4689999999999999999999999965432110000  0000000  0


Q ss_pred             ----cccccccccC---ccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 ----CERKFSELAD---PRLN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ----~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          ....+.....   ....   ..........+.+++.+||+.+|.+|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                0000000000   0000   00112234678889999999999999999999974

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-39  Score=306.22  Aligned_cols=265  Identities=20%  Similarity=0.284  Sum_probs=196.8

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----C
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----Q  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~  107 (400)
                      ..++|.+.+.||+|+||+||+|.+ .++..||+|.+...  .......+..|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            356899999999999999999954 56899999988642  223344677899999999999999999987654     3


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..|+||||+. ++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence            4799999996 68988886432    3888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhh---ccccc---
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TIT---DWALP---  259 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~---~~~~~---  259 (400)
                      +........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .+.   ....+   
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         155 ARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             ccccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            986543321 1223458899999998865 56899999999999999999999999654321000 000   00000   


Q ss_pred             -hhccccccccc-------CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 -LACERKFSELA-------DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 -~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ...........       ..... ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence             00000000000       00000 0011234567889999999999999999999975

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.4e-38  Score=297.42  Aligned_cols=264  Identities=20%  Similarity=0.230  Sum_probs=193.5

Q ss_pred             CCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      |.+++.+|.|+++.||++. .++..+|+|++...  .......+..|+.+++.++||||+++++++.+++..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            3455556666666666664 37999999998754  34445678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc-
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-  196 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~-  196 (400)
                      +|+|.+++......  .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||.+........ 
T Consensus        83 ~~~l~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          83 YGSCEDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CCCHHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99999998754322  3788889999999999999999998   99999999999999999999999999875432111 


Q ss_pred             -----eeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhcc--------ccc
Q 015797          197 -----HVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDW--------ALP  259 (400)
Q Consensus       197 -----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~--------~~~  259 (400)
                           .......++..|+|||++.+  ..++.++|||||||++|+|++|..||........  ......        ..+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                 11122347788999999876  3588999999999999999999999975432211  000000        000


Q ss_pred             hhccccccc----ccCc----cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LACERKFSE----LADP----RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .... ....    ...+    .............+.+++.+||..||++|||+.++++.
T Consensus       238 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         238 LYED-SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhcC-CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000 0000    0000    00011122234567889999999999999999999973

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-38  Score=295.05  Aligned_cols=242  Identities=22%  Similarity=0.256  Sum_probs=184.4

Q ss_pred             cccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHH---HhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           45 KLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEI---LARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~---l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      .||+|+||.||++.. .+++.+|+|.+....   ......+..|..+   +...+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 468899999886432   1122233444433   334579999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            999999886443    3899999999999999999999998   99999999999999999999999999875533221 


Q ss_pred             eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCC
Q 015797          198 VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                        ....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..........+.....          .....   
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~---  217 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TVNVE---  217 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------cCCcC---
Confidence              22358999999999864 568999999999999999999999997543211111100000          00011   


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                       ........+.+++.+||..||.+||     |+.++++.
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             1112234677888999999999999     59999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=288.86  Aligned_cols=247  Identities=27%  Similarity=0.412  Sum_probs=201.0

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|++.+.||+|++|.||+|.+ .+++.+++|.+.....  .....+..|+++++.++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            588999999999999999954 4688999999875443  4456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999987542    4899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      .. .....++..|+|||.+.+..++.++||||||+++|+|++|..||............    .   ...     .+.  
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~----~---~~~-----~~~--  218 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI----V---QDD-----HPP--  218 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----h---ccC-----CCC--
Confidence            32 22345889999999998888999999999999999999999999754321110000    0   000     000  


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ........+..++.+||..+|++|||+.+++.
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              11112346778889999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-39  Score=321.88  Aligned_cols=272  Identities=21%  Similarity=0.263  Sum_probs=187.5

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc--CCCEEEEEEEe-----------------cCChHHHHHHHHHHHHHhcCCCCc
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW--DGSQIAVKRLK-----------------VWSNKAEMEFAVEVEILARVRHKN   95 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~l~-----------------~~~~~~~~~~~~E~~~l~~l~hpn   95 (400)
                      ...++|++++.||+|+||.||++...  .+...+.|.+.                 .........+..|+.+|+.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34579999999999999999998532  22222222110                 011223345788999999999999


Q ss_pred             cceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCc-ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797           96 LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSS-ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus        96 Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                      |+++++++...+..|+|++++. ++|.+++...... ........+..++.|++.||.|||+++   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999995 5787776533211 112334567789999999999999998   9999999999999


Q ss_pred             CCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCC-Chhhhhhh----h
Q 015797          175 DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK-PIEKVNSA----I  249 (400)
Q Consensus       175 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~-Pf~~~~~~----~  249 (400)
                      +.++.+||+|||++..+............||+.|+|||++.+..++.++|||||||++|||++|.. ||......    .
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999998765433333334569999999999999999999999999999999999875 44322111    1


Q ss_pred             hhhhhccccc-hhccc---ccccccCcc-C--CCCCcHH------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          250 KRTITDWALP-LACER---KFSELADPR-L--NGNFVEE------ELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       250 ~~~~~~~~~~-~~~~~---~~~~~~~~~-~--~~~~~~~------~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...+...... ...+.   .+...+... .  .......      ...++.+++.+||+.||.+|||+.|++..
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1100000000 00000   000000000 0  0000000      12356677899999999999999999973

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-38  Score=297.57  Aligned_cols=246  Identities=28%  Similarity=0.420  Sum_probs=193.8

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..|...+.||.|++|.||+|.. .++..+++|.+...   .......+..|+++++.++|||++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4477788999999999999965 46788999988642   2233456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+. |+|.+.+.....   .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 688887754322   3788999999999999999999998   99999999999999999999999999876533


Q ss_pred             CCceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhccccchhcccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDWALPLACERKFSEL  269 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  269 (400)
                      .     ....+++.|+|||.+.   .+.++.++|||||||++|+|++|..||.......... ......           
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------  231 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------  231 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----------
Confidence            2     1234889999999985   3567899999999999999999999986543211110 000000           


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                        +...   .......+.++|.+||+.+|.+||++.++++..
T Consensus       232 --~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 --PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              0000   112234677888999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=288.85  Aligned_cols=242  Identities=22%  Similarity=0.252  Sum_probs=185.8

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEEecCChH---HHHHHHHHHHHH-hcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK---AEMEFAVEVEIL-ARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||.|++|.||+|.. .+++.||+|.+......   ....+..|..++ ..++||||+++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999954 46899999998643221   122344454444 456899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      ++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999986533    3788899999999999999999998   99999999999999999999999999875432     


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                      .....|++.|+|||.+.+..++.++||||||+++|+|+||..||........ .....        ....      ....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~------~~~~  215 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS--------RRIN------WPEE  215 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------cccC------CCCc
Confidence            1223488999999999988899999999999999999999999975432211 00000        0000      0000


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                      ........+.+++.+||+.+|++||++.++.+.|
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            1112235788899999999999999776554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.3e-38  Score=298.34  Aligned_cols=268  Identities=20%  Similarity=0.281  Sum_probs=193.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----  107 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----  107 (400)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|.+.....  .....+..|+.+++.++||||+++++++....    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3446899999999999999999965 4689999998864322  22335667999999999999999999987654    


Q ss_pred             ----eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          108 ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       108 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                          ..++||||+. ++|.+.+....   ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEEC
Confidence                4599999996 58888776432   23889999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCce---eeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh----hhc
Q 015797          184 DFGFAKLIPDGATH---VTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRT----ITD  255 (400)
Q Consensus       184 Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~----~~~  255 (400)
                      |||++.........   ......++..|+|||.+.+. .++.++||||||+++|+|+||+.||..........    +..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999765432211   11223478899999988764 47899999999999999999999996543211100    000


Q ss_pred             cccchhccc-----ccccccCccCCCCCcH------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          256 WALPLACER-----KFSELADPRLNGNFVE------EELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       256 ~~~~~~~~~-----~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ...+...+.     .......+........      .....+.+++.+||..||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000000000     0000000000000000      01235678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-38  Score=303.78  Aligned_cols=264  Identities=21%  Similarity=0.279  Sum_probs=199.9

Q ss_pred             CCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC-----eEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ-----ERL  110 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~  110 (400)
                      +|++.+.||.|++|.||+|... ++..+|+|.+....  ......+..|+.+++.++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6899999999999999999654 58999999987533  334457888999999999999999999988775     789


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ++|||+. ++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 58888886433    4889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCc--eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhcc-ccch--h--
Q 015797          191 IPDGAT--HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDW-ALPL--A--  261 (400)
Q Consensus       191 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~-~~~~--~--  261 (400)
                      ......  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......... .+... ..+.  .  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            654321  112234588999999999887 8899999999999999999999999755432110 00000 0000  0  


Q ss_pred             --cccccccccC---ccC---CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 --CERKFSELAD---PRL---NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 --~~~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ..........   ...   .....+.....+.+++.+||+.+|.+|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              0000000000   000   000111134567889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-38  Score=303.72  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=195.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC--ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC--CeE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW--SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG--QER  109 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~  109 (400)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+...  .......+..|+.+++.+ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4678999999999999999999654 6889999988532  223344577899999999 999999999998653  468


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+. ++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 5999888643     3788899999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCce----eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccc-cch--
Q 015797          190 LIPDGATH----VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWA-LPL--  260 (400)
Q Consensus       190 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~-~~~--  260 (400)
                      ........    ......|++.|+|||.+.+ ..++.++||||||+++|+|+||+.||........ ....... .+.  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            66433221    1223458999999998765 5678999999999999999999999964332110 0000000 000  


Q ss_pred             -------hccc-ccccccCcc--CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 -------ACER-KFSELADPR--LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 -------~~~~-~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                             .... .+.......  ......+.....+.+++.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   0000 000000000  0000111124578889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.8e-38  Score=289.50  Aligned_cols=251  Identities=24%  Similarity=0.278  Sum_probs=192.8

Q ss_pred             cHHHHHHHccCCCcCCcc--cccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           29 SLKELHSATNNFNYDNKL--GEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        29 ~~~~~~~~~~~y~~~~~L--G~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      +..++....++|.+.+.+  |.|+||.||++.. .++..+|+|.+........     |+.....+ +||||+++++.+.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            345556667888888887  9999999999954 5688899998864322111     22222222 7999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEE
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVA  183 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~  183 (400)
                      ..+..++||||+++|+|.+++....    .+++..++.++.|+++||.|||+.+   ++||||||+||+++.++ .++|+
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence            9999999999999999999987543    4899999999999999999999998   99999999999999998 99999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE  263 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  263 (400)
                      |||++.......     ...|++.|+|||++.+..++.++||||||+++|+|++|..||......... ...+.      
T Consensus       153 dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~------  220 (267)
T PHA03390        153 DYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLL------  220 (267)
T ss_pred             cCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHH------
Confidence            999987654321     234899999999999999999999999999999999999999744321100 00000      


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-MLEVLD  309 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~ell~  309 (400)
                      .......      .........+.+++.+||+.+|.+||+ +.++++
T Consensus       221 ~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        221 KRQQKKL------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HhhcccC------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            0000000      011123346788889999999999996 698885

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.7e-38  Score=297.42  Aligned_cols=262  Identities=22%  Similarity=0.286  Sum_probs=191.5

Q ss_pred             Cccccc--CceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEG--GFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G--~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      ..||.|  +||+||+|.+ .+++.||+|++....  ......+..|+.+++.++||||++++++|..+...++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999965 579999999987432  33345688899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++......  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999988764322  3788889999999999999999998   9999999999999999999999998654332111100


Q ss_pred             ------eeecccccCcCChhhhccC--CCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhc-cccch-------
Q 015797          199 ------TTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITD-WALPL-------  260 (400)
Q Consensus       199 ------~~~~~gt~~y~aPE~~~~~--~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~-~~~~~-------  260 (400)
                            .....++..|+|||++.+.  .++.++|||||||++|+|++|..||........  ..+.. ...|.       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  0112256679999999764  478999999999999999999999975432111  00000 00000       


Q ss_pred             hcc---------------ccc-----ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 ACE---------------RKF-----SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 ~~~---------------~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...               ...     .......+...........+.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            000               000     00000111111122345678899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=336.70  Aligned_cols=255  Identities=29%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             HHHHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      +...+-++..+..||.|.||.||.| ...+|...|+|-+......  ......+|+.+|..++|||+|++||+-.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            4556678888899999999999999 4567999999988643332  234577899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +|.||||.+|+|.+.+....    ..++.....+..|++.|++|||++|   ||||||||.||+++.+|.+|++|||.+.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence            99999999999999886332    2555566667889999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCcee---eeecccccCcCChhhhccC---CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchh
Q 015797          190 LIPDGATHV---TTRVKGTLGYLAPEYAMLG---KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLA  261 (400)
Q Consensus       190 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~  261 (400)
                      .+.......   .....||+.|||||++.+.   .-..+.|||||||++.||+||+.||......  +.-.+.....|  
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P-- 1460 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP-- 1460 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC--
Confidence            876543222   1235699999999999764   3467899999999999999999999876532  11111111111  


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                                     .+.......=.+++..||..||.+|.++.||++.-
T Consensus      1461 ---------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 ---------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             ---------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence                           11222334556788999999999999999998753

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.2e-38  Score=293.41  Aligned_cols=256  Identities=18%  Similarity=0.232  Sum_probs=183.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecCChHHH-----------HHHHHHHHHHhcCCCCccceee
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWSNKAE-----------MEFAVEVEILARVRHKNLLSLR  100 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~~~  100 (400)
                      ..++|.+.+.||+|+||.||+|....    +..+|+|+.........           .....+...+..+.|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34789999999999999999996543    34566665432221110           1122344556677999999999


Q ss_pred             eEEEeCC----eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC
Q 015797          101 GYCAEGQ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA  176 (400)
Q Consensus       101 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~  176 (400)
                      +++....    ..+++++++. .++.+.+....    ..++..+..++.|++.||.|||+.+   ++||||||+|||++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            9765543    3467888874 46666654322    2567778899999999999999998   999999999999999


Q ss_pred             CCcEEEEecCCccccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-
Q 015797          177 DFKAQVADFGFAKLIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-  249 (400)
Q Consensus       177 ~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-  249 (400)
                      ++.++|+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... 
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999865422111      1122359999999999999999999999999999999999999997653211 


Q ss_pred             -hhhh-hccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          250 -KRTI-TDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       250 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                       .... .++.         ..+..+...   .+.....+.+++..||+.+|++||++.+|++.|
T Consensus       242 ~~~~~~~~~~---------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAAKCDFI---------KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHhHHHHH---------HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence             0000 0000         000000000   011235678888999999999999999999876

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.7e-38  Score=293.59  Aligned_cols=253  Identities=24%  Similarity=0.297  Sum_probs=195.4

Q ss_pred             CCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecCC----hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS----NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  109 (400)
                      +|++.+.||+|++|.||++..    .++..+|+|.+....    ......+..|+.++..+ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478899999999999999853    357889999986422    22234577899999999 699999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999886432    3788899999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCC--CCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      ..............|++.|+|||.+.+..  .+.++||||||+++|+|+||..||....... ...+...        ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~  225 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR--------IL  225 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH--------HH
Confidence            65443322222345899999999987765  7889999999999999999999996322110 0000000        00


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ..  .+...    ......+.+++.+||+.||++|||+.++.+.|.
T Consensus       226 ~~--~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         226 KS--KPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             cc--CCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            00  00011    111235677889999999999999887776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.3e-38  Score=290.04  Aligned_cols=243  Identities=23%  Similarity=0.314  Sum_probs=192.2

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           46 LGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        46 LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ||.|+||.||++... +++.+++|.+.....   .....+..|+++++.++||||+++++.+..+...|++|||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999654 599999999865433   3445688899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc-----
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-----  196 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~-----  196 (400)
                      .+++....    .+++..++.++.|++.||.|||..+   ++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99987543    3888999999999999999999998   99999999999999999999999999875433211     


Q ss_pred             --eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCcc
Q 015797          197 --HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       197 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                        .......++..|+|||.+.+..++.++||||||+++|+|++|..||........ .....        ....   .+ 
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~---~~-  221 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--------GKIE---WP-  221 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------CCcC---CC-
Confidence              112234588899999999988899999999999999999999999975442211 01100        0000   00 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                          ........+.+++.+||+.+|.+|||+..+.+.|
T Consensus       222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         222 ----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ----ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                0000135778899999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-37  Score=294.82  Aligned_cols=244  Identities=29%  Similarity=0.418  Sum_probs=191.5

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      |...+.||+|+||.||+|.. .++..+++|.+....   ......+..|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            56677899999999999964 568899999986432   23334678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +. |+|.+++.....   .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 588887754332   3889999999999999999999998   99999999999999999999999999864322  


Q ss_pred             ceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          196 THVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                         .....|+..|+|||++.   .+.++.++|||||||++|+|++|..||.............       ....     +
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-------~~~~-----~  238 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QNDS-----P  238 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------hcCC-----C
Confidence               12345889999999984   4668899999999999999999999987544211110000       0000     0


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...   .......+.+++.+||+.+|.+||++.+++..
T Consensus       239 ~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 TLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000   11112357778899999999999999999963

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-38  Score=304.54  Aligned_cols=264  Identities=19%  Similarity=0.261  Sum_probs=194.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC---------
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG---------  106 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---------  106 (400)
                      .++|.+.+.||.|+||.||+|.. .++..||+|.+..........+..|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            57999999999999999999954 56899999998766655566788999999999999999999876543         


Q ss_pred             -----CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcE
Q 015797          107 -----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKA  180 (400)
Q Consensus       107 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~  180 (400)
                           ...|+||||+. ++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||||+||+++. ++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence                 35789999997 5888877532     3788999999999999999999998   999999999999974 5678


Q ss_pred             EEEecCCccccCCCCce--eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccc
Q 015797          181 QVADFGFAKLIPDGATH--VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWA  257 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~  257 (400)
                      +|+|||++.........  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...............
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999765432111  1122347889999998754 56789999999999999999999999754422111100000


Q ss_pred             cchhcccc-------cccccC-ccCCC-----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          258 LPLACERK-------FSELAD-PRLNG-----NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       258 ~~~~~~~~-------~~~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .|......       +..... .....     .........+.+++.+||+.||.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000000       000000 00000     001112356778999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=288.96  Aligned_cols=261  Identities=24%  Similarity=0.347  Sum_probs=194.1

Q ss_pred             CCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh--HHHHHHHHHHHHHhcC---CCCccceeeeEEEeCCe-----
Q 015797           40 FNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN--KAEMEFAVEVEILARV---RHKNLLSLRGYCAEGQE-----  108 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~-----  108 (400)
                      |++.+.||.|+||.||+|... ++..+|+|.+.....  .....+..|+.+++.+   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999764 589999999874322  2233456677776655   69999999999988776     


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .+++|||++ ++|.+++.....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999997 489888865432  24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhcccc------ch
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWAL------PL  260 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~------~~  260 (400)
                      ........  .....++..|+|||.+.+..++.++|||||||++|+|++|..||.......  .........      +.
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            77643322  122347889999999999999999999999999999999999987544211  000000000      00


Q ss_pred             hc---ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          261 AC---ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       261 ~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..   ...+...... ......+.....+.+++.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPR-SFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             Ccccchhhccccccc-chhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00   0000000000 001122334467788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3e-38  Score=293.03  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=200.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|.+.+.||.|++|.||+|.. .++..+++|++...   .......+..|+.+++.++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4799999999999999999965 47999999998642   2233456788999999998 99999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+.+++|.+++....    .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999987543    4899999999999999999999998   9999999999999999999999999988654


Q ss_pred             CCCc-------------------eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hh
Q 015797          193 DGAT-------------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RT  252 (400)
Q Consensus       193 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~  252 (400)
                      ....                   .......++..|+|||.+.+..++.++||||||+++++|++|..||........ ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK  233 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            3221                   111224578999999999988899999999999999999999999975542110 00


Q ss_pred             hhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 015797          253 ITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM----LEVLD  309 (400)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~ell~  309 (400)
                      ...        ..+          .........+.+++.+||+.+|++||++    .++++
T Consensus       234 ~~~--------~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 ILK--------LEY----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHh--------cCC----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            000        000          0111113467889999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.9e-38  Score=292.35  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=193.4

Q ss_pred             CCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecCCh----HHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWSN----KAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  109 (400)
                      +|++.+.||.|+||.||.|..    .+|..||+|++.....    .....+..|++++..+ +||||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            588899999999999999965    3688999999874322    2235677899999999 689999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+||||+++++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999986543    3778888999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccC--CCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKF  266 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~  266 (400)
                      ..............|+..|+|||.+.++  .++.++||||||+++|+|+||..||........ .......         
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---------  224 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI---------  224 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh---------
Confidence            6543322222234589999999998753  468899999999999999999999864321100 0000000         


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  309 (400)
                      ... .+.    ........+.+++.+||+.||.+||     ++.+++.
T Consensus       225 ~~~-~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         225 LKS-EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hcc-CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            000 000    0111234677888999999999997     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.9e-38  Score=290.36  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=194.1

Q ss_pred             CCCcCCcccccCceEEEEEEEc-CCCEEEEEEEec-----CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKV-----WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +|.+.+.||+|+||.||++.+. .+..+++|+++.     ........+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            6889999999999999999653 345556665542     1223344577899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988653333345899999999999999999999998   999999999999975 569999999987654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ......             ...
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-------------~~~  222 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-------------GPT  222 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------CCC
Confidence            3222 1223458899999999988889999999999999999999999996432210 000000             000


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +    .........+.++|.+||..+|++||++.++++
T Consensus       223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 P----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             C----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            0    111223457788999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=325.88  Aligned_cols=210  Identities=26%  Similarity=0.340  Sum_probs=187.2

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec---CChHHHHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      +.++.-...+|.++++||+|+||.|..++. .+++.+|+|+++.   ....+..-|..|-.+|..-+.+-|+.++-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            455667788999999999999999999964 5688999999986   333445568889999999999999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      +.++|+||||++||+|..++....    .+++.-+..++..++.||.-||+.|   +|||||||+|||+|..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999997654    3888889999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhc----c-CCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAM----L-GKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      |.|..+.......+...+|||-|++||+++    + +.|++.+|+||+||++|||+.|..||....
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            999988866666666778999999999996    3 678999999999999999999999997554

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.6e-38  Score=299.57  Aligned_cols=267  Identities=23%  Similarity=0.298  Sum_probs=196.0

Q ss_pred             HHccCCCc-CCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH--------------HHHHHHHHHHHhcCCCCccce
Q 015797           35 SATNNFNY-DNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA--------------EMEFAVEVEILARVRHKNLLS   98 (400)
Q Consensus        35 ~~~~~y~~-~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~   98 (400)
                      +..++|.. .+.||.|+||.||+|.+ ..++.||+|.+.......              ...+..|+.+++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            45678864 57799999999999964 468999999986432211              124678999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797           99 LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      +++++..++..++||||+. |+|.+++....    .+++.....++.|++.||.|||+.+   ++||||+|+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKG  156 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCC
Confidence            9999999999999999997 69999886432    3788999999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCccccCCCC-------------ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhh
Q 015797          179 KAQVADFGFAKLIPDGA-------------THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEK  244 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~  244 (400)
                      .++|+|||++.......             ........+++.|+|||.+.+. .++.++|||||||++|+|+||..||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999997654110             0111122468899999998764 468999999999999999999999975


Q ss_pred             hhhhhh-hhh-hccccchh--ccc--c---ccc---ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          245 VNSAIK-RTI-TDWALPLA--CER--K---FSE---LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       245 ~~~~~~-~~~-~~~~~~~~--~~~--~---~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+.... ..+ .....|..  +..  .   ...   ....... .........+.+++.+||+.+|++|||+.+++..
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            542210 000 00000000  000  0   000   0000000 0011224567889999999999999999999963

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-37  Score=288.74  Aligned_cols=242  Identities=22%  Similarity=0.256  Sum_probs=184.9

Q ss_pred             cccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHH---HHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           45 KLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVE---VEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E---~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      .||+|+||.||+|.. .+++.||+|.+.....   .....+..|   +..++...||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999954 5688999998864321   112223333   344555689999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++....    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........ 
T Consensus        81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            999999886432    4899999999999999999999998   99999999999999999999999999876543221 


Q ss_pred             eeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                        ....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||..............          .......+..
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~  220 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------TLTMAVELPD  220 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH----------hhccCCCCCC
Confidence              223589999999999754 689999999999999999999999975422110000000          0000011111


Q ss_pred             CCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          277 NFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       277 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                          .....+.+++.+||..+|.+||     ++.++++.
T Consensus       221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                1134677888999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-38  Score=300.70  Aligned_cols=270  Identities=21%  Similarity=0.248  Sum_probs=199.6

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      +....++..+.++|.+.+.||+|+||.||+|.. .+++.||+|++....  ......+..|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            344566778889999999999999999999954 578999999986432  22345677899999999999999999988


Q ss_pred             EeC------CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC
Q 015797          104 AEG------QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD  177 (400)
Q Consensus       104 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~  177 (400)
                      ...      ...|++++++ +++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~  156 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED  156 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence            543      3467888877 78998877532     2888999999999999999999998   9999999999999999


Q ss_pred             CcEEEEecCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhc
Q 015797          178 FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITD  255 (400)
Q Consensus       178 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~  255 (400)
                      +.++|+|||++......    .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...+..
T Consensus       157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998764322    123458899999999876 568899999999999999999999996433210 000000


Q ss_pred             ---cccchhccc-------c----cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          256 ---WALPLACER-------K----FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       256 ---~~~~~~~~~-------~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ...+.....       .    +......... .........+.+++.+||+.||.+||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence               000000000       0    0000000000 0000123467889999999999999999999974

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-38  Score=300.60  Aligned_cols=250  Identities=21%  Similarity=0.347  Sum_probs=204.2

Q ss_pred             HHHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..-.+.|.+.+.||+|.|+.|.+|. ..++..||||.+....  ......+.+|+++|..|+|||||+++++......+|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            3446889999999999999999995 4679999999997533  333456889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+.+|.+.+++.....    +....+..++.|++.|++|||.++   |||||||++|||++.+..+||+|||++..
T Consensus       132 lV~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence            99999999999999987654    555788889999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  268 (400)
                      +..+  ....+.+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++.+... .....        .+++. 
T Consensus       205 ~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--------~gk~r-  273 (596)
T KOG0586|consen  205 FDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--------RGKYR-  273 (596)
T ss_pred             eccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--------eeeec-
Confidence            7633  33456789999999999998877 589999999999999999999998654211 01100        00100 


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           + ..+..   .+.-++|.+++-.+|.+|++..++.+.
T Consensus       274 -----I-p~~ms---~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  274 -----I-PFYMS---CDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -----c-cceee---chhHHHHHHhhccCccccCCHHHhhhh
Confidence                 0 00111   244556688888999999999999874

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.2e-38  Score=295.17  Aligned_cols=266  Identities=24%  Similarity=0.304  Sum_probs=193.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCAEGQ------  107 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------  107 (400)
                      .++|++.+.||.|++|.||+|.. .+++.+|+|.+......  ....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            58999999999999999999964 46899999998643322  2345678999999999999999999875433      


Q ss_pred             --eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          108 --ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       108 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                        ..++||||+. ++|...+....   ..+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence              4699999996 47777765432   24899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCce----------eeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhh
Q 015797          186 GFAKLIPDGATH----------VTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTI  253 (400)
Q Consensus       186 gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~  253 (400)
                      |++.........          ......+++.|+|||.+.+. .++.++|||||||++|+|++|++||....... ...+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211          11223578899999988654 58999999999999999999999997544221 0110


Q ss_pred             hc-cccch----hccccccccc----CccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          254 TD-WALPL----ACERKFSELA----DPRLNGN---FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       254 ~~-~~~~~----~~~~~~~~~~----~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .. +..+.    .....+....    .......   ........+.+++.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00 00000    0000000000    0000000   00112256888999999999999999999985

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.8e-37  Score=289.63  Aligned_cols=254  Identities=25%  Similarity=0.387  Sum_probs=192.3

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN-KAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ...++|++.+.||+|++|.||+|.+. +++.+|+|.+..... .....+..|+.++..+ .||||+++++++.++...|+
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            34577899999999999999999754 489999999875332 2334566677766666 59999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|||+. ++|.+++.....   .+++..+..++.|++.||.|||+ .+   ++||||+|+||+++.++.+||+|||++..
T Consensus        92 v~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EeeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence            999985 577776654322   48889999999999999999997 46   99999999999999999999999999876


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCC----CCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGK----ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF  266 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  266 (400)
                      .......  ....+++.|+|||.+.+..    ++.++||||||+++|+|++|+.||........ ........     ..
T Consensus       165 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~-----~~  236 (296)
T cd06618         165 LVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTKILQE-----EP  236 (296)
T ss_pred             ccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHHHhcC-----CC
Confidence            5432221  2234788999999987554    78999999999999999999999965322110 00000000     00


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           +....  .......+.+++.+||+.||.+||++.++++.
T Consensus       237 -----~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 -----PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -----CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 00000  00123467888999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.6e-38  Score=298.20  Aligned_cols=265  Identities=22%  Similarity=0.272  Sum_probs=196.0

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe-CCe
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE-GQE  108 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~  108 (400)
                      +..++++|++.+.||.|+||.||+|.. .++..+|+|.+...  .......+..|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            455789999999999999999999954 57999999987532  22234567789999999999999999999866 567


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .+++|||+ +++|.+++...     .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence            89999998 56898887532     2677888889999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhcccc--ch-hc-
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWAL--PL-AC-  262 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~--~~-~~-  262 (400)
                      .......    ....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||......... .......  +. .. 
T Consensus       156 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         156 RIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             cccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            7543211    22347889999998765 56899999999999999999999999654321100 0000000  00 00 


Q ss_pred             ---cccccccc-CccCCCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          263 ---ERKFSELA-DPRLNGN-----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       263 ---~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ......+. .......     ..+.....+.++|.+||+.+|++|||+.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000000 0000000     001123578889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=306.98  Aligned_cols=202  Identities=29%  Similarity=0.446  Sum_probs=172.8

Q ss_pred             cCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC------eE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ------ER  109 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~  109 (400)
                      ..|...+.||+|+||.||+|+ ..+|+.||||.++... ....+....|+++|++|+|||||+++++-++..      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            445667899999999999997 4679999999987633 334556778999999999999999998765544      45


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC--CCCc--EEEEec
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD--ADFK--AQVADF  185 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~--~~~~--~kl~Df  185 (400)
                      .+|||||+||||...|..-.+ ...+++.+.+.++.+++.||.|||.++   |+||||||.||++-  .+|+  .||+||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             eEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence            799999999999999975433 346999999999999999999999998   99999999999994  3344  899999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      |.|+.+.++.  .....+||+.|++||++.. +.|+...|.|||||++|+.+||..||...
T Consensus       169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            9999887655  4666789999999999984 88999999999999999999999999654

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=289.49  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=194.6

Q ss_pred             CCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEEEEcc
Q 015797           40 FNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN-KAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      |.+.+.||.|++|.||+|... +++.+++|.+..... ........|+..++.++ ||||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            678899999999999999654 578899998864322 22334557899999998 999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                       +|+|.+.+.....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             7899998875431  24899999999999999999999998   99999999999999999999999999986543222


Q ss_pred             eeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhc---------cccchhcccc
Q 015797          197 HVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITD---------WALPLACERK  265 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~---------~~~~~~~~~~  265 (400)
                        .....++..|+|||.+.. ..++.++||||||+++++|++|+.||........ .....         |.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              223458889999998754 5679999999999999999999999965432110 00000         0000000000


Q ss_pred             cccccCccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELADPRLN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +.........   ....+.....+.+++.+||+.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000   0001111357889999999999999999999985

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-38  Score=299.15  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=190.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC------C
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG------Q  107 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~  107 (400)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|.+....  ......+..|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            48999999999999999999964 468999999886422  22234578899999999999999999998654      3


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..++|+||+. .+|..++. .     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~-~-----~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG-H-----PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence            4689999996 47766542 1     2788899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhc-cccch--hc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITD-WALPL--AC  262 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~-~~~~~--~~  262 (400)
                      +.......    ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...+.. ...+.  ..
T Consensus       164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            87543221    12347889999999876 468999999999999999999999997543210 000000 00000  00


Q ss_pred             ----ccccccccC--ccCCC-C---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          263 ----ERKFSELAD--PRLNG-N---FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       263 ----~~~~~~~~~--~~~~~-~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          .........  +.... .   ..+.....+.+++.+||+.||.+||++.+++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000000000  00000 0   001123467889999999999999999999963

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-37  Score=298.11  Aligned_cols=263  Identities=20%  Similarity=0.276  Sum_probs=195.7

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC--
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ--  107 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  107 (400)
                      +-...++|.+.+.||+|+||.||+|. ..++..||+|++....  ......+..|+.+++.++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            44467899999999999999999995 4578999999985422  223346788999999999999999999987654  


Q ss_pred             ----eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          108 ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       108 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                          ..++||||+ +++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence                458999999 67898887532     3888999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhcc-ccc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDW-ALP  259 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~-~~~  259 (400)
                      |||++.......    ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......  ....... ..+
T Consensus       161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998654322    12347899999999876 458899999999999999999999997543210  0000000 000


Q ss_pred             hhccc------------ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          260 LACER------------KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       260 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .....            .+.......+ ..........+.+++.+|++.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000            0000000000 0001122346788999999999999999999995

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=288.27  Aligned_cols=262  Identities=23%  Similarity=0.298  Sum_probs=197.4

Q ss_pred             CCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           40 FNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      |++.+.||.|++|.||+|... +++.+|+|.+....  ......+..|+.+++.++||||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            677889999999999999654 58999999987543  233456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      . ++|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 59999987543   24889999999999999999999998   99999999999999999999999999986644322


Q ss_pred             eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhc-c--ccchhcc--cc---c
Q 015797          197 HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITD-W--ALPLACE--RK---F  266 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~-~--~~~~~~~--~~---~  266 (400)
                      . .....++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ..+.. .  ..+..+.  ..   .
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            1 1223467889999998876 889999999999999999999999965432100 00000 0  0000000  00   0


Q ss_pred             ccccCccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          267 SELADPRLN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .........   ....+.....+.+++.+||..||++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000   0011112457889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=281.11  Aligned_cols=248  Identities=24%  Similarity=0.324  Sum_probs=197.0

Q ss_pred             HccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .-++|.++++||+|.||.|.+++ ..+++.+|+|+++..   ..++...-..|-++|+..+||.+..+.-.|+....+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            44678899999999999999995 467999999998742   22333455679999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||.+||.|.-.|.+.    ..+++.....+-..|+.||.|||+++   ||+||||.+|.|+|.||++||+|||+|+.-
T Consensus       246 VMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999888643    24888889999999999999999988   999999999999999999999999999753


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      -. ....+.+.+|||.|+|||++....|+.+.|.|.+|+++|||++|+.||...... +...+.-           .   
T Consensus       319 I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-----------e---  383 (516)
T KOG0690|consen  319 IK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-----------E---  383 (516)
T ss_pred             cc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------h---
Confidence            22 223345678999999999999999999999999999999999999999765432 1111100           0   


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                      +-.++... +   .+...|+...|.+||.+|..     +.||.+
T Consensus       384 d~kFPr~l-s---~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  384 DLKFPRTL-S---PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             hccCCccC-C---HHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            00111111 2   23444557788899999964     566664

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.6e-38  Score=317.59  Aligned_cols=252  Identities=29%  Similarity=0.427  Sum_probs=187.1

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC------
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG------  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------  106 (400)
                      .-.++|+....||+||||.||++++ -+|+.+|||++.... ......+.+|+..|++|+|||||++|..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3445677789999999999999965 579999999997653 33345688999999999999999987321100      


Q ss_pred             --------------------------------------------------------------------------------
Q 015797          107 --------------------------------------------------------------------------------  106 (400)
Q Consensus       107 --------------------------------------------------------------------------------  106 (400)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHH
Q 015797          107 ---------------------------------QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY  153 (400)
Q Consensus       107 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~y  153 (400)
                                                       -.+||-||||+..+|.+++..+....   .-...|.++++|++||.|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence                                             13578899999877777776554321   357899999999999999


Q ss_pred             HHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC----C------------CCce-eeeecccccCcCChhhhcc
Q 015797          154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP----D------------GATH-VTTRVKGTLGYLAPEYAML  216 (400)
Q Consensus       154 LH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~----~------------~~~~-~~~~~~gt~~y~aPE~~~~  216 (400)
                      +|+.|   +|||||||.|||+++++.|||+|||++....    .            +... ..+..+||..|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999   9999999999999999999999999998721    0            0011 1233569999999999976


Q ss_pred             C---CCCCccceehhhHHHHHHHhCCCChhhhhh--hhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHH
Q 015797          217 G---KASESCDVYSFGILLLELASGKKPIEKVNS--AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVAL  291 (400)
Q Consensus       217 ~---~~s~ksDIwSlGiil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  291 (400)
                      .   .|+.|+|+|||||||+||+.   ||.....  ..-..+.....|..              .++..+....=..+|.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~--------------~~f~~~~~~~e~slI~  852 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP--------------ADFFDPEHPEEASLIR  852 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC--------------cccccccchHHHHHHH
Confidence            5   49999999999999999986   4543221  11122222222211              1122222334455778


Q ss_pred             hccccCCCCCCCHHHHHH
Q 015797          292 TCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       292 ~cl~~dP~~Rps~~ell~  309 (400)
                      ++++.||.+|||+.|||.
T Consensus       853 ~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHhcCCCccCCCHHHHhh
Confidence            999999999999999996

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-37  Score=298.50  Aligned_cols=264  Identities=22%  Similarity=0.273  Sum_probs=196.6

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe--
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE--  108 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--  108 (400)
                      ....++|.+.+.||.|++|.||+|.. .++..+|+|++...  .......+..|+.+++.++||||+++++++.....  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            34578899999999999999999965 46889999988643  22233557789999999999999999998866554  


Q ss_pred             ----EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          109 ----RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       109 ----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                          .++|+||+ +++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence                89999999 57999988642     3889999999999999999999998   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhcc---ccc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDW---ALP  259 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~---~~~  259 (400)
                      ||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|+||+.||....... ...+...   ..+
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            9999865432    122357889999999865 367899999999999999999999996443210 0000000   000


Q ss_pred             hhcccc----cccc---cCccCCCCC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LACERK----FSEL---ADPRLNGNF---VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~~~~----~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ......    ...+   ........+   .......+.+++.+||+.||.+|||+.+|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000000    0000   000000000   01124578899999999999999999999863

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=277.54  Aligned_cols=237  Identities=30%  Similarity=0.355  Sum_probs=190.9

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           46 LGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        46 LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      ||.|+||.||++... +++.+++|.+.....   .....+..|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999654 589999999875322   2345688899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeee
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR  201 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~  201 (400)
                      .+++....    .+++..+..++.|++.||.|||..+   ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT  152 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence            99987543    3788999999999999999999988   99999999999999999999999999986543321 1223


Q ss_pred             cccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccCccCCCCCcH
Q 015797          202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELADPRLNGNFVE  280 (400)
Q Consensus       202 ~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (400)
                      ..++..|+|||...+...+.++|+||||+++|+|++|..||...... ....+...        .      .    ....
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~------~----~~~~  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--------P------L----RFPE  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--------C------C----CCCC
Confidence            45889999999999888999999999999999999999999654421 11111100        0      0    0111


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCH---HHHH
Q 015797          281 EELKRVVLVALTCAHSKPEKRPTM---LEVL  308 (400)
Q Consensus       281 ~~~~~l~~li~~cl~~dP~~Rps~---~ell  308 (400)
                      .....+.+++.+||..||++||++   .+++
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~  245 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIK  245 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence            113467888999999999999999   5554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.9e-37  Score=292.18  Aligned_cols=262  Identities=20%  Similarity=0.282  Sum_probs=189.6

Q ss_pred             CCCcCCcccccCceEEEEEEEc-C--CCEEEEEEEecC--ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC----Ce
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW-D--GSQIAVKRLKVW--SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG----QE  108 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~-~--~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----~~  108 (400)
                      +|++.+.||+|+||.||++... .  +..+|+|.+...  .......+..|+.+++.+ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5888999999999999999653 3  778999988642  222245677899999999 599999999875432    45


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .+++++|+. ++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788999986 68998886432    3889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCce---eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchh-
Q 015797          189 KLIPDGATH---VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLA-  261 (400)
Q Consensus       189 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~-  261 (400)
                      .........   ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||......  ....+.....+.. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            865432211   1123458999999998765 46899999999999999999999999654311  0000000000000 


Q ss_pred             -----cccc-------cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          262 -----CERK-------FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       262 -----~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                           ....       ........+. ...+.....+.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 0000       0000000000 000112346788999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=303.44  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=214.7

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      ...++.+.+.++-|++.+.||.|.+|.||+++. .+++..|+|++... .+...++..|+++|+.+ .|||++.+||+|.
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            345677888899999999999999999999954 56888888887643 34455688899999988 6999999999985


Q ss_pred             e-----CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          105 E-----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       105 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      .     ++.++||||||.+||..|++.+..  ...+.|..+..|++.++.||.+||...   ++|||||-.|||++.+|.
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCc
Confidence            3     568999999999999999997665  335899999999999999999999887   999999999999999999


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhccC-----CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhh
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-----KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT  254 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~  254 (400)
                      |||+|||++..+...... ..+.+|||+|||||++...     .|+..+|+|||||+..||.-|.+|+.++...-.-...
T Consensus       162 VKLvDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I  240 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  240 (953)
T ss_pred             EEEeeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence            999999999987654333 3445699999999999753     4678999999999999999999999876643111111


Q ss_pred             ccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                    ..+|...-.......+++.++|..||.+|-.+||++.++++.
T Consensus       241 --------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  241 --------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                          111111112344567899999999999999999999999974

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=287.46  Aligned_cols=256  Identities=29%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             HHHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ....+.|+.-++||+||||.||-.+ ..+|.-+|.|.+...   ..........|-++|..++.+.||.+--.|+..+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            3445667888999999999999984 457999999987642   223344577899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+|+..|+||+|.-+|.+..+.  .+++..++.++.+|+.||.+||+.+   ||+||+||+|||+|+.|+++|+|+|++.
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~--gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNP--GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCC--CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence            9999999999999998776654  4999999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .+..+.....  .+||.+|||||+++++.|+...|.|||||+||||+.|+-||.........--.+..          .+
T Consensus       336 ei~~g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr----------~~  403 (591)
T KOG0986|consen  336 EIPEGKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR----------TL  403 (591)
T ss_pred             ecCCCCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH----------Hh
Confidence            8876655432  36999999999999999999999999999999999999999765433222100000          00


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                      .++.   .+.....++..++....|++||.+|..     +.++.+
T Consensus       404 ~~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~  445 (591)
T KOG0986|consen  404 EDPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE  445 (591)
T ss_pred             cchh---hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence            0000   111222234555567778899999976     456655

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=307.72  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=205.0

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcC-CCCccceeeeE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSN-KAEMEFAVEVEILARV-RHKNLLSLRGY  102 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~  102 (400)
                      ++...++..+.+.||.|.||.|++|...        ....||||.++.... .....+..|+++|+.+ .||||+.+.|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3444455567779999999999999532        145789999875433 4556789999999998 69999999999


Q ss_pred             EEeCCeEEEEEEccCCCChhhhhhcCC---Ccc---------cccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 015797          103 CAEGQERLIVYDYMPNLSLLSHLHGQH---SSE---------CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKAS  170 (400)
Q Consensus       103 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~  170 (400)
                      |..++..++|+||+..|+|.++++...   .-.         ..+.....++++.||+.||+||++..   +|||||-.+
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999997665   000         13788899999999999999999987   999999999


Q ss_pred             CeEECCCCcEEEEecCCccccCCCCceeeeeccc--ccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhh-
Q 015797          171 NVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVN-  246 (400)
Q Consensus       171 NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~-  246 (400)
                      |||++.+..+||+|||+++..............|  ...|||||.+....|+.+||||||||+||||+| |..||.... 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999999655444333222223  345999999999999999999999999999999 899997522 


Q ss_pred             -hhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          247 -SAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                       ......+..                 ..+-.....+..++..+|+.||+.+|++||++.++.+.+...
T Consensus       528 ~~~l~~~l~~-----------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TEELLEFLKE-----------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHHHhc-----------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence             111111111                 000011122245788899999999999999999999998764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=279.82  Aligned_cols=267  Identities=25%  Similarity=0.371  Sum_probs=202.1

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHh--cCCCCccceeeeEEEeC----Ce
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILA--RVRHKNLLSLRGYCAEG----QE  108 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~hpnIv~~~~~~~~~----~~  108 (400)
                      ....+-.+.+.||+|.||.||+|+ +.|+.||||++....   +....+|.++..  .|+|+||+.|++.-..+    ..
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~-wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGR-WRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecc-ccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            344566788999999999999997 689999999997543   445666666666  56999999999875443    35


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH-----HHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-----~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                      ++||++|.+.|||.|+|.+.     .++....+.++..+|.||++||     .+|.|.|.|||||+.||||..+|.+-|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            78999999999999999763     3888999999999999999999     4678889999999999999999999999


Q ss_pred             ecCCccccCCCCce---eeeecccccCcCChhhhccCC----C--CCccceehhhHHHHHHHhC----------CCChhh
Q 015797          184 DFGFAKLIPDGATH---VTTRVKGTLGYLAPEYAMLGK----A--SESCDVYSFGILLLELASG----------KKPIEK  244 (400)
Q Consensus       184 Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--s~ksDIwSlGiil~elltg----------~~Pf~~  244 (400)
                      |+||+....+....   .....+||-.|||||++...-    +  -..+||||||.++||++-+          ++||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999876554322   223457999999999996432    1  1368999999999999852          356654


Q ss_pred             hhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .....  .-........|..++...++.   .....+.+..+..+|..||..+|.-|.|+--+.+.|.++.
T Consensus       439 ~Vp~D--Ps~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  439 VVPSD--PSFEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCC--CCHHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            32110  000001112233333322222   2456678899999999999999999999999988886553

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.5e-36  Score=308.95  Aligned_cols=146  Identities=25%  Similarity=0.358  Sum_probs=129.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....   ......+..|+.++..++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999654 68999999986432   23345688899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |||+.+++|.+++....    .+++..++.++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999986432    3788889999999999999999998   9999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=267.19  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=189.1

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH-HHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEcc
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA-EMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      ...+..||.|+.|.|++++. .+|..+|||.+....+.. ..++...+.++... ++|.||+.+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34456799999999999965 458899999997655443 45677777777655 4899999999999999999999998


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      . ..+..++.....   ++++..+-.+...+++||.||-.+.  .|+|||+||+|||+|..|.+||+|||++-.+.++..
T Consensus       174 s-~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  174 S-TCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             H-HHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            4 244444443222   3787778889999999999999876  499999999999999999999999999987655433


Q ss_pred             eeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCcc
Q 015797          197 HVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      +  +...|-+.|||||-+.   ...|+.++|||||||+|+||+||+.||......... +..          +..-.+|.
T Consensus       248 h--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-ltk----------vln~ePP~  314 (391)
T KOG0983|consen  248 H--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LTK----------VLNEEPPL  314 (391)
T ss_pred             c--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HHH----------HHhcCCCC
Confidence            2  2345899999999886   357899999999999999999999999865432110 000          00001122


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +....  .....+.+++..||++|+.+||...++++.
T Consensus       315 L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  315 LPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            21111  022367788899999999999999999974

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=300.88  Aligned_cols=253  Identities=27%  Similarity=0.394  Sum_probs=205.0

Q ss_pred             CcCCcccccCceEEEEEEEc-C----CCEEEEEEEec-CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           41 NYDNKLGEGGFGSVYWGQLW-D----GSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        41 ~~~~~LG~G~~g~Vy~a~~~-~----~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      +.+++||.|+||+||+|-+. .    .-+||+|++.. ...+...++..|+-+|..|+|||+++++++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            56789999999999999653 3    34689998864 34455678999999999999999999999998766 789999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |++.|+|.++++.+..   .+-....+.|..||++||.|||.+.   ++||||-.+||||.+-.++|++|||+++.+...
T Consensus       778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999986433   4788899999999999999999998   999999999999999999999999999987655


Q ss_pred             Cceeeee-cccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          195 ATHVTTR-VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       195 ~~~~~~~-~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ....... ..-.+-|||-|.+....|+++||||||||++||++| |..|+..........+..                .
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle----------------~  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE----------------K  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----------------c
Confidence            4433222 223567999999999999999999999999999999 999998765432211111                1


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ..+-...+....++..+|.+||..|+..||+|+++...+.+..+
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            00111233345678889999999999999999999988776544

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=270.45  Aligned_cols=251  Identities=25%  Similarity=0.285  Sum_probs=192.9

Q ss_pred             HHHccCCCcC-CcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEe----C
Q 015797           34 HSATNNFNYD-NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAE----G  106 (400)
Q Consensus        34 ~~~~~~y~~~-~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~  106 (400)
                      ...+++|.+. ++||-|-.|.|-.. ...+++.+|+|++..     ....++|+++.-.. .|||||.++++|..    .
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            3467888877 57999999999988 456799999998753     23466777765544 69999999998754    3


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEE
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVA  183 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~  183 (400)
                      ..+.+|||.++||.|...+..+...  .+++.++-.|+.||..|+.|||+.+   |.||||||+|+|.+.   +..+||+
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEec
Confidence            4567899999999999999876543  5999999999999999999999998   999999999999964   4569999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-----hhhhhhcccc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-----IKRTITDWAL  258 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-----~~~~~~~~~~  258 (400)
                      |||+++....  .....+.+-||.|.|||++....|+..+|+||+||++|-|++|.+||......     ....+.... 
T Consensus       207 DfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq-  283 (400)
T KOG0604|consen  207 DFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ-  283 (400)
T ss_pred             ccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC-
Confidence            9999986543  22334556899999999999999999999999999999999999999754321     111111100 


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                              .++.+     ..=+...+..-++|+..|..+|.+|.|+.++++.
T Consensus       284 --------y~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  284 --------YEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             --------ccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                    00111     1112233445556678888999999999999974

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5e-36  Score=272.06  Aligned_cols=219  Identities=21%  Similarity=0.214  Sum_probs=173.6

Q ss_pred             cCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhc
Q 015797           49 GGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHG  127 (400)
Q Consensus        49 G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  127 (400)
                      |.+|.||++.+ .+++.+|+|.+....     .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999954 578999999986532     233445555566799999999999999999999999999999999865


Q ss_pred             CCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccC
Q 015797          128 QHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG  207 (400)
Q Consensus       128 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~  207 (400)
                      ..    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||.+.......    ....++..
T Consensus        79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  147 (237)
T cd05576          79 FL----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM  147 (237)
T ss_pred             hc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence            43    3889999999999999999999998   9999999999999999999999999886554321    12236778


Q ss_pred             cCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHH
Q 015797          208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVV  287 (400)
Q Consensus       208 y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  287 (400)
                      |+|||.+.+..++.++||||+|+++|+|++|..|+........                 ......+.    ......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~~~----~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTLNIP----EWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccccCCc----ccCCHHHH
Confidence            9999999888899999999999999999999988753221100                 00000011    11224677


Q ss_pred             HHHHhccccCCCCCCCH
Q 015797          288 LVALTCAHSKPEKRPTM  304 (400)
Q Consensus       288 ~li~~cl~~dP~~Rps~  304 (400)
                      +++.+||+.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            78899999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=281.11  Aligned_cols=269  Identities=27%  Similarity=0.379  Sum_probs=192.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhc--CCCCccceeeeEEEeCC----eEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR--VRHKNLLSLRGYCAEGQ----ERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~----~~~l  111 (400)
                      ....+.+.||+|.||.||+|.. .++.||||++.   ..+...+..|-++.+.  +.|+||++|++.-....    .+.|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            4456778999999999999974 67999999986   3445567777777764  58999999998865444    7899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh------cCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH------HATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~------~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      |++|.+.|+|.++|..+.     ++|.....++.-+++||+|||+      +..|.|+|||||+.||||.+|+++.|+||
T Consensus       286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999998653     9999999999999999999995      33567999999999999999999999999


Q ss_pred             CCccccCCCCce-eeeecccccCcCChhhhccCC-CC-----CccceehhhHHHHHHHhCCCChhh-hhhhhhhhhhccc
Q 015797          186 GFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGK-AS-----ESCDVYSFGILLLELASGKKPIEK-VNSAIKRTITDWA  257 (400)
Q Consensus       186 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDIwSlGiil~elltg~~Pf~~-~~~~~~~~~~~~~  257 (400)
                      |++..+...... .....+||..|||||++.+.- +.     .+.||||+|.+||||+++..-+.. ......-.+....
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999988643322 222356999999999997531 11     368999999999999986543321 0000000000000


Q ss_pred             cchhc-----ccccccccCccCCCCC-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          258 LPLAC-----ERKFSELADPRLNGNF-VEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       258 ~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ...+.     .-.+.+-..|.+.... .-..+..+.+.+..||..||+.|.|+.=+-+++..+.
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            00000     0001111111111100 1133567788899999999999999988887776543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=291.67  Aligned_cols=241  Identities=22%  Similarity=0.311  Sum_probs=191.0

Q ss_pred             HccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhc-CCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR-VRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++..|.+...+|.|+|+.|-.+ ...+++..++|++....    .+...|+.++.. -+||||+++++++.++.+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            5778999999999999999988 45678899999987542    223345544444 48999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-CCCCcEEEEecCCccccC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL-DADFKAQVADFGFAKLIP  192 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv-~~~~~~kl~Dfgl~~~~~  192 (400)
                      |.+.|+-|.+.+....     .....+..|+.+|+.|+.|||.+|   +|||||||+|||+ ++.++++|+|||.++...
T Consensus       396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999999998886543     222677789999999999999999   9999999999999 699999999999999776


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..    ..+.+-|..|.|||++....|+++|||||||++||+||+|+.||....... ..                 ...
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-ei-----------------~~~  525 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-EI-----------------HTR  525 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-HH-----------------HHh
Confidence            54    223346889999999999999999999999999999999999997543320 00                 000


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...+.+.........+|+.+||+.||.+||++.++...
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            00111112223344556689999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-37  Score=278.92  Aligned_cols=244  Identities=26%  Similarity=0.334  Sum_probs=193.7

Q ss_pred             HHHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  108 (400)
                      ..-..+|.++.+||+|+||.|.+| +..+.+.+|||+++..-   .++.+--+.|-++|... +-|.+++++.+|+.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            444578999999999999999999 55678899999987422   12222244577888766 46789999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      +|+||||++||+|.-.+++-..    +.+..+..++..|+-||-+||++|   ||+||||.+|||++.+|++||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence            9999999999999988876543    777888899999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ..--- ....+.+.+|||.|+|||++..++|+.+.|+||||++||||+.|++||++..... .+.+.+-.        . 
T Consensus       498 KEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--------v-  567 (683)
T KOG0696|consen  498 KENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--------V-  567 (683)
T ss_pred             ccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--------C-
Confidence            74211 2223456789999999999999999999999999999999999999998765431 11111100        0 


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT  303 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  303 (400)
                               .+......+.+.+....|.+.|.+|..
T Consensus       568 ---------syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 ---------SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---------cCcccccHHHHHHHHHHhhcCCccccC
Confidence                     122223346667778888899999965

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=267.08  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=192.6

Q ss_pred             CcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           44 NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      +.||+|+|+.|-.+ ...+|..+|||++.........+..+|++++.+. .|+||++++++|+++.++|||||-+.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            68999999999988 5678999999999888777788899999999988 599999999999999999999999999999


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc---EEEEecCCccccCCCC--c
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVADFGFAKLIPDGA--T  196 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~---~kl~Dfgl~~~~~~~~--~  196 (400)
                      ...|..+.    .+++.++..+..+|+.||.+||.+|   |.|||+||+|||......   +||+||.+..-..-..  .
T Consensus       164 LshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  164 LSHIQKRK----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            99997654    3899999999999999999999999   999999999999976655   8999998875432111  1


Q ss_pred             e----eeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          197 H----VTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       197 ~----~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .    ...+.+|+..|||||+..     ...|+.++|.||||+|||-||.|.+||.+.-..    --.|.....|+.-..
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~----dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA----DCGWDRGEVCRVCQN  312 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC----cCCccCCCccHHHHH
Confidence            1    112356888999999874     246899999999999999999999999653211    011222222111111


Q ss_pred             cccCccCCC---------CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNG---------NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+....-.+         .-.+.+.++++   ...+-.||.+|.++.+++..
T Consensus       313 ~LFesIQEGkYeFPdkdWahIS~eakdli---snLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  313 KLFESIQEGKYEFPDKDWAHISSEAKDLI---SNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHHHHHhccCCcCChhhhHHhhHHHHHHH---HHHHhccHHhhhhhhhccCC
Confidence            111110000         11333444444   55555899999999999873

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=282.42  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=197.1

Q ss_pred             ccCCCc--CCcccccCceEEEEEE-EcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNY--DNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~--~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..-|.+  .+.||.|.||+||-|. ..+|+.||||++...  ....+..++.|+.+|.++.||.||.+.-.|+..+.+++
T Consensus       561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV  640 (888)
T KOG4236|consen  561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV  640 (888)
T ss_pred             HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence            334444  3789999999999994 468999999999753  34455779999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC---CcEEEEecCCc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD---FKAQVADFGFA  188 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~---~~~kl~Dfgl~  188 (400)
                      |||-+. |+..+.+......+  +++.....++.||+.||.|||.++   |+|+||||+|||+.+.   -++||+|||++
T Consensus       641 VMEKl~-GDMLEMILSsEkgR--L~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  641 VMEKLH-GDMLEMILSSEKGR--LPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             Eehhhc-chHHHHHHHhhccc--chHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccce
Confidence            999996 57777765444333  888888889999999999999998   9999999999999654   46999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      +.+.+..  ....++|||.|+|||+++++.|...-|+||.|+|+|--+.|..||..... +..++.+...-. ....|.+
T Consensus       715 RiIgEks--FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-IndQIQNAaFMy-Pp~PW~e  790 (888)
T KOG4236|consen  715 RIIGEKS--FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-INDQIQNAAFMY-PPNPWSE  790 (888)
T ss_pred             eecchhh--hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-hhHHhhcccccc-CCCchhh
Confidence            9886433  34457899999999999999999999999999999999999999975432 222222211100 0111221


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                   .....++||...|+..-.+|.|...-+..
T Consensus       791 -------------is~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  791 -------------ISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             -------------cCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence                         22355667778888888999999887763

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.8e-36  Score=267.86  Aligned_cols=206  Identities=23%  Similarity=0.365  Sum_probs=169.8

Q ss_pred             HccCCCcCCcccccCceEEEEE-EEcC----CCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEe-CC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWG-QLWD----GSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAE-GQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a-~~~~----~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~  107 (400)
                      -...|+.+..||+|.||.||+| +.++    ...+|+|.++..+.  ......-+|+.+++.++||||+.+..+|.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3456899999999999999999 4332    23689998875422  223457789999999999999999999877 88


Q ss_pred             eEEEEEEccCCCChhhhhhcCCC-cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC----CcEEE
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD----FKAQV  182 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~----~~~kl  182 (400)
                      .+++++||.+. +|.+.|+-+.. ....++-..+.+|+.||+.|+.|||++-   |+||||||.||||..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence            89999999975 99988853322 2246888899999999999999999987   9999999999999877    99999


Q ss_pred             EecCCccccCCCCcee--eeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          183 ADFGFAKLIPDGATHV--TTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      +|||+++.+.+.-.-.  ...++-|..|.|||++.|. .|+.+.|||+.|||+.||+|-.+-|...
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999999887643322  2346789999999999874 6899999999999999999988877544

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=276.82  Aligned_cols=260  Identities=25%  Similarity=0.348  Sum_probs=195.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHH-------HHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKA-------EMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      .....+|-++.+||+|||+.||+| +....+.||+|+-.......       .....+|.++.+.|+||.||++|++|.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            345578899999999999999999 55668888999865433221       1345679999999999999999999854


Q ss_pred             -CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC---CCCcEE
Q 015797          106 -GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD---ADFKAQ  181 (400)
Q Consensus       106 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~---~~~~~k  181 (400)
                       ...+|-|+|||+|.+|.-+|..+.    .+++.++.+|+.||+.||.||... .++|||-||||.|||+-   ..|.+|
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence             567889999999988888886543    389999999999999999999998 57799999999999994   457899


Q ss_pred             EEecCCccccCCCCce------eeeecccccCcCChhhhccC----CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh
Q 015797          182 VADFGFAKLIPDGATH------VTTRVKGTLGYLAPEYAMLG----KASESCDVYSFGILLLELASGKKPIEKVNSAIKR  251 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~  251 (400)
                      |+|||++.++.+....      .+....||..|++||.+.-+    ..+.|.||||.|||+|+.+.|+.||........-
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            9999999988654332      23345699999999988643    4688999999999999999999999764432111


Q ss_pred             hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          252 TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .-.+...   ....+.....|     ..+   ...-.+|.+||+.--++|....+|..
T Consensus       694 LqeNTIl---kAtEVqFP~KP-----vVs---seAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  694 LQENTIL---KATEVQFPPKP-----VVS---SEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             Hhhhchh---cceeccCCCCC-----ccC---HHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            0000000   00001100111     122   24455779999999999998887764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-36  Score=284.70  Aligned_cols=202  Identities=25%  Similarity=0.339  Sum_probs=171.4

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      -|..++.||-|+||.|.+++. .+...+|+|.+...   ........+.|-.+|..-+++-||++|-.|.++.++|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            355678899999999999954 55778899988642   22333457779999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC-
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-  193 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~-  193 (400)
                      |++||++..+|.+..    .+.+..+..++..+..|+.+.|..|   +|||||||+|||||.+|++||+|||||.-+.- 
T Consensus       710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            999999999987654    3888888999999999999999999   99999999999999999999999999965421 


Q ss_pred             --------CCcee--------------------------------eeecccccCcCChhhhccCCCCCccceehhhHHHH
Q 015797          194 --------GATHV--------------------------------TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLL  233 (400)
Q Consensus       194 --------~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~  233 (400)
                              +....                                ....+||+.|+|||++....|+..+|+||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    00000                                11356999999999999999999999999999999


Q ss_pred             HHHhCCCChhhhhh
Q 015797          234 ELASGKKPIEKVNS  247 (400)
Q Consensus       234 elltg~~Pf~~~~~  247 (400)
                      ||+.|++||.....
T Consensus       863 em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTP  876 (1034)
T ss_pred             HHhhCCCCccCCCC
Confidence            99999999976543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.1e-35  Score=295.69  Aligned_cols=265  Identities=18%  Similarity=0.226  Sum_probs=172.8

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cC----CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeE------EE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WD----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY------CA  104 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~------~~  104 (400)
                      ..++|.+.+.||+|+||.||+|.. .+    +..||+|.+......  .....+  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            678999999999999999999965 34    689999987643221  111111  1222222333322221      24


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCcc----------------cccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSSE----------------CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIK  168 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dik  168 (400)
                      .+...++||||+.+++|.+++......-                .......+..++.|++.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            5677899999999999999886542110                00112345678999999999999998   9999999


Q ss_pred             CCCeEECC-CCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC----------------------CCCCccce
Q 015797          169 ASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG----------------------KASESCDV  225 (400)
Q Consensus       169 p~NIlv~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDI  225 (400)
                      |+|||++. ++.+||+|||++..+............+|+.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999986654433333445689999999976432                      23456799


Q ss_pred             ehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCC------CcHHHHHHHHHHHHhccccCCC
Q 015797          226 YSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN------FVEEELKRVVLVALTCAHSKPE  299 (400)
Q Consensus       226 wSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~  299 (400)
                      |||||+||||+++..|+..........+.....+.   ..+.....+....+      ..........+|+.+||+.||.
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDL---VAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcH---HHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            99999999999988776543222111111100000   00111111110000      0001112345789999999999


Q ss_pred             CCCCHHHHHHH
Q 015797          300 KRPTMLEVLDL  310 (400)
Q Consensus       300 ~Rps~~ell~~  310 (400)
                      +|||+.++++.
T Consensus       440 kR~ta~e~L~H  450 (566)
T PLN03225        440 QRISAKAALAH  450 (566)
T ss_pred             cCCCHHHHhCC
Confidence            99999999984

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=265.91  Aligned_cols=251  Identities=25%  Similarity=0.304  Sum_probs=188.9

Q ss_pred             CCcccccCceEEEEEE-EcCCCEEEEEEEecCCh-HHHHHHHHHHHHHhc-CCCCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           43 DNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSN-KAEMEFAVEVEILAR-VRHKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      ...||.|+||+|++-. ...|+..|||++..... .+..+++.|...... -++||||+|||.+..++..++.||.|. .
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            4689999999999984 45799999999986554 556678888876554 478999999999999999999999996 4


Q ss_pred             Chhhhhh---cCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          120 SLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       120 sL~~~l~---~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ||..+..   .-...  .+++..+-.|....+.||.||-..-  +|||||+||+|||++..|.+||||||++-.+.++..
T Consensus       148 SlDklYk~vy~vq~~--~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKS--RIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA  223 (361)
T ss_pred             hHHHHHHHHHHHHhc--cCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence            7755432   11122  3777777788888899999998754  599999999999999999999999999987654322


Q ss_pred             eeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                        .+.-.|-..|||||-+..  ..|+.+|||||||++|||++||..||..-++...+. ....     .+....+..   
T Consensus       224 --kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql-~~Vv-----~gdpp~l~~---  292 (361)
T KOG1006|consen  224 --KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL-CQVV-----IGDPPILLF---  292 (361)
T ss_pred             --hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH-HHHH-----cCCCCeecC---
Confidence              122348888999998863  358999999999999999999999987654422111 1100     011111111   


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       +.........+..++..|+.+|-+.||...+++++
T Consensus       293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             11122344578889999999999999999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=243.00  Aligned_cols=197  Identities=23%  Similarity=0.375  Sum_probs=167.3

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +|.-.++||+|.||+||+|++ .+++.||+|.+.....+  ......+|+.+|+.|.|.|||+++++...++...+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            566678999999999999965 45889999998754333  345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      |.. +|..+......   .++.....+++.|+++||.++|+++   +.|||+||.|.||+.+|.+||+|||+++.+.-..
T Consensus        83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            974 88887765433   3888899999999999999999998   9999999999999999999999999999876544


Q ss_pred             ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHh-CCCChh
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELAS-GKKPIE  243 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~ellt-g~~Pf~  243 (400)
                      ..... -+-|..|.+|.++.+. -|+++.|+||.|||+.|+.. |++-|.
T Consensus       156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp  204 (292)
T KOG0662|consen  156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_pred             Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence            33332 3479999999999874 58999999999999999998 555454

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.9e-34  Score=260.72  Aligned_cols=236  Identities=29%  Similarity=0.395  Sum_probs=190.3

Q ss_pred             CceEEEEEEEc-CCCEEEEEEEecCChHH-HHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhc
Q 015797           50 GFGSVYWGQLW-DGSQIAVKRLKVWSNKA-EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHG  127 (400)
Q Consensus        50 ~~g~Vy~a~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  127 (400)
                      +||.||+|... +++.+++|++....... ...+..|++.++.++|+||+++++.+......+++|||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999665 58999999987654443 56789999999999999999999999999999999999999999999865


Q ss_pred             CCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccC
Q 015797          128 QHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG  207 (400)
Q Consensus       128 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~  207 (400)
                      ...    +++..++.++.+++.++.|||..+   ++|+||+|+||+++.++.++|+|||.+.......  ......++..
T Consensus        81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 RGR----LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             ccC----CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            432    788999999999999999999998   9999999999999999999999999998765432  2223458899


Q ss_pred             cCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh-hh-hhhhhhccccchhcccccccccCccCCCCCcHHHHHH
Q 015797          208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN-SA-IKRTITDWALPLACERKFSELADPRLNGNFVEEELKR  285 (400)
Q Consensus       208 y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (400)
                      |+|||.+.+..++.++||||||+++++|++|..||.... .. ....+.....+      .   .      .........
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~------~---~------~~~~~~~~~  216 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP------F---P------PPEWKISPE  216 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC------C---c------cccccCCHH
Confidence            999999998889999999999999999999999997522 11 11111100000      0   0      000002347


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHH
Q 015797          286 VVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       286 l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +.+++.+||..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            888999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=282.84  Aligned_cols=251  Identities=25%  Similarity=0.308  Sum_probs=201.8

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCC-CEEEEEEEec---CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDG-SQIAVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .....++.++..||-||||.|=++..... ..+|+|+++.   -.......+..|-++|...+.|.||++|..|.+...+
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            34456777888999999999999965433 3478887763   3445566788899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+.||-|-||.|...|..++.    ++......++..+++|+.|||+++   ||+|||||+|++++.+|.+||.|||+++
T Consensus       496 YmLmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence            999999999999999976653    888888889999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSE  268 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  268 (400)
                      .+..+..  +-+.+|||.|.|||++.+...+.+.|.|||||++|||+||.+||...+.... ..+..             
T Consensus       569 ki~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk-------------  633 (732)
T KOG0614|consen  569 KIGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK-------------  633 (732)
T ss_pred             HhccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh-------------
Confidence            8865543  4457899999999999999999999999999999999999999987653211 11100             


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                      -++..   .+.....+.-.++|++.+..+|.+|..     +.+|.+
T Consensus       634 Gid~i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  634 GIDKI---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             hhhhh---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            00000   122222345566778888899999976     566665

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=266.42  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=196.1

Q ss_pred             ccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC--CCc----cceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR--HKN----LLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--hpn----Iv~~~~~~~~~~~~  109 (400)
                      +++|.+...+|+|.||.|-... ...+..||+|+++.-. .-....+.|+++|..+.  .|+    ++.+.++|.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            7999999999999999999984 3458899999886422 22345677999999993  233    77788889999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-------------
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-------------  176 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-------------  176 (400)
                      |||+|.+ |-|+.++|..+.  -.+++...+..++.|+++++++||+.+   ++|-||||+|||+.+             
T Consensus       167 Civfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            9999998 459999997644  345888999999999999999999998   999999999999932             


Q ss_pred             -------CCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-
Q 015797          177 -------DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-  248 (400)
Q Consensus       177 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-  248 (400)
                             +-.++|+|||.++......    ..++.|..|.|||++.+-.++.++||||+||||+||.||..-|..-.+. 
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   2348999999998643322    3456899999999999999999999999999999999999988543211 


Q ss_pred             ---hhhhhhccccchhcc-------------c--ccccc---------cCccCC----CCCcHHHHHHHHHHHHhccccC
Q 015797          249 ---IKRTITDWALPLACE-------------R--KFSEL---------ADPRLN----GNFVEEELKRVVLVALTCAHSK  297 (400)
Q Consensus       249 ---~~~~~~~~~~~~~~~-------------~--~~~~~---------~~~~~~----~~~~~~~~~~l~~li~~cl~~d  297 (400)
                         ..+.+.+   |.+..             +  .|.+.         .++...    -...+.+...|++|+.+||..|
T Consensus       317 HLaMMerIlG---p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  317 HLAMMERILG---PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             HHHHHHHhhC---CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence               1111111   11100             0  00000         000000    0123445678999999999999


Q ss_pred             CCCCCCHHHHHH
Q 015797          298 PEKRPTMLEVLD  309 (400)
Q Consensus       298 P~~Rps~~ell~  309 (400)
                      |.+|+|+.|++.
T Consensus       394 P~~RiTl~EAL~  405 (415)
T KOG0671|consen  394 PARRITLREALS  405 (415)
T ss_pred             ccccccHHHHhc
Confidence            999999999986

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-36  Score=260.15  Aligned_cols=266  Identities=22%  Similarity=0.338  Sum_probs=195.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--------C
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--------G  106 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~  106 (400)
                      +.|.-..+||+|.||.||+|+. .+|+.||+|++-..  ...-.....+|+.+|..|.|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            5677778999999999999954 56788888865432  22224567889999999999999999988743        3


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      ..+|+||.+|+. +|.-+|.+...   .++...+..++.+++.||.|+|...   |+|||+|+.|+||+.+|.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            458999999985 88888865432   3888999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCc---eeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh----h----hhh
Q 015797          187 FAKLIPDGAT---HVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK----R----TIT  254 (400)
Q Consensus       187 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~----~----~~~  254 (400)
                      +++.+.....   ...+..+.|..|.+||.+.+ ..|+++.|||..|||+.+|+||.+-+.+......    .    .+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            9987654332   22333457999999999886 5799999999999999999999998865443211    1    112


Q ss_pred             ccccchhccc-ccccccCccCCCCC---cHHHHH------HHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          255 DWALPLACER-KFSELADPRLNGNF---VEEELK------RVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       255 ~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~------~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...+|....- .+..+-.+.+....   ..+.++      .-.+|+.+++..||.+|+++.+++..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            2222221111 11111111111111   112222      55678889999999999999999864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-33  Score=278.06  Aligned_cols=268  Identities=19%  Similarity=0.308  Sum_probs=179.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-----------------cCCCEEEEEEEecCChHHHHHH--------------HHH
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-----------------WDGSQIAVKRLKVWSNKAEMEF--------------AVE   84 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-----------------~~~~~vavK~l~~~~~~~~~~~--------------~~E   84 (400)
                      ..++|.+.++||+|+||+||+|..                 ..++.||||.+.........+|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999842                 2356799999875433322222              346


Q ss_pred             HHHHhcCCCCcc-----ceeeeEEEe--------CCeEEEEEEccCCCChhhhhhcCCCc--------------------
Q 015797           85 VEILARVRHKNL-----LSLRGYCAE--------GQERLIVYDYMPNLSLLSHLHGQHSS--------------------  131 (400)
Q Consensus        85 ~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------  131 (400)
                      +.++..++|.++     ++++++|..        .+..++||||+++|+|.+++......                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     667777643        35689999999999999988643210                    


Q ss_pred             ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCCh
Q 015797          132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP  211 (400)
Q Consensus       132 ~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP  211 (400)
                      ...+++..+..++.|++.||.|||..+   ++||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            113467788899999999999999998   99999999999999999999999999976543322211222358999999


Q ss_pred             hhhccCCC----------------------CCccceehhhHHHHHHHhCCC-Chhhhhhhhhhhhhccccchhccccccc
Q 015797          212 EYAMLGKA----------------------SESCDVYSFGILLLELASGKK-PIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       212 E~~~~~~~----------------------s~ksDIwSlGiil~elltg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      |.+.....                      ..+.||||+||++|+|++|.. ||......... +..+...   ...+..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~~~~---~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQYDND---LNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhccch---HHHHHh
Confidence            98864321                      134799999999999999876 76543211000 0000000   000000


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKP---EKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~ell~~  310 (400)
                      .......-...........+++.++|..+|   .+|+|+.|+|+.
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            000000000111123456667788888766   689999999964

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=262.00  Aligned_cols=267  Identities=24%  Similarity=0.287  Sum_probs=206.5

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeE
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGY  102 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~  102 (400)
                      .+++..-..+++....+-+|.||.||.|.+.      +.+.|-+|.++... .-....+..|.-.+..++|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4556666677888899999999999999443      23456677766433 3334568889999999999999999999


Q ss_pred             EEe-CCeEEEEEEccCCCChhhhhhcCC----CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC
Q 015797          103 CAE-GQERLIVYDYMPNLSLLSHLHGQH----SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD  177 (400)
Q Consensus       103 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~  177 (400)
                      +.+ ....++++.+..-|+|..+|....    .....++-.+...++.|++.|++|||+++   +||.||-.+||+|++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            865 466789999999999999997221    11224666788899999999999999999   9999999999999999


Q ss_pred             CcEEEEecCCccccCCCCceeee-ecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhc
Q 015797          178 FKAQVADFGFAKLIPDGATHVTT-RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITD  255 (400)
Q Consensus       178 ~~~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~  255 (400)
                      .++||+|=.+++.+.....+... .-..+..||+||.+++..|+.+||+||||++||||+| |+.|+-..++........
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            99999999999876554443322 2235778999999999999999999999999999999 999987665432222111


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..      ..+          ...-+++.+|..+|.-||..+|++||++.++..-|.+..
T Consensus       513 dG------yRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  513 DG------YRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             cc------cee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            00      000          011223458899999999999999999999999887653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=256.37  Aligned_cols=203  Identities=24%  Similarity=0.341  Sum_probs=173.8

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..++|.+..+||+|+|+.|..++. .+.+.+|+|+++..   ...+..-...|-.+..+. +||.+|.++.+|.....++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            357899999999999999999964 56888999998742   222233456677777765 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|.||++||+|.-.+.++.    .++++.+..+...|+.||.|||++|   ||+||||.+|+|++..|++||+|+|.++.
T Consensus       328 fvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence            9999999999987776443    3899999999999999999999999   99999999999999999999999999975


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      --. ....+.+.+|||.|+|||++++..|+.+.|+|+||++++||+.|+-||+...
T Consensus       401 ~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  401 GLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             CCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            322 2233556789999999999999999999999999999999999999997543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=238.94  Aligned_cols=213  Identities=23%  Similarity=0.337  Sum_probs=172.2

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      +....++...+...-+..||+|++|.|-+-++ .+|...|+|.+... +.....+...|+.+..+. .+|.+|.|||...
T Consensus        36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            33444566666677788999999999988854 68999999999854 344456677888876654 7999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                      .....+|.||.|. .||..+...-......+++..+-.|+..++.||.|||++-  .+||||+||+||||+.+|++|+||
T Consensus       116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence            9999999999996 4887665433333445888889999999999999999875  599999999999999999999999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhcc----CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAML----GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      ||++-.+.++....  -..|--.|||||.+..    ..|+.+|||||||+++.||.+++.||..-
T Consensus       193 FGIsG~L~dSiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  193 FGISGYLVDSIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             cccceeehhhhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            99998775533211  1237778999998853    37899999999999999999999998643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=277.51  Aligned_cols=244  Identities=23%  Similarity=0.360  Sum_probs=185.2

Q ss_pred             CCcccccCce-EEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEccCCCC
Q 015797           43 DNKLGEGGFG-SVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNLS  120 (400)
Q Consensus        43 ~~~LG~G~~g-~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~gs  120 (400)
                      .+.+|.|+.| .||+|. ..|+.||||++-.   ....-..+|+..|+.- .||||+++|+.-.++...||..|.|. .+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGV-YEGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS  588 (903)
T ss_pred             HHHcccCCCCcEEEEEe-eCCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence            3578899888 578886 6899999998742   2234567899999988 69999999999899999999999996 69


Q ss_pred             hhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---C--CcEEEEecCCccccCCCC
Q 015797          121 LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---D--FKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       121 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~--~~~kl~Dfgl~~~~~~~~  195 (400)
                      |.+++...........-...+.++.|+++||++||+.+   ||||||||.||||+.   +  .+++|+|||+|+.+..+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999864111111111455788999999999999988   999999999999976   3  468999999999886654


Q ss_pred             cee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhC-CCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          196 THV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASG-KKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...  .....||.+|+|||++....-+.+.|||||||++|+.++| .+||.+.-......+..       ...+..+.. 
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~~L~~-  737 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLVHLEP-  737 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------ccceeeecc-
Confidence            432  3345699999999999998889999999999999999995 99998654322111111       000111100 


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            ..+.  .-.+||.+|++.+|..||++.+|+..
T Consensus       738 ------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  738 ------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                  0001  45667899999999999999999963

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=268.46  Aligned_cols=284  Identities=26%  Similarity=0.357  Sum_probs=223.3

Q ss_pred             HhcCCCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 015797           88 LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDI  167 (400)
Q Consensus        88 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~di  167 (400)
                      |+.+.|.|+.+|+|.+.+++..++|.+||..|+|.|.+...   ...+++.+...++++++.||.|||+..  ...|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence            46789999999999999999999999999999999999863   335999999999999999999999865  3499999


Q ss_pred             CCCCeEECCCCcEEEEecCCccccCCC-CceeeeecccccCcCChhhhccC-------CCCCccceehhhHHHHHHHhCC
Q 015797          168 KASNVLLDADFKAQVADFGFAKLIPDG-ATHVTTRVKGTLGYLAPEYAMLG-------KASESCDVYSFGILLLELASGK  239 (400)
Q Consensus       168 kp~NIlv~~~~~~kl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDIwSlGiil~elltg~  239 (400)
                      ++.||+++..+.+||+|||+....... .........-...|.|||.+++.       ..+.++||||||++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998876431 11111122345689999999864       1467899999999999999999


Q ss_pred             CChhhhhhhhh--hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchh
Q 015797          240 KPIEKVNSAIK--RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE  317 (400)
Q Consensus       240 ~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  317 (400)
                      .||........  ..+.. .     .........|.+....  +....+..++.+||..+|.+||++.++-..++...+.
T Consensus       156 ~~~~~~~~~~~~~eii~~-~-----~~~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILR-V-----KKGGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCChHHHHHH-H-----HhcCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99986443221  11111 0     0001111112111110  2233688899999999999999999999998877665


Q ss_pred             hh-cccccccccccccccccCCccccchhhHHHHHhh-hhhhhccc---cccc-ccCCCccccccccccchhh
Q 015797          318 KL-TELENDELFKSHQVADYNDGKAVAEDSAEKLAEL-ENDELFKS---HQVA-DYNDGKAVAEDSTDSISEE  384 (400)
Q Consensus       318 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~~~ll~~---~~va-~~~~g~~~~~~~~d~~~~~  384 (400)
                      .. ..+..|.++...+.|+.++++.+.+++.++.+|+ +++.||++   ++|| .++.|..|.+++|+++.-.
T Consensus       228 ~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~~~~vti~  300 (484)
T KOG1023|consen  228 GSSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPESFDSVTIY  300 (484)
T ss_pred             ccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccccCceeee
Confidence            43 3367899999999999999999999999999988 99999986   6899 8899999999999977543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=8.8e-31  Score=231.00  Aligned_cols=210  Identities=34%  Similarity=0.554  Sum_probs=181.4

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChhh
Q 015797           46 LGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLS  123 (400)
Q Consensus        46 LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~  123 (400)
                      ||.|++|.||++... +++.+++|.+...... ....+.+|++.++.++|++|+++++++......+++||++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999654 4899999998754432 34578899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecCCccccCCCCceeeeec
Q 015797          124 HLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTRV  202 (400)
Q Consensus       124 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~  202 (400)
                      ++....   ..+++..++.++.+++.++.+||..+   ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987542   23788999999999999999999998   999999999999999 89999999999987654321 12223


Q ss_pred             ccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHH
Q 015797          203 KGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE  281 (400)
Q Consensus       203 ~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (400)
                      .+...|++||.+... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            478899999999877 889999999999999999                                              


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          282 ELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       282 ~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ..+.+++.+|++.+|.+||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              256778899999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-33  Score=268.31  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=205.4

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ....+|.+...+|.|+||.||+|++ .++...|+|+++.....+..-+.+|+-+++..+||||+.++|.+......++.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            4557899999999999999999954 679999999999887777778889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||.+|+|.+..+...    ++.+.++....+..++||+|||+.+   -+|||||-.||++++.|.+|++|||.+..+..
T Consensus        92 EycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence            9999999999775433    4888888889999999999999998   79999999999999999999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      .... .....||+.|||||+..   .+.|...+|||++|++..|+---++|.......-...+-...          .+-
T Consensus       165 ti~K-rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS----------~~q  233 (829)
T KOG0576|consen  165 TIAK-RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS----------GFQ  233 (829)
T ss_pred             hhhh-hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc----------CCC
Confidence            3222 23456999999999874   578999999999999999999988886654432111111000          000


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .+.+.+  .......+.+++..|+.++|.+||+++.+|.
T Consensus       234 pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            111110  1122346778889999999999999988875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-33  Score=241.57  Aligned_cols=264  Identities=23%  Similarity=0.320  Sum_probs=191.7

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEec--CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC-----eEEE
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ-----ERLI  111 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~l  111 (400)
                      .+-.+.||.|+||.||.+.+ .+|+.||.|.+..  .+--....+.+|+.+|..++|.|++...++..-.+     .+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            35568999999999999954 6799999998753  22233467889999999999999999988765443     4678


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ++|.+. .+|...+-.-.    .++.+.+..++.||++||.|||+.+   |.||||||.|.||+++..+||+|||+++..
T Consensus       135 ~TELmQ-SDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHH-hhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            899885 48888775332    4777888889999999999999998   999999999999999999999999999976


Q ss_pred             CCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhh-h-------ccccchhc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI-T-------DWALPLAC  262 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~-~-------~~~~~~~~  262 (400)
                      ........+.-+-|..|.|||++.|. .|+.+.||||.|||+.||+.++.-|...+......+ .       ...+...|
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            54444333444578999999999874 689999999999999999998888765443211110 0       01111222


Q ss_pred             ccccccccCccCCC-C------CcH--HHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          263 ERKFSELADPRLNG-N------FVE--EELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       263 ~~~~~~~~~~~~~~-~------~~~--~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                      ++.-..++...... .      ..+  .....-+.+...++..||++|.+..+.+..+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            22211111111100 0      011  1123455677889999999999999888654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=256.17  Aligned_cols=204  Identities=24%  Similarity=0.331  Sum_probs=172.9

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH--HH------HHHHHHHHHhcCC---CCccc
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA--EM------EFAVEVEILARVR---HKNLL   97 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~--~~------~~~~E~~~l~~l~---hpnIv   97 (400)
                      .+.......+|...+.+|.|+||.|+.|.+ .+...|++|.+...+.-.  +.      ..-.|+++|+.|+   |+||+
T Consensus       553 ~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl  632 (772)
T KOG1152|consen  553 CEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL  632 (772)
T ss_pred             ceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence            334455667799999999999999999954 456778899886432211  11      2446999999996   99999


Q ss_pred             eeeeEEEeCCeEEEEEEcc-CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC
Q 015797           98 SLRGYCAEGQERLIVYDYM-PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA  176 (400)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~  176 (400)
                      +++++|++++.+||+||-- +|.+|.+++..+..    +++.++..|+.|++.|+++||+++   |||||||-+|+.+++
T Consensus       633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~  705 (772)
T KOG1152|consen  633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDS  705 (772)
T ss_pred             hhhheeecCCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhccccccccC---ceecccccccEEEec
Confidence            9999999999999999975 56799999986653    889999999999999999999999   999999999999999


Q ss_pred             CCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChh
Q 015797          177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE  243 (400)
Q Consensus       177 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~  243 (400)
                      +|-+||+|||.+....++..   ...+||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus       706 ~g~~klidfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  706 NGFVKLIDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CCeEEEeeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999999987655433   34569999999999999888 567899999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.2e-30  Score=230.89  Aligned_cols=199  Identities=33%  Similarity=0.495  Sum_probs=172.2

Q ss_pred             CCcCCcccccCceEEEEEEEcC-CCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      |.+.+.||.|++|.||++.... +..+++|.+...... ....+..|+..++.++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6778899999999999996654 899999998765544 56678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +++|.+++......   +++..++.++.+++.++.+||..+   ++|+||+|.||+++.++.++|+|||++.........
T Consensus        81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            99999998754321   778899999999999999999998   999999999999999999999999999876544311


Q ss_pred             eeeecccccCcCChhhh-ccCCCCCccceehhhHHHHHHHhCCCChhh
Q 015797          198 VTTRVKGTLGYLAPEYA-MLGKASESCDVYSFGILLLELASGKKPIEK  244 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDIwSlGiil~elltg~~Pf~~  244 (400)
                      ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            12234578899999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.3e-31  Score=251.24  Aligned_cols=210  Identities=20%  Similarity=0.218  Sum_probs=172.6

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC------CCccceee
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR------HKNLLSLR  100 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~  100 (400)
                      |.+.--+...++|.+....|+|-|++|..|.+ ..|+.||||++..... -...=+.|+++|+.|+      --|.++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            33444455568999999999999999999954 4588999999974221 1223456999999995      24899999


Q ss_pred             eEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-Cc
Q 015797          101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FK  179 (400)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~  179 (400)
                      ..|...+++|+|+|-+. .+|.++|...+. ...+....+..++.|+..||..|-..+   |+|.||||+||||++. ..
T Consensus       501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence            99999999999999885 699999875543 345778889999999999999999998   9999999999999865 56


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      +||||||.|........   +.+..+-.|.|||++.|-.|+...|+||.||+||||.||+.-|.+..
T Consensus       576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            99999999987654332   22335678999999999999999999999999999999999886543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.5e-31  Score=226.14  Aligned_cols=257  Identities=18%  Similarity=0.305  Sum_probs=191.8

Q ss_pred             HHccCCCcCCcccccCceEEEEEE-EcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeC--CeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEG--QERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~  110 (400)
                      ...++|++.+++|+|.++.||.|. ..+++.++||+++.-   ....+.+|+.+|..|. ||||++++++..+.  ....
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            356789999999999999999995 467889999998743   2456889999999997 99999999998765  4567


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCcc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAK  189 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~  189 (400)
                      +|+||+++.+...+...       ++...+..++.++++||.|+|+.|   |.|||+||.|++||... .++|+|+|++.
T Consensus       112 LiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHh
Confidence            99999998777775532       556678889999999999999999   99999999999999654 59999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhc-cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh---------------h
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAM-LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT---------------I  253 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~---------------~  253 (400)
                      ....+...  .-.+.+..|--||++. .+.|+.+-|+|||||+|..|+..+.||....+...+.               +
T Consensus       182 FYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  182 FYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            76543321  1223677789999886 4678999999999999999999999996543221111               0


Q ss_pred             hcccc---c-------hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          254 TDWAL---P-------LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       254 ~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..+..   |       ......|..++.+.-.. ..   ..+.++++.+.|..|-++|||+.|.+..
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h-l~---~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQH-LV---SPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccc-cC---ChHHHHHHHHHHhhccccccchHHHhcC
Confidence            11110   0       00112223333222111 11   2356677788888999999999998863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-30  Score=238.90  Aligned_cols=132  Identities=27%  Similarity=0.373  Sum_probs=110.5

Q ss_pred             ccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-----C---CccceeeeEEEe--
Q 015797           37 TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-----H---KNLLSLRGYCAE--  105 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~~~~~~~~--  105 (400)
                      .++|.+.++||.|-|++||++ +....+.||+|+.+... .-.+....|+.+|++++     |   .+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            389999999999999999999 55778999999987422 22345677999999872     3   369999999854  


Q ss_pred             --CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797          106 --GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus       106 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                        +.++|+|+|++ |.+|+.+|....-..  ++...+.+|++|++.||.|||...  .|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              56889999999 679999987665544  888999999999999999999876  49999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-31  Score=233.16  Aligned_cols=263  Identities=23%  Similarity=0.248  Sum_probs=194.4

Q ss_pred             HHccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----  106 (400)
                      ....+|.-.+.+|.|.- .|..| +.-.++.||+|.+...  ......+..+|+.++..+.|+||++++.+|.-.     
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34568888899999998 66666 4457999999987532  233445688899999999999999999998644     


Q ss_pred             -CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 -QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       ...|+|||++. ++|.+.+...      ++=..+..++.|++.|+.|||+.+   |+||||||+||++..+..+||.||
T Consensus        93 ~~e~y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   93 FQEVYLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             HHhHHHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccc
Confidence             35799999996 6998887622      555778889999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-----h-------hh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-----R-------TI  253 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-----~-------~~  253 (400)
                      |+++....  ....+.++.|..|.|||++.+-.|.+..||||+||++.||++|..-|.+...-..     +       .+
T Consensus       163 g~ar~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  163 GLARTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             hhhcccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence            99985432  2345567789999999999988899999999999999999999988764321100     0       00


Q ss_pred             --------hcccc--chhcccccccccCc-cCCC--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          254 --------TDWAL--PLACERKFSELADP-RLNG--NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       254 --------~~~~~--~~~~~~~~~~~~~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                              ..+..  |........+..+. .+..  +..........+++.+||-.||++|.|+.++|+.
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                    00000  10000111111111 1111  1112234456677899999999999999999974

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=5.4e-29  Score=229.25  Aligned_cols=201  Identities=27%  Similarity=0.382  Sum_probs=167.1

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  107 (400)
                      +....+.|..+++||.|.|++||++.+.    .++.||+|.+...+  ...++..|+++|..+ -+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4556778999999999999999999543    47789999987543  345688999999999 5899999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFG  186 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfg  186 (400)
                      ...+|+||++.....+++..       ++...+..+++.++.||.++|..|   ||||||||+|+|.+. .+.-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            99999999999888888753       667889999999999999999999   999999999999984 4678999999


Q ss_pred             CccccCCCC--------------c---------------------e--------eeeecccccCcCChhhhcc-CCCCCc
Q 015797          187 FAKLIPDGA--------------T---------------------H--------VTTRVKGTLGYLAPEYAML-GKASES  222 (400)
Q Consensus       187 l~~~~~~~~--------------~---------------------~--------~~~~~~gt~~y~aPE~~~~-~~~s~k  222 (400)
                      ++.......              .                     .        ......||++|.|||++.. +.-+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997211000              0                     0        0012359999999999864 567899


Q ss_pred             cceehhhHHHHHHHhCCCChhhh
Q 015797          223 CDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       223 sDIwSlGiil~elltg~~Pf~~~  245 (400)
                      .||||.|+|+..+++++.||...
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             cceeeccceeehhhccccccccC
Confidence            99999999999999999998643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.9e-29  Score=266.15  Aligned_cols=197  Identities=17%  Similarity=0.186  Sum_probs=139.0

Q ss_pred             hcCCC-CccceeeeEE-------EeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCC
Q 015797           89 ARVRH-KNLLSLRGYC-------AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP  160 (400)
Q Consensus        89 ~~l~h-pnIv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~  160 (400)
                      +.++| +||.++++.|       .+...+++++||+ +++|.++|....   ..+++..++.++.||+.||.|||+++  
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            34556 5788888876       2334567888887 569999996432   24889999999999999999999998  


Q ss_pred             CeEecCCCCCCeEECCCCc-------------------EEEEecCCccccCCCCc---------------eeeeeccccc
Q 015797          161 HIIHRDIKASNVLLDADFK-------------------AQVADFGFAKLIPDGAT---------------HVTTRVKGTL  206 (400)
Q Consensus       161 ~iiH~dikp~NIlv~~~~~-------------------~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~  206 (400)
                       |+||||||+||||+..|.                   +|++|||+++.......               .......||+
T Consensus       101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence             999999999999965444                   55555555543211000               0001135788


Q ss_pred             CcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHH
Q 015797          207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRV  286 (400)
Q Consensus       207 ~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  286 (400)
                      .|||||++.+..++.++|||||||+||||++|..|+.......... ...            ..++.     ........
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~-~~~------------~~~~~-----~~~~~~~~  241 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSL-RHR------------VLPPQ-----ILLNWPKE  241 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHH-HHh------------hcChh-----hhhcCHHH
Confidence            9999999999999999999999999999999999976432211111 000            00000     00112234


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHH
Q 015797          287 VLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       287 ~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..++.+||+.+|.+||++.++++.
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            567789999999999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=213.96  Aligned_cols=251  Identities=19%  Similarity=0.324  Sum_probs=179.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeE-EEeCCeEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGY-CAEGQERLIV  112 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~-~~~~~~~~lv  112 (400)
                      ..+.|.+.+.||+|.||.+-++.+ .+.+.+++|.+.... ....+|.+|...--.| .|.||+.-|++ |+..+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            456789999999999999999965 457888999876432 2356788888776666 58999998876 6777788899


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC--CCCcEEEEecCCccc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD--ADFKAQVADFGFAKL  190 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~--~~~~~kl~Dfgl~~~  190 (400)
                      +||++.|+|..-+...+     +-+.....++.|+++|+.|+|+.+   +||||||.+||||-  +.-++||||||+.+.
T Consensus       101 qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence            99999999999886533     666777889999999999999998   99999999999994  334799999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhhcc---C--CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhcc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAML---G--KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACE  263 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~  263 (400)
                      ......    ...-+..|.|||....   +  ...+.+|||.|||++|.++||..||......  .......|..     
T Consensus       173 ~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~-----  243 (378)
T KOG1345|consen  173 VGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK-----  243 (378)
T ss_pred             cCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-----
Confidence            543221    2235677999997753   2  2478999999999999999999999743211  1111111111     


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +....  -|..-..+.+    .+..+-.+-|..+|++|--..+..+.
T Consensus       244 rk~~~--~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  244 RKNPA--LPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             ccCcc--CchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHH
Confidence            11110  0111112222    34445578888999999555554443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.9e-28  Score=209.83  Aligned_cols=165  Identities=21%  Similarity=0.208  Sum_probs=123.9

Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++.....   .+++..++.++.|++.||.|||+.+         ||+|||++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence            789999875332   4899999999999999999999875         999999999999999  99988654322   


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhcccccccccCccCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERKFSELADPRLNG  276 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (400)
                         ..||+.|+|||++.+..++.++|||||||++|||+||+.||......  ....+.....+         .. +.. .
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~-~~~-~  129 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA---------DD-PRD-R  129 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc---------CC-ccc-c
Confidence               24899999999999999999999999999999999999999654321  00011000000         00 000 0


Q ss_pred             CCcHHHH--HHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          277 NFVEEEL--KRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       277 ~~~~~~~--~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      .......  ..+.+++.+||..+|.+||++.++++.+...
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            0111122  2588899999999999999999999987544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.3e-26  Score=215.61  Aligned_cols=178  Identities=20%  Similarity=0.182  Sum_probs=135.6

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEc--CCCEEEEEEEecC-----ChHHHHHHHHHHHHHhcCCCCccce-eeeE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLW--DGSQIAVKRLKVW-----SNKAEMEFAVEVEILARVRHKNLLS-LRGY  102 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~  102 (400)
                      ..+....++|.+.+.||+|+||+||+|...  +++.+|+|++...     .......+..|+++|+.++|+|+++ +++ 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            445677789999999999999999999653  5777899986532     1223456889999999999999985 443 


Q ss_pred             EEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEECCCCcEE
Q 015797          103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDI-KASNVLLDADFKAQ  181 (400)
Q Consensus       103 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~di-kp~NIlv~~~~~~k  181 (400)
                         .+..|+|||||+|++|.. +.  .     ..   ...++.++++||.|||+.+   |+|||| ||+|||++.++.+|
T Consensus        90 ---~~~~~LVmE~~~G~~L~~-~~--~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         90 ---TGKDGLVRGWTEGVPLHL-AR--P-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             ---cCCcEEEEEccCCCCHHH-hC--c-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence               246799999999999963 21  1     01   1457889999999999998   999999 99999999999999


Q ss_pred             EEecCCccccCCCCcee-------eeecccccCcCChhhhccCC------CCCcccee
Q 015797          182 VADFGFAKLIPDGATHV-------TTRVKGTLGYLAPEYAMLGK------ASESCDVY  226 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~s~ksDIw  226 (400)
                      |+|||+++.+.......       .....+++.|+|||.+.-..      .+..+|-|
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999998765432111       12456888999999886432      23446666

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-27  Score=205.05  Aligned_cols=247  Identities=25%  Similarity=0.410  Sum_probs=188.1

Q ss_pred             CCcCCcccccCceEEEEEEEcCCCEEEEEEEec--CChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      ..+..+|.+.-.|..|+|++ .|..+++|+++.  .......+|..|.-.|+-++||||+++++.|....+..++..|++
T Consensus       192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            34567889999999999985 566677787764  334445679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE--ecCCccccCCCC
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA--DFGFAKLIPDGA  195 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~--Dfgl~~~~~~~~  195 (400)
                      -|||..+++...  ...++-.++.+++.+++.|++|||+.. |.|.---|.+..++||++.+.+|.  |--++...    
T Consensus       271 ~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe----  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE----  343 (448)
T ss_pred             chHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec----
Confidence            999999997643  445788899999999999999999985 445556799999999999886653  32222110    


Q ss_pred             ceeeeecccccCcCChhhhccCCCC---CccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKAS---ESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                          ....-.|.||+||.++..+-+   .++|+|||+++||||.|+..||.......            |..+   +.-.
T Consensus       344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------------cgmk---iale  404 (448)
T KOG0195|consen  344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------------CGMK---IALE  404 (448)
T ss_pred             ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------------hhhh---hhhc
Confidence                011247899999999876543   58999999999999999999998665321            1100   0001


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      .++....+.....+..||.-|+..||.+||.+..++-.|+.
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            11112223334578888999999999999999998877754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1e-24  Score=206.61  Aligned_cols=258  Identities=22%  Similarity=0.274  Sum_probs=189.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCC--CEEEEEEEecCChHHHHHHHHHHHHHhcCCC----CccceeeeEE-EeCCeEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLWDG--SQIAVKRLKVWSNKAEMEFAVEVEILARVRH----KNLLSLRGYC-AEGQERLI  111 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~-~~~~~~~l  111 (400)
                      +|.+.+.||+|+||.||.+.....  ..+|+|............+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999975443  4788888765433322267788888888863    6899999988 47778899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-----CcEEEEecC
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-----FKAQVADFG  186 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-----~~~kl~Dfg  186 (400)
                      ||+.+ |.+|.++.....  ...++....+.++.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 679999775544  234899999999999999999999999   9999999999999765     359999999


Q ss_pred             Ccc--ccCCCCc---e---e-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhcc
Q 015797          187 FAK--LIPDGAT---H---V-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDW  256 (400)
Q Consensus       187 l~~--~~~~~~~---~---~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~  256 (400)
                      +++  .......   .   . .....||..|+++.+..+...+.+.|+||++.++.+++.|..||........ ..+...
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  3222111   0   1 1224599999999999999999999999999999999999999965542111 111000


Q ss_pred             ccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ...        .....  .....+.....+..   .+-..+...+|....+...|+...
T Consensus       253 ~~~--------~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  253 PRK--------LLTDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             hhh--------hcccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHH
Confidence            000        00000  11223333444443   333378999999999988876543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=6.8e-24  Score=199.36  Aligned_cols=256  Identities=30%  Similarity=0.408  Sum_probs=194.7

Q ss_pred             CCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChH---HHHHHHHHHHHHhcCCCC-ccceeeeEEEeCCeEEEEEEc
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK---AEMEFAVEVEILARVRHK-NLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~e~  115 (400)
                      |.+.+.||.|+||.||.+...  ..+++|.+......   ....+..|+..++.+.|+ +|+++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            778899999999999999654  88899988753322   366788999999999988 799999999888888999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~~~~~~  194 (400)
                      +.++++.+++...... ..+.......++.|++.++.|+|..+   ++|||+||+||+++..+ .++++|||++......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999776543311 24788889999999999999999998   99999999999999988 7999999999865443


Q ss_pred             Cce-----eeeecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhh-----hhhhhhhccccchh
Q 015797          195 ATH-----VTTRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNS-----AIKRTITDWALPLA  261 (400)
Q Consensus       195 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~-----~~~~~~~~~~~~~~  261 (400)
                      ...     ......||..|+|||.+.+   ..++...|+||+|++++++++|..||.....     .....+.....+  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            321     2345679999999999987   5789999999999999999999999765442     111111110000  


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                             .................+.+++..|+..+|..|.+..+....
T Consensus       234 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                   000000000001223467778889999999999998877653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-25  Score=224.78  Aligned_cols=263  Identities=19%  Similarity=0.229  Sum_probs=192.0

Q ss_pred             CcccccHHHHHHHcc-CCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCC-hHHHHHHHH---HHHHHhcCCCCccce
Q 015797           24 TWRIFSLKELHSATN-NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS-NKAEMEFAV---EVEILARVRHKNLLS   98 (400)
Q Consensus        24 ~~~~~~~~~~~~~~~-~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~-~~~~~~~~~---E~~~l~~l~hpnIv~   98 (400)
                      +.+..+++.+.+-.. +|...+.||.+.|=.|.+|++..|. |+||++-... .-....+.+   |++ ...++|||.++
T Consensus         8 ~sQi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lP   85 (1431)
T KOG1240|consen    8 PSQISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLP   85 (1431)
T ss_pred             ccccchHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccc
Confidence            455666666655444 7888899999999999999877777 8889875433 223334443   444 55669999999


Q ss_pred             eeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797           99 LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      |..+...+.-.|+|-+|..+ +|.|.+..++.    +...+..-|+.|++.||.-+|..|   |+|||||.+||||++-+
T Consensus        86 fqk~~~t~kAAylvRqyvkh-nLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWN  157 (1431)
T KOG1240|consen   86 FQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWN  157 (1431)
T ss_pred             hHHHHHhhHHHHHHHHHHhh-hhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeec
Confidence            99988888888999999975 99999987654    667777889999999999999999   99999999999999999


Q ss_pred             cEEEEecCCcccc--CCCCc----eeeeecccccCcCChhhhccC-----------CCCCccceehhhHHHHHHHh-CCC
Q 015797          179 KAQVADFGFAKLI--PDGAT----HVTTRVKGTLGYLAPEYAMLG-----------KASESCDVYSFGILLLELAS-GKK  240 (400)
Q Consensus       179 ~~kl~Dfgl~~~~--~~~~~----~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDIwSlGiil~ellt-g~~  240 (400)
                      -+.|+||..-+..  +....    ....+...-.+|+|||-+...           ..+++.||||+||++.||++ |++
T Consensus       158 W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P  237 (1431)
T KOG1240|consen  158 WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP  237 (1431)
T ss_pred             hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence            9999999876532  22222    122233456789999987531           25789999999999999998 788


Q ss_pred             ChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          241 PIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       241 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ||.-..--..+...    ....+..+..+-+            ..+..+++.|++.||++|.++++.|+.-+
T Consensus       238 lF~LSQL~aYr~~~----~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  238 LFTLSQLLAYRSGN----ADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             cccHHHHHhHhccC----ccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            88643211111100    0000111222222            25677889999999999999999998644

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=3.2e-24  Score=189.69  Aligned_cols=172  Identities=14%  Similarity=0.160  Sum_probs=134.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHH---H------HHHHHHHHhcCCCCccceeeeEEEeC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM---E------FAVEVEILARVRHKNLLSLRGYCAEG  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~hpnIv~~~~~~~~~  106 (400)
                      ..++|++.+.||.|+||.||.+.. ++..+|+|.+.........   .      +.+|++.+.++.||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468999999999999999999865 5778999999753332222   2      57899999999999999999886543


Q ss_pred             --------CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          107 --------QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       107 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                              +..+++|||++|.+|.++..        ++.    ....+++.+|..+|..|   ++|||++|+||+++.+|
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence                    35789999999999988632        222    24568899999999999   99999999999999998


Q ss_pred             cEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh
Q 015797          179 KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS  237 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt  237 (400)
                       ++|+|||...........             ..++....|+.++||||||+++..+..
T Consensus       173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence             999999988754221110             013445567789999999999877643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=6.6e-25  Score=221.23  Aligned_cols=255  Identities=21%  Similarity=0.279  Sum_probs=184.0

Q ss_pred             cCC-CcCCcccccCceEEEEEEE-cCCCEEEEEEEe-----cCChHHH-HHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           38 NNF-NYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLK-----VWSNKAE-MEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        38 ~~y-~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~-----~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ..| .....+|.|++|.|+.+.. ......+.|...     ....... ..+..|+.+-..|+|||++.....+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            335 4567899999997777743 233333333322     1111111 1256688888899999998888777776666


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +-+||||++ +|..++....    .+....+..++.|++.|+.|+|..|   +.|||+|++|++++.+|.+||+|||.+.
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~  468 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAAS  468 (601)
T ss_pred             hhhhhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcce
Confidence            666999998 9999887542    2677888899999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCc---eeeeecccccCcCChhhhccCCCCC-ccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhccccchhccc
Q 015797          190 LIPDGAT---HVTTRVKGTLGYLAPEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDWALPLACER  264 (400)
Q Consensus       190 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~-ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~  264 (400)
                      .+...-.   ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.......... ...+.       
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~-------  541 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS-------  541 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc-------
Confidence            7653322   3344567999999999999999976 6899999999999999999997544321110 00000       


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ......  .-..............+|.++|+.||.+|.|+.+|++
T Consensus       542 ~~~~~~--~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  542 DQRNIF--EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccc--cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000000  0000112233456677889999999999999999996

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=5.9e-24  Score=182.62  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=190.0

Q ss_pred             HccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC-CccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH-KNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|.++++||.|+||.+|.| ...+|..||||+-+....  .-.+..|..+.+.|++ ..|..+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            4689999999999999999999 456799999997653221  2246778999999975 78888888888999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC---CcEEEEecCCccc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD---FKAQVADFGFAKL  190 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~---~~~kl~Dfgl~~~  190 (400)
                      +.. |.||.++..-...   .++...++-++.|++.-++|+|.++   +|||||||+|+|..-+   ..+.|+|||+++.
T Consensus        91 dLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             ecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence            988 6799888764433   2888899999999999999999998   9999999999999643   4689999999988


Q ss_pred             cCCCCcee------eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          191 IPDGATHV------TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       191 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      +.+.....      .....||..|.+--...+-.-+.+-|+-|+|.+|.++.-|..||.+.......+.....    .+.
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~Ek  239 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SEK  239 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HHh
Confidence            75543321      22356999999988888888899999999999999999999999876543222211100    000


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      +.+..+.     ..+...+.++...+.=|-..--++-|...-+.+.++.
T Consensus       240 K~s~~ie-----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  240 KMSTPIE-----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             hcCCCHH-----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence            1110000     0111112345555566666667777876655554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=6.6e-23  Score=183.72  Aligned_cols=201  Identities=22%  Similarity=0.323  Sum_probs=169.3

Q ss_pred             ccCCCcCCcccccCceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .-+|+++++||+|+||..+.| ...+++.||||.-...+  ..-.+..|++..+.| ..++|..+|-+..++.+..+|+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            457999999999999999999 55789999999654322  233577889999988 56999999988888888899999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-----CcEEEEecCCcc
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-----FKAQVADFGFAK  189 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-----~~~kl~Dfgl~~  189 (400)
                      .+ |-||.|+..-...   .++...++.++.|++.-++|+|.+.   +|.|||||+|+||...     ..+.++|||+++
T Consensus       105 LL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            98 6788887654433   2899999999999999999999998   9999999999999643     358999999999


Q ss_pred             ccCCCCcee------eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          190 LIPDGATHV------TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       190 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      ...+..+..      .....||..||+--...+..-+.+-|+-|||-++++.|-|..||.+..
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            876544322      233569999999999999999999999999999999999999998764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.3e-22  Score=177.19  Aligned_cols=139  Identities=14%  Similarity=0.138  Sum_probs=107.6

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCChH--H------------------------HHHHHHHHHHHhcCCCCcc
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK--A------------------------EMEFAVEVEILARVRHKNL   96 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~hpnI   96 (400)
                      ...||+|++|.||+|...+|+.||+|++......  .                        ......|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            5789999999999997668999999999753211  0                        0122349999999988877


Q ss_pred             ceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeEEC
Q 015797           97 LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL-HHHATPHIIHRDIKASNVLLD  175 (400)
Q Consensus        97 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiH~dikp~NIlv~  175 (400)
                      .....+..  ...+|||||++++++...+...    ..++...+..++.|++.+|.|+ |+.+   ++||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            54433322  2238999999987776543222    1378888999999999999999 6888   99999999999998


Q ss_pred             CCCcEEEEecCCcccc
Q 015797          176 ADFKAQVADFGFAKLI  191 (400)
Q Consensus       176 ~~~~~kl~Dfgl~~~~  191 (400)
                       ++.++|+|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.7e-21  Score=170.51  Aligned_cols=142  Identities=17%  Similarity=0.156  Sum_probs=110.3

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEecCChH----------------------H----HHHHHHHHHHHhcCCCCc
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK----------------------A----EMEFAVEVEILARVRHKN   95 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~----------------------~----~~~~~~E~~~l~~l~hpn   95 (400)
                      +...||+|++|.||+|...+|+.||+|++......                      .    ...+..|++.+..+.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            35789999999999997668999999998753211                      0    112357899999999998


Q ss_pred             cceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEE
Q 015797           96 LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLL  174 (400)
Q Consensus        96 Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv  174 (400)
                      +.....+...  ..++||||++|+++.......    ..++......++.|++.++.++|. .|   ++||||||+||++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll  151 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY  151 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence            7554443333  248999999988654432221    126677888999999999999999 88   9999999999999


Q ss_pred             CCCCcEEEEecCCccccCC
Q 015797          175 DADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       175 ~~~~~~kl~Dfgl~~~~~~  193 (400)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.8e-21  Score=168.71  Aligned_cols=186  Identities=14%  Similarity=0.070  Sum_probs=141.6

Q ss_pred             CcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHH----HHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEEEEc
Q 015797           41 NYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA----EMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        41 ~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .+...|++|+||+||.+.. .+..++.+.+.......    ...+..|+++|++|. |+++.+++++    +..+++|+|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998863 78888877776433211    124788999999995 5889999886    457999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEECCCCcEEEEecCCccccCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDI-KASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~di-kp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      +.|.+|.+.+..           ....++.|++.+|.++|.+|   |+|||| ||.|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999888654321           11346789999999999999   999999 799999999999999999999865432


Q ss_pred             Cce----e--------eeecccccCcCChhhhccC-CCC-CccceehhhHHHHHHHhCCCChhhh
Q 015797          195 ATH----V--------TTRVKGTLGYLAPEYAMLG-KAS-ESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       195 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      ...    .        ......++.|++|+..... ..+ ...+.++.|+-+|.++|++.|....
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            210    0        1112368889999865532 333 5779999999999999999986543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-22  Score=195.90  Aligned_cols=225  Identities=26%  Similarity=0.267  Sum_probs=173.5

Q ss_pred             cccccCceEEEEEEE----cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEEEEccC
Q 015797           45 KLGEGGFGSVYWGQL----WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      .+|+|.||.|++++.    ..+..+|+|++......  .......|..++...+ ||.+++++..+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999998743    34777888887642211  1114556888888886 9999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      ||.|...+....    .+.+.....+...++-|+.++|..+   ++|||+|++||+++.+|++++.|||+++..-.....
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999998886543    2566666677788899999999999   999999999999999999999999999876543332


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN  277 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (400)
                           +||..|||||++.  ....++|.||||+++++|+||..||....   ...+...           ++       .
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~---~~~Il~~-----------~~-------~  205 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT---MKRILKA-----------EL-------E  205 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH---HHHHhhh-----------cc-------C
Confidence                 6999999999998  67889999999999999999999998611   1111100           00       1


Q ss_pred             CcHHHHHHHHHHHHhccccCCCCCCCH
Q 015797          278 FVEEELKRVVLVALTCAHSKPEKRPTM  304 (400)
Q Consensus       278 ~~~~~~~~l~~li~~cl~~dP~~Rps~  304 (400)
                      ..........+++..++..+|..|.-.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            222333445556677777899999654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=7.6e-21  Score=173.23  Aligned_cols=233  Identities=18%  Similarity=0.251  Sum_probs=145.7

Q ss_pred             CCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCC----------CccceeeeEE--
Q 015797           40 FNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRH----------KNLLSLRGYC--  103 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h----------pnIv~~~~~~--  103 (400)
                      +..+..||.|+++.||.+.+ .+++.+|+|++.....   ...+.+.+|.-....+.+          -.++-.++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            35567899999999999965 4589999999864332   223455555544444322          1222222222  


Q ss_pred             -------EeCC--------eEEEEEEccCCCChhhhhhc---CCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 015797          104 -------AEGQ--------ERLIVYDYMPNLSLLSHLHG---QHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHR  165 (400)
Q Consensus       104 -------~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~  165 (400)
                             ....        +.+++|+-+. ++|.+++..   .......+....++.+..|+++.+++||..|   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                   1111        3367888774 688777532   2111222445566777899999999999999   9999


Q ss_pred             CCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC--------CCCCccceehhhHHHHHHHh
Q 015797          166 DIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG--------KASESCDVYSFGILLLELAS  237 (400)
Q Consensus       166 dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDIwSlGiil~ellt  237 (400)
                      ||+|+|++++.+|.++|+||+.......  ....  ...+..|.|||.....        .++.+.|.|+||+++|.|++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999988765432  2111  2356889999977542        46889999999999999999


Q ss_pred             CCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCC
Q 015797          238 GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR  301 (400)
Q Consensus       238 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  301 (400)
                      |..||..........   +                .+. ... +.++.+..||..+|+.||.+|
T Consensus       246 ~~lPf~~~~~~~~~~---~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE---W----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG---G----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc---c----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999997543210000   0                010 122 556678888899999999987

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.9e-20  Score=163.91  Aligned_cols=136  Identities=15%  Similarity=0.183  Sum_probs=105.3

Q ss_pred             CcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-----CCCccceeeeEEEeCC---eEE-E
Q 015797           41 NYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-----RHKNLLSLRGYCAEGQ---ERL-I  111 (400)
Q Consensus        41 ~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~---~~~-l  111 (400)
                      .-.+.||+|+||.||.  .......+||++..........+.+|+.+++.+     +||||++++|++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  333333478888765444556789999999999     5799999999998874   334 7


Q ss_pred             EEEc--cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeEECC----CCcEEEEe
Q 015797          112 VYDY--MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGI-VYLHHHATPHIIHRDIKASNVLLDA----DFKAQVAD  184 (400)
Q Consensus       112 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~~~~iiH~dikp~NIlv~~----~~~~kl~D  184 (400)
                      |+||  +.+|+|.+++.+..     +++.  ..++.+++.++ .|||+++   |+||||||+|||++.    ++.++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  55799999996432     4444  35677888777 9999998   999999999999974    34799999


Q ss_pred             cCCc
Q 015797          185 FGFA  188 (400)
Q Consensus       185 fgl~  188 (400)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.6e-20  Score=193.46  Aligned_cols=200  Identities=21%  Similarity=0.213  Sum_probs=162.3

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC---CCccceeeeEEEeCCe
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQE  108 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~  108 (400)
                      +++.....|.|.+.||+|+||.||.|...+|+.||+|+-+..+..   +|..-.+++.+|+   -+.|+.+...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            345667889999999999999999997777999999987654433   2333345555554   3567777777777888


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-------CCCcEE
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-------ADFKAQ  181 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-------~~~~~k  181 (400)
                      .++|+||.+-|+|.++++.    ...++|...+.++.|++.-+..||..+   ||||||||+|+||.       ....++
T Consensus       769 S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence            8999999999999999973    235999999999999999999999999   99999999999994       234599


Q ss_pred             EEecCCccccCCC-CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCC
Q 015797          182 VADFGFAKLIPDG-ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP  241 (400)
Q Consensus       182 l~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~P  241 (400)
                      |+|||-+..+.-- ........++|..+-.+|+..|..++...|.|.|+-+++-||.|+.-
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9999998654321 11234456799999999999999999999999999999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=3.8e-21  Score=182.74  Aligned_cols=173  Identities=24%  Similarity=0.369  Sum_probs=128.1

Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..||.|++|...+|.+||..+.. ....++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence            57899999999999999975433 2347788899999999999999   66   89999999999999999999999999


Q ss_pred             ccccCCCC-----ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchh
Q 015797          188 AKLIPDGA-----THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLA  261 (400)
Q Consensus       188 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  261 (400)
                      ........     ....+...||..||+||++.+..|+.|+||||||+||+||++ -..++.-..               
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------------  467 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---------------  467 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------------
Confidence            98765544     112234569999999999999999999999999999999998 344433211               


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLE  306 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  306 (400)
                         .+..+-+..++..+..+.+.+ ..++.+++...|.+||++.+
T Consensus       468 ---t~~d~r~g~ip~~~~~d~p~e-~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  468 ---TLTDIRDGIIPPEFLQDYPEE-YTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ---hhhhhhcCCCChHHhhcCcHH-HHHHHHhcCCCcccCchHHH
Confidence               111111111111121222222 34668999999999995433

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=6.1e-19  Score=159.17  Aligned_cols=147  Identities=14%  Similarity=0.116  Sum_probs=112.0

Q ss_pred             HHHccCCCcCCcccccCceEEEEEE--EcCCCEEEEEEEecCChH------------------------HHHHHHHHHHH
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQ--LWDGSQIAVKRLKVWSNK------------------------AEMEFAVEVEI   87 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~   87 (400)
                      ..-.--|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|+..
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3333458899999999999999997  468999999998743210                        11235679999


Q ss_pred             HhcCCCC--ccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 015797           88 LARVRHK--NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHR  165 (400)
Q Consensus        88 l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~  165 (400)
                      +..+.+.  .+.++++.    ...++||||+++++|........    .+.......++.|++.++.+||..+  .++||
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~  173 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEG--ELVHG  173 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence            9999753  33444432    23589999999988877553222    2445566789999999999999886  39999


Q ss_pred             CCCCCCeEECCCCcEEEEecCCcccc
Q 015797          166 DIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       166 dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+||+++ ++.++|+|||.+...
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=9.5e-19  Score=155.72  Aligned_cols=134  Identities=21%  Similarity=0.320  Sum_probs=112.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChH--------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK--------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      +.||+|++|.||+|.. .+..+++|+.......        ....+..|+.++..+.|++|.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999975 7788999976532211        123567899999999999988877777778888999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ++|++|.+++....       . .+..++.+++.+|.++|..+   ++|||++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999885321       1 67889999999999999998   99999999999999 78899999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=6.9e-19  Score=155.18  Aligned_cols=130  Identities=22%  Similarity=0.319  Sum_probs=106.5

Q ss_pred             cccccCceEEEEEEEcCCCEEEEEEEecCCh---H-----HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           45 KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN---K-----AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~---~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .||+|++|.||+|. ..+..+++|.......   .     ....+..|++++..+.|+++....-++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            48999999999997 5678899998653221   1     1245678999999999887666655666777789999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|++|.+.+....     .      .++.+++.+|.+||..+   ++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999875321     1      68899999999999998   99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=6.8e-19  Score=161.53  Aligned_cols=192  Identities=23%  Similarity=0.298  Sum_probs=132.5

Q ss_pred             CCCccceeeeEEEe---------------------------CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHH
Q 015797           92 RHKNLLSLRGYCAE---------------------------GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA  144 (400)
Q Consensus        92 ~hpnIv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  144 (400)
                      .|||||++.++|.+                           +...|+||..++ .+|.+++-.+.     .+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence            59999999887632                           346789999886 59999987654     3445566689


Q ss_pred             HHHHHHHHHHHhcCCCCeEecCCCCCCeEEC--CCC--cEEEEecCCccccCCCC-----ceeeeecccccCcCChhhhc
Q 015797          145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLD--ADF--KAQVADFGFAKLIPDGA-----THVTTRVKGTLGYLAPEYAM  215 (400)
Q Consensus       145 ~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~--~~~--~~kl~Dfgl~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~  215 (400)
                      .|+++|+.|||.+|   |.|||+|++||||.  +|+  .++|+|||.|.....-.     .......-|.-.-||||+..
T Consensus       348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99999999999999   99999999999994  333  48999999986432210     01111234777899999886


Q ss_pred             cCCC------CCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchhcccccccccCccCCCCCcHHHHHHHH
Q 015797          216 LGKA------SESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLACERKFSELADPRLNGNFVEEELKRVV  287 (400)
Q Consensus       216 ~~~~------s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  287 (400)
                      .-+-      -.|+|.|+.|.+.||+++...||.......-  +...+...|             .+    .+.....+.
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-------------al----p~~vpp~~r  487 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-------------AL----PSRVPPVAR  487 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-------------CC----cccCChHHH
Confidence            4221      2589999999999999999999986432211  111111111             11    111223455


Q ss_pred             HHHHhccccCCCCCCCHHHHHH
Q 015797          288 LVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       288 ~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +++...|+.||++|++..-...
T Consensus       488 qlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  488 QLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             HHHHHHhcCCccccCCccHHHh
Confidence            6667888899999998544333

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2.9e-18  Score=151.10  Aligned_cols=146  Identities=20%  Similarity=0.196  Sum_probs=113.1

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChH----------------------HHHHHHHHHHHH
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK----------------------AEMEFAVEVEIL   88 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l   88 (400)
                      .++......|.+.+.||+|+||.||++...+|+.||||++......                      ....+..|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            4455555568999999999999999997778999999987642210                      112356788889


Q ss_pred             hcCCCCc--cceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 015797           89 ARVRHKN--LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRD  166 (400)
Q Consensus        89 ~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~d  166 (400)
                      ..+.|++  +...++    ....++||||++|++|......          .....++.+++.++.++|..+   ++|||
T Consensus        88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~D  150 (198)
T cd05144          88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGD  150 (198)
T ss_pred             HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence            8887774  444443    2456899999999998765421          234568889999999999998   99999


Q ss_pred             CCCCCeEECCCCcEEEEecCCccccCC
Q 015797          167 IKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       167 ikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |+|+||+++.++.++|+|||.+..+..
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=3.5e-18  Score=172.73  Aligned_cols=146  Identities=20%  Similarity=0.293  Sum_probs=116.1

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEec--CCh------HHHHHHHHHHHHHhcCCCCcccee
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSN------KAEMEFAVEVEILARVRHKNLLSL   99 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~--~~~------~~~~~~~~E~~~l~~l~hpnIv~~   99 (400)
                      .++.........|...+.||+|+||+||+|... +..+++|+...  ...      .....+..|+++++.++|++++..
T Consensus       323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  401 (535)
T PRK09605        323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP  401 (535)
T ss_pred             eeeccccccccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence            344445555667778899999999999999754 34444443221  111      112457889999999999999988


Q ss_pred             eeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      +.++......++||||+++++|.+++.            ....++.+++.+|.|||+.+   ++||||||+|||+ .++.
T Consensus       402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~  465 (535)
T PRK09605        402 VIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDR  465 (535)
T ss_pred             EEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCc
Confidence            877777778899999999999999874            24568899999999999998   9999999999999 6788


Q ss_pred             EEEEecCCccc
Q 015797          180 AQVADFGFAKL  190 (400)
Q Consensus       180 ~kl~Dfgl~~~  190 (400)
                      ++|+|||+++.
T Consensus       466 ~~liDFGla~~  476 (535)
T PRK09605        466 LYLIDFGLGKY  476 (535)
T ss_pred             EEEEeCccccc
Confidence            99999999975

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=1.4e-18  Score=176.45  Aligned_cols=211  Identities=21%  Similarity=0.249  Sum_probs=139.8

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ......+|..++.|..|+||.||.+++. +.+..|+|+ +..+.    -+++   ++....+|.+               
T Consensus        78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfv---------------  134 (1205)
T KOG0606|consen   78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFV---------------  134 (1205)
T ss_pred             cCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCcce---------------
Confidence            3455678999999999999999999654 467778843 32110    0000   2222223322               


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |      |+-...+.....    ++.        +.+.+++|||+.+   |+|||+||+|.+|+.-|++|++|||++..-
T Consensus       135 v------gDc~tllk~~g~----lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  135 V------GDCATLLKNIGP----LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             e------chhhhhcccCCC----Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence            2      444444433221    222        2278999999998   999999999999999999999999998653


Q ss_pred             CCCCc--------------eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhcc
Q 015797          192 PDGAT--------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDW  256 (400)
Q Consensus       192 ~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~  256 (400)
                      .....              .....++|||.|+|||++....|+...|+|++|+|+|+.+-|+.||...... +...+...
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd  273 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  273 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence            21110              0122468999999999999999999999999999999999999999876432 11111110


Q ss_pred             ccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC
Q 015797          257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP  302 (400)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  302 (400)
                      ..      .|.+-      ....   ..+..+++.+.|..+|..|.
T Consensus       274 ~i------~wpE~------dea~---p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 DI------EWPEE------DEAL---PPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hc------ccccc------CcCC---CHHHHHHHHHHHHhChHhhc
Confidence            00      01110      0112   23455566777778999994

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.8e-18  Score=174.71  Aligned_cols=257  Identities=23%  Similarity=0.273  Sum_probs=188.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc--CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW--DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~  110 (400)
                      ....|.+.+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |+|++++++........+
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            4567888899999999999888543  34456666665433  333344556777777776 999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeEECCCC-cEEEEecCCc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH-HHATPHIIHRDIKASNVLLDADF-KAQVADFGFA  188 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~  188 (400)
                      ++++|..+|++.+.+.....  ...+....-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ .++++|||++
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             cccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence            99999999999998831111  12555667778999999999999 887   99999999999999999 9999999999


Q ss_pred             cccCC--CCceeeeeccc-ccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          189 KLIPD--GATHVTTRVKG-TLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       189 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      ..+..  +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........... .|.     ..
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~~-----~~  246 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SWK-----SN  246 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-eec-----cc
Confidence            88765  34444445668 9999999998874 457889999999999999999999875543221110 000     00


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .  ......    ...........++.+++..+|..|.+.+++..
T Consensus       247 ~--~~~~~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  247 K--GRFTQL----PWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             c--cccccC----ccccCChhhhhcccccccCCchhccccccccc
Confidence            0  000000    00111124555667888899999999888765

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.70  E-value=1.2e-16  Score=139.42  Aligned_cols=138  Identities=19%  Similarity=0.174  Sum_probs=98.3

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEecCChHH--HHH----------------------HHHHHHHHhcCCCC--c
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA--EME----------------------FAVEVEILARVRHK--N   95 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~--~~~----------------------~~~E~~~l~~l~hp--n   95 (400)
                      +.+.||+|+||.||+|...+++.||+|++.......  ...                      ...|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357899999999999976689999999987432111  111                      13455666665433  2


Q ss_pred             cceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEE
Q 015797           96 LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLL  174 (400)
Q Consensus        96 Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv  174 (400)
                      +.+.+++    ...++||||++++++.........    .. .....++.+++.++.++|. .+   ++|+||||+||++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            4444443    245899999998654322111100    11 5567889999999999999 87   9999999999999


Q ss_pred             CCCCcEEEEecCCccccC
Q 015797          175 DADFKAQVADFGFAKLIP  192 (400)
Q Consensus       175 ~~~~~~kl~Dfgl~~~~~  192 (400)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=4.1e-16  Score=130.34  Aligned_cols=135  Identities=18%  Similarity=0.135  Sum_probs=111.7

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC--CccceeeeEEEeCCeEEEEEEccCCC
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH--KNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +.+.||.|.++.||++... +..+++|.......  ...+..|+..+..++|  +++.++++++...+..+++|||+.++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4578999999999999754 47899998765433  4568889999999976  58999998888888899999999987


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ++..+           +......++.+++.+|+++|......++|+|++|.||+++..+.++++|||.+..
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77654           3345667889999999999985333499999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=9.7e-16  Score=138.59  Aligned_cols=145  Identities=19%  Similarity=0.219  Sum_probs=107.6

Q ss_pred             cccHHHHHHHccCCCcCCccc-ccCceEEEEEEEcCCCEEEEEEEecCC-------------hHHHHHHHHHHHHHhcCC
Q 015797           27 IFSLKELHSATNNFNYDNKLG-EGGFGSVYWGQLWDGSQIAVKRLKVWS-------------NKAEMEFAVEVEILARVR   92 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG-~G~~g~Vy~a~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~   92 (400)
                      -|+.+.+..      -...|| .||.|+||.+.. .+..+++|.+....             ......+..|+.++..|.
T Consensus        26 ~~~~~~~~~------~~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~   98 (239)
T PRK01723         26 LFDPDFWQQ------QARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY   98 (239)
T ss_pred             hcCHHHHhh------cCceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH
Confidence            455544443      345687 788999999864 47889998875311             112245778999999999


Q ss_pred             CCcc--ceeeeEEEeCCe----EEEEEEccCC-CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 015797           93 HKNL--LSLRGYCAEGQE----RLIVYDYMPN-LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHR  165 (400)
Q Consensus        93 hpnI--v~~~~~~~~~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~  165 (400)
                      |++|  +..+++......    .++|||+++| .+|.+++....     ++..    .+.+++.+|.+||..|   |+||
T Consensus        99 ~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~~G---I~Hr  166 (239)
T PRK01723         99 EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHDAG---VYHA  166 (239)
T ss_pred             hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHHCC---CCCC
Confidence            8775  667766443222    2599999997 68888875421     3332    3568999999999999   9999


Q ss_pred             CCCCCCeEECCCCcEEEEecCCccc
Q 015797          166 DIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       166 dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ||||.|||++.++.++|+|||.+..
T Consensus       167 Dlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        167 DLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCchhEEEcCCCCEEEEECCCccc
Confidence            9999999999999999999999875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=1.1e-15  Score=137.56  Aligned_cols=203  Identities=18%  Similarity=0.256  Sum_probs=141.3

Q ss_pred             HHHHhcCCCCccceeeeEEEe-----CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCC
Q 015797           85 VEILARVRHKNLLSLRGYCAE-----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT  159 (400)
Q Consensus        85 ~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~  159 (400)
                      +..|-++.|.||++++.++.+     .....+++||+..|++.++|++.......+......+|+.||+.||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            344556689999999998754     3457899999999999999987665555677777789999999999999998 5


Q ss_pred             CCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc----eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHH
Q 015797          160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT----HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLEL  235 (400)
Q Consensus       160 ~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~el  235 (400)
                      |+++|+++..+-|++..+|-+|++-- ..........    .......+-++|.|||.-...+.+.++|||+||+...+|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            78999999999999999888887532 1111111000    011123477899999977767778899999999999999


Q ss_pred             HhCCCCh-hhhhhhh-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          236 ASGKKPI-EKVNSAI-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       236 ltg~~Pf-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..+..-- ....... ...+.         ..+..+-++.            =..++.+|++..|..||++++++..
T Consensus       276 ailEiq~tnseS~~~~ee~ia---------~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIA---------NVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCcceeehhhhhh---------hheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence            8876531 1111000 00000         0011111111            1124579999999999999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=2.6e-15  Score=145.69  Aligned_cols=249  Identities=22%  Similarity=0.236  Sum_probs=182.7

Q ss_pred             cCCCcCCcccc--cCceEEEEEEE---cCCCEEEEEEEec--CChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeE
Q 015797           38 NNFNYDNKLGE--GGFGSVYWGQL---WDGSQIAVKRLKV--WSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        38 ~~y~~~~~LG~--G~~g~Vy~a~~---~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  109 (400)
                      ..+.+.+.+|.  |.+|.||.+..   .++..+|+|.-+.  ........-..|+...+.+ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34567789999  99999999954   4577888887332  2222223334466556666 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeEECCC-CcEEEEe
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE----GIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVAD  184 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~~kl~D  184 (400)
                      ++-+|+|. .+|.++.......   ++...++..+.+...    ||.++|..+   ++|-|+||.||+...+ ..++++|
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~---~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNF---LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeecccc-chhHHhhhccccc---CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            99999996 6888887655432   666778888888888    999999887   9999999999999999 7899999


Q ss_pred             cCCccccCCCCceee----eecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccch
Q 015797          185 FGFAKLIPDGATHVT----TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL  260 (400)
Q Consensus       185 fgl~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~  260 (400)
                      ||+...+.++.....    ....|...|++||..+ +.++.++|||++|.++.+-.++..+......             
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------------  332 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-------------  332 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-------------
Confidence            999998876543221    1224788899999664 6889999999999999999988776532210             


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ..|..+....+..++...-...+...+.++++.+|-.|++...+...
T Consensus       333 ---~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  333 ---SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ---CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence               01111222222223333333445557789999999999999888763

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=5.2e-14  Score=138.12  Aligned_cols=140  Identities=19%  Similarity=0.263  Sum_probs=98.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHH----------------------------------------HHHHHH
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA----------------------------------------EMEFAV   83 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~~   83 (400)
                      +.||.|++|.||+|+..+|+.||||+........                                        +.++..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999998899999999985422110                                        012444


Q ss_pred             HHHHHhcC----CCCccceeeeEEE-eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHH-HHHHHHhc
Q 015797           84 EVEILARV----RHKNLLSLRGYCA-EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE-GIVYLHHH  157 (400)
Q Consensus        84 E~~~l~~l----~hpnIv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-aL~yLH~~  157 (400)
                      |++.+..+    +|.+-+.+-.++. .....++||||++|++|.+........   .   ....++..++. .+..+|..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHhC
Confidence            66555554    2333333333332 234568999999999998876432111   2   13345555555 46788988


Q ss_pred             CCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       158 ~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |   ++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.50  E-value=2.7e-13  Score=133.11  Aligned_cols=168  Identities=16%  Similarity=0.144  Sum_probs=126.8

Q ss_pred             EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccCh
Q 015797           58 QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNW  137 (400)
Q Consensus        58 ~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  137 (400)
                      +..++.+|.|...+..+........+-++.|+.++||||++++..++..+..|||+|-+  -.|..++....       .
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-------~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-------K  103 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-------H
Confidence            44578888888877655533445677788999999999999999999999999999998  46777775432       3


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC
Q 015797          138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG  217 (400)
Q Consensus       138 ~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  217 (400)
                      .....-+.||+.||.+||+.+  +++|++|.-+.|+|+..|..||++|.++........ ......---.|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            455567899999999999665  499999999999999999999999988865432221 11111122346667654322


Q ss_pred             CCCCccceehhhHHHHHHHhCC
Q 015797          218 KASESCDVYSFGILLLELASGK  239 (400)
Q Consensus       218 ~~s~ksDIwSlGiil~elltg~  239 (400)
                      .  -..|.|-|||++++++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  3569999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=2.7e-13  Score=134.83  Aligned_cols=145  Identities=17%  Similarity=0.254  Sum_probs=94.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcC-CCEEEEEEEecCChHH----------------------------------H----
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKA----------------------------------E----   78 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~l~~~~~~~----------------------------------~----   78 (400)
                      ..|.. +.||.|++|.||+|...+ |+.||||++.......                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 789999999999998776 9999999986431100                                  0    


Q ss_pred             --HHHHHHHHHHhcC----CCCccceeeeEEEe-CCeEEEEEEccCCCChhhh--hhcCCCcccccChHHHHHHHHHHHH
Q 015797           79 --MEFAVEVEILARV----RHKNLLSLRGYCAE-GQERLIVYDYMPNLSLLSH--LHGQHSSECLLNWNRRMDIAIGSAE  149 (400)
Q Consensus        79 --~~~~~E~~~l~~l----~hpnIv~~~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~qi~~  149 (400)
                        .++..|+..+.++    .+.+.+.+-.++.+ ....++||||+.|+.+.+.  +.........+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              1233455444444    23333444344433 4556799999999999874  22222111112222233333443  


Q ss_pred             HHHHHHhcCCCCeEecCCCCCCeEECCCC----cEEEEecCCccccCC
Q 015797          150 GIVYLHHHATPHIIHRDIKASNVLLDADF----KAQVADFGFAKLIPD  193 (400)
Q Consensus       150 aL~yLH~~~~~~iiH~dikp~NIlv~~~~----~~kl~Dfgl~~~~~~  193 (400)
                           +..|   ++|+|++|.||+++.+|    .++++|||+...++.
T Consensus       277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3466   99999999999999988    999999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=6.1e-13  Score=113.90  Aligned_cols=131  Identities=16%  Similarity=0.130  Sum_probs=95.8

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccc-eeeeEEEeCCeEEEEEEccCCCCh
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL-SLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      .+.|+.|.++.||+++. .+..+++|....... ....+..|+.+++.+.+.+++ +++...  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            35789999999999974 478899998654321 223467899999988665544 454433  3345799999999887


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA--TPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      .+.-         .   ....++.+++.+|+.||..+  ...++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6530         0   01235678999999999886  12259999999999999 67899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=3.5e-11  Score=104.47  Aligned_cols=137  Identities=15%  Similarity=0.105  Sum_probs=97.1

Q ss_pred             CCcccccCceEEEEEEEcC-------CCEEEEEEEecCC----------------------hHHHHHH----HHHHHHHh
Q 015797           43 DNKLGEGGFGSVYWGQLWD-------GSQIAVKRLKVWS----------------------NKAEMEF----AVEVEILA   89 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~-------~~~vavK~l~~~~----------------------~~~~~~~----~~E~~~l~   89 (400)
                      ...||.|--+.||.|...+       +..+|+|+.....                      ......+    ..|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999996442       4799999874200                      0111122    36999999


Q ss_pred             cCCC--CccceeeeEEEeCCeEEEEEEccCCCChhh-hhhcCCCcccccChHHHHHHHHHHHHHHHHH-HhcCCCCeEec
Q 015797           90 RVRH--KNLLSLRGYCAEGQERLIVYDYMPNLSLLS-HLHGQHSSECLLNWNRRMDIAIGSAEGIVYL-HHHATPHIIHR  165 (400)
Q Consensus        90 ~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiH~  165 (400)
                      ++..  -++..++++    ...+|||||+.+..+.. .+...     .++......+..+++.+|..| |..+   +|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            8843  456666654    56789999997654422 22211     134445667788999999999 8888   9999


Q ss_pred             CCCCCCeEECCCCcEEEEecCCccccC
Q 015797          166 DIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       166 dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||++.||+++ ++.+.|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999997 4689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=3.8e-12  Score=123.92  Aligned_cols=247  Identities=17%  Similarity=0.159  Sum_probs=170.3

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE--cCCCEEEEEEEecCChHH--HHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL--WDGSQIAVKRLKVWSNKA--EMEFAVEVEILARV-RHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~--~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  107 (400)
                      ...-..+|..+..||.|.|+.|+....  .++..+++|.+.......  ...-..|+.+...+ .|.+++.++..+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            344556888889999999999999843  457888998876433222  22234566666666 6899999888888888


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-CcEEEEecC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFG  186 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~~kl~Dfg  186 (400)
                      +.|+=-|||+++++...+...    ..++...++.+..|++.++.++|+..   ++|+|++|+||++..+ +..+++|||
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccc
Confidence            888999999999987766322    13677888999999999999999887   9999999999999886 778999999


Q ss_pred             CccccCCCCceeeeecccccCcC--ChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYL--APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      .+..+.-...    ....+..+.  +|.......+-.+.|++|||..+.+.+++..--.....        |.       
T Consensus       413 ~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~-------  473 (524)
T KOG0601|consen  413 CWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL-------  473 (524)
T ss_pred             cccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce-------
Confidence            9874221111    111333344  55555566778899999999999999997754221110        00       


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+..-.-+...+     ....+..+...+...++..||.+.++...
T Consensus       474 ~i~~~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  474 TIRSGDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             eeecccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhccc
Confidence            000000011111     11344445567777899999998877643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=6.2e-11  Score=105.91  Aligned_cols=142  Identities=20%  Similarity=0.237  Sum_probs=107.2

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCC--CccceeeeEEEeC---CeEEEEEEccC
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRH--KNLLSLRGYCAEG---QERLIVYDYMP  117 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~---~~~~lv~e~~~  117 (400)
                      +.|+.|..+.||++...+|..+++|....... .....+..|+.+++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999765568899998654222 134568889999999965  3456677766553   36689999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA---------------------------------------  158 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------------  158 (400)
                      |.++.+.+..     ..++......++.+++.+|.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776531     12566677778888888888888421                                       


Q ss_pred             --------------CCCeEecCCCCCCeEECC--CCcEEEEecCCccc
Q 015797          159 --------------TPHIIHRDIKASNVLLDA--DFKAQVADFGFAKL  190 (400)
Q Consensus       159 --------------~~~iiH~dikp~NIlv~~--~~~~kl~Dfgl~~~  190 (400)
                                    ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          123799999999999998  66789999988763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=8.4e-11  Score=98.48  Aligned_cols=143  Identities=20%  Similarity=0.239  Sum_probs=104.9

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEecCChH--------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK--------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ....|-+|+-+.|+++. ..|+..+||.-......        ...+..+|++.|..+.--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~-~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS-FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeec-cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            45788899999999997 57888777753321111        1235667999999886555555444667777888999


Q ss_pred             EccCC-CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc---EEEEecCCcc
Q 015797          114 DYMPN-LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVADFGFAK  189 (400)
Q Consensus       114 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~---~kl~Dfgl~~  189 (400)
                      ||++| .++.+++...-..+  ........++..|-+.+.-||..+   +|||||..+||++.+++.   +.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence            99986 37777775443321  222333678899999999999998   999999999999976653   5899999986


Q ss_pred             c
Q 015797          190 L  190 (400)
Q Consensus       190 ~  190 (400)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.2e-10  Score=97.99  Aligned_cols=131  Identities=23%  Similarity=0.297  Sum_probs=97.8

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCCh--HH-H-----HHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN--KA-E-----MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~--~~-~-----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..+++|+-+.+|.+.+ -|..+++|.=.....  .. .     .+-..|+++++.+.--.|.-.+=+..+..+..|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4688999999999964 455566664322111  11 1     2355699999988665555555456677888899999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ++|-.|.+.+...           ...++..+-.-+.-||..+   |+||||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888888643           2346667777788899999   99999999999998775 99999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.24  E-value=1.4e-10  Score=111.04  Aligned_cols=171  Identities=18%  Similarity=0.273  Sum_probs=130.4

Q ss_pred             CceEEEEE-EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEE----eCCeEEEEEEccCC-CChhh
Q 015797           50 GFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA----EGQERLIVYDYMPN-LSLLS  123 (400)
Q Consensus        50 ~~g~Vy~a-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~~lv~e~~~~-gsL~~  123 (400)
                      ...+.|++ ...+|..|++|+++............-+++.+++.|+|+|+|.++|.    .+..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            45688999 56789999999996444333334445678899999999999999886    35678999999875 57766


Q ss_pred             hhhcCCC-----------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          124 HLHGQHS-----------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       124 ~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      .-.....           .....++..+|.++.|+..||.++|+.|   +.-+-|.|.+|+++.+.+++|...|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5432211           1234678899999999999999999999   8889999999999999999999999887665


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP  241 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~P  241 (400)
                      ....             +|  +..   -.+-|.=-||.++..|.||..-
T Consensus       445 ~d~~-------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT-------------EP--LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC-------------cc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4331             11  111   1467888999999999998653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.21  E-value=7.8e-10  Score=103.53  Aligned_cols=194  Identities=19%  Similarity=0.228  Sum_probs=130.5

Q ss_pred             CcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccce--------eeeEEEeCCeEEE
Q 015797           41 NYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLS--------LRGYCAEGQERLI  111 (400)
Q Consensus        41 ~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~--------~~~~~~~~~~~~l  111 (400)
                      ..+..||+|+-+.+|..-  .-...+.|+..........+..   ..|... .||-+..        ++|- .....+.+
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence            466889999999999763  2223345666544333332222   223332 5654433        1111 12233678


Q ss_pred             EEEccCCCC-hhhhhhcC--CCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          112 VYDYMPNLS-LLSHLHGQ--HSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       112 v~e~~~~gs-L~~~l~~~--~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .|+.+++.. ...++.-.  ..+-...+|...+..++.++.+.+-||.+|   .+-||++++|+||++++.+.|.|-...
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            999887652 23333211  112234799999999999999999999999   899999999999999999999985554


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccC-----CCCCccceehhhHHHHHHHhC-CCChhhh
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLG-----KASESCDVYSFGILLLELASG-KKPIEKV  245 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDIwSlGiil~elltg-~~Pf~~~  245 (400)
                      ....++...  ...+|.+.|++||.-.-+     ..+..+|-|.||+++++|+.| ++||.+.
T Consensus       165 qi~~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         165 QINANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eeccCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            433222222  223589999999976523     346789999999999999885 9999764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.20  E-value=4.2e-12  Score=130.00  Aligned_cols=206  Identities=20%  Similarity=0.219  Sum_probs=147.7

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .+....+.+.+.+-.|.++.++.+.- ..+...+.+.....   ..........+-.++-.-.+|-++.....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            45556667778899999999998842 23444444433211   111111222233333334556677666556667788


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +|+++|..+++|...|+.-..    .+.......+..+..+++|||...   ++|+|++|.|.++..+|+.+++|||...
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence            999999999999998876542    444556667778889999999886   8999999999999999999999998432


Q ss_pred             ccCCC--------Cc----------------------eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCC
Q 015797          190 LIPDG--------AT----------------------HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK  239 (400)
Q Consensus       190 ~~~~~--------~~----------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~  239 (400)
                      ...--        ..                      .......||+.|.+||.+.+......+|+|++|+++++.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            22100        00                      0112346899999999999999999999999999999999999


Q ss_pred             CChhhhh
Q 015797          240 KPIEKVN  246 (400)
Q Consensus       240 ~Pf~~~~  246 (400)
                      .||....
T Consensus      1033 pp~na~t 1039 (1205)
T KOG0606|consen 1033 PPFNAET 1039 (1205)
T ss_pred             CCCCCcc
Confidence            9998654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=3.6e-09  Score=91.55  Aligned_cols=126  Identities=25%  Similarity=0.313  Sum_probs=81.1

Q ss_pred             EEEEEEEcCCCEEEEEEEecCCh---------------------H-----HHHHHHHHHHHHhcCCCC--ccceeeeEEE
Q 015797           53 SVYWGQLWDGSQIAVKRLKVWSN---------------------K-----AEMEFAVEVEILARVRHK--NLLSLRGYCA  104 (400)
Q Consensus        53 ~Vy~a~~~~~~~vavK~l~~~~~---------------------~-----~~~~~~~E~~~l~~l~hp--nIv~~~~~~~  104 (400)
                      .||.|...+|..+|+|.......                     .     .......|++.|..+..-  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999878899999998742100                     0     012356799999999765  45666644  


Q ss_pred             eCCeEEEEEEccC--CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          105 EGQERLIVYDYMP--NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY-LHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       105 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                        ...+|||||+.  |..+.. +....     ++......++.+++..+.. +|..|   ++||||.+.||+++.+ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence              23469999998  555544 33221     1123455667777775555 57888   9999999999999887 899


Q ss_pred             EEecCCccccC
Q 015797          182 VADFGFAKLIP  192 (400)
Q Consensus       182 l~Dfgl~~~~~  192 (400)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=1.1e-08  Score=93.88  Aligned_cols=141  Identities=15%  Similarity=0.067  Sum_probs=97.6

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHH-----------HHHHHHHHHHHhcCCCCc--cceeeeEEEe-----
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-----------EMEFAVEVEILARVRHKN--LLSLRGYCAE-----  105 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~-----  105 (400)
                      +.+-......|++.. ..|+.+.+|......-..           ...+..|...+..|..-+  ....+.+...     
T Consensus        28 e~v~~~~~rrvvr~~-~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFE-LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEE-ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            344444444566664 478899999764322111           113678888888874332  3334444432     


Q ss_pred             CCeEEEEEEccCCC-ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-------C
Q 015797          106 GQERLIVYDYMPNL-SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-------D  177 (400)
Q Consensus       106 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-------~  177 (400)
                      ....+||||++++. +|.+++......  ..+......++.+++..+.-||..|   ++|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~--~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATN--PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence            23578999999875 788887543211  2455667789999999999999999   999999999999975       4


Q ss_pred             CcEEEEecCCccc
Q 015797          178 FKAQVADFGFAKL  190 (400)
Q Consensus       178 ~~~kl~Dfgl~~~  190 (400)
                      +.+.|+||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6799999998853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.98  E-value=7.2e-09  Score=92.46  Aligned_cols=135  Identities=21%  Similarity=0.191  Sum_probs=95.8

Q ss_pred             CCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh----------------------HHHHHHHHHHHHHhcCCCC--
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN----------------------KAEMEFAVEVEILARVRHK--   94 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~hp--   94 (400)
                      =+.++..||-|--|.||.|....|.++|+|.-.....                      -......+|.++|..|.-.  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            4578899999999999999888899999996532111                      0112356799999999654  


Q ss_pred             ccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797           95 NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus        95 nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                      .+.+.++    .+...+||||++|-.|...-..      .-+...   ++..|+.-+.-+-..|   +||||+++-||+|
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r~~------~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV  235 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLRLD------VENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILV  235 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeecccCc------ccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence            6666665    3677899999998666553211      122233   3333444444444566   9999999999999


Q ss_pred             CCCCcEEEEecCCcc
Q 015797          175 DADFKAQVADFGFAK  189 (400)
Q Consensus       175 ~~~~~~kl~Dfgl~~  189 (400)
                      +++|.+.++||--+.
T Consensus       236 ~~dg~~~vIDwPQ~v  250 (304)
T COG0478         236 TEDGDIVVIDWPQAV  250 (304)
T ss_pred             ecCCCEEEEeCcccc
Confidence            999999999996654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.2e-10  Score=111.37  Aligned_cols=149  Identities=19%  Similarity=0.309  Sum_probs=101.2

Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeee--------ecccccCcCChhhhccC
Q 015797          146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT--------RVKGTLGYLAPEYAMLG  217 (400)
Q Consensus       146 qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~~  217 (400)
                      +++.||.|+|...  .+||++|.|++|.++..+.+||+.|+++............        -......|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4458999999865  5999999999999999999999999998765542222111        12246689999999998


Q ss_pred             CCCCccceehhhHHHHHHHhCCCCh-hhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhcccc
Q 015797          218 KASESCDVYSFGILLLELASGKKPI-EKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHS  296 (400)
Q Consensus       218 ~~s~ksDIwSlGiil~elltg~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  296 (400)
                      ..+.++|+||+|+++|.+..|..+. ...+..+...+...             ....-......+...++.+=+.+.+..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-------------~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-------------LLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-------------ccccccccccccCcHHHHHHHHHHhcC
Confidence            8899999999999999999655553 32221111111100             000000011223344566666788888


Q ss_pred             CCCCCCCHHHHHH
Q 015797          297 KPEKRPTMLEVLD  309 (400)
Q Consensus       297 dP~~Rps~~ell~  309 (400)
                      ++.-||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998777765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=8.3e-08  Score=84.91  Aligned_cols=106  Identities=22%  Similarity=0.248  Sum_probs=81.0

Q ss_pred             HHHHHHHHHHhcCCC--CccceeeeEEEeC----CeEEEEEEccCCC-ChhhhhhcCCCcccccChHHHHHHHHHHHHHH
Q 015797           79 MEFAVEVEILARVRH--KNLLSLRGYCAEG----QERLIVYDYMPNL-SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGI  151 (400)
Q Consensus        79 ~~~~~E~~~l~~l~h--pnIv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  151 (400)
                      .....|...+..|..  =.+.+.+++....    ...++|||++++. +|.+++.....    .+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence            357778888877743  2344555555442    2458999999874 78888865322    44456778999999999


Q ss_pred             HHHHhcCCCCeEecCCCCCCeEECCCC---cEEEEecCCcccc
Q 015797          152 VYLHHHATPHIIHRDIKASNVLLDADF---KAQVADFGFAKLI  191 (400)
Q Consensus       152 ~yLH~~~~~~iiH~dikp~NIlv~~~~---~~kl~Dfgl~~~~  191 (400)
                      +-||..|   ++|+|+++.|||++.++   .+.++||+-+...
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999   99999999999999887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=5.1e-08  Score=96.75  Aligned_cols=143  Identities=13%  Similarity=0.207  Sum_probs=91.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChH----------------------------------------HHHHHHH
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK----------------------------------------AEMEFAV   83 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~----------------------------------------~~~~~~~   83 (400)
                      ..|+.++-|.||+|...+|+.||||+....-..                                        .+.++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            689999999999999989999999987431110                                        0112444


Q ss_pred             HHHHHhcC----CCCccceeeeEEE-eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC
Q 015797           84 EVEILARV----RHKNLLSLRGYCA-EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA  158 (400)
Q Consensus        84 E~~~l~~l----~hpnIv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~  158 (400)
                      |+..+.++    ++..-+.+=.++. -.+...++|||++|-.+.+...-...   .++...+.....++.  +..+-..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~f--~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRAF--LRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHHH--HHHHHhcC
Confidence            66666555    2222222323333 24566799999999888887422111   133222222222221  11222245


Q ss_pred             CCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       159 ~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                         ++|+|.+|.||+++.+|++.+.|||+...+...
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence               999999999999999999999999998876543

>PRK09902 hypothetical protein; Provisional

Probab=98.72  E-value=3.3e-07  Score=79.96  Aligned_cols=138  Identities=14%  Similarity=0.133  Sum_probs=99.9

Q ss_pred             ccccCceEEEEEEEcCCCEEEEEEEecC-----C-hHHHHHHHHHHHHHhcCCC--CccceeeeEEE-e----CCeEEEE
Q 015797           46 LGEGGFGSVYWGQLWDGSQIAVKRLKVW-----S-NKAEMEFAVEVEILARVRH--KNLLSLRGYCA-E----GQERLIV  112 (400)
Q Consensus        46 LG~G~~g~Vy~a~~~~~~~vavK~l~~~-----~-~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~-~----~~~~~lv  112 (400)
                      -|+||.+-|+.... .|..+-+|.-...     . +.....|..|+..|..|..  -++.++. ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            45699999999863 4557778875411     1 2345679999999998843  2244444 222 1    1235799


Q ss_pred             EEccCC-CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc--EEEEecCCcc
Q 015797          113 YDYMPN-LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK--AQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~--~kl~Dfgl~~  189 (400)
                      +|-+.| -+|.+++......  ..+...+..++.+++.+++-||..|   +.|+|+.+.||+++.+|.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998764 4788887654322  2566777889999999999999999   999999999999987677  9999997766


Q ss_pred             c
Q 015797          190 L  190 (400)
Q Consensus       190 ~  190 (400)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=2.4e-07  Score=83.11  Aligned_cols=138  Identities=14%  Similarity=0.175  Sum_probs=84.3

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc--cceeeeEEEeCCeEEEEEEccCCCC-
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN--LLSLRGYCAEGQERLIVYDYMPNLS-  120 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~gs-  120 (400)
                      ..||+|..+.||+.   .+..+++|......  ......+|+++++.+..-+  +.+++++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   35567788765422  2344688999999886433  4677888877888889999999863 


Q ss_pred             hhhhh---------------------hcCCCcccccChHHHHH-HHH----------HHHH-HHHHHHh-cCCCCeEecC
Q 015797          121 LLSHL---------------------HGQHSSECLLNWNRRMD-IAI----------GSAE-GIVYLHH-HATPHIIHRD  166 (400)
Q Consensus       121 L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------qi~~-aL~yLH~-~~~~~iiH~d  166 (400)
                      +...+                     +.-....  ........ +..          .+.. ...+|.. ...+.++|+|
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            21111                     1100000  01010000 000          0001 1112221 1133579999


Q ss_pred             CCCCCeEECCCCcEEEEecCCcc
Q 015797          167 IKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       167 ikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +.|.||+++.++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.71  E-value=2.4e-09  Score=105.03  Aligned_cols=194  Identities=16%  Similarity=0.113  Sum_probs=141.3

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeEE
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN-LLSLRGYCAEGQERL  110 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~  110 (400)
                      .+.+.+..|.....+++|+++.+|+.+....+....+.+...     ....-++++|.+++||| .+..++-+..+....
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~  310 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW  310 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence            345666667777789999999999986444444445554432     44566889999999999 777777777778889


Q ss_pred             EEEEccCCC-ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          111 IVYDYMPNL-SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       111 lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++++++.+| +....+.   ..+..+...+...+.+.-.++++|+|+.-   -+|+|    ||+.++ +..+.+||+...
T Consensus       311 i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~  379 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPP  379 (829)
T ss_pred             hhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCc
Confidence            999999887 3322221   12222333344455556678999999874   48888    777655 678999999988


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChh
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE  243 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~  243 (400)
                      .+....  ......+|+.|+|||+...+.+..+.|.|++|.--.+|.-|-+|-.
T Consensus       380 ~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  380 QLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            776543  2233459999999999999999999999999998778888877743

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.62  E-value=8.8e-07  Score=77.63  Aligned_cols=137  Identities=16%  Similarity=0.172  Sum_probs=90.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHH---------HHHHHHhcC---CCCccceeeeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFA---------VEVEILARV---RHKNLLSLRGYC  103 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~---------~E~~~l~~l---~hpnIv~~~~~~  103 (400)
                      ..++|...+.+-......|.+-. .+|..+++|.........+..|.         +.+..+..+   .-..+..++-+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe-i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE-IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE-ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45778888888877777776664 46788999987654333333222         233333333   223334433333


Q ss_pred             Ee-----CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          104 AE-----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       104 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      ..     ....+++|||++|..|.+...        ++.    .+...+++++.-||..|   ++|||..|.|++++.++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence            22     234568999999988877532        221    24456678899999999   99999999999998654


Q ss_pred             cEEEEecCCcc
Q 015797          179 KAQVADFGFAK  189 (400)
Q Consensus       179 ~~kl~Dfgl~~  189 (400)
                       ++++||+..+
T Consensus       173 -i~iID~~~k~  182 (229)
T PF06176_consen  173 -IRIIDTQGKR  182 (229)
T ss_pred             -EEEEECcccc
Confidence             9999997765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=2.8e-06  Score=76.22  Aligned_cols=143  Identities=19%  Similarity=0.164  Sum_probs=82.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCC--ccceeeeEEE---eCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK--NLLSLRGYCA---EGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~---~~~~~~lv~e~~~~  118 (400)
                      +.|+.|..+.||++...+ ..+++|.....  .....+..|+.+++.|...  .+.+++....   .....+++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            578999999999998655 69999986543  4456677888888888433  3556665442   33457899999998


Q ss_pred             CChhh----------------hh---hcCCCcccccChHH---------HHHH------------HHHHHH-HHHHHHhc
Q 015797          119 LSLLS----------------HL---HGQHSSECLLNWNR---------RMDI------------AIGSAE-GIVYLHHH  157 (400)
Q Consensus       119 gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~qi~~-aL~yLH~~  157 (400)
                      .++..                .+   +........+....         ....            ...+.. .+..++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87766                11   11100000011100         0000            011122 23333321


Q ss_pred             ----CCCCeEecCCCCCCeEEC-CCCcEEEEecCCcc
Q 015797          158 ----ATPHIIHRDIKASNVLLD-ADFKAQVADFGFAK  189 (400)
Q Consensus       158 ----~~~~iiH~dikp~NIlv~-~~~~~kl~Dfgl~~  189 (400)
                          ....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                234599999999999999 66777899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=4.5e-06  Score=74.07  Aligned_cols=159  Identities=17%  Similarity=0.170  Sum_probs=106.5

Q ss_pred             CCCCcccccHHHHHHHccCCCcCCccc---ccCceEEEEEEEcCCCEEEEEEEecCChHHH-------------------
Q 015797           21 KQPTWRIFSLKELHSATNNFNYDNKLG---EGGFGSVYWGQLWDGSQIAVKRLKVWSNKAE-------------------   78 (400)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~y~~~~~LG---~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~-------------------   78 (400)
                      ....+...+...+....++..+....|   .|--+.||+|...++..+|+|+.......-.                   
T Consensus        28 ~~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r  107 (268)
T COG1718          28 VDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR  107 (268)
T ss_pred             hhhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence            344556778888888888888877655   5666699999878899999999863221110                   


Q ss_pred             -----HHHHHHHHHHhcCC--CCccceeeeEEEeCCeEEEEEEccCCC-ChhhhhhcCCCcccccChHHHHHHHHHHHHH
Q 015797           79 -----MEFAVEVEILARVR--HKNLLSLRGYCAEGQERLIVYDYMPNL-SLLSHLHGQHSSECLLNWNRRMDIAIGSAEG  150 (400)
Q Consensus        79 -----~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  150 (400)
                           .-...|+..|+++.  +-.+.+.+.+.    +..|||||+... .-.-.|..-     .+.......+..++++.
T Consensus       108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~  178 (268)
T COG1718         108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEY  178 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHH
Confidence                 01234777777773  33344444432    346999999543 112222211     12223455666777777


Q ss_pred             HHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          151 IVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       151 L~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      +.-|-. .+   +||+||+.-|||+. ++.+.++|||-+....
T Consensus       179 ~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         179 MRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            777776 55   99999999999999 8899999999886543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.43  E-value=3.8e-06  Score=76.36  Aligned_cols=141  Identities=17%  Similarity=0.210  Sum_probs=83.3

Q ss_pred             cccccCc-eEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEEEEccCCCChh
Q 015797           45 KLGEGGF-GSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIVYDYMPNLSLL  122 (400)
Q Consensus        45 ~LG~G~~-g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~  122 (400)
                      .|..|.+ +.||+... .+..+++|+.....   ...+..|+++++.+. +--+.+++++....+..++||++++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3444444 78999964 35778888765432   335667888888873 444667787777666789999999987765


Q ss_pred             hhh-------------------hcCCCcccccC--hHHHHHHHHH--------------------HHHHHHHHHh----c
Q 015797          123 SHL-------------------HGQHSSECLLN--WNRRMDIAIG--------------------SAEGIVYLHH----H  157 (400)
Q Consensus       123 ~~l-------------------~~~~~~~~~l~--~~~~~~i~~q--------------------i~~aL~yLH~----~  157 (400)
                      ...                   +........+.  ....+.....                    +...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   11110000110  0000000000                    1111112211    1


Q ss_pred             CCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       158 ~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ..+.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            12348999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=2.1e-06  Score=85.09  Aligned_cols=138  Identities=15%  Similarity=0.246  Sum_probs=89.2

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHH-------------------------------------HHHHHHHHH
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-------------------------------------EMEFAVEVE   86 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~   86 (400)
                      +.||..+.|.||+|+..+|+.||||+-+..-...                                     +-+|..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6899999999999999999999999865321110                                     012334554


Q ss_pred             HHhc----CCCCc------cceeeeEEEeCCeEEEEEEccCCCChhhh--hhcCCCcccccChHHHHHHHHHHHHHHHHH
Q 015797           87 ILAR----VRHKN------LLSLRGYCAEGQERLIVYDYMPNLSLLSH--LHGQHSSECLLNWNRRMDIAIGSAEGIVYL  154 (400)
Q Consensus        87 ~l~~----l~hpn------Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~qi~~aL~yL  154 (400)
                      -...    +.|-+      |.++|..+  .....|+||||+|..+.|.  |....     ++...+..-+.+...-+  +
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~i~~~l~~~~~~q--I  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-----ISPHDILNKLVEAYLEQ--I  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-----CCHHHHHHHHHHHHHHH--H
Confidence            4433    34444      44444333  3456799999999888665  33222     44444433333322111  2


Q ss_pred             HhcCCCCeEecCCCCCCeEECC----CCcEEEEecCCccccCC
Q 015797          155 HHHATPHIIHRDIKASNVLLDA----DFKAQVADFGFAKLIPD  193 (400)
Q Consensus       155 H~~~~~~iiH~dikp~NIlv~~----~~~~kl~Dfgl~~~~~~  193 (400)
                      =..|   ++|+|-.|.||+++.    ++.+.+.|||+......
T Consensus       318 f~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2334   899999999999984    67899999999986654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.30  E-value=2.1e-05  Score=68.63  Aligned_cols=133  Identities=15%  Similarity=0.192  Sum_probs=90.8

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCC----------------hHHHHHHHHHHHHHhcCC------CCccceee
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS----------------NKAEMEFAVEVEILARVR------HKNLLSLR  100 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~~~  100 (400)
                      ...||+|+.-.||.=  ..+....||+.....                .....+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            467999999999864  456667788876544                112344556666665555      88999999


Q ss_pred             eEEEeCCeEEEEEEccCC------CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797          101 GYCAEGQERLIVYDYMPN------LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                      |+.+++....+|+|.+.+      -+|.+++....     ++. .....+.++   ..||-..+   |+.+|++|.||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence            999999999999998632      35677774332     443 344444444   45666666   9999999999999


Q ss_pred             CCC---C-cEEEEe-cCCcc
Q 015797          175 DAD---F-KAQVAD-FGFAK  189 (400)
Q Consensus       175 ~~~---~-~~kl~D-fgl~~  189 (400)
                      ...   . .+.|+| ||...
T Consensus       152 ~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             EecCCCceEEEEEeCCCCcc
Confidence            533   2 577777 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.23  E-value=6e-06  Score=71.70  Aligned_cols=105  Identities=20%  Similarity=0.208  Sum_probs=81.7

Q ss_pred             HHHHHHHhcCCC-CccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCC
Q 015797           82 AVEVEILARVRH-KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP  160 (400)
Q Consensus        82 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~  160 (400)
                      ..|.-+|+.+++ +++.+++|+|..    ++++||...+++....... ..-...+|..+..++.++++.+.+|+.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            347888888876 699999999843    6899999877665321000 0001278999999999999999999986545


Q ss_pred             CeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          161 HIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       161 ~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      .+.-.|++++|+-++++|++|++|.......
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            5889999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.20  E-value=2e-05  Score=84.12  Aligned_cols=79  Identities=10%  Similarity=0.265  Sum_probs=55.7

Q ss_pred             CCcccccCceEEEEEEEcCC---CEEEEEEEecCC-hHHHHHHHHHHHHHhcCC-CCcc--ceeeeEEEeC---CeEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWDG---SQIAVKRLKVWS-NKAEMEFAVEVEILARVR-HKNL--LSLRGYCAEG---QERLIV  112 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~---~~~~lv  112 (400)
                      .+.|+.|.++.+|+.....+   ..+++|+..... ......+..|+++|+.+. |+++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999865443   356777654321 122346789999999995 6654  7788877664   467899


Q ss_pred             EEccCCCCh
Q 015797          113 YDYMPNLSL  121 (400)
Q Consensus       113 ~e~~~~gsL  121 (400)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.16  E-value=4.7e-05  Score=66.07  Aligned_cols=137  Identities=23%  Similarity=0.356  Sum_probs=94.4

Q ss_pred             CCCCcccccHHHHHHHccCCCcCCcccccCc-eEEEEEEEcCCCEEEEEEEec---CCh------------------HHH
Q 015797           21 KQPTWRIFSLKELHSATNNFNYDNKLGEGGF-GSVYWGQLWDGSQIAVKRLKV---WSN------------------KAE   78 (400)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~-g~Vy~a~~~~~~~vavK~l~~---~~~------------------~~~   78 (400)
                      +.|....|+.     -+.+++.++.||.|.- |.||+++ -.|+.+|+|.+..   ...                  ...
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~-I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVE-IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEE-ECCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            3344456665     2278899999999999 9999997 4788999999421   000                  011


Q ss_pred             HHHHHHHHHHhcCC---CCcc--ceeeeEEEeC------------------CeEEEEEEccCCCChhhhhhcCCCccccc
Q 015797           79 MEFAVEVEILARVR---HKNL--LSLRGYCAEG------------------QERLIVYDYMPNLSLLSHLHGQHSSECLL  135 (400)
Q Consensus        79 ~~~~~E~~~l~~l~---hpnI--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l  135 (400)
                      ..|..|-++..+|+   +.++  ++.+|+..-.                  ....||.||.+...             .+
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~  165 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL  165 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc
Confidence            24777888888774   4566  8999986322                  12357777776533             01


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       136 ~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .    ..-+.++.+-|..+|..|   |+-+|+++.|..     .-+|+|||.+
T Consensus       166 ~----~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  166 Q----IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             c----hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            1    223455667778899999   999999999988     4579999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.13  E-value=2.5e-05  Score=70.62  Aligned_cols=73  Identities=15%  Similarity=0.179  Sum_probs=44.9

Q ss_pred             CcccccCce-EEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCC---ccceeeeEEEeC---CeEEEEEEcc
Q 015797           44 NKLGEGGFG-SVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK---NLLSLRGYCAEG---QERLIVYDYM  116 (400)
Q Consensus        44 ~~LG~G~~g-~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~---~~~~lv~e~~  116 (400)
                      +.|+.|+.. .||+.    +..+++|....  ......+..|++++..|...   .+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567777776 48876    23566775432  12234688899999888532   344444433322   2347899999


Q ss_pred             CCCChh
Q 015797          117 PNLSLL  122 (400)
Q Consensus       117 ~~gsL~  122 (400)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.12  E-value=5e-05  Score=71.12  Aligned_cols=76  Identities=8%  Similarity=0.017  Sum_probs=55.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC---CccceeeeEEEe---CCeEEEEEEcc
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH---KNLLSLRGYCAE---GQERLIVYDYM  116 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~---~~~~~lv~e~~  116 (400)
                      .+.||.|..+.||.....++ .+++|..+.  ......+..|+..|+.|.-   -.+.++++++..   .+..++|||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            45799999999999965445 466676432  1123468889999998843   467888887754   36689999999


Q ss_pred             CCCCh
Q 015797          117 PNLSL  121 (400)
Q Consensus       117 ~~gsL  121 (400)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.10  E-value=3.6e-05  Score=69.43  Aligned_cols=73  Identities=12%  Similarity=0.150  Sum_probs=47.4

Q ss_pred             CcccccCceEEEEEEEcC--CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEEEccCCCC
Q 015797           44 NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVYDYMPNLS  120 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~gs  120 (400)
                      +.|..|-...+|+....+  +..+++|+.... .........|+.+++.+...++ .+++..+.  +  .++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            567888899999997553  678888876532 2112234568888888854333 34443322  2  48999998866


Q ss_pred             h
Q 015797          121 L  121 (400)
Q Consensus       121 L  121 (400)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=2.7e-05  Score=71.30  Aligned_cols=140  Identities=13%  Similarity=0.086  Sum_probs=77.8

Q ss_pred             cccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEEEccCCCChhh
Q 015797           45 KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVYDYMPNLSLLS  123 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~gsL~~  123 (400)
                      .+..|-.+.+|+.. .++..+++|...............|..+++.+...++ .+++...  .  -++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence            45678888999986 4567788886543221111235678888888864333 3344332  2  368999999866532


Q ss_pred             h-----------------hhcCCCcccccChHHH-HHHHHHH---------HHHHHHHHhc-----CCCCeEecCCCCCC
Q 015797          124 H-----------------LHGQHSSECLLNWNRR-MDIAIGS---------AEGIVYLHHH-----ATPHIIHRDIKASN  171 (400)
Q Consensus       124 ~-----------------l~~~~~~~~~l~~~~~-~~i~~qi---------~~aL~yLH~~-----~~~~iiH~dikp~N  171 (400)
                      .                 ++........++.... ..+..++         ...+..+-..     ..+.++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 1111111111221111 1111111         1112222111     12248999999999


Q ss_pred             eEECCCCcEEEEecCCccc
Q 015797          172 VLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~  190 (400)
                      |+++.++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999988763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.08  E-value=3.4e-05  Score=64.93  Aligned_cols=129  Identities=22%  Similarity=0.294  Sum_probs=89.9

Q ss_pred             CcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccce-eeeEEEeCCeEEEEEEccCCC
Q 015797           41 NYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS-LRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        41 ~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      +..+.|++|.+|.||++. +.|..+|+|+-...+  ....+..|+++|..+.--++.+ +|.+.    ..++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~-~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGE-WRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEee-ccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            556789999999999997 466788888765433  3456888999999887666544 44332    223559999988


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCeEECCCCcEEEEecCCccc
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIK-ASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dik-p~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|.+.-...       +    ..-+..++++-.-|...|   |-|+.|. |...+|..++.+.|+||..++.
T Consensus        98 ~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG-------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc-------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            888765421       1    112334555555566777   8899887 5555555666999999998873

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.96  E-value=2.8e-05  Score=81.97  Aligned_cols=196  Identities=23%  Similarity=0.243  Sum_probs=135.2

Q ss_pred             HHHHHHHhcCCCCccceeeeEEEeCCeEE----EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc
Q 015797           82 AVEVEILARVRHKNLLSLRGYCAEGQERL----IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH  157 (400)
Q Consensus        82 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~  157 (400)
                      ..|+..+....|+|++.++.+..+.....    +..++|+.-++...+..-.    .++....+.+..++.+||.|+|..
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHHh
Confidence            34777888889999999998876554333    4567888888888775433    377888888999999999999988


Q ss_pred             CCCCeEecCCCCC---CeEECCCCcEEEE--ecCCccccCCCCceeeeecccccCcCChhhhccCCCCC--ccceehhhH
Q 015797          158 ATPHIIHRDIKAS---NVLLDADFKAQVA--DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE--SCDVYSFGI  230 (400)
Q Consensus       158 ~~~~iiH~dikp~---NIlv~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDIwSlGi  230 (400)
                      .   ..|.-+..+   +--++..+.+..+  ||+.+...........  ..-+..|.+||......++.  ..|+|.+|.
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence            5   555555544   4555666777777  8988876654333222  22456788899887766654  479999999


Q ss_pred             HHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          231 LLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       231 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+..+..|..+-....                  ....+.+    .....    .+.+...+|+..++++|+++.+++..
T Consensus       381 l~~~~~~~~~i~~~~~------------------~~~~~l~----~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSA------------------VPVSLLD----VLSTS----ELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHhhhhhcCccccccc------------------chhhhhc----cccch----hhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999988766522110                  0000111    01111    34556689999999999999999986


Q ss_pred             hc
Q 015797          311 LK  312 (400)
Q Consensus       311 L~  312 (400)
                      ..
T Consensus       435 ~f  436 (1351)
T KOG1035|consen  435 PF  436 (1351)
T ss_pred             hh
Confidence            53

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.0002  Score=69.25  Aligned_cols=75  Identities=15%  Similarity=0.201  Sum_probs=52.7

Q ss_pred             CcccccCceEEEEEEEcCC-CEEEEEEEecC-----C--hHHHHHHHHHHHHHhcCC---CCccceeeeEEEeCCeEEEE
Q 015797           44 NKLGEGGFGSVYWGQLWDG-SQIAVKRLKVW-----S--NKAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +.||.|.+..||++...+| +.++||.-...     .  .....+...|.+.|..+.   -.++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999987666 48999974311     1  123456677888888762   2456677665  44667899


Q ss_pred             EEccCCCC
Q 015797          113 YDYMPNLS  120 (400)
Q Consensus       113 ~e~~~~gs  120 (400)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998644

>PRK05231 homoserine kinase; Provisional

Probab=97.88  E-value=0.00037  Score=65.96  Aligned_cols=158  Identities=15%  Similarity=0.164  Sum_probs=83.1

Q ss_pred             ccHHHHHHHccCCCc-----CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc--cceee
Q 015797           28 FSLKELHSATNNFNY-----DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN--LLSLR  100 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~-----~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~  100 (400)
                      .+.+++......|.+     .+.|+.|....+|.....+| .+++|+.....   ...+..|+.++..|...+  +.+++
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence            345555555566755     24567788789999975544 68888765211   223334555555552111  23333


Q ss_pred             e------EEEeCCeEEEEEEccCCCChh-----------hhh---hcCCCc-------cccc-ChHHHHH----------
Q 015797          101 G------YCAEGQERLIVYDYMPNLSLL-----------SHL---HGQHSS-------ECLL-NWNRRMD----------  142 (400)
Q Consensus       101 ~------~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~~~~-------~~~l-~~~~~~~----------  142 (400)
                      .      +....+..+++++|++|..+.           +.+   +.....       ...+ .|.....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            2      123356678999999886431           111   110000       0001 1111111          


Q ss_pred             --HHHH-HHHHHHHHHhc----CCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          143 --IAIG-SAEGIVYLHHH----ATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       143 --i~~q-i~~aL~yLH~~----~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                        .+.+ +...+..+...    -...+||+|+.|.||+++.+...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              1111 11112222211    12349999999999999876556899999876

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.84  E-value=0.00028  Score=66.01  Aligned_cols=143  Identities=17%  Similarity=0.193  Sum_probs=82.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc--cceeeeE------EEeCCeEEEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN--LLSLRGY------CAEGQERLIVYD  114 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~------~~~~~~~~lv~e  114 (400)
                      .+.|..|....+|+... ++..+++|+...   .....+..|+.++..|.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45677888889999864 345788887654   22345666777777774322  3444331      233456789999


Q ss_pred             ccCCCChhh-----------hh---hcC----CCc---ccccChHHHH----------HHHHHHHHHHHHHHhc----CC
Q 015797          115 YMPNLSLLS-----------HL---HGQ----HSS---ECLLNWNRRM----------DIAIGSAEGIVYLHHH----AT  159 (400)
Q Consensus       115 ~~~~gsL~~-----------~l---~~~----~~~---~~~l~~~~~~----------~i~~qi~~aL~yLH~~----~~  159 (400)
                      +++|..+..           .+   +..    ...   .....|....          .....+..++.++...    ..
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998866422           00   100    000   0011111110          0111123344444431    12


Q ss_pred             CCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          160 PHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       160 ~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ..++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            249999999999999998778899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.81  E-value=2.9e-05  Score=71.49  Aligned_cols=148  Identities=17%  Similarity=0.147  Sum_probs=99.2

Q ss_pred             cccHHHHHHHcc---CCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh----------------------HHHHHH
Q 015797           27 IFSLKELHSATN---NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN----------------------KAEMEF   81 (400)
Q Consensus        27 ~~~~~~~~~~~~---~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~----------------------~~~~~~   81 (400)
                      -+.+-.+....+   =|.++..||-|--+.+|.+-...|++.++|.-.....                      -.....
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            344444433333   4678899999999999999878899999885421100                      011234


Q ss_pred             HHHHHHHhcCC-C-CccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCC
Q 015797           82 AVEVEILARVR-H-KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT  159 (400)
Q Consensus        82 ~~E~~~l~~l~-h-pnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~  159 (400)
                      ..|+..|+.|. | =-+.+.++    .+..++|||++.|..|.+.-+-       .+...+.   ..+..-+--|-.+| 
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly---~~lm~~Iv~la~~G-  222 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLY---DDLMGLIVRLANHG-  222 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHH---HHHHHHHHHHHHcC-
Confidence            56888888884 3 22444443    4667899999999888764321       1222333   33334445577788 


Q ss_pred             CCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       160 ~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                        +||||.+--||+|+.++.++++||--+...
T Consensus       223 --lIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             --ceecccchheeEEecCCCEEEeechHhhcc
Confidence              999999999999999999999999665433

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.73  E-value=0.00037  Score=65.60  Aligned_cols=158  Identities=18%  Similarity=0.215  Sum_probs=87.7

Q ss_pred             cHHHHHHHccCCCc-----CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc--cceeee
Q 015797           29 SLKELHSATNNFNY-----DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN--LLSLRG  101 (400)
Q Consensus        29 ~~~~~~~~~~~y~~-----~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~  101 (400)
                      +.+++.....+|.+     .+.++.|....+|+....++ .+++|+......  ...+..|++++..|...+  +.+++.
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~   84 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVK   84 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence            44566665556655     34577777789999865444 677887654221  233455667776663222  334433


Q ss_pred             E------EEeCCeEEEEEEccCCCChh-----------hh---hhcCCC----c-c---cccChHHHHH-----------
Q 015797          102 Y------CAEGQERLIVYDYMPNLSLL-----------SH---LHGQHS----S-E---CLLNWNRRMD-----------  142 (400)
Q Consensus       102 ~------~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~----~-~---~~l~~~~~~~-----------  142 (400)
                      .      ....+..+++++|++|..+.           ..   ++....    . .   ..-.|.....           
T Consensus        85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~  164 (307)
T TIGR00938        85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA  164 (307)
T ss_pred             CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence            2      12245678999999875432           11   111000    0 0   0011111100           


Q ss_pred             -HHHHHHHHHHHHHh----cCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          143 -IAIGSAEGIVYLHH----HATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       143 -i~~qi~~aL~yLH~----~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                       ....+...+.++..    .....++|+|+.+.||+++.++...|+||+.+.
T Consensus       165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             01112334555532    112359999999999999998877899998875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.71  E-value=0.00025  Score=66.63  Aligned_cols=74  Identities=20%  Similarity=0.268  Sum_probs=47.8

Q ss_pred             CcccccCceEEEEEEEcC-------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEEEc
Q 015797           44 NKLGEGGFGSVYWGQLWD-------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~  115 (400)
                      +.|..|-...+|+....+       +..+++|+..... ........|+.++..+...++ .++++++. +   .+|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            456778888999986544       4788888865432 223456778888888754333 34555443 2   358999


Q ss_pred             cCCCChh
Q 015797          116 MPNLSLL  122 (400)
Q Consensus       116 ~~~gsL~  122 (400)
                      ++|.++.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.42  E-value=2e-05  Score=84.93  Aligned_cols=211  Identities=10%  Similarity=-0.048  Sum_probs=136.8

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEcC--CCEEEEEEEecCChHH-----HHHHHHHHHHHhcCCCCccceeeeE
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKA-----EMEFAVEVEILARVRHKNLLSLRGY  102 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~--~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~  102 (400)
                      .-.+..+-..|++.--+|.|.++   ++++-.  -....+++.+......     .+....|...++...|+++...+.-
T Consensus      1221 mskM~s~~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~r 1297 (2724)
T KOG1826|consen 1221 MSKMFSAMEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLR 1297 (2724)
T ss_pred             HHHHHHHhhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeeccccc
Confidence            33455666666655445544443   332211  1112333333222221     1223345566667789998887765


Q ss_pred             EEe--CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEECCCC
Q 015797          103 CAE--GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA--TPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       103 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiH~dikp~NIlv~~~~  178 (400)
                      ...  ...-+..++|+.+|.+.+.+.........++.........+.+.+..-+|...  ....+|+++|+.|.+|..+.
T Consensus      1298 I~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny 1377 (2724)
T KOG1826|consen 1298 IPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY 1377 (2724)
T ss_pred             CCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC
Confidence            543  34558999999999999998765444433443333333333355555555432  23479999999999999999


Q ss_pred             cEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhh
Q 015797          179 KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEK  244 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~  244 (400)
                      .++++++|+.+...... .......+++.|++|++...-.++.++|||+.|+-+|.+..|..||-.
T Consensus      1378 ~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1378 NVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred             cccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence            99999999998433322 222334588899999999888999999999999999999999988754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.33  E-value=0.0023  Score=59.42  Aligned_cols=73  Identities=14%  Similarity=0.152  Sum_probs=48.0

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC---CCccceeeeEEEeCCeEEEEEEccCCC
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQERLIVYDYMPNL  119 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~g  119 (400)
                      .+.++.|....+|+.. .+++.+.+|.-.   ......|..|+.-|+.|.   --.+.+++++....+..+|||||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            3568899999999987 678899999765   223345778888888883   345778888888777889999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.29  E-value=0.004  Score=58.35  Aligned_cols=138  Identities=18%  Similarity=0.243  Sum_probs=84.8

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEe--cCChHHHHHHHHHHHHHhcCCC--CccceeeeEEEeCC--eEEEEEEc
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLK--VWSNKAEMEFAVEVEILARVRH--KNLLSLRGYCAEGQ--ERLIVYDY  115 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~--~~~lv~e~  115 (400)
                      +.+.+..|....+|.... +++.+++. ..  ...........+|+.+++.+.-  .-+...+++|.++.  ..+.||+|
T Consensus        29 ~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          29 IVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            334444444445555532 37777777 33  1223334556778888887742  34555677776665  67999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHH-HHHHHHHHHHHhc-------------------------------------
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGSAEGIVYLHHH-------------------------------------  157 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~qi~~aL~yLH~~-------------------------------------  157 (400)
                      +.|..+.+.+....     .  .  ...+ ..++..|+-||+-                                     
T Consensus       107 veGe~~~~~~~~~~-----~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~  177 (321)
T COG3173         107 VEGEVVWSALPPES-----L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI  177 (321)
T ss_pred             ecceeccCcCCccc-----c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence            98854443332111     0  1  1112 2455555555531                                     


Q ss_pred             ------------------CCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          158 ------------------ATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       158 ------------------~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                                        +.+.++|||+.+.|++++.++-+=+.||+++..
T Consensus       178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                              123499999999999999988899999999874

>PLN02236 choline kinase

Probab=97.28  E-value=0.0024  Score=61.16  Aligned_cols=141  Identities=15%  Similarity=0.188  Sum_probs=79.2

Q ss_pred             CcccccCceEEEEEEEcC-----CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccc-eeeeEEEeCCeEEEEEEccC
Q 015797           44 NKLGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL-SLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~  117 (400)
                      ..|-.|-...+|++....     +..+++++..... ........|..+++.+..-++. ++++.+.. +   .|++|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            456668888999986432     3678888765433 2222346788888888644443 45555432 2   5899997


Q ss_pred             CCChhhh-----------------hhcCCCc--ccccChHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 015797          118 NLSLLSH-----------------LHGQHSS--ECLLNWNRRMDIAIGS-----------------AEGIVYL----HH-  156 (400)
Q Consensus       118 ~gsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~qi-----------------~~aL~yL----H~-  156 (400)
                      +.+|...                 ++.....  .....+..+..+..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665311                 1111100  0011223332332211                 1111112    11 


Q ss_pred             cCCCCeEecCCCCCCeEECC-CCcEEEEecCCcc
Q 015797          157 HATPHIIHRDIKASNVLLDA-DFKAQVADFGFAK  189 (400)
Q Consensus       157 ~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~~  189 (400)
                      .....++|+|+++.||+++. ++.+.++||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11224899999999999986 4679999998875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.25  E-value=0.0053  Score=56.80  Aligned_cols=30  Identities=27%  Similarity=0.555  Sum_probs=25.3

Q ss_pred             CeEecCCCCCCeEECCCCc-EEEEecCCccc
Q 015797          161 HIIHRDIKASNVLLDADFK-AQVADFGFAKL  190 (400)
Q Consensus       161 ~iiH~dikp~NIlv~~~~~-~kl~Dfgl~~~  190 (400)
                      .++|+|++|.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997565 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.22  E-value=0.0042  Score=60.12  Aligned_cols=73  Identities=14%  Similarity=0.149  Sum_probs=49.7

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEec----CCh---HHHHHHHHHHHHHhcCC---CCccceeeeEEEeCCeEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKV----WSN---KAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~----~~~---~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .+.||.|....||+... .+..++||+-..    ...   ....+...|+..|+.+.   -.++.+++.++.  ...+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            46889999999999975 456788887541    111   12334555677777663   247778887766  446789


Q ss_pred             EEccCC
Q 015797          113 YDYMPN  118 (400)
Q Consensus       113 ~e~~~~  118 (400)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.17  E-value=0.001  Score=65.08  Aligned_cols=186  Identities=17%  Similarity=0.237  Sum_probs=100.6

Q ss_pred             EEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-CeEEEEEEccCCCChhhhhhcCCCcc
Q 015797           54 VYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-QERLIVYDYMPNLSLLSHLHGQHSSE  132 (400)
Q Consensus        54 Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~  132 (400)
                      ++.|....|..+ .--+..  ......+....++++.+.|+|...++++.... ....+|||++. .||.+.+..+....
T Consensus         5 ~~~a~~~~~~~c-~nglpl--t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~~   80 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPL--TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLKD   80 (725)
T ss_pred             EEehhcCCCccc-cCCCcC--CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccch
Confidence            455554455443 211221  22345677888999999999999999887554 34678999995 69999876543210


Q ss_pred             cccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChh
Q 015797          133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE  212 (400)
Q Consensus       133 ~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE  212 (400)
                                     .+++  .|  +   +.|-     |+       ++.+| -+..   ..     ....|        
T Consensus        81 ---------------~s~~--~~--~---~~~~-----~~-------~~~td-~~~t---~~-----~~~~~--------  109 (725)
T KOG1093|consen   81 ---------------ESLL--AH--G---VLHL-----NI-------IYITD-HFLT---KY-----PSPIG--------  109 (725)
T ss_pred             ---------------hhhc--cc--c---ccee-----hh-------hhccc-cccc---cC-----CCCCC--------
Confidence                           0111  11  1   3332     22       22333 0000   00     00011        


Q ss_pred             hhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhcc-ccchhcccccccccCccCCCCCcHHHHHHHHHHH
Q 015797          213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDW-ALPLACERKFSELADPRLNGNFVEEELKRVVLVA  290 (400)
Q Consensus       213 ~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  290 (400)
                              +|+||||+|.++.++.-|..-+.......... +..+ ..+.    ....+...   ..+.-...+.+..+.
T Consensus       110 --------pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~----~~~~~a~e---~~~~~~~d~~~~~~~  174 (725)
T KOG1093|consen  110 --------PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQ----ELLSTAME---HLIQLLADKKRLPLL  174 (725)
T ss_pred             --------cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCch----hHHHHHHH---HHHHHhhhHhHHHHh
Confidence                    49999999999999999887765443221111 1000 0000    00000000   012223345677788


Q ss_pred             HhccccCCCCCCCHHHHHH
Q 015797          291 LTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       291 ~~cl~~dP~~Rps~~ell~  309 (400)
                      ..|+...|..||...++.+
T Consensus       175 ~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  175 KKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             ccCCccccccccchhHHhc
Confidence            9999999999997665553

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.05  E-value=0.01  Score=56.11  Aligned_cols=139  Identities=17%  Similarity=0.214  Sum_probs=91.8

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEec----CCh-----------------HHHH-----HHHHHHHHHhcCCCCc
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV----WSN-----------------KAEM-----EFAVEVEILARVRHKN   95 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~----~~~-----------------~~~~-----~~~~E~~~l~~l~hpn   95 (400)
                      +...|..|--+.||.|...+|..+|||+++.    ...                 ....     -...|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3345778889999999888899999998741    000                 0011     1335888888886655


Q ss_pred             cceeeeEEEeCCeEEEEEEccCCCCh-hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797           96 LLSLRGYCAEGQERLIVYDYMPNLSL-LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus        96 Iv~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                      |.-.--+..  ....|||+|+.+... .-.|.     ...++...+..+-.+++.-|.-|...+  .+||.||.--|+|+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            332211111  234699999953221 11222     223666677777788888888887766  49999999999998


Q ss_pred             CCCCcEEEEecCCccc
Q 015797          175 DADFKAQVADFGFAKL  190 (400)
Q Consensus       175 ~~~~~~kl~Dfgl~~~  190 (400)
                       .+|.+.++|-+-+..
T Consensus       299 -hdG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 -HDGKLYIIDVSQSVE  313 (520)
T ss_pred             -ECCEEEEEEcccccc
Confidence             456899999877653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.02  E-value=0.0075  Score=57.38  Aligned_cols=73  Identities=14%  Similarity=0.076  Sum_probs=48.0

Q ss_pred             cccccCceEEEEEEEcCC-CEEEEEEEec-------CChHHHHHHHHHHHHHhcCC--CC-ccceeeeEEEeCCeEEEEE
Q 015797           45 KLGEGGFGSVYWGQLWDG-SQIAVKRLKV-------WSNKAEMEFAVEVEILARVR--HK-NLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv~  113 (400)
                      .||.|....||++....+ +.++||.-..       .-+-...+...|...|+...  .| .+.++|.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999976544 5788886421       11223345667888887763  35 3445543  3556667999


Q ss_pred             EccCCC
Q 015797          114 DYMPNL  119 (400)
Q Consensus       114 e~~~~g  119 (400)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.93  E-value=0.0041  Score=59.87  Aligned_cols=74  Identities=11%  Similarity=0.061  Sum_probs=49.8

Q ss_pred             CCcccccCceEEEEEEEcC-CCEEEEEEEec------CChHHHHHHHHHHHHHhcCC--CC-ccceeeeEEEeCCeEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWD-GSQIAVKRLKV------WSNKAEMEFAVEVEILARVR--HK-NLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~-~~~vavK~l~~------~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv  112 (400)
                      .+.||.|....||++.+.+ +..|+||.-..      .-+-...+...|..+|+.+.  .| .+.++|.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            4589999999999997632 56788886421      11223456777888888763  35 3555643  456667799


Q ss_pred             EEccCC
Q 015797          113 YDYMPN  118 (400)
Q Consensus       113 ~e~~~~  118 (400)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.93  E-value=0.0043  Score=54.39  Aligned_cols=150  Identities=13%  Similarity=0.176  Sum_probs=87.2

Q ss_pred             cCceEEEEEEEcCCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhc
Q 015797           49 GGFGSVYWGQLWDGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHG  127 (400)
Q Consensus        49 G~~g~Vy~a~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  127 (400)
                      |+.++.-.+...-| +..+|++...... ...-+..+++++.+++  .|+++..-  ..-.+.++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            34444444432223 3344544433322 3445677888888775  46766632  33445699999954111      


Q ss_pred             CCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccC
Q 015797          128 QHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG  207 (400)
Q Consensus       128 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~  207 (400)
                             ..    ..++.-=+++|.-.|+. ....+|||-.|+||+.|..|.+||.|-+....             .+..
T Consensus       142 -------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~  196 (308)
T PF07387_consen  142 -------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVN  196 (308)
T ss_pred             -------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heee
Confidence                   00    11122224677778855 34699999999999999999999999775431             1112


Q ss_pred             cCChhhhccCCCCCccceehhhHHHHHHHh
Q 015797          208 YLAPEYAMLGKASESCDVYSFGILLLELAS  237 (400)
Q Consensus       208 y~aPE~~~~~~~s~ksDIwSlGiil~ellt  237 (400)
                      |.--   .....++++.+-+|=.-++++..
T Consensus       197 ~vN~---~Y~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  197 MVNI---EYESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             EEee---eccccChHHHHHHHHHHHHHHHH
Confidence            2221   12345667777777666666665

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.81  E-value=0.0089  Score=56.87  Aligned_cols=141  Identities=13%  Similarity=0.179  Sum_probs=77.8

Q ss_pred             CcccccCceEEEEEEEcC----CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccc-eeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL-SLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.|..|-...+|+....+    +..+++++...... ....-..|..+++.+..-++- ++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            566668888899885432    23788887654322 233456788888888655553 4555542 22   58999876


Q ss_pred             CChhh--------------hhhcCCCccc-----ccChHHHHHHHHHH-------------------------HHHHH-H
Q 015797          119 LSLLS--------------HLHGQHSSEC-----LLNWNRRMDIAIGS-------------------------AEGIV-Y  153 (400)
Q Consensus       119 gsL~~--------------~l~~~~~~~~-----~l~~~~~~~i~~qi-------------------------~~aL~-y  153 (400)
                      -+|..              .+..-+....     .-.|..+..+..++                         +..+. .
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            55421              1111111110     11122222222111                         11111 1


Q ss_pred             HHhcC-CCCeEecCCCCCCeEECC-CCcEEEEecCCcc
Q 015797          154 LHHHA-TPHIIHRDIKASNVLLDA-DFKAQVADFGFAK  189 (400)
Q Consensus       154 LH~~~-~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~~  189 (400)
                      +...+ ...++|+|+.+.||+++. ++.++++||..+.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            11111 123799999999999974 5789999998875

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.73  E-value=0.022  Score=53.57  Aligned_cols=28  Identities=29%  Similarity=0.464  Sum_probs=24.7

Q ss_pred             CeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          161 HIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       161 ~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      .++|||+.+.||+++. +.+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            4899999999999987 678899998765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.72  E-value=0.11  Score=49.42  Aligned_cols=97  Identities=9%  Similarity=0.041  Sum_probs=60.4

Q ss_pred             CCcccccHHHHHHHccCCCcCC----cccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc--c
Q 015797           23 PTWRIFSLKELHSATNNFNYDN----KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN--L   96 (400)
Q Consensus        23 ~~~~~~~~~~~~~~~~~y~~~~----~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--I   96 (400)
                      .++..++++.+..+...+-+..    ..-.+.-..||+....++..+++|+..... .....+..|...+..|....  +
T Consensus         6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv   84 (325)
T PRK11768          6 FPFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPV   84 (325)
T ss_pred             CCCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCC
Confidence            4677888888888888885531    122345668999977778889999765322 23445667777777663211  2


Q ss_pred             ce---eee--EEEeCCeEEEEEEccCCCC
Q 015797           97 LS---LRG--YCAEGQERLIVYDYMPNLS  120 (400)
Q Consensus        97 v~---~~~--~~~~~~~~~lv~e~~~~gs  120 (400)
                      +.   .-|  +...++..+.++++++|..
T Consensus        85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            22   112  2233566788999988754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.60  E-value=0.006  Score=53.98  Aligned_cols=29  Identities=28%  Similarity=0.590  Sum_probs=20.8

Q ss_pred             eEecCCCCCCeEE-CCCCcEEEEecCCccc
Q 015797          162 IIHRDIKASNVLL-DADFKAQVADFGFAKL  190 (400)
Q Consensus       162 iiH~dikp~NIlv-~~~~~~kl~Dfgl~~~  190 (400)
                      ++|+|+.|.||++ +.++.++|+||..+..
T Consensus       145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            8999999999999 8889999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.48  E-value=0.075  Score=50.33  Aligned_cols=158  Identities=24%  Similarity=0.316  Sum_probs=88.8

Q ss_pred             ccHHHHHHHccCCCcCC-----cccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC---Cc---c
Q 015797           28 FSLKELHSATNNFNYDN-----KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH---KN---L   96 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~-----~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---pn---I   96 (400)
                      +.-.++..+...|.++-     .|.+ .-..+|+....+|+. ++|+....  ....++..|...|..|.-   |-   +
T Consensus        11 ~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl   86 (331)
T COG2334          11 LTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPL   86 (331)
T ss_pred             cChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            34455555555665542     2334 556789887666666 78876654  344556777777777732   21   2


Q ss_pred             ceeee----EEEeCCeEEEEEEccCCCChhh-h-----------h-------hcC----CCcccccChHH----H-----
Q 015797           97 LSLRG----YCAEGQERLIVYDYMPNLSLLS-H-----------L-------HGQ----HSSECLLNWNR----R-----  140 (400)
Q Consensus        97 v~~~~----~~~~~~~~~lv~e~~~~gsL~~-~-----------l-------~~~----~~~~~~l~~~~----~-----  140 (400)
                      ...-|    ........+-+++|++|..+.. .           +       .+.    ........|..    .     
T Consensus        87 ~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~  166 (331)
T COG2334          87 PSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLD  166 (331)
T ss_pred             cCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhc
Confidence            22222    1222247788999999877662 0           0       111    01111223321    0     


Q ss_pred             ----HHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCCeEECCCCc-EEEEecCCcc
Q 015797          141 ----MDIAIGSAEGIVYLHHHA-------TPHIIHRDIKASNVLLDADFK-AQVADFGFAK  189 (400)
Q Consensus       141 ----~~i~~qi~~aL~yLH~~~-------~~~iiH~dikp~NIlv~~~~~-~kl~Dfgl~~  189 (400)
                          .....++...+..+...-       ...+||+|+.|.||+++.+.. +-+.||+-+.
T Consensus       167 ~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         167 LVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                012223344444444321       123899999999999998875 8899999876

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.41  E-value=0.048  Score=51.33  Aligned_cols=30  Identities=20%  Similarity=0.298  Sum_probs=27.3

Q ss_pred             CeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          161 HIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       161 ~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      .+||+|+.++|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            499999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.14  E-value=0.098  Score=46.40  Aligned_cols=74  Identities=15%  Similarity=0.153  Sum_probs=51.4

Q ss_pred             cccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC---CCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           45 KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        45 ~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      .+..|..-..|... ....++.+|+-   .......|..|+.-|..|.   .-++.+++.+..+....|+||||++-|.+
T Consensus        23 ~v~gG~inea~~v~-dg~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLR-DGTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEee-cCCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            45556555666654 35677888853   2223355777887777763   35678888888899999999999987665


Q ss_pred             h
Q 015797          122 L  122 (400)
Q Consensus       122 ~  122 (400)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            4

>PTZ00384 choline kinase; Provisional

Probab=95.77  E-value=0.078  Score=51.43  Aligned_cols=75  Identities=16%  Similarity=0.256  Sum_probs=44.8

Q ss_pred             CCcccccCceEEEEEEEcCC--CE-----EEEEEEecCChHHHHHHHHHHHHHhcCCCCccce-eeeEEEeCCeEEEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWDG--SQ-----IAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS-LRGYCAEGQERLIVYD  114 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~--~~-----vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e  114 (400)
                      .+.|..|-...+|++....+  ..     |.+.. .........+-..|+++++.|...++-+ +++.+.    -++++|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence            35676788999999864332  22     33332 2222222234467899999997655544 555443    259999


Q ss_pred             ccCCCChh
Q 015797          115 YMPNLSLL  122 (400)
Q Consensus       115 ~~~~gsL~  122 (400)
                      |++|-+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99886653

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.58  E-value=0.051  Score=51.41  Aligned_cols=73  Identities=12%  Similarity=0.173  Sum_probs=55.5

Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      ...|++|++- |+++. .+.       ...+.+.++++.+.+..+.-+...-  +.-|||+.-.||||+ .|.+-|+||-
T Consensus       299 ~y~yl~~kdh-gt~is-~ik-------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-IIK-------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceee-eee-------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence            3445677764 33443 332       1567889999998888777777654  589999999999999 9999999999


Q ss_pred             Ccccc
Q 015797          187 FAKLI  191 (400)
Q Consensus       187 l~~~~  191 (400)
                      +++.-
T Consensus       367 lsRl~  371 (488)
T COG5072         367 LSRLS  371 (488)
T ss_pred             eeecc
Confidence            99953

>PRK06148 hypothetical protein; Provisional

Probab=95.40  E-value=0.29  Score=53.74  Aligned_cols=159  Identities=19%  Similarity=0.245  Sum_probs=83.3

Q ss_pred             ccHHHH-HHHccCCCcC---CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-------CCCcc
Q 015797           28 FSLKEL-HSATNNFNYD---NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-------RHKNL   96 (400)
Q Consensus        28 ~~~~~~-~~~~~~y~~~---~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-------~hpnI   96 (400)
                      ++.+++ ..+...|-+.   +.|+ |..-.+|+....++..+++|+.+....  ......|.+.|..|       .-|.+
T Consensus        11 ~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~   87 (1013)
T PRK06148         11 FTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRL   87 (1013)
T ss_pred             CCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCee
Confidence            444444 2333445443   4454 456788999777788999999875322  22333444555444       23333


Q ss_pred             ceee-e----EEEe-CC--eEEEEEEccCCCChhhhh---------------------hcCCC--cccccChHH------
Q 015797           97 LSLR-G----YCAE-GQ--ERLIVYDYMPNLSLLSHL---------------------HGQHS--SECLLNWNR------  139 (400)
Q Consensus        97 v~~~-~----~~~~-~~--~~~lv~e~~~~gsL~~~l---------------------~~~~~--~~~~l~~~~------  139 (400)
                      ++-. |    .... ++  ..+.+++|++|..+.+..                     .....  ....+.|..      
T Consensus        88 i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l  167 (1013)
T PRK06148         88 IPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRA  167 (1013)
T ss_pred             eecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhh
Confidence            3321 1    1111 22  456789999987665410                     00000  001123321      


Q ss_pred             -----------HHHHHHHHHHHHH-----HHHhcCCCCeEecCCCCCCeEECCCC--cEE-EEecCCccc
Q 015797          140 -----------RMDIAIGSAEGIV-----YLHHHATPHIIHRDIKASNVLLDADF--KAQ-VADFGFAKL  190 (400)
Q Consensus       140 -----------~~~i~~qi~~aL~-----yLH~~~~~~iiH~dikp~NIlv~~~~--~~k-l~Dfgl~~~  190 (400)
                                 ...++.+++..+.     .+... ...+||+|+++.|||++.++  .+. |+|||-+..
T Consensus       168 ~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        168 RDRLHFIDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             hhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                       1112222222221     12111 22499999999999999875  555 999998864

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.44  E-value=0.26  Score=44.78  Aligned_cols=79  Identities=16%  Similarity=0.057  Sum_probs=52.7

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC-CCC
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP-NLS  120 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~-~gs  120 (400)
                      ....+..|..+.|+.++..+|.+.++|+......... + ......|+..+-...+++++.-  ...-.+.+|.+. +-+
T Consensus         6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-E-~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~   81 (253)
T PF04655_consen    6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-E-ARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRS   81 (253)
T ss_pred             cCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-h-hhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCc
Confidence            3456678999999999888999999998653221111 1 1112457777778888998763  334568889884 446


Q ss_pred             hhhh
Q 015797          121 LLSH  124 (400)
Q Consensus       121 L~~~  124 (400)
                      |.+.
T Consensus        82 L~~~   85 (253)
T PF04655_consen   82 LASL   85 (253)
T ss_pred             hhhc
Confidence            6544

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	400
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-70
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-69
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-46
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-28
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-21
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		9e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		9e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  263 bits (672), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 135/314 (42%), Positives = 198/314 (63%), Gaps = 8/314 (2%)
Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-EMEFAVEVE 86
           FSL+EL  A++NF+  N LG GGFG VY G+L DG+ +AVKRLK    +  E++F  EVE
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 87  ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG 146
           +++   H+NLL LRG+C    ERL+VY YM N             +  L+W +R  IA+G
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           SA G+ YLH H  P IIHRD+KA+N+LLD +F+A V DFG AKL+     HV   V+GT+
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTI 207
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE--KVNSAIKRTITDWALPLACER 264
           G++APEY   GK+SE  DV+ +G++LLEL +G++  +  ++ +     + DW   L  E+
Sbjct: 208 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 267
Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES-KEKLTELE 323
           K   L D  L GN+ +EE+++++ VAL C  S P +RP M EV+ +L+G+   E+  E +
Sbjct: 268 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQ 327
Query: 324 NDELFKSHQVADYN 337
            +E+F+     D+N
Sbjct: 328 KEEMFRQ----DFN 337

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/307 (42%), Positives = 192/307 (62%), Gaps = 4/307 (1%)
Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV-WSNKAEMEFAVEVE 86
           FSL+EL  A++NF   N LG GGFG VY G+L DG  +AVKRLK   +   E++F  EVE
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 87  ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG 146
           +++   H+NLL LRG+C    ERL+VY YM N             +  L+W +R  IA+G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           SA G+ YLH H  P IIHRD+KA+N+LLD +F+A V DFG AKL+     HV   V+G +
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE--KVNSAIKRTITDWALPLACER 264
           G++APEY   GK+SE  DV+ +G++LLEL +G++  +  ++ +     + DW   L  E+
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES-KEKLTELE 323
           K   L D  L GN+ +EE+++++ VAL C  S P +RP M EV+ +L+G+   E+  E +
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQ 319
Query: 324 NDELFKS 330
            +E+F+ 
Sbjct: 320 KEEMFRQ 326

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 105/286 (36%), Positives = 162/286 (56%), Gaps = 5/286 (1%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV 83
           ++R+  L +L  ATNNF++   +G G FG VY G L DG+++A+KR    S++   EF  
Sbjct: 26  SYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           E+E L+  RH +L+SL G+C E  E +++Y YM N                ++W +R++I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRV 202
            IG+A G+ YLH  A   IIHRD+K+ N+LLD +F  ++ DFG +K   + G TH+   V
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC 262
           KGTLGY+ PEY + G+ +E  DVYSFG++L E+   +  I +        + +WA+    
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
             +  ++ DP L      E L++    A+ C     E RP+M +VL
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 161/286 (56%), Gaps = 5/286 (1%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV 83
           ++R+  L +L  ATNNF++   +G G FG VY G L DG+++A+KR    S++   EF  
Sbjct: 26  SYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           E+E L+  RH +L+SL G+C E  E +++Y YM N                ++W +R++I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRV 202
            IG+A G+ YLH  A   IIHRD+K+ N+LLD +F  ++ DFG +K   +   TH+   V
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC 262
           KGTLGY+ PEY + G+ +E  DVYSFG++L E+   +  I +        + +WA+    
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
             +  ++ DP L      E L++    A+ C     E RP+M +VL
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 170/304 (55%), Gaps = 29/304 (9%)
Query: 25  WRIFSLKELHSATNNFNY------DNKLGEGGFGSVYWGQLWDGSQIAVKRLK----VWS 74
           +  FS  EL + TNNF+        NK+GEGGFG VY G + + + +AVK+L     + +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 75  NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL 134
            + + +F  E++++A+ +H+NL+ L G+ ++G +  +VY YMPN              CL
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN------GSLLDRLSCL 124
Query: 135 -----LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK 189
                L+W+ R  IA G+A GI +LH +   H IHRDIK++N+LLD  F A+++DFG A+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 190 LIPDGA-THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
                A T + +R+ GT  Y+APE A+ G+ +   D+YSFG++LLE+ +G   +++ +  
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE-HRE 239
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +  +         E+   +  D ++N +     ++ +  VA  C H K  KRP + +V 
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 309 DLLK 312
            LL+
Sbjct: 299 QLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 169/304 (55%), Gaps = 29/304 (9%)
Query: 25  WRIFSLKELHSATNNFNY------DNKLGEGGFGSVYWGQLWDGSQIAVKRLK----VWS 74
           +  FS  EL + TNNF+        NK+GEGGFG VY G + + + +AVK+L     + +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 75  NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL 134
            + + +F  E++++A+ +H+NL+ L G+ ++G +  +VY YMPN              CL
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN------GSLLDRLSCL 124
Query: 135 -----LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK 189
                L+W+ R  IA G+A GI +LH +   H IHRDIK++N+LLD  F A+++DFG A+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 190 LIPDGA-THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
                A T +  R+ GT  Y+APE A+ G+ +   D+YSFG++LLE+ +G   +++ +  
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE-HRE 239
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +  +         E+   +  D ++N +     ++ +  VA  C H K  KRP + +V 
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 309 DLLK 312
            LL+
Sbjct: 299 QLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 168/304 (55%), Gaps = 29/304 (9%)
Query: 25  WRIFSLKELHSATNNFNY------DNKLGEGGFGSVYWGQLWDGSQIAVKRLK----VWS 74
           +  FS  EL + TNNF+        NK+GEGGFG VY G + + + +AVK+L     + +
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 64
Query: 75  NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL 134
            + + +F  E++++A+ +H+NL+ L G+ ++G +  +VY YMPN              CL
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN------GSLLDRLSCL 118
Query: 135 -----LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK 189
                L+W+ R  IA G+A GI +LH +   H IHRDIK++N+LLD  F A+++DFG A+
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 175
Query: 190 LIPDGATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
                A  V   R+ GT  Y+APE A+ G+ +   D+YSFG++LLE+ +G   +++ +  
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE-HRE 233
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +  +         E+   +  D ++N +     ++ +  VA  C H K  KRP + +V 
Sbjct: 234 PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 292
Query: 309 DLLK 312
            LL+
Sbjct: 293 QLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 101/304 (33%), Positives = 163/304 (53%), Gaps = 29/304 (9%)
Query: 25  WRIFSLKELHSATNNFNY------DNKLGEGGFGSVYWGQLWDGSQIAVKRLK----VWS 74
           +  FS  EL + TNNF+        NK GEGGFG VY G + + + +AVK+L     + +
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 61
Query: 75  NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL 134
            + + +F  E+++ A+ +H+NL+ L G+ ++G +  +VY Y PN              CL
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL------SCL 115
Query: 135 -----LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK 189
                L+W+ R  IA G+A GI +LH +   H IHRDIK++N+LLD  F A+++DFG A+
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 172
Query: 190 LIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
                A  V  +R+ GT  Y APE A+ G+ +   D+YSFG++LLE+ +G   +++ +  
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE-HRE 230
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +  +         E+   +  D + N +     ++    VA  C H K  KRP + +V 
Sbjct: 231 PQLLLDIKEEIEDEEKTIEDYIDKKXN-DADSTSVEAXYSVASQCLHEKKNKRPDIKKVQ 289
Query: 309 DLLK 312
            LL+
Sbjct: 290 QLLQ 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 145/277 (52%), Gaps = 23/277 (8%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNL 96
           + N   K+G G FG+V+  + W GS +AVK L      AE   EF  EV I+ R+RH N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           +   G   +     IV +Y+               E  L+  RR+ +A   A+G+ YLH+
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHN 155
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-VKGTLGYLAPEYAM 215
              P I+HR++K+ N+L+D  +  +V DFG ++L    +T ++++   GT  ++APE   
Sbjct: 156 R-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN 275
              ++E  DVYSFG++L ELA+ ++P   +N A  + +   A+   C+R    L  PR N
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVA--AVGFKCKR----LEIPR-N 263
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
            N       +V  +   C  ++P KRP+   ++DLL+
Sbjct: 264 LN------PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 147/292 (50%), Gaps = 23/292 (7%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNL 96
           + N   K+G G FG+V+  + W GS +AVK L      AE   EF  EV I+ R+RH N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           +   G   +     IV +Y+               E  L+  RR+ +A   A+G+ YLH+
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHN 155
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-VKGTLGYLAPEYAM 215
              P I+HRD+K+ N+L+D  +  +V DFG ++L    +  + ++   GT  ++APE   
Sbjct: 156 R-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLR 212
Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN 275
              ++E  DVYSFG++L ELA+ ++P   +N A  + +   A+   C+R    L  PR N
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVA--AVGFKCKR----LEIPR-N 263
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDEL 327
            N       +V  +   C  ++P KRP+   ++DLL+   K  +      +L
Sbjct: 264 LN------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 15  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 73  SE-EPIXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 126
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P    +  +  
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPECPESLHD-- 236
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
                 +   C   +PE+RPT 
Sbjct: 237 ------LMCQCWRKEPEERPTF 252

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 274 KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVV 331
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 492
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C   +PE+RPT 
Sbjct: 493 LHDLM---CQCWRKEPEERPTF 511

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 191 KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 409
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C   +PE+RPT 
Sbjct: 410 LHDLM---CQCWRKEPEERPTF 428

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 191 KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 409
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C   +PE+RPT 
Sbjct: 410 LHDLM---CQCWRKEPEERPTF 428

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 18  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 76  SE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 129
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P    +  +  
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPECPESLHD-- 239
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
                 +   C   +PE+RPT 
Sbjct: 240 ------LMCQCWRKEPEERPTF 255

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 83  SE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 243
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C    PE+RPT 
Sbjct: 244 LHDLM---CQCWRKDPEERPTF 262

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 191 KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 249 SE-EPIYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 409
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C   +PE+RPT 
Sbjct: 410 LHDLM---CQCWRKEPEERPTF 428

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 83  SE-EPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P    +  +  
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPECPESLHD-- 246
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
                 +   C    PE+RPT 
Sbjct: 247 ------LMCQCWRKDPEERPTF 262

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 83  SE-EPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 243
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C    PE+RPT 
Sbjct: 244 LHDLM---CQCWRKDPEERPTF 262

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 16  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 74  SE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 127
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P    +  +  
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPECPESLHD-- 237
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
                 +   C    PE+RPT 
Sbjct: 238 ------LMCQCWRKDPEERPTF 253

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 48/273 (17%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNW-----------NRRMDIAIGSAEGIV 152
           +E +   IV +YM                CLL++            + +D+A   A G+ 
Sbjct: 83  SE-EPIYIVMEYMSKG-------------CLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           Y+      + +HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
            A+ G+ +   DV+SFGILL EL + G+ P   +   + R + D       ER +     
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCP 237
Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
           P        E L  ++     C    PE+RPT 
Sbjct: 238 PE-----CPESLHDLM---CQCWRKDPEERPTF 262

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 83  SE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 243
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C    PE+RPT 
Sbjct: 244 LHDLM---CQCWRKDPEERPTF 262

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 14  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 72  SE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 125
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P    +  +  
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPECPESLHD-- 235
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
                 +   C    PE+RPT 
Sbjct: 236 ------LMCQCWRKDPEERPTF 251

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 83  SE-EPIYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 243
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C    PE+RPT 
Sbjct: 244 LHDLM---CQCWRKDPEERPTF 262

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 48/278 (17%)
Query: 44  NKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
            +LG G FG V  G+ W G   +AVK +K   + +E EF  E + + ++ H  L+   G 
Sbjct: 14  KELGSGQFGVVKLGK-WKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR----------MDIAIGSAEGIV 152
           C++     IV +Y+ N              CLLN+ R           +++     EG+ 
Sbjct: 72  CSKEYPIYIVTEYISNG-------------CLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           +L  H     IHRD+ A N L+D D   +V+DFG  + + D     +   K  + + APE
Sbjct: 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE 175
Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELA 270
                K S   DV++FGIL+ E+ S GK P +   NS +   ++          +   L 
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS----------QGHRLY 225
Query: 271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            P L  + + +       +  +C H  PEKRPT  ++L
Sbjct: 226 RPHLASDTIYQ-------IMYSCWHELPEKRPTFQQLL 256

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 48/273 (17%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNW-----------NRRMDIAIGSAEGIV 152
           +E +   IV +YM                CLL++            + +D+A   A G+ 
Sbjct: 83  SE-EPIYIVTEYMSKG-------------CLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           Y+      + +HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
            A+ G+ +   DV+SFGILL EL + G+ P   +   + R + D       ER +     
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCP 237
Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
           P        E L  ++     C    PE+RPT 
Sbjct: 238 PE-----CPESLHDLM---CQCWRKDPEERPTF 262

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK   N +   F  E +++ ++RH+ L+ L    
Sbjct: 192 KLGQGCFGEVWMGT-WNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 250 SE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 303
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG  +LI D         K  + + APE A+ G+ +   
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 410
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C    PE+RPT 
Sbjct: 411 LHDLM---CQCWRKDPEERPTF 429

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 22  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D++   A G+ Y+      + +
Sbjct: 80  SE-EPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERM---NYV 133
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 240
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C   +PE+RPT 
Sbjct: 241 LHDLM---CQCWRKEPEERPTF 259

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 22  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D++   A G+ Y+      + +
Sbjct: 80  SE-EPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERM---NYV 133
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P    +  +  
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPECPESLHD-- 243
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
                 +   C   +PE+RPT 
Sbjct: 244 ------LMCQCWRKEPEERPTF 259

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 125/262 (47%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG+G FG V+ G  W+G+ ++A+K LK  +   E  F  E +++ ++RH+ L+ L    
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM                  L   + +D+A   A G+ Y+      + +
Sbjct: 83  SE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD+ A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL EL + G+ P   +   + R + D       ER +     P        E 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGM---VNREVLD-----QVERGYRMPCPPE-----CPES 243
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L  ++     C    PE+RPT 
Sbjct: 244 LHDLM---CQCWRKDPEERPTF 262

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 41  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 99  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 151
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +    
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 241

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 42  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 100 YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 152
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +    
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 16  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 74  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 126
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +    
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 19  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 77  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 129
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +    
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 14  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 72  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 124
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +    
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 19  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 77  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 129
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +    
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 44/279 (15%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRGY 102
           ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   GY
Sbjct: 19  RIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 103 CAEGQERLI--------VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYL 154
             + Q  ++        +Y ++               E      + +DIA  +A G+ YL
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHL------------HASETKFEMKKLIDIARQTARGMDYL 124
Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEY 213
           H  +   IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE 
Sbjct: 125 HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 214 AMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS-EL 269
             +  +   S   DVY+FGI+L EL +G+ P   +N+       D  + +      S +L
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIEMVGRGSLSPDL 235
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           +  R N     + +KR++     C   K ++RP+   +L
Sbjct: 236 SKVRSN---CPKRMKRLM---AECLKKKRDERPSFPRIL 268

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 14  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y    Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 124
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +    
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 129/289 (44%), Gaps = 58/289 (20%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE-------ILARVRHKNLLS 98
           +G GGFG VY    W G ++AVK  +   +  + + +  +E       + A ++H N+++
Sbjct: 15  IGIGGFGKVY-RAFWIGDEVAVKAAR---HDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 99  LRGYCAEGQERLIVYDYM-PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           LRG C +     +V ++                 + L+NW      A+  A G+ YLH  
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDE 124
Query: 158 ATPHIIHRDIKASNVLL-----DADFK---AQVADFGFAKLIPDGATHVTTRVK--GTLG 207
           A   IIHRD+K+SN+L+     + D      ++ DFG A+       H TT++   G   
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYA 179
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKP---IEKVNSAIKRTITDWALPL--AC 262
           ++APE       S+  DV+S+G+LL EL +G+ P   I+ +  A    +   ALP+   C
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              F++L +                     C +  P  RP+   +LD L
Sbjct: 240 PEPFAKLME--------------------DCWNPDPHSRPSFTNILDQL 268

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 34  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 92  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 144
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A        +H   ++ G++ ++APE   +    
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 42  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 100 YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 152
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A        +H   ++ G++ ++APE   +    
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 14  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y  + Q  ++      +             E +    + +DIA  +A+G+ YLH  +   
Sbjct: 72  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI----KLIDIARQTAQGMDYLHAKS--- 124
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAML---G 217
           IIHRD+K++N+ L  D   ++ DFG A        +H   ++ G++ ++APE   +    
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNS 247
             S   DVY+FGI+L EL +G+ P   +N+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 50/293 (17%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +  +  +LG G FG V +G+ W G   +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 9   DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 66
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM----------DIAIGS 147
            L G C + +   I+ +YM N              CLLN+ R M          ++    
Sbjct: 67  QLYGVCTKQRPIFIITEYMANG-------------CLLNYLREMRHRFQTQQLLEMCKDV 113
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E + YL    +   +HRD+ A N L++     +V+DFG ++ + D     +   K  + 
Sbjct: 114 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 170
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF 266
           +  PE  M  K S   D+++FG+L+ E+ S GK P E+  ++   T    A  L   R  
Sbjct: 171 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-- 226
Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT----MLEVLDLLKGES 315
                P L         ++V  +  +C H K ++RPT    +  +LD++  ES
Sbjct: 227 -----PHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 267

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 50/293 (17%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +  +  +LG G FG V +G+ W G   +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 5   DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM----------DIAIGS 147
            L G C + +   I+ +YM N              CLLN+ R M          ++    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANG-------------CLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E + YL    +   +HRD+ A N L++     +V+DFG ++ + D     +   K  + 
Sbjct: 110 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF 266
           +  PE  M  K S   D+++FG+L+ E+ S GK P E+  ++   T    A  L   R  
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-- 222
Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT----MLEVLDLLKGES 315
                P L         ++V  +  +C H K ++RPT    +  +LD++  ES
Sbjct: 223 -----PHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 263

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 132/280 (47%), Gaps = 44/280 (15%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 30  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 102 YCAEGQERLI--------VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           Y  + Q  ++        +Y ++               E      + +DIA  +A G+ Y
Sbjct: 88  YSTKPQLAIVTQWCEGSSLYHHL------------HASETKFEMKKLIDIARQTARGMDY 135
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPE 212
           LH  +   IIHRD+K++N+ L  D   ++ DFG A        +H   ++ G++ ++APE
Sbjct: 136 LHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 213 YAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS-E 268
              +  +   S   DVY+FGI+L EL +G+ P   +N+       D  + +      S +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIEMVGRGSLSPD 246
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           L+  R N     + +KR++     C   K ++RP+   +L
Sbjct: 247 LSKVRSN---CPKRMKRLM---AECLKKKRDERPSFPRIL 280

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 30/260 (11%)
Query: 34  HSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEI 87
           H   +N     +LGEG FG V+  + +      D   +AVK LK  S+ A  +F  E E+
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL---------LNWN 138
           L  ++H++++   G C EG   ++V++YM +               L         L  +
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV 198
           + + IA   A G+VYL   A+ H +HRD+   N L+  +   ++ DFG ++   D  +  
Sbjct: 129 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTD 182
Query: 199 TTRVKG----TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRT 252
             RV G     + ++ PE  M  K +   DV+S G++L E+ + GK+P  ++ N+ +   
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242
Query: 253 ITDWAL---PLACERKFSEL 269
           IT   +   P  C ++  EL
Sbjct: 243 ITQGRVLQRPRTCPQEVYEL 262

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 50/293 (17%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +  +  +LG G FG V +G+ W G   +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 16  DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 73
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM----------DIAIGS 147
            L G C + +   I+ +YM N              CLLN+ R M          ++    
Sbjct: 74  QLYGVCTKQRPIFIITEYMANG-------------CLLNYLREMRHRFQTQQLLEMCKDV 120
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E + YL    +   +HRD+ A N L++     +V+DFG ++ + D     +   K  + 
Sbjct: 121 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 177
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF 266
           +  PE  M  K S   D+++FG+L+ E+ S GK P E+  ++   T    A  L   R  
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-- 233
Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT----MLEVLDLLKGES 315
                P L         ++V  +  +C H K ++RPT    +  +LD++  ES
Sbjct: 234 -----PHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 274

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 50/293 (17%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +  +  +LG G FG V +G+ W G   +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 25  DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM----------DIAIGS 147
            L G C + +   I+ +YM N              CLLN+ R M          ++    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANG-------------CLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E + YL    +   +HRD+ A N L++     +V+DFG ++ + D     +   K  + 
Sbjct: 130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF 266
           +  PE  M  K S   D+++FG+L+ E+ S GK P E+  ++   T    A  L   R  
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-- 242
Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT----MLEVLDLLKGES 315
                P L         ++V  +  +C H K ++RPT    +  +LD++  ES
Sbjct: 243 -----PHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 50/293 (17%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +  +  +LG G FG V +G+ W G   +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 25  DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM----------DIAIGS 147
            L G C + +   I+ +YM N              CLLN+ R M          ++    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANG-------------CLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E + YL    +   +HRD+ A N L++     +V+DFG ++ + D     +   K  + 
Sbjct: 130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR 186
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF 266
           +  PE  M  K S   D+++FG+L+ E+ S GK P E+  ++   T    A  L   R  
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-- 242
Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT----MLEVLDLLKGES 315
                P L         ++V  +  +C H K ++RPT    +  +LD++  ES
Sbjct: 243 -----PHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 44/280 (15%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK L V +   +    F  EV +L + RH N+L   G
Sbjct: 30  QRIGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 102 YCAEGQERLI--------VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           Y    Q  ++        +Y ++               E      + +DIA  +A G+ Y
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHL------------HASETKFEMKKLIDIARQTARGMDY 135
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPE 212
           LH  +   IIHRD+K++N+ L  D   ++ DFG A        +H   ++ G++ ++APE
Sbjct: 136 LHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 213 YAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS-E 268
              +  +   S   DVY+FGI+L EL +G+ P   +N+       D  + +      S +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIEMVGRGSLSPD 246
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           L+  R N     + +KR++     C   K ++RP+   +L
Sbjct: 247 LSKVRSN---CPKRMKRLM---AECLKKKRDERPSFPRIL 280

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 53/290 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +  +  +LG G FG V +G+ W G   +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 10  DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM----------DIAIGS 147
            L G C + +   I+ +YM N              CLLN+ R M          ++    
Sbjct: 68  QLYGVCTKQRPIFIITEYMANG-------------CLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E + YL    +   +HRD+ A N L++     +V+DFG ++ + D     +   K  + 
Sbjct: 115 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 171
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF 266
           +  PE  M  K S   D+++FG+L+ E+ S GK P E+  ++   T    A  L   R  
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-- 227
Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-------MLEVLD 309
                P L         ++V  +  +C H K ++RPT       +L+V+D
Sbjct: 228 -----PHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAV 84
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 85  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 139
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 245
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 246 ELYQLMRL---CWKERPEDRPTF 265

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 137/307 (44%), Gaps = 47/307 (15%)
Query: 34  HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ------IAVKRLKVWSNKAEMEFAVEVEI 87
           H    +     +LGEG FG V+  + ++ S       +AVK LK  +  A  +F  E E+
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL------------L 135
           L  ++H++++   G C +G   ++V++YM +               +            L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
             ++ + IA   A G+VYL   A+ H +HRD+   N L+ A+   ++ DFG ++   D  
Sbjct: 131 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVY 184
Query: 196 THVTTRVKG----TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP-IEKVNSAI 249
           +    RV G     + ++ PE  M  K +   DV+SFG++L E+ + GK+P  +  N+ +
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
              IT   +          L  PR+         K V  V L C   +P++R  + E+  
Sbjct: 245 IECITQGRV----------LERPRVCP-------KEVYDVMLGCWQREPQQRLNIKEIYK 287
Query: 310 LLKGESK 316
           +L    K
Sbjct: 288 ILHALGK 294

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAV 82
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 243
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 244 ELYQLMRL---CWKERPEDRPTF 263

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 85
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 86  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 140
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 246
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 247 ELYQLMRL---CWKERPEDRPTF 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 76
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 237
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTF 257

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 78
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 79  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 133
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 239
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 240 ELYQLMRL---CWKERPEDRPTF 259

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 77
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 78  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 132
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 238
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 239 ELYQLMRL---CWKERPEDRPTF 258

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 76
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 237
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTF 257

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 53/290 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +  +  +LG G FG V +G+ W G   +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 10  DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM----------DIAIGS 147
            L G C + +   I+ +YM N              CLLN+ R M          ++    
Sbjct: 68  QLYGVCTKQRPIFIITEYMANG-------------CLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E + YL    +   +HRD+ A N L++     +V+DFG ++ + D     +   K  + 
Sbjct: 115 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR 171
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKF 266
           +  PE  M  K S   D+++FG+L+ E+ S GK P E+  ++   T    A  L   R  
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-- 227
Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-------MLEVLD 309
                P L         ++V  +  +C H K ++RPT       +L+V+D
Sbjct: 228 -----PHLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 86
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 87  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 141
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 247
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 248 ELYQLMRL---CWKERPEDRPTF 267

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 81
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 82  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 136
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 242
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 243 ELYQLMRL---CWKERPEDRPTF 262

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 82
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 243
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 244 ELYQLMRL---CWKERPEDRPTF 263

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 71
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 72  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 126
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL E+ + G+ P           +T+  +    ER +  +  P    +   EE
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPG--------MTNPEVIQNLERGY-RMVRP----DNCPEE 233
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L +++ +   C   +PE RPT 
Sbjct: 234 LYQLMRL---CWKERPEDRPTF 252

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 10/205 (4%)
Query: 45  KLGEGGFGSVYWGQLWDG-SQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           +LG G FG V+ G  W+G +++A+K LK  +   E  F  E +I+ +++H  L+ L    
Sbjct: 16  RLGNGQFGEVWMGT-WNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM N               L   N  +D+A   A G+ Y+      + I
Sbjct: 74  SE-EPIYIVTEYM-NKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMAYIERM---NYI 127
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++++N+L+      ++ADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 224 DVYSFGILLLELAS-GKKPIEKVNS 247
           DV+SFGILL EL + G+ P   +N+
Sbjct: 188 DVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 76
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 237
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTF 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G G FG V   + W    +A+K+++  S      F VE+  L+RV H N++ L G C  
Sbjct: 16  VGRGAFGVVCKAK-WRAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 106 GQERLIVYDY-----MPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
                +V +Y     + N                ++W       +  ++G+ YLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 124
Query: 161 HIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            +IHRD+K  N+LL A     ++ DFG A    D  TH+T   KG+  ++APE       
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN-KGSAAWMAPEVFEGSNY 180
Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
           SE CDV+S+GI+L E+ + +KP +++     R +  WA+             P L  N  
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV--------HNGTRPPLIKNLP 230
Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
               K +  +   C    P +RP+M E++ ++
Sbjct: 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G G FG V   + W    +A+K+++  S      F VE+  L+RV H N++ L G C  
Sbjct: 17  VGRGAFGVVCKAK-WRAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 106 GQERLIVYDY-----MPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
                +V +Y     + N                ++W       +  ++G+ YLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 125
Query: 161 HIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            +IHRD+K  N+LL A     ++ DFG A    D  TH+T   KG+  ++APE       
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN-KGSAAWMAPEVFEGSNY 181
Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
           SE CDV+S+GI+L E+ + +KP +++     R +  WA+             P L  N  
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV--------HNGTRPPLIKNLP 231
Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
               K +  +   C    P +RP+M E++ ++
Sbjct: 232 ----KPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +   +  ++G G FG V+ G   +  ++A+K +K   + +E +F  E E++ ++ H  L+
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKE-GSMSEDDFIEEAEVMMKLSHPKLV 85
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C E     +V+++M +               L      + + +   EG+ YL   
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA 142
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     
Sbjct: 143 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 218 KASESCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLN 275
           + S   DV+SFG+L+ E+ S GK P E + NS +   I+              L  PRL 
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------RLYKPRLA 249
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              V + +         C   +PE RP    +L  L
Sbjct: 250 STHVYQIMNH-------CWKERPEDRPAFSRLLRQL 278

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 72
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 73  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 127
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HR+++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 224 DVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEE 282
           DV+SFGILL E+ + G+ P           +T+  +    ER +  +  P    +   EE
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPG--------MTNPEVIQNLERGY-RMVRP----DNCPEE 234
Query: 283 LKRVVLVALTCAHSKPEKRPTM 304
           L +++ +   C   +PE RPT 
Sbjct: 235 LYQLMRL---CWKERPEDRPTF 253

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 120/237 (50%), Gaps = 19/237 (8%)
Query: 46  LGEGGFGSVYWGQLWDGS-----QIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSL 99
           +G G FG VY G L   S      +A+K LK  ++ K  ++F  E  I+ +  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 100 RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
            G  ++ +  +I+ +YM N               +L   + + +  G A G+ YL   A 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGIAAGMKYL---AN 165
Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAMLG 217
            + +HRD+ A N+L++++   +V+DFG ++++ D   AT+ T+  K  + + APE     
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 218 KASESCDVYSFGILLLELAS-GKKPI-EKVNSAIKRTITD---WALPLACERKFSEL 269
           K + + DV+SFGI++ E+ + G++P  E  N  + + I D      P+ C     +L
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 282

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 147
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 255
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 256 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 287

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 148
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 256
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 257 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 288

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 147
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 255
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 256 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 287

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +   +  ++G G FG V+ G   +  ++A+K ++     +E +F  E E++ ++ H  L+
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 68
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C E     +V+++M +               L      + + +   EG+ YL   
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA 125
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     
Sbjct: 126 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 218 KASESCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLN 275
           + S   DV+SFG+L+ E+ S GK P E + NS +   I+              L  PRL 
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------RLYKPRLA 232
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              V + +         C   +PE RP    +L  L
Sbjct: 233 STHVYQIMNH-------CWRERPEDRPAFSRLLRQL 261

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +   +  ++G G FG V+ G   +  ++A+K ++     +E +F  E E++ ++ H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C E     +V+++M +               L      + + +   EG+ YL   
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA 120
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 218 KASESCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLN 275
           + S   DV+SFG+L+ E+ S GK P E + NS +   I+              L  PRL 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------RLYKPRLA 227
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              V + +         C   +PE RP    +L  L
Sbjct: 228 STHVYQIMNH-------CWKERPEDRPAFSRLLRQL 256

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 148
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 256
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 257 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 288

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +   +  ++G G FG V+ G   +  ++A+K ++     +E +F  E E++ ++ H  L+
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C E     +V+++M +               L      + + +   EG+ YL   
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA 122
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     
Sbjct: 123 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 218 KASESCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLN 275
           + S   DV+SFG+L+ E+ S GK P E + NS +   I+              L  PRL 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------RLYKPRLA 229
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              V + +         C   +PE RP    +L  L
Sbjct: 230 STHVYQIMNH-------CWKERPEDRPAFSRLLRQL 258

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G+ W G  +AVK LKV     E    F  EV +L + RH N+L   G
Sbjct: 42  TRIGSGSFGTVYKGK-WHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 102 YCAEGQERLI--------VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           Y  +    ++        +Y ++               E      + +DIA  +A+G+ Y
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHL------------HVQETKFQMFQLIDIARQTAQGMDY 147
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP--DGATHVTTRVKGTLGYLAP 211
           LH     +IIHRD+K++N+ L      ++ DFG A +     G+  V  +  G++ ++AP
Sbjct: 148 LH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV-EQPTGSVLWMAP 203
Query: 212 EYAML---GKASESCDVYSFGILLLELASGKKPIEKVNS 247
           E   +      S   DVYS+GI+L EL +G+ P   +N+
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +   +  ++G G FG V+ G   +  ++A+K ++     +E +F  E E++ ++ H  L+
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C E     +V+++M +               L      + + +   EG+ YL   
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA 122
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
           +   +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     
Sbjct: 123 S---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 218 KASESCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLN 275
           + S   DV+SFG+L+ E+ S GK P E + NS +   I+              L  PRL 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------RLYKPRLA 229
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              V + +         C   +PE RP    +L  L
Sbjct: 230 STHVYQIMNH-------CWKERPEDRPAFSRLLRQL 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 90  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 145
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 253
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 254 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 285

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 88  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 143
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 251
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 252 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 283

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 111 VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 166
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 274
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 275 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 306

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 146
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 254
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 255 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 286

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 85  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 140
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 248
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 249 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 280

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G  G V+ G     +++AVK LK  S   +  F  E  ++ +++H+ L+ L  Y  
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAV 76
Query: 105 EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             QE + I+ +YM N             +  L  N+ +D+A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           DV+SFGILL E+ + G+ P   + N  + + +         ER +       +  +   E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYR-----MVRPDNCPE 237
Query: 282 ELKRVVLVALTCAHSKPEKRPTM 304
           EL +++ +   C   +PE RPT 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTF 257

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 26/271 (9%)
Query: 43  DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           + KLG G FG V+       +++AVK +K  S   E  F  E  ++  ++H  L+ L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAV 78
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
             + +   I+ ++M               +  L   + +D +   AEG+ ++      + 
Sbjct: 79  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---NY 132
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           IHRD++A+N+L+ A    ++ADFG A++I D         K  + + APE    G  +  
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 223 CDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVE 280
            DV+SFGILL+E+ + G+ P   + N  + R         A ER +     PR       
Sbjct: 193 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---------ALERGYRM---PRPEN--CP 238
Query: 281 EELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
           EEL  ++   + C  ++PE+RPT   +  +L
Sbjct: 239 EELYNIM---MRCWKNRPEERPTFEYIQSVL 266

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ Y
Sbjct: 112 VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKY 167
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 275
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 276 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 307

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 26/271 (9%)
Query: 43  DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           + KLG G FG V+       +++AVK +K  S   E  F  E  ++  ++H  L+ L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 251
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
             + +   I+ ++M               +  L   + +D +   AEG+ ++      + 
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---NY 305
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           IHRD++A+N+L+ A    ++ADFG A++I D         K  + + APE    G  +  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 223 CDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVE 280
            DV+SFGILL+E+ + G+ P   + N  + R         A ER +     PR       
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---------ALERGYRM---PRPEN--CP 411
Query: 281 EELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
           EEL  ++   + C  ++PE+RPT   +  +L
Sbjct: 412 EELYNIM---MRCWKNRPEERPTFEYIQSVL 439

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ +
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKF 146
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 254
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 255 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 286

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ +
Sbjct: 98  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKF 153
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 261
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 262 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 293

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V+ G   + +++AVK LK  +   +  F  E  ++  ++H  L+ L     
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 105 EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIH 164
             +   I+ +YM               + LL   + +D +   AEG+ Y+      + IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERK---NYIH 133
Query: 165 RDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCD 224
           RD++A+NVL+      ++ADFG A++I D         K  + + APE    G  +   D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 225 VYSFGILLLELAS-GKKP 241
           V+SFGILL E+ + GK P
Sbjct: 194 VWSFGILLYEIVTYGKIP 211

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ +
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKF 149
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 257
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 258 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ +
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKF 148
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 256
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 257 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 288

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ +
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKF 149
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 257
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 258 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ +
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKF 148
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 256
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 257 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 288

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)
Query: 41  NYDNKLGEGGFGSVYWGQLWD--GSQI--AVKRLKVWSNKAEM-EFAVEVEILARVRHKN 95
           +++  +G G FG VY G L D  G +I  AVK L   ++  E+ +F  E  I+    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 96  LLSLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +LSL G C  +EG   L+V  YM +               + +    +   +  A+G+ +
Sbjct: 152 VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKF 207
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD---GATHVTTRVKGTLGYLA 210
           L   A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
            E     K +   DV+SFG+LL EL + G  P   VN+       D  + L   R+    
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL--- 315
Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               L   +  + L  V+   L C H K E RP+  E++
Sbjct: 316 ----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELV 347

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +   +  ++G G FG V+ G   +  ++A+K ++     +E +F  E E++ ++ H  L+
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C E     +V ++M +               L      + + +   EG+ YL   
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA 123
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     
Sbjct: 124 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 218 KASESCDVYSFGILLLELAS-GKKPIE-KVNSAIKRTITDWALPLACERKFSELADPRLN 275
           + S   DV+SFG+L+ E+ S GK P E + NS +   I+              L  PRL 
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------TGFRLYKPRLA 230
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              V + +         C   +PE RP    +L  L
Sbjct: 231 STHVYQIMNH-------CWRERPEDRPAFSRLLRQL 259

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG A+++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 15/224 (6%)
Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAE 78
           G   P W I           +     KLG G FG V+ G   + +++AVK LK  +   +
Sbjct: 1   GAMDPAWEI--------PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ 52
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN 138
             F  E  ++  ++H  L+ L     + +   I+ ++M               + LL   
Sbjct: 53  -AFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP-- 109
Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV 198
           + +D +   AEG+ Y+      + IHRD++A+NVL+      ++ADFG A++I D     
Sbjct: 110 KLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 166
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
               K  + + APE    G  +   +V+SFGILL E+ + GK P
Sbjct: 167 REGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 135/301 (44%), Gaps = 47/301 (15%)
Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKA 77
           G + P  R+ +L     A N   Y+ ++G+GGFG V+ G+L  D S +A+K L +  ++ 
Sbjct: 5   GSEFPKSRLPTL-----ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59
Query: 78  E-------MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXX 130
           E        EF  EV I++ + H N++ L G         +V +++P             
Sbjct: 60  ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH 117
Query: 131 XECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL-----DADFKAQVADF 185
               + W+ ++ + +  A GI Y+ +   P I+HRD+++ N+ L     +A   A+VADF
Sbjct: 118 P---IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES----CDVYSFGILLLELASGKKP 241
           G ++     + H  + + G   ++APE   +G   ES     D YSF ++L  + +G+ P
Sbjct: 174 GLSQ----QSVHSVSGLLGNFQWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 242 IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR 301
            ++ +   K    +            E   PRL  N +E            C    P+KR
Sbjct: 228 FDEYSYG-KIKFINMIREEGLRPTIPEDCPPRLR-NVIE-----------LCWSGDPKKR 274
Query: 302 P 302
           P
Sbjct: 275 P 275

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 11  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 125
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 126 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 38  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 152
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 153 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 210 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G  G V +G+L    Q    +A+K LK  ++ +   +F  E  I+ +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G    G+  +IV +YM N               ++     + +  G   G+ YL      
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYLSDLG-- 171
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPD--GATHVTTRVKGTLGYLAPEYAMLGK 218
             +HRD+ A NVL+D++   +V+DFG ++++ D   A + TT  K  + + APE      
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 219 ASESCDVYSFGILLLE-LASGKKPI-EKVNSAIKRTITD---WALPLACERKFSELADPR 273
            S + DV+SFG+++ E LA G++P     N  +  ++ +      P+ C     +L    
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQL---- 286
Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                            L C H    +RP   +++ +L
Sbjct: 287 ----------------MLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 28  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 142
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 143 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 200 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 45  KLGEGGFGSVYWGQL------WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +LGEG FG V+  +        D   +AVK LK  S  A  +F  E E+L  ++H++++ 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL-----------LNWNRRMDIAIGS 147
             G C EG+  L+V++YM +               L           L   + + +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTL 206
           A G+VYL   A  H +HRD+   N L+      ++ DFG ++ I     + V  R    +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
            ++ PE  +  K +   DV+SFG++L E+ + GK+P  ++++ 
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 45  KLGEGGFGSVYWGQL------WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +LGEG FG V+  +        D   +AVK LK  S  A  +F  E E+L  ++H++++ 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL-----------LNWNRRMDIAIGS 147
             G C EG+  L+V++YM +               L           L   + + +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTL 206
           A G+VYL   A  H +HRD+   N L+      ++ DFG ++ I     + V  R    +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
            ++ PE  +  K +   DV+SFG++L E+ + GK+P  ++++ 
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 238

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 45  KLGEGGFGSVYWGQL------WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +LGEG FG V+  +        D   +AVK LK  S  A  +F  E E+L  ++H++++ 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL-----------LNWNRRMDIAIGS 147
             G C EG+  L+V++YM +               L           L   + + +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTL 206
           A G+VYL   A  H +HRD+   N L+      ++ DFG ++ +       V  R    +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
            ++ PE  +  K +   DV+SFG++L E+ + GK+P  ++++ 
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV +YM N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG  +++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 135/301 (44%), Gaps = 47/301 (15%)
Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKA 77
           G + P  R+ +L     A N   Y+ ++G+GGFG V+ G+L  D S +A+K L +  ++ 
Sbjct: 5   GSEFPKSRLPTL-----ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59
Query: 78  E-------MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXX 130
           E        EF  EV I++ + H N++ L G         +V +++P             
Sbjct: 60  ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH 117
Query: 131 XECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL-----DADFKAQVADF 185
               + W+ ++ + +  A GI Y+ +   P I+HRD+++ N+ L     +A   A+VADF
Sbjct: 118 P---IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES----CDVYSFGILLLELASGKKP 241
           G ++     + H  + + G   ++APE   +G   ES     D YSF ++L  + +G+ P
Sbjct: 174 GTSQ----QSVHSVSGLLGNFQWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 242 IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR 301
            ++ +   K    +            E   PRL  N +E            C    P+KR
Sbjct: 228 FDEYSYG-KIKFINMIREEGLRPTIPEDCPPRLR-NVIE-----------LCWSGDPKKR 274
Query: 302 P 302
           P
Sbjct: 275 P 275

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 14/204 (6%)
Query: 46  LGEGGFGSVYWGQL-WDGSQ---IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L   G +   +A+K LKV ++ K   +F  E  I+ +  H N++ L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G    G+  +IV ++M N               ++   + + +  G A G+ YL   A  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI---QLVGMLRGIAAGMRYL---ADM 164
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAMLGK 218
             +HRD+ A N+L++++   +V+DFG +++I D   A + TT  K  + + APE     K
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 219 ASESCDVYSFGILLLELAS-GKKP 241
            + + DV+S+GI++ E+ S G++P
Sbjct: 225 FTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 40/279 (14%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G  G V +G+L    Q    +A+K LK  ++ +   +F  E  I+ +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G    G+  +IV +YM N               ++     + +  G   G+ YL      
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYLSDLG-- 171
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKGTLGYLAPEYAMLG 217
             +HRD+ A NVL+D++   +V+DFG ++++   PD A   TT  K  + + APE     
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX-TTTGGKIPIRWTAPEAIAFR 229
Query: 218 KASESCDVYSFGILLLE-LASGKKPI-EKVNSAIKRTITD---WALPLACERKFSELADP 272
             S + DV+SFG+++ E LA G++P     N  +  ++ +      P+ C     +L   
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQL--- 286
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                             L C H    +RP   +++ +L
Sbjct: 287 -----------------MLDCWHKDRAQRPRFSQIVSVL 308

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAE---MEFAVEVEILARVRHKNLLSL 99
           +KLG GG  +VY  +      ++A+K + +   + E     F  EV   +++ H+N++S+
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 100 RGYCAEGQERLIVYDYM--PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                E     +V +Y+  P              +  +N+  ++       +GI + H  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI------LDGIKHAHDM 130
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               I+HRDIK  N+L+D++   ++ DFG AK + + +   T  V GT+ Y +PE A  G
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-G 186
Query: 218 KASESC-DVYSFGILLLELASGKKP 241
           +A++ C D+YS GI+L E+  G+ P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANAL 126
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 180
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 138
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 139 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 192
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKA 77
           G + P  R+ +L     A N   Y+ ++G+GGFG V+ G+L  D S +A+K L +  ++ 
Sbjct: 5   GSEFPKSRLPTL-----ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59
Query: 78  E-------MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXX 130
           E        EF  EV I++ + H N++ L G         +V +++P             
Sbjct: 60  ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH 117
Query: 131 XECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL-----DADFKAQVADF 185
               + W+ ++ + +  A GI Y+ +   P I+HRD+++ N+ L     +A   A+VADF
Sbjct: 118 P---IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES----CDVYSFGILLLELASGKKP 241
             ++     + H  + + G   ++APE   +G   ES     D YSF ++L  + +G+ P
Sbjct: 174 SLSQ----QSVHSVSGLLGNFQWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 242 IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR 301
            ++ +   K    +            E   PRL  N +E            C    P+KR
Sbjct: 228 FDEYSYG-KIKFINMIREEGLRPTIPEDCPPRLR-NVIE-----------LCWSGDPKKR 274
Query: 302 P 302
           P
Sbjct: 275 P 275

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 122
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TTLSGTLDYLPP 176
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 147
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 148 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 201
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 126
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 180
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 178
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV + M N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 126
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 180
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANAL 126
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P         + GTL YL P
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGTLDYLPP 180
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 11  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV + M N               ++   + + +  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---QLVGMLR 125
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 126 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 122
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 176
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 126
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 180
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 178
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 16/219 (7%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEV 85
           KEL +   N + D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E 
Sbjct: 40  KELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            I+ +  H N++ L G   + +  +IV + M N               ++   + + +  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---QLVGMLR 154
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVK 203
           G A G+ YL        +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             + + +PE     K + + DV+S+GI+L E+ S G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 120
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 174
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 125
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL YL P
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 179
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 36/271 (13%)
Query: 43  DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           + KLG G FG V+       +++AVK +K  S   E  F  E  ++  ++H  L+ L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 245
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
             + +   I+ ++M               +  L   + +D +   AEG+ ++      + 
Sbjct: 246 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---NY 299
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           IHRD++A+N+L+ A    ++ADFG A++   GA       K  + + APE    G  +  
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV---GA-------KFPIKWTAPEAINFGSFTIK 349
Query: 223 CDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKFSELADPRLNGNFVE 280
            DV+SFGILL+E+ + G+ P   + N  + R         A ER +     PR       
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---------ALERGYRM---PRPEN--CP 395
Query: 281 EELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
           EEL  ++   + C  ++PE+RPT   +  +L
Sbjct: 396 EELYNIM---MRCWKNRPEERPTFEYIQSVL 423

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFA-------VEVEIL 88
           A  +F     LG+G FG+VY  +  +  +  +  LKV   KA++E A        EVEI 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAR--EKQRKFILALKVLF-KAQLEKAGVEHQLRREVEIQ 59
Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSA 148
           + +RH N+L L GY  +     ++ +Y P                  +  R        A
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 115
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
             + Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P       T + GTL Y
Sbjct: 116 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 169
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           L PE        E  D++S G+L  E   GK P E
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 123
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++A+FG++   P       T + GTL YL P
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPP 177
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 122
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P           GTL YL P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC---GTLDYLPP 176
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARVRHK 94
           +F+    LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYL 154
           N+L L GY  +     ++ +Y P                  +  R        A  + Y 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALSYC 128
Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
           H   +  +IHRDIK  N+LL ++ + ++ADFG++   P       T + GTL YL PE  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMI 182
Query: 215 MLGKASESCDVYSFGILLLELASGKKPIE 243
                 E  D++S G+L  E   G  P E
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 123
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P         + GTL YL P
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPP 177
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 91/360 (25%), Positives = 149/360 (41%), Gaps = 93/360 (25%)
Query: 16  KEKGKKQPTWRIFSLKELHSAT-----------------NNFNYDNKLGEGGFGSVYWGQ 58
           K+K K Q  W+I    E +S T                 NN  +   LG G FG V    
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 59  LWDGSQ------IAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLLSLRGYCAEGQERL 110
            +   +      +AVK LK  ++  E E    E++I++ + +H+N+++L G C  G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 111 IVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR-------------------MDIAIGSA 148
           ++ +Y                 C   LLN+ RR                   +  +   A
Sbjct: 127 VITEYC----------------CYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT--- 205
           +G+ +L   A+ + IHRD+ A NVLL     A++ DFG A+ I + + ++   VKG    
Sbjct: 171 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNARL 224
Query: 206 -LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK--VNSAIKRTITDWALPLA 261
            + ++APE       +   DV+S+GILL E+ S G  P     VNS   + + D      
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG----- 279
Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTE 321
                 ++A P           K +  +   C   +P  RPT  ++   L+ +++E   E
Sbjct: 280 -----YQMAQPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 327

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 147
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P         + GTL YL P
Sbjct: 148 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPP 201
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++A+FG++   P       T + GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPP 178
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 46  LGEGGFGSVYWGQL-WDGSQ---IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L   G +   +A+K LKV ++ K   +F  E  I+ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   + +  +IV +YM N               ++   + + +  G + G+ YL      
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI---QLVGMLRGISAGMKYLSDMG-- 144
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAMLGK 218
             +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K  + + APE     K
Sbjct: 145 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 219 ASESCDVYSFGILLLELAS-GKKP 241
            + + DV+S+GI++ E+ S G++P
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERP 227

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARV 91
           +  +F     LG G FG V+  +   +G   A+K LK   V   K       E  +L+ V
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG---SA 148
            H  ++ + G   + Q+  ++ DY+                 LL  ++R    +    +A
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELF----------SLLRKSQRFPNPVAKFYAA 113
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           E  + L +  +  II+RD+K  N+LLD +   ++ DFGFAK +PD    VT  + GT  Y
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDY 169
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS 247
           +APE       ++S D +SFGIL+ E+ +G  P    N+
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P         + GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPP 178
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEV 85
            SL +      +    +KLG G FG VY G +W      +AVK LK  + + E EF  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEA 58
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            ++  ++H NL+ L G C       I+ ++M                 LL++ R  +   
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN-------------LLDYLRECNRQE 105
Query: 146 GSAEGIVYLHHHATP--------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH 197
            SA  ++Y+    +         + IHRD+ A N L+  +   +VADFG ++L+      
Sbjct: 106 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT 165
Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
                K  + + APE     K S   DV++FG+LL E+A+ G  P   ++ +
Sbjct: 166 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P           GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---GTLDYLPP 178
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 33/289 (11%)
Query: 34  HSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVW---SNKAEMEFAVEVEILA 89
           ++   NF  + K+G G F  VY    L DG  +A+K+++++     KA  +   E+++L 
Sbjct: 28  YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN----WNRRMDIAI 145
           ++ H N++       E  E  IV +                 + L+     W  +  + +
Sbjct: 88  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW--KYFVQL 145
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT 205
            SA     L H  +  ++HRDIK +NV + A    ++ D G  +      T   + V GT
Sbjct: 146 CSA-----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 199
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACE 263
             Y++PE       +   D++S G LL E+A+ + P   +K+N           L   C 
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LYSLC- 247
Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
           +K  +   P L  +   EEL+++V +   C +  PEKRP +  V D+ K
Sbjct: 248 KKIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAK 293

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P         + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 116/269 (43%), Gaps = 40/269 (14%)
Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           ++G G FG+VY+ +    S++ A+K++      SN+   +   EV  L ++RH N +  R
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI---GSAEGIVYLHHH 157
           G         +V +Y                +        ++IA    G+ +G+ YLH H
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ-------EVEIAAVTHGALQGLAYLHSH 134
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML- 216
              ++IHRD+KA N+LL      ++ DFG A ++      V     GT  ++APE  +  
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 217 --GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL 274
             G+     DV+S GI  +ELA  K P+  +N+            ++     ++   P L
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNESPAL 234
Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPT 303
                 E  +  V    +C    P+ RPT
Sbjct: 235 QSGHWSEYFRNFV---DSCLQKIPQDRPT 260

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 117/267 (43%), Gaps = 36/267 (13%)
Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           ++G G FG+VY+ +    S++ A+K++      SN+   +   EV  L ++RH N +  R
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 101 G-YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
           G Y  E    L++   + +             E  +       +  G+ +G+ YLH H  
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLHSH-- 173
Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML--- 216
            ++IHRD+KA N+LL      ++ DFG A ++      V     GT  ++APE  +    
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDE 227
Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
           G+     DV+S GI  +ELA  K P+  +N+            ++     ++   P L  
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNESPALQS 275
Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPT 303
               E  +  V    +C    P+ RPT
Sbjct: 276 GHWSEYFRNFV---DSCLQKIPQDRPT 299

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +  +   I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P           GTL YL P
Sbjct: 122 SYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---GTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P           GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---GTLDYLPP 175
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 38  HKLGGGQYGEVYVG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 95
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       IV +YMP              E        M   I SA     + +    +
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSA-----MEYLEKKN 150
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE       S 
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPYPGID 236

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 92/360 (25%), Positives = 149/360 (41%), Gaps = 97/360 (26%)
Query: 16  KEKGKKQPTWRIFSLKELHSAT-----------------NNFNYDNKLGEGGFGSVYWGQ 58
           K+K K Q  W+I    E +S T                 NN  +   LG G FG V    
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 59  LWDGSQ------IAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLLSLRGYCAEGQERL 110
            +   +      +AVK LK  ++  E E    E++I++ + +H+N+++L G C  G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 111 IVYDYMPNXXXXXXXXXXXXXEC---LLNWNRRMD--------IAIGS------------ 147
           ++ +Y                 C   LLN+ RR           AI +            
Sbjct: 127 VITEYC----------------CYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 148 ---AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
              A+G+ +L   A+ + IHRD+ A NVLL     A++ DFG A+ I + + ++   VKG
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKG 224
Query: 205 T----LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK--VNSAIKRTITDWA 257
                + ++APE       +   DV+S+GILL E+ S G  P     VNS   + + D  
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG- 283
Query: 258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE 317
                     ++A P           K +  +   C   +P  RPT  ++   L+ +++E
Sbjct: 284 ---------YQMAQPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 130
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 129
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 133
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 128
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 92/360 (25%), Positives = 149/360 (41%), Gaps = 97/360 (26%)
Query: 16  KEKGKKQPTWRIFSLKELHSAT-----------------NNFNYDNKLGEGGFGSVYWGQ 58
           K+K K Q  W+I    E +S T                 NN  +   LG G FG V    
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 59  LWDGSQ------IAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLLSLRGYCAEGQERL 110
            +   +      +AVK LK  ++  E E    E++I++ + +H+N+++L G C  G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 111 IVYDYMPNXXXXXXXXXXXXXEC---LLNWNRRMD--------IAIGS------------ 147
           ++ +Y                 C   LLN+ RR           AI +            
Sbjct: 127 VITEYC----------------CYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 148 ---AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
              A+G+ +L   A+ + IHRD+ A NVLL     A++ DFG A+ I + + ++   VKG
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKG 224
Query: 205 T----LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK--VNSAIKRTITDWA 257
                + ++APE       +   DV+S+GILL E+ S G  P     VNS   + + D  
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG- 283
Query: 258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE 317
                     ++A P           K +  +   C   +P  RPT  ++   L+ +++E
Sbjct: 284 ---------YQMAQPAF-------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 134
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 130
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 135
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 137
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARV 91
           A  +F     LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L L GY  +     ++ +Y P                  +  R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H   +  +IHRDIK  N+LL +  + ++ADFG++   P         + GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPP 178
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++S G+L  E   GK P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 130
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL-KVWSNKAEMEFAV--EVEILARVRHK 94
           +F+    LG+G FG+VY  +      I A+K L K    KA +E  +  EVEI + +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYL 154
           N+L L GY  +     ++ +Y P                  +  R        A  + Y 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALSYC 128
Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
           H   +  +IHRDIK  N+LL ++ + ++ADFG++   P           GTL YL PE  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC---GTLDYLPPEMI 182
Query: 215 MLGKASESCDVYSFGILLLELASGKKPIE 243
                 E  D++S G+L  E   G  P E
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 136
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER---IDHIKLLQYTSQICKGMEYL--- 133
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 29  SLKELHSATNNFNYDNKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVE 86
           SL +      +    +KLG G +G VY G +W      +AVK LK  + + E EF  E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 59
Query: 87  ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG 146
           ++  ++H NL+ L G C       I+ ++M                 LL++ R  +    
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGN-------------LLDYLRECNRQEV 106
Query: 147 SAEGIVYLHHHATP--------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV 198
           SA  ++Y+    +         + IHRD+ A N L+  +   +VADFG ++L+       
Sbjct: 107 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
               K  + + APE     K S   DV++FG+LL E+A+ G  P   ++ +
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 161
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 148
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGSAEGI 151
           +G C + G+  L ++ +++P              E L     R+D            +G+
Sbjct: 80  KGVCYSAGRRNLKLIMEFLP---------YGSLREYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYL 209
            YL    T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + 
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 210 APEYAMLGKASESCDVYSFGILLLELAS 237
           APE     K S + DV+SFG++L EL +
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 38  NNFNYDNKLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVR 92
            +  Y ++LG+G FGSV    +  L D  G+ +AVK+L+      + +F  E++IL  + 
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 69
Query: 93  HKNLLSLRG--YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
              ++  RG  Y    Q   +V +Y+P+              CL ++ +R    + ++  
Sbjct: 70  SDFIVKYRGVSYGPGRQSLRLVMEYLPSG-------------CLRDFLQRHRARLDASRL 116
Query: 151 IVY-------LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
           ++Y       + +  +   +HRD+ A N+L++++   ++ADFG AKL+P    +   R  
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 204 G--TLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           G   + + APE       S   DV+SFG++L EL
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEV 85
            SL +      +    +KLG G +G VY G +W      +AVK LK  + + E EF  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEA 58
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            ++  ++H NL+ L G C       I+ ++M                 LL++ R  +   
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN-------------LLDYLRECNRQE 105
Query: 146 GSAEGIVYLHHHATP--------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH 197
            SA  ++Y+    +         + IHRD+ A N L+  +   +VADFG ++L+      
Sbjct: 106 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFT 165
Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
                K  + + APE     K S   DV++FG+LL E+A+ G  P   ++ +
Sbjct: 166 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 148
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHRD+   N+L++ + + ++ DFG  K++P        +  G   + + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 45  KLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +LG+G FGSV    +  L D  G  +AVK+L+  + +   +F  E+EIL  ++H N++  
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 100 RGYC-AEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
           +G C + G+  L ++ +Y+P                 ++  + +       +G+ YL   
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 131
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAM 215
            T   IHR++   N+L++ + + ++ DFG  K++P    +   +  G   + + APE   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 216 LGKASESCDVYSFGILLLELAS 237
             K S + DV+SFG++L EL +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLLS 98
           LGEG FG V   + +D      G Q+AVK LK  S    + +   E+EIL  + H+N++ 
Sbjct: 29  LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 99  LRGYCAE--GQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
            +G C E  G    ++ +++P+                +N  +++  A+   +G+ YL  
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL-- 142
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   +HRD+ A NVL++++ + ++ DFG  K I       T +      + + APE  
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 215 MLGKASESCDVYSFGILLLELAS 237
           M  K   + DV+SFG+ L EL +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 91/366 (24%), Positives = 149/366 (40%), Gaps = 99/366 (27%)
Query: 16  KEKGKKQPTWRIFSLKELHSAT-----------------NNFNYDNKLGEGGFGSVYWGQ 58
           K+K K Q  W+I    E +S T                 NN  +   LG G FG V    
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 59  LWDGSQ------IAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLLSLRGYCAEGQERL 110
            +   +      +AVK LK  ++  E E    E++I++ + +H+N+++L G C  G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 111 IVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR-------------------------MD 142
           ++ +Y                 C   LLN+ RR                         + 
Sbjct: 127 VITEYC----------------CYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
            +   A+G+ +L   A+ + IHRD+ A NVLL     A++ DFG A+ I + + ++   V
Sbjct: 171 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---V 224
Query: 203 KGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK--VNSAIKRTITD 255
           KG     + ++APE       +   DV+S+GILL E+ S G  P     VNS   + + D
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 284
Query: 256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES 315
                       ++A P           K +  +   C   +P  RPT  ++   L+ ++
Sbjct: 285 G----------YQMAQPAF-------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 327
Query: 316 KEKLTE 321
           +E   E
Sbjct: 328 QEDRRE 333

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLLS 98
           LGEG FG V   + +D      G Q+AVK LK  S    + +   E+EIL  + H+N++ 
Sbjct: 17  LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 99  LRGYCAE--GQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
            +G C E  G    ++ +++P+                +N  +++  A+   +G+ YL  
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL-- 130
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   +HRD+ A NVL++++ + ++ DFG  K I       T +      + + APE  
Sbjct: 131 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 215 MLGKASESCDVYSFGILLLELAS 237
           M  K   + DV+SFG+ L EL +
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/354 (25%), Positives = 146/354 (41%), Gaps = 93/354 (26%)
Query: 18  KGKKQPTWRIFSLKELHSAT-----------------NNFNYDNKLGEGGFGSVYWGQLW 60
           K K Q  W+I    E +S T                 NN  +   LG G FG V     +
Sbjct: 1   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 60
Query: 61  DGSQ------IAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLLSLRGYCAEGQERLIV 112
              +      +AVK LK  ++  E E    E++I++ + +H+N+++L G C  G   L++
Sbjct: 61  GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 120
Query: 113 YDYMPNXXXXXXXXXXXXXEC---LLNWNRR-------------------MDIAIGSAEG 150
            +Y                 C   LLN+ RR                   +  +   A+G
Sbjct: 121 TEYC----------------CYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT----L 206
           + +L   A+ + IHRD+ A NVLL     A++ DFG A+ I + + ++   VKG     +
Sbjct: 165 MAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNARLPV 218
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK--VNSAIKRTITDWALPLACE 263
            ++APE       +   DV+S+GILL E+ S G  P     VNS   + + D        
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG------- 271
Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE 317
               ++A P           K +  +   C   +P  RPT  ++   L+ +++E
Sbjct: 272 ---YQMAQPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 315

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 38  NNFNYDNKLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVR 92
            +  Y ++LG+G FGSV    +  L D  G+ +AVK+L+      + +F  E++IL  + 
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 70
Query: 93  HKNLLSLRG--YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
              ++  RG  Y    Q   +V +Y+P+              CL ++ +R    + ++  
Sbjct: 71  SDFIVKYRGVSYGPGRQSLRLVMEYLPSG-------------CLRDFLQRHRARLDASRL 117
Query: 151 IVY-------LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
           ++Y       + +  +   +HRD+ A N+L++++   ++ADFG AKL+P    +   R  
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 204 G--TLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           G   + + APE       S   DV+SFG++L EL
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG V     +D      G  +AVK LK     +    +  E+EIL  + H++++ 
Sbjct: 17  LGEGHFGKVSL-YCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 99  LRGYCAEGQERLI--VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
            +G C +  E+ +  V +Y+P               C+    + +  A    EG+ YLH 
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVP----LGSLRDYLPRHCV-GLAQLLLFAQQICEGMAYLH- 129
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYA 214
               H IHR + A NVLLD D   ++ DFG AK +P+G  +   R  G   + + APE  
Sbjct: 130 --AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 215 MLGKASESCDVYSFGILLLELA----SGKKPIEKVNSAIKRT 252
              K   + DV+SFG+ L EL     S + P  K    I  T
Sbjct: 188 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHT 229

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 38  NNFNYDNKLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVR 92
            +  Y ++LG+G FGSV    +  L D  G+ +AVK+L+      + +F  E++IL  + 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 93  HKNLLSLRG--YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
              ++  RG  Y    Q   +V +Y+P+              CL ++ +R    + ++  
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSG-------------CLRDFLQRHRARLDASRL 129
Query: 151 IVY-------LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
           ++Y       + +  +   +HRD+ A N+L++++   ++ADFG AKL+P    +   R  
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 204 G--TLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           G   + + APE       S   DV+SFG++L EL
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L    +    +A+K LK  +++K   +F  E  I+ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   + +  +I+ +YM N               ++   + + +  G   G+ YL   +  
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLSDMSA- 152
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAMLGK 218
             +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K  + + APE     K
Sbjct: 153 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 219 ASESCDVYSFGILLLELAS-GKKP 241
            + + DV+S+GI++ E+ S G++P
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERP 234

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG V     +D      G  +AVK LK     +    +  E+EIL  + H++++ 
Sbjct: 16  LGEGHFGKVSL-YCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 99  LRGYCAEGQERLI--VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
            +G C +  E+ +  V +Y+P               C+    + +  A    EG+ YLH 
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVP----LGSLRDYLPRHCV-GLAQLLLFAQQICEGMAYLH- 128
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYA 214
               H IHR + A NVLLD D   ++ DFG AK +P+G  +   R  G   + + APE  
Sbjct: 129 --AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 215 MLGKASESCDVYSFGILLLELA----SGKKPIEKVNSAIKRT 252
              K   + DV+SFG+ L EL     S + P  K    I  T
Sbjct: 187 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHT 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 36/211 (17%)
Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG V     +D      G  +AVK LK     +    +  E++IL  + H++++ 
Sbjct: 22  LGEGHFGKVSL-YCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 99  LRGYCA-EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS--------A 148
            +G C  +G++ L +V +Y+P                L ++  R  I +           
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGS-------------LRDYLPRHSIGLAQLLLFAQQIC 127
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TL 206
           EG+ YLH   + H IHR++ A NVLLD D   ++ DFG AK +P+G  +   R  G   +
Sbjct: 128 EGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 184
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS 237
            + APE     K   + DV+SFG+ L EL +
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 20  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 77
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 132
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGID 218

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 19  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP- 160
            C       I+ ++M                 LL++ R  +    SA  ++Y+    +  
Sbjct: 77  VCTREPPFYIITEFMTYGN-------------LLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 161 -------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
                  + IHRD+ A N L+  +   +VADFG ++L+           K  + + APE 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKPIEKVN 246
               K S   DV++FG+LL E+A+ G  P   ++
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 19  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP- 160
            C       I+ ++M                 LL++ R  +    SA  ++Y+    +  
Sbjct: 77  VCTREPPFYIIIEFMTYGN-------------LLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 161 -------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
                  + IHRD+ A N L+  +   +VADFG ++L+           K  + + APE 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKPIEKVN 246
               K S   DV++FG+LL E+A+ G  P   ++
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 21  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 78
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 133
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 24  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 81
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP- 160
            C       I+ ++M                 LL++ R  +    SA  ++Y+    +  
Sbjct: 82  VCTREPPFYIITEFMTYGN-------------LLDYLRECNRQEVSAVVLLYMATQISSA 128
Query: 161 -------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
                  + IHRD+ A N L+  +   +VADFG ++L+           K  + + APE 
Sbjct: 129 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 188
Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKPIEKVN 246
               K S   DV++FG+LL E+A+ G  P   ++
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 19  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP- 160
            C       I+ ++M                 LL++ R  +    SA  ++Y+    +  
Sbjct: 77  VCTREPPFYIIIEFMTYGN-------------LLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 161 -------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
                  + IHRD+ A N L+  +   +VADFG ++L+           K  + + APE 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKPIEKVN 246
               K S   DV++FG+LL E+A+ G  P   ++
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 19  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP- 160
            C       I+ ++M                 LL++ R  +    SA  ++Y+    +  
Sbjct: 77  VCTREPPFYIITEFMTYGN-------------LLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 161 -------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
                  + IHRD+ A N L+  +   +VADFG ++L+           K  + + APE 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKPIEKVN 246
               K S   DV++FG+LL E+A+ G  P   ++
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 20  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 77
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 132
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGID 218

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 36/211 (17%)
Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG V     +D      G  +AVK LK     +    +  E++IL  + H++++ 
Sbjct: 22  LGEGHFGKVSL-YCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 99  LRGYCA-EGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS--------A 148
            +G C  +G++ L +V +Y+P                L ++  R  I +           
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGS-------------LRDYLPRHSIGLAQLLLFAQQIC 127
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TL 206
           EG+ YLH     H IHR++ A NVLLD D   ++ DFG AK +P+G  +   R  G   +
Sbjct: 128 EGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 184
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS 237
            + APE     K   + DV+SFG+ L EL +
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+ L G   E
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 106 GQERL-IVYDYMPNXXXXXXXXXXXXX----ECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
            +  L IV +YM                   +CLL ++  +D+     E + YL  +   
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVC----EAMEYLEGN--- 308
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           + +HRD+ A NVL+  D  A+V+DFG  K     A+      K  + + APE     K S
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 221 ESCDVYSFGILLLELAS-GKKPIEKV 245
              DV+SFGILL E+ S G+ P  ++
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRI 390

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+ L G   E
Sbjct: 14  IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 106 GQERL-IVYDYMPNXXXX----XXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
            +  L IV +YM                   +CLL ++  +D+     E + YL  +   
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVC----EAMEYLEGN--- 121
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           + +HRD+ A NVL+  D  A+V+DFG  K     A+      K  + + APE     K S
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 221 ESCDVYSFGILLLELAS-GKKPIEKV 245
              DV+SFGILL E+ S G+ P  ++
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRI 203

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L    +    +A+K LK  +++K   +F  E  I+ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   + +  +I+ +YM N               ++   + + +  G   G+ YL   +  
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLSDMSY- 137
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAMLGK 218
             +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K  + + APE     K
Sbjct: 138 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 219 ASESCDVYSFGILLLELAS-GKKP 241
            + + DV+S+GI++ E+ S G++P
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERP 219

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+ L G   E
Sbjct: 29  IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 106 GQERL-IVYDYMPNXXXX----XXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
            +  L IV +YM                   +CLL ++  +D+     E + YL  +   
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVC----EAMEYLEGN--- 136
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           + +HRD+ A NVL+  D  A+V+DFG  K     A+      K  + + APE     K S
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 221 ESCDVYSFGILLLELAS-GKKPIEKV 245
              DV+SFGILL E+ S G+ P  ++
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRI 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 104/251 (41%), Gaps = 17/251 (6%)
Query: 34  HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL---KVWSNKAEMEFAVEVEILA 89
           H   ++F     LG+G FG+VY  +      I A+K L   ++     E +   E+EI A
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE 149
            + H N+L L  Y  + +   ++ +Y P               C  +  R   I    A+
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK----SCTFDEQRTATIMEELAD 134
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
            ++Y H      +IHRDIK  N+LL    + ++ADFG++   P           GTL YL
Sbjct: 135 ALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC---GTLDYL 188
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKV--NSAIKRTI-TDWALPLACERKF 266
            PE       +E  D++  G+L  EL  G  P E    N   +R +  D   P +     
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGA 248
Query: 267 SELADPRLNGN 277
            +L    L  N
Sbjct: 249 QDLISKLLRHN 259

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 24  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 81
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 136
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 21  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 78
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E        M   I SA     + +    +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKN 133
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 24  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 81
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 136
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 24  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 81
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 136
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 21  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 78
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E        M   I SA     + +    +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKN 133
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 32  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 89
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E        M   I SA     + +    +
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKN 144
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPGID 230

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 38  NNFNYDNKLGEGGFGSV---YWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVR 92
            +  Y ++LG+G FGSV    +  L D  G+ +AVK+L+      + +F  E++IL  + 
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 66
Query: 93  HKNLLSLRG--YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
              ++  RG  Y     E  +V +Y+P+              CL ++ +R    + ++  
Sbjct: 67  SDFIVKYRGVSYGPGRPELRLVMEYLPSG-------------CLRDFLQRHRARLDASRL 113
Query: 151 IVY-------LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
           ++Y       + +  +   +HRD+ A N+L++++   ++ADFG AKL+P        R  
Sbjct: 114 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREP 173
Query: 204 G--TLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           G   + + APE       S   DV+SFG++L EL
Sbjct: 174 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 24  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 81
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 136
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L    +    +A+K LK  +++K   +F  E  I+ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   + +  +I+ +YM N               ++   + + +  G   G+ YL   +  
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLSDMSY- 131
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYLAPEYAMLGK 218
             +HRD+ A N+L++++   +V+DFG ++++ D   A + T   K  + + APE     K
Sbjct: 132 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 219 ASESCDVYSFGILLLELAS-GKKP 241
            + + DV+S+GI++ E+ S G++P
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 23  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 80
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 135
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGID 221

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 19  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 131
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 83/339 (24%), Positives = 148/339 (43%), Gaps = 54/339 (15%)
Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQI--AVKRLKVWSN 75
           GK  P   I+ + +     N+  + + +GEG FG V   ++  DG ++  A+KR+K +++
Sbjct: 10  GKNNPDPTIYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 76  KAE-MEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC 133
           K +  +FA E+E+L ++  H N+++L G C       +  +Y P+             E 
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 134 ------------LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ 181
                        L+  + +  A   A G+ YL   +    IHRD+ A N+L+  ++ A+
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 182
Query: 182 VADFGFAKLIPDGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-G 238
           +ADFG ++    G      +  G L   ++A E       + + DV+S+G+LL E+ S G
Sbjct: 183 IADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 238
Query: 239 KKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELK---RVVLVALTCAH 295
             P                    C    +EL +    G  +E+ L     V  +   C  
Sbjct: 239 GTPY-------------------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWR 279
Query: 296 SKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSHQVA 334
            KP +RP+  ++L  L    +E+ T + N  L++    A
Sbjct: 280 EKPYERPSFAQILVSLNRMLEERKTYV-NTTLYEKFTYA 317

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 135/299 (45%), Gaps = 46/299 (15%)
Query: 45  KLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLL 97
           +LG+G FG VY G   D       +++AVK + +  S +  +EF  E  ++      +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR-------RMDIAIGSAEG 150
            L G  ++GQ  L+V + M +             E   N  R        + +A   A+G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--Y 208
           + YL+       +HRD+ A N ++  DF  ++ DFG  + I + A +     KG L   +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA-YYRKGGKGLLPVRW 198
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKF 266
           +APE    G  + S D++SFG++L E+ S  ++P + + N  + + + D           
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----------- 247
Query: 267 SELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
                    G ++++     +RV  +   C    P+ RPT LE+++LLK +      E+
Sbjct: 248 ---------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 19  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E  +N    + +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---N 131
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHRD+ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN 246
             DV++FG+LL E+A+ G  P   ++
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 67/306 (21%)
Query: 34  HSATNNFNYDNK----LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEIL 88
           H+    F  D K    +G GGFG V+  +   DG    +KR+K  + KAE E    V+ L
Sbjct: 3   HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKAL 58
Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLL------------N 136
           A++ H N++   G C +G      +DY P              +CL              
Sbjct: 59  AKLDHVNIVHYNG-CWDG------FDYDPETSSKNSSRSKT--KCLFIQMEFCDKGTLEQ 109
Query: 137 W--NRR---------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF 185
           W   RR         +++     +G+ Y+H   +  +I+RD+K SN+ L    + ++ DF
Sbjct: 110 WIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDF 166
Query: 186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV 245
           G    + +       R KGTL Y++PE        +  D+Y+ G++L EL          
Sbjct: 167 GLVTSLKNDGKR--XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-------- 216
Query: 246 NSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
                  + D A   +  + F++L D  ++  F ++E  + +L  L     KPE RP   
Sbjct: 217 -------VCDTAFETS--KFFTDLRDGIISDIFDKKE--KTLLQKLLS--KKPEDRPNTS 263
Query: 306 EVLDLL 311
           E+L  L
Sbjct: 264 EILRTL 269

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE 105
           +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+ L G   E
Sbjct: 20  IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 106 GQERL-IVYDYMPNXXXX----XXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
            +  L IV +YM                   +CLL ++  +D+     E + YL  +   
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVC----EAMEYLEGN--- 127
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           + +HRD+ A NVL+  D  A+V+DFG  K     A+      K  + + APE       S
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 221 ESCDVYSFGILLLELAS-GKKPIEKV 245
              DV+SFGILL E+ S G+ P  ++
Sbjct: 184 TKSDVWSFGILLWEIYSFGRVPYPRI 209

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 46  LGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLS 98
           LGEG FG V     +D      G  +AVK LK  +       +  E++IL  + H++++ 
Sbjct: 39  LGEGHFGKVSL-YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 99  LRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS--------A 148
            +G C  A      +V +Y+P                L ++  R  I +           
Sbjct: 98  YKGCCEDAGAASLQLVMEYVP-------------LGSLRDYLPRHSIGLAQLLLFAQQIC 144
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TL 206
           EG+ YLH     H IHRD+ A NVLLD D   ++ DFG AK +P+G      R  G   +
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV 201
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELAS 237
            + APE     K   + DV+SFG+ L EL +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 86/181 (47%), Gaps = 18/181 (9%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK----G 204
           EG+ YLH +     IHRD+KA N+LL  D   Q+ADFG +  +  G      +V+    G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 205 TLGYLAPEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE 263
           T  ++APE     +  +   D++SFGI  +ELA+G  P  K        +T    P + E
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLT 320
              + + D  +   + +   K + L    C    PEKRPT  E+L      K ++KE L 
Sbjct: 249 ---TGVQDKEMLKKYGKSFRKMISL----CLQKDPEKRPTAAELLRHKFFQKAKNKEFLQ 301
Query: 321 E 321
           E
Sbjct: 302 E 302

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 115/238 (48%), Gaps = 20/238 (8%)
Query: 46  LGEGGFGSVYWGQL-WDGSQ---IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G L   G +   +A+K LK  ++ K   +F  E  I+ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   +    +I+ ++M N               ++   + + +  G A G+ YL   A  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---ADM 154
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT-TRVKG---TLGYLAPEYAML 216
           + +HRD+ A N+L++++   +V+DFG ++ + D  +  T T   G    + + APE    
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 217 GKASESCDVYSFGILLLELAS-GKKPI-EKVNSAIKRTI-TDWAL--PLACERKFSEL 269
            K + + DV+S+GI++ E+ S G++P  +  N  +   I  D+ L  P+ C     +L
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQL 272

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/320 (24%), Positives = 141/320 (44%), Gaps = 50/320 (15%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLW-DGSQI--AVKRLKVWSNKAE-MEFAVEVEILARV-R 92
           N+  + + +GEG FG V   ++  DG ++  A+KR+K +++K +  +FA E+E+L ++  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC------------LLNWNRR 140
           H N+++L G C       +  +Y P+             E              L+  + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
           +  A   A G+ YL   +    IHRD+ A N+L+  ++ A++ADFG ++    G      
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 187
Query: 201 RVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWA 257
           +  G L   ++A E       + + DV+S+G+LL E+ S G  P                
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--------------- 232
Query: 258 LPLACERKFSELADPRLNGNFVEEELK---RVVLVALTCAHSKPEKRPTMLEVLDLLKGE 314
               C    +EL +    G  +E+ L     V  +   C   KP +RP+  ++L  L   
Sbjct: 233 ----CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288
Query: 315 SKEKLTELENDELFKSHQVA 334
            +E+ T + N  L++    A
Sbjct: 289 LEERKTYV-NTTLYEKFTYA 307

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 46  LGEGGFGSVYWGQLW--DGSQIAVKR-LKVWSNKAEMEF--AVEVEILA--RVRHKNLLS 98
           LG G FG+V+ G +W  +G  I +   +KV  +K+  +   AV   +LA   + H +++ 
Sbjct: 39  LGSGVFGTVHKG-VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 99  LRGYCAEGQERLIVYDYMPNXXX---XXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C  G    +V  Y+P                 + LLNW  ++      A+G+ YL 
Sbjct: 98  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYLE 150
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEYA 214
            H    ++HR++ A NVLL +  + QVADFG A L+ PD    + +  K  + ++A E  
Sbjct: 151 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKP 241
             GK +   DV+S+G+ + EL + G +P
Sbjct: 208 HFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 134/299 (44%), Gaps = 46/299 (15%)
Query: 45  KLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLL 97
           +LG+G FG VY G   D       +++AVK + +  S +  +EF  E  ++      +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR-------RMDIAIGSAEG 150
            L G  ++GQ  L+V + M +             E   N  R        + +A   A+G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--Y 208
           + YL+       +HRD+ A N ++  DF  ++ DFG  + I +   +     KG L   +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRW 198
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKF 266
           +APE    G  + S D++SFG++L E+ S  ++P + + N  + + + D           
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----------- 247
Query: 267 SELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
                    G ++++     +RV  +   C    P+ RPT LE+++LLK +      E+
Sbjct: 248 ---------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 134/299 (44%), Gaps = 46/299 (15%)
Query: 45  KLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLL 97
           +LG+G FG VY G   D       +++AVK + +  S +  +EF  E  ++      +++
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR-------RMDIAIGSAEG 150
            L G  ++GQ  L+V + M +             E   N  R        + +A   A+G
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--Y 208
           + YL+       +HRD+ A N ++  DF  ++ DFG  + I +   +     KG L   +
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRW 197
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKF 266
           +APE    G  + S D++SFG++L E+ S  ++P + + N  + + + D           
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----------- 246
Query: 267 SELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
                    G ++++     +RV  +   C    P+ RPT LE+++LLK +      E+
Sbjct: 247 ---------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 296

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 44  NKLGEGGFG-SVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLR 100
            K+GEG FG ++      DG Q  +K + +   S+K   E   EV +LA ++H N++  R
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 101 GYCAEGQERLIVYDYMPN----XXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
               E     IV DY                    + +L+W  ++ +A         L H
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA---------LKH 140
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
                I+HRDIK+ N+ L  D   Q+ DFG A+++ +    +     GT  YL+PE    
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEICEN 199
Query: 217 GKASESCDVYSFGILLLELASGKKPIE 243
              +   D+++ G +L EL + K   E
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 226 HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 283
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP- 160
            C       I+ ++M                 LL++ R  +    SA  ++Y+    +  
Sbjct: 284 VCTREPPFYIITEFM-------------TYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 161 -------HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
                  + IHR++ A N L+  +   +VADFG ++L+           K  + + APE 
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKPIEKVN 246
               K S   DV++FG+LL E+A+ G  P   ++
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 66/298 (22%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +G GGFG V+  +   DG    ++R+K  + KAE E    V+ LA++ H N++   G C 
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNG-CW 74
Query: 105 EG--------QERLIVYDYMPNXXXXXXXXXXXXXECLL------------NW--NRR-- 140
           +G         + L   DY P              +CL              W   RR  
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKT---KCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 141 -------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD 193
                  +++     +G+ Y+H   +  +IHRD+K SN+ L    + ++ DFG    + +
Sbjct: 132 KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
                 TR KGTL Y++PE        +  D+Y+ G++L EL                 +
Sbjct: 189 DGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---------------V 231
Query: 254 TDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
            D A   +  + F++L D  ++  F ++E  + +L  L     KPE RP   E+L  L
Sbjct: 232 CDTAFETS--KFFTDLRDGIISDIFDKKE--KTLLQKLLS--KKPEDRPNTSEILRTL 283

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 79/165 (47%), Gaps = 15/165 (9%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK----G 204
           EG+ YLH +     IHRD+KA N+LL  D   Q+ADFG +  +  G      +V+    G
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 205 TLGYLAPEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE 263
           T  ++APE     +  +   D++SFGI  +ELA+G  P  K        +T    P + E
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
              + + D  +   + +   K + L    C    PEKRPT  E+L
Sbjct: 244 ---TGVQDKEMLKKYGKSFRKMISL----CLQKDPEKRPTAAELL 281

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 137/317 (43%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEM 79
           +F   E   +        +LG+G FG VY G   D       +++AVK + +  S +  +
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 80  EFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR 139
           EF  E  ++      +++ L G  ++GQ  L+V + M +             E   N  R
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGR 121
Query: 140 -------RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
                   + +A   A+G+ YL+       +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 178
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +         KG L   ++APE    G  + S D++SFG++L E+ S  ++P + + N  
Sbjct: 179 E-TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 237
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTML 305
           + + + D                    G ++++     +RV  +   C    P+ RPT L
Sbjct: 238 VLKFVMD--------------------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFL 277
Query: 306 EVLDLLKGESKEKLTEL 322
           E+++LLK +      E+
Sbjct: 278 EIVNLLKDDLHPSFPEV 294

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 137/317 (43%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEM 79
           +F   E   +        +LG+G FG VY G   D       +++AVK + +  S +  +
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 80  EFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR 139
           EF  E  ++      +++ L G  ++GQ  L+V + M +             E   N  R
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGR 124
Query: 140 -------RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
                   + +A   A+G+ YL+       +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +         KG L   ++APE    G  + S D++SFG++L E+ S  ++P + + N  
Sbjct: 182 E-TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTML 305
           + + + D                    G ++++     +RV  +   C    P+ RPT L
Sbjct: 241 VLKFVMD--------------------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 306 EVLDLLKGESKEKLTEL 322
           E+++LLK +      E+
Sbjct: 281 EIVNLLKDDLHPSFPEV 297

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 46  LGEGGFGSVYWGQLW--DGSQIAVKR-LKVWSNKAEMEF--AVEVEILA--RVRHKNLLS 98
           LG G FG+V+ G +W  +G  I +   +KV  +K+  +   AV   +LA   + H +++ 
Sbjct: 21  LGSGVFGTVHKG-VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 99  LRGYCAEGQERLIVYDYMPNXXX---XXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C  G    +V  Y+P                 + LLNW  ++      A+G+ YL 
Sbjct: 80  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYLE 132
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEYA 214
            H    ++HR++ A NVLL +  + QVADFG A L+ PD    + +  K  + ++A E  
Sbjct: 133 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKP 241
             GK +   DV+S+G+ + EL + G +P
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/344 (24%), Positives = 151/344 (43%), Gaps = 56/344 (16%)
Query: 14  DRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQI--AVKRL 70
           +RK K    PT  I+ + +     N+  + + +GEG FG V   ++  DG ++  A+KR+
Sbjct: 4   NRKVKNNPDPT--IYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 57
Query: 71  KVWSNKAE-MEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXX 128
           K +++K +  +FA E+E+L ++  H N+++L G C       +  +Y P+          
Sbjct: 58  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 117
Query: 129 XXXEC------------LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
              E              L+  + +  A   A G+ YL   +    IHR++ A N+L+  
Sbjct: 118 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGE 174
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLE 234
           ++ A++ADFG ++    G      +  G L   ++A E       + + DV+S+G+LL E
Sbjct: 175 NYVAKIADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 230
Query: 235 LAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELK---RVVLVA 290
           + S G  P                    C    +EL +    G  +E+ L     V  + 
Sbjct: 231 IVSLGGTPY-------------------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLM 271
Query: 291 LTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSHQVA 334
             C   KP +RP+  ++L  L    +E+ T + N  L++    A
Sbjct: 272 RQCWREKPYERPSFAQILVSLNRMLEERKTYV-NTTLYEKFTYA 314

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 16/229 (6%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV--EVEILARVRHK 94
           +F   N LG+G F  VY  + +  G ++A+K + K    KA M   V  EV+I  +++H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYL 154
           ++L L  Y  +     +V +   N                 + N           G++YL
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYL 128
Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYLAPEY 213
           H H    I+HRD+  SN+LL  +   ++ADFG A +L      H T  + GT  Y++PE 
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEK---VNSAIKRTITDWALP 259
           A         DV+S G +   L  G+ P +     N+  K  + D+ +P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 125/305 (40%), Gaps = 44/305 (14%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V+S +
Sbjct: 33  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQ 90
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 91  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 150
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPI-EK 244
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S G  P   K
Sbjct: 208 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
            N  +   +T                DP  N          V  +   C   +PE RP  
Sbjct: 265 SNQEVLEFVTSGG-----------RMDPPKNCP------GPVYRIMTQCWQHQPEDRPNF 307
Query: 305 LEVLD 309
             +L+
Sbjct: 308 AIILE 312

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 45  KLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLL 97
           +LG+G FG VY G   D       +++AVK + +  S +  +EF  E  ++      +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR-------RMDIAIGSAEG 150
            L G  ++GQ  L+V + M +             E   N  R        + +A   A+G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--Y 208
           + YL+       +HRD+ A N ++  DF  ++ DFG  + I +         KG L   +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-TDXXRKGGKGLLPVRW 198
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKF 266
           +APE    G  + S D++SFG++L E+ S  ++P + + N  + + + D           
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----------- 247
Query: 267 SELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
                    G ++++     +RV  +   C    P  RPT LE+++LLK +      E+
Sbjct: 248 ---------GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 14/233 (6%)
Query: 44  NKLGEGGFGSVYWGQLWD--GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W      +AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 265 HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 322
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M               E        M   I SA     + +    +
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKN 377
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHR++ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTI-TDWAL--PLACERKFSEL 269
             DV++FG+LL E+A+ G  P   ++ S +   +  D+ +  P  C  K  EL
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 490

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 45  KLGEGGFGSVY-WGQLWDGSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           +LG GGFG V  W     G Q+A+K+ +   S K    + +E++I+ ++ H N++S R  
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-E 80
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV---------- 152
             +G ++L      PN             + L  +  + +   G  EG +          
Sbjct: 81  VPDGLQKL-----APNDLPLLAMEYCEGGD-LRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 153 --YLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTRVKGTLG 207
             YLH +    IIHRD+K  N++L    +    ++ D G+AK +  G   + T   GTL 
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQ 189
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           YLAPE     K + + D +SFG L  E  +G +P 
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 45  KLGEGGFGSVY-WGQLWDGSQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           +LG GGFG V  W     G Q+A+K+ +   S K    + +E++I+ ++ H N++S R  
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-E 79
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV---------- 152
             +G ++L      PN             + L  +  + +   G  EG +          
Sbjct: 80  VPDGLQKL-----APNDLPLLAMEYCEGGD-LRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 153 --YLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTRVKGTLG 207
             YLH +    IIHRD+K  N++L    +    ++ D G+AK +  G   + T   GTL 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQ 188
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           YLAPE     K + + D +SFG L  E  +G +P 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRL-KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G +W  +G  +    A+K L +    KA +EF  E  I+A + H +L+ 
Sbjct: 23  LGSGAFGTVYKG-IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 99  LRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C     +L+    MP+                + LLNW       +  A+G++YL 
Sbjct: 82  LLGVCLSPTIQLVT-QLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 134
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGTLGYLAPEYA 214
                 ++HRD+ A NVL+ +    ++ DFG A+L+  D   +     K  + ++A E  
Sbjct: 135 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITD 255
              K +   DV+S+G+ + EL + G KP + + +   R I D
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPD 230

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 28/272 (10%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           F+   KLGEG +GSVY     +  QI A+K++ V S+  E+    E+ I+ +    +++ 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI--IKEISIMQQCDSPHVVK 88
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             G   +  +  IV +Y                   L  +    I   + +G+ YLH   
Sbjct: 89  YYGSYFKNTDLWIVMEYC---GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
               IHRDIKA N+LL+ +  A++ADFG A  + D        V GT  ++APE  ++ +
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPE--VIQE 199
Query: 219 ASESC--DVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
              +C  D++S GI  +E+A GK P   ++    R I  + +P      F +   P L  
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAI--FMIPTNPPPTFRK---PELWS 252
Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           +   + +K+       C    PE+R T  ++L
Sbjct: 253 DNFTDFVKQ-------CLVKSPEQRATATQLL 277

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 104/231 (45%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 19  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 76
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I++++ H+N++   G   +   R I+ + M                   +
Sbjct: 77  DELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 136
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 194 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 45  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 102
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 103 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 162
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 163 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 219
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 220 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 125/305 (40%), Gaps = 44/305 (14%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 33  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 90
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I++++ H+N++   G   +   R I+ + M                   +
Sbjct: 91  DELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 150
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPI-EK 244
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S G  P   K
Sbjct: 208 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
            N  +   +T                DP  N          V  +   C   +PE RP  
Sbjct: 265 SNQEVLEFVTSGG-----------RMDPPKNCP------GPVYRIMTQCWQHQPEDRPNF 307
Query: 305 LEVLD 309
             +L+
Sbjct: 308 AIILE 312

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 35  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 92
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 93  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 152
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 153 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 209
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 210 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 25  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 82
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 83  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 142
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 143 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 199
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 200 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRL-KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G +W  +G  +    A+K L +    KA +EF  E  I+A + H +L+ 
Sbjct: 46  LGSGAFGTVYKG-IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 99  LRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C     +L V   MP+                + LLNW       +  A+G++YL 
Sbjct: 105 LLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 157
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGTLGYLAPEYA 214
                 ++HRD+ A NVL+ +    ++ DFG A+L+  D   +     K  + ++A E  
Sbjct: 158 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITD 255
              K +   DV+S+G+ + EL + G KP + + +   R I D
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPD 253

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 133/299 (44%), Gaps = 46/299 (15%)
Query: 45  KLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLL 97
           +LG+G FG VY G   D       +++AVK + +  S +  +EF  E  ++      +++
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR-------RMDIAIGSAEG 150
            L G  ++GQ  L+V + M +             E   N  R        + +A   A+G
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--Y 208
           + YL+       +HR++ A N ++  DF  ++ DFG  + I +   +     KG L   +
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRW 199
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKF 266
           +APE    G  + S D++SFG++L E+ S  ++P + + N  + + + D           
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----------- 248
Query: 267 SELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
                    G ++++     +RV  +   C    P  RPT LE+++LLK +      E+
Sbjct: 249 ---------GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 133/299 (44%), Gaps = 46/299 (15%)
Query: 45  KLGEGGFGSVYWGQLWD------GSQIAVKRL-KVWSNKAEMEFAVEVEILARVRHKNLL 97
           +LG+G FG VY G   D       +++AVK + +  S +  +EF  E  ++      +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR-------RMDIAIGSAEG 150
            L G  ++GQ  L+V + M +             E   N  R        + +A   A+G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP-EAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG--Y 208
           + YL+       +HR++ A N ++  DF  ++ DFG  + I +   +     KG L   +
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRW 198
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITDWALPLACERKF 266
           +APE    G  + S D++SFG++L E+ S  ++P + + N  + + + D           
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----------- 247
Query: 267 SELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
                    G ++++     +RV  +   C    P  RPT LE+++LLK +      E+
Sbjct: 248 ---------GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 124/305 (40%), Gaps = 44/305 (14%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 33  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 90
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 91  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 150
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPI-EK 244
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S G  P   K
Sbjct: 208 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
            N  +   +T                DP  N          V  +   C   +PE RP  
Sbjct: 265 SNQEVLEFVTSGG-----------RMDPPKNCP------GPVYRIMTQCWQHQPEDRPNF 307
Query: 305 LEVLD 309
             +L+
Sbjct: 308 AIILE 312

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 18  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 75
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 76  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 193 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 136/330 (41%), Gaps = 89/330 (26%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ------IAVKRLKVWSNKAEME-FAVEVEILAR 90
           NN  +   LG G FG V     +   +      +AVK LK  ++  E E    E++I++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR------ 140
           + +H+N+++L G C  G   L++ +Y                 C   LLN+ RR      
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYC----------------CYGDLLNFLRRKAEAML 134
Query: 141 --------------------------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL 174
                                     +  +   A+G+ +L   A+ + IHRD+ A NVLL
Sbjct: 135 GPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 191
Query: 175 DADFKAQVADFGFAKLIPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGI 230
                A++ DFG A+ I + + ++   VKG     + ++APE       +   DV+S+GI
Sbjct: 192 TNGHVAKIGDFGLARDIMNDSNYI---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 248
Query: 231 LLLELAS-GKKPIEK--VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVV 287
           LL E+ S G  P     VNS   + + D            ++A P           K + 
Sbjct: 249 LLWEIFSLGLNPYPGILVNSKFYKLVKDG----------YQMAQPAF-------APKNIY 291
Query: 288 LVALTCAHSKPEKRPTMLEVLDLLKGESKE 317
            +   C   +P  RPT  ++   L+ +++E
Sbjct: 292 SIMQACWALEPTHRPTFQQICSFLQEQAQE 321

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 18  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 75
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 76  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 135
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 193 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 132/317 (41%), Gaps = 39/317 (12%)
Query: 45  KLGEGGFGSVYWGQLWDGSQ-----IAVKRLK--VWSNKAEME-FAVEVEILARVRHKNL 96
           KLG+G FG V  G+ WD        +AVK LK  V S    M+ F  EV  +  + H+NL
Sbjct: 19  KLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G       +++  +  P                L   +R    A+  AEG+ YL  
Sbjct: 78  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE- 132
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   IHRD+ A N+LL      ++ DFG  + +P    H   +   K    + APE  
Sbjct: 133 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                S + D + FG+ L E+ + G++P   +N S I   I         +++   L  P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---------DKEGERLPRP 241
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELEN-DELFKSH 331
                  E+  + +  V + C   KPE RPT + + D L       +  L++ +E  K H
Sbjct: 242 -------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPDKLH 294
Query: 332 QVADYNDGKAVAEDSAE 348
                ND   V E  AE
Sbjct: 295 --IQMNDVITVIEGRAE 309

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 46  LGEGGFG-SVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG+G FG ++       G  + +K L  +  + +  F  EV+++  + H N+L   G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 105 EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIH 164
           + +    + +Y+               +    W++R+  A   A G+ YLH   + +IIH
Sbjct: 78  KDKRLNFITEYI---KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 165 RDIKASNVLLDADFKAQVADFGFAKLIPDGATHV-------------TTRVKGTLGYLAP 211
           RD+ + N L+  +    VADFG A+L+ D  T                  V G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS---AIKRTITDWALPLACERKF-S 267
           E        E  DV+SFGI+L E+      I +VN+    + RT+ D+ L +   R F  
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEI------IGRVNADPDYLPRTM-DFGLNV---RGFLD 241
Query: 268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEV 307
               P    +F          + + C    PEKRP+ +++
Sbjct: 242 RYCPPNCPPSFFP--------ITVRCCDLDPEKRPSFVKL 273

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 38/303 (12%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAE---MEFAVEVEILARVRHKNLLSL-- 99
           LG GG   V+  + L D   +AVK L+    +     + F  E +  A + H  ++++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 100 --RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                   G    IV +Y+               E  +   R +++   + + + + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV--TTRVKGTLGYLAPEYAM 215
               IIHRD+K +N+L+ A    +V DFG A+ I D    V  T  V GT  YL+PE A 
Sbjct: 136 G---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN 275
                   DVYS G +L E+ +G+ P             D  + +A +    +   P   
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG----------DSPVSVAYQHVREDPIPPSAR 242
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKR-PTMLEV-LDLLK---GESKEK---LTELENDEL 327
              +  +L  VVL AL      PE R  T  E+  DL++   GE  E    LT+ E   L
Sbjct: 243 HEGLSADLDAVVLKALA---KNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSL 299
Query: 328 FKS 330
             S
Sbjct: 300 LSS 302

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 123/305 (40%), Gaps = 44/305 (14%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 59  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 116
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPI-EK 244
           I     +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S G  P   K
Sbjct: 234 IYRAGYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
Query: 245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
            N  +   +T                DP  N          V  +   C   +PE RP  
Sbjct: 291 SNQEVLEFVTSGG-----------RMDPPKNCP------GPVYRIMTQCWQHQPEDRPNF 333
Query: 305 LEVLD 309
             +L+
Sbjct: 334 AIILE 338

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 36  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 93
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 94  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 153
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 154 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 210
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I     +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 211 IYRAGYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 19  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 76
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 77  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 136
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 194 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 46  LGEGGFGSVYWGQLWDG----SQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L       S +A+K LK  ++ +   EF  E  I+ +  H N++ L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G        +I+ ++M N               ++   + + +  G A G+ YL   +  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 138
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV----KGTLGYLAPEYAML 216
             +HRD+ A N+L++++   +V+DFG ++ + + ++  T       K  + + APE    
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 217 GKASESCDVYSFGILLLELAS-GKKP 241
            K + + D +S+GI++ E+ S G++P
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 19  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 76
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 77  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 136
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQD 193
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 194 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 24  TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGS--QIAVKRL-KVWSNK 76
           T  I  LKE+     N      LG G FG VY GQ+     D S  Q+AVK L +V S +
Sbjct: 10  TSSISDLKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 67
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E++F +E  I+++  H+N++   G   +   R I+ + M                   +
Sbjct: 68  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 127
Query: 137 WNRRMD---IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA---DFGFAKL 190
               +D   +A   A G  YL  +   H IHRDI A N LL      +VA   DFG A+ 
Sbjct: 128 SLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 184
Query: 191 IPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           I   + +   R  G     + ++ PE  M G  +   D +SFG+LL E+ S
Sbjct: 185 IYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 123/289 (42%), Gaps = 39/289 (13%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG+G +G VY G+ L +  +IA+K +    ++       E+ +   ++HKN++   G  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 105 EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD--IAIGS-----AEGIVYLHHH 157
           E     I  + +P                   W    D    IG       EG+ YLH +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRS--------KWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 158 ATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               I+HRDIK  NVL++      +++DFG +K +  G    T    GTL Y+APE    
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDK 197
Query: 217 GKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL 274
           G     ++ D++S G  ++E+A+GK P  ++             P A   K       ++
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----------PQAAMFKVGMF---KV 243
Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL--DLLKGESKEKLTE 321
           +    E          L C    P+KR    ++L  + LK  SK+K T+
Sbjct: 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ 292

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 46  LGEGGFGSVYWGQLWDGSQ-IAVKRL-KVWSNKAEMEFAVEVEI--LARVRHKNLLSLRG 101
           LGEG FG V     +   Q +A+K + +    K++M   VE EI  L  +RH +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
                 + ++V +Y                E   +  RR    I  A  I Y H H    
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTE---DEGRRFFQQIICA--IEYCHRHK--- 128
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK--A 219
           I+HRD+K  N+LLD +   ++ADFG + ++ DG    T+   G+  Y APE  + GK  A
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VINGKLYA 185
Query: 220 SESCDVYSFGILLLELASGKKPIE---------KVNSAI 249
               DV+S GI+L  +  G+ P +         KVNS +
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+VY    +  G ++A++++ +     +     E+ ++   ++ N+++     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+               E  ++  +   +     + + +LH +    +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HRDIK+ N+LL  D   ++ DFGF A++ P+ +   T  + GT  ++APE          
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 196
Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 46  LGEGGFGSVYWGQLWDG----SQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G+L       S +A+K LK  ++ +   EF  E  I+ +  H N++ L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G        +I+ ++M N               ++   + + +  G A G+ YL   +  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 136
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV----KGTLGYLAPEYAML 216
             +HRD+ A N+L++++   +V+DFG ++ + + ++  T       K  + + APE    
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 217 GKASESCDVYSFGILLLELAS-GKKP 241
            K + + D +S+GI++ E+ S G++P
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 125/303 (41%), Gaps = 38/303 (12%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAE---MEFAVEVEILARVRHKNLLSL-- 99
           LG GG   V+  + L D   +AVK L+    +     + F  E +  A + H  ++++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 100 --RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                   G    IV +Y+               E  +   R +++   + + + + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV--TTRVKGTLGYLAPEYAM 215
               IIHRD+K +N+++ A    +V DFG A+ I D    V  T  V GT  YL+PE A 
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLN 275
                   DVYS G +L E+ +G+ P             D  + +A +    +   P   
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG----------DSPVSVAYQHVREDPIPPSAR 242
Query: 276 GNFVEEELKRVVLVALTCAHSKPEKR-PTMLEV-LDLLK---GESKEK---LTELENDEL 327
              +  +L  VVL AL      PE R  T  E+  DL++   GE  E    LT+ E   L
Sbjct: 243 HEGLSADLDAVVLKALA---KNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSL 299
Query: 328 FKS 330
             S
Sbjct: 300 LSS 302

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 114/238 (47%), Gaps = 20/238 (8%)
Query: 46  LGEGGFGSVYWGQL-WDGSQ---IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +G G FG V  G L   G +   +A+K LK  ++ K   +F  E  I+ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   +    +I+ ++M N               ++   + + +  G A G+ YL   A  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---ADM 128
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT-TRVKG---TLGYLAPEYAML 216
           + +HR + A N+L++++   +V+DFG ++ + D  +  T T   G    + + APE    
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 217 GKASESCDVYSFGILLLELAS-GKKPI-EKVNSAIKRTI-TDWAL--PLACERKFSEL 269
            K + + DV+S+GI++ E+ S G++P  +  N  +   I  D+ L  P+ C     +L
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQL 246

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 91
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N              CLL + R++           +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG-------------CLLKYIRKIGSFDETCTRFYT 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 139 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      AS+S D+++ G ++ +L +G  P    N
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 45  KLGEGGFGSVYWGQLWDGSQ-----IAVKRLK--VWSNKAEME-FAVEVEILARVRHKNL 96
           KLG+G FG V  G+ WD        +AVK LK  V S    M+ F  EV  +  + H+NL
Sbjct: 15  KLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G       +++  +  P                L   +R    A+  AEG+ YL  
Sbjct: 74  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE- 128
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   IHRD+ A N+LL      ++ DFG  + +P    H   +   K    + APE  
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                S + D + FG+ L E+ + G++P   +N S I   I         +++   L  P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---------DKEGERLPRP 237
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  E+  + +  V + C   KPE RPT + + D L
Sbjct: 238 -------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 45  KLGEGGFGSVYWGQLWDGSQ-----IAVKRLK--VWSNKAEME-FAVEVEILARVRHKNL 96
           KLG+G FG V  G+ WD        +AVK LK  V S    M+ F  EV  +  + H+NL
Sbjct: 25  KLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G       +++  +  P                L   +R    A+  AEG+ YL  
Sbjct: 84  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE- 138
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   IHRD+ A N+LL      ++ DFG  + +P    H   +   K    + APE  
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                S + D + FG+ L E+ + G++P   +N S I   I         +++   L  P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---------DKEGERLPRP 247
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  E+  + +  V + C   KPE RPT + + D L
Sbjct: 248 -------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 45  KLGEGGFGSVYWGQLWDGSQ-----IAVKRLK--VWSNKAEME-FAVEVEILARVRHKNL 96
           KLG+G FG V  G+ WD        +AVK LK  V S    M+ F  EV  +  + H+NL
Sbjct: 25  KLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G       +++  +  P                L   +R    A+  AEG+ YL  
Sbjct: 84  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE- 138
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   IHRD+ A N+LL      ++ DFG  + +P    H   +   K    + APE  
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                S + D + FG+ L E+ + G++P   +N S I   I         +++   L  P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---------DKEGERLPRP 247
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  E+  + +  V + C   KPE RPT + + D L
Sbjct: 248 -------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 45  KLGEGGFGSVYWGQLWDGSQ-----IAVKRLK--VWSNKAEME-FAVEVEILARVRHKNL 96
           KLG+G FG V  G+ WD        +AVK LK  V S    M+ F  EV  +  + H+NL
Sbjct: 19  KLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G       +++  +  P                L   +R    A+  AEG+ YL  
Sbjct: 78  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE- 132
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   IHRD+ A N+LL      ++ DFG  + +P    H   +   K    + APE  
Sbjct: 133 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                S + D + FG+ L E+ + G++P   +N S I   I         +++   L  P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---------DKEGERLPRP 241
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  E+  + +  V + C   KPE RPT + + D L
Sbjct: 242 -------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 45  KLGEGGFGSVYWGQLWDGSQ-----IAVKRLK--VWSNKAEME-FAVEVEILARVRHKNL 96
           KLG+G FG V  G+ WD        +AVK LK  V S    M+ F  EV  +  + H+NL
Sbjct: 15  KLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G       +++  +  P                L   +R    A+  AEG+ YL  
Sbjct: 74  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE- 128
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   IHRD+ A N+LL      ++ DFG  + +P    H   +   K    + APE  
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                S + D + FG+ L E+ + G++P   +N S I   I         +++   L  P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---------DKEGERLPRP 237
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  E+  + +  V + C   KPE RPT + + D L
Sbjct: 238 -------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 134/330 (40%), Gaps = 84/330 (25%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           N  ++   LG G FG V     +          +AVK LK  ++  E E    E+++L+ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR------ 140
           +  H N+++L G C  G   L++ +Y                 C   LLN+ RR      
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYC----------------CYGDLLNFLRRKRDSFI 142
Query: 141 ---------------------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK 179
                                +  +   A+G+ +L   A+ + IHRD+ A N+LL     
Sbjct: 143 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRI 199
Query: 180 AQVADFGFAKLIPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLE- 234
            ++ DFG A+ I + + +V   VKG     + ++APE       +   DV+S+GI L E 
Sbjct: 200 TKICDFGLARDIKNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256
Query: 235 --LASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT 292
             L S   P   V+S   + I +    L+ E   +E+ D                 +  T
Sbjct: 257 FSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKT 299
Query: 293 CAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
           C  + P KRPT  +++ L++ +  E    +
Sbjct: 300 CWDADPLKRPTFKQIVQLIEKQISESTNHI 329

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 45  KLGEGGFGSVYWGQLWDGSQ-----IAVKRLK--VWSNKAEME-FAVEVEILARVRHKNL 96
           KLG+G FG V  G+ WD        +AVK LK  V S    M+ F  EV  +  + H+NL
Sbjct: 15  KLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G       +++  +  P                L   +R    A+  AEG+ YL  
Sbjct: 74  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE- 128
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYA 214
             +   IHRD+ A N+LL      ++ DFG  + +P    H   +   K    + APE  
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                S + D + FG+ L E+ + G++P   +N S I   I         +++   L  P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---------DKEGERLPRP 237
Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  E+  + +  V + C   KPE RPT + + D L
Sbjct: 238 -------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAE---MEFAVEVEILARVRHKNLLSL-- 99
           LG GG   V+  + L D   +AVK L+    +     + F  E +  A + H  ++++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 100 --RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                   G    IV +Y+               E  +   R +++   + + + + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV--TTRVKGTLGYLAPEYAM 215
               IIHRD+K +N+++ A    +V DFG A+ I D    V  T  V GT  YL+PE A 
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 216 LGKASESCDVYSFGILLLELASGKKP 241
                   DVYS G +L E+ +G+ P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 10/222 (4%)
Query: 45  KLGEGGFGSVYWGQLW-DGSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           ++G G FG V+ G+L  D + +AVK  +       + +F  E  IL +  H N++ L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
           C + Q   IV + +                  L     + +   +A G+ YL        
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-LGYLAPEYAMLGKASE 221
           IHRD+ A N L+      +++DFG ++   DG    +  ++   + + APE    G+ S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLAC 262
             DV+SFGILL E  S G  P   +++   R   +    L C
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           + LG G FG V  G+    G ++AVK   R K+ S     +   E++ L   RH +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 100 RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
               +   +  +V +Y+               E +    RR+   I SA  + Y H H  
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EARRLFQQILSA--VDYCHRHM- 131
Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK- 218
             ++HRD+K  NVLLDA   A++ADFG + ++ DG    T+   G+  Y APE  + G+ 
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRL 186
Query: 219 -ASESCDVYSFGILLLELASGKKPIE 243
            A    D++S G++L  L  G  P +
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG+G +G VY G+ L +  +IA+K +    ++       E+ +   ++HKN++   G  +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 105 EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD--IAIGS-----AEGIVYLHHH 157
           E     I  + +P                   W    D    IG       EG+ YLH +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRS--------KWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 158 ATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               I+HRDIK  NVL++      +++DFG +K +  G    T    GTL Y+APE    
Sbjct: 128 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDK 183
Query: 217 GK--ASESCDVYSFGILLLELASGKKPI 242
           G     ++ D++S G  ++E+A+GK P 
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 134/330 (40%), Gaps = 84/330 (25%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           N  ++   LG G FG V     +          +AVK LK  ++  E E    E+++L+ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR------ 140
           +  H N+++L G C  G   L++ +Y                 C   LLN+ RR      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYC----------------CYGDLLNFLRRKRDSFI 149
Query: 141 ---------------------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK 179
                                +  +   A+G+ +L   A+ + IHRD+ A N+LL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRI 206
Query: 180 AQVADFGFAKLIPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLE- 234
            ++ DFG A+ I + + +V   VKG     + ++APE       +   DV+S+GI L E 
Sbjct: 207 TKICDFGLARHIKNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263
Query: 235 --LASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT 292
             L S   P   V+S   + I +    L+ E   +E+ D                 +  T
Sbjct: 264 FSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKT 306
Query: 293 CAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
           C  + P KRPT  +++ L++ +  E    +
Sbjct: 307 CWDADPLKRPTFKQIVQLIEKQISESTNHI 336

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           +F   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 63
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 181 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 239
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 240 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 279
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 280 EIISSIKEEMEPGFREV 296

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+VY    +  G ++A++++ +     +     E+ ++   ++ N+++     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+               E  ++  +   +     + + +LH +    +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HRDIK+ N+LL  D   ++ DFGF A++ P+ +    + + GT  ++APE          
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYGPK 196
Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+VY    +  G ++A++++ +     +     E+ ++   ++ N+++     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+               E  ++  +   +     + + +LH +    +I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HRDIK+ N+LL  D   ++ DFGF A++ P+ +    + + GT  ++APE          
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 197
Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL--KVWSNKAEMEFAVEVEI--LARVRH 93
           N+     LGEG FG V        G ++A+K +  KV + K++M+  +E EI  L  +RH
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRH 72
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            +++ L        E ++V +Y  N             E      RR    I SA  + Y
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE---QEARRFFQQIISA--VEY 127
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
            H H    I+HRD+K  N+LLD     ++ADFG + ++ DG    T+   G+  Y APE 
Sbjct: 128 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE- 181
Query: 214 AMLGK--ASESCDVYSFGILLLELASGKKPIE 243
            + GK  A    DV+S G++L  +   + P +
Sbjct: 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+VY    +  G ++A++++ +     +     E+ ++   ++ N+++     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+               E  ++  +   +     + + +LH +    +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HRDIK+ N+LL  D   ++ DFGF A++ P+ +    + + GT  ++APE          
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 196
Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 10/222 (4%)
Query: 45  KLGEGGFGSVYWGQLW-DGSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           ++G G FG V+ G+L  D + +AVK  +       + +F  E  IL +  H N++ L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
           C + Q   IV + +                  L     + +   +A G+ YL        
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGT-LGYLAPEYAMLGKASE 221
           IHRD+ A N L+      +++DFG ++   DG    +  ++   + + APE    G+ S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 222 SCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLAC 262
             DV+SFGILL E  S G  P   +++   R   +    L C
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL--KVWSNKAEMEFAVEVEI--LARVRH 93
           N+     LGEG FG V        G ++A+K +  KV + K++M+  +E EI  L  +RH
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRH 63
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            +++ L        E ++V +Y  N             E      RR    I SA  + Y
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE---QEARRFFQQIISA--VEY 118
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
            H H    I+HRD+K  N+LLD     ++ADFG + ++ DG    T+   G+  Y APE 
Sbjct: 119 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE- 172
Query: 214 AMLGK--ASESCDVYSFGILLLELASGKKPIE 243
            + GK  A    DV+S G++L  +   + P +
Sbjct: 173 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL--KVWSNKAEMEFAVEVEI--LARVRH 93
           N+     LGEG FG V        G ++A+K +  KV + K++M+  +E EI  L  +RH
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRH 73
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            +++ L        E ++V +Y  N             E      RR    I SA  + Y
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE---QEARRFFQQIISA--VEY 128
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
            H H    I+HRD+K  N+LLD     ++ADFG + ++ DG    T+   G+  Y APE 
Sbjct: 129 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE- 182
Query: 214 AMLGK--ASESCDVYSFGILLLELASGKKPIE 243
            + GK  A    DV+S G++L  +   + P +
Sbjct: 183 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 134/330 (40%), Gaps = 84/330 (25%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           N  ++   LG G FG V     +          +AVK LK  ++  E E    E+++L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR------ 140
           +  H N+++L G C  G   L++ +Y                 C   LLN+ RR      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYC----------------CYGDLLNFLRRKRDSFI 126
Query: 141 ---------------------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK 179
                                +  +   A+G+ +L   A+ + IHRD+ A N+LL     
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRI 183
Query: 180 AQVADFGFAKLIPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLE- 234
            ++ DFG A+ I + + +V   VKG     + ++APE       +   DV+S+GI L E 
Sbjct: 184 TKICDFGLARDIKNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 235 --LASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT 292
             L S   P   V+S   + I +    L+ E   +E+ D                 +  T
Sbjct: 241 FSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKT 283
Query: 293 CAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
           C  + P KRPT  +++ L++ +  E    +
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQISESTNHI 313

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 134/330 (40%), Gaps = 84/330 (25%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           N  ++   LG G FG V     +          +AVK LK  ++  E E    E+++L+ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR------ 140
           +  H N+++L G C  G   L++ +Y                 C   LLN+ RR      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYC----------------CYGDLLNFLRRKRDSFI 149
Query: 141 ---------------------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK 179
                                +  +   A+G+ +L   A+ + IHRD+ A N+LL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRI 206
Query: 180 AQVADFGFAKLIPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLE- 234
            ++ DFG A+ I + + +V   VKG     + ++APE       +   DV+S+GI L E 
Sbjct: 207 TKICDFGLARDIKNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263
Query: 235 --LASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT 292
             L S   P   V+S   + I +    L+ E   +E+ D                 +  T
Sbjct: 264 FSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKT 306
Query: 293 CAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
           C  + P KRPT  +++ L++ +  E    +
Sbjct: 307 CWDADPLKRPTFKQIVQLIEKQISESTNHI 336

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 134/330 (40%), Gaps = 84/330 (25%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           N  ++   LG G FG V     +          +AVK LK  ++  E E    E+++L+ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC---LLNWNRR------ 140
           +  H N+++L G C  G   L++ +Y                 C   LLN+ RR      
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYC----------------CYGDLLNFLRRKRDSFI 144
Query: 141 ---------------------MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK 179
                                +  +   A+G+ +L   A+ + IHRD+ A N+LL     
Sbjct: 145 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRI 201
Query: 180 AQVADFGFAKLIPDGATHVTTRVKGT----LGYLAPEYAMLGKASESCDVYSFGILLLE- 234
            ++ DFG A+ I + + +V   VKG     + ++APE       +   DV+S+GI L E 
Sbjct: 202 TKICDFGLARDIKNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258
Query: 235 --LASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT 292
             L S   P   V+S   + I +    L+ E   +E+ D                 +  T
Sbjct: 259 FSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKT 301
Query: 293 CAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
           C  + P KRPT  +++ L++ +  E    +
Sbjct: 302 CWDADPLKRPTFKQIVQLIEKQISESTNHI 331

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL--KVWSNKAEMEFAVEVEI--LARVRH 93
           N+     LGEG FG V        G ++A+K +  KV + K++M+  +E EI  L  +RH
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRH 67
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            +++ L        E ++V +Y  N             E      RR    I SA  + Y
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE---QEARRFFQQIISA--VEY 122
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
            H H    I+HRD+K  N+LLD     ++ADFG + ++ DG    T+   G+  Y APE 
Sbjct: 123 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE- 176
Query: 214 AMLGK--ASESCDVYSFGILLLELASGKKPIE 243
            + GK  A    DV+S G++L  +   + P +
Sbjct: 177 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 44  NKLGEGGFGSVYWGQL-WDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           + LG G FG V  G+    G ++AVK   R K+ S     +   E++ L   RH +++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 100 RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
               +   +  +V +Y+               +     +RR+   I S  G+ Y H H  
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLD--EKESRRLFQQILS--GVDYCHRHM- 136
Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK- 218
             ++HRD+K  NVLLDA   A++ADFG + ++ DG         G+  Y APE  + G+ 
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSCGSPNYAAPE-VISGRL 191
Query: 219 -ASESCDVYSFGILLLELASGKKPIE 243
            A    D++S G++L  L  G  P +
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 118/268 (44%), Gaps = 28/268 (10%)
Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G Q+AVK + +   +       EV I+   +H N++ +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G+E  ++ +++               +  LN  +   +     + + YLH      +I
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRDIK+ ++LL  D + +++DFGF   I          V GT  ++APE       +   
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATEV 222
Query: 224 DVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
           D++S GI+++E+  G+ P   +    A+KR + D   P   + K S    P L  +F+E 
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPP---KLKNSHKVSPVLR-DFLER 277
Query: 282 ELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            L R            P++R T  E+LD
Sbjct: 278 MLVR-----------DPQERATAQELLD 294

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 25/233 (10%)
Query: 29  SLKELHSATNNFNYDN------KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-F 81
           S+K+    T + N ++      +LG+G FG VY  Q  + S +A  ++    ++ E+E +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 82  AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
            VE++ILA   H N++ L           I+ ++                E  L  ++  
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQ 138
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR 201
            +   + + + YLH +    IIHRD+KA N+L   D   ++ADFG +       T    R
Sbjct: 139 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQR 191
Query: 202 ---VKGTLGYLAPEYAMLGKASE-----SCDVYSFGILLLELASGKKPIEKVN 246
                GT  ++APE  M   + +       DV+S GI L+E+A  + P  ++N
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+G+G  G+VY    +  G ++A++++ +     +     E+ ++   ++ N+++     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +Y+               E  ++  +   +     + + +LH +    +I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 164 HRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           HR+IK+ N+LL  D   ++ DFGF A++ P+ +   T  + GT  ++APE          
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 197
Query: 223 CDVYSFGILLLELASGKKP 241
            D++S GI+ +E+  G+ P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 41/232 (17%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILAR 90
             F     LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A 
Sbjct: 12  TEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 70
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS--- 147
           V + ++  L G C     +LI    MP               CLL++ R     IGS   
Sbjct: 71  VDNPHVCRLLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYL 116
Query: 148 -------AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
                  AEG+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA     
Sbjct: 117 LNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEY 171
Query: 201 RVKG---TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
             +G    + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 190 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 288
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 289 EIISSIKEEMEPGFREV 305

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 25/233 (10%)
Query: 29  SLKELHSATNNFNYDN------KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-F 81
           S+K+    T + N ++      +LG+G FG VY  Q  + S +A  ++    ++ E+E +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 82  AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
            VE++ILA   H N++ L           I+ ++                E  L  ++  
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQ 138
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR 201
            +   + + + YLH +    IIHRD+KA N+L   D   ++ADFG +       T    R
Sbjct: 139 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRXIQR 191
Query: 202 ---VKGTLGYLAPEYAMLGKASE-----SCDVYSFGILLLELASGKKPIEKVN 246
                GT  ++APE  M   + +       DV+S GI L+E+A  + P  ++N
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 62
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 180 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 238
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 239 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 278
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 279 EIISSIKEEMEPGFREV 295

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRGY 102
           K+GEG +G VY  +   G  +A+KR+++ +    +      E+ +L  + H N++SL   
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS-AEGIVYLHHHATPH 161
               +   +V+++M               +     + ++ I +     G+ + H H    
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQ-----DSQIKIYLYQLLRGVAHCHQH---R 139
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-S 220
           I+HRD+K  N+L+++D   ++ADFG A+         T  V  TL Y AP+  M  K  S
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYS 198
Query: 221 ESCDVYSFGILLLELASGK 239
            S D++S G +  E+ +GK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 25/233 (10%)
Query: 29  SLKELHSATNNFNYDN------KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-F 81
           S+K+    T + N ++      +LG+G FG VY  Q  + S +A  ++    ++ E+E +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 82  AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
            VE++ILA   H N++ L           I+ ++                E  L  ++  
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQ 138
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR 201
            +   + + + YLH +    IIHRD+KA N+L   D   ++ADFG +       T    R
Sbjct: 139 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRXIQR 191
Query: 202 ---VKGTLGYLAPEYAMLGKASE-----SCDVYSFGILLLELASGKKPIEKVN 246
                GT  ++APE  M   + +       DV+S GI L+E+A  + P  ++N
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRGY 102
           K+GEG +G VY  +   G  +A+KR+++ +    +      E+ +L  + H N++SL   
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS-AEGIVYLHHHATPH 161
               +   +V+++M               +     + ++ I +     G+ + H H    
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQ-----DSQIKIYLYQLLRGVAHCHQH---R 139
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-S 220
           I+HRD+K  N+L+++D   ++ADFG A+         T  V  TL Y AP+  M  K  S
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYS 198
Query: 221 ESCDVYSFGILLLELASGK 239
            S D++S G +  E+ +GK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 184 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 242
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 243 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 282
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 283 EIISSIKEEMEPGFREV 299

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 65
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 183 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 241
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 242 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 281
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 282 EIISSIKEEMEPGFREV 298

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 132
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 190 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 288
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 289 EIISSIKEEMEPGFREV 305

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 65
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 183 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 241
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 242 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 281
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 282 EIISSIKEEMEPGFREV 298

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 135/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 183
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +         KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 184 E-TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 242
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 243 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 282
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 283 EIISSIKEEMEPGFREV 299

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 33  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 92  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 137
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 138 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 192
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 236

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 24  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 83  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 183
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 227

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 27  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 86  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 186
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 230

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 48  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 107 LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 152
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 153 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 207
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 251

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 23  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 82  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 25  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 84  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 184
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSL 99
           + LG G FG V  G+    G ++AVK   R K+ S     +   E++ L   RH +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 100 RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
               +   +  +V +Y+               E +    RR+   I SA  + Y H H  
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EARRLFQQILSA--VDYCHRHM- 131
Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK- 218
             ++HRD+K  NVLLDA   A++ADFG + ++ DG         G+  Y APE  + G+ 
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRDSCGSPNYAAPE-VISGRL 186
Query: 219 -ASESCDVYSFGILLLELASGKKPIE 243
            A    D++S G++L  L  G  P +
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 26  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 85  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 134/312 (42%), Gaps = 46/312 (14%)
Query: 32  ELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAEMEFAV 83
           E   A        +LG+G FG VY G +  G       +++A+K + +  S +  +EF  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL---NW 137
           E  ++      +++ L G  ++GQ  L++ + M                    +L   + 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH 197
           ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I +   +
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDY 180
Query: 198 VTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTI 253
                KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  + R +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240
Query: 254 TDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL 310
            +  L   P  C     EL                       C    P+ RP+ LE++  
Sbjct: 241 MEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFLEIISS 280
Query: 311 LKGESKEKLTEL 322
           +K E +    E+
Sbjct: 281 IKEEMEPGFREV 292

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 94
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 95  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I 
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 211
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 212 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 270
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 271 VLRFVMEGGLLDKPDNCPDMLFELMR--------------------MCWQYNPKMRPSFL 310
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 311 EIISSIKEEMEPGFREV 327

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 29  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 88  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 133
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 134 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 188
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 232

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 48/260 (18%)
Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW--DGSQI-- 65
           G +  R  +   Q   RI  LKE       F     LG G FG+VY G LW  +G ++  
Sbjct: 1   GAMGIRSGEAPNQALLRI--LKE-----TEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI 52
Query: 66  --AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXX 122
             A+K L+   S KA  E   E  ++A V + ++  L G C     +LI    MP     
Sbjct: 53  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMP----- 106
Query: 123 XXXXXXXXXECLLNWNRRMDIAIGS----------AEGIVYLHHHATPHIIHRDIKASNV 172
                     CLL++ R     IGS          A+G+ YL       ++HRD+ A NV
Sbjct: 107 --------FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 155
Query: 173 LLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPEYAMLGKASESCDVYSFG 229
           L+      ++ DFG AKL+  GA       +G    + ++A E  +    +   DV+S+G
Sbjct: 156 LVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 230 ILLLELAS-GKKPIEKVNSA 248
           + + EL + G KP + + ++
Sbjct: 214 VTVWELMTFGSKPYDGIPAS 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 96
Query: 94  KNLLSLRGYCAEGQERLIV-YDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIG 146
              + L  +C +  E+L     Y  N               LL + R++           
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFY 142
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGT 205
           +AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT
Sbjct: 143 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
             Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 243

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 23  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 82  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 25  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 84  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 184
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 228

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 26  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 85  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 26  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 85  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 229

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 17  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 76  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 176
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 26  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 85  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 133/312 (42%), Gaps = 46/312 (14%)
Query: 32  ELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAEMEFAV 83
           E   A        +LG+G FG VY G +  G       +++A+K + +  S +  +EF  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL---NW 137
           E  ++      +++ L G  ++GQ  L++ + M                    +L   + 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH 197
           ++ + +A   A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I +    
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE-TDX 178
Query: 198 VTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTI 253
                KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  + R +
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 238
Query: 254 TDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL 310
            +  L   P  C     EL                       C    P+ RP+ LE++  
Sbjct: 239 MEGGLLDKPDNCPDMLLELMR--------------------MCWQYNPKMRPSFLEIISS 278
Query: 311 LKGESKEKLTEL 322
           +K E +    E+
Sbjct: 279 IKEEMEPGFREV 290

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 41/232 (17%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILAR 90
             F     LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS--- 147
           V + ++  L G C     +LI    MP               CLL++ R     IGS   
Sbjct: 74  VDNPHVCRLLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYL 119
Query: 148 -------AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
                  A+G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA     
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEY 174
Query: 201 RVKG---TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
             +G    + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
           E  +   R +++   + + + + H +    IIHRD+K +N+++ A    +V DFG A+ I
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 192 PDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            D    V  T  V GT  YL+PE A         DVYS G +L E+ +G+ P        
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----- 221
Query: 250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR-PTMLEV- 307
                D  + +A +    +   P      +  +L  VVL AL      PE R  T  E+ 
Sbjct: 222 -----DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALA---KNPENRYQTAAEMR 273
Query: 308 LDLLK---GESKEK---LTELENDELFKS 330
            DL++   GE  E    LT+ E   L  S
Sbjct: 274 ADLVRVHNGEPPEAPKVLTDAERTSLLSS 302

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
           E  +   R +++   + + + + H +    IIHRD+K +N+++ A    +V DFG A+ I
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 192 PDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            D    V  T  V GT  YL+PE A         DVYS G +L E+ +G+ P        
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----- 221
Query: 250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR-PTMLEV- 307
                D  + +A +    +   P      +  +L  VVL AL      PE R  T  E+ 
Sbjct: 222 -----DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALA---KNPENRYQTAAEMR 273
Query: 308 LDLLK---GESKEK---LTELENDELFKS 330
            DL++   GE  E    LT+ E   L  S
Sbjct: 274 ADLVRVHNGEPPEAPKVLTDAERTSLLSS 302

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G Q+AVK++ +   +       EV I+    H N++ +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++                  +N  +   + +     + YLH+     +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQG---VI 163
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKASE 221
           HRDIK+ ++LL +D + +++DFGF   +   +  V  R  + GT  ++APE         
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 222 SCDVYSFGILLLELASGKKP 241
             D++S GI+++E+  G+ P
Sbjct: 221 EVDIWSLGIMVIEMIDGEPP 240

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 2/91 (2%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
            I++RD+K  N+LLD     +++D G A  +P+G T +  RV GT+GY+APE     + +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 363
Query: 221 ESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            S D ++ G LL E+ +G+ P ++    IKR
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 2/91 (2%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
            I++RD+K  N+LLD     +++D G A  +P+G T +  RV GT+GY+APE     + +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 363
Query: 221 ESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            S D ++ G LL E+ +G+ P ++    IKR
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE 86
           +H   N+F+    +G GGFG VY       G+++    +  KR+K+   + E     E  
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERI 240
Query: 87  ILARVRHKN--LLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           +L+ V   +   +    Y     ++L  + D M                         D+
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EADM 293
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
              +AE I+ L H     +++RD+K +N+LLD     +++D G A        H +    
Sbjct: 294 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 350
Query: 204 GTLGYLAPEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC 262
           GT GY+APE    G A + S D +S G +L +L  G  P  +  +  K  I    L +A 
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 410
Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTC 293
           E    +   P L  + +E  L+R V   L C
Sbjct: 411 E--LPDSFSPELR-SLLEGLLQRDVNRRLGC 438

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE 86
           +H   N+F+    +G GGFG VY       G+++    +  KR+K+   + E     E  
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERI 241
Query: 87  ILARVRHKN--LLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           +L+ V   +   +    Y     ++L  + D M                         D+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EADM 294
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
              +AE I+ L H     +++RD+K +N+LLD     +++D G A        H +    
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 204 GTLGYLAPEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC 262
           GT GY+APE    G A + S D +S G +L +L  G  P  +  +  K  I    L +A 
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTC 293
           E    +   P L  + +E  L+R V   L C
Sbjct: 412 E--LPDSFSPELR-SLLEGLLQRDVNRRLGC 439

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 25  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 84  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 184
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 27  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 86  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 186
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 230

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 25  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI+   MP               CLL++ R     IGS          A
Sbjct: 84  LLGICLTSTVQLIM-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 184
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 228

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE 86
           +H   N+F+    +G GGFG VY       G+++    +  KR+K+   + E     E  
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERI 241
Query: 87  ILARVRHKN--LLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           +L+ V   +   +    Y     ++L  + D M                         D+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EADM 294
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
              +AE I+ L H     +++RD+K +N+LLD     +++D G A        H +    
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 204 GTLGYLAPEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC 262
           GT GY+APE    G A + S D +S G +L +L  G  P  +  +  K  I    L +A 
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTC 293
           E    +   P L  + +E  L+R V   L C
Sbjct: 412 E--LPDSFSPELR-SLLEGLLQRDVNRRLGC 439

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVE 86
           +H   N+F+    +G GGFG VY       G+++    +  KR+K+   + E     E  
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERI 241
Query: 87  ILARVRHKN--LLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           +L+ V   +   +    Y     ++L  + D M                         D+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EADM 294
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
              +AE I+ L H     +++RD+K +N+LLD     +++D G A        H +    
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 204 GTLGYLAPEYAMLGKASE-SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC 262
           GT GY+APE    G A + S D +S G +L +L  G  P  +  +  K  I    L +A 
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTC 293
           E    +   P L  + +E  L+R V   L C
Sbjct: 412 E--LPDSFSPELR-SLLEGLLQRDVNRRLGC 439

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 135/317 (42%), Gaps = 46/317 (14%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDG-------SQIAVKRL-KVWSNKAE 78
           ++   E   A        +LG+G FG VY G +  G       +++A+K + +  S +  
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 59
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLL 135
           +EF  E  ++      +++ L G  ++GQ  L++ + M                    +L
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 136 ---NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
              + ++ + +A   A+G+ YL+ +     +HRD+ A N  +  DF  ++ DFG  + I 
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 193 DGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSA 248
           +   +     KG L   +++PE    G  +   DV+SFG++L E+A+  ++P + + N  
Sbjct: 177 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 235
Query: 249 IKRTITDWAL---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           + R + +  L   P  C     EL                       C    P+ RP+ L
Sbjct: 236 VLRFVMEGGLLDKPDNCPDMLLELMR--------------------MCWQYNPKMRPSFL 275
Query: 306 EVLDLLKGESKEKLTEL 322
           E++  +K E +    E+
Sbjct: 276 EIISSIKEEMEPGFREV 292

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 25  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 84  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 184
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 228

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARVR 92
            +FN+   LG+G FG V   +     ++ AVK LK    +  +  E    VE  +LA   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLALPG 399
Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
               L+    C +  +RL  V +Y+               +         +IAIG    +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----L 455
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLA 210
            +L       II+RD+K  NV+LD++   ++ADFG  K  I DG T  T    GT  Y+A
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIA 510
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           PE        +S D ++FG+LL E+ +G+ P E
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 48/260 (18%)
Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW--DGSQI-- 65
           G +  R  +   Q   RI  LKE       F     LG G FG+VY G LW  +G ++  
Sbjct: 1   GAMGIRSGEAPNQALLRI--LKE-----TEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI 52
Query: 66  --AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXX 122
             A+K L+   S KA  E   E  ++A V + ++  L G C     +LI    MP     
Sbjct: 53  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMP----- 106
Query: 123 XXXXXXXXXECLLNWNRRMDIAIGS----------AEGIVYLHHHATPHIIHRDIKASNV 172
                     CLL++ R     IGS          A+G+ YL       ++HRD+ A NV
Sbjct: 107 --------FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 155
Query: 173 LLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPEYAMLGKASESCDVYSFG 229
           L+      ++ DFG AKL+  GA       +G    + ++A E  +    +   DV+S+G
Sbjct: 156 LVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 230 ILLLELAS-GKKPIEKVNSA 248
           + + EL + G KP + + ++
Sbjct: 214 VTVWELMTFGSKPYDGIPAS 233

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 23  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 82  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 182
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRGYC 103
           +LG+G FG VY  +  +   +A  ++    ++ E+E + VE+EILA   H  ++ L G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM---DIAIGSAEGIVYLHHHATP 160
               +  I+ ++ P                +L  +R +    I +   + +  L+   + 
Sbjct: 86  YHDGKLWIMIEFCPGGAVDA---------IMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK-----GTLGYLAPEYAM 215
            IIHRD+KA NVL+  +   ++ADFG +      A ++ T  K     GT  ++APE  M
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 216 LGKASES-----CDVYSFGILLLELASGKKPIEKVN 246
                ++      D++S GI L+E+A  + P  ++N
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRGYC 103
           +LG+G FG VY  +  +   +A  ++    ++ E+E + VE+EILA   H  ++ L G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM---DIAIGSAEGIVYLHHHATP 160
               +  I+ ++ P                +L  +R +    I +   + +  L+   + 
Sbjct: 78  YHDGKLWIMIEFCPGGAVDA---------IMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK-----GTLGYLAPEYAM 215
            IIHRD+KA NVL+  +   ++ADFG +      A ++ T  K     GT  ++APE  M
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 216 LGKASES-----CDVYSFGILLLELASGKKPIEKVN 246
                ++      D++S GI L+E+A  + P  ++N
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 218

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 20  KKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK----VWS 74
           +KQP+  +  +K       +FN+   LG+G FG V         ++ A+K LK    +  
Sbjct: 6   RKQPSNNLDRVK-----LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 75  NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXEC 133
           +  E    VE  +LA +     L+    C +  +RL  V +Y+               + 
Sbjct: 61  DDVECTM-VEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE 119
Query: 134 LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIP 192
                   +I+I    G+ +LH      II+RD+K  NV+LD++   ++ADFG  K  + 
Sbjct: 120 PQAVFYAAEISI----GLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMM 172
Query: 193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           DG T  T    GT  Y+APE        +S D +++G+LL E+ +G+ P +
Sbjct: 173 DGVT--TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           +G+ YLH       IHRDIKA+NVLL    + ++ADFG A  + D      T V GT  +
Sbjct: 115 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFW 170
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE 268
           +APE           D++S GI  +ELA G+ P  +++            P+       +
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------------PMKVLFLIPK 218
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
              P L GN+  + LK  V     C + +P  RPT  E+L
Sbjct: 219 NNPPTLEGNY-SKPLKEFVEA---CLNKEPSFRPTAKELL 254

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAE--MEFAVEVEILARV 91
           + F     LG+G FG V+  +   GS      A+K LK  + K    +   +E +IL  V
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 92  RHKNLLSLR-GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
            H  ++ L   +  EG+  LI+ D++               E +       D+    AE 
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLIL-DFL----RGGDLFTRLSKEVMFTEE---DVKFYLAEL 135
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
            + L H  +  II+RD+K  N+LLD +   ++ DFG +K   D      +   GT+ Y+A
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 194
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           PE       ++S D +SFG+L+ E+ +G  P +
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 35  SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVR 92
           S+++ F    KLG G + +VY G     G  +A+K +K+ S +     A+ E+ ++  ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----- 147
           H+N++ L        +  +V+++M N               + N  R +++ +       
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS-----RTVGNTPRGLELNLVKYFQWQ 116
Query: 148 -AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
             +G+ + H +    I+HRD+K  N+L++   + ++ DFG A+         ++ V  TL
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 207 GYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVN 246
            Y AP+  M  +  S S D++S G +L E+ +GK      N
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 49  GGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE 108
           G FG V+  QL +   +AVK   +  +K   +   EV  L  ++H+N+L   G  AE + 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPI-QDKQSWQNEYEVYSLPGMKHENILQFIG--AEKRG 90
Query: 109 RLIVYD-YMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHAT-------P 160
             +  D ++                 +++WN    IA   A G+ YLH           P
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP 150
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK-GTLGYLAPEYA----- 214
            I HRDIK+ NVLL  +  A +ADFG A     G +   T  + GT  Y+APE       
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN 210
Query: 215 MLGKASESCDVYSFGILLLELAS 237
               A    D+Y+ G++L ELAS
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK----VWSNKAEMEFAVEVEILARVR 92
            +FN+   LG+G FG V   +     ++ AVK LK    +  +  E    VE  +LA   
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALPG 78
Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
               L+    C +  +RL  V +Y+               +         +IAIG    +
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----L 134
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLA 210
            +L       II+RD+K  NV+LD++   ++ADFG  K  I DG T  T    GT  Y+A
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIA 189
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           PE        +S D ++FG+LL E+ +G+ P E
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
           E  +   R +++   + + + + H +    IIHRD+K +N+++ A    +V DFG A+ I
Sbjct: 127 EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 183
Query: 192 PDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            D    V  T  V GT  YL+PE A         DVYS G +L E+ +G+ P
Sbjct: 184 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILAR 90
             F     LG G FG+VY G LW  +G ++    A+  L+   S KA  E   E  ++A 
Sbjct: 49  TEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMAS 107
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS--- 147
           V + ++  L G C     +LI    MP               CLL++ R     IGS   
Sbjct: 108 VDNPHVCRLLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYL 153
Query: 148 -------AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
                  A+G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA     
Sbjct: 154 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEY 208
Query: 201 RVKG---TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
             +G    + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 209 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 260

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 24  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXX---XXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C     +LI+   MP                 + LLNW       +  A+G+ YL 
Sbjct: 83  LLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 135
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPE 212
                 ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    + ++A E
Sbjct: 136 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMALE 190
Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
             +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 227

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           +G+ YLH       IHRDIKA+NVLL    + ++ADFG A  + D      T V GT  +
Sbjct: 135 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFW 190
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE 268
           +APE           D++S GI  +ELA G+ P  +++            P+       +
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------------PMKVLFLIPK 238
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
              P L GN+  + LK  V     C + +P  RPT  E+L
Sbjct: 239 NNPPTLEGNY-SKPLKEFVEA---CLNKEPSFRPTAKELL 274

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAE--MEFAVEVEILARV 91
           + F     LG+G FG V+  +   GS      A+K LK  + K    +   +E +IL  V
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 92  RHKNLLSLR-GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
            H  ++ L   +  EG+  LI+ D++               E +       D+    AE 
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSK----EVMFTEE---DVKFYLAEL 136
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
            + L H  +  II+RD+K  N+LLD +   ++ DFG +K   D      +   GT+ Y+A
Sbjct: 137 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 195
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           PE       ++S D +SFG+L+ E+ +G  P +
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 115/260 (44%), Gaps = 48/260 (18%)
Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW--DGSQI-- 65
           G +  R  +   Q   RI  LKE       F     L  G FG+VY G LW  +G ++  
Sbjct: 1   GAMGIRSGEAPNQALLRI--LKE-----TEFKKIKVLSSGAFGTVYKG-LWIPEGEKVKI 52
Query: 66  --AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXX 122
             A+K L+   S KA  E   E  ++A V + ++  L G C     +LI+   MP     
Sbjct: 53  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMP----- 106
Query: 123 XXXXXXXXXECLLNWNRRMDIAIGS----------AEGIVYLHHHATPHIIHRDIKASNV 172
                     CLL++ R     IGS          A+G+ YL       ++HRD+ A NV
Sbjct: 107 --------FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 155
Query: 173 LLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPEYAMLGKASESCDVYSFG 229
           L+      ++ DFG AKL+  GA       +G    + ++A E  +    +   DV+S+G
Sbjct: 156 LVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 230 ILLLELAS-GKKPIEKVNSA 248
           + + EL + G KP + + ++
Sbjct: 214 VTVWELMTFGSKPYDGIPAS 233

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAE--MEFAVEVEILARV 91
           + F     LG+G FG V+  +   GS      A+K LK  + K    +   +E +IL  V
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 92  RHKNLLSLR-GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
            H  ++ L   +  EG+  LI+ D++               E +       D+    AE 
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSK----EVMFTEE---DVKFYLAEL 135
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
            + L H  +  II+RD+K  N+LLD +   ++ DFG +K   D      +   GT+ Y+A
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 194
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           PE       ++S D +SFG+L+ E+ +G  P +
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 23  LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXX---XXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C     +LI    MP                 + LLNW       +  A+G+ YL 
Sbjct: 82  LLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPE 212
                 ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    + ++A E
Sbjct: 135 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMALE 189
Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
             +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLK--VWSNKAEMEFAV-EVEILARV 91
             +NF +   LG+G FG V   ++ + G   AVK LK  V     ++E  + E  IL+  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIA---IGSA 148
           R+   L+    C +  +RL       N                +  +RR D A     +A
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH---------IQKSRRFDEARARFYAA 131
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLG 207
           E I  L       II+RD+K  NVLLD +   ++ADFG  K  I +G T  T    GT  
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPD 189
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
           Y+APE         + D ++ G+LL E+  G  P E  N
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLS 98
           L  G FG+VY G LW  +G ++    A+K L+   S KA  E   E  ++A V + ++  
Sbjct: 23  LSSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS----------A 148
           L G C     +LI    MP               CLL++ R     IGS          A
Sbjct: 82  LLGICLTSTVQLIT-QLMP-------------FGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---T 205
           +G+ YL       ++HRD+ A NVL+      ++ DFG AKL+  GA       +G    
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           + ++A E  +    +   DV+S+G+ + EL + G KP + + ++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL---KVWSNKAEMEFAVEVEILARV 91
             ++F+    LG+G FG+VY  +      I A+K L   ++     E +   E+EI + +
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L +  Y  + +   ++ ++ P                  +  R        A+ +
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADAL 128
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H      +IHRDIK  N+L+    + ++ADFG++   P           GTL YL P
Sbjct: 129 HYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLPP 182
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++  G+L  E   G  P +
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 114/260 (43%), Gaps = 48/260 (18%)
Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW--DGSQI-- 65
           G +  R  +   Q   RI  LKE       F     L  G FG+VY G LW  +G ++  
Sbjct: 1   GAMGIRSGEAPNQALLRI--LKE-----TEFKKIKVLSSGAFGTVYKG-LWIPEGEKVKI 52
Query: 66  --AVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXX 122
             A+K L+   S KA  E   E  ++A V + ++  L G C     +LI    MP     
Sbjct: 53  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMP----- 106
Query: 123 XXXXXXXXXECLLNWNRRMDIAIGS----------AEGIVYLHHHATPHIIHRDIKASNV 172
                     CLL++ R     IGS          A+G+ YL       ++HRD+ A NV
Sbjct: 107 --------FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 155
Query: 173 LLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPEYAMLGKASESCDVYSFG 229
           L+      ++ DFG AKL+  GA       +G    + ++A E  +    +   DV+S+G
Sbjct: 156 LVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 213
Query: 230 ILLLELAS-GKKPIEKVNSA 248
           + + EL + G KP + + ++
Sbjct: 214 VTVWELMTFGSKPYDGIPAS 233

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 91
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 139 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            Y++PE      A +S D+++ G ++ +L +G  P    N  +
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 68
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 115
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 116 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            Y++PE      A +S D+++ G ++ +L +G  P    N  +
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 218

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 69
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 116
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 117 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 216

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQ-IAVKRLKVWS--NKAEMEFAVEVEILARVRHKNL 96
           +N    LG+G FG V   +     Q  AVK +   S  NK       EVE+L ++ H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L     +     IV +                     + +    I      GI Y+H 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHK 139
Query: 157 HATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           H   +I+HRD+K  N+LL++   D   ++ DFG +       T +  R+ GT  Y+APE 
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE- 193
Query: 214 AMLGKASESCDVYSFGILLLELASGKKPI 242
            + G   E CDV+S G++L  L SG  P 
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 67
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 114
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 115 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            Y++PE      A +S D+++ G ++ +L +G  P    N  +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 91
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 139 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            Y++PE      A +S D+++ G ++ +L +G  P    N  +
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 66
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 113
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 114 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 213

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKG 204
           +AE I+ L    +  I++RD+K  N+LLD D   ++ADFG  K  ++ D  T+      G
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC---G 180
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           T  Y+APE  +  K + S D +SFG+LL E+  G+ P 
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRL---KVWSNKAEMEFAVEVEILARV 91
             ++F+    LG+G FG+VY  +      I A+K L   ++     E +   E+EI + +
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH N+L +  Y  + +   ++ ++ P                  +  R        A+ +
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADAL 127
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            Y H      +IHRDIK  N+L+    + ++ADFG++   P           GTL YL P
Sbjct: 128 HYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLPP 181
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           E        E  D++  G+L  E   G  P +
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 89
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 136
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 89
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 136
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 79/163 (48%), Gaps = 23/163 (14%)
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGT 205
           + +G+ YLH++    +IHRD+K  N+ L+ D   ++ DFG A  I  DG    T  + GT
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGT 205
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERK 265
             Y+APE       S   D++S G +L  L  GK P E   S +K T            K
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRI--------K 255
Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +E + PR + N V   L R +L      H+ P  RP++ E+L
Sbjct: 256 KNEYSVPR-HINPVASALIRRML------HADPTLRPSVAELL 291

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 91
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 139 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MXGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 221

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 73
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 120
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 121 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 220

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 91
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 139 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 92
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 139
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 140 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 92
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 139
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 140 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G  +AVK++ +   +       EV I+   +H+N++ +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++                  +N  +   + +   + +  LH      +I
Sbjct: 218 LVGDELWVVMEFL-----EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 269
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKASE 221
           HRDIK+ ++LL  D + +++DFGF   +   +  V  R  + GT  ++APE         
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 222 SCDVYSFGILLLELASGKKP 241
             D++S GI+++E+  G+ P
Sbjct: 327 EVDIWSLGIMVIEMVDGEPP 346

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 91
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 139 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 89
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 136
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I A + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 221

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRGY 102
           K+GEG +G VY  Q   G   A+K++++      +      E+ IL  ++H N++ L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
               +  ++V++++               E +   +  + +      GI Y H      +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL----NGIAYCHDR---RV 121
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SE 221
           +HRD+K  N+L++ + + ++ADFG A+         T  V  TL Y AP+  M  K  S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 222 SCDVYSFGILLLELASGKKPIEKVNSA 248
           + D++S G +  E+ +G      V+ A
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEA 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 88
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 135
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 136 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 235

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 46/291 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKR-LKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  D G  +A+K+ L+   +K   + A+ E+++L ++RH+NL++L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
           C + +   +V++++ +                L++            GI + H H   +I
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSH---NI 145
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG--KAS 220
           IHRDIK  N+L+      ++ DFGFA+ +          V  T  Y APE  ++G  K  
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPE-LLVGDVKYG 203
Query: 221 ESCDVYSFGILLLELASGKKPIEKVNSAIKR-----------------------TITDWA 257
           ++ DV++ G L+ E+  G +P+   +S I +                             
Sbjct: 204 KAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           LP   ER+  E   P+L+        + V+ +A  C H  P+KRP   E+L
Sbjct: 263 LPEIKEREPLERRYPKLS--------EVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MXGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 220

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 17  EKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK---- 71
           E  K++P+ +I  LK       +F     LG+G FG V+  +    +Q  A+K LK    
Sbjct: 3   ELNKERPSLQI-KLK-----IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 56
Query: 72  VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI-VYDYMPNXXXXXXXXXXXX 130
           +  +  E    VE  +L+       L+      + +E L  V +Y+              
Sbjct: 57  LMDDDVECT-MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK 115
Query: 131 XECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK- 189
                + +R    A     G+ +LH      I++RD+K  N+LLD D   ++ADFG  K 
Sbjct: 116 ----FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 168
Query: 190 -LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            ++ D     T    GT  Y+APE  +  K + S D +SFG+LL E+  G+ P 
Sbjct: 169 NMLGDAK---TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 88
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 135
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 136 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            Y++PE      A +S D+++ G ++ +L +G  P    N  +
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 238

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 51/222 (22%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLS----- 98
           +G+G +G V W  LW G  +AVK   ++S++ E  +  E EI   V  RH N+L      
Sbjct: 16  VGKGRYGEV-WRGLWHGESVAVK---IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 99  LRGYCAEGQERLI--------VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEG 150
           +    +  Q  LI        +YD++                  L  +  + +A+ +A G
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--------------LEPHLALRLAVSAACG 117
Query: 151 IVYLH-----HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----TTR 201
           + +LH         P I HRD K+ NVL+ ++ +  +AD G A +   G+ ++      R
Sbjct: 118 LAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR 177
Query: 202 VKGTLGYLAPEYAMLGKASESC-------DVYSFGILLLELA 236
           V GT  Y+APE  +  +    C       D+++FG++L E+A
Sbjct: 178 V-GTKRYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 80
Query: 102 YC-AEGQERLIVY-----DYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +  + G+++ +VY     DY+P              + L     ++ +       + Y+H
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 193
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRGY 102
           K+GEG +G VY  Q   G   A+K++++      +      E+ IL  ++H N++ L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
               +  ++V++++               E +   +  + +      GI Y H      +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL----NGIAYCHDR---RV 121
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SE 221
           +HRD+K  N+L++ + + ++ADFG A+         T  V  TL Y AP+  M  K  S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 222 SCDVYSFGILLLELASGKKPIEKVNSA 248
           + D++S G +  E+ +G      V+ A
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEA 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRGY 102
           K+GEG +G VY  Q   G   A+K++++      +      E+ IL  ++H N++ L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 103 CAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
               +  ++V++++               E +   +  + +      GI Y H      +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL----NGIAYCHDR---RV 121
Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SE 221
           +HRD+K  N+L++ + + ++ADFG A+         T  +  TL Y AP+  M  K  S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 222 SCDVYSFGILLLELASGKKPIEKVNSA 248
           + D++S G +  E+ +G      V+ A
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEA 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           +G+ YLH       IHRDIKA+NVLL    + ++ADFG A  + D        V GT  +
Sbjct: 115 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFW 170
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE 268
           +APE           D++S GI  +ELA G+ P  +++            P+       +
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------------PMKVLFLIPK 218
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
              P L GN+  + LK  V     C + +P  RPT  E+L
Sbjct: 219 NNPPTLEGNY-SKPLKEFV---EACLNKEPSFRPTAKELL 254

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           +G+ YLH       IHRDIKA+NVLL    + ++ADFG A  + D        V GT  +
Sbjct: 130 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFW 185
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE 268
           +APE           D++S GI  +ELA G+ P  +++            P+       +
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------------PMKVLFLIPK 233
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
              P L GN+  + LK  V     C + +P  RPT  E+L
Sbjct: 234 NNPPTLEGNY-SKPLKEFVEA---CLNKEPSFRPTAKELL 269

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 100/229 (43%), Gaps = 63/229 (27%)
Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLS---- 98
           ++G+G +G V+ G+ W G ++AVK   V+    E  +  E EI   V  RH+N+L     
Sbjct: 44  QIGKGRYGEVWMGK-WRGEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 99  -LRGYCAEGQERLI--------VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE 149
            ++G  +  Q  LI        +YDY+ +                L+    + +A  S  
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------------LDAKSMLKLAYSSVS 145
Query: 150 GIVYLHH-----HATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGA---THVTT 200
           G+ +LH         P I HRD+K+ N+L+  +    +AD G A K I D         T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 201 RVKGTLGYLAPE-------------YAMLGKASESCDVYSFGILLLELA 236
           RV GT  Y+ PE             Y M        D+YSFG++L E+A
Sbjct: 206 RV-GTKRYMPPEVLDESLNRNHFQSYIM-------ADMYSFGLILWEVA 246

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F +V    +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 94
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 141
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 142 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 241

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQ-IAVKRLKVWS--NKAEMEFAVEVEILARVRHKNL 96
           +N    LG+G FG V   +     Q  AVK +   S  NK       EVE+L ++ H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 97  LSLRGYCAEGQERLIVYD-YMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           + L     +     IV + Y                E     +    I      GI Y+H
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGITYMH 138
Query: 156 HHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
            H   +I+HRD+K  N+LL++   D   ++ DFG +       T +  R+ GT  Y+APE
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE 193
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             + G   E CDV+S G++L  L SG  P 
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 126/295 (42%), Gaps = 38/295 (12%)
Query: 43  DNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAEMEFAVEVEILAR-VRHKNLL 97
           D  +G+G FG VY G+  D +Q     A+K L   +   ++E  +   +L R + H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 98  SLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +L G     EG   +++  YM +               + +    +   +  A G+ YL 
Sbjct: 86  ALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYL- 140
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR---VKGTLGYLAPE 212
             A    +HRD+ A N +LD  F  +VADFG A+ I D   +   +    +  + + A E
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
                + +   DV+SFG+LL EL + G  P   ++        D    LA  R+  +   
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------FDLTHFLAQGRRLPQ--- 249
Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDE 326
                 +  + L +V+     C  + P  RPT      +L GE ++ ++ L  D 
Sbjct: 250 ----PEYCPDSLYQVM---QQCWEADPAVRPT----FRVLVGEVEQIVSALLGDH 293

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQ-IAVKRLKVWS--NKAEMEFAVEVEILARVRHKNL 96
           +N    LG+G FG V   +     Q  AVK +   S  NK       EVE+L ++ H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 97  LSLRGYCAEGQERLIVYD-YMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           + L     +     IV + Y                E     +    I      GI Y+H
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGITYMH 138
Query: 156 HHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
            H   +I+HRD+K  N+LL++   D   ++ DFG +       T +  R+ GT  Y+APE
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE 193
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             + G   E CDV+S G++L  L SG  P 
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 220

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 38  NNFNYDNKLGEGGFGSVYW---------GQLWDGSQIAVKRLKVWSNKAEMEFAVEVEIL 88
           ++F     LG+G FG V+          G L+    +    LKV   +  +   +E +IL
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKV---RDRVRTKMERDIL 84
Query: 89  ARVRHKNLLSLR-GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS 147
           A V H  ++ L   +  EG+  LI+ D++               E +       D+    
Sbjct: 85  ADVNHPFVVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSK----EVMFTEE---DVKFYL 136
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           AE  + L H  +  II+RD+K  N+LLD +   ++ DFG +K   D      +   GT+ 
Sbjct: 137 AELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC-GTVE 195
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE 243
           Y+APE       S S D +S+G+L+ E+ +G  P +
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MXGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G  +AVK++ +   +       EV I+   +H+N++ +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++                  +N  +   + +   + +  LH      +I
Sbjct: 96  LVGDELWVVMEFL-----EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 147
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKASE 221
           HRDIK+ ++LL  D + +++DFGF   +   +  V  R  + GT  ++APE         
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 222 SCDVYSFGILLLELASGKKP 241
             D++S GI+++E+  G+ P
Sbjct: 205 EVDIWSLGIMVIEMVDGEPP 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           +G+ YLH       IHRDIKA+NVLL      ++ADFG A  + D      T V GT  +
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFW 186
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE 268
           +APE           D++S GI  +ELA G+ P    NS +         P+       +
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----NSDMH--------PMRVLFLIPK 234
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
              P L G+F  +  K  +     C +  P  RPT  E+L
Sbjct: 235 NNPPTLVGDFT-KSFKEFI---DACLNKDPSFRPTAKELL 270

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MXGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 220

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G  +AVK++ +   +       EV I+   +H+N++ +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++                  +N  +   + +   + +  LH      +I
Sbjct: 98  LVGDELWVVMEFL-----EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 149
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKASE 221
           HRDIK+ ++LL  D + +++DFGF   +   +  V  R  + GT  ++APE         
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 222 SCDVYSFGILLLELASGKKP 241
             D++S GI+++E+  G+ P
Sbjct: 207 EVDIWSLGIMVIEMVDGEPP 226

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNRRMDIAIGS------ 147
           +++L G C +     ++ +Y    N             E   N +   +  + S      
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 148 ----AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
               A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+    K
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDXXKK 208
Query: 204 GTLG-----YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
            T G     ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLK--VWSNKAEMEFAV-EVEILARVRH 93
           N+F+Y   LG+G FG V    +   G   A+K L+  V   K E+   V E  +L   RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
             L +L+ Y  +  +RL    ++               E +    R           + Y
Sbjct: 68  PFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 123
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPE 212
           LH   +  +++RDIK  N++LD D   ++ DFG  K  I DGAT  T    GT  YLAPE
Sbjct: 124 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 178
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
                    + D +  G+++ E+  G+ P 
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 39  NFNYDNKLGEGGFGS-VYWGQLWDGSQIAVKRLK----VWSNKAEMEFAVEVEILARVRH 93
           +F +   LGEG F + V   +L    + A+K L+    +  NK       E ++++R+ H
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDH 89
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD------IAIGS 147
              + L     + ++      Y  N               LL + R++           +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGE-------------LLKYIRKIGSFDETCTRFYT 136
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTL 206
           AE +  L +     IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT 
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
            Y++PE      A +S D+++ G ++ +L +G  P    N
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MXGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE-YSDW 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G  +AVK++ +   +       EV I+   +H+N++ +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++                  +N  +   + +   + +  LH      +I
Sbjct: 141 LVGDELWVVMEFL-----EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 192
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKASE 221
           HRDIK+ ++LL  D + +++DFGF   +   +  V  R  + GT  ++APE         
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 222 SCDVYSFGILLLELASGKKP 241
             D++S GI+++E+  G+ P
Sbjct: 250 EVDIWSLGIMVIEMVDGEPP 269

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 26/233 (11%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWSNKAEM----EFA 82
           LKE+  +   F    +LGE  FG VY G L+    G Q     +K   +KAE     EF 
Sbjct: 20  LKEISLSAVRFM--EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXX------------X 130
            E  + AR++H N++ L G   + Q   +++ Y  +                        
Sbjct: 78  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 131 XECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG-FAK 189
            +  L     + +    A G+ YL  H   H++H+D+   NVL+      +++D G F +
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           +       +       + ++APE  M GK S   D++S+G++L E+ S G +P
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G  +AVK++ +   +       EV I+   +H+N++ +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++                  +N  +   + +   + +  LH      +I
Sbjct: 87  LVGDELWVVMEFL-----EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 138
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKASE 221
           HRDIK+ ++LL  D + +++DFGF   +   +  V  R  + GT  ++APE         
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 222 SCDVYSFGILLLELASGKKP 241
             D++S GI+++E+  G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 26/233 (11%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWSNKAEM----EFA 82
           LKE+  +   F    +LGE  FG VY G L+    G Q     +K   +KAE     EF 
Sbjct: 3   LKEISLSAVRFM--EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXX------------X 130
            E  + AR++H N++ L G   + Q   +++ Y  +                        
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 131 XECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG-FAK 189
            +  L     + +    A G+ YL  H   H++H+D+   NVL+      +++D G F +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           +       +       + ++APE  M GK S   D++S+G++L E+ S G +P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLK--VWSNKAEMEFAV-EVEILARVRH 93
           N+F+Y   LG+G FG V    +   G   A+K L+  V   K E+   V E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
             L +L+ Y  +  +RL    ++               E +    R           + Y
Sbjct: 65  PFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPE 212
           LH   +  +++RDIK  N++LD D   ++ DFG  K  I DGAT  T    GT  YLAPE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
                    + D +  G+++ E+  G+ P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGT 205
           + +G+ YLH++    +IHRD+K  N+ L+ D   ++ DFG A  I  DG       + GT
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGT 205
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERK 265
             Y+APE       S   D++S G +L  L  GK P E   S +K T            K
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRI--------K 255
Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +E + PR + N V   L R +L      H+ P  RP++ E+L
Sbjct: 256 KNEYSVPR-HINPVASALIRRML------HADPTLRPSVAELL 291

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           K+GEG  G V    +   G  +AVK++ +   +       EV I+   +H+N++ +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
             G E  +V +++                  +N  +   + +   + +  LH      +I
Sbjct: 91  LVGDELWVVMEFL-----EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 142
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKASE 221
           HRDIK+ ++LL  D + +++DFGF   +   +  V  R  + GT  ++APE         
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 222 SCDVYSFGILLLELASGKKP 241
             D++S GI+++E+  G+ P
Sbjct: 200 EVDIWSLGIMVIEMVDGEPP 219

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGT 205
           + +G+ YLH++    +IHRD+K  N+ L+ D   ++ DFG A  I  DG       + GT
Sbjct: 135 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGT 189
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERK 265
             Y+APE       S   D++S G +L  L  GK P E   S +K T            K
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRI--------K 239
Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +E + PR + N V   L R +L      H+ P  RP++ E+L
Sbjct: 240 KNEYSVPR-HINPVASALIRRML------HADPTLRPSVAELL 275

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLK--VWSNKAEMEFAV-EVEILARVRH 93
           N+F+Y   LG+G FG V    +   G   A+K L+  V   K E+   V E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
             L +L+ Y  +  +RL    ++               E +    R           + Y
Sbjct: 65  PFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPE 212
           LH   +  +++RDIK  N++LD D   ++ DFG  K  I DGAT  T    GT  YLAPE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
                    + D +  G+++ E+  G+ P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 28/220 (12%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQI----AVKRLK----VWSNKAEMEFAVEVEILAR 90
           NF     LG G +G V+  +   G       A+K LK    V   K       E ++L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 91  VRHKNLLSLRGYCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRR-----MDIA 144
           +R    L    Y  + + +L ++ DY+               E   + ++R      ++ 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGG------------ELFTHLSQRERFTEHEVQ 162
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
           I   E ++ L H     II+RDIK  N+LLD++    + DFG +K      T       G
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 205 TLGYLAPEYAMLGKAS--ESCDVYSFGILLLELASGKKPI 242
           T+ Y+AP+    G +   ++ D +S G+L+ EL +G  P 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 52/282 (18%)
Query: 46  LGEGGFGSVYWGQLW--DGS--QIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSL 99
           LGEG FGSV  G L   DG+  ++AVK +K+   S +   EF  E   +    H N++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 100 RGYCAEGQER-----LIVYDYMPNXXXXXXXXXXXX--------XECLLNWNRRMDIAIG 146
            G C E   +     +++  +M                       + LL +   +DIA+G
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF--MVDIALG 159
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV-KGT 205
                  + + +  + +HRD+ A N +L  D    VADFG +K I  G  +   R+ K  
Sbjct: 160 -------MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACER 264
           + ++A E       +   DV++FG+ + E+A+ G  P   V +                 
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN----------------- 255
Query: 265 KFSELADPRLNGNFV---EEELKRVVLVALTCAHSKPEKRPT 303
              E+ D  L+G+ +   E+ L  +  +  +C  + P  RPT
Sbjct: 256 --HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPT 295

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 13  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 107
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 108 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 165 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 219

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 221

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 114
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 173
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL- 227
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 267

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 220

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNRRMDIAIGS------ 147
           +++L G C +     ++ +Y    N             E   N +   +  + S      
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 148 ----AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
               A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 193
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW 220

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR------------MDI 143
           +++L G C +     ++ +Y                    ++N              +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 197
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR------------MDI 143
           +++L G C +     ++ +Y                    ++N              +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 200
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 248

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGT 205
           + +G+ YLH++    +IHRD+K  N+ L+ D   ++ DFG A  I  DG       + GT
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGT 205
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERK 265
             Y+APE       S   D++S G +L  L  GK P E   S +K T            K
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRI--------K 255
Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            +E + PR + N V   L R +L      H+ P  RP++ E+L
Sbjct: 256 KNEYSVPR-HINPVASALIRRML------HADPTLRPSVAELL 291

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 221

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG +G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 109
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 167 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 221

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR------------MDI 143
           +++L G C +     ++ +Y                    ++N              +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 201
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 249

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR------------MDI 143
           +++L G C +     ++ +Y                    ++N              +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 208
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR------------MDI 143
           +++L G C +     ++ +Y                    ++N              +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 208
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 88
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 147
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 148 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 201
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 241

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 99
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 158
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 159 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 212
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 252

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 14/218 (6%)
Query: 31  KELHSAT-NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEV 85
           K  H  T N F Y   LG+G FG V    +   G   A+K LK     A+ E A    E 
Sbjct: 143 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 202
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            +L   RH  L +L+ Y  +  +RL    ++               E + + +R      
Sbjct: 203 RVLQNSRHPFLTALK-YSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGA 258
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKG 204
                + YLH  +  ++++RD+K  N++LD D   ++ DFG  K  I DGAT  T    G
Sbjct: 259 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCG 314
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           T  YLAPE         + D +  G+++ E+  G+ P 
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCNIVRLRY 80
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 192 E-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 108
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 167
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 219
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 220 EL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 261

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCNIVRLRY 80
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 192 E-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNRRMDIAIGS------ 147
           +++L G C +     ++ +Y    N             E   N +   +  + S      
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 148 ----AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
               A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 208
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV 245
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 92
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 151
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 205
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 245

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCNIVRLRY 80
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 193
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 92
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 151
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL- 205
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 57/295 (19%)
Query: 46  LGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +            +++AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR------------MDI 143
           +++L G C +     ++ +Y                    ++N              +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----- 198
           A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I     H+     
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 249
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWA 257
           TT  +  + ++APE       +   DV+SFG+LL E+ + G  P   V            
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------------ 297
Query: 258 LPLACERKFSELADPRLNGNFVEEE---LKRVVLVALTCAHSKPEKRPTMLEVLD 309
                E  F  L +    G+ +++       + ++   C H+ P +RPT  ++++
Sbjct: 298 ---PVEELFKLLKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 114
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 173
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 226 EL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 267

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 81
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 140
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 141 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 194
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 234

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 116
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 175
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 227
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 228 EL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 269

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 80
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 193
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 93
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 152
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 153 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPE-L 206
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 246

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 80
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 193
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 118
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 177
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 229
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 230 EL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 271

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 84
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 143
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 144 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPE-L 197
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 237

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLK--VWSNKAEMEFAV-EVEILARV 91
             N+F+Y   LG+G FG V    +   G   A+K L+  V   K E+   V E  +L   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH  L +L+ Y  +  +RL    ++               E +    R           +
Sbjct: 63  RHPFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLA 210
            YLH   +  +++RDIK  N++LD D   ++ DFG  K  I DGAT       GT  YLA
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLA 173
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           PE         + D +  G+++ E+  G+ P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 14/218 (6%)
Query: 31  KELHSAT-NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEV 85
           K  H  T N F Y   LG+G FG V    +   G   A+K LK     A+ E A    E 
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
            +L   RH  L +L+ Y  +  +RL    ++               E + + +R      
Sbjct: 200 RVLQNSRHPFLTALK-YSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGA 255
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKG 204
                + YLH  +  ++++RD+K  N++LD D   ++ DFG  K  I DGAT  T    G
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCG 311
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           T  YLAPE         + D +  G+++ E+  G+ P 
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 159
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 218
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 219 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 270
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 271 EL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 312

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 44/239 (18%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQ------LWDGSQIAVKRLKV-WSNKAEMEFAVEVEILAR 90
           NN  Y   +GEG FG V+  +          + +AVK LK   S   + +F  E  ++A 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYM-------------PNXXXXXXXXXXXXXECL--- 134
             + N++ L G CA G+   ++++YM             P+               +   
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 135 ----LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
               L+   ++ IA   A G+ YL        +HRD+   N L+  +   ++ADFG ++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 191 I-------PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           I        DG   +  R      ++ PE     + +   DV+++G++L E+ S G +P
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 85
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 144
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
                 I HRDIK  N+LLD D    ++ DFG AK +  G    +++ +R      Y AP
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 196
Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           E  + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 197 EL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 238

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 17/222 (7%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVE 86
           + +LH    N+     +G+G F  V   + +  G ++AVK + K   N + ++    EV 
Sbjct: 1   MADLH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR 58
Query: 87  ILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIG 146
           I+  + H N++ L       +   +V +Y                     W +  +    
Sbjct: 59  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-------GWMKEKEARAK 111
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
             + +  + +     I+HRD+KA N+LLDAD   ++ADFGF+     G    T    G+ 
Sbjct: 112 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSP 169
Query: 207 GYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 170 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLK--VWSNKAEMEFAV-EVEILARV 91
             N+F+Y   LG+G FG V    +   G   A+K L+  V   K E+   V E  +L   
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH  L +L+ Y  +  +RL    ++               E +    R           +
Sbjct: 68  RHPFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 123
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLA 210
            YLH   +  +++RDIK  N++LD D   ++ DFG  K  I DGAT       GT  YLA
Sbjct: 124 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLA 178
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           PE         + D +  G+++ E+  G+ P 
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 14/212 (6%)
Query: 36  ATNNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLK--VWSNKAEMEFAV-EVEILARV 91
             N+F+Y   LG+G FG V    +   G   A+K L+  V   K E+   V E  +L   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           RH  L +L+ Y  +  +RL    ++               E +    R           +
Sbjct: 63  RHPFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLA 210
            YLH   +  +++RDIK  N++LD D   ++ DFG  K  I DGAT       GT  YLA
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLA 173
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           PE         + D +  G+++ E+  G+ P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 14/210 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLK--VWSNKAEMEFAV-EVEILARVRH 93
           N+F+Y   LG+G FG V    +   G   A+K L+  V   K E+   V E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
             L +L+ Y  +  +RL    ++               E +    R           + Y
Sbjct: 65  PFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPE 212
           LH   +  +++RDIK  N++LD D   ++ DFG  K  I DGAT       GT  YLAPE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPE 175
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
                    + D +  G+++ E+  G+ P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D    +++A+K++  + ++   +  + E++IL R RH+N++ +R 
Sbjct: 51  IGEGAYGMV--SSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 102 YCAEG-----QERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                     ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQI------LRGLKYIH- 161
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV--TTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+L++     ++ DFG A++      H    T    T  Y APE  
Sbjct: 162 --SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG VY  +L D G  +A+K++   K + N+       E++I+ ++ H N++ LR 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 80
Query: 102 YCAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           +     E+       +V DY+P              + L     ++ +       + Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 156 HHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD D    ++ DFG AK +  G  +V+     +  Y APE  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPE-L 193
Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           + G    + S DV+S G +L EL  G +PI   +S + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEF---AVEVEILARVRHKNLLSLRG 101
           LG GGFG V+  Q+   G   A K+L     K    +    VE +ILA+V  + ++SL  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 102 YCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  E +  L +V   M                      R +        G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           +II+RD+K  NVLLD D   +++D G A  +  G T  T    GT G++APE  +  +  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 221 ESCDVYSFGILLLELASGKKPI----EKV-NSAIKRTITDWAL 258
            S D ++ G+ L E+ + + P     EKV N  +K+ + + A+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEF---AVEVEILARVRHKNLLSLRG 101
           LG GGFG V+  Q+   G   A K+L     K    +    VE +ILA+V  + ++SL  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 102 YCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  E +  L +V   M                      R +        G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           +II+RD+K  NVLLD D   +++D G A  +  G T  T    GT G++APE  +  +  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 221 ESCDVYSFGILLLELASGKKPI----EKV-NSAIKRTITDWAL 258
            S D ++ G+ L E+ + + P     EKV N  +K+ + + A+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEF---AVEVEILARVRHKNLLSLRG 101
           LG GGFG V+  Q+   G   A K+L     K    +    VE +ILA+V  + ++SL  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 102 YCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  E +  L +V   M                      R +        G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           +II+RD+K  NVLLD D   +++D G A  +  G T  T    GT G++APE  +  +  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 221 ESCDVYSFGILLLELASGKKPI----EKV-NSAIKRTITDWAL 258
            S D ++ G+ L E+ + + P     EKV N  +K+ + + A+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 85/206 (41%), Gaps = 23/206 (11%)
Query: 49  GGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE 108
           G FG V+  QL +   +AVK   +  +K   +   E+     ++H+NLL        G  
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPL-QDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 109 RLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHAT--------P 160
            L V  ++                 ++ WN    +A   + G+ YLH            P
Sbjct: 84  -LEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKP 142
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLI----PDGATHVTTRVKGTLGYLAPEYA-- 214
            I HRD K+ NVLL +D  A +ADFG A       P G TH      GT  Y+APE    
Sbjct: 143 SIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYMAPEVLEG 199
Query: 215 ---MLGKASESCDVYSFGILLLELAS 237
                  A    D+Y+ G++L EL S
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEF---AVEVEILARVRHKNLLSLRG 101
           LG GGFG V+  Q+   G   A K+L     K    +    VE +ILA+V  + ++SL  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 102 YCAEGQERL-IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           Y  E +  L +V   M                      R +        G+ +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
           +II+RD+K  NVLLD D   +++D G A  +  G T  T    GT G++APE  +  +  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 221 ESCDVYSFGILLLELASGKKPI----EKV-NSAIKRTITDWAL 258
            S D ++ G+ L E+ + + P     EKV N  +K+ + + A+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY--AM--- 215
           H +HRDIK  NVLLD +   ++ADFG    + D  T  ++   GT  Y++PE   AM   
Sbjct: 211 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 270
Query: 216 LGKASESCDVYSFGILLLELASGKKPI 242
           +GK    CD +S G+ + E+  G+ P 
Sbjct: 271 MGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY--AM--- 215
           H +HRDIK  NVLLD +   ++ADFG    + D  T  ++   GT  Y++PE   AM   
Sbjct: 195 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 254
Query: 216 LGKASESCDVYSFGILLLELASGKKPI 242
           +GK    CD +S G+ + E+  G+ P 
Sbjct: 255 MGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +      TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 141
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 43  DNKLGEGGFGSVYWGQLWDGSQ---IAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLS 98
           D +LG G FGSV  G      +   +A+K LK  + KA+ E    E +I+ ++ +  ++ 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L G C    E L++   M               E  ++     ++    + G+ YL    
Sbjct: 75  LIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEK- 129
Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAML 216
             + +HRD+ A NVLL     A+++DFG +K +    ++ T R  G   L + APE    
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 217 GKASESCDVYSFGILLLE-LASGKKPIEKV 245
            K S   DV+S+G+ + E L+ G+KP +K+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSV--YWGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 145
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 46  LGEGGFGSVYWGQLW--DGSQI----AVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLS 98
           LG G FG+VY G +W  DG  +    A+K L+   S KA  E   E  ++A V    +  
Sbjct: 25  LGSGAFGTVYKG-IWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 99  LRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L G C     +L+    MP                 + LLNW  ++      A+G+ YL 
Sbjct: 84  LLGICLTSTVQLVT-QLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYLE 136
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTRVKGTLGYLAPEYA 214
                 ++HRD+ A NVL+ +    ++ DFG A+L+  D   +     K  + ++A E  
Sbjct: 137 DV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 215 MLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITD 255
           +  + +   DV+S+G+ + EL + G KP + + +   R I D
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPD 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           IIHRDIK SN+LLD     ++ DFG +  + D      TR  G   Y+APE      + +
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQ 204
Query: 222 S----CDVYSFGILLLELASGKKPIEKVNSAI 249
                 DV+S GI L ELA+G+ P  K NS  
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +      TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           G+ YLH H   +I+HRD+K  N+LL++   D   ++ DFG + +  +    +  R+ GT 
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTA 202
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            Y+APE  +  K  E CDV+S G++L  L +G  P 
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 141
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 142 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 141
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 58/238 (24%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLK---VWSNKAEMEFAV--------EVEILARVRHK 94
           LGEG  G V         Q+AV R+    V     +M+ AV        E+ I   + H+
Sbjct: 14  LGEGAAGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----- 149
           N++   G+  EG  + +  +Y                        R++  IG  E     
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFD----------------RIEPDIGMPEPDAQR 108
Query: 150 -------GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP-DGATHVTTR 201
                  G+VYLH      I HRDIK  N+LLD     +++DFG A +   +    +  +
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 202 VKGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           + GTL Y+APE  +L +    +E  DV+S GI+L  + +G+ P ++ + + +   +DW
Sbjct: 166 MCGTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSV--YWGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 145
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 60/306 (19%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           +  N    LG G FG V     +          +AVK LK  +  +E      E++IL  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 91  V-RHKNLLSLRGYCAEGQERLIVY------------------DYMPNXXXXXXXXXXXXX 131
           +  H N+++L G C +    L+V                   +++P              
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
           E L+ ++ ++      A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I
Sbjct: 148 EHLICYSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 192 ---PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKV 245
              PD       R+   L ++APE       +   DV+SFG+LL E   L +   P  K+
Sbjct: 199 XKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 246 NSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML 305
           +    R +          ++ + +  P    ++   E+ + +   L C H +P +RPT  
Sbjct: 257 DEEFCRRL----------KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFS 299
Query: 306 EVLDLL 311
           E+++ L
Sbjct: 300 ELVEHL 305

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 39  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 149
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 150 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 141
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 142 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 139
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEVEILARVRH 93
           N F Y   LG+G FG V    +   G   A+K LK     A+ E A    E  +L   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
             L +L+ Y  +  +RL    ++               E + + +R           + Y
Sbjct: 70  PFLTALK-YSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPE 212
           LH  +  ++++RD+K  N++LD D   ++ DFG  K  I DGAT       GT  YLAPE
Sbjct: 126 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPE 181
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
                    + D +  G+++ E+  G+ P 
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEVEILARVRH 93
           N F Y   LG+G FG V    +   G   A+K LK     A+ E A    E  +L   RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
             L +L+ Y  +  +RL    ++               E + + +R           + Y
Sbjct: 69  PFLTALK-YSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 124
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPE 212
           LH  +  ++++RD+K  N++LD D   ++ DFG  K  I DGAT       GT  YLAPE
Sbjct: 125 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPE 180
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
                    + D +  G+++ E+  G+ P 
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 143
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 144 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 141
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFA---VEVEILARVRH 93
           N F Y   LG+G FG V    +   G   A+K LK     A+ E A    E  +L   RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
             L +L+ Y  +  +RL    ++               E + + +R           + Y
Sbjct: 68  PFLTALK-YSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 123
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYLAPE 212
           LH  +  ++++RD+K  N++LD D   ++ DFG  K  I DGAT       GT  YLAPE
Sbjct: 124 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPE 179
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
                    + D +  G+++ E+  G+ P 
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 146
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 37  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 95
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 147
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 148 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 28  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 86
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 138
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 139 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 145
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 139
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQ-IAVKRLKVWSNKAEMEFAV--EVEIL 88
           L  A   +    ++GEG +G V+  + L +G + +A+KR++V + +  M  +   EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 89  ARVR---HKNLLSLRGYCAEGQ-----ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR 140
             +    H N++ L   C   +     +  +V++++               E  +     
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETI 122
Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
            D+      G+ +LH H    ++HRD+K  N+L+ +  + ++ADFG A++         T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALT 177
Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            V  TL Y APE  +    +   D++S G +  E+   +KP+ + +S +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDV 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQ-IAVKRLKVWSNKAEMEFAV--EVEIL 88
           L  A   +    ++GEG +G V+  + L +G + +A+KR++V + +  M  +   EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 89  ARVR---HKNLLSLRGYCAEGQ-----ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR 140
             +    H N++ L   C   +     +  +V++++               E  +     
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETI 122
Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
            D+      G+ +LH H    ++HRD+K  N+L+ +  + ++ADFG A++         T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALT 177
Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            V  TL Y APE  +    +   D++S G +  E+   +KP+ + +S +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDV 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +  GAT       GT  YLAPE
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGATWTLC---GTPEYLAPE 229
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 46  LGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAV------EVEILARVRHKNLLS 98
           LGEG F +VY  +  + +QI A+K++K+  +++E +  +      E+++L  + H N++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKL-GHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L           +V+D+M                 +L  +      + + +G+ YLH H 
Sbjct: 77  LLDAFGHKSNISLVFDFM----ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 131
Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--PDGAT--HVTTRVKGTLGYLAPEYA 214
              I+HRD+K +N+LLD +   ++ADFG AK    P+ A    V TR      Y APE  
Sbjct: 132 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR-----WYRAPELL 184
Query: 215 MLGKA-SESCDVYSFGILLLEL 235
              +      D+++ G +L EL
Sbjct: 185 FGARMYGVGVDMWAVGCILAEL 206

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKN 95
           N+     +G+G F  V   + +  G ++AVK + K   N   ++    EV I+  + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 96  LLSL-------------RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           ++ L               Y + G+    V+DY+                 +++      
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGE----VFDYLVAHGRMKEKEARAKFRQIVS------ 125
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   + Y H     +I+HRD+KA N+LLD D   ++ADFGF+     G    T   
Sbjct: 126 -------AVQYCHQK---YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--F 173
Query: 203 KGTLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            G+  Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 174 CGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQI------LRGLKYIH-- 145
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV-TTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKN 95
           N+     +G+G F  V   + +  G ++A+K + K   N   ++    EV I+  + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 96  LLSL-------------RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           ++ L               Y + G+    V+DY+                 +++      
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGE----VFDYLVAHGRMKEKEARSKFRQIVS------ 122
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   + Y H      I+HRD+KA N+LLDAD   ++ADFGF+     G    T   
Sbjct: 123 -------AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--F 170
Query: 203 KGTLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            G+  Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 171 CGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 21/224 (9%)
Query: 34  HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI--AVKRLK---VWSNKAEMEFAVEVEIL 88
           H+  ++F++   +G+G FG V   +     ++  AVK L+   +   K E     E  +L
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL 92
Query: 89  AR-VRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIA-IG 146
            + V+H  L+ L        +   V DY+                C L    R   A I 
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYI---NGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH--VTTRVKG 204
           SA G  YLH   + +I++RD+K  N+LLD+     + DFG  K   +   H   T+   G
Sbjct: 150 SALG--YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCG 201
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           T  YLAPE         + D +  G +L E+  G  P    N+A
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 245

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWD----GSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SK 510
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ A    ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 613

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 45/297 (15%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           +  N    LG G FG V     +          +AVK LK  +  +E      E++IL  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL---------LNWNRR 140
           +  H N+++L G C +    L+V                   E +         L     
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATH 197
           +  +   A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD    
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTIT 254
              R+   L ++APE       +   DV+SFG+LL E   L +   P  K++    R + 
Sbjct: 204 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRL- 260
Query: 255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                    ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 261 ---------KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 51  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 161
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 162 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLL 97
            N+  KL E   G ++ G+ W G+ I VK LKV  WS +   +F  E   L    H N+L
Sbjct: 12  LNFLTKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 98  SLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
            + G C         ++  +MP                +++ ++ +  A+  A G+ +L 
Sbjct: 71  PVLGACQSPPAPHPTLITHWMP--YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL- 127
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQV--ADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           H   P I    + + +V++D D  A++  AD  F+   P G  +          ++APE 
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-GRMYAP-------AWVAPEA 179
Query: 214 AMLGKASE-----SCDVYSFGILLLELASGKKPI 242
             L K  E     S D++SF +LL EL + + P 
Sbjct: 180 --LQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWD----GSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SK 510
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 613

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKN 95
           N+     +G+G F  V   + +  G ++AVK + K   N + ++    EV I+  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 96  LLSL-------------RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           ++ L               Y + G+    V+DY+                 +++      
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGE----VFDYLVAHGRMKEKEARAKFRQIVS------ 124
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   + Y H      I+HRD+KA N+LLDAD   ++ADFGF+     G    T   
Sbjct: 125 -------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--F 172
Query: 203 KGTLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            G+  Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 173 CGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQ-IAVKRLKVWSNKAEMEFAV--EVEIL 88
           L  A   +    ++GEG +G V+  + L +G + +A+KR++V + +  M  +   EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 89  ARVR---HKNLLSLRGYCAEGQ-----ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR 140
             +    H N++ L   C   +     +  +V++++               E  +     
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETI 122
Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
            D+      G+ +LH H    ++HRD+K  N+L+ +  + ++ADFG A++         T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALT 177
Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI 249
            V  TL Y APE  +    +   D++S G +  E+   +KP+ + +S +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDV 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 43  DNKLGEGGFGSVYWGQLWDGSQ---IAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLS 98
           D +LG G FGSV  G      +   +A+K LK  + KA+ E    E +I+ ++ +  ++ 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L G C    E L++   M               E  +  +   ++    + G+ YL    
Sbjct: 401 LIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEK- 455
Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAML 216
             + +HR++ A NVLL     A+++DFG +K +    ++ T R  G   L + APE    
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 217 GKASESCDVYSFGILLLE-LASGKKPIEKV 245
            K S   DV+S+G+ + E L+ G+KP +K+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 28/243 (11%)
Query: 16  KEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYW------GQLWDGSQIAVKR 69
           +E G+   +W+    K+       F +   LG G F  V        G+L+    I  K 
Sbjct: 4   RENGESSSSWK----KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKA 59
Query: 70  LKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXX 129
           LK   +  E E AV    L +++H+N+++L     E    L    Y+             
Sbjct: 60  LKGKESSIENEIAV----LRKIKHENIVALED-IYESPNHL----YLVMQLVSGGELFDR 110
Query: 130 XXECLLNWNRRMDIAIGSA-EGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADF 185
             E      +     I    + + YLH      I+HRD+K  N+L    D + K  ++DF
Sbjct: 111 IVEKGFYTEKDASTLIRQVLDAVYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDF 167
Query: 186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV 245
           G +K+  +G   V +   GT GY+APE       S++ D +S G++   L  G  P    
Sbjct: 168 GLSKM--EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 225
Query: 246 NSA 248
           N +
Sbjct: 226 NDS 228

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 162 IIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
           ++HRD+K  N+L    + + + ++ DFGFA+L P     + T    TL Y APE      
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 219 ASESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
             ESCD++S G++L  + SG+ P +  + ++  T
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT 219

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A++++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 145
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKN 95
           N+     +G+G F  V   + +  G ++AVK + K   N + ++    EV I+  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 96  LLSL-------------RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           ++ L               Y + G+    V+DY+                 +++      
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGE----VFDYLVAHGRMKEKEARAKFRQIVS------ 124
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   + Y H      I+HRD+KA N+LLDAD   ++ADFGF+     G    T   
Sbjct: 125 -------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--F 172
Query: 203 KGTLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            G+  Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 173 CGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS 237
           +  + ++APE       +   DV+SFG+L+ E+ +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 23/226 (10%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEME---FAVEV 85
           +K++     +F     +G G FG V   +L +  ++ A+K L  W      E   F  E 
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPN---XXXXXXXXXXXXXECLLNWNRRMD 142
           ++L     K + +L     +     +V DY                   E    +   M 
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTR 201
           IAI S   +         H +HRDIK  N+L+D +   ++ADFG   KL+ DG    +  
Sbjct: 186 IAIDSVHQL---------HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 202 VKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPI 242
           V GT  Y++PE         G+    CD +S G+ + E+  G+ P 
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           ++ L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++ +Y    N             E   + NR           +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK----VWSNKAEMEFAVEVEILARVRHKNLL 97
           LG+GG+G V+  +   G+      A+K LK    V + K       E  IL  V+H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXX--XXXXECLLNWNRRMDIAIGSAEGIVYLH 155
            L      G +  ++ +Y+                 +    +   + +A+G      +LH
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HLH 138
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTLGYLAPEYA 214
                 II+RD+K  N++L+     ++ DFG  K  I DG   VT    GT+ Y+APE  
Sbjct: 139 QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEIL 193
Query: 215 MLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           M    + + D +S G L+ ++ +G  P    N   K+TI
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTI 230

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK----VWSNKAEMEFAVEVEILARVRHKNLL 97
           LG+GG+G V+  +   G+      A+K LK    V + K       E  IL  V+H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXX--XXXXECLLNWNRRMDIAIGSAEGIVYLH 155
            L      G +  ++ +Y+                 +    +   + +A+G      +LH
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HLH 138
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTLGYLAPEYA 214
                 II+RD+K  N++L+     ++ DFG  K  I DG   VT    GT+ Y+APE  
Sbjct: 139 QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEIL 193
Query: 215 MLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           M    + + D +S G L+ ++ +G  P    N   K+TI
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTI 230

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 46  LGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+GGF   +     D       +I  K L +  ++ E + ++E+ I   + H++++   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 87
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----------G 150
           G+  +     +V +                   LL  ++R   A+   E          G
Sbjct: 88  GFFEDNDFVFVVLELC-------------RRRSLLELHKRRK-ALTEPEARYYLRQIVLG 133
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYL 209
             YLH +    +IHRD+K  N+ L+ D + ++ DFG A K+  DG    T  + GT  Y+
Sbjct: 134 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYI 188
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
           APE       S   DV+S G ++  L  GK P E   S +K T
Sbjct: 189 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKET 229

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 46  LGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+GGF   +     D       +I  K L +  ++ E + ++E+ I   + H++++   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 83
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----------G 150
           G+  +     +V +                   LL  ++R   A+   E          G
Sbjct: 84  GFFEDNDFVFVVLELC-------------RRRSLLELHKRRK-ALTEPEARYYLRQIVLG 129
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYL 209
             YLH +    +IHRD+K  N+ L+ D + ++ DFG A K+  DG    T  + GT  Y+
Sbjct: 130 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYI 184
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
           APE       S   DV+S G ++  L  GK P E   S +K T
Sbjct: 185 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKET 225

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 46  LGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+GGF   +     D       +I  K L +  ++ E + ++E+ I   + H++++   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 83
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----------G 150
           G+  +     +V +                   LL  ++R   A+   E          G
Sbjct: 84  GFFEDNDFVFVVLELC-------------RRRSLLELHKRRK-ALTEPEARYYLRQIVLG 129
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYL 209
             YLH +    +IHRD+K  N+ L+ D + ++ DFG A K+  DG    T  + GT  Y+
Sbjct: 130 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYI 184
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
           APE       S   DV+S G ++  L  GK P E   S +K T
Sbjct: 185 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKET 225

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVR 92
           ++ +    KLG G +G V   +    G++ A+K +K   V +         EV +L ++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN-RRMDIAIGSAE-- 149
           H N++ L  +  + +   +V +                 E +L      +D A+   +  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFD--------EIILRQKFSEVDAAVIMKQVL 114
Query: 150 -GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGT 205
            G  YLH H   +I+HRD+K  N+LL++   D   ++ DFG +     G   +  R+ GT
Sbjct: 115 SGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERL-GT 169
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
             Y+APE  +  K  E CDV+S G++L  L  G  P 
Sbjct: 170 AYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++  Y    N             E   + NR           +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 33/250 (13%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK----AEMEFAVEVEILARVRHKN 95
             +D ++G G F +VY G L   + + V   ++   K        F  E E L  ++H N
Sbjct: 28  LKFDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPN 86
Query: 96  LLSLRGY-----CAEGQERLIVYDYMPNXXXXXX---XXXXXXXECLLNWNRRMDIAIGS 147
           ++  R Y       +G++ +++   +                  + L +W R++      
Sbjct: 87  IV--RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------ 138
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATHVTTRVKGTL 206
            +G+ +LH   TP IIHRD+K  N+ +       ++ D G A L           V GT 
Sbjct: 139 LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTP 194
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACER 264
            + APE     K  ES DVY+FG   LE A+ + P  +  +A  I R +T    P +   
Sbjct: 195 EFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPAS--- 250
Query: 265 KFSELADPRL 274
            F ++A P +
Sbjct: 251 -FDKVAIPEV 259

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLS----- 98
           +G+G +G V+ G  W G  +AVK   ++S++ E  +  E E+   V  RH+N+L      
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 99  LRGYCAEGQERLIV-YDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH-- 155
           +    +  Q  LI  Y  M +              CL        I +  A G+ +LH  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASGLAHLHIE 124
Query: 156 ---HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----TTRVKGTLGY 208
                  P I HRD+K+ N+L+  + +  +AD G A +       +      RV GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 209 LAPEY------AMLGKASESCDVYSFGILLLELA 236
           +APE            + +  D+++FG++L E+A
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 23/233 (9%)
Query: 23  PTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA----E 78
           P W     K+     + +++ + LG G F  V   +  D     +  +K  + KA    E
Sbjct: 8   PRW-----KQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKKALEGKE 60
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN 138
                E+ +L +++H N+++L      G    ++   +               +      
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTER 116
Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL---LDADFKAQVADFGFAKLIPDGA 195
               +     + + YLH      I+HRD+K  N+L   LD D K  ++DFG +K+   G+
Sbjct: 117 DASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
             V +   GT GY+APE       S++ D +S G++   L  G  P    N A
Sbjct: 174 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           I+HRD+KA N+LLDAD   ++ADFGF+     G    T    G+  Y APE    GK  +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPE-LFQGKKYD 190
Query: 222 S--CDVYSFGILLLELASGKKPIEKVN 246
               DV+S G++L  L SG  P +  N
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLSLRGYC 103
           +G+G FG V+ G+ W G ++AVK   ++S++ E  +  E EI   V  RH+N+L   G+ 
Sbjct: 12  IGKGRFGEVWRGK-WRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 64
Query: 104 AEGQ-------ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           A          +  +V DY  +                +     + +A+ +A G+ +LH 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 119
Query: 157 -----HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-----RVKGTL 206
                   P I HRD+K+ N+L+  +    +AD G A +  D AT         RV GT 
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTK 177
Query: 207 GYLAPEY---AMLGKASES---CDVYSFGILLLELA 236
            Y+APE    ++  K  ES    D+Y+ G++  E+A
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I    G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 119 VSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 173
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y+APE       S   D++S G+ L+ELA G+ PI
Sbjct: 174 VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 39/282 (13%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILA--RVRHKNLLSLRGYC 103
           +G+G FG VY G+ W G ++A++ + +  +  +   A + E++A  + RH+N++   G C
Sbjct: 41  IGKGRFGQVYHGR-WHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
                  I+                   + +L+ N+   IA    +G+ YLH      I+
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 164 HRDIKASNVLLDADFKAQVADFGF---AKLIPDGATHVTTRVK-GTLGYLAPEYAMLGKA 219
           H+D+K+ NV  D + K  + DFG    + ++  G      R++ G L +LAPE       
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 220 ---------SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA 270
                    S+  DV++ G +  EL + + P  K   A       W +    +   S++ 
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPA---EAIIWQMGTGMKPNLSQIG 267
Query: 271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                   + +E+  ++L    C   + E+RPT  +++D+L+
Sbjct: 268 --------MGKEISDILLF---CWAFEQEERPTFTKLMDMLE 298

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 46  LGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV-RHKN 95
           LGEG FG V   +          +   +AVK LK  + + ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 96  LLSLRGYCAEGQERLIVYDYMP--NXXXXXXXXXXXXXECLLNWNR----------RMDI 143
           +++L G C +     ++  Y    N             E   + NR           +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRV 202
               A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +   +  TT  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLEL 235
           +  + ++APE       +   DV+SFG+L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLS----- 98
           +G+G +G V+ G  W G  +AVK   ++S++ E  +  E E+   V  RH+N+L      
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 99  LRGYCAEGQERLIV-YDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH-- 155
           +    +  Q  LI  Y  M +              CL        I +  A G+ +LH  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASGLAHLHIE 124
Query: 156 ---HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----TTRVKGTLGY 208
                  P I HRD+K+ N+L+  + +  +AD G A +       +      RV GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 209 LAPEY------AMLGKASESCDVYSFGILLLELA 236
           +APE            + +  D+++FG++L E+A
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLSLRGYC 103
           +G+G FG V+ G+ W G ++AVK   ++S++ E  +  E EI   V  RH+N+L   G+ 
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 63
Query: 104 AEGQ-------ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           A          +  +V DY  +                +     + +A+ +A G+ +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 118
Query: 157 -----HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-----RVKGTL 206
                   P I HRD+K+ N+L+  +    +AD G A +  D AT         RV GT 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTK 176
Query: 207 GYLAPEY---AMLGKASES---CDVYSFGILLLELA 236
            Y+APE    ++  K  ES    D+Y+ G++  E+A
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLSLRGYC 103
           +G+G FG V+ G+ W G ++AVK   ++S++ E  +  E EI   V  RH+N+L   G+ 
Sbjct: 50  IGKGRFGEVWRGK-WRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 102
Query: 104 AEGQ-------ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           A          +  +V DY  +                +     + +A+ +A G+ +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 157 -----HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-----RVKGTL 206
                   P I HRD+K+ N+L+  +    +AD G A +  D AT         RV GT 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTK 215
Query: 207 GYLAPEY---AMLGKASES---CDVYSFGILLLELA 236
            Y+APE    ++  K  ES    D+Y+ G++  E+A
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 45/297 (15%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           +  N    LG G FG V     +          +AVK LK  +  +E      E++IL  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL---------LNWNRR 140
           +  H N+++L G C +    L+V                   E +         L     
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATH 197
           +  +   A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD    
Sbjct: 147 ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTIT 254
              R+   L ++APE       +   DV+SFG+LL E   L +   P  K++    R + 
Sbjct: 204 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL- 260
Query: 255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                    ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 261 ---------KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEIL 88
               ++ +    KLG G +G V   +    G++ A+K +K   V +         EV +L
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN-RRMDIAIGS 147
            ++ H N++ L  +  + +   +V +                 E +L      +D A+  
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFD--------EIILRQKFSEVDAAVIM 127
Query: 148 AE---GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTR 201
            +   G  YLH H   +I+HRD+K  N+LL++   D   ++ DFG +     G   +  R
Sbjct: 128 KQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKER 183
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + GT  Y+APE  +  K  E CDV+S G++L  L  G  P 
Sbjct: 184 L-GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLSLRGYC 103
           +G+G FG V+ G+ W G ++AVK   ++S++ E  +  E EI   V  RH+N+L   G+ 
Sbjct: 37  IGKGRFGEVWRGK-WRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 89
Query: 104 AEGQ-------ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           A          +  +V DY  +                +     + +A+ +A G+ +LH 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 144
Query: 157 -----HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-----RVKGTL 206
                   P I HRD+K+ N+L+  +    +AD G A +  D AT         RV GT 
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTK 202
Query: 207 GYLAPEY---AMLGKASES---CDVYSFGILLLELA 236
            Y+APE    ++  K  ES    D+Y+ G++  E+A
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLSLRGYC 103
           +G+G FG V+ G+ W G ++AVK   ++S++ E  +  E EI   V  RH+N+L   G+ 
Sbjct: 14  IGKGRFGEVWRGK-WRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 66
Query: 104 AEGQ-------ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           A          +  +V DY  +                +     + +A+ +A G+ +LH 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 121
Query: 157 -----HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-----RVKGTL 206
                   P I HRD+K+ N+L+  +    +AD G A +  D AT         RV GT 
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTK 179
Query: 207 GYLAPEY---AMLGKASES---CDVYSFGILLLELA 236
            Y+APE    ++  K  ES    D+Y+ G++  E+A
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 151 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 203
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 204 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           GI YLH H   +I+HRDIK  N+LL   ++    ++ DFG +         +  R+ GT 
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTA 212
Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            Y+APE  +  K +E CDV+S G+++  L  G  P 
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLS----- 98
           +G+G +G V+ G  W G  +AVK   ++S++ E  +  E E+   V  RH+N+L      
Sbjct: 45  VGKGRYGEVWRGS-WQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 99  LRGYCAEGQERLIV-YDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH-- 155
           +    +  Q  LI  Y  M +              CL        I +  A G+ +LH  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASGLAHLHIE 153
Query: 156 ---HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV----TTRVKGTLGY 208
                  P I HRD+K+ N+L+  + +  +AD G A +       +      RV GT  Y
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 212
Query: 209 LAPEY------AMLGKASESCDVYSFGILLLELA 236
           +APE            + +  D+++FG++L E+A
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV--RHKNLLSLRGYC 103
           +G+G FG V+ G+ W G ++AVK   ++S++ E  +  E EI   V  RH+N+L   G+ 
Sbjct: 17  IGKGRFGEVWRGK-WRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 69
Query: 104 AEGQ-------ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           A          +  +V DY  +                +     + +A+ +A G+ +LH 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 124
Query: 157 -----HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT-----RVKGTL 206
                   P I HRD+K+ N+L+  +    +AD G A +  D AT         RV GT 
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTK 182
Query: 207 GYLAPEY---AMLGKASES---CDVYSFGILLLELA 236
            Y+APE    ++  K  ES    D+Y+ G++  E+A
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSV--YWGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 145
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T        T  Y APE  +
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWD----GSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ A    ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 46  LGEGGFGSV--YWGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
           +GEG +G V   +  L +  ++A+K++  + ++   +  + E++IL R RH+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 103 CA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                  + ++  IV D M               + +  +  ++        G+ Y+H  
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH-- 146
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAM 215
            + +++HRD+K SN+LL+     ++ DFG A++  PD   T        T  Y APE  +
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI 242
             K  ++S D++S G +L E+ S  +PI
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 75  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 127
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 149 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 201
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKN 95
           N+     +G+G F  V   + +  G ++AV+ + K   N + ++    EV I+  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 96  LLSL-------------RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           ++ L               Y + G+    V+DY+                 +++      
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGE----VFDYLVAHGRMKEKEARAKFRQIVS------ 124
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   + Y H      I+HRD+KA N+LLDAD   ++ADFGF+     G  +     
Sbjct: 125 -------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDEF 172
Query: 203 KGTLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            G+  Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 173 CGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 41/226 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKN 95
           N+     +G+G F  V   + +  G ++A+K + K   N   ++    EV I+  + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 96  LLSL-------------RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           ++ L               Y + G+    V+DY+                 +++      
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGE----VFDYLVAHGRMKEKEARSKFRQIVS------ 125
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   + Y H      I+HRD+KA N+LLDAD   ++ADFGF+     G        
Sbjct: 126 -------AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAF 173
Query: 203 KGTLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            G   Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 174 CGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 149 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 201
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 212 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 265 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 80  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 132
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 193 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 235

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 256 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 229
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     +VADFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 142 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPE 194
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     +VADFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 212 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 265 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 229
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 143 YLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 195
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 196 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKN 95
           N+     +G+G F  V   + +  G ++AVK + K   N + ++    EV I+  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 96  LLSL-------------RGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           ++ L               Y + G+    V+DY+                 +++      
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGE----VFDYLVAHGRMKEKEARAKFRQIVS------ 124
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   + Y H      I+HRD+KA N+LLDAD   ++ADFGF+     G  +     
Sbjct: 125 -------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDAF 172
Query: 203 KGTLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIEKVN 246
            G   Y APE    GK  +    DV+S G++L  L SG  P +  N
Sbjct: 173 CGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     +VADFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 81  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 133
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 194 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 236

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     +VADFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 256 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWD----GSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 130
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 23/233 (9%)
Query: 23  PTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA----E 78
           P W     K+     + +++ + LG G F  V   +  D     +  +K  + +A    E
Sbjct: 8   PRW-----KQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKE 60
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN 138
                E+ +L +++H N+++L      G    ++   +               +      
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTER 116
Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL---LDADFKAQVADFGFAKLIPDGA 195
               +     + + YLH      I+HRD+K  N+L   LD D K  ++DFG +K+   G+
Sbjct: 117 DASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
             V +   GT GY+APE       S++ D +S G++   L  G  P    N A
Sbjct: 174 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLA 210
           YLH      II+RD+K  NVLLD++   ++ D+G  K  L P G T  T+   GT  Y+A
Sbjct: 136 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT--TSXFCGTPNYIA 189
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           PE         S D ++ G+L+ E+ +G+ P + V S+
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 227

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAVEVEI 87
           +E+H AT+      +LG G FG V+  ++ D   G Q AVK++++   +AE     E+  
Sbjct: 90  EEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMA 138
Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS 147
            A +    ++ L G   EG     V  +M                CL   +R +     +
Sbjct: 139 CAGLTSPRIVPLYGAVREGP---WVNIFMELLEGGSLGQLVKEQGCLPE-DRALYYLGQA 194
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFK-AQVADFGFAK-LIPDG---ATHVTTRV 202
            EG+ YLH      I+H D+KA NVLL +D   A + DFG A  L PDG   +      +
Sbjct: 195 LEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYI 251
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            GT  ++APE  +        DV+S   ++L + +G  P
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 53/105 (50%), Gaps = 19/105 (18%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVK--- 203
           GI Y+H +    I+HRD+K  N+LL++   D   ++ DFG +       TH     K   
Sbjct: 138 GITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKD 187
Query: 204 --GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
             GT  Y+APE  + G   E CDV+S G++L  L SG  P    N
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 130
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           +G+ YLH       IHRDIKA+NVLL      ++ADFG A  + D        V GT  +
Sbjct: 127 KGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFW 182
Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE 268
           +APE           D++S GI  +ELA G+ P    NS +         P+       +
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPP----NSDLH--------PMRVLFLIPK 230
Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            + P L G    +  K  V     C +  P  RPT  E+L
Sbjct: 231 NSPPTLEGQH-SKPFKEFVEA---CLNKDPRFRPTAKELL 266

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 23/233 (9%)
Query: 23  PTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA----E 78
           P W     K+     + +++ + LG G F  V   +  D     +  +K  + +A    E
Sbjct: 8   PRW-----KQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKE 60
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN 138
                E+ +L +++H N+++L      G    ++   +               +      
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTER 116
Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL---LDADFKAQVADFGFAKLIPDGA 195
               +     + + YLH      I+HRD+K  N+L   LD D K  ++DFG +K+   G+
Sbjct: 117 DASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
             V +   GT GY+APE       S++ D +S G++   L  G  P    N A
Sbjct: 174 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLA 210
           YLH      II+RD+K  NVLLD++   ++ D+G  K  L P G T  T+   GT  Y+A
Sbjct: 168 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT--TSTFCGTPNYIA 221
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           PE         S D ++ G+L+ E+ +G+ P + V S+
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 259

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 214 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 266
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 267 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 307

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 5/115 (4%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           + +   E ++ L +     IIHRD+K  N+LLD      + DF  A ++P   T +TT +
Sbjct: 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT-M 174
Query: 203 KGTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT 254
            GT  Y+APE     K    S + D +S G+   EL  G++P    +S   + I 
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 53/105 (50%), Gaps = 19/105 (18%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVK--- 203
           GI Y+H +    I+HRD+K  N+LL++   D   ++ DFG +       TH     K   
Sbjct: 161 GITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKD 210
Query: 204 --GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
             GT  Y+APE  + G   E CDV+S G++L  L SG  P    N
Sbjct: 211 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 212 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 265 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 23/233 (9%)
Query: 23  PTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA----E 78
           P W     K+     + +++ + LG G F  V   +  D     +  +K  + +A    E
Sbjct: 8   PRW-----KQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKE 60
Query: 79  MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN 138
                E+ +L +++H N+++L      G    ++   +               +      
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTER 116
Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL---LDADFKAQVADFGFAKLIPDGA 195
               +     + + YLH      I+HRD+K  N+L   LD D K  ++DFG +K+   G+
Sbjct: 117 DASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
             V +   GT GY+APE       S++ D +S G++   L  G  P    N A
Sbjct: 174 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLA 210
           YLH      II+RD+K  NVLLD++   ++ D+G  K  L P G T  T+   GT  Y+A
Sbjct: 121 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT--TSXFCGTPNYIA 174
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           PE         S D ++ G+L+ E+ +G+ P + V S+
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 212

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 53/105 (50%), Gaps = 19/105 (18%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVK--- 203
           GI Y+H +    I+HRD+K  N+LL++   D   ++ DFG +       TH     K   
Sbjct: 162 GITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKD 211
Query: 204 --GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
             GT  Y+APE  + G   E CDV+S G++L  L SG  P    N
Sbjct: 212 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 44  NKLGEGGFGSVYWGQ--LWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLR 100
           +KLGEG + +VY G+  L D + +A+K +++   +     A+ EV +L  ++H N+++L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC--LLNWNRRMDIAIGSAEGIVYLHHHA 158
                 +   +V++Y+               +C  ++N +           G+ Y H   
Sbjct: 67  DIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGYLAPEYA 214
              ++HRD+K  N+L++   + ++ADFG A+     A  + T+       TL Y  P+  
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYDNEVVTLWYRPPD-I 171
Query: 215 MLGKA--SESCDVYSFGILLLELASGK 239
           +LG    S   D++  G +  E+A+G+
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL   RH+N++ +  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 143
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 144 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 83  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 135
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 238

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK--LIPDGATHVTTRVKGTLGYLA 210
           YLH      II+RD+K  NVLLD++   ++ D+G  K  L P G T  T+   GT  Y+A
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT--TSXFCGTPNYIA 178
Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           PE         S D ++ G+L+ E+ +G+ P + V S+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 38/223 (17%)
Query: 46  LGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+GGF   +     D       +I  K L +  ++ E + ++E+ I   + H++++   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 105
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----------G 150
           G+  +     +V +                   LL  ++R   A+   E          G
Sbjct: 106 GFFEDNDFVFVVLELC-------------RRRSLLELHKRRK-ALTEPEARYYLRQIVLG 151
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYL 209
             YLH +    +IHRD+K  N+ L+ D + ++ DFG A K+  DG       + GT  Y+
Sbjct: 152 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYI 206
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
           APE       S   DV+S G ++  L  GK P E   S +K T
Sbjct: 207 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKET 247

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 53/105 (50%), Gaps = 19/105 (18%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVK--- 203
           GI Y+H +    I+HRD+K  N+LL++   D   ++ DFG +       TH     K   
Sbjct: 144 GITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKD 193
Query: 204 --GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
             GT  Y+APE  + G   E CDV+S G++L  L SG  P    N
Sbjct: 194 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 47/291 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECL-----------LNWNRRMDIAIG 146
           +L G C +    L+V                   E +           L     +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVK 203
            A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R+ 
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL- 212
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWALPL 260
             L ++APE       +   DV+SFG+LL E   L +   P  K++    R +       
Sbjct: 213 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------- 264
Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
              ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 265 ---KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
             +  +LG G FG V+  ++ D   G Q AVK++++   + E     E+   A +    +
Sbjct: 74  MTHQPRLGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRI 126
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G   EG     V  +M                CL   +R +     + EG+ YLH 
Sbjct: 127 VPLYGAVREGP---WVNIFMELLEGGSLGQLIKQMGCLPE-DRALYYLGQALEGLEYLH- 181
Query: 157 HATPHIIHRDIKASNVLLDAD-FKAQVADFGFA-KLIPDG---ATHVTTRVKGTLGYLAP 211
             T  I+H D+KA NVLL +D  +A + DFG A  L PDG   +      + GT  ++AP
Sbjct: 182 --TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 239
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKP 241
           E  M        D++S   ++L + +G  P
Sbjct: 240 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAVEVEI 87
           +E+H AT+      +LG G FG V+  ++ D   G Q AVK++++   +AE     E+  
Sbjct: 71  EEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMA 119
Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGS 147
            A +    ++ L G   EG     V  +M                CL   +R +     +
Sbjct: 120 CAGLTSPRIVPLYGAVREGP---WVNIFMELLEGGSLGQLVKEQGCLPE-DRALYYLGQA 175
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFK-AQVADFGFAK-LIPDGATH---VTTRV 202
            EG+ YLH      I+H D+KA NVLL +D   A + DFG A  L PDG          +
Sbjct: 176 LEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            GT  ++APE  +        DV+S   ++L + +G  P
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWDGSQ----IAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 106 GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 158
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + +
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 219 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 261

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL R RH+N++ +  
Sbjct: 51  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
                    +   Y+               + L N +           G+ Y+H   + +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN-DHICYFLYQILRGLKYIH---SAN 164
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYAMLGKA 219
           ++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  +  K 
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 220 -SESCDVYSFGILLLELASGKKPI 242
            ++S D++S G +L E+ S  +PI
Sbjct: 225 YTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ ++A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 15/223 (6%)
Query: 46  LGEGGFGSVYWGQLWD----GSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G   E      V+  M               +  L+    +  A   +  + YL    + 
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS 220
             +HRDI A NVL+ ++   ++ DFG ++ + D      ++ K  + ++APE     + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 221 ESCDVYSFGILLLE-LASGKKPIEKV--NSAIKRTITDWALPL 260
            + DV+ FG+ + E L  G KP + V  N  I R      LP+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 256 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 38/223 (17%)
Query: 46  LGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+GGF   +     D       +I  K L +  ++ E + ++E+ I   + H++++   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 107
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----------G 150
           G+  +     +V +                   LL  ++R   A+   E          G
Sbjct: 108 GFFEDNDFVFVVLELC-------------RRRSLLELHKRRK-ALTEPEARYYLRQIVLG 153
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYL 209
             YLH +    +IHRD+K  N+ L+ D + ++ DFG A K+  DG       + GT  Y+
Sbjct: 154 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYI 208
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
           APE       S   DV+S G ++  L  GK P E   S +K T
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKET 249

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 256 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 136 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 190
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI--LARVRHKNLLSL---- 99
           +G G +G+VY G L D   +AVK   V+S      F  E  I  +  + H N+       
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVK---VFSFANRQNFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 100 RGYCAEGQ-ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH--- 155
               A+G+ E L+V +Y PN                 +W     +A     G+ YLH   
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTEL 131
Query: 156 ---HHATPHIIHRDIKASNVLLDADFKAQVADFGFA------KLI-PDGATHVTTRVKGT 205
               H  P I HRD+ + NVL+  D    ++DFG +      +L+ P    +      GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 206 LGYLAPEY---AMLGKASESC----DVYSFGILLLEL 235
           + Y+APE    A+  +  ES     D+Y+ G++  E+
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     QV DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 46  LGEGGFGSVYWGQLWDGS---QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           +GEG +G V     +D     ++A+K++  + ++   +  + E++IL   RH+N++ +  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 102 YCA-----EGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                   + ++  IV D M               + +  +  ++        G+ Y+H 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGLKYIH- 143
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PD-GATHVTTRVKGTLGYLAPEYA 214
             + +++HRD+K SN+LL+     ++ DFG A++  PD   T   T    T  Y APE  
Sbjct: 144 --SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPI 242
           +  K  ++S D++S G +L E+ S  +PI
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV----EVEI 87
           +++ +++F   + LGEG +G V        G  +A+K+++ +       FA+    E++I
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKI 62
Query: 88  LARVRHKNLLSL----RGYCAEG-QERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           L   +H+N++++    R    E   E  I+ + M                   + +R + 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-----------------DLHRVIS 105
Query: 143 IAIGSAEGIVYLHHHAT--------PHIIHRDIKASNVLLDADFKAQVADFGFAKLI--- 191
             + S + I Y  +            ++IHRD+K SN+L++++   +V DFG A++I   
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 192 ------PDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPI 242
                 P G     T    T  Y APE  +   K S + DV+S G +L EL   ++PI
Sbjct: 166 AADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILARV-RHKNLL 97
           LG G FG V     +          +AVK LK  +  +E      E++IL  +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 98  SLRGYCAE-GQERLIVYDYMP------------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           +L G C + G   +++ ++              N             +  L     +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTR 201
              A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWAL 258
           +   L ++APE       +   DV+SFG+LL E   L +   P  K++    R +     
Sbjct: 249 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 301
Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 302 -----KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 342

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 33/235 (14%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGYC 103
           LG GGFG V+  +   D    A+KR+++ + +   E  + EV+ LA++ H  ++      
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 104 AE--GQERLI-----VYDYMPNXXXXXXXXXX-XXXECLLNWNRR---MDIAIGSAEGIV 152
            E    E+L      VY Y+                 C +    R   + I +  AE + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-----------LIPDGATHVTTR 201
           +LH      ++HRD+K SN+    D   +V DFG              L P  A    T 
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA-SGKKPIEKVNSAIKRTITD 255
             GT  Y++PE       S   D++S G++L EL       +E+V     RT+TD
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERV-----RTLTD 239

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 128 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 182
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 183 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 171 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 225
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 226 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV----EVEI 87
           +++ +++F   + LGEG +G V        G  +A+K+++ +       FA+    E++I
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKI 62
Query: 88  LARVRHKNLLSL----RGYCAEG-QERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           L   +H+N++++    R    E   E  I+ + M                   + +R + 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-----------------DLHRVIS 105
Query: 143 IAIGSAEGIVYLHHHAT--------PHIIHRDIKASNVLLDADFKAQVADFGFAKLI--- 191
             + S + I Y  +            ++IHRD+K SN+L++++   +V DFG A++I   
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 192 ------PDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPI 242
                 P G     T    T  Y APE  +   K S + DV+S G +L EL   ++PI
Sbjct: 166 AADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 128/305 (41%), Gaps = 62/305 (20%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV 91
           N      LGEG FG V     +        + +AVK LK  ++ +E+ +   E  +L +V
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 92  RHKNLLSLRGYCAEGQERLIVYDY--------------------MPNXXXXXXXXXXXXX 131
            H +++ L G C++    L++ +Y                    + +             
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
           E  L     +  A   ++G+ YL   A   ++HRD+ A N+L+    K +++DFG ++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 192 PDGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
            +  ++V  R +G +   ++A E       +   DV+SFG+LL E+ + G  P   +   
Sbjct: 201 YEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP- 258
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVE------EELKRVVLVALTCAHSKPEKRP 302
                         ER F+ L      G+ +E      EE+ R++   L C   +P+KRP
Sbjct: 259 --------------ERLFNLLK----TGHRMERPDNCSEEMYRLM---LQCWKQEPDKRP 297
Query: 303 TMLEV 307
              ++
Sbjct: 298 VFADI 302

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 44/240 (18%)
Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
             L  L      F     +G G +G VY G+     Q+A  ++   +   E E   E+ +
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 88  LARV-RHKNLLSLRG-------------------YCAEGQERLIVYDYMPNXXXXXXXXX 127
           L +   H+N+ +  G                   +C  G     V D + N         
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS----VTDLIKNTKGNTLKEE 129
Query: 128 XXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
                C     R +        G+ +LH H    +IHRDIK  NVLL  + + ++ DFG 
Sbjct: 130 WIAYIC-----REI------LRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC-----DVYSFGILLLELASGKKPI 242
           +  +        T + GT  ++APE     +  ++      D++S GI  +E+A G  P+
Sbjct: 176 SAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 38/223 (17%)
Query: 46  LGEGGFGSVYWGQLWD-----GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLR 100
           LG+GGF   +     D       +I  K L +  ++ E + ++E+ I   + H++++   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 81
Query: 101 GYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE----------G 150
           G+  +     +V +                   LL  ++R   A+   E          G
Sbjct: 82  GFFEDNDFVFVVLELC-------------RRRSLLELHKRRK-ALTEPEARYYLRQIVLG 127
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYL 209
             YLH +    +IHRD+K  N+ L+ D + ++ DFG A K+  DG       + GT  Y+
Sbjct: 128 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYI 182
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
           APE       S   DV+S G ++  L  GK P E   S +K T
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKET 223

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
             +  ++G G FG V+  ++ D   G Q AVK++++   + E     E+   A +    +
Sbjct: 76  MTHQPRVGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRI 128
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G   EG     V  +M                CL   +R +     + EG+ YLH 
Sbjct: 129 VPLYGAVREGP---WVNIFMELLEGGSLGQLIKQMGCLPE-DRALYYLGQALEGLEYLH- 183
Query: 157 HATPHIIHRDIKASNVLLDAD-FKAQVADFGFA-KLIPDG---ATHVTTRVKGTLGYLAP 211
             T  I+H D+KA NVLL +D  +A + DFG A  L PDG   +      + GT  ++AP
Sbjct: 184 --TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 241
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKP 241
           E  M        D++S   ++L + +G  P
Sbjct: 242 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 104/241 (43%), Gaps = 39/241 (16%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSV---------YWGQLWDGSQIAVKRLKVWSNKAEM- 79
           +KE     N++     L +G F  +         Y  + ++ S +  KR    SN  ++ 
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 80  ------EFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC 133
                 +F  E++I+  ++++  L+  G      E  I+Y+YM N               
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF---- 138
Query: 134 LLNWNRRMDIAIGSAEGIV------YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
           +L+ N    I I   + I+      + + H   +I HRD+K SN+L+D + + +++DFG 
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES------CDVYSFGILLLELASGKKP 241
           ++ + D     +   +GT  ++ PE+     ++ES       D++S GI L  +     P
Sbjct: 199 SEYMVDKKIKGS---RGTYEFMPPEFF----SNESSYNGAKVDIWSLGICLYVMFYNVVP 251
Query: 242 I 242
Sbjct: 252 F 252

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/87 (40%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           I+HRD+KA N+LLDAD   ++ADFGF+     G  +      G   Y APE    GK  +
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG--NKLDAFCGAPPYAAPE-LFQGKKYD 190
Query: 222 S--CDVYSFGILLLELASGKKPIEKVN 246
               DV+S G++L  L SG  P +  N
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
             +  ++G G FG V+  ++ D   G Q AVK++++   + E     E+   A +    +
Sbjct: 60  MTHQPRVGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRI 112
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G   EG     V  +M                CL   +R +     + EG+ YLH 
Sbjct: 113 VPLYGAVREGP---WVNIFMELLEGGSLGQLIKQMGCLPE-DRALYYLGQALEGLEYLH- 167
Query: 157 HATPHIIHRDIKASNVLLDAD-FKAQVADFGFA-KLIPDG---ATHVTTRVKGTLGYLAP 211
             T  I+H D+KA NVLL +D  +A + DFG A  L PDG   +      + GT  ++AP
Sbjct: 168 --TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKP 241
           E  M        D++S   ++L + +G  P
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            + YLH +    IIHRD+K  NVLL +   D   ++ DFG +K++  G T +   + GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 180
Query: 207 GYLAPEYAM-LGKA--SESCDVYSFGILLLELASGKKPIE--KVNSAIKRTIT 254
            YLAPE  + +G A  + + D +S G++L    SG  P    +   ++K  IT
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 39  NFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
            F +   LG G F  V+   Q   G   A+K +K      +     E+ +L +++H+N++
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSA-EGIVYLHH 156
           +L     E       + Y+               E  +   +   + I      + YLH 
Sbjct: 70  TL-----EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 157 HATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           +    I+HRD+K  N+L    + + K  + DFG +K+  +G   + +   GT GY+APE 
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEV 178
Query: 214 AMLGKASESCDVYSFGILLLELASGKKPI 242
                 S++ D +S G++   L  G  P 
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 41/227 (18%)
Query: 45  KLGEGGFGSVYWGQL--WDGSQIAVKRL-KVWSNKAEMEFAV-EVEILARVR-HKNLLSL 99
           KLG+G +G V W  +    G  +AVK++   + N  + +    E+ IL  +  H+N+++L
Sbjct: 16  KLGKGAYGIV-WKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 100 RGYCAEGQER--LIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
                   +R   +V+DYM                 +L    +  +     + I YLH  
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKL----------IP----------DGATH 197
               ++HRD+K SN+LL+A+   +VADFG ++           IP          D    
Sbjct: 129 G---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 198 VTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y APE  +LG  K ++  D++S G +L E+  G KPI
Sbjct: 186 ILTDYVATRWYRAPE-ILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GT  Y++PE       S   D++S G+ L+E+A G+ PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            + YLH +    IIHRD+K  NVLL +   D   ++ DFG +K++  G T +   + GT 
Sbjct: 265 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 319
Query: 207 GYLAPEYAM-LGKA--SESCDVYSFGILLLELASGKKPIE--KVNSAIKRTIT 254
            YLAPE  + +G A  + + D +S G++L    SG  P    +   ++K  IT
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 372

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            + YLH +    IIHRD+K  NVLL +   D   ++ DFG +K++  G T +   + GT 
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 179
Query: 207 GYLAPEYAM-LGKA--SESCDVYSFGILLLELASGKKPIE--KVNSAIKRTIT 254
            YLAPE  + +G A  + + D +S G++L    SG  P    +   ++K  IT
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 232

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           ++HRD+K +NV LD     ++ DFG A+++    +   T V GT  Y++PE       +E
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNE 195
Query: 222 SCDVYSFGILLLELASGKKPI 242
             D++S G LL EL +   P 
Sbjct: 196 KSDIWSLGCLLYELCALMPPF 216

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            + YLH +    IIHRD+K  NVLL +   D   ++ DFG +K++  G T +   + GT 
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 305
Query: 207 GYLAPEYAM-LGKA--SESCDVYSFGILLLELASGKKPIE--KVNSAIKRTIT 254
            YLAPE  + +G A  + + D +S G++L    SG  P    +   ++K  IT
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            + YLH +    IIHRD+K  NVLL +   D   ++ DFG +K++  G T +   + GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 180
Query: 207 GYLAPEYAM-LGKA--SESCDVYSFGILLLELASGKKPIE--KVNSAIKRTIT 254
            YLAPE  + +G A  + + D +S G++L    SG  P    +   ++K  IT
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 52/105 (49%), Gaps = 19/105 (18%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVK--- 203
           GI Y H +    I+HRD+K  N+LL++   D   ++ DFG +       TH     K   
Sbjct: 138 GITYXHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKXKD 187
Query: 204 --GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
             GT  Y+APE  + G   E CDV+S G++L  L SG  P    N
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            + YLH +    IIHRD+K  NVLL +   D   ++ DFG +K++  G T +   + GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 180
Query: 207 GYLAPEYAM-LGKA--SESCDVYSFGILLLELASGKKPIE--KVNSAIKRTIT 254
            YLAPE  + +G A  + + D +S G++L    SG  P    +   ++K  IT
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT  YLAP 
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPA 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            + YLH +    IIHRD+K  NVLL +   D   ++ DFG +K++  G T +   + GT 
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 186
Query: 207 GYLAPEYAM-LGKA--SESCDVYSFGILLLELASGKKPIE--KVNSAIKRTIT 254
            YLAPE  + +G A  + + D +S G++L    SG  P    +   ++K  IT
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 239

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 20/158 (12%)
Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY- 213
           H H+   +IHRD+K SNVL++A  + ++ DFG +  + D      T   G   Y+APE  
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK--TIDAGCKPYMAPERI 225
Query: 214 -AMLGKASESC--DVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA 270
              L +   S   D++S GI ++ELA  + P +            W  P    ++  E  
Sbjct: 226 NPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEP 274
Query: 271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            P+L  +    E    V     C     ++RPT  E++
Sbjct: 275 SPQLPADKFSAEF---VDFTSQCLKKNSKERPTYPELM 309

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     +V DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     +V DFGFAK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 254

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTR 201
           IG+A  I +LH H   +I HRD+K  N+L  +   D   ++ DFGFAK     A      
Sbjct: 118 IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 172
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITDW 256
              T  Y+APE     K  +SCD++S G+++  L  G  P      + ++  +KR I   
Sbjct: 173 ---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI--- 226
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                   +  +   P    + V E+ K+++ + L    + P +R T+ + ++
Sbjct: 227 --------RLGQYGFPNPEWSEVSEDAKQLIRLLLK---TDPTERLTITQFMN 268

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     +V DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     +V DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     +V DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     +V DFGFAK +       T  + GT  YLAPE
Sbjct: 157 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPE 209
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 205 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 262

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 264

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 264

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 248

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 185 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 242

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTR 201
           IG+A  I +LH H   +I HRD+K  N+L  +   D   ++ DFGFAK     A      
Sbjct: 137 IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 191
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITDW 256
              T  Y+APE     K  +SCD++S G+++  L  G  P      + ++  +KR I   
Sbjct: 192 ---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI--- 245
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                   +  +   P    + V E+ K+++ + L    + P +R T+ + ++
Sbjct: 246 --------RLGQYGFPNPEWSEVSEDAKQLIRLLLK---TDPTERLTITQFMN 287

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLI--PDGATHVTTRVKGTLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +   +      T  K  + + APE     K
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 248

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 13/206 (6%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 120
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE-IL 175
Query: 216 LGKA--SESCDVYSFGILLLELASGK 239
           LG    S + D++S G +  E+ + +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 62/305 (20%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV 91
           N      LGEG FG V     +        + +AVK LK  ++ +E+ +   E  +L +V
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 92  RHKNLLSLRGYCAEGQERLIVYDY--------------------MPNXXXXXXXXXXXXX 131
            H +++ L G C++    L++ +Y                    + +             
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
           E  L     +  A   ++G+ YL   A   ++HRD+ A N+L+    K +++DFG ++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 192 PDGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
            +  + V  R +G +   ++A E       +   DV+SFG+LL E+ + G  P   +   
Sbjct: 201 YEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP- 258
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVE------EELKRVVLVALTCAHSKPEKRP 302
                         ER F+ L      G+ +E      EE+ R++   L C   +P+KRP
Sbjct: 259 --------------ERLFNLLK----TGHRMERPDNCSEEMYRLM---LQCWKQEPDKRP 297
Query: 303 TMLEV 307
              ++
Sbjct: 298 VFADI 302

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 49/238 (20%)
Query: 33  LHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV----EVEI 87
           +++ +++F   + LGEG +G V        G  +A+K+++ +       FA+    E++I
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKI 62
Query: 88  LARVRHKNLLSL----RGYCAEG-QERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           L   +H+N++++    R    E   E  I+ + M                   + +R + 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-----------------DLHRVIS 105
Query: 143 IAIGSAEGIVYLHHHAT--------PHIIHRDIKASNVLLDADFKAQVADFGFAKLI--- 191
             + S + I Y  +            ++IHRD+K SN+L++++   +V DFG A++I   
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 192 ------PDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPI 242
                 P G          T  Y APE  +   K S + DV+S G +L EL   ++PI
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEME-FAVEVEILARV 91
           N  +   LG G FG V     +  S      Q+AVK LK  ++ +E E    E++++ ++
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 92  -RHKNLLSLRGYCAEGQERLIVYDYM-----------------PNXXXXXXXXXXXXXEC 133
             H+N+++L G C       ++++Y                   +             E 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 134 L--LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-L 190
           L  L +   +  A   A+G+ +L   +    +HRD+ A NVL+      ++ DFG A+ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           + D    V    +  + ++APE    G  +   DV+S+GILL E+ S G  P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTLG--YLAP 211
           H H+   +IHRD+K SNVL++A  + ++ DFG +  L+ D A  +    K  +    + P
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
           E    G + +S D++S GI ++ELA  + P +            W  P    ++  E   
Sbjct: 184 ELNQKGYSVKS-DIWSLGITMIELAILRFPYDS-----------WGTPFQQLKQVVEEPS 231
Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           P+L  +    E    V     C     ++RPT  E++
Sbjct: 232 PQLPADKFSAEF---VDFTSQCLKKNSKERPTYPELM 265

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 20/182 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSLRGYCA------EGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++ L           E Q+  IV + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G+++ E+ 
Sbjct: 162 DATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
Query: 237 SG 238
            G
Sbjct: 220 KG 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKR-LKVWSNKAEMEFAV-EVEILARVRHKNLLSLRG 101
           K+GEG +G V+  +  D  QI A+K+ L+   +    + A+ E+ +L +++H NL++L  
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXX-XXECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
                +   +V++Y  +              E L+       I   + + + + H H   
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-----SITWQTLQAVNFCHKH--- 121
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG--K 218
           + IHRD+K  N+L+      ++ DFGFA+L+   + +    V  T  Y +PE  ++G  +
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPE-LLVGDTQ 179
Query: 219 ASESCDVYSFGILLLELASG 238
                DV++ G +  EL SG
Sbjct: 180 YGPPVDVWAIGCVFAELLSG 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 124
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 180
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 62/305 (20%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEM-EFAVEVEILARV 91
           N      LGEG FG V     +        + +AVK LK  ++ +E+ +   E  +L +V
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 92  RHKNLLSLRGYCAEGQERLIVYDY--------------------MPNXXXXXXXXXXXXX 131
            H +++ L G C++    L++ +Y                    + +             
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
           E  L     +  A   ++G+ YL   A   ++HRD+ A N+L+    K +++DFG ++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 192 PDGATHVTTRVKGTLG--YLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
            +  + V  R +G +   ++A E       +   DV+SFG+LL E+ + G  P   +   
Sbjct: 201 YEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP- 258
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVE------EELKRVVLVALTCAHSKPEKRP 302
                         ER F+ L      G+ +E      EE+ R++   L C   +P+KRP
Sbjct: 259 --------------ERLFNLLK----TGHRMERPDNCSEEMYRLM---LQCWKQEPDKRP 297
Query: 303 TMLEV 307
              ++
Sbjct: 298 VFADI 302

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 20/182 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSLRGYCA------EGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++ L           E Q+  IV + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G+++ E+ 
Sbjct: 162 DATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
Query: 237 SG 238
            G
Sbjct: 220 KG 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 17/103 (16%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           E + +LH +   +I+HRD+K  N+LLD + + +++DFGF+  +  G       + GT GY
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGY 265
Query: 209 LAPE---------YAMLGKASESCDVYSFGILLLELASGKKPI 242
           LAPE         +   GK     D+++ G++L  L +G  P 
Sbjct: 266 LAPEILKCSMDETHPGYGK---EVDLWACGVILFTLLAGSPPF 305

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 86/208 (41%), Gaps = 11/208 (5%)
Query: 40  FNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLL 97
           F +  KLG G FG V+   +   G +  +K +    ++  ME    E+E+L  + H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 98  SLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHH 157
            +     +     IV +                    L+     ++       + Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141
Query: 158 ATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
            + H++H+D+K  N+L          ++ DFG A+L    +   +T   GT  Y+APE  
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPE-V 197
Query: 215 MLGKASESCDVYSFGILLLELASGKKPI 242
                +  CD++S G+++  L +G  P 
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     QV DFG AK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 127
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 46  LGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAE-MEFAVEVEILARVRH-KNLL 97
           LGE G G+   GQ+W       G  IAVK+++   NK E     ++++++ +      ++
Sbjct: 30  LGEMGSGTC--GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 98  SLRGYCAEGQERLIVYDYMPN-XXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
              G      +  I  + M                E +L    +M +AI  A     L++
Sbjct: 88  QCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG---KMTVAIVKA-----LYY 139
Query: 157 HATPH-IIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYLAPEYA 214
               H +IHRD+K SN+LLD   + ++ DFG + +L+ D A     R  G   Y+APE  
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD---RSAGCAAYMAPERI 196
Query: 215 MLGKASES-----CDVYSFGILLLELASGKKP 241
                ++       DV+S GI L+ELA+G+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 550 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 607

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 119
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 7/118 (5%)
Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG--TLGYLAPEYAMLGK 218
           + +HRD+ A NVLL     A+++DFG +K +     +   +  G   + + APE     K
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 219 ASESCDVYSFGILLLE-LASGKKPIEKVN----SAIKRTITDWALPLACERKFSELAD 271
            S   DV+SFG+L+ E  + G+KP   +     +A+         P  C R+  +L +
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 120
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 119
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 118
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           + H H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 174
Query: 213 YAMLGK-ASESCDVYSFGILLLELASGK 239
             +  K  S + D++S G +  E+ + +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 120
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A G+ +L   ++   IHRD+ A N+LL  +   ++ DFG A+ I   PD      TR+  
Sbjct: 209 ARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL-- 263
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACE 263
            L ++APE       S   DV+S+G+LL E+ S G  P   V                 +
Sbjct: 264 PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQ---------------MD 308
Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
             F       +     E     +  + L C H  P++RP   E+++ L
Sbjct: 309 EDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 127
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  + D    +    
Sbjct: 112 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---EMANEF 166
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            GT  Y++PE       S   D++S G+ L+E+A G+ P
Sbjct: 167 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+L+D     QV DFGFAK +       T  + GT   LAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           K+GEG +G+V+  +  +  +I A+KR+++  +   +  +   E+ +L  ++HKN++ L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSA------EGIVYLH 155
                ++  +V+++                    + N  +D  I  +      +G+ + H
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFD----------SCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
                +++HRD+K  N+L++ + + ++ADFG A+         +  V  TL Y  P+   
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI---EKVNSAIKRTITDWALP 259
             K  S S D++S G +  ELA+  +P+     V+  +KR       P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTP 222

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 46  LGEGGFGSVYWGQLWDGSQIAVKRL---KVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
           +G G FG V+  +L +  ++A+K++   K + N+       E++I+  V+H N++ L+ +
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAF 100
Query: 103 CAEGQERL------IVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
                ++       +V +Y+P              + +     ++ +       + Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY-QLLRSLAYIHS 159
Query: 157 HATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
                I HRDIK  N+LLD      ++ DFG AK++  G  +V+     +  Y APE  +
Sbjct: 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAPEL-I 213
Query: 216 LGKA--SESCDVYSFGILLLELASGK 239
            G    + + D++S G ++ EL  G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 237 SGK 239
             K
Sbjct: 220 RHK 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           K+G+G FG V+  +    G ++A+K++ + + K         E++IL  ++H+N+++L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 102 YC---AEGQER-----LIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            C   A    R      +V+D+  +               L    R M + +    G+ Y
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQMLLN---GLYY 140
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLA 210
           +H +    I+HRD+KA+NVL+  D   ++ADFG A+           R      TL Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 211 PEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNS 247
           PE  +LG+       D++  G ++ E+ + + PI + N+
Sbjct: 198 PEL-LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLSFCH 120
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R+  
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 264
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWALPLA 261
            L ++APE       +   DV+SFG+LL E   L +   P  K++    R +        
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 316
Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
             ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 317 --KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 357

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 114/279 (40%), Gaps = 30/279 (10%)
Query: 75  NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC 133
           +K++ + + E+EIL R  +H N+++L+    +G+   +V + M                 
Sbjct: 61  DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS- 119
Query: 134 LLNWNRRMDIAIGS-AEGIVYLHHHATPHIIHRDIKASNVL-LDADFKAQ---VADFGFA 188
                R     + +  + + YLH      ++HRD+K SN+L +D     +   + DFGFA
Sbjct: 120 ----EREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           K +      + T    T  ++APE        E CD++S GILL  + +G  P     S 
Sbjct: 173 KQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               I    L      KF+       N N V E  K +V   L   H  P +R T  +VL
Sbjct: 232 TPEEI----LTRIGSGKFTLSGG---NWNTVSETAKDLVSKML---HVDPHQRLTAKQVL 281
Query: 309 DLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSA 347
                  K+KL + +      SHQ      G   A  SA
Sbjct: 282 QHPWVTQKDKLPQSQ-----LSHQDLQLVKGAMAATYSA 315

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R+  
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 255
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWALPLA 261
            L ++APE       +   DV+SFG+LL E   L +   P  K++    R +        
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 307
Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
             ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 308 --KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 348

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R+  
Sbjct: 208 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 262
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWALPLA 261
            L ++APE       +   DV+SFG+LL E   L +   P  K++    R +        
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 314
Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
             ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 315 --KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 355

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 1/81 (1%)
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           ++HRD+K +NV LD     ++ DFG A+++    +     V GT  Y++PE       +E
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRMSYNE 195
Query: 222 SCDVYSFGILLLELASGKKPI 242
             D++S G LL EL +   P 
Sbjct: 196 KSDIWSLGCLLYELCALMPPF 216

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGT 205
           +AE ++ L    +  +IHRD+K  N+LLD     ++ADFG   K+   G  H  T V GT
Sbjct: 180 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GT 238
Query: 206 LGYLAPEYAML----GKASESCDVYSFGILLLELASGKKPI 242
             Y++PE        G     CD +S G+ L E+  G  P 
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 103/250 (41%), Gaps = 34/250 (13%)
Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNK-LGEGGFGSVYWGQLWDGSQIAVKRLKV-WSNK 76
           GKK    RI ++     +  N     K LG G  G+V +   + G  +AVKR+ + + + 
Sbjct: 13  GKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI 72
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY-MPNXXXXXXXXXXXXXECLL 135
           A ME  +  E      H N++  R YC+E  +R +     + N             +  L
Sbjct: 73  ALMEIKLLTE---SDDHPNVI--RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENL 127
Query: 136 NWNRR---MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-------------DFK 179
              +    + +    A G+ +LH   +  IIHRD+K  N+L+               + +
Sbjct: 128 KLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 184
Query: 180 AQVADFGFAKLIPDGATHVTTRVK---GTLGYLAPEY---AMLGKASESCDVYSFG-ILL 232
             ++DFG  K +  G       +    GT G+ APE    +   + + S D++S G +  
Sbjct: 185 ILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY 244
Query: 233 LELASGKKPI 242
             L+ GK P 
Sbjct: 245 YILSKGKHPF 254

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLL 97
            N+  KL E   G ++ G+ W G+ I VK LKV  WS +   +F  E   L    H N+L
Sbjct: 12  LNFLTKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 98  SLRGYC--AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
            + G C         ++  + P                +++ ++ +  A+  A G  +L 
Sbjct: 71  PVLGACQSPPAPHPTLITHWXP--YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL- 127
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQV--ADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           H   P I    + + +V +D D  A++  AD  F+   P G  +          ++APE 
Sbjct: 128 HTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSP-GRXYAP-------AWVAPE- 178
Query: 214 AMLGKASE----SCDVYSFGILLLELASGKKPI 242
           A+  K  +    S D +SF +LL EL + + P 
Sbjct: 179 ALQKKPEDTNRRSADXWSFAVLLWELVTREVPF 211

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 34/250 (13%)
Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNK-LGEGGFGSVYWGQLWDGSQIAVKRLKV-WSNK 76
           GKK    RI ++     +  N     K LG G  G+V +   + G  +AVKR+ + + + 
Sbjct: 13  GKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI 72
Query: 77  AEMEFAVEVEILARVRHKNLLSLRGYCAEGQER-LIVYDYMPNXXXXXXXXXXXXXECLL 135
           A ME  +  E      H N++  R YC+E  +R L +   + N             +  L
Sbjct: 73  ALMEIKLLTE---SDDHPNVI--RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENL 127
Query: 136 NWNRR---MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-------------DFK 179
              +    + +    A G+ +LH   +  IIHRD+K  N+L+               + +
Sbjct: 128 KLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 184
Query: 180 AQVADFGFAKLIPDGATHVTTRVK---GTLGYLAPEY---AMLGKASESCDVYSFG-ILL 232
             ++DFG  K +  G       +    GT G+ APE    +   + + S D++S G +  
Sbjct: 185 ILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY 244
Query: 233 LELASGKKPI 242
             L+ GK P 
Sbjct: 245 YILSKGKHPF 254

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKG 204
           A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I   PD       R+  
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 257
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLE---LASGKKPIEKVNSAIKRTITDWALPLA 261
            L ++APE       +   DV+SFG+LL E   L +   P  K++    R +        
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 309
Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
             ++ + +  P    ++   E+ + +   L C H +P +RPT  E+++ L
Sbjct: 310 --KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           AT+ +    ++G G +G+VY  +    G  +A+K ++V + +  +  +   EV +L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 93  ---HKNLLSLRGYCAEGQ-----ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIA 144
              H N++ L   CA  +     +  +V++++                  L      D+ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIKDLM 118
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
                G+ +LH +    I+HRD+K  N+L+ +    ++ADFG A++           V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVVV 173
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS 247
           TL Y APE  +    +   D++S G +  E+   +KP+   NS
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 27/145 (18%)
Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL---------- 190
           + I I  AE + +LH      ++HRD+K SN+    D   +V DFG              
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 191 ---IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA-SGKKPIEKVN 246
              +P  ATH      GT  Y++PE       S   D++S G++L EL  S    +E+V 
Sbjct: 224 LTPMPAYATHXGQ--VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV- 280
Query: 247 SAIKRTITD---WALPLACERKFSE 268
               R ITD      PL   +K+ +
Sbjct: 281 ----RIITDVRNLKFPLLFTQKYPQ 301

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 119
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 117
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 169
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 119
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 171
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 117
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 169
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 120
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 172
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 119
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 171
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 118
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 170
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 117
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 169
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL---FQLLQGLA 120
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 172
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           K+G+G FG V+  +    G ++A+K++ + + K         E++IL  ++H+N+++L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 102 YC---AEGQER-----LIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            C   A    R      +V+D+  +               L    R M + +    G+ Y
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFT-LSEIKRVMQMLLN---GLYY 140
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLA 210
           +H +    I+HRD+KA+NVL+  D   ++ADFG A+           R      TL Y  
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 211 PEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNS 247
           PE  +LG+       D++  G ++ E+ + + PI + N+
Sbjct: 198 PEL-LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 120
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 172
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 121
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 173
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 119
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGYLAP 211
            H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y AP
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWYRAP 171
Query: 212 EYAMLGK-ASESCDVYSFGILLLELASGK 239
           E  +  K  S + D++S G +  E+ + +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           K+G+G FG V+  +    G ++A+K++ + + K         E++IL  ++H+N+++L  
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 102 YC---AEGQER-----LIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            C   A    R      +V+D+  +               L    R M + +    G+ Y
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQMLLN---GLYY 139
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLA 210
           +H +    I+HRD+KA+NVL+  D   ++ADFG A+           R      TL Y  
Sbjct: 140 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 211 PEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNS 247
           PE  +LG+       D++  G ++ E+ + + PI + N+
Sbjct: 197 PE-LLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 233

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 117
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 169
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 119
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 171
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVADFGFAKLIPDGATHVTTRVKGT 205
           EG+ YLH +   +I+H D+K  N+LL + +     ++ DFG ++ I  G       + GT
Sbjct: 142 EGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGT 196
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITDWALPL 260
             YLAPE       + + D+++ GI+   L +   P      ++    I +   D++   
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS--- 253
Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT 303
             E  FS ++  +L  +F++  L +            PEKRPT
Sbjct: 254 --EETFSSVS--QLATDFIQSLLVK-----------NPEKRPT 281

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           K+G+G FG V+  +    G ++A+K++ + + K         E++IL  ++H+N+++L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 102 YC---AEGQER-----LIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            C   A    R      +V+D+  +               L    R M + +    G+ Y
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT-LSEIKRVMQMLLN---GLYY 140
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLA 210
           +H +    I+HRD+KA+NVL+  D   ++ADFG A+           R      TL Y  
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 211 PEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNS 247
           PE  +LG+       D++  G ++ E+ + + PI + N+
Sbjct: 198 PEL-LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 119
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGYLAP 211
            H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y AP
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWYRAP 171
Query: 212 EYAMLGK-ASESCDVYSFGILLLELASGK 239
           E  +  K  S + D++S G +  E+ + +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           AT+ +    ++G G +G+VY  +    G  +A+K ++V + +  +  +   EV +L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 93  ---HKNLLSLRGYCAEGQ-----ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIA 144
              H N++ L   CA  +     +  +V++++                  L      D+ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIKDLM 118
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
                G+ +LH +    I+HRD+K  N+L+ +    ++ADFG A++           V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPVVV 173
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS 247
           TL Y APE  +    +   D++S G +  E+   +KP+   NS
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 237 SGK 239
             K
Sbjct: 220 RHK 222

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL---FQLLQGLA 120
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 172
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 114/279 (40%), Gaps = 30/279 (10%)
Query: 75  NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC 133
           +K++ + + E+EIL R  +H N+++L+    +G+   +V + M                 
Sbjct: 61  DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS- 119
Query: 134 LLNWNRRMDIAIGS-AEGIVYLHHHATPHIIHRDIKASNVL-LDADFKAQ---VADFGFA 188
                R     + +  + + YLH      ++HRD+K SN+L +D     +   + DFGFA
Sbjct: 120 ----EREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
           K +      + T    T  ++APE        E CD++S GILL  + +G  P     S 
Sbjct: 173 KQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231
Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
               I    L      KF+       N N V E  K +V   L   H  P +R T  +VL
Sbjct: 232 TPEEI----LTRIGSGKFTLSGG---NWNTVSETAKDLVSKML---HVDPHQRLTAKQVL 281
Query: 309 DLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSA 347
                  K+KL + +      SHQ      G   A  SA
Sbjct: 282 QHPWVTQKDKLPQSQ-----LSHQDLQLVKGAMAATYSA 315

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 118
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 170
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 120
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 172
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSLRGYCA------EGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++ L           E Q+  IV + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 237 SG 238
            G
Sbjct: 220 KG 221

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL---FQLLQGLA 119
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 171
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYL---FQLLQGLA 117
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 169
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 118
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 170
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 121
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGYLAP 211
            H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y AP
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWYRAP 173
Query: 212 EYAMLGK-ASESCDVYSFGILLLELASGK 239
           E  +  K  S + D++S G +  E+ + +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 84  EVEILARVR-HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           EV+IL +V  H N++ L+          +V+D M               +  L+      
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLM----KKGELFDYLTEKVTLSEKETRK 115
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           I     E I  LH     +I+HRD+K  N+LLD D   ++ DFGF+  +  G       V
Sbjct: 116 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 170
Query: 203 KGTLGYLAPEYAMLGK------ASESCDVYSFGILLLELASGKKPI 242
            GT  YLAPE              +  D++S G+++  L +G  P 
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH      IIHRD+K SN+++ +
Sbjct: 105 -------DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKS 154
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 155 DXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 237 SGK 239
             K
Sbjct: 213 RHK 215

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YLH   +  +I+RD+K  N+++D     +V DFG AK +       T  + GT  YLAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPE 208
Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPI 242
             +    +++ D ++ G+L+ E+A+G  P 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           AT+ +    ++G G +G+VY  +    G  +A+K ++V + +  +  +   EV +L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 93  ---HKNLLSLRGYCAEGQ-----ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIA 144
              H N++ L   CA  +     +  +V++++                  L      D+ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIKDLM 118
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
                G+ +LH +    I+HRD+K  N+L+ +    ++ADFG A++           V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALFPVVV 173
Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS 247
           TL Y APE  +    +   D++S G +  E+   +KP+   NS
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 215

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 84  EVEILARVR-HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           EV+IL +V  H N++ L+          +V+D M               +  L+      
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLM----KKGELFDYLTEKVTLSEKETRK 128
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           I     E I  LH     +I+HRD+K  N+LLD D   ++ DFGF+  +  G       V
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 183
Query: 203 KGTLGYLAPEYAMLGK------ASESCDVYSFGILLLELASGKKPI 242
            GT  YLAPE              +  D++S G+++  L +G  P 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLXQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 237 SGK 239
             K
Sbjct: 220 RHK 222

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 39/233 (16%)
Query: 38  NNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           + F  +   G+G FG+V  G +   G  +A+K++         E  + ++ LA + H N+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNI 81
Query: 97  LSLRGYCAEGQER-------LIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAE 149
           + L+ Y     ER        +V +Y+P+              C  N+ RR  +A     
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH----------RCCRNYYRR-QVAPPPIL 130
Query: 150 GIVYLH---------HHATPHIIHRDIKASNVLLD-ADFKAQVADFGFA-KLIPD--GAT 196
             V+L          H  + ++ HRDIK  NVL++ AD   ++ DFG A KL P      
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 197 HVTTRVKGTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPIEKVNSA 248
           ++ +R      Y APE     +  + + D++S G +  E+  G+      NSA
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 84  EVEILARVR-HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           EV+IL +V  H N++ L+          +V+D M               +  L+      
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLM----KKGELFDYLTEKVTLSEKETRK 128
Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
           I     E I  LH     +I+HRD+K  N+LLD D   ++ DFGF+  +  G       V
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSV 183
Query: 203 KGTLGYLAPEYAMLGK------ASESCDVYSFGILLLELASGKKPI 242
            GT  YLAPE              +  D++S G+++  L +G  P 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+ ++++ +    +      E+ +L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 120
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 11/205 (5%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+ ++++ +    +      E+ +L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++                 L      +       +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCH 119
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V  TL Y APE  +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 216 LGK-ASESCDVYSFGILLLELASGK 239
             K  S + D++S G +  E+ + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 193
Query: 210 APEYAMLGKASESCDVYSFGILLLELASG 238
           APE  +     E+ D++S G ++ E+  G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSLRGYCA------EGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++ L           E Q+  IV + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLSQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 237 SG 238
            G
Sbjct: 220 KG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 210 APEYAMLGKASESCDVYSFGILLLELASG 238
           APE  +     E+ D++S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 210 APEYAMLGKASESCDVYSFGILLLELASG 238
           APE  +     E+ D++S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 210 APEYAMLGKASESCDVYSFGILLLELASG 238
           APE  +     E+ D++S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVR 92
           +  NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           H N++ L        +  +V++++                 L      +       +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLA 120
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG----TLGY 208
           + H H    ++HRD+K  N+L++ +   ++ADFG A+     A  V  R       TL Y
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVVTLWY 172
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELASGK 239
            APE  +  K  S + D++S G +  E+ + +
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 210 APEYAMLGKASESCDVYSFGILLLELASG 238
           APE  +     E+ D++S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 53/105 (50%), Gaps = 14/105 (13%)
Query: 153 YLHHHATPHIIHRDIKASNVLLDAD--FKAQVADFGFAK---LIPDGATHVTTRVKGTLG 207
           YLH+     I HRDIK  N L   +  F+ ++ DFG +K    + +G  +  T   GT  
Sbjct: 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 208 YLAPEYAMLGKASES----CDVYSFGILLLELASGKKPIEKVNSA 248
           ++APE  +L   +ES    CD +S G+LL  L  G  P   VN A
Sbjct: 240 FVAPE--VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 237 SGK 239
             K
Sbjct: 220 RHK 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 23/226 (10%)
Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKA-----EMEFAVEVEILA 89
           AT+ +    ++G G +G+VY  +    G  +A+K ++V +         +    EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 90  RVR---HKNLLSLRGYCAEGQ-----ERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
           R+    H N++ L   CA  +     +  +V++++                  L      
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIK 123
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR 201
           D+      G+ +LH +    I+HRD+K  N+L+ +    ++ADFG A++         T 
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTP 178
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS 247
           V  TL Y APE  +    +   D++S G +  E+   +KP+   NS
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 223

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 62  GSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVY 113
           G  +AVK+L + + N+   + A  E+ +L  V HKN++SL      +    E Q+  +V 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 114 DYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL 173
           + M                  L+  R   +      GI +LH   +  IIHRD+K SN++
Sbjct: 107 ELMDANLCQVIHME-------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 156
Query: 174 LDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLL 233
           + +D   ++ DFG A+        + T    T  Y APE  +     E+ D++S G ++ 
Sbjct: 157 VKSDCTLKILDFGLARTA--STNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 214
Query: 234 ELASG 238
           EL  G
Sbjct: 215 ELVKG 219

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 45  KLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           K+GEG +G+V+  +  +  +I A+KR+++  +   +  +   E+ +L  ++HKN++ L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 102 YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSA------EGIVYLH 155
                ++  +V+++                 C    N  +D  I  +      +G+ + H
Sbjct: 69  VLHSDKKLTLVFEFC------DQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
                +++HRD+K  N+L++ + + ++A+FG A+         +  V  TL Y  P+   
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 216 LGKA-SESCDVYSFGILLLELASGKKPI---EKVNSAIKRTITDWALP 259
             K  S S D++S G +  ELA+  +P+     V+  +KR       P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           +GI YLH+     IIHRDIK SN+L+  D   ++ADFG +     G+  + +   GT  +
Sbjct: 148 KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSNTVGTPAF 203
Query: 209 LAPEYAMLGK---ASESCDVYSFGILLLELASGKKPI 242
           +APE     +   + ++ DV++ G+ L     G+ P 
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 44/100 (44%), Gaps = 9/100 (9%)
Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD+K  N+L+ AD  A + DFG A    D          GTL Y APE      A+   
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 224 DVYSFGILLLELASGKKPIE---------KVNSAIKRTIT 254
           D+Y+   +L E  +G  P +          +N AI R  T
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPST 256

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           ++HRD+K +NV LD     ++ DFG A+++          V GT  Y++PE       +E
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRMSYNE 195
Query: 222 SCDVYSFGILLLELASGKKPI 242
             D++S G LL EL +   P 
Sbjct: 196 KSDIWSLGCLLYELCALMPPF 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 103/250 (41%), Gaps = 44/250 (17%)
Query: 26  RIFSLKELHSATNNFNYDNK-LGEGGFGSVYWGQLWDGSQIAVKRLKV-WSNKAEMEFAV 83
           RI ++     +  N     K LG G  G+V +   + G  +AVKR+ + + + A ME  +
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM-- 141
             E      H N++  R YC+E  +R +   Y+               + + + N ++  
Sbjct: 62  LTE---SDDHPNVI--RYYCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 142 -----DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-------------DFKAQVA 183
                 +    A G+ +LH   +  IIHRD+K  N+L+               + +  ++
Sbjct: 114 EYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 184 DFGFAKLIPDGATHVTTRVK---GTLGYLAPE-------YAMLGKASESCDVYSFG-ILL 232
           DFG  K +  G +   T +    GT G+ APE            + + S D++S G +  
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 233 LELASGKKPI 242
             L+ GK P 
Sbjct: 231 YILSKGKHPF 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 150 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 199
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 200 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257
Query: 237 SGK 239
             K
Sbjct: 258 RHK 260

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH      IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRYYR 192
Query: 210 APEYAMLGKASESCDVYSFGILLLELASG 238
           APE  +     E+ D++S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 46  LGEGGFGSVYWGQLWDGS----QIAVKRLK---VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG VY G   +       +AVK  K      NK +  F  E  I+  + H +++ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FMSEAVIMKNLDHPHIVK 73
Query: 99  LRGYCAEGQERLI--VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           L G   E    +I  +Y Y                  L+ ++ ++  A+   E I     
Sbjct: 74  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI----- 128
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               + +HRDI   N+L+ +    ++ DFG ++ I D   +  +  +  + +++PE    
Sbjct: 129 ----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 217 GKASESCDVYSFGILLLELAS-GKKPI 242
            + + + DV+ F + + E+ S GK+P 
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 43/294 (14%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWGQLW--DGS--QIAVKRLK---VWSNKAEMEFA 82
           L+++      F     LG+G FGSV   QL   DGS  ++AVK LK   + S+  E EF 
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFL 73
Query: 83  VEVEILARVRHKNLLSLRGYCAEGQER------LIVYDYMPNXXXXXXXXXXXXXECLLN 136
            E   +    H ++  L G     + +      +++  +M +             E   N
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 137 WNRR--MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG 194
              +  +   +  A G+ YL   ++ + IHRD+ A N +L  D    VADFG ++ I  G
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 195 ATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRT 252
             +      K  + +LA E       +   DV++FG+ + E+ + G+ P   + +A    
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---- 246
Query: 253 ITDWALPLACERKFSELADPRLNGNFVE---EELKRVVLVALTCAHSKPEKRPT 303
                          E+ +  + GN ++   E ++ V  +   C  + P++RP+
Sbjct: 247 ---------------EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPS 285

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 150 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 199
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 200 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257
Query: 237 SGK 239
             K
Sbjct: 258 RHK 260

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 113 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 162
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 163 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220
Query: 237 SGK 239
             K
Sbjct: 221 RHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH      IIHRD+K SN+++ +
Sbjct: 106 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 155
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 156 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213
Query: 237 SGK 239
             K
Sbjct: 214 RHK 216

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 24/228 (10%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM------- 79
           I  +++L     ++     +G G FG V   +    S   V  +K+ S K EM       
Sbjct: 58  INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVR--HKSTRKVYAMKLLS-KFEMIKRSDSA 114
Query: 80  EFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR 139
            F  E +I+A      ++ L     + +   +V +YMP              E    W R
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWAR 171
Query: 140 RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHV 198
                  +AE ++ L    +   IHRD+K  N+LLD     ++ADFG   K+  +G    
Sbjct: 172 -----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 199 TTRVKGTLGYLAPEYAML----GKASESCDVYSFGILLLELASGKKPI 242
            T V GT  Y++PE        G     CD +S G+ L E+  G  P 
Sbjct: 227 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 237 SGK 239
             K
Sbjct: 220 RHK 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 24/228 (10%)
Query: 27  IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM------- 79
           I  +++L     ++     +G G FG V   +    S   V  +K+ S K EM       
Sbjct: 63  INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVR--HKSTRKVYAMKLLS-KFEMIKRSDSA 119
Query: 80  EFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNR 139
            F  E +I+A      ++ L     + +   +V +YMP              E    W R
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWAR 176
Query: 140 RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHV 198
                  +AE ++ L    +   IHRD+K  N+LLD     ++ADFG   K+  +G    
Sbjct: 177 -----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 231
Query: 199 TTRVKGTLGYLAPEYAML----GKASESCDVYSFGILLLELASGKKPI 242
            T V GT  Y++PE        G     CD +S G+ L E+  G  P 
Sbjct: 232 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGT 205
           +AE ++ L    +   IHRD+K  N+LLD     ++ADFG   K+  +G     T V GT
Sbjct: 179 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 206 LGYLAPEYAML----GKASESCDVYSFGILLLELASGKKPI 242
             Y++PE        G     CD +S G+ L E+  G  P 
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 112 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 162 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 237 SGK 239
             K
Sbjct: 220 RHK 222

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 46  LGEGGFGSVYWGQLWDGS----QIAVKRLK---VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG VY G   +       +AVK  K      NK +  F  E  I+  + H +++ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FMSEAVIMKNLDHPHIVK 77
Query: 99  LRGYCAEGQERLI--VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           L G   E    +I  +Y Y                  L+ ++ ++  A+   E I     
Sbjct: 78  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI----- 132
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               + +HRDI   N+L+ +    ++ DFG ++ I D   +  +  +  + +++PE    
Sbjct: 133 ----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 217 GKASESCDVYSFGILLLELAS-GKKPI 242
            + + + DV+ F + + E+ S GK+P 
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 18/230 (7%)
Query: 26  RIFSLKELHSATNNFNYDNK---LGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEMEF 81
           RI + K+   A N+F   +K   LG G FG V+   +   G ++A K +K    K + E 
Sbjct: 76  RIVTAKQ--GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV 133
Query: 82  AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
             E+ ++ ++ H NL+ L        + ++V +Y+                  L+    M
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFM 193
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVL-LDADFKA-QVADFGFAKLI-PDGATHV 198
                  EGI ++H     +I+H D+K  N+L ++ D K  ++ DFG A+   P     V
Sbjct: 194 KQI---CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
                GT  +LAPE       S   D++S G++   L SG  P    N A
Sbjct: 248 NF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 113 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 162
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 163 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220
Query: 237 SGK 239
             K
Sbjct: 221 RHK 223

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 46  LGEGGFGSVYWGQLWDGS----QIAVKRLK---VWSNKAEMEFAVEVEILARVRHKNLLS 98
           LGEG FG VY G   +       +AVK  K      NK +  F  E  I+  + H +++ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FMSEAVIMKNLDHPHIVK 89
Query: 99  LRGYCAEGQERLI--VYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           L G   E    +I  +Y Y                  L+ ++ ++  A+   E I     
Sbjct: 90  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI----- 144
Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               + +HRDI   N+L+ +    ++ DFG ++ I D   +  +  +  + +++PE    
Sbjct: 145 ----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 217 GKASESCDVYSFGILLLELAS-GKKPI 242
            + + + DV+ F + + E+ S GK+P 
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH      IIHRD+K SN+++ +
Sbjct: 105 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 154
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 155 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 237 SGK 239
             K
Sbjct: 213 RHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 110
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH      IIHRD+K SN+++ +
Sbjct: 111 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 160
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 161 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218
Query: 237 SGK 239
             K
Sbjct: 219 RHK 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 65  IAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVYDYM 116
           +A+K+L + + N+   + A  E+ ++  V HKN++SL      +    E Q+  +V + M
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 117 PNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA 176
                          +  L+  R   +      GI +LH   +  IIHRD+K SN+++ +
Sbjct: 106 -------DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 155
Query: 177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELA 236
           D   ++ DFG A+    G + + T    T  Y APE  +     E+ D++S G ++ E+ 
Sbjct: 156 DCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213
Query: 237 SGK 239
             K
Sbjct: 214 RHK 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 29/239 (12%)
Query: 37  TNNFNYDNKLGEGGFGSVYWGQLWDGSQ--IAVKRLKVWSNKAEMEFAVEVEILARVRHK 94
           ++ F  +++LG G    VY  +   G+Q   A+K LK   +K  +    E+ +L R+ H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHP 108
Query: 95  NLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR--MDIAIGSAEGIV 152
           N++ L+       E  +V + +                    ++ R   D      E + 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEAVA 162
Query: 153 YLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           YLH +    I+HRD+K  N+L      D   ++ADFG +K++       T  V GT GY 
Sbjct: 163 YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYC 217
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLACERKF 266
           APE           D++S GI+   L  G +P   E+ +  + R I      L CE  F
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI------LNCEYYF 270

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD  + V     GT+ 
Sbjct: 166 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 221
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 275
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 276 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 26/235 (11%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFA 82
           +KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           +EV +L +V         G+   G  RL+ +   P+             +       R  
Sbjct: 61  MEVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 111
Query: 143 IAIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGAT 196
           +    A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D   
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 197 HVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
            V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 170 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH      IIHRD+K SN+++ +D   ++ DFG A+    G + +      T  Y 
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVVTRYYR 194
Query: 210 APEYAMLGKASESCDVYSFGILLLELASG 238
           APE  +     E+ D++S G ++ E+  G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 26/235 (11%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFA 82
           +KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           +EV +L +V         G+   G  RL+ +   P+             +       R  
Sbjct: 61  MEVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 111
Query: 143 IAIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGAT 196
           +    A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D   
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 197 HVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
            V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 170 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD  + V     GT+ 
Sbjct: 166 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 221
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 275
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 276 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTRVKGTLG--YLAP 211
           H H+   +IHRD+K SNVL++A  + +  DFG +  L+ D A  +    K       + P
Sbjct: 151 HLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINP 210
Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
           E    G + +S D++S GI  +ELA  + P +            W  P    ++  E   
Sbjct: 211 ELNQKGYSVKS-DIWSLGITXIELAILRFPYDS-----------WGTPFQQLKQVVEEPS 258
Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEV 307
           P+L  +    E    V     C     ++RPT  E+
Sbjct: 259 PQLPADKFSAEF---VDFTSQCLKKNSKERPTYPEL 291

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD  + V     GT+ 
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 247
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 248 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 186
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGK 239
           APE  +     E+ D++S G ++ E+   K
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 26/238 (10%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFA 82
           +KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           +EV +L +V         G+   G  RL+ +   P+             +       R  
Sbjct: 61  MEVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 111
Query: 143 IAIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGAT 196
           +    A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D   
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 197 HVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
            V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+  +
Sbjct: 170 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + + T    T  Y 
Sbjct: 143 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 197
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGK 239
           APE  +     E+ D++S G ++ E+   K
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD  + V     GT+ 
Sbjct: 122 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 177
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 231
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 232 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD  + V     GT+ 
Sbjct: 119 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------- 227
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 228 -------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 189 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           ++++   +LG G FG V+   +   G+  A K +       +     E++ ++ +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           ++L     +  E +++Y++M                  ++ +  ++      +G+ ++H 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHE 167
Query: 157 HATPHIIHRDIKASNVLLDA--DFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEY 213
           +   + +H D+K  N++       + ++ DFG  A L P  +  VTT   GT  + APE 
Sbjct: 168 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 221
Query: 214 AMLGKASESCDVYSFGILLLELASGKKPI 242
           A         D++S G+L   L SG  P 
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD  + V     GT+ 
Sbjct: 118 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 173
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 227
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 228 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 218
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 194 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 194 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 62  GSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSL------RGYCAEGQERLIVY 113
           G  +AVK+L + + N+   + A  E+ +L  V HKN++SL      +    E Q+  +V 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 114 DYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL 173
           + M                  L+  R   +      GI +LH   +  IIHRD+K SN++
Sbjct: 109 ELMDANLCQVIHME-------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 158
Query: 174 LDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLL 233
           + +D   ++ DFG A+        + T    T  Y APE  +    + + D++S G ++ 
Sbjct: 159 VKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMG 216
Query: 234 ELASG 238
           EL  G
Sbjct: 217 ELVKG 221

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 26/235 (11%)
Query: 30  LKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFA 82
           +KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 83  VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMD 142
           +EV +L +V         G+   G  RL+ +   P+             +       R  
Sbjct: 83  MEVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 133
Query: 143 IAIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGAT 196
           +    A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D   
Sbjct: 134 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 191
Query: 197 HVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
            V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 192 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 245

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 36/225 (16%)
Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFA-VEVEILARV-RHKNL 96
           +F   + LG G  G++ +  ++D   +AVKR+          FA  EV++L     H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNV 80
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWN-RRMDIAIGSAEGIVYLH 155
           +  R +C E   +   + Y+               +   +     + +   +  G+ +LH
Sbjct: 81  I--RYFCTEKDRQ---FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 156 HHATPHIIHRDIKASNVLLD-----ADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGY 208
              + +I+HRD+K  N+L+         KA ++DFG  K +  G    + R  V GT G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 209 LAPEYAMLGKASESC--------DVYSFGILLLELAS-GKKPIEK 244
           +APE  ML   SE C        D++S G +   + S G  P  K
Sbjct: 193 IAPE--ML---SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 26/234 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 61  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGAL 111
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 112 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 168
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 224
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 225 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 196 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 179
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 178
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 40/244 (16%)
Query: 37  TNNFNYDNKLGEGGFGSV------YWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR 90
           ++N++   +LG+G F  V        G  +    I  K+L   S +   +   E  I  +
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRK 60
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMP------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           ++H N++ L     E     +V+D +       +              C+          
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------- 112
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDG-ATHVTT 200
               E I Y H +    I+HR++K  N+LL +  K    ++ADFG A  + D  A H   
Sbjct: 113 --ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 164
Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITD 255
              GT GYL+PE       S+  D+++ G++L  L  G  P       ++ + IK    D
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 224
Query: 256 WALP 259
           +  P
Sbjct: 225 YPSP 228

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 26/234 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 61  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 111
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 112 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 168
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 180
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 173 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 189 RAPE-IMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 40/244 (16%)
Query: 37  TNNFNYDNKLGEGGFGSV------YWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR 90
           ++N++   +LG+G F  V        G  +    I  K+L   S +   +   E  I  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRK 61
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMP------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           ++H N++ L     E     +V+D +       +              C+          
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------- 113
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDG-ATHVTT 200
               E I Y H +    I+HR++K  N+LL +  K    ++ADFG A  + D  A H   
Sbjct: 114 --ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165
Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITD 255
              GT GYL+PE       S+  D+++ G++L  L  G  P       ++ + IK    D
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225
Query: 256 WALP 259
           +  P
Sbjct: 226 YPSP 229

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 40/244 (16%)
Query: 37  TNNFNYDNKLGEGGFGSV------YWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR 90
           ++N++   +LG+G F  V        G  +    I  K+L   S +   +   E  I  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRK 61
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMP------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           ++H N++ L     E     +V+D +       +              C+          
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------- 113
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDG-ATHVTT 200
               E I Y H +    I+HR++K  N+LL +  K    ++ADFG A  + D  A H   
Sbjct: 114 --ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165
Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITD 255
              GT GYL+PE       S+  D+++ G++L  L  G  P       ++ + IK    D
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225
Query: 256 WALP 259
           +  P
Sbjct: 226 YPSP 229

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 40/244 (16%)
Query: 37  TNNFNYDNKLGEGGFGSV------YWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR 90
           ++N++   +LG+G F  V        G  +    I  K+L   S +   +   E  I  +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRK 84
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMP------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           ++H N++ L     E     +V+D +       +              C+          
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI------- 137
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDG-ATHVTT 200
               E I Y H +    I+HR++K  N+LL +  K    ++ADFG A  + D  A H   
Sbjct: 138 ---LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 188
Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITD 255
              GT GYL+PE       S+  D+++ G++L  L  G  P       ++ + IK    D
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248
Query: 256 WALP 259
           +  P
Sbjct: 249 YPSP 252

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 189 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 173
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 194 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 136 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 187
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 188 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 195
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 196 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 26/234 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 76  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 126
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 127 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 183
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 237

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 38  NNFNYDNKLGEGGFGSVYW-GQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           ++++   +LG G FG V+   +   G+  A K +       +     E++ ++ +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHH 156
           ++L     +  E +++Y++M                  ++ +  ++      +G+ ++H 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHE 273
Query: 157 HATPHIIHRDIKASNVLLDA--DFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEY 213
           +   + +H D+K  N++       + ++ DFG  A L P  +  VTT   GT  + APE 
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 327
Query: 214 AMLGKASESCDVYSFGILLLELASGKKPI 242
           A         D++S G+L   L SG  P 
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 79  MEFAV------------EVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXX 125
           MEFAV            E+EIL R  +H N+++L+    +G+   +V + M         
Sbjct: 48  MEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI 107
Query: 126 XXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF----KAQ 181
                 +   +      +     + + YLH      ++HRD+K SN+L   +       +
Sbjct: 108 LR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR 160
Query: 182 VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
           + DFGFAK +      + T    T  ++APE         +CD++S G+LL  + +G  P
Sbjct: 161 ICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
Query: 242 I 242
Sbjct: 220 F 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 77  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 127
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 128 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+  +
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 77  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 127
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 128 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+  +
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 195 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 147 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 26/234 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 76  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 126
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 127 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 183
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 191 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 77  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 127
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 128 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+  +
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 26/234 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 89  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 139
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 140 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 250

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 195 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 211
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVT-TRVK 203
            E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H + T   
Sbjct: 141 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPC 194
Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            T  Y+APE     K  +SCD++S G+++  L  G  P 
Sbjct: 195 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 26/234 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 104 EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 154
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 155 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 211
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 265

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 55/119 (46%), Gaps = 12/119 (10%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTRVKGT 205
           E + ++H H    I+HRD+K  N+LL +  K    ++ADFG A  +  G         GT
Sbjct: 141 ESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGEQQAWFGFAGT 196
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITDWALP 259
            GYL+PE        +  D+++ G++L  L  G  P       K+   IK    D+  P
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSP 255

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 195 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 104 EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 154
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 155 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 211
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+  +
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 268

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 36/170 (21%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--------------PDG 194
           E + Y+H      IIHRD+K  N+ +D     ++ DFG AK +              P  
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 195 ATHVTTRVKGTLGYLAPEYA-MLGKASESCDVYSFGILLLELA-SGKKPIEKVNSAIKRT 252
           + ++T+ + GT  Y+A E     G  +E  D+YS GI+  E+       +E+VN   K  
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLR 242
Query: 253 ITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP 302
                 P            P  + N ++ E K   ++ L   H  P KRP
Sbjct: 243 SVSIEFP------------PDFDDNKMKVEKK---IIRLLIDHD-PNKRP 276

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 36/170 (21%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--------------PDG 194
           E + Y+H      IIHRD+K  N+ +D     ++ DFG AK +              P  
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 195 ATHVTTRVKGTLGYLAPEYA-MLGKASESCDVYSFGILLLELA-SGKKPIEKVNSAIKRT 252
           + ++T+ + GT  Y+A E     G  +E  D+YS GI+  E+       +E+VN   K  
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLR 242
Query: 253 ITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP 302
                 P            P  + N ++ E K   ++ L   H  P KRP
Sbjct: 243 SVSIEFP------------PDFDDNKMKVEKK---IIRLLIDHD-PNKRP 276

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 19/215 (8%)
Query: 35  SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH 93
           S  + ++   +LG G FG V+   +   G     K +       +     E+ I+ ++ H
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC---LLNWNRRMDIAIGSAEG 150
             L++L     +  E +++ +++                    ++N+ R+      + EG
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ACEG 161
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDAD--FKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           + ++H H+   I+H DIK  N++ +       ++ DFG A KL PD    VTT    T  
Sbjct: 162 LKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAE 215
Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + APE           D+++ G+L   L SG  P 
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 96  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 146
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 147 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 203
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+  +
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 260

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD    V     GT+ 
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVN 193
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 247
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 248 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SNV ++ D + ++ DFG A+   +  T +V TR      Y
Sbjct: 135 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WY 186
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL  GK
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 135 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 186
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 90  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 140
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 141 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SNV ++ D + ++ DFG A+   +  T +V TR      Y
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL  GK
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SNV ++ D + ++ DFG A+   +  T +V TR      Y
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL  GK
Sbjct: 195 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 89  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 139
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 140 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 90  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 140
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 141 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 89  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 139
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 140 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 26/234 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 109 EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 159
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 160 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 216
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E     I+
Sbjct: 217 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 270

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 90  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 140
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 141 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 89  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 139
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 140 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAV 83
           KE     + +     LG GGFGSVY G ++ D   +A+K     R+  W          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           EV +L +V         G+   G  RL+ +   P+             +       R  +
Sbjct: 90  EVVLLKKVS-------SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 140
Query: 144 AIGSAEGIVYLHHHATPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATH 197
               A    +    A  H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    
Sbjct: 141 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 198 VTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           V T   GT  Y  PE+    +    S  V+S GILL ++  G  P E
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 101/236 (42%), Gaps = 36/236 (15%)
Query: 37  TNNFNYDNKLGEGGFGSVYWGQL--WDGSQIAVKRLK-------VWSNKAEM-EFAVEVE 86
           +  ++  + LG G FG V W  +      ++ VK +K        W    ++ +  +E+ 
Sbjct: 23  SQKYSTMSPLGSGAFGFV-WTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 87  ILARVRHKNLLS-LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAI 145
           IL+RV H N++  L  +  +G  +L++  +                   ++ + R+D  +
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF----------AFIDRHPRLDEPL 131
Query: 146 GS------AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT 199
            S         + YL       IIHRDIK  N+++  DF  ++ DFG A  +  G    T
Sbjct: 132 ASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 200 TRVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI 253
               GT+ Y APE  ++G        +++S G+ L  L   + P  ++   ++  I
Sbjct: 189 --FCGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAVEVEILARVRHKNLLS 98
           LG GGFGSVY G ++ D   +A+K     R+  W          +EV +L +V       
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS------ 68
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             G+   G  RL+ +   P+             +       R  +    A    +    A
Sbjct: 69  -SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 125
Query: 159 TPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
             H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    V T   GT  Y  PE
Sbjct: 126 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 182
Query: 213 YAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           +    +    S  V+S GILL ++  G  P E     I+
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 221

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 48/245 (19%)
Query: 37  TNNFNYDNKLGEGGFGSVYW--GQLWDGSQ--IAVKRLKVWSNKAEMEFAVEVEILARVR 92
           +N F  ++K+GEG F SVY    QL  G +  IA+K L   S+   +  A E++ L    
Sbjct: 20  SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAG 77
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
            ++ +    YC    + +++   MP                 L++    +  +   + + 
Sbjct: 78  GQDNVMGVKYCFRKNDHVVI--AMPYLEHESFLDILNS----LSFQEVREYMLNLFKALK 131
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPDGATHVTTRVK-------- 203
            +H      I+HRD+K SN L +   K   + DFG A+   D    +   V+        
Sbjct: 132 RIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERC 188
Query: 204 -------------------GTLGYLAPEYAMLGKA---SESCDVYSFGILLLELASGKKP 241
                              GT G+ APE  +L K    + + D++S G++ L L SG+ P
Sbjct: 189 SQNKCSICLSRRQQVAPRAGTPGFRAPE--VLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246
Query: 242 IEKVN 246
             K +
Sbjct: 247 FYKAS 251

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 50/226 (22%)
Query: 84  EVEILARVRHKNLLSLRG--YCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
           E+++L R+RHKN++ L    Y  E Q+  +V +Y                 C+      +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-----------------CVCGMQEML 98
Query: 142 D------IAIGSA--------EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
           D        +  A        +G+ YLH      I+H+DIK  N+LL      +++  G 
Sbjct: 99  DSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV 155
Query: 188 AKLIPDGATHVTTRV-KGTLGYLAPEYA--MLGKASESCDVYSFGILLLELASGKKPIEK 244
           A+ +   A   T R  +G+  +  PE A  +   +    D++S G+ L  + +G  P E 
Sbjct: 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
Query: 245 VNSAIKRTITD-----WALPLACERKFSELADPRLNGNFVEEELKR 285
            N  I +   +     +A+P  C    S+L    L G    E  KR
Sbjct: 216 DN--IYKLFENIGKGSYAIPGDCGPPLSDL----LKGMLEYEPAKR 255

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAVEVEILARVRHKNLLS 98
           LG GGFGSVY G ++ D   +A+K     R+  W          +EV +L +V       
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS------ 65
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             G+   G  RL+ +   P+             +       R  +    A    +    A
Sbjct: 66  -SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 159 TPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
             H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    V T   GT  Y  PE
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 179
Query: 213 YAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           +    +    S  V+S GILL ++  G  P E     I+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 44/223 (19%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAVEVEILARVR----HK 94
           LG+GGFG+V+ G +L D  Q+A+K     R+  WS  ++ +   +EV +L +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 95  NLLSLRGYCAEGQERLIV-----------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
            ++ L  +  E QE  ++           +DY+                C          
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFG------- 146
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK-AQVADFGFAKLIPDGATHVTTRV 202
                + +  + H  +  ++HRDIK  N+L+D     A++ DFG   L+ D      T  
Sbjct: 147 -----QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDF 198
Query: 203 KGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEK 244
            GT  Y  PE+    +  +    V+S GILL ++  G  P E+
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 20/217 (9%)
Query: 35  SATNNFNYDNKLGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEIL 88
           S T+ +    +LG+G F  V        GQ +    I  K+L   S +   +   E  I 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL---SARDHQKLEREARIC 57
Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSA 148
             ++H N++ L    +E     +V+D +                    +    D +    
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQ 110
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTRVKGT 205
           + +  ++H     I+HRD+K  N+LL +  K    ++ADFG A  +  G         GT
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQQAWFGFAGT 169
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GYL+PE        +  D+++ G++L  L  G  P 
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T +V TR      Y
Sbjct: 166 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 217
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     + + D++S G ++ EL +G+
Sbjct: 218 RAPE-IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ D+G A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 189 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 30/172 (17%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLG 207
           E +  +H H    I+H D+K +N L+  D   ++ DFG A ++ PD  + V     G + 
Sbjct: 166 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 208 YLAPEYAMLGKASE-----------SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
           Y+ PE      +S              DV+S G +L  +  GK P +++ + I       
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 275
Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                   K   + DP     F +   K +  V   C    P++R ++ E+L
Sbjct: 276 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 20/217 (9%)
Query: 35  SATNNFNYDNKLGEGGFGSVY------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEIL 88
           S T+ +    +LG+G F  V        GQ +    I  K+L   S +   +   E  I 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL---SARDHQKLEREARIC 57
Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSA 148
             ++H N++ L    +E     +V+D +                    +    D +    
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQ 110
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTRVKGT 205
           + +  ++H     I+HRD+K  N+LL +  K    ++ADFG A  +  G         GT
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQQAWFGFAGT 169
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            GYL+PE        +  D+++ G++L  L  G  P 
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAVEVEILARVRHKNLLS 98
           LG GGFGSVY G ++ D   +A+K     R+  W          +EV +L +V       
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS------ 65
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             G+   G  RL+ +   P+             +       R  +    A    +    A
Sbjct: 66  -SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 159 TPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
             H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    V T   GT  Y  PE
Sbjct: 123 VRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 179
Query: 213 YAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           +    +    S  V+S GILL ++  G  P E     I+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 101/250 (40%), Gaps = 44/250 (17%)
Query: 26  RIFSLKELHSATNNFNYDNK-LGEGGFGSVYWGQLWDGSQIAVKRLKV-WSNKAEMEFAV 83
           RI ++     +  N     K LG G  G+V +   + G  +AVKR+ + + + A ME  +
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61
Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRM-- 141
             E      H N++  R YC+E  +R +   Y+               + + + N ++  
Sbjct: 62  LTE---SDDHPNVI--RYYCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 142 -----DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-------------DFKAQVA 183
                 +    A G+ +LH   +  IIHRD+K  N+L+               + +  ++
Sbjct: 114 EYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 184 DFGFAKLIPDGATHVTTRVK---GTLGYLAPE-------YAMLGKASESCDVYSFG-ILL 232
           DFG  K +  G       +    GT G+ APE            + + S D++S G +  
Sbjct: 171 DFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 233 LELASGKKPI 242
             L+ GK P 
Sbjct: 231 YILSKGKHPF 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  T  V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + +      T  Y 
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYR 192
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGK 239
           APE  +     E+ D++S G ++ E+   K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 10/105 (9%)
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHV 198
           +I     E I YLH   + +I HRD+K  N+L  +   +   ++ DFGFAK   +  +H 
Sbjct: 165 EIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 218
Query: 199 T-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           + T    T  Y+APE     K  +SCD +S G++   L  G  P 
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG  +   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLK-----VWSNKAEMEFAVEVEILARVRHKNLLSL 99
           +G G +G V   +    G Q+A+K++      V + K  +    E++IL   +H N++++
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR---ELKILKHFKHDNIIAI 118
Query: 100 RGYC------AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
           +          E +   +V D M +                L              G+ Y
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP-----LTLEHVRYFLYQLLRGLKY 173
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKGTLGYLA 210
           +H   +  +IHRD+K SN+L++ + + ++ DFG A+ +   P    +  T    T  Y A
Sbjct: 174 MH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 211 PEYAM-LGKASESCDVYSFGILLLELASGKK 240
           PE  + L + +++ D++S G +  E+ + ++
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 26/212 (12%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAE-MEFAVEVEILARVRHKNLLS 98
           LG GGFGSVY G ++ D   +A+K     R+  W          +EV +L +V       
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS------ 65
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             G+   G  RL+ +   P+             +       R  +    A    +    A
Sbjct: 66  -SGF--SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 159 TPH-----IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
             H     ++HRDIK  N+L+D +  + ++ DFG   L+ D    V T   GT  Y  PE
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 179
Query: 213 YAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
           +    +    S  V+S GILL ++  G  P E
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  A  V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  A  V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 94/242 (38%), Gaps = 31/242 (12%)
Query: 35  SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL--KVWSNKAEMEFAVEVEILARV 91
           S T+ +     +G+G F  V    +L  G + A K +  K  S +   +   E  I   +
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMP------NXXXXXXXXXXXXXECLLNWNRRMDIAI 145
           +H N++ L    +E     +V+D +       +              C+           
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQ--------- 111
Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTRV 202
              E +++ H      ++HRD+K  N+LL +  K    ++ADFG A  +  G        
Sbjct: 112 -ILEAVLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGDQQAWFGF 166
Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI-----EKVNSAIKRTITDWA 257
            GT GYL+PE        +  D+++ G++L  L  G  P       K+   IK    D+ 
Sbjct: 167 AGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFP 226
Query: 258 LP 259
            P
Sbjct: 227 SP 228

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D    +V TR      Y
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WY 211
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 212 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 46  LGEGGFGSVYWGQL-WDGSQIAVKRLK-----VWSNKAEMEFAVEVEILARVRHKNLLS- 98
           +G G +G V   +    G Q+A+K++      V + K  +    E++IL   +H N+++ 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR---ELKILKHFKHDNIIAI 119
Query: 99  ---LRGYCAEGQER--LIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
              LR     G+ +   +V D M +                L              G+ Y
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP-----LTLEHVRYFLYQLLRGLKY 174
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI---PDGATHVTTRVKGTLGYLA 210
           +H   +  +IHRD+K SN+L++ + + ++ DFG A+ +   P    +  T    T  Y A
Sbjct: 175 MH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 211 PEYAM-LGKASESCDVYSFGILLLELASGKK 240
           PE  + L + +++ D++S G +  E+ + ++
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 162 IIHRDIKASNVLLDADF-KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA- 219
           ++HRDIK  N+L+D +  + ++ DFG   L+ D    V T   GT  Y  PE+    +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 234
Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIK 250
             S  V+S GILL ++  G  P E     I+
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 265

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+   D  A  V TR      Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+    G + +      T  Y 
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYR 192
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGK 239
           APE  +     E+ D++S G ++ E+   K
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 32/213 (15%)
Query: 45  KLGEGGFG------SVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +LG+G F        V  GQ +    I  K+L   S +   +   E  I   ++H N++ 
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL---SARDHQKLEREARICRLLKHPNIVR 85
Query: 99  LRGYCAEGQERLIVYDYMP------NXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           L    +E     +++D +       +              C+              E ++
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ----------ILEAVL 135
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           + H      ++HRD+K  N+LL +  K    ++ADFG A  + +G         GT GYL
Sbjct: 136 HCHQMG---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTPGYL 191
Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           +PE        +  D+++ G++L  L  G  P 
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 41/220 (18%)
Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG+G FG V   +   D    A+K+++    K     + EV +LA + H+ ++  R Y A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVXLLASLNHQYVV--RYYAA 70
Query: 105 EGQERLIVYDYMPNXXXXXXXXXXXXXE-C-------LL---NWNRRMD----IAIGSAE 149
             + R  V    P              E C       L+   N N++ D    +     E
Sbjct: 71  WLERRNFV---KPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--------------PDGA 195
            + Y+H      IIHR++K  N+ +D     ++ DFG AK +              P  +
Sbjct: 128 ALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 196 THVTTRVKGTLGYLAPEYA-MLGKASESCDVYSFGILLLE 234
            ++T+ + GT  Y+A E     G  +E  D YS GI+  E
Sbjct: 185 DNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 19/223 (8%)
Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           ++ +  KLGEGGF  V   + L DG   A+KR+     +   E   E ++     H N+L
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 98  SLRGYC----AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVY 153
            L  YC        E  ++  +                   L  ++ + + +G   G+  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGF---AKLIPDGATHVTT-----RVKGT 205
           +H        HRD+K +N+LL  + +  + D G    A +  +G+    T       + T
Sbjct: 150 IHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 206 LGYLAPEYAMLGK---ASESCDVYSFGILLLELASGKKPIEKV 245
           + Y APE   +       E  DV+S G +L  +  G+ P + V
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 37  TNNFNYDNKLGEGGFG------SVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR 90
           T  +    +LG+G F        V  GQ +    I  K+L   S +   +   E  I   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRL 66
Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMP------NXXXXXXXXXXXXXECLLNWNRRMDIA 144
           ++H N++ L    +E     +++D +       +              C+          
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ-------- 118
Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA---QVADFGFAKLIPDGATHVTTR 201
               E +++ H      ++HR++K  N+LL +  K    ++ADFG A  + +G       
Sbjct: 119 --ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFG 172
Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
             GT GYL+PE        +  D+++ G++L  L  G  P 
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++  FG A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 14/94 (14%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG-- 207
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+       H    + G +   
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATR 206
Query: 208 -YLAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            Y APE  +     +++ D++S G ++ EL +G+
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DF  A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 189 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ D G A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 12/93 (12%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ D G A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  ML     +++ D++S G ++ EL +G+
Sbjct: 189 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK-N 95
           N +    K+G G FG +Y G  +  G ++A+K   V +   ++   +E +I   ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH--IESKIYKMMQGGVG 66
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR-------MDIAIGSA 148
           + ++R   AEG   ++V + +               E L N+  R       + +A    
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-----------GPSLEDLFNFCSRKFSLKTVLLLADQMI 115
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ---VADFGFAKLIPDGAT--HVTTR-- 201
             I Y+H   + + IHRD+K  N L+    K     + DFG AK   D  T  H+  R  
Sbjct: 116 SRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 202 --VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
             + GT  Y +    +  + S   D+ S G +L+    G  P + + +A KR
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK-N 95
           N +    K+G G FG +Y G  +  G ++A+K   V +   ++   +E +I   ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH--IESKIYKMMQGGVG 64
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR-------MDIAIGSA 148
           + ++R   AEG   ++V + +               E L N+  R       + +A    
Sbjct: 65  IPTIRWCGAEGDYNVMVMELL-----------GPSLEDLFNFCSRKFSLKTVLLLADQMI 113
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ---VADFGFAKLIPDGAT--HVTTR-- 201
             I Y+H   + + IHRD+K  N L+    K     + DFG AK   D  T  H+  R  
Sbjct: 114 SRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 202 --VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
             + GT  Y +    +  + S   D+ S G +L+    G  P + + +A KR
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 38  NNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           N F    K+G G FG +Y G  +    ++A+K   V +   ++ +  ++  + +     +
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG-GTGI 65
Query: 97  LSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR---MDIAIGSAEGIV- 152
            ++R +  EG   ++V D +               E L N+  R   +   +  A+ ++ 
Sbjct: 66  PNVRWFGVEGDYNVLVMDLL-----------GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
Query: 153 ---YLHHHATPHIIHRDIKASNVLLDADFKAQ---VADFGFAKLIPDGAT--HVTTR--- 201
              ++H  +    +HRDIK  N L+    +A    + DFG AK   D +T  H+  R   
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 202 -VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
            + GT  Y +    +  + S   D+ S G +L+    G  P + + +  K+
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H   +  IIHRD+K SN+ ++ D + ++ D G A+   D  T +V TR      Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WY 188
Query: 209 LAPEYAM-LGKASESCDVYSFGILLLELASGK 239
            APE  +     +++ D++S G ++ EL +G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 40  FNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEM------EFAVEVEILARVR 92
           ++   +LG G F  V    +   G + A K +K   ++A        E   EV IL +V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 93  HKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           H N+++L        + +++         +D++               + +L+       
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------- 126
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADFKA---QVADFGFAKLIPDGATHVT 199
                 G+ YLH   T  I H D+K  N+ LLD +      ++ DFG A  I DG     
Sbjct: 127 ------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
             + GT  ++APE           D++S G++   L SG  P 
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 19/218 (8%)
Query: 40  FNYDN-KLGEGGFGSVYWGQLWDGSQIAVKRLK-VWSNKAEMEFAVEVEILARVRHKNLL 97
           F Y+  K+G G +G VY  +  DG       LK +      M    E+ +L  ++H N++
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVI 81
Query: 98  SLRGYCAEGQER--LIVYDY----MPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           SL+       +R   +++DY    + +                L       +     +GI
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 152 VYLHHHATPHIIHRDIKASNVLLDAD----FKAQVADFGFAKLI--PDGATHVTTRVKGT 205
            YLH +    ++HRD+K +N+L+  +     + ++AD GFA+L   P         V  T
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 206 LGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPI 242
             Y APE  +  +  +++ D+++ G +  EL +  +PI
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRL------KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +G G +G+V        G+++A+K+L      ++++ +A  E    + +L  +RH+N++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMRHENVIG 88
Query: 99  LRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L       +      D+                   L  +R   +     +G+ Y+H   
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEYAM-L 216
              IIHRD+K  N+ ++ D + ++ DFG A+    +    V TR      Y APE  +  
Sbjct: 149 ---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNW 200
Query: 217 GKASESCDVYSFGILLLELASGK 239
            + +++ D++S G ++ E+ +GK
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 75/173 (43%), Gaps = 13/173 (7%)
Query: 75  NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXEC 133
           +K++ +   E+EIL R  +H N+++L+    +G+   +V +                 + 
Sbjct: 56  DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILR----QK 111
Query: 134 LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF----KAQVADFGFAK 189
             +      +     + + YLH      ++HRD+K SN+L   +       ++ DFGFAK
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
            +      + T    T  ++APE         +CD++S G+LL    +G  P 
Sbjct: 169 QLRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGT 205
           E + Y H +   +IIHRD+K  NVLL   +     ++ DFG A  + +       RV GT
Sbjct: 141 EALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GT 196
Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
             ++APE        +  DV+  G++L  L SG  P 
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYC 103
           LGEG +  V     L +G + AVK ++  +  +      EVE L + + +KN+L L  + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 104 AEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
            +     +V++ +                   N      +    A  + +LH   T  I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 164 HRDIKASNVLLDADFK---AQVADF--GFAKLIPDGATHVT----TRVKGTLGYLAPEY- 213
           HRD+K  N+L ++  K    ++ DF  G    + +  T +T    T   G+  Y+APE  
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 214 -AMLGKAS---ESCDVYSFGILLLELASGKKPI 242
                +A+   + CD++S G++L  + SG  P 
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 3/86 (3%)
Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           ++ L H  +  ++H D+K +N+ L    + ++ DFG   L+  G        +G   Y+A
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMA 224
Query: 211 PEYAMLGKASESCDVYSFGILLLELA 236
           PE  + G    + DV+S G+ +LE+A
Sbjct: 225 PEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRL------KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +G G +GSV        G ++A+K+L      ++++ +A  E      +L  ++H+N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLKHMQHENVIG 87
Query: 99  LRGYCAEGQERLIVYDY---MPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L             YD+   MP                  +  +   +     +G+ Y+H
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKIQYLVYQMLKGLKYIH 143
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPE 212
              +  ++HRD+K  N+ ++ D + ++ DFG A+       H    + G   T  Y APE
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPE 193
Query: 213 YAM-LGKASESCDVYSFGILLLELASGK 239
             +     +++ D++S G ++ E+ +GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 163 IHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYLAPEY-------A 214
           +HRDIK  N+LLD     ++ADFG   KL  DG       V GT  YL+PE         
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGP 242
Query: 215 MLGKASESCDVYSFGILLLELASGKKPIEKVNSA 248
             G     CD ++ G+   E+  G+ P    ++A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 35  SATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARV 91
           ++ + +    KLGEG +G VY          +A+KR+++   +  +      EV +L  +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGI 151
           +H+N++ L+          ++++Y  N                   ++  D+++   +  
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM-------------DKNPDVSMRVIKSF 137
Query: 152 VY-----LHHHATPHIIHRDIKASNVLLDADFKAQ-----VADFGFAKLIPDGATHVTTR 201
           +Y     ++   +   +HRD+K  N+LL     ++     + DFG A+         T  
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 202 VKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAI 249
           +  TL Y  PE  +LG    S S D++S   +  E+   K P+   +S I
Sbjct: 198 II-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEI 244

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRL------KVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +G G +GSV        G ++A+K+L      ++++ +A  E      +L  ++H+N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLKHMQHENVIG 105
Query: 99  LRGYCAEGQERLIVYDY---MPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIVYLH 155
           L             YD+   MP                  +  +   +     +G+ Y+H
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGME----FSEEKIQYLVYQMLKGLKYIH 161
Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG---TLGYLAPE 212
              +  ++HRD+K  N+ ++ D + ++ DFG A+       H    + G   T  Y APE
Sbjct: 162 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPE 211
Query: 213 YAM-LGKASESCDVYSFGILLLELASGK 239
             +     +++ D++S G ++ E+ +GK
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 34/232 (14%)
Query: 38  NNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK-N 95
           N +    K+G G FG +Y G  +  G ++A+K   V +   ++   +E +    ++    
Sbjct: 9   NKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLH--IESKFYKMMQGGVG 66
Query: 96  LLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRR-------MDIAIGSA 148
           + S++   AEG   ++V + +               E L N+  R       + +A    
Sbjct: 67  IPSIKWCGAEGDYNVMVMELL-----------GPSLEDLFNFCSRKFSLKTVLLLADQMI 115
Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ---VADFGFAKLIPDGAT--HVTTR-- 201
             I Y+H   + + IHRD+K  N L+    K     + DFG AK   D  T  H+  R  
Sbjct: 116 SRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 202 --VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR 251
             + GT  Y +    +  + S   D+ S G +L+    G  P + + +A KR
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 38/222 (17%)
Query: 40  FNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEM------EFAVEVEILARVR 92
           ++   +LG G F  V    +   G + A K +K   ++A        E   EV IL +V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 93  HKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           H N+++L        + +++         +D++               + +L+       
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------- 126
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADFKA---QVADFGFAKLIPDGATHVT 199
                 G+ YLH   T  I H D+K  N+ LLD +      ++ DFG A  I DG     
Sbjct: 127 ------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             + GT  ++APE           D++S G++   L SG  P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 38/222 (17%)
Query: 40  FNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEM------EFAVEVEILARVR 92
           ++   +LG G F  V    +   G + A K +K   ++A        E   EV IL +V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 93  HKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           H N+++L        + +++         +D++               + +L+       
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------- 126
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADFKA---QVADFGFAKLIPDGATHVT 199
                 G+ YLH   T  I H D+K  N+ LLD +      ++ DFG A  I DG     
Sbjct: 127 ------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             + GT  ++APE           D++S G++   L SG  P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 38/222 (17%)
Query: 40  FNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEM------EFAVEVEILARVR 92
           ++   +LG G F  V    +   G + A K +K   ++A        E   EV IL +V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 93  HKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           H N+++L        + +++         +D++               + +L+       
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------- 126
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADFKA---QVADFGFAKLIPDGATHVT 199
                 G+ YLH   T  I H D+K  N+ LLD +      ++ DFG A  I DG     
Sbjct: 127 ------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             + GT  ++APE           D++S G++   L SG  P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 40  FNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEM------EFAVEVEILARVR 92
           ++   +LG G F  V    +   G + A K +K   ++A        E   EV IL +V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 93  HKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           H N+++L        + +++         +D++               + +L+       
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------- 126
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADFKA---QVADFGFAKLIPDGATHVT 199
                 G+ YLH   T  I H D+K  N+ LLD +      ++ DFG A  I DG     
Sbjct: 127 ------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
             + GT  ++APE           D++S G++   L SG  P 
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 40  FNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEM------EFAVEVEILARVR 92
           ++   +LG G F  V    +   G + A K +K   ++A        E   EV IL +V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 93  HKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           H N+++L        + +++         +D++               + +L+       
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------- 126
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADF---KAQVADFGFAKLIPDGATHVT 199
                 G+ YLH   T  I H D+K  N+ LLD +      ++ DFG A  I DG     
Sbjct: 127 ------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
             + GT  ++APE           D++S G++   L SG  P 
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 40/223 (17%)
Query: 42  YDN--KLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEM------EFAVEVEILARVR 92
           YD   +LG G F  V    +   G Q A K +K    K+        +   EV IL  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 93  HKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRMDI 143
           H N+++L        + +++         +D++               + +LN       
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN------- 125
Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADF---KAQVADFGFAKLIPDGATHVT 199
                 G+ YLH   +  I H D+K  N+ LLD +    + ++ DFG A  I  G     
Sbjct: 126 ------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 174
Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
             + GT  ++APE           D++S G++   L SG  P 
Sbjct: 175 KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 42  YDNKLGEGGFGSVY---------WGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR 92
           ++  LG+G F  ++         +GQL + +++ +K L          F     +++++ 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNXXXXXXXXXXXXXECLLNWNRRMDIAIGSAEGIV 152
           HK+L+   G C  G E ++V +++                C +N   ++++A   A  + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMH 127
Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL----GY 208
           +L  +    +IH ++ A N+LL  +   +  +  F KL  D    +T   K  L     +
Sbjct: 128 FLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL-SDPGISITVLPKDILQERIPW 183
Query: 209 LAPEYAMLGK-ASESCDVYSFGILLLELAS-GKKPIEKVNSAIK 250
           + PE     K  + + D +SFG  L E+ S G KP+  ++S  K
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 16/101 (15%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDAD--FKAQVADFGFAKLIPDGATHVTTRVK---G 204
           G+ Y H      + HRD+K  N LLD     + ++ADFG++K     A+ + ++ K   G
Sbjct: 127 GVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK-----ASVLHSQPKSAVG 178
Query: 205 TLGYLAPEYAMLGKASES--CDVYSFGILLLELASGKKPIE 243
           T  Y+APE  +L K  +    DV+S G+ L  +  G  P E
Sbjct: 179 TPAYIAPE-VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 38/225 (16%)
Query: 38  NNFNYDNKLGEGGFGSVY-WGQLWDGSQIA---VKRLKVWSNK---AEMEFAVEVEILAR 90
           +++    +LG G F  V    Q   G + A   +K+ ++ S++   +  E   EV IL  
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 91  VRHKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
           +RH N+++L        + +++         +D++               + +L+     
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD----- 126
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADF---KAQVADFGFAKLIPDGATH 197
                   G+ YLH   +  I H D+K  N+ LLD +    + ++ DFG A  I  G   
Sbjct: 127 --------GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 175
Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
               + GT  ++APE           D++S G++   L SG  P 
Sbjct: 176 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 16/101 (15%)
Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDAD--FKAQVADFGFAKLIPDGATHVTTR-VKGTL 206
           G+ Y H   +  I HRD+K  N LLD     + ++ DFG++K       H   +   GT 
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 181
Query: 207 GYLAPEYAML----GKASESCDVYSFGILLLELASGKKPIE 243
            Y+APE  +     GK +   DV+S G+ L  +  G  P E
Sbjct: 182 AYIAPEVLLRQEYDGKIA---DVWSCGVTLYVMLVGAYPFE 219

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 38  NNFNYDNKLGEGGFGSVY-WGQLWDGSQIA---VKRLKVWSNK---AEMEFAVEVEILAR 90
           +++    +LG G F  V    Q   G + A   +K+ ++ S++   +  E   EV IL  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 91  VRHKNLLSLRGYCAEGQERLIV---------YDYMPNXXXXXXXXXXXXXECLLNWNRRM 141
           +RH N+++L        + +++         +D++               + +L+     
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD----- 119
Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNV-LLDADF---KAQVADFGFAKLIPDGATH 197
                   G+ YLH   +  I H D+K  N+ LLD +    + ++ DFG A  I  G   
Sbjct: 120 --------GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
               + GT  ++APE           D++S G++   L SG  P
Sbjct: 169 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	400
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-177
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-142
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-133
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-85
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  494 bits (1274), Expect = e-177
 Identities = 140/309 (45%), Positives = 205/309 (66%), Gaps = 4/309 (1%)

Query: 25  WRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-EMEFAV 83
            + FSL+EL  A++NF+  N LG GGFG VY G+L DG+ +AVKRLK    +  E++F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 84  EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDI 143
           EVE+++   H+NLL LRG+C    ERL+VY YM N S+ S L  +  S+  L+W +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
           A+GSA G+ YLH H  P IIHRD+KA+N+LLD +F+A V DFG AKL+    THVTT V+
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE--KVNSAIKRTITDWALPLA 261
           GT+G++APEY   GK+SE  DV+ +G++LLEL +G++  +  ++ +     + DW   L 
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE-SKEKLT 320
            E+K   L D  L GN+ +EE+++++ VAL C  S P +RP M EV+ +L+G+   E+  
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316

Query: 321 ELENDELFK 329
           E + +E+F+
Sbjct: 317 EWQKEEMFR 325

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  407 bits (1049), Expect = e-142
 Identities = 109/289 (37%), Positives = 167/289 (57%), Gaps = 4/289 (1%)

Query: 26  RIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEV 85
               L +L  ATNNF++   +G G FG VY G L DG+++A+KR    S++   EF  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAI 145
           E L+  RH +L+SL G+C E  E +++Y YM N +L  HL+G       ++W +R++I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG-ATHVTTRVKG 204
           G+A G+ YLH   T  IIHRD+K+ N+LLD +F  ++ DFG +K   +   TH++T VKG
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER 264
           TLGY+ PEY + G+ +E  DVYSFG++L E+   +  I +        + +WA+      
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263

Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG 313
           +  ++ DP L      E L++    A+ C     E RP+M +VL  L+ 
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  383 bits (986), Expect = e-133
 Identities = 104/302 (34%), Positives = 171/302 (56%), Gaps = 21/302 (6%)

Query: 26  RIFSLKELHSATNNFN------YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-- 77
             FS  EL + TNNF+        NK+GEGGFG VY G + + + +AVK+L    +    
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 78  --EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLL 135
             + +F  E++++A+ +H+NL+ L G+ ++G +  +VY YMPN SLL  L     +   L
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PL 130

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
           +W+ R  IA G+A GI +LH +   H IHRDIK++N+LLD  F A+++DFG A+     A
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 196 -THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT 254
            T +T+R+ GT  Y+APE  + G+ +   D+YSFG++LLE+ +G   +++      + + 
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244

Query: 255 DWALPLACE-RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG 313
           D    +  E +   +  D ++  +     ++ +  VA  C H K  KRP + +V  LL+ 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

Query: 314 ES 315
            +
Sbjct: 304 MT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  260 bits (666), Expect = 8e-85
 Identities = 73/320 (22%), Positives = 113/320 (35%), Gaps = 35/320 (10%)

Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
              + L+  +           G FG V+  Q      +AVK      +K   +   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP-IQDKQSWQNEYEVYS 71

Query: 88  LARVRHKNLLSLRGYCAEG----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDI 143
           L  ++H+N+L   G    G     +  ++  +    SL   L        +++WN    I
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHI 126

Query: 144 AIGSAEGIVYLHHHA-------TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT 196
           A   A G+ YLH           P I HRDIK+ NVLL  +  A +ADFG A     G +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 197 HV-TTRVKGTLGYLAPEYAMLG-----KASESCDVYSFGILLLELASGKKPIEKVNSAIK 250
              T    GT  Y+APE           A    D+Y+ G++L ELAS     +       
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 251 RTITDWALPLACERKFSEL-----ADPRLNGNFVEEE-LKRVVLVALTCAHSKPEKRPTM 304
               +            E+       P L   + +   +  +      C     E R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 305 LEVLDLLKGESKEKLTELEN 324
             V + +      ++  L N
Sbjct: 307 GCVGERI-----TQMQRLTN 321

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  210 bits (536), Expect = 2e-65
 Identities = 81/329 (24%), Positives = 133/329 (40%), Gaps = 41/329 (12%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
                +  +G G FG V   + W    +A+K+++  S      F VE+  L+RV H N++
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAK-WRAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C       +V +Y    SL + LHG             M   +  ++G+ YLH  
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 158 ATPHIIHRDIKASNVLLDADFK-AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               +IHRD+K  N+LL A     ++ DFG A  I        T  KG+  ++APE    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEG 177

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWA--------LPLACERKFSE 268
              SE CDV+S+GI+L E+ + +KP +++     R +  WA        L     +    
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRPPLIKNLPKPIES 235

Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELF 328
           L             + R       C    P +RP+M E++ ++    +      E  +  
Sbjct: 236 L-------------MTR-------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275

Query: 329 KSHQVADYNDGKAVAEDSAEKLAELENDE 357
             H +    DG+        +   L + +
Sbjct: 276 CQHSLPPGEDGRVEPYVDFAEFYRLWSVD 304

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  210 bits (536), Expect = 2e-65
 Identities = 80/278 (28%), Positives = 137/278 (49%), Gaps = 31/278 (11%)

Query: 42  YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSL 99
              K+G G FG+V+  + W GS +AVK L    +  +   EF  EV I+ R+RH N++  
Sbjct: 41  IKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
            G   +     IV +Y+   SL   LH   + E  L+  RR+ +A   A+G+ YLH+   
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNR-N 157

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
           P I+HR++K+ N+L+D  +  +V DFG ++L         +   GT  ++APE      +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPS 216

Query: 220 SESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDW----ALPLACERKFSELADPRL 274
           +E  DVYSFG++L ELA+ ++P   +N + +   +        +P     + + +     
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI----- 271

Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                   ++        C  ++P KRP+   ++DLL+
Sbjct: 272 --------IEG-------CWTNEPWKRPSFATIMDLLR 294

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  203 bits (518), Expect = 1e-62
 Identities = 65/329 (19%), Positives = 112/329 (34%), Gaps = 51/329 (15%)

Query: 28  FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEI 87
            +  E     +N      +G G +G+VY G   D   +AVK    ++N+        +  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFS-FANRQNFINEKNIYR 60

Query: 88  LARVRHKNLLSLRGYCAEG-----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD 142
           +  + H N+                E L+V +Y PN SL  +L          +W     
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCR 115

Query: 143 IAIGSAEGIVYLH------HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI----- 191
           +A     G+ YLH       H  P I HRD+ + NVL+  D    ++DFG +  +     
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 192 --PDGATHVTTRVKGTLGYLAPEYAM-------LGKASESCDVYSFGILLLELASGKKPI 242
             P    +      GT+ Y+APE             A +  D+Y+ G++  E+      +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 243 EKVNSAIKRTITDWALPLACE----RKFSELAD--------PRLNGNFVEEELKRVVLVA 290
                    ++ ++ +    E      F ++          P+    + E  L    L  
Sbjct: 236 FP-----GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 291 LT--CAHSKPEKRPTMLEVLDLLKGESKE 317
               C     E R T     + +      
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMI 319

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (509), Expect = 6e-62
 Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 54/290 (18%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN----KAEMEFAVEVEILARVRHKNLLSL 99
             +G GGFG VY    W G ++AVK  +   +    +       E ++ A ++H N+++L
Sbjct: 13  EIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
           RG C +     +V ++     L   L G+      +  +  ++ A+  A G+ YLH  A 
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAI 126

Query: 160 PHIIHRDIKASNVLLDADFKAQ--------VADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
             IIHRD+K+SN+L+    +          + DFG A+      T   +   G   ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWMAP 183

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKP---------IEKVNSAIKRTITDWALPLAC 262
           E       S+  DV+S+G+LL EL +G+ P            V            +P  C
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL----PIPSTC 239

Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
              F++L             ++        C +  P  RP+   +LD L 
Sbjct: 240 PEPFAKL-------------MED-------CWNPDPHSRPSFTNILDQLT 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (508), Expect = 1e-61
 Identities = 70/297 (23%), Positives = 130/297 (43%), Gaps = 52/297 (17%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM-------EFAVEVEILA 89
           N   Y+ ++G+GGFG V+ G+ + D S +A+K L +  ++ E        EF  EV I++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
            + H N++ L G         +V +++P   L   L  +      + W+ ++ + +  A 
Sbjct: 79  NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIAL 133

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLD-----ADFKAQVADFGFAKLIPDGATHVTTRVKG 204
           GI Y+ +   P I+HRD+++ N+ L      A   A+VADFG ++       H  + + G
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLG 188

Query: 205 TLGYLAPE--YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWA----- 257
              ++APE   A     +E  D YSF ++L  + +G+ P ++ +    + I         
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248

Query: 258 --LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
             +P  C  +   +             ++        C    P+KRP    ++  L 
Sbjct: 249 PTIPEDCPPRLRNV-------------IEL-------CWSGDPKKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  197 bits (504), Expect = 3e-61
 Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 54/293 (18%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKN 95
              N+  KL E   G ++ G  W G+ I VK LKV  WS +   +F  E   L    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 96  LLSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           +L + G C         ++  +MP  SL + LH   +    ++ ++ +  A+  A G+ +
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAF 126

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           LH    P I    + + +V++D D  A+++            +  +        ++APE 
Sbjct: 127 LHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE- 178

Query: 214 AMLGKA----SESCDVYSFGILLLELASGKKP---------IEKVNSAIKR-TITDWALP 259
           A+  K       S D++SF +LL EL + + P           KV     R TI     P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI-----P 233

Query: 260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                  S+L             +K        C +  P KRP    ++ +L+
Sbjct: 234 PGISPHVSKL-------------MKI-------CMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (505), Expect = 8e-61
 Identities = 67/314 (21%), Positives = 124/314 (39%), Gaps = 57/314 (18%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLLSLRG 101
             +G+G FG VY G+ W G ++A++ + +  +  +    F  EV    + RH+N++   G
Sbjct: 39  ELIGKGRFGQVYHGR-WHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+       +L S +         L+ N+   IA    +G+ YLH      
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLI----PDGATHVTTRVKGTLGYLAPE----- 212
           I+H+D+K+ NV  D + K  + DFG   +                 G L +LAPE     
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 213 ----YAMLGKASESCDVYSFGILLLELASGKKP---------IEKVNSAIKRTITDWALP 259
                      S+  DV++ G +  EL + + P         I ++ + +K  ++     
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS----Q 265

Query: 260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKL 319
           +   ++ S++             L         C   + E+RPT  +++D+L+   K   
Sbjct: 266 IGMGKEISDI-------------LLF-------CWAFEQEERPTFTKLMDMLEKLPKRNR 305

Query: 320 TELENDELFKSHQV 333
                   +KS ++
Sbjct: 306 RLSHPGHFWKSAEL 319

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  196 bits (501), Expect = 2e-60
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 26/280 (9%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLSLRG 101
            ++G G FG+VY G  W G  +AVK L V   + +    F  EV +L + RH N+L   G
Sbjct: 30  QRIGSGSFGTVYKG-KWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
           Y    Q   IV  +    SL  HLH   +        + +DIA  +A G+ YLH      
Sbjct: 88  YSTAPQ-LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAK---S 140

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPE---YAMLG 217
           IIHRD+K++N+ L  D   ++ DFG A        +H   ++ G++ ++APE        
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN 277
             S   DVY+FGI+L EL +G+ P   +N+          +     R        ++  N
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGSLSPDLSKVRSN 253

Query: 278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE 317
              + +KR++     C   K ++RP+   +L  ++  ++E
Sbjct: 254 -CPKRMKRLMA---ECLKKKRDERPSFPRILAEIEELARE 289

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  188 bits (480), Expect = 3e-57
 Identities = 65/290 (22%), Positives = 109/290 (37%), Gaps = 48/290 (16%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQ--IAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
             LG+G FG          +   + +K L  +  + +  F  EV+++  + H N+L   G
Sbjct: 16  EVLGKGCFGQAIKV-THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
              + +    + +Y+   +L   +    S      W++R+  A   A G+ YLH     +
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSM---N 128

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-------------VKGTLGY 208
           IIHRD+ + N L+  +    VADFG A+L+ D  T                  V G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKP---IEKVNSAIKRTITDWA---LPLAC 262
           +APE        E  DV+SFGI+L E+                    +  +     P  C
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248

Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
              F  +                     + C    PEKRP+ +++   L+
Sbjct: 249 PPSFFPI--------------------TVRCCDLDPEKRPSFVKLEHWLE 278

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  178 bits (454), Expect = 2e-53
 Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 46/300 (15%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
             +G+G +G V+ G  W G  +AVK      ++       E+     +RH+N+L      
Sbjct: 14  ECVGKGRYGEVWRGS-WQGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASD 71

Query: 104 AEGQ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH---- 155
              +    +  ++  Y    SL  +L         L+    + I +  A G+ +LH    
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 156 -HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK---GTLGYLAP 211
                P I HRD+K+ N+L+  + +  +AD G A +       +        GT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 212 E------YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALP----LA 261
           E            + +  D+++FG++L E+A        V         D+  P    + 
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE--------DYKPPFYDVVP 238

Query: 262 CERKFSELAD--------PRLNGNFVEEE-LKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
            +  F ++          P +   +  +  L  +  +   C +  P  R T L +   L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (453), Expect = 6e-53
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 46/302 (15%)

Query: 42  YDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
              ++G+G +G V+ G+ W G ++AVK     + +A      E+     +RH+N+L    
Sbjct: 41  MVKQIGKGRYGEVWMGK-WRGEKVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 102 YCAEGQER----LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH-- 155
              +G        ++ DY  N SL  +L         L+    + +A  S  G+ +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153

Query: 156 ---HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV---TTRVKGTLGYL 209
                  P I HRD+K+ N+L+  +    +AD G A         V        GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 210 APE------YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE 263
            PE           ++    D+YSFG++L E+A        V         ++ LP    
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE--------EYQLPYHDL 265

Query: 264 RK----FSELAD--------PRLNGNFVEEE-LKRVVLVALTCAHSKPEKRPTMLEVLDL 310
                 + ++ +        P     +  +E L+++  +   C    P  R T L V   
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 311 LK 312
           L 
Sbjct: 326 LA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  169 bits (430), Expect = 2e-49
 Identities = 63/318 (19%), Positives = 115/318 (36%), Gaps = 40/318 (12%)

Query: 19  GKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAE 78
           G      R  + + +            +G+G FG V+ G+ W G ++AVK       +  
Sbjct: 31  GLPLLVQRTIA-RTIV-------LQESIGKGRFGEVWRGK-WRGEEVAVKIFS-SREERS 80

Query: 79  MEFAVEVEILARVRHKNLLSLRGYC----AEGQERLIVYDYMPNLSLLSHLHGQHSSECL 134
                E+     +RH+N+L              +  +V DY  + SL  +L+        
Sbjct: 81  WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----- 135

Query: 135 LNWNRRMDIAIGSAEGIVYLH-----HHATPHIIHRDIKASNVLLDADFKAQVADFGFAK 189
           +     + +A+ +A G+ +LH         P I HRD+K+ N+L+  +    +AD G A 
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

Query: 190 LIPDGATHVTTRVK---GTLGYLAPE------YAMLGKASESCDVYSFGILLLELASGKK 240
                   +        GT  Y+APE           ++ +  D+Y+ G++  E+A    
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255

Query: 241 PIEKVNS-AIKRTITDWALPLACERKFSELAD---PRLNGNFVEEELKRVVLVALT--CA 294
                    +       + P   E +         P +   +   E  R V+  +   C 
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR-VMAKIMRECW 314

Query: 295 HSKPEKRPTMLEVLDLLK 312
           ++    R T L +   L 
Sbjct: 315 YANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  149 bits (378), Expect = 1e-41
 Identities = 70/286 (24%), Positives = 113/286 (39%), Gaps = 40/286 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS-QIAVKRLKVWSNKAE-MEFAVEVEILARVRHKN 95
            +     ++G G FG V+ G+L   +  +AVK  +         +F  E  IL +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L G C + Q   IV + +     L+ L  + +    L     + +   +A G+ YL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLE 230

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY----LAP 211
                  IHRD+ A N L+      +++DFG ++   DG   V     G         AP
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAP 284

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKF 266
           E    G+ S   DV+SFGILL E  S G  P   + N   +  +        P  C    
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC---- 340

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                P        + + R++     C   +P +RP+   +   L+
Sbjct: 341 -----P--------DAVFRLM---EQCWAYEPGQRPSFSTIYQELQ 370

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (370), Expect = 2e-39
 Identities = 70/275 (25%), Positives = 113/275 (41%), Gaps = 34/275 (12%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQI--AVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W    +  AVK LK        EF  E  ++  ++H NL+ L G
Sbjct: 226 HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M   +LL +L  +  +   ++    + +A   +  + YL      +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
            IHR++ A N L+  +   +VADFG ++L+           K  + + APE     K S 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 222 SCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELADPRLNG 276
             DV++FG+LL E+A+ G  P   +  S +   +        P  C  K  EL       
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL------- 451

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                           C    P  RP+  E+    
Sbjct: 452 -------------MRACWQWNPSDRPSFAEIHQAF 473

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (358), Expect = 4e-39
 Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 36/235 (15%)

Query: 22  QPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ-----IAVKRLKVW-SN 75
           Q   RI    E             LG G FG+VY G      +     +A+K L+   S 
Sbjct: 6   QALLRILKETEFK-------KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58

Query: 76  KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSE 132
           KA  E   E  ++A V + ++  L G C       ++   MP   LL ++        S+
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
            LLNW       +  A+G+ YL       ++HRD+ A NVL+      ++ DFG AKL+ 
Sbjct: 118 YLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 193 DGATHVTTR-----VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
                         +K      A E  +    +   DV+S+G+ + EL + G KP
Sbjct: 169 AEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 5e-39
 Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 32/273 (11%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
            KLG+G FG V+ G     +++A+K LK     +   F  E +++ ++RH+ L+ L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM   SLL  L  +  +   L   + +D+A   A G+ Y+      + +
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELADPRLNGNF 278
           DV+SFGILL EL + G+ P   + N  +   +        P  C     +L         
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL--------- 496

Query: 279 VEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                         C   +PE+RPT   +   L
Sbjct: 497 -----------MCQCWRKEPEERPTFEYLQAFL 518

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  141 bits (357), Expect = 6e-39
 Identities = 68/294 (23%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 42  YDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEMEFAVEVEILARVRHKN 95
           Y ++LG+G FGSV     +D         +AVK+L+      + +F  E++IL  +    
Sbjct: 27  YISQLGKGNFGSVELC-RYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 96  LLSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           ++  RG       +   +V +Y+P+  L   L    +    L+ +R +  +    +G+ Y
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 142

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYLAP 211
           L        +HRD+ A N+L++++   ++ADFG AKL+P    +   R  G     + AP
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELA 270
           E       S   DV+SFG++L EL +   K                  P A   +     
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---------------CSPSAEFLRMMGCE 244

Query: 271 DPRLNGNFVEEELKR-------------VVLVALTCAHSKPEKRPTMLEVLDLL 311
                 + + E L+              V  +   C    P+ RP+   +   L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  143 bits (363), Expect = 7e-39
 Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 32/273 (11%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
            KLG+G FG V+ G     +++A+K LK     +   F  E +++ ++RH+ L+ L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
           +E +   IV +YM   SLL  L  +  +   L   + +D+A   A G+ Y+      + +
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G+ +   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELADPRLNGNF 278
           DV+SFGILL EL + G+ P   + N  +   +        P  C     +L         
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL--------- 413

Query: 279 VEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                         C   +PE+RPT   +   L
Sbjct: 414 -----------MCQCWRKEPEERPTFEYLQAFL 435

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  139 bits (353), Expect = 1e-38
 Identities = 64/292 (21%), Positives = 123/292 (42%), Gaps = 41/292 (14%)

Query: 42  YDNKLGEGGFGSVY---WGQLWDGSQI--AVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           +  +LG+G FGSV    +  L D +    AVK+L+  + +   +F  E+EIL  ++H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 97  LSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           +  +G C     R   ++ +Y+P  SL  +L         ++  + +       +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 130

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYLAPE 212
                   IHRD+   N+L++ + + ++ DFG  K++P        +  G     + APE
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP 272
                K S + DV+SFG++L EL +  +                + P    R        
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEK-------------SKSPPAEFMRMIGNDKQG 234

Query: 273 RLNGNFVEEELKR-------------VVLVALTCAHSKPEKRPTMLEVLDLL 311
           ++    + E LK              + ++   C ++   +RP+  ++   +
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  139 bits (353), Expect = 2e-38
 Identities = 64/292 (21%), Positives = 124/292 (42%), Gaps = 41/292 (14%)

Query: 42  YDNKLGEGGFGSVY---WGQLWDGSQI--AVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           +  +LG+G FGSV    +  L D +    AVK+L+  + +   +F  E+EIL  ++H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 97  LSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           +  +G C     R   ++ +Y+P  SL  +L         ++  + +       +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 161

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYLAPE 212
                   IHRD+   N+L++ + + ++ DFG  K++P    +   +  G     + APE
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP 272
                K S + DV+SFG++L EL +  +                + P    R        
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEK-------------SKSPPAEFMRMIGNDKQG 265

Query: 273 RLNGNFVEEELKR-------------VVLVALTCAHSKPEKRPTMLEVLDLL 311
           ++    + E LK              + ++   C ++   +RP+  ++   +
Sbjct: 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  138 bits (349), Expect = 6e-38
 Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 23/298 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS--NKAEMEFAV-EVEILARVRH 93
            NF  + K+G G F  VY      DG  +A+K+++++   +       + E+++L ++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
            N++       E  E  IV +      L   +      + L+         +     + +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           +H      ++HRDIK +NV + A    ++ D G  +      T   + + GT  Y++PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPER 207

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR 273
                 +   D++S G LL E+A+ + P       +             +  +     P 
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDY-----PP 257

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSH 331
           L  +   EEL+++V     C +  PEKRP +  V D+ K       + LE+      H
Sbjct: 258 LPSDHYSEELRQLV---NMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH--HHH 310

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (351), Expect = 9e-38
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 14/207 (6%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLL 97
           D  +G G FG V  G+L   S+    +A+K LKV ++ K   +F  E  I+ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G   + +  +IV +YM N SL S L      +      + + +  G A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL--APEYAM 215
                +HRD+ A N+L++++   +V+DFG  +++ D      T   G +     +PE   
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 216 LGKASESCDVYSFGILLLELAS-GKKP 241
             K + + DV+S+GI+L E+ S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  135 bits (343), Expect = 1e-37
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
            ++G G FG V+ G   +  ++A+K ++  +   E +F  E E++ ++ H  L+ L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 104 AEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
            E     +V ++M +  L  +L    G  ++E LL       + +   EG+ YL      
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL------GMCLDVCEGMAYLEEA--- 123

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA--THVTTR--VKGTLGYLAPEYAML 216
            +IHRD+ A N L+  +   +V+DFG  + + D    +   T+  VK      +PE    
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSF 179

Query: 217 GKASESCDVYSFGILLLELAS-GKKP 241
            + S   DV+SFG+L+ E+ S GK P
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  137 bits (346), Expect = 2e-37
 Identities = 74/296 (25%), Positives = 119/296 (40%), Gaps = 49/296 (16%)

Query: 42  YDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEM-EFAVEVEILARVRHK 94
               LGEG FG V     +D +       +AVK LK  +       +  E++IL  + H+
Sbjct: 35  KIRDLGEGHFGKVSLY-CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 95  NLLSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           +++  +G C +       +V +Y+P  SL  +L         +   + +  A    EG+ 
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMA 148

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYLA 210
           YLH     H IHRD+ A NVLLD D   ++ DFG AK +P+G  +   R  G     + A
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205

Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
           PE     K   + DV+SFG+ L EL +            ++                   
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ------------- 252

Query: 270 ADPRLNGNFVEEELKR-------------VVLVALTCAHSKPEKRPTMLEVLDLLK 312
              ++    + E L+R             V  +   C  ++   RPT   ++ +LK
Sbjct: 253 --GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (346), Expect = 3e-37
 Identities = 67/282 (23%), Positives = 130/282 (46%), Gaps = 41/282 (14%)

Query: 45  KLGEGGFGSVYWGQLWDGS------QIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLL 97
            +G G FG VY G +   S       +A+K LK  ++ K  ++F  E  I+ +  H N++
Sbjct: 51  VIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G  ++ +  +I+ +YM N +L   L      +   +  + + +  G A G+ YL + 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY--LAPEYAM 215
              + +HRD+ A N+L++++   +V+DFG ++++ D      T   G +     APE   
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 216 LGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELA 270
             K + + DV+SFGI++ E+ + G++P  ++ N  + + I D      P+ C     +L 
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL- 282

Query: 271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                               + C   +  +RP   +++ +L 
Sbjct: 283 -------------------MMQCWQQERARRPKFADIVSILD 305

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 4e-37
 Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 47/295 (15%)

Query: 42  YDNKLGEGGFGSVYWGQLWDGSQ------IAVKRLKVWSNKAEM-EFAVEVEILARVRHK 94
               LGEG FG V     +D         +AVK LK  S    + +   E+EIL  + H+
Sbjct: 25  RIRDLGEGHFGKVELC-RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 95  NLLSLRGYCAEGQER--LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           N++  +G C E       ++ +++P+ SL  +L    +    +N  +++  A+   +G+ 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMD 140

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYLA 210
           YL        +HRD+ A NVL++++ + ++ DFG  K I     + T +        + A
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197

Query: 211 PEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
           PE  M  K   + DV+SFG+ L EL +                      P+A   K    
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS---------------PMALFLKMIGP 242

Query: 270 ADPRLNGNFVEEELKR-------------VVLVALTCAHSKPEKRPTMLEVLDLL 311
              ++    +   LK              V  +   C   +P  R +   +++  
Sbjct: 243 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  136 bits (344), Expect = 5e-37
 Identities = 72/325 (22%), Positives = 123/325 (37%), Gaps = 55/325 (16%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ-----IAVKRLKVWS-NKAEMEFAVEVEILARVRHKNL 96
              LG G FG+VY G      +     +A+K L+  +  KA  E   E  ++A V + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVY 153
             L G C       ++   MP   LL ++        S+ LLNW       +  A+G+ Y
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 132

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-----VKGTLGY 208
           L       ++HRD+ A NVL+      ++ DFG AKL+               +K     
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM--- 186

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACE 263
            A E  +    +   DV+S+G+ + EL + G KP + +  S I   +        P  C 
Sbjct: 187 -ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC- 244

Query: 264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG--ESKEKLTE 321
                                 V ++ + C     + RP   E++          ++   
Sbjct: 245 -------------------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285

Query: 322 LENDELFKSHQVADYNDGKAVAEDS 346
           ++ DE        D N  +A+ ++ 
Sbjct: 286 IQGDERMHLPSPTDSNFYRALMDEE 310

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (341), Expect = 6e-37
 Identities = 65/283 (22%), Positives = 120/283 (42%), Gaps = 42/283 (14%)

Query: 42  YDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNLLS 98
           +D ++G G F +VY G       ++A   L+    +      F  E E+L  ++H N++ 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 99  LRGYC---AEGQERLIVY-DYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIV 152
                    +G++ +++  + M + +L ++L        + L +W R++       +G+ 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQ 143

Query: 153 YLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
           +LH    P IIHRD+K  N+ +       ++ D G A L           V GT  ++AP
Sbjct: 144 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAP 199

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS--AIKRTITDWALPLACERKFSEL 269
           E     K  ES DVY+FG+ +LE+A+ + P  +  +   I R +T    P + ++     
Sbjct: 200 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                    +E            C     ++R +   + DLL 
Sbjct: 259 VK-----EIIEG-----------CIRQNKDERYS---IKDLLN 282

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  134 bits (340), Expect = 6e-37
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
            +LG G FG V +G+      +A+K +K   + +E EF  E +++  + H+ L+ L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 104 AEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
            + +   I+ +YM N  LL++L     +  ++ LL      ++     E + YL      
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLESK--- 139

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR----VKGTLGYLAPEYAML 216
             +HRD+ A N L++     +V+DFG ++ + D     +      V+ +     PE  M 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMY 195

Query: 217 GKASESCDVYSFGILLLELAS-GKKP 241
            K S   D+++FG+L+ E+ S GK P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  138 bits (349), Expect = 8e-37
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 38/275 (13%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
             +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+ L G  
Sbjct: 199 QTIGKGEFGDVMLG-DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 104 AEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
            E +  L IV +YM   SL+ +L  +  S   L  +  +  ++   E + YL  +   + 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---NF 310

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES 222
           +HRD+ A NVL+  D  A+V+DFG  K            VK T    APE     K S  
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 366

Query: 223 CDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELADPRLNGN 277
            DV+SFGILL E+ S G+ P  ++    +   +        P  C     ++        
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV-------- 418

Query: 278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                          C H     RPT L++ + L+
Sbjct: 419 ------------MKNCWHLDAATRPTFLQLREQLE 441

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (342), Expect = 9e-37
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 30/227 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEMEFAVEVEILARV 91
            +     +LGEG FG V+  +  +         +AVK LK  S  A  +F  E E+L  +
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-----------HGQHSSECLLNWNRR 140
           +H++++   G C EG+  L+V++YM +  L   L            G+  +   L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
           + +A   A G+VYL   A  H +HRD+   N L+      ++ DFG ++ I         
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YY 214

Query: 201 RVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           R  G    L      PE  +  K +   DV+SFG++L E+ + GK+P
Sbjct: 215 R-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (340), Expect = 9e-37
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 31/228 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEMEFAVEVEILARV 91
            +     +LGEG FG V+  + ++ S       +AVK LK  +  A  +F  E E+L  +
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL------------HGQHSSECLLNWNR 139
           +H++++   G C +G   ++V++YM +  L   L                 ++  L  ++
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 140 RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT 199
            + IA   A G+VYL   A+ H +HRD+   N L+ A+   ++ DFG ++ +     +  
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-- 189

Query: 200 TRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
               G    L      PE  M  K +   DV+SFG++L E+ + GK+P
Sbjct: 190 --RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  135 bits (341), Expect = 1e-36
 Identities = 70/309 (22%), Positives = 130/309 (42%), Gaps = 50/309 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAE-MEFAVEVEILAR 90
                  +LG+G FG VY G            ++A+K +   ++  E +EF  E  ++  
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL------HGQHSSECLLNWNRRMDIA 144
               +++ L G  ++GQ  L++ + M    L S+L         +      + ++ + +A
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
              A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I +   +     KG
Sbjct: 145 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKG 197

Query: 205 TLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD-- 255
             G L     +PE    G  +   DV+SFG++L E+A+  ++P + + N  + R + +  
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257

Query: 256 -WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE 314
               P  C     EL                       C    P+ RP+ LE++  +K E
Sbjct: 258 LLDKPDNCPDMLFEL--------------------MRMCWQYNPKMRPSFLEIISSIKEE 297

Query: 315 SKEKLTELE 323
            +    E+ 
Sbjct: 298 MEPGFREVS 306

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  134 bits (340), Expect = 1e-36
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 14/207 (6%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS----QIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLL 97
           +  +G G  G V +G+L         +A+K LK  ++ +   +F  E  I+ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G    G+  +IV +YM N SL + L    + +      + + +  G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL--APEYAM 215
                +HRD+ A NVL+D++   +V+DFG ++++ D      T   G +     APE   
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 216 LGKASESCDVYSFGILLLELAS-GKKP 241
               S + DV+SFG+++ E+ + G++P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  132 bits (335), Expect = 2e-36
 Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 40/277 (14%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           +LG G FG V  G+      +AVK +K  S   + EF  E + + ++ H  L+   G C+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIH 164
           +     IV +Y+ N  LL++L         L  ++ +++     EG+ +L  H     IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---QFIH 127

Query: 165 RDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR----VKGTLGYLAPEYAMLGKAS 220
           RD+ A N L+D D   +V+DFG  + + D     +      VK +    APE     K S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYS 183

Query: 221 ESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELADPRLN 275
              DV++FGIL+ E+ S GK P +   NS +   ++       P        ++      
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI------ 237

Query: 276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                           +C H  PEKRPT  ++L  ++
Sbjct: 238 --------------MYSCWHELPEKRPTFQQLLSSIE 260

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (338), Expect = 3e-36
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 29/214 (13%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ-----IAVKRLKVWSN-KAEMEFAVEVEILARVRHKNL 96
              LG G FG+V+ G      +     + +K ++  S  ++       +  +  + H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGIVY 153
           + L G C  G    +V  Y+P  SLL H+    G    + LLNW       +  A+G+ Y
Sbjct: 78  VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYY 130

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-----VKGTLGY 208
           L  H    ++HR++ A NVLL +  + QVADFG A L+P     +        +K     
Sbjct: 131 LEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM--- 184

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            A E    GK +   DV+S+G+ + EL + G +P
Sbjct: 185 -ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  133 bits (337), Expect = 3e-36
 Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 41/292 (14%)

Query: 38  NNFNYD--NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK 94
           +N +Y    KLGEGGF  V   + L DG   A+KR+     +   E   E ++     H 
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86

Query: 95  NLLSLRGYCAE----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
           N+L L  YC        E  ++  +    +L + +         L  ++ + + +G   G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK------- 203
           +  +H        HRD+K +N+LL  + +  + D G               +        
Sbjct: 147 LEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 204 -GTLGYLAPE------YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW 256
             T+ Y APE      + ++    E  DV+S G +L  +  G+ P + V           
Sbjct: 204 RCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------ 254

Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           ++ LA + + S    PR +       L +++   +T     P +RP +  +L
Sbjct: 255 SVALAVQNQLSIPQSPRHS-----SALWQLLNSMMT---VDPHQRPHIPLLL 298

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (335), Expect = 3e-36
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS---QIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLS 98
           D +LG G FGSV  G          +A+K LK         E   E +I+ ++ +  ++ 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L G C + +  ++V +      L   L G+      +  +   ++    + G+ YL    
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYLAPEYAML 216
             + +HRD+ A NVLL     A+++DFG +K +    ++ T R  G     + APE    
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 217 GKASESCDVYSFGILLLELAS-GKKP 241
            K S   DV+S+G+ + E  S G+KP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (343), Expect = 5e-36
 Identities = 68/273 (24%), Positives = 121/273 (44%), Gaps = 32/273 (11%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
            KLG G FG V+       +++AVK +K   + +   F  E  ++  ++H  L+ L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
            + +   I+ ++M   SLL  L  +          + +D +   AEG+ ++      + I
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESC 223
           HRD++A+N+L+ A    ++ADFG A++I D         K  + + APE    G  +   
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 224 DVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELADPRLNGNF 278
           DV+SFGILL+E+ + G+ P   + N  + R +        P  C  +   +         
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI--------- 417

Query: 279 VEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                       + C  ++PE+RPT   +  +L
Sbjct: 418 -----------MMRCWKNRPEERPTFEYIQSVL 439

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (332), Expect = 8e-36
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 18/202 (8%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
             +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+ L G  
Sbjct: 27  QTIGKGEFGDVMLG-DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 104 AEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHI 162
            E +  L IV +YM   SL+ +L  +  S   L  +  +  ++   E + YL  +   + 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---NF 138

Query: 163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAMLGKAS 220
           +HRD+ A NVL+  D  A+V+DFG  K      T  T +  VK T    APE     K S
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWT----APEALREKKFS 192

Query: 221 ESCDVYSFGILLLELAS-GKKP 241
              DV+SFGILL E+ S G+ P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (332), Expect = 1e-35
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS-----QIAVKRLKV---WSNKAEMEFAVEVEILARVRHK 94
             KLG+G FG V  G  WD        +AVK LK       +A  +F  EV  +  + H+
Sbjct: 23  LEKLGDGSFGVVRRG-EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGSAEGI 151
           NL+ L G         +V +  P  SLL  L    G      L  +      A+  AEG+
Sbjct: 82  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGM 134

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY--L 209
            YL        IHRD+ A N+LL      ++ DFG  + +P    H   +    + +   
Sbjct: 135 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 210 APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           APE       S + D + FG+ L E+ + G++P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (331), Expect = 1e-35
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 22/210 (10%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS----QIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNL 96
           D +LG G FG+V  G  +        +AVK LK        + E   E  ++ ++ +  +
Sbjct: 22  DKELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           + + G C E +  ++V +      L  +L  +     + ++            + G+ YL
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL 133

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL--GYLAPE 212
                 + +HRD+ A NVLL     A+++DFG +K +     +   +  G     + APE
Sbjct: 134 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190

Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKP 241
                K S   DV+SFG+L+ E  S G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  131 bits (331), Expect = 2e-35
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLL 97
           D  +G+G FG VY G+  D +Q     A+K L   +   ++  F  E  ++  + H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 98  SLRGYCAEGQER-LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           +L G     +    ++  YM +  LL  +    S +        +   +  A G+ YL  
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYL-- 140

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL-----AP 211
            A    +HRD+ A N +LD  F  +VADFG A+ I D      +  +     L     A 
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRHARLPVKWTAL 197

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           E     + +   DV+SFG+LL EL + G  P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (329), Expect = 2e-35
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQI--AVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +KLG G +G VY G +W    +  AVK LK  + + E EF  E  ++  ++H NL+ L G
Sbjct: 19  HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH 161
            C       I+ ++M   +LL +L   +  E  ++    + +A   +  + YL      +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---N 131

Query: 162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR----VKGTLGYLAPEYAMLG 217
            IHRD+ A N L+  +   +VADFG ++L+              +K T    APE     
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187

Query: 218 KASESCDVYSFGILLLELAS-GKKP 241
           K S   DV++FG+LL E+A+ G  P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP 212

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (328), Expect = 3e-35
 Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 16/203 (7%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
            +LG G FG V+ G     +++AVK LK   + +   F  E  ++ +++H+ L+ L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
            + +   I+ +YM N SL+  L  +  S   L  N+ +D+A   AEG+ ++      + I
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGA--THVTTR--VKGTLGYLAPEYAMLGKA 219
           HRD++A+N+L+      ++ADFG A+LI D         +  +K T    APE    G  
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTF 187

Query: 220 SESCDVYSFGILLLELAS-GKKP 241
           +   DV+SFGILL E+ + G+ P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  130 bits (330), Expect = 4e-35
 Identities = 69/223 (30%), Positives = 96/223 (43%), Gaps = 26/223 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVW-SNKAEMEFAVEVEILAR 90
            N      LG G FG VY GQ+          Q+AVK L    S + E++F +E  I+++
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGS 147
             H+N++   G   +   R I+ + M    L S L     + S    L     + +A   
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKG 204
           A G  YL      H IHRDI A N LL        A++ DFG A+ I   + +     KG
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKG 202

Query: 205 TLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
               L      PE  M G  +   D +SFG+LL E+ S G  P
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  129 bits (326), Expect = 6e-35
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 13/203 (6%)

Query: 45  KLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSL 99
            +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++ L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
            G         I+ +      L S L  +  S   L+    +  A   +  + YL     
Sbjct: 82  IGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESK-- 135

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
              +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     + 
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 220 SESCDVYSFGILLLELAS-GKKP 241
           + + DV+ FG+ + E+   G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (329), Expect = 1e-34
 Identities = 69/223 (30%), Positives = 95/223 (42%), Gaps = 26/223 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKV-WSNKAEMEFAVEVEILAR 90
            N      LG G FG VY GQ+          Q+AVK L    S + E++F +E  I+++
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLH---GQHSSECLLNWNRRMDIAIGS 147
             H+N++   G   +   R I+ + M    L S L     + S    L     + +A   
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKG 204
           A G  YL      H IHRDI A N LL        A++ DFG A+ I     +     KG
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKG 243

Query: 205 TLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
               L      PE  M G  +   D +SFG+LL E+ S G  P
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  129 bits (326), Expect = 1e-34
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS----QIAVKRLKV--WSNKAEMEFAVEVEILARV 91
           N       LGEG FGSV  G L        ++AVK +K+   S +   EF  E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 92  RHKNLLSLRGYCAEGQ-----ERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIA 144
            H N++ L G C E       + +++  +M    L ++L      +    +     +   
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKG 204
           +  A G+ YL   +  + +HRD+ A N +L  D    VADFG +K I  G  +     +G
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQG 206

Query: 205 TLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            +  +     A E       +   DV++FG+ + E+A+ G  P
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  129 bits (326), Expect = 3e-34
 Identities = 68/310 (21%), Positives = 124/310 (40%), Gaps = 37/310 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAV-EVEILARVRHK 94
             +    K+GEG FG     +   DG Q  +K + +   +  E E +  EV +LA ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHL---HGQHSSECLLNWNRRMDIAIGSAEGI 151
           N++  R    E     IV DY     L   +    G    E     ++ +D  +     +
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-----DQILDWFVQICLAL 138

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            ++H      I+HRDIK+ N+ L  D   Q+ DFG A+++          + GT  YL+P
Sbjct: 139 KHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSP 194

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALPLACERKFSEL 269
           E       +   D+++ G +L EL + K   E  +  + + + I+    P+     +S  
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV--SLHYS-- 250

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD--LLKGESKEKLTELENDEL 327
                       +L+ +V          P  RP++  +L+   +    ++ L+     E 
Sbjct: 251 -----------YDLRSLVSQLFKR---NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296

Query: 328 FKSHQVADYN 337
           F     + + 
Sbjct: 297 FCLKTFSKFG 306

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  127 bits (321), Expect = 3e-34
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 13/203 (6%)

Query: 45  KLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSL 99
            LGEG FG VY G   +       +AVK  K   +   + +F  E  I+  + H +++ L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
            G   E +   I+ +  P   L  +L    +S   L     +  ++   + + YL     
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESI-- 132

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            + +HRDI   N+L+ +    ++ DFG ++ I D   +  +  +  + +++PE     + 
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 220 SESCDVYSFGILLLELAS-GKKP 241
           + + DV+ F + + E+ S GK+P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  133 bits (335), Expect = 3e-34
 Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 38/281 (13%)

Query: 43  DNKLGEGGFGSVYWGQLWDGS---QIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLS 98
           D +LG G FGSV  G          +A+K LK         E   E +I+ ++ +  ++ 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L G C + +  ++V +      L   L G+      +  +   ++    + G+ YL    
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 455

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY--LAPEYAML 216
             + +HR++ A NVLL     A+++DFG +K +    ++ T R  G       APE    
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 217 GKASESCDVYSFGILLLELAS-GKKPIEKV-NSAIKRTITD---WALPLACERKFSELAD 271
            K S   DV+S+G+ + E  S G+KP +K+    +   I        P  C  +   L  
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL-- 571

Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                                C   K E RP  L V   ++
Sbjct: 572 ------------------MSDCWIYKWEDRPDFLTVEQRMR 594

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (321), Expect = 3e-34
 Identities = 45/222 (20%), Positives = 94/222 (42%), Gaps = 29/222 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQL--------WDGSQIAVKRLKVWSNKAEMEFAVEVEILA 89
            +  ++  LG+G F  ++ G             +++ +K L          F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
           ++ HK+L+   G C  G E ++V +++   SL ++L    +    +N   ++++A   A 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAA 124

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQ--------VADFGFAKLIPDGATHVTTR 201
            + +L  +    +IH ++ A N+LL  +   +        ++D G +  +      +  R
Sbjct: 125 AMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-KDILQER 180

Query: 202 VKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELAS-GKKP 241
           +        PE     K  + + D +SFG  L E+ S G KP
Sbjct: 181 IPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  126 bits (320), Expect = 5e-34
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 32/229 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVW-SNKAEMEFAVEVEILAR 90
           +   +  +LGE  FG VY G L+  +       +A+K LK         EF  E  + AR
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL------------HGQHSSECLLNWN 138
           ++H N++ L G   + Q   +++ Y  +  L   L                + +  L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV 198
             + +    A G+ YL   ++ H++H+D+   NVL+      +++D G  + +     + 
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY- 184

Query: 199 TTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
                     L     APE  M GK S   D++S+G++L E+ S G +P
Sbjct: 185 ---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  127 bits (320), Expect = 9e-34
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 27/224 (12%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLK--VWSNKAEMEFAVEVEILARV 91
             F     LG+G FGSV   QL         +AVK LK  + ++    EF  E   +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 92  RHKNLLSLRGYCAEGQER------LIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDI 143
            H ++  L G     + +      +++  +M +  L + L       +   L     +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
            +  A G+ YL   ++ + IHRD+ A N +L  D    VADFG ++ I  G  +     +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQ 195

Query: 204 GTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           G    L     A E       +   DV++FG+ + E+ + G+ P
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (323), Expect = 9e-34
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 20/211 (9%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLL 97
           +  +G G FG VY G L D        AVK L   ++  E+ +F  E  I+    H N+L
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 98  SLRGYCAEGQE-RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           SL G C   +   L+V  YM +  L + +  +  +         +   +  A+G+ +L  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFL-- 208

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL-----AP 211
            A+   +HRD+ A N +LD  F  +VADFG A+ + D           T   L     A 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMAL 265

Query: 212 EYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           E     K +   DV+SFG+LL EL + G  P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (319), Expect = 9e-34
 Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 16/209 (7%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAEM-EFAVEVEILARVRHKNLL 97
           +  +G G FG VY G L D        AVK L   ++  E+ +F  E  I+    H N+L
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 98  SLRGYCAEGQE-RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           SL G C   +   L+V  YM +  L + +    +          +   +  A+G+ YL  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYL-- 144

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLAPEY 213
            A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 214 AMLGKASESCDVYSFGILLLELAS-GKKP 241
               K +   DV+SFG+LL EL + G  P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  126 bits (318), Expect = 3e-33
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 31/228 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVEILAR 90
           NN  +   LG G FG V     +         ++AVK LK  ++  E      E++I++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL----------HGQHSSECLLNWNR 139
           + +H+N+++L G C  G   L++ +Y     LL+ L               +    +   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 140 RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT 199
            +  +   A+G+ +L   A+ + IHRD+ A NVLL     A++ DFG A+ I + + +  
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-- 220

Query: 200 TRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             +      L     APE       +   DV+S+GILL E+ S G  P
Sbjct: 221 --IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (313), Expect = 4e-33
 Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 57/303 (18%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
            +F     +G GGFG V+  +   DG    +KR+         +   EV+ LA++ H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66

Query: 97  LSLRGYCAEGQERL----------------IVYDYMPNLSLLSHLH---GQHSSECLLNW 137
           +   G                         I  ++    +L   +    G+   + L   
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-- 124

Query: 138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH 197
              +++     +G+ Y+H      +I+RD+K SN+ L    + ++ DFG    + +    
Sbjct: 125 ---LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWA 257
             +  KGTL Y++PE        +  D+Y+ G++L EL        + +           
Sbjct: 179 TRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD------ 230

Query: 258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD--LLKGES 315
                +   S++ D +     +++ L +           KPE RP   E+L    +  +S
Sbjct: 231 ---LRDGIISDIFDKKEK-TLLQKLLSK-----------KPEDRPNTSEILRTLTVWKKS 275

Query: 316 KEK 318
            EK
Sbjct: 276 PEK 278

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (316), Expect = 4e-33
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 35/232 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEIL 88
           +       LGEG FG V   +              +AVK LK  + + ++ +   E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 89  ARV-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL------------HGQHSSECLL 135
             + +HKN+++L G C +     ++ +Y    +L  +L                  E  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
            +   +      A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +  
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 196 THVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            +     K T G L     APE       +   DV+SFG+L+ E+ + G  P
Sbjct: 212 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (313), Expect = 9e-33
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 40/237 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDG------SQIAVKRLKVWSNKAEM-EFAVEVEILAR 90
            N      LGEG FG V     +        + +AVK LK  ++ +E+ +   E  +L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--------------------HGQHS 130
           V H +++ L G C++    L++ +Y    SL   L                       H 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 131 SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
            E  L     +  A   ++G+ YL   A   ++HRD+ A N+L+    K +++DFG ++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 191 IPDGATHVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           + +  ++    VK + G +     A E       +   DV+SFG+LL E+ + G  P
Sbjct: 200 VYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (322), Expect = 2e-32
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 13/205 (6%)

Query: 43  DNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLL 97
              +GEG FG V+ G           +A+K  K   S+    +F  E   + +  H +++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G         I+ +      L S L  +  S   L+    +  A   +  + YL   
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESK 510

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
                +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE     
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 218 KASESCDVYSFGILLLELAS-GKKP 241
           + + + DV+ FG+ + E+   G KP
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP 592

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  124 bits (313), Expect = 3e-32
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 35/232 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEIL 88
           +       LGEG FG V   +              +AVK LK  + + ++ +   E+E++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 89  ARV-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL------------HGQHSSECLL 135
             + +HKN+++L G C +     ++ +Y    +L  +L                  E  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
            +   +      A G+ YL   A+   IHRD+ A NVL+  +   ++ADFG A+ I +  
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 196 THVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            +     K T G L     APE       +   DV+SFG+L+ E+ + G  P
Sbjct: 258 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (310), Expect = 3e-32
 Identities = 63/227 (27%), Positives = 111/227 (48%), Gaps = 33/227 (14%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ---IAVKRLKVWSNKAEM-EFAVEVEILARV-R 92
           N+  + + +GEG FG V   ++         A+KR+K +++K +  +FA E+E+L ++  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL------------HGQHSSECLLNWNRR 140
           H N+++L G C       +  +Y P+ +LL  L               +S+   L+  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
           +  A   A G+ YL   +    IHRD+ A N+L+  ++ A++ADFG ++       +   
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--- 195

Query: 201 RVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            VK T+G L     A E       + + DV+S+G+LL E+ S G  P
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (310), Expect = 4e-32
 Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 40/276 (14%)

Query: 44  NKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGY 102
            ++G G FG V+  +    G Q AVK++++   + E     E+   A +    ++ L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118

Query: 103 CAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
             EG    I  + +   SL   +   G    +  L +  +        EG+ YLH     
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA------LEGLEYLHTR--- 169

Query: 161 HIIHRDIKASNVLLDAD-FKAQVADFGFAKLIPDGATHVTTR----VKGTLGYLAPEYAM 215
            I+H D+KA NVLL +D  +A + DFG A  +       +      + GT  ++APE  M
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALPLACERKFSELADPR 273
                   D++S   ++L + +G  P  +        +  ++           + L    
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA-- 287

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                ++E L++           +P  R + +E+  
Sbjct: 288 ---QAIQEGLRK-----------EPVHRASAMELRR 309

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (310), Expect = 4e-32
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 40/237 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDG------SQIAVKRLKVW-SNKAEMEFAVEVEILAR 90
           NN  Y   +GEG FG V+  +          + +AVK LK   S   + +F  E  ++A 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--------------------HGQHS 130
             + N++ L G CA G+   ++++YM    L   L                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 131 SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
               L+   ++ IA   A G+ YL   +    +HRD+   N L+  +   ++ADFG ++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 191 IPDGATHVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           I     +           +      PE     + +   DV+++G++L E+ S G +P
Sbjct: 224 IYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (308), Expect = 4e-32
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 35/232 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVEILAR 90
           N  ++   LG G FG V     +          +AVK LK  ++  E      E+++L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--------------HGQHSSECLL 135
           +  H N+++L G C  G   L++ +Y     LL+ L                    E  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
           +    +  +   A+G+ +L   A+ + IHRD+ A N+LL      ++ DFG A+ I + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 196 THVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            +    V      L     APE       +   DV+S+GI L EL S G  P
Sbjct: 200 NY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (307), Expect = 6e-32
 Identities = 62/306 (20%), Positives = 106/306 (34%), Gaps = 40/306 (13%)

Query: 11  KVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKR 69
           +VS R E  +   +      +       +F   ++LG G +G V+  +   DG   AVKR
Sbjct: 30  RVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89

Query: 70  LKV--WSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL- 125
                   K       EV    +V +H   + L     EG    +  +     SL  H  
Sbjct: 90  SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGP-SLQQHCE 148

Query: 126 -HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD 184
             G    E  + W    D        + +LH      ++H D+K +N+ L    + ++ D
Sbjct: 149 AWGASLPEAQV-WGYLRDTL----LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGD 200

Query: 185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEK 244
           FG    +           +G   Y+APE  + G    + DV+S G+ +LE+A   +    
Sbjct: 201 FGLLVELGTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHG 257

Query: 245 VNS--AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP 302
                 +++               S              EL+ V+   +      P+ R 
Sbjct: 258 GEGWQQLRQGYLPPEFT----AGLS-------------SELRSVL---VMMLEPDPKLRA 297

Query: 303 TMLEVL 308
           T   +L
Sbjct: 298 TAEALL 303

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (304), Expect = 8e-32
 Identities = 64/284 (22%), Positives = 110/284 (38%), Gaps = 26/284 (9%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS-NKAEMEFAV-EVEILARV 91
           S   ++     +G G +G     +   DG  +  K L   S  +AE +  V EV +L  +
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 92  RHKNLLSLRGYCAEGQERL--IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
           +H N++       +       IV +Y     L S +         L+    + +      
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 150 GIVYLH--HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            +   H        ++HRD+K +NV LD     ++ DFG A+++    +   T V GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPY 181

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACERKF 266
           Y++PE       +E  D++S G LL EL +   P    +   +   I         E KF
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------REGKF 233

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL 310
             +           +EL  ++   L     K   RP++ E+L+ 
Sbjct: 234 RRIPY------RYSDELNEIITRMLNL---KDYHRPSVEEILEN 268

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (304), Expect = 2e-31
 Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 34/231 (14%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVEILAR 90
           +       LG G FG V     +          +AVK LK  +  +E      E++IL  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 91  V-RHKNLLSLRGYC-AEGQERLIVYDYMPNLSLLSHL------------HGQHSSECLLN 136
           +  H N+++L G C   G   +++ ++    +L ++L              +   +  L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 137 WNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT 196
               +  +   A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I     
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 197 HVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           +    V+     L     APE       +   DV+SFG+LL E+ S G  P
Sbjct: 204 Y----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 2e-31
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 35/232 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEM-EFAVEVEIL 88
           +       LGEG FG V   +            +++AVK LK  + + ++ +   E+E++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 89  ARV-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL------------HGQHSSECLL 135
             + +HKN+++L G C +     ++ +Y    +L  +L            +  H+ E  L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
           +    +  A   A G+ YL   A+   IHRD+ A NVL+  D   ++ADFG A+ I    
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 196 THVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
            +     K T G L     APE       +   DV+SFG+LL E+ + G  P
Sbjct: 246 YY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  118 bits (299), Expect = 5e-31
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 46  LGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
           LG+G +G VY G+      +IA+K +    ++       E+ +   ++HKN++   G  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 105 EGQERLIVYDYMPNLSLLSHLHGQH----SSECLL-NWNRRMDIAIGSAEGIVYLHHHAT 159
           E     I  + +P  SL + L  +      +E  +  + +++       EG+ YLH +  
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLHDN-- 141

Query: 160 PHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
             I+HRDIK  NVL++      +++DFG +K +        T   GTL Y+APE    G 
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199

Query: 219 --ASESCDVYSFGILLLELASGKKP 241
               ++ D++S G  ++E+A+GK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  118 bits (298), Expect = 2e-30
 Identities = 65/328 (19%), Positives = 126/328 (38%), Gaps = 45/328 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVK-----------------RLKVWSNKAEME 80
           N++     L +G F  +   +  D    A+K                   K+       +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 81  FAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRR 140
           F  E++I+  ++++  L+  G      E  I+Y+YM N S+L         +        
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 141 MDIAI----GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT 196
           + +             Y+H+    +I HRD+K SN+L+D + + +++DFG ++ + D   
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 197 HVTTRVKGTLGYLAPEYAML-GKAS---ESCDVYSFGILLLELASGKKP------IEKVN 246
              +R  GT  ++ PE      ++S      D++S GI L  +     P      + ++ 
Sbjct: 208 K-GSR--GTYEFMPPE--FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262

Query: 247 SAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLE 306
           + I+    ++ L                + NF+  E    + + L      P +R T  +
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR---KNPAERITSED 319

Query: 307 VLD--LLKGESKEKLTELENDELFKSHQ 332
            L    L   + E L E  + EL+K  +
Sbjct: 320 ALKHEWLADTNIEDLRE-FSKELYKKRK 346

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (296), Expect = 3e-30
 Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 40/237 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGS------QIAVKRLKVWSNKAEM-EFAVEVEILAR 90
            N  +   LG G FG V     +  S      Q+AVK LK  ++ +E      E++++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-------------------HGQHS 130
           +  H+N+++L G C       ++++Y     LL++L                     +  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 131 SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
              +L +   +  A   A+G+ +L        +HRD+ A NVL+      ++ DFG A+ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 191 IPDGATHVTTRVKGTLGYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
           I   + +    V      L     APE    G  +   DV+S+GILL E+ S G  P
Sbjct: 222 IMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  119 bits (299), Expect = 4e-30
 Identities = 61/288 (21%), Positives = 113/288 (39%), Gaps = 48/288 (16%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARV-RHKNL 96
           +F   + LG G  G++ +  ++D   +AVKR+          FA  EV++L     H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           +       + Q + I  +     +L  ++  +  +   L     + +   +  G+ +LH 
Sbjct: 81  IRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHLHS 136

Query: 157 HATPHIIHRDIKASNVLL-----DADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYL 209
               +I+HRD+K  N+L+         KA ++DFG  K +  G  +    + V GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 210 APEY---AMLGKASESCDVYSFGILLLELASGKKP------IEKVNSAIKRTITDWALPL 260
           APE          + + D++S G +   + S            + N  +     D    L
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD---CL 250

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
             E+    +A        +E+                P+KRP+   VL
Sbjct: 251 HPEKHEDVIAR-----ELIEK-----------MIAMDPQKRPSAKHVL 282

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 5e-30
 Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 49/285 (17%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL---KVWSNKAEMEFAVEVEILARVRH 93
            +F     LG+G FG+VY  +       +A+K L   ++     E +   EVEI + +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS------ 147
            N+L L GY  +     ++ +Y P  ++   L              + D    +      
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITEL 118

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           A  + Y H      +IHRDIK  N+LL +  + ++ADFG++   P           GTL 
Sbjct: 119 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLD 172

Query: 208 YLAPEYAMLGKAS--ESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACER 264
           YL PE  M+      E  D++S G+L  E   GK P E        + I         E 
Sbjct: 173 YLPPE--MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SRVEF 224

Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            F     P    +FV E  + ++   L      P +RP + EVL+
Sbjct: 225 TF-----P----DFVTEGARDLISRLLK---HNPSQRPMLREVLE 257

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (293), Expect = 6e-30
 Identities = 80/326 (24%), Positives = 136/326 (41%), Gaps = 42/326 (12%)

Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATN---NFNYDNKLGEGGFGSVYWGQ-LWDGSQI 65
           G  +   + G         +L+ +    +     +   K+GEG  G V   +    G Q+
Sbjct: 14  GTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQV 73

Query: 66  AVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL 125
           AVK + +   +       EV I+   +H N++ +      G+E  ++ +++   +L   +
Sbjct: 74  AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 133

Query: 126 HGQHSSECLLNWNRRMDIAIGSAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQV 182
                +E          IA         + YLH      +IHRDIK+ ++LL  D + ++
Sbjct: 134 SQVRLNE--------EQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKL 182

Query: 183 ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           +DFGF   I        + V GT  ++APE       +   D++S GI+++E+  G+ P 
Sbjct: 183 SDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241

Query: 243 EKVN--SAIKRTITDWALP-LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPE 299
              +   A+KR + D   P L    K S    P L  +F+E  L R            P+
Sbjct: 242 FSDSPVQAMKR-LRDSPPPKLKNSHKVS----PVLR-DFLERMLVR-----------DPQ 284

Query: 300 KRPTMLEVLD---LLKGESKEKLTEL 322
           +R T  E+LD   LL+    E L  L
Sbjct: 285 ERATAQELLDHPFLLQTGLPECLVPL 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (291), Expect = 7e-30
 Identities = 64/291 (21%), Positives = 111/291 (38%), Gaps = 49/291 (16%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGY 102
            LG GGFG V+  +   D    A+KR+++ + +   E  + EV+ LA++ H  ++     
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 103 CAEGQERL------------IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
             E                 I        +L   ++G+ + E     +  + I +  AE 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVCLHIFLQIAEA 130

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-----------PDGATHVT 199
           + +LH      ++HRD+K SN+    D   +V DFG    +           P  A    
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 200 TRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWAL 258
           T   GT  Y++PE  + G + S   D++S G++L EL     P       ++       L
Sbjct: 188 TGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR------TL 237

Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                 KF  L   +            +V   L      P +RP  + +++
Sbjct: 238 TDVRNLKFPPLFTQKY------PCEYVMVQDML---SPSPMERPEAINIIE 279

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (289), Expect = 1e-29
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 42/306 (13%)

Query: 30  LKELHSATN---NFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEV 85
           L+ + S  +    +    K+G+G  G+VY    +  G ++A++++ +     +     E+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAI 145
            ++   ++ N+++       G E  +V +Y+   SL   +      E          IA 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAA 120

Query: 146 GSAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
              E    + +LH +    +IHRDIK+ N+LL  D   ++ DFGF   I    +  +T V
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALP- 259
            GT  ++APE           D++S GI+ +E+  G+ P    N   A+   I     P 
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPE 235

Query: 260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESK 316
           L    K S         +F+   L+              EKR +  E+L    L   +  
Sbjct: 236 LQNPEKLS----AIFR-DFLNRCLEM-----------DVEKRGSAKELLQHQFLKIAKPL 279

Query: 317 EKLTEL 322
             LT L
Sbjct: 280 SSLTPL 285

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (296), Expect = 4e-29
 Identities = 83/361 (22%), Positives = 139/361 (38%), Gaps = 47/361 (13%)

Query: 39  NFNYDNKLGEGGFGSVY-WGQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNL 96
            +    +LG GGFG V  W     G Q+A+K+ +   +    E + +E++I+ ++ H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 97  LSL------RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWN--RRMDIAIGSA 148
           +S           A     L+  +Y     L  +L+ Q  + C L     R +   I SA
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSA 133

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ---VADFGFAKLIPDGATHVTTRVKGT 205
             + YLH +    IIHRD+K  N++L    +     + D G+AK +  G    T  V GT
Sbjct: 134 --LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GT 186

Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE----------KVNSAIKRTITD 255
           L YLAPE     K + + D +SFG L  E  +G +P            KV       I  
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES 315
           +       +  S L  P      +  +L+R +   L        +R T  +  ++     
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW---HQRQRGTDPQNPNV----- 298

Query: 316 KEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDELFKSHQVADYNDGKAVAE 375
                 L++    K   V +   G+            +  +E  ++ +     D     E
Sbjct: 299 -GCFQALDSILSLKLLSVMNMVSGRVHTY-------PVTENENLQNLKSWLQQDTGIPEE 350

Query: 376 D 376
           +
Sbjct: 351 E 351

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  112 bits (282), Expect = 1e-28
 Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 40/239 (16%)

Query: 20  KKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL---KVWSN 75
             +  + I          ++F+    LG+G FG+VY  +   +   +A+K L   ++   
Sbjct: 6   MPKRKFTI----------DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE 55

Query: 76  KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLL 135
             E +   E+EI + +RH N+L +  Y  + +   ++ ++ P   L   L          
Sbjct: 56  GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-------- 107

Query: 136 NWNRRMDIAIGS------AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK 189
             + R D    +      A+ + Y H      +IHRDIK  N+L+    + ++ADFG++ 
Sbjct: 108 --HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSV 162

Query: 190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKAS--ESCDVYSFGILLLELASGKKPIEKVN 246
             P           GTL YL PE  M+   +  E  D++  G+L  E   G  P +  +
Sbjct: 163 HAPSLRRRTMC---GTLDYLPPE--MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (281), Expect = 3e-28
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 36/273 (13%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRGY 102
           K+G+G FG V+ G        +A+K + +   + E+E    E+ +L++     +    G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE---GIVYLHHHAT 159
             +  +  I+ +Y+   S L  L      E          IA    E   G+ YLH    
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLDE--------TQIATILREILKGLDYLHSE-- 138

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
              IHRDIKA+NVLL    + ++ADFG A  + D      T V GT  ++APE       
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 196

Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
               D++S GI  +ELA G+ P  +++            P+       +   P L GN+ 
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELH------------PMKVLFLIPKNNPPTLEGNY- 243

Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
            + LK  V   L     +P  RPT     +LLK
Sbjct: 244 SKPLKEFVEACLN---KEPSFRPT---AKELLK 270

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  111 bits (280), Expect = 3e-28
 Identities = 72/301 (23%), Positives = 130/301 (43%), Gaps = 48/301 (15%)

Query: 40  FNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
           +    +LG+G FG VY  +    G+  A K ++  S +   ++ VE+EILA   H  ++ 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD---IAIGSAE---GIV 152
           L G      +  I+ ++ P  ++            +L  +R +    I +   +    + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAV---------DAIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           +LH      IIHRD+KA NVL+  +   ++ADFG +           + + GT  ++APE
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPE 187

Query: 213 YAMLGKASES-----CDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALP-LACER 264
             M     ++      D++S GI L+E+A  + P  ++N    + + I     P L    
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSDPPTLLTPS 246

Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLTE 321
           K+S         +F++  L +            PE RP+  ++L+   +    S + L E
Sbjct: 247 KWS----VEFR-DFLKIALDK-----------NPETRPSAAQLLEHPFVSSITSNKALRE 290

Query: 322 L 322
           L
Sbjct: 291 L 291

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (280), Expect = 3e-28
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 19/205 (9%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEME-----FAVEVEILARVRHKNL 96
           KLG GG  +VY  +  D     ++A+K +       E E     F  EV   +++ H+N+
Sbjct: 18  KLGGGGMSTVYLAE--DTILNIKVAIKAIF--IPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           +S+     E     +V +Y+   +L  ++         L+ +  ++      +GI + H 
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHD 129

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
                I+HRDIK  N+L+D++   ++ DFG AK + + +   T  V GT+ Y +PE A  
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 217 GKASESCDVYSFGILLLELASGKKP 241
               E  D+YS GI+L E+  G+ P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  111 bits (280), Expect = 3e-28
 Identities = 81/326 (24%), Positives = 131/326 (40%), Gaps = 48/326 (14%)

Query: 13  SDRKEKGKKQPTWRIFSLKELHSATN---NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVK 68
           S    + +  P  ++  L E          F+   KLGEG +GSVY       G  +A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 69  RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ 128
           ++ V       E   E+ I+ +    +++   G   +  +  IV +Y    S+       
Sbjct: 61  QVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV------- 111

Query: 129 HSSECLLNWNRRMD---IAIGSAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQV 182
             S+ +   N+ +    IA        G+ YLH       IHRDIKA N+LL+ +  A++
Sbjct: 112 --SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL 166

Query: 183 ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI 242
           ADFG A  + D      T + GT  ++APE       +   D++S GI  +E+A GK P 
Sbjct: 167 ADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

Query: 243 EKVN--SAIKRTITDWALP-LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPE 299
             ++   AI   I     P       +S         +FV+            C    PE
Sbjct: 226 ADIHPMRAI-FMIPTNPPPTFRKPELWS----DNFT-DFVK-----------QCLVKSPE 268

Query: 300 KRPTMLEVLD---LLKGESKEKLTEL 322
           +R T  ++L    +   +    L +L
Sbjct: 269 QRATATQLLQHPFVRSAKGVSILRDL 294

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  111 bits (280), Expect = 3e-28
 Identities = 62/329 (18%), Positives = 112/329 (34%), Gaps = 77/329 (23%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN 95
            ++F     LG+G FG V   +   D    A+K+++  + +       EV +LA + H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 96  LLSLRGYCAEGQERL-------------IVYDYMPNLSLLSHL--HGQHSSECL-LNWNR 139
           ++       E +  +             I  +Y  N +L   +     +          R
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 140 RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV- 198
           ++       E + Y+H      IIHRD+K  N+ +D     ++ DFG AK +      + 
Sbjct: 124 QI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 199 -------------TTRVKGTLGYLAPEYAMLGKAS--ESCDVYSFGILLLELASG----- 238
                        T+ + GT  Y+A E  + G     E  D+YS GI+  E+        
Sbjct: 175 LDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232

Query: 239 --KKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHS 296
                ++K+ S           P   +    ++         +   +             
Sbjct: 233 ERVNILKKLRSVSIE------FPPDFDDNKMKVE-----KKIIRLLIDH----------- 270

Query: 297 KPEKRPTMLEVLD---LLKGESKEKLTEL 322
            P KRP    +L+   L      E + E 
Sbjct: 271 DPNKRPGARTLLNSGWLPVKHQDEVIKEA 299

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  111 bits (279), Expect = 5e-28
 Identities = 61/292 (20%), Positives = 113/292 (38%), Gaps = 45/292 (15%)

Query: 38  NNFNYD--NKLGEGGFGSVYWGQLWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRH 93
               Y    ++G GG   V+          A+K +    ++   ++ +  E+  L +++ 
Sbjct: 26  KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 94  KNL--LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGI 151
            +   + L  Y    Q   +V +   N+ L S L  + S    ++   R        E +
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERKSYWKNMLEAV 140

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-VKGTLGYLA 210
             +H H    I+H D+K +N L+  D   ++ DFG A  +    T V      GT+ Y+ 
Sbjct: 141 HTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 211 PE-----------YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITDWA 257
           PE                K S   DV+S G +L  +  GK P +++ + I +   I D  
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256

Query: 258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
             +                +  E++L+ V+     C    P++R ++ E+L 
Sbjct: 257 HEIEFP-------------DIPEKDLQDVL---KCCLKRDPKQRISIPELLA 292

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (281), Expect = 5e-28
 Identities = 36/305 (11%), Positives = 75/305 (24%), Gaps = 49/305 (16%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV---EVEILARVRHK 94
                  L  G    V+  +  +     A+K   + +  +  E           AR+  +
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 95  NLLSLRGYC-----------------------AEGQERLIVYDYMP-----NLSLLSHLH 126
           +    R                           +          MP        L S L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 127 GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG 186
             +             +          L       ++H      N+ +  D +  + D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPIEK 244
               +       +      + Y   E+     A  + + + +  G+ +  +     P   
Sbjct: 240 ALWKVGTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
           V   IK +   W  P         LA        + + +K ++   L        +R   
Sbjct: 296 VTPGIKGS---WKRPSLRVPGTDSLAFGSCTP--LPDFVKTLIGRFLN---FDRRRRLLP 347

Query: 305 LEVLD 309
           LE ++
Sbjct: 348 LEAME 352

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (276), Expect = 1e-27
 Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 34/296 (11%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRGY 102
            +G G    V          ++A+KR+ +   +  M+    E++ +++  H N++S    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD---IAIGSAE---GIVYLHH 156
                E  +V   +   S+L  +  +H      + +  +D   IA    E   G+ YLH 
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK----GTLGYLAPE 212
           +     IHRD+KA N+LL  D   Q+ADFG +  +  G      +V+    GT  ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 213 YAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
                +      D++SFGI  +ELA+G  P  K             L L  +     L  
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------KVLMLTLQNDPPSLET 249

Query: 272 PRLNGNFVEE---ELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLTE 321
              +   +++     ++++ + L      PEKRPT  E+L      K ++KE L E
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQ---KDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (278), Expect = 1e-27
 Identities = 63/294 (21%), Positives = 107/294 (36%), Gaps = 52/294 (17%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGY 102
            L EGGF  VY  Q +  G + A+KRL     +       EV  + ++  H N++     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 103 CAEGQER--------LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
            + G+E         L++ +      L+  L  +  S   L+ +  + I   +   + ++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKG-QLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK----------- 203
           H    P IIHRD+K  N+LL      ++ DFG A  I     +  +  +           
Sbjct: 153 HRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 204 GTLGYLAPEYAMLGKAS-----ESCDVYSFGILLLELASGKKPIEKVNS-AIKRTITDWA 257
            T  Y  PE  ++   S     E  D+++ G +L  L   + P E      I        
Sbjct: 212 TTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN------ 263

Query: 258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL 311
                  K+S                  ++   L      PE+R ++ EV+  L
Sbjct: 264 ------GKYSIPPHDT-----QYTVFHSLIRAMLQ---VNPEERLSIAEVVHQL 303

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (280), Expect = 2e-27
 Identities = 65/304 (21%), Positives = 113/304 (37%), Gaps = 57/304 (18%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARV-RHKN 95
           N    +  LG G  G+V +   + G  +AVKR+         + A+ E+++L     H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLLTESDDHPN 70

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAI---GSAEGIV 152
           ++         +   I  +   NL+L   +  ++ S+  L   +  +        A G+ 
Sbjct: 71  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 153 YLHHHATPHIIHRDIKASNVLLD-------------ADFKAQVADFGFAKLIPDGATHVT 199
           +LH      IIHRD+K  N+L+               + +  ++DFG  K +  G +   
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 200 TRVK---GTLGYLAPE-------YAMLGKASESCDVYSFGILLLELASGKKP----IEKV 245
           T +    GT G+ APE            + + S D++S G +   + S  K         
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 246 NSAIKRTITDW-ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
            S I R I     +    +R     A      + + +                P KRPT 
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEAT-----DLISQ-----------MIDHDPLKRPTA 290

Query: 305 LEVL 308
           ++VL
Sbjct: 291 MKVL 294

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (277), Expect = 2e-27
 Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 45/292 (15%)

Query: 38  NNFNYD--NKLGEGGFGSVYWGQLWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRH 93
               Y    ++G GG   V+          A+K +    ++   ++ +  E+  L +++ 
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 94  KNL--LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGI 151
            +   + L  Y    Q   +V +   N+ L S L  + S    ++   R        E +
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAV 121

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR-VKGTLGYLA 210
             +H H    I+H D+K +N L+  D   ++ DFG A  +    T V      GT+ Y+ 
Sbjct: 122 HTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 211 PE-----------YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITDWA 257
           PE                K S   DV+S G +L  +  GK P +++ + I +   I D  
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237

Query: 258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
             +       +           ++ LK        C    P++R ++ E+L 
Sbjct: 238 HEIEFPDIPEKDL---------QDVLKC-------CLKRDPKQRISIPELLA 273

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  113 bits (283), Expect = 3e-27
 Identities = 49/278 (17%), Positives = 92/278 (33%), Gaps = 48/278 (17%)

Query: 45  KLGEGGFGSVYWG--QLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHKNLLSLRG 101
            +  GG G +Y    +  +G  + +K L    +         E + LA V H +++ +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 102 YCAEGQERL-----IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           +             IV +Y+   SL      +      L     +   +     + YLH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLHS 200

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
                +++ D+K  N++L  + + ++ D G    I          + GT G+ APE    
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIVR- 250

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
              + + D+Y+ G  L  L                      LP        +    +   
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLP-------EDDPVLKTY- 294

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRP-TMLEVLDLLKG 313
               +   R++  A+      P +R  T  E+   L G
Sbjct: 295 ----DSYGRLLRRAI---DPDPRQRFTTAEEMSAQLTG 325

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  110 bits (276), Expect = 5e-27
 Identities = 76/403 (18%), Positives = 139/403 (34%), Gaps = 61/403 (15%)

Query: 11  KVSDRKEKGKKQPTWRIFSLKELHSATNNFNYD--NKLGEGGFGSVYWGQLWDGSQIAVK 68
           +  D  + G         S  E  S      Y    ++G GG   V+          A+K
Sbjct: 28  QHMDSPDLGTDDDDKASSSANECIS-VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86

Query: 69  R--LKVWSNKAEMEFAVEVEILARVRHKNL--LSLRGYCAEGQERLIVYDYMPNLSLLSH 124
              L+   N+    +  E+  L +++  +   + L  Y    Q   +V +   N+ L S 
Sbjct: 87  YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145

Query: 125 LHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD 184
           L  + S    ++   R        E +  +H H    I+H D+K +N L+  D   ++ D
Sbjct: 146 LKKKKS----IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 197

Query: 185 FGFAKLIPDGATHVTTR-VKGTLGYLAPE-----------YAMLGKASESCDVYSFGILL 232
           FG A  +    T V      G + Y+ PE                K S   DV+S G +L
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

Query: 233 LELASGKKPIEKVNSAIKR--TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVA 290
             +  GK P +++ + I +   I D    +    +F +           E++L+ V+   
Sbjct: 258 YYMTYGKTPFQQIINQISKLHAIIDPNHEI----EFPD---------IPEKDLQDVL--- 301

Query: 291 LTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKL 350
             C    P++R ++ E+L                    +          K   E+    L
Sbjct: 302 KCCLKRDPKQRISIPELL---------------AHPYVQIQTHPVNQMAKGTTEEMKYVL 346

Query: 351 AELENDELFKSHQVADYNDGKAVAEDSTDSISEEKDLKQVKEE 393
            +L       S   A     +  +   + + S  K  ++ + +
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 389

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (269), Expect = 7e-27
 Identities = 59/303 (19%), Positives = 103/303 (33%), Gaps = 63/303 (20%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKV--WSNKAEMEFAVEVEILARV-R 92
           T  F+   K+G G FGSV+      DG   A+KR K     +  E     EV   A + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           H +++      AE    LI  +Y    SL   +   +            D+ +    G+ 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 153 YLHHHATPHIIHRDIKASNVLLDAD-------------------FKAQVADFGFAKLIPD 193
           Y+H      ++H DIK SN+ +                         ++ D G    I  
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 194 GATHVTTRVKGTLGYLAPE-----YAMLGKASESCDVYSFGILLLELASGKKPIEKVNS- 247
                    +G   +LA E     Y  L KA    D+++  + ++  A  +      +  
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAEPLPRNGDQW 237

Query: 248 -AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLE 306
             I++                    PR+      +E   ++       H  PE+RP+ + 
Sbjct: 238 HEIRQGRL-----------------PRIPQVL-SQEFTELL---KVMIHPDPERRPSAMA 276

Query: 307 VLD 309
           ++ 
Sbjct: 277 LVK 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  108 bits (271), Expect = 7e-27
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 24/223 (10%)

Query: 37  TNNFNY--DNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAVEVEILARVR 92
           T+N  +   + LG+G   +V+ G+    G   A+K    +   +       E E+L ++ 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 93  HKNLLSLRGYCAEGQERLI--VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
           HKN++ L     E   R    + ++ P  SL + L  + S+   L  +  + +      G
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGG 124

Query: 151 IVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           + +L  +    I+HR+IK  N++     D     ++ DFG A+ + D    V+  + GT 
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTE 179

Query: 207 GYLAPE--------YAMLGKASESCDVYSFGILLLELASGKKP 241
            YL P+             K   + D++S G+     A+G  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  108 bits (271), Expect = 1e-26
 Identities = 78/333 (23%), Positives = 137/333 (41%), Gaps = 56/333 (16%)

Query: 11  KVSDRKEKGKKQPTWRIFSLKELHSATN---NFNYDNKLGEGGFGSVYWGQ-LWDGSQIA 66
              D    G +  + +   + EL    +    F+   ++G G FG+VY+ + + +   +A
Sbjct: 24  GAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVA 83

Query: 67  VKRLKVWSNKAEMEFA---VEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLS 123
           +K++     ++  ++     EV  L ++RH N +  RG         +V +Y        
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC------- 136

Query: 124 HLHGQHSSECLLNWNRRMD---IAIGSAE---GIVYLHHHATPHIIHRDIKASNVLLDAD 177
                 +S+ L    + +    IA  +     G+ YLH H   ++IHRD+KA N+LL   
Sbjct: 137 ---LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 190

Query: 178 FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE---SCDVYSFGILLLE 234
              ++ DFG A ++    + V     GT  ++APE  +     +     DV+S GI  +E
Sbjct: 191 GLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245

Query: 235 LASGKKPIEKVN--SAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT 292
           LA  K P+  +N  SA+   I     P      +S         NFV+           +
Sbjct: 246 LAERKPPLFNMNAMSAL-YHIAQNESPALQSGHWS----EYFR-NFVD-----------S 288

Query: 293 CAHSKPEKRPTMLEVLD---LLKGESKEKLTEL 322
           C    P+ RPT   +L    +L+      + +L
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  107 bits (269), Expect = 1e-26
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEME-----FAVEVEILARVRHKNL 96
            LG GG   V+  +  D      +AVK L+  ++ A        F  E +  A + H  +
Sbjct: 19  ILGFGGMSEVHLAR--DLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 97  LSLRGY-CAEGQERLIVY---DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           +++     AE     + Y   +Y+  ++L   +H +      +   R +++   + + + 
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALN 130

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT--RVKGTLGYLA 210
           + H +    IIHRD+K +N+++ A    +V DFG A+ I D    VT    V GT  YL+
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKP 241
           PE A         DVYS G +L E+ +G+ P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (269), Expect = 2e-26
 Identities = 48/252 (19%), Positives = 82/252 (32%), Gaps = 32/252 (12%)

Query: 13  SDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKR--- 69
            +  E   K P  +     E    +      + LGEG F  VY     D +    K+   
Sbjct: 42  PNTFEWQCKLPAIKPK--TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFV 99

Query: 70  LKVWSNKAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL- 125
           LKV       EF +  +++ R++       +            ++V +     +LL+ + 
Sbjct: 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN 159

Query: 126 HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL----------- 174
             +++ E ++     +  A+     I  +H      IIH DIK  N +L           
Sbjct: 160 LYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216

Query: 175 DADFKAQVADFGFA---KLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS--ESCDVYSFG 229
           D      + D G +   KL P G          T G+   E  ML         D +   
Sbjct: 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKC--ETSGFQCVE--MLSNKPWNYQIDYFGVA 272

Query: 230 ILLLELASGKKP 241
             +  +  G   
Sbjct: 273 ATVYCMLFGTYM 284

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  105 bits (265), Expect = 3e-26
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 29/211 (13%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG+G F  VY  + +  G ++A+K   +  ++          EV+I  +++H ++L L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS------AEGIVYLH 155
           Y  +     +V +   N  +  +L  +          +                G++YLH
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNR---------VKPFSENEARHFMHQIITGMLYLH 129

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFA-KLIPDGATHVTTRVKGTLGYLAPEYA 214
            H    I+HRD+  SN+LL  +   ++ADFG A +L      H T    GT  Y++PE  
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPE-- 182

Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIE 243
           +  ++      DV+S G +   L  G+ P +
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  107 bits (269), Expect = 3e-26
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 24/223 (10%)

Query: 37  TNNFNY--DNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAVEVEILARVR 92
           T+N  +   + LG+G   +V+ G+    G   A+K    +   +       E E+L ++ 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 93  HKNLLSLRGYCAEGQERLI--VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
           HKN++ L     E   R    + ++ P  SL + L  + S+   L  +  + +      G
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGG 124

Query: 151 IVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
           + +L  +    I+HR+IK  N++     D     ++ DFG A+ + D      +   GT 
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTE 179

Query: 207 GYLAPE--------YAMLGKASESCDVYSFGILLLELASGKKP 241
            YL P+             K   + D++S G+     A+G  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (264), Expect = 6e-26
 Identities = 46/208 (22%), Positives = 76/208 (36%), Gaps = 25/208 (12%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEME--------FAVEVEILARVRH 93
            +G GG G VY  +  D      +A+K +        +            E     R++ 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMS-----ETLSSDPVFRTRMQREARTAGRLQE 93

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
            +++ +  +     +  +    +  + L + L  Q      L   R + I       +  
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDA 149

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
            H        HRD+K  N+L+ AD  A + DFG A    D          GTL Y+APE 
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 214 AMLGKASESCDVYSFGILLLELASGKKP 241
                A+   D+Y+   +L E  +G  P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (264), Expect = 7e-26
 Identities = 66/308 (21%), Positives = 121/308 (39%), Gaps = 49/308 (15%)

Query: 21  KQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM 79
              +     L  L      F     +G G +G VY G+ +  G   A+K + V  ++ E 
Sbjct: 7   PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE- 65

Query: 80  EFAVEVEILARV-RHKNLLS-----LRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSE 132
           E   E+ +L +   H+N+ +     ++       ++L +V ++    S+   +       
Sbjct: 66  EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--- 122

Query: 133 CLLNWNRRMD---IAIGSAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG 186
                   +    IA    E   G+ +LH H    +IHRDIK  NVLL  + + ++ DFG
Sbjct: 123 -----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174

Query: 187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASES-----CDVYSFGILLLELASGKKP 241
            +  +        T + GT  ++APE     +  ++      D++S GI  +E+A G  P
Sbjct: 175 VSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

Query: 242 IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSK-PEK 300
           +  ++          AL L           PRL      ++ +  +   L     K   +
Sbjct: 234 LCDMHPM-------RALFLIPRNPA-----PRLKSKKWSKKFQSFIESCLV----KNHSQ 277

Query: 301 RPTMLEVL 308
           RP   +++
Sbjct: 278 RPATEQLM 285

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  104 bits (261), Expect = 3e-25
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 30/211 (14%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG+GGF   +           A K   +  +       + ++E+ I   + H++++   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD------IAIGSAEGIVYLH 155
           +  +     +V +     SLL     +          + +              G  YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLH 158

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEYA 214
            +    +IHRD+K  N+ L+ D + ++ DFG A  +  DG         GT  Y+APE  
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPE-- 211

Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIE 243
           +L K   S   DV+S G ++  L  GK P E
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  103 bits (259), Expect = 3e-25
 Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 30/211 (14%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG+GGF   +           A K   +  +       + ++E+ I   + H++++   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD------IAIGSAEGIVYLH 155
           +  +     +V +     SLL                + +              G  YLH
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLH 132

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEYA 214
            +    +IHRD+K  N+ L+ D + ++ DFG A  +  DG         GT  Y+APE  
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPE-- 185

Query: 215 MLGKA--SESCDVYSFGILLLELASGKKPIE 243
           +L K   S   DV+S G ++  L  GK P E
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  103 bits (260), Expect = 3e-25
 Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 46/284 (16%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME-FAVEVEILAR-VRHKNLLSLRG 101
           ++G G +GSV        G  +AVKR++   ++ E +   ++++++ R      ++   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMD------IAIGSAEGIVYLH 155
                 +  I  + M + S                 +  +       I + + + + +L 
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYK-----YVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPE-- 212
            +    IIHRDIK SN+LLD     ++ DFG   +L+    +   TR  G   Y+APE  
Sbjct: 143 ENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERI 197

Query: 213 --YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWA---LPLACERK 265
              A         DV+S GI L ELA+G+ P  K NS       +       L  + ER+
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257

Query: 266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
           FS         NFV             C      KRP   E+L 
Sbjct: 258 FSPSFI-----NFVN-----------LCLTKDESKRPKYKELLK 285

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (260), Expect = 3e-25
 Identities = 60/326 (18%), Positives = 122/326 (37%), Gaps = 47/326 (14%)

Query: 15  RKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW 73
           ++ +       ++  LK+     ++F   ++LG G  G V+       G  +A K + + 
Sbjct: 15  KRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69

Query: 74  SNKAEMEFAV-EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSL--LSHLHGQHS 130
              A     + E+++L       ++   G      E  I  ++M   SL  +    G+  
Sbjct: 70  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 129

Query: 131 SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
            + L        ++I   +G+ YL       I+HRD+K SN+L+++  + ++ DFG +  
Sbjct: 130 EQIL------GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181

Query: 191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK 250
           + D  +   + V GT  Y++PE       S   D++S G+ L+E+A G+ PI   ++   
Sbjct: 182 LID--SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

Query: 251 RTITDWALPLACERKFSELADPRLNGNFVEEELK--RVVLVALT---------------- 292
             +    +             P    N    + +    +   L                 
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298

Query: 293 ---------CAHSKPEKRPTMLEVLD 309
                    C    P +R  + +++ 
Sbjct: 299 LEFQDFVNKCLIKNPAERADLKQLMV 324

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (261), Expect = 4e-25
 Identities = 62/364 (17%), Positives = 117/364 (32%), Gaps = 58/364 (15%)

Query: 44  NKLGEG--GFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLS 98
             +G+G     +V   +    G  + V+R+ + +   EM   +  E+ +     H N++ 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAI---GSAEGIVYLH 155
            R       E  +V  +M   S    L   H  + +      + IA    G  + + Y+H
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGM----NELAIAYILQGVLKALDYIH 145

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK------GTLGYL 209
           H      +HR +KAS++L+  D K  ++       +                    L +L
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 210 APEYAMLGKA--SESCDVYSFGILLLELASGKKP------------IEKVNSAIKRTITD 255
           +PE             D+YS GI   ELA+G  P                        + 
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262

Query: 256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSK-----------------P 298
                        +A+  L+ +      +     + +  + +                 P
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322

Query: 299 EKRPTMLEVLD-----LLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAEL 353
           + RP+   +L+      +K  + E L EL       ++     +   +        L EL
Sbjct: 323 DARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEEL 382

Query: 354 ENDE 357
           E D+
Sbjct: 383 EVDD 386

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  105 bits (264), Expect = 5e-25
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 16/212 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK---VWSNKAEMEFAVEVEILARVRH 93
           + F     LG GGFG V+  Q+    ++ A K+L    +   K      VE +ILA+V  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 94  KNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE--- 149
           + ++SL  Y  E +  L +V   M    +  H++            R       +A+   
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR---AIFYTAQIVS 300

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           G+ +LH     +II+RD+K  NVLLD D   +++D G A  +  G T       GT G++
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFM 356

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKP 241
           APE  +  +   S D ++ G+ L E+ + + P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (259), Expect = 9e-25
 Identities = 37/302 (12%), Positives = 82/302 (27%), Gaps = 62/302 (20%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV---EVEILARVRH-------- 93
           LG+    +         G    V                   EV  L  +R         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 94  --------KNLLSLRGYCAEGQER--------LIVYDYMP-----NLSLLSHLHGQHSSE 132
                    +L+         + R        L  +   P       +    L    S+ 
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
             L  + R+ + +     +  LHH+    ++H  ++  +++LD      +  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 193 DGATHVTTRVKGTLGYLAPEYAMLGKA-----SESCDVYSFGILLLELASGKKPIEKVNS 247
             A     R        A      G+      + + D ++ G+ +  +     P    ++
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DA 321

Query: 248 AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEV 307
           A+  +          E  F    +       + + ++ ++   L       E R   L+ 
Sbjct: 322 ALGGS----------EWIFRSCKN-------IPQPVRALLEGFLR---YPKEDRLLPLQA 361

Query: 308 LD 309
           ++
Sbjct: 362 ME 363

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (255), Expect = 2e-24
 Identities = 36/308 (11%), Positives = 85/308 (27%), Gaps = 73/308 (23%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKA--------------------------- 77
           LG+    +         G    V                                     
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 78  -EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM----PNLSLLSHLHGQHSSE 132
             + F    +++   + K ++ +R    +       + Y        +    L    S+ 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
             L  + R+ + +     +  LHH+    ++H  ++  +++LD      +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 255

Query: 193 DGATHVTTRVKGTLGYLAPEY-----------AMLGKASESCDVYSFGILLLELASGKKP 241
           DGA  V++    + G+  PE                  + S D ++ G+++  +     P
Sbjct: 256 DGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 242 IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR 301
           I K        +          +                + ++ ++   L       E R
Sbjct: 313 ITKDA-----ALGGSEWIFRSCKNIP-------------QPVRALLEGFLR---YPKEDR 351

Query: 302 PTMLEVLD 309
              L+ ++
Sbjct: 352 LLPLQAME 359

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 62/276 (22%), Positives = 110/276 (39%), Gaps = 32/276 (11%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME-FAVEVEILAR-VRHKNLLSLR 100
            +LG G +G V   + +  G  +AVKR++   N  E +   ++++I  R V     ++  
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
           G      +  I  + M + SL             +  +    IA+   + + +LH     
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPE----YAM 215
            +IHRD+K SNVL++A  + ++ DFG    L+            G   Y+APE       
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPELN 186

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLACERKFSELADPR 273
               S   D++S GI ++ELA  + P +   +  +  + + +   P     KFS      
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV-- 244

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
              +F              C     ++RPT  E++ 
Sbjct: 245 ---DFTS-----------QCLKKNSKERPTYPELMQ 266

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (257), Expect = 6e-24
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 19/212 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK---VWSNKAEMEFAVEVEILARVRH 93
           N F     LG+GGFG V   Q+    ++ A K+L+   +   K E     E +IL +V  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 94  KNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE--- 149
           + ++SL  Y  E ++ L +V   M    L  H+   H  +      R       +AE   
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHI--YHMGQAGFPEAR---AVFYAAEICC 297

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           G+  LH      I++RD+K  N+LLD     +++D G A  +P+G T +  RV GT+GY+
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 352

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKP 241
           APE     + + S D ++ G LL E+ +G+ P
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
            +F +   LGEG F +V   +    S+  A+K L+    K  +    +V        +++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE----KRHIIKENKVPYVTRERDVMS 85

Query: 90  RVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG-- 146
           R+ H   + L  +  +  E+L     Y  N  LL ++                D      
Sbjct: 86  RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKI----------GSFDETCTRF 134

Query: 147 -SAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR- 201
            +AE    + YLH      IIHRD+K  N+LL+ D   Q+ DFG AK++   +       
Sbjct: 135 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191

Query: 202 VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             GT  Y++PE      A +S D+++ G ++ +L +G  P
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (254), Expect = 1e-23
 Identities = 66/305 (21%), Positives = 118/305 (38%), Gaps = 33/305 (10%)

Query: 13  SDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL- 70
            +   +G  Q T  +F   +    +  +    KLG G +G V          + A+K + 
Sbjct: 12  ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71

Query: 71  -KVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ- 128
               S  +  +   EV +L  + H N++ L  +  + +   +V +      L   +  + 
Sbjct: 72  KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131

Query: 129 HSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADF 185
             +E          I      G+ YLH H   +I+HRD+K  N+LL   + D   ++ DF
Sbjct: 132 KFNE-----VDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF 183

Query: 186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE-K 244
           G + +  +          GT  Y+APE  +  K  E CDV+S G++L  L +G  P   +
Sbjct: 184 GLSAVFENQ--KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240

Query: 245 VNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM 304
            +  I R +         +  F            V E  K ++   L       ++R + 
Sbjct: 241 TDQEILRKV------EKGKYTFDSPEWKN-----VSEGAKDLIKQMLQ---FDSQRRISA 286

Query: 305 LEVLD 309
            + L+
Sbjct: 287 QQALE 291

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 39/278 (14%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME-FAVEVEILAR-VRHKNLLSLRG 101
           ++G G  G V+  +    G  IAVK+++   NK E +   ++++++ +      ++   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 102 YCAEGQERLIVYDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHATP 160
                 +  I  + M   +       Q    E +L       + +   + + YL      
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL-----GKMTVAIVKALYYLKEKH-- 144

Query: 161 HIIHRDIKASNVLLDADFKAQVADFGF-AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
            +IHRD+K SN+LLD   + ++ DFG   +L+         R  G   Y+APE       
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 220 SES-----CDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP-LACERKFSELAD 271
           ++       DV+S GI L+ELA+G+ P +   +  +    +     P L     FS    
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261

Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                +FV+            C      KRP   ++L+
Sbjct: 262 -----SFVK-----------DCLTKDHRKRPKYNKLLE 283

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 23/227 (10%)

Query: 29  SLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWS--NKAEMEFA-VE 84
            LKE+    ++F     +G G F  V   ++    Q+ A+K +  W    + E+     E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 85  VEILARVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDI 143
            ++L     + +  L  +  + +  L +V +Y     LL+ L      E +     R  +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYL 168

Query: 144 A-IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTR 201
           A I  A  I  +H       +HRDIK  N+LLD     ++ADFG    L  DG       
Sbjct: 169 AEIVMA--IDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223

Query: 202 VKGTLGYLAPE-------YAMLGKASESCDVYSFGILLLELASGKKP 241
           V GT  YL+PE           G     CD ++ G+   E+  G+ P
Sbjct: 224 V-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 99.8 bits (249), Expect = 5e-23
 Identities = 69/301 (22%), Positives = 111/301 (36%), Gaps = 34/301 (11%)

Query: 18  KGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL---KVW 73
                 T  +F        ++ +     LG+G FG V        G + AVK +   +V 
Sbjct: 6   MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65

Query: 74  SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ-HSSE 132
               +     EV++L ++ H N++ L  +  +     +V +      L   +  +   SE
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125

Query: 133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAK 189
                     I      GI Y+H +    I+HRD+K  N+LL     D   ++ DFG + 
Sbjct: 126 -----VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177

Query: 190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP-IEKVNSA 248
                         GT  Y+APE  + G   E CDV+S G++L  L SG  P        
Sbjct: 178 HFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234

Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
           I + +         +  F      +     V E  K ++   LT     P  R +  + L
Sbjct: 235 ILKKV------EKGKYTFELPQWKK-----VSESAKDLIRKMLT---YVPSMRISARDAL 280

Query: 309 D 309
           D
Sbjct: 281 D 281

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 24/215 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK---VWSNKAEMEFAVEVEILARVRH 93
           ++F     +G+G FG V   Q  D  ++ A+K +                E++I+  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 94  KNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGSAEGI 151
             L++L  Y  + +E + +V D +    L  HL  Q +         ++ I  +  A  +
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQN-VHFKEETVKLFICELVMA--L 128

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
            YL +     IIHRD+K  N+LLD      + DF  A ++P      T  + GT  Y+AP
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAP 183

Query: 212 EYAMLGKASESC-----DVYSFGILLLELASGKKP 241
           E  M      +      D +S G+   EL  G++P
Sbjct: 184 E--MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 30/250 (12%)

Query: 9   CGKVSDRKEKGKKQPTWR----IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQ 64
               + RK K       R    I  +++L     ++     +G G FG V   +     +
Sbjct: 36  LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95

Query: 65  I-AVKRLKVWS--NKAEMEFA-VEVEILARVRHKNLLSLRGYCAEGQERL-IVYDYMPNL 119
           + A+K L  +    +++  F   E +I+A      ++ L  Y  +    L +V +YMP  
Sbjct: 96  VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGG 154

Query: 120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAE---GIVYLHHHATPHIIHRDIKASNVLLDA 176
            L++ +      E    W R       +AE    +  +H       IHRD+K  N+LLD 
Sbjct: 155 DLVNLMSNYDVPE---KWAR-----FYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK 203

Query: 177 DFKAQVADFGFAK-LIPDGATHVTTRVKGTLGYLAPE----YAMLGKASESCDVYSFGIL 231
               ++ADFG    +  +G     T V GT  Y++PE        G     CD +S G+ 
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262

Query: 232 LLELASGKKP 241
           L E+  G  P
Sbjct: 263 LYEMLVGDTP 272

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.0 bits (244), Expect = 3e-22
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 31/239 (12%)

Query: 17  EKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK---V 72
           +K  +   W+   L   H   N+F+    +G GGFG VY  +  D  ++ A+K L    +
Sbjct: 169 DKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227

Query: 73  WSNKAEMEFAVEVEILARVRHKN---LLSLRGYCAEGQERL-IVYDYMPNLSLLSHL--H 126
              + E     E  +L+ V   +   ++ +  Y     ++L  + D M    L  HL  H
Sbjct: 228 KMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH 286

Query: 127 GQHSSECLLNWNRRMDIAIGSAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA 183
           G  S           D+   +AE   G+ ++H+     +++RD+K +N+LLD     +++
Sbjct: 287 GVFSEA---------DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 334

Query: 184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKP 241
           D G A        H    V GT GY+APE    G A   S D +S G +L +L  G  P
Sbjct: 335 DLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 21/225 (9%)

Query: 29  SLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWS--NKAEME-FAVE 84
            +K++     +F     +G G FG V   +L +  ++ A+K L  W    +AE   F  E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 85  VEILARVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDI 143
            ++L     K + +L  Y  +    L +V DY     LL+ L      + L     R  +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYL 181

Query: 144 A-IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK-LIPDGATHVTTR 201
           A +  A  I  +H     H +HRDIK  N+L+D +   ++ADFG    L+ DG    +  
Sbjct: 182 AEMVIA--IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236

Query: 202 VKGTLGYLAPE-----YAMLGKASESCDVYSFGILLLELASGKKP 241
           V GT  Y++PE         G+    CD +S G+ + E+  G+ P
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 94.9 bits (236), Expect = 5e-22
 Identities = 56/330 (16%), Positives = 99/330 (30%), Gaps = 44/330 (13%)

Query: 2   AFGSIFCCGKVSDRKE------KGKKQPTWRIFSLKE--LHSATNNFNYDNKLGEGGFGS 53
            FG +F      D         +   +   R   ++E    +   +              
Sbjct: 18  GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77

Query: 54  VYWGQLWDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL 110
               Q              W   S       +V++  +     KN +      +      
Sbjct: 78  PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLY 137

Query: 111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKAS 170
           I        +L      +  S         + I I  AE + +LH      ++HRD+K S
Sbjct: 138 IQMQLCRKENL-KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPS 193

Query: 171 NVLLDADFKAQVADFGFAKLI-----------PDGATHVTTRVKGTLGYLAPEYAMLGKA 219
           N+    D   +V DFG    +           P  A    T   GT  Y++PE       
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253

Query: 220 SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFV 279
           S   D++S G++L EL        +    I   + +   PL   +K+ +           
Sbjct: 254 SHKVDIFSLGLILFELLYSFSTQMERVRIITD-VRNLKFPLLFTQKYPQEHM-------- 304

Query: 280 EEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                   +V    + S P +RP   ++++
Sbjct: 305 --------MVQDMLSPS-PTERPEATDIIE 325

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 70/319 (21%), Positives = 123/319 (38%), Gaps = 46/319 (14%)

Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK 68
           G+ +   +     P    +  K+      ++    KLG G +G V    +    S+ A+K
Sbjct: 10  GRENLYFQGIAINPGM--YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67

Query: 69  RLK-------------VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY 115
            +K                 K   E   E+ +L  + H N++ L     + +   +V ++
Sbjct: 68  VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127

Query: 116 MPNLSLLSHLHGQ-HSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL 174
                L   +  +    E         +I      GI YLH H   +I+HRDIK  N+LL
Sbjct: 128 YEGGELFEQIINRHKFDE-----CDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179

Query: 175 ---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGIL 231
              ++    ++ DFG +         +  R+ GT  Y+APE  +  K +E CDV+S G++
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVI 236

Query: 232 LLELASGKKP-IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVA 290
           +  L  G  P   + +  I + +         +  F            + +E K ++ + 
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKV------EKGKYYFDFNDWKN-----ISDEAKELIKLM 285

Query: 291 LTCAHSKPEKRPTMLEVLD 309
           LT       KR T  E L+
Sbjct: 286 LT---YDYNKRCTAEEALN 301

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 33/281 (11%)

Query: 37  TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL--KVWSNKAEMEFAVEVEILARVRH 93
              +N    LG+G FG V          + AVK +      NK       EVE+L ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ-HSSECLLNWNRRMDIAIGSAEGIV 152
            N++ L     +     IV +      L   +  +   SE     +    I      GI 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGIT 135

Query: 153 YLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           Y+H H   +I+HRD+K  N+LL   + D   ++ DFG +         +  R+ GT  Y+
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYI 190

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKP-IEKVNSAIKRTITDWALPLACERKFSE 268
           APE  + G   E CDV+S G++L  L SG  P   K    I + +         +  F  
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------ETGKYAFDL 243

Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                     + ++ K ++   LT     P  R T  + L+
Sbjct: 244 PQWRT-----ISDDAKDLIRKMLT---FHPSLRITATQCLE 276

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 32/226 (14%)

Query: 31  KELHSATNNFN--YD--NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEV 85
           ++LH  +  F   Y+    +G G +             + AVK +    +K++ +   E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEI 66

Query: 86  EILAR-VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ-HSSECLLNWNRRM-- 141
           EIL R  +H N+++L+    +G+   +V + M    LL  +  Q   SE       R   
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-------REAS 119

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGFAKLIPDGATH 197
            +     + + YLH      ++HRD+K SN+L           ++ DFGFAK +      
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 198 VTTRVKGTLGYLAPEYAMLGKAS--ESCDVYSFGILLLELASGKKP 241
           + T    T  ++APE  +L +     +CD++S G+LL  + +G  P
Sbjct: 177 LMTPC-YTANFVAPE--VLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 47/254 (18%), Positives = 82/254 (32%), Gaps = 52/254 (20%)

Query: 37  TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVK-----RLKVWSNKAEMEFAVEVEILAR 90
              ++    +G+G +G V    +    +  A+K     +++  + K       EV ++ +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 91  VRHKNLLSLRG-------------YCAEGQ--ERLIVYDYMPNLSLLSHLHGQHSSECLL 135
           + H N+  L                C  G   ++L V+           +       C  
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 136 NWNRRMDIAIGSA---------------------EGIVYLHHHATPHIIHRDIKASNVLL 174
                ++ +I                          + YLH+     I HRDIK  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201

Query: 175 DADFKAQV--ADFGFAKLIPDGATHVTTRVK---GTLGYLAPE--YAMLGKASESCDVYS 227
             +   ++   DFG +K            +    GT  ++APE            CD +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 228 FGILLLELASGKKP 241
            G+LL  L  G  P
Sbjct: 262 AGVLLHLLLMGAVP 275

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 52/224 (23%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK-----RLKVWSNKAEME-FAVEVEILARVR----HK 94
           LG+GGFG+V+ G  L D  Q+A+K     R+  WS  ++     +EV +L +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 95  NLLSLRG-------------YCAEGQERLIVYDYMPNLSLLSHLHGQHS-SECLLNWNRR 140
            ++ L                    Q+   ++DY+          G            R 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQD---LFDYI-------TEKGPLGEGPS-----RC 143

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAKLIPDGATHVT 199
               + +A  I + H      ++HRDIK  N+L+D     A++ DFG   L+ D      
Sbjct: 144 FFGQVVAA--IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF 198

Query: 200 TRVKGTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKP 241
               GT  Y  PE+ +      +    V+S GILL ++  G  P
Sbjct: 199 D---GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 32/212 (15%)

Query: 43  DNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLR 100
           D  LGEG F               AVK +   S + E     E+  L     H N++ L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHLHGQHS------SECLLNWNRRMDIAIGSAEGIVYL 154
               +     +V + +    L   +  +        S  +    R++         + ++
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM----RKL------VSAVSHM 122

Query: 155 HHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
           H      ++HRD+K  N+L    + + + ++ DFGFA+L P     + T    TL Y AP
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAP 178

Query: 212 EYAMLGKA--SESCDVYSFGILLLELASGKKP 241
           E  +L +    ESCD++S G++L  + SG+ P
Sbjct: 179 E--LLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 11/210 (5%)

Query: 37  TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHK 94
            + F +  KLG G FG V+   +   G +  +K +    ++  ME    E+E+L  + H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           N++ +     +     IV +      LL  +    +    L+     ++       + Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 155 HHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
           H     H++H+D+K  N+L          ++ DFG A+L      H T    GT  Y+AP
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYMAP 195

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKP 241
           E       +  CD++S G+++  L +G  P
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 26/207 (12%)

Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
            +G G +G V          + A K++  +  +    F  E+EI+  + H N++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 104 AEGQERLIVYDYMPNLSLLSH-LHGQHSSECLLNWNRRMDIA-----IGSAEGIVYLHHH 157
            +  +  +V +      L    +H +   E         D A     + SA  + Y H  
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRE--------SDAARIMKDVLSA--VAYCHKL 125

Query: 158 ATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
              ++ HRD+K  N L      D   ++ DFG A     G     T+V GT  Y++P+  
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-GTPYYVSPQ-V 179

Query: 215 MLGKASESCDVYSFGILLLELASGKKP 241
           + G     CD +S G+++  L  G  P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 31/215 (14%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLK------VWSNKAEMEFAV--EVEILARVRHKN 95
            LG G  G V    +     ++A++ +         + +A+    V  E+EIL ++ H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHS-SECLLNWNRRMDIAIGSAEGIV 152
           ++ ++ +  + ++  IV + M    L   +  + +   + C     +     +     + 
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-----KLYFYQM--LLAVQ 253

Query: 153 YLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           YLH +    IIHRD+K  NVLL   + D   ++ DFG +K++ +  + + T   GT  YL
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYL 308

Query: 210 APE---YAMLGKASESCDVYSFGILLLELASGKKP 241
           APE          + + D +S G++L    SG  P
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 31/236 (13%)

Query: 38  NNFNYDN-KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFAVEVEILARVRH 93
           + F Y+  K+G G +G VY  +  D       A+K+++       M    E+ +L  ++H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKH 77

Query: 94  KNLLSLRGYCAEGQERLI--VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGS--- 147
            N++SL+       +R +  ++DY     L   +   H +        ++    + S   
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIK-FHRASKANKKPVQLPRGMVKSLLY 135

Query: 148 --AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ----VADFGFAKL--IPDGA-THV 198
              +GI YLH +    ++HRD+K +N+L+  +   +    +AD GFA+L   P      +
Sbjct: 136 QILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 199 TTRVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPIEKVNSAIKRT 252
              V  T  Y APE  +LG    +++ D+++ G +  EL +  +PI        +T
Sbjct: 193 DPVVV-TFWYRAPEL-LLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKT 245

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 63/283 (22%), Positives = 105/283 (37%), Gaps = 59/283 (20%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK-----RLKVWSNKAEME-FAVEVEILARVRHK--NL 96
           LG GGFGSVY G  + D   +A+K     R+  W          +EV +L +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 97  LSLRGYCAEGQERLIVYDY-MPNLSLLSHL--HGQHS-SECLLNWNRRMDIAIGSAEGIV 152
           + L  +       +++ +   P   L   +   G            R     +  A  + 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-----RSFFWQVLEA--VR 163

Query: 153 YLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
           + H+     ++HRDIK  N+L+D +  + ++ DFG   L+ D          GT  Y  P
Sbjct: 164 HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPP 217

Query: 212 EYAMLGK--ASESCDVYSFGILLLELASGKKP---IEKVNSAIKRTITDWALPLACERKF 266
           E+ +        S  V+S GILL ++  G  P    E++              +   ++ 
Sbjct: 218 EW-IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ----------VFFRQRV 266

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
           S             + L R  L        +P  RPT  E+ +
Sbjct: 267 SSEC----------QHLIRWCLAL------RPSDRPTFEEIQN 293

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 49/225 (21%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
            +F     LG G FG V+  +     +  A+K LK    K  +    +VE       +L+
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK----KEIVVRLKQVEHTNDERLMLS 61

Query: 90  RVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG-- 146
            V H  ++ +     +  +++ ++ DY+    L S L  + S        +R    +   
Sbjct: 62  IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL--RKS--------QRFPNPVAKF 110

Query: 147 -SAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
            +AE    + YLH      II+RD+K  N+LLD +   ++ DFGFAK +PD    VT  +
Sbjct: 111 YAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTL 163

Query: 203 KGTLGYLAPE------YAMLGKASESCDVYSFGILLLELASGKKP 241
            GT  Y+APE      Y    K+    D +SFGIL+ E+ +G  P
Sbjct: 164 CGTPDYIAPEVVSTKPY---NKS---IDWWSFGILIYEMLAGYTP 202

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 66/295 (22%), Positives = 111/295 (37%), Gaps = 51/295 (17%)

Query: 46  LGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYC 103
           LGEG    V     L    + AVK ++            EVE+L + + H+N+L L  + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQ-HSSE----CLLNWNRRMDIAIGSAEGIVYLHHHA 158
            E     +V++ M   S+LSH+H + H +E     ++      D+A      + +LH+  
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DVA----SALDFLHNK- 130

Query: 159 TPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHV-------TTRVKGTLGY 208
              I HRD+K  N+L    +     ++ DF     I               T   G+  Y
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187

Query: 209 LAPE-----YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE 263
           +APE             + CD++S G++L  L SG  P          +   W    AC 
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF----VGRCGSDCGWDRGEACP 243

Query: 264 RKFSELADPRLNGNF---------VEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
              + L +    G +         +    K ++   L       ++R +  +VL 
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLV---RDAKQRLSAAQVLQ 295

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 37/219 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
           + F+    LG G FG V   +  +     A+K L     K ++    ++E       IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD----KQKVVKLKQIEHTLNEKRILQ 96

Query: 90  RVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG-- 146
            V    L+ L  +  +    L +V +Y+    + SHL              R        
Sbjct: 97  AVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARF 145

Query: 147 -SAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
            +A+      YLH      +I+RD+K  N+L+D     QV DFGFAK +       T  +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTL 198

Query: 203 KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            GT   LAPE  +    +++ D ++ G+L+ E+A+G  P
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 28/217 (12%)

Query: 37  TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRL--KVWSNKAEMEFAVEVEILARVRH 93
              +N    LG+G FG V          + AVK +      NK       EVE+L ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLL------SHLHGQHSSECLLNWNRRMDIAIGS 147
            N++ L     +     IV +      L              ++  +    +++      
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII----KQV------ 130

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKG 204
             GI Y+H H   +I+HRD+K  N+LL   + D   ++ DFG +            R+ G
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI-G 185

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
           T  Y+APE  + G   E CDV+S G++L  L SG  P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.8 bits (213), Expect = 8e-19
 Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 21/210 (10%)

Query: 45  KLGEGGFGSVYW------GQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS 98
            +G+G F  V        GQ +    + V +       +  +   E  I   ++H +++ 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           L    +      +V+++M    L   +  +  +  + +            E + Y H + 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149

Query: 159 TPHIIHRDIKASNVLL-----DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
             +IIHRD+K   VLL      A  K     FG A  + +       RV GT  ++APE 
Sbjct: 150 --NIIHRDVKPHCVLLASKENSAPVKL--GGFGVAIQLGESGLVAGGRV-GTPHFMAPE- 203

Query: 214 AMLGKA--SESCDVYSFGILLLELASGKKP 241
            ++ +    +  DV+  G++L  L SG  P
Sbjct: 204 -VVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.8 bits (210), Expect = 9e-19
 Identities = 31/275 (11%), Positives = 63/275 (22%), Gaps = 57/275 (20%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAE---MEFAVEVEILARVRHKNLLS 98
             G       +     D     Q+A+  +       +    E       L+R+    +  
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 99  LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA 158
           +          L+V +++   SL              +    +      A      H   
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA- 148

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              +       S V +  D        G   L                  +         
Sbjct: 149 --GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPD------- 178

Query: 219 ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNF 278
           A+   D+   G  L  L   + P+               L  A      +  +P      
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLP-------EAGVRSGLAPAERDTAGQPIEPADIDRD 231

Query: 279 VEEELKRVVLVALTCAHSKPEKRP--TMLEVLDLL 311
           +  ++  V   ++         R   T+L ++   
Sbjct: 232 IPFQISAVAARSV---QGDGGIRSASTLLNLMQQA 263

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 59/217 (27%), Positives = 87/217 (40%), Gaps = 32/217 (14%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVK-------RLKVWSNKAEMEFAV--EVEILARV-RH 93
            LG G    V          + AVK                E+  A   EV+IL +V  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHS-SECLLNWNRRMDIAIGSAEG 150
            N++ L+          +V+D M    L  +L      S  E      R++  A+   E 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET-----RKIMRAL--LEV 136

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           I  LH     +I+HRD+K  N+LLD D   ++ DFGF+  +  G       V GT  YLA
Sbjct: 137 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 191

Query: 211 PE------YAMLGKASESCDVYSFGILLLELASGKKP 241
           PE              +  D++S G+++  L +G  P
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)

Query: 32  ELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME----FAV-EV 85
           ++ S    +   + LGEG F +VY  +       +A+K++K+       +     A+ E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPN-LSLLSHLHGQHSSE----CLLNWNRR 140
           ++L  + H N++ L           +V+D+M   L ++   +    +       +     
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM----L 119

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
           M +     +G+ YLH H    I+HRD+K +N+LLD +   ++ADFG AK         T 
Sbjct: 120 MTL-----QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

Query: 201 RVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
           +V  T  Y APE  + G        D+++ G +L EL    
Sbjct: 172 QVV-TRWYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 27/216 (12%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
           N F Y   LG+G FG V   +     +  A+K LK    K  +    EV        +L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK----KEVIVAKDEVAHTLTENRVLQ 203

Query: 90  RVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGS 147
             RH  L +L+ Y  +  +RL  V +Y     L  HL  +   SE       R       
Sbjct: 204 NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE------DRA--RFYG 254

Query: 148 AEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGT 205
           AE +  L + H+  ++++RD+K  N++LD D   ++ DFG  K  I DGAT       GT
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGT 312

Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             YLAPE         + D +  G+++ E+  G+ P
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 82.6 bits (205), Expect = 6e-18
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 37  TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN 95
              F +   LG G F  V+   Q   G   A+K +K      +     E+ +L +++H+N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSH-LHGQHSSECLLNWNRRM--DIAIGSAEGIV 152
           +++L           +V   +    L    L     +E       +    +       + 
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTE-------KDASLVIQQVLSAVK 120

Query: 153 YLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYL 209
           YLH +    I+HRD+K  N+L    + + K  + DFG +K+  +G    +T   GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STAC-GTPGYV 174

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKP 241
           APE       S++ D +S G++   L  G  P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 82.6 bits (205), Expect = 6e-18
 Identities = 48/222 (21%), Positives = 98/222 (44%), Gaps = 38/222 (17%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME----FAV-EVEILARV 91
             +    K+GEG +G+V+  +       +A+KR+++     + E     A+ E+ +L  +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKEL 58

Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPN-LSLLSHLHGQHSSEC--------LLNWNRRMD 142
           +HKN++ L       ++  +V+++    L                      LL       
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL------- 111

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                 +G+ + H     +++HRD+K  N+L++ + + ++A+FG A+         +  V
Sbjct: 112 ------KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162

Query: 203 KGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKPI 242
             TL Y  P+  + G    S S D++S G +  ELA+  +P+
Sbjct: 163 V-TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 57/227 (25%), Positives = 109/227 (48%), Gaps = 37/227 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEF-AV-EVEILARVRHK 94
           + +    K+G+G FG V+  +    G ++A+K++ + + K      A+ E++IL  ++H+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 95  NLLSLRGYCAEGQERL--------IVYDYMPN--LSLLSHLHGQHSSE---CLLNWNRRM 141
           N+++L   C               +V+D+  +    LLS++  + +      ++    +M
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM----QM 132

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG----FAKLIPDGATH 197
            +      G+ Y+H +    I+HRD+KA+NVL+  D   ++ADFG    F+         
Sbjct: 133 LL-----NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 198 VTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPI 242
            T RV  TL Y  PE  +LG        D++  G ++ E+ + + PI
Sbjct: 185 YTNRVV-TLWYRPPEL-LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 47/302 (15%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEME-FAVEVEILARVRHKNLLSLRGY 102
           +G+G F  V   + +  G ++A+K + K   N   ++    EV I+  + H N++ L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 103 CAEGQERLIVYDYMPNLSLLSHL--HGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
               +   ++ +Y     +  +L  HG+    E      R     I SA  + Y H    
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFRQIVSA--VQYCHQK-- 133

Query: 160 PHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA 219
             I+HRD+KA N+LLDAD   ++ADFGF+     G   +     G   Y APE    GK 
Sbjct: 134 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE-LFQGKK 189

Query: 220 SE--SCDVYSFGILLLELASGKKPIEKVN-SAIKRTITD--WALPLACERKFSELADPRL 274
            +    DV+S G++L  L SG  P +  N   ++  +    + +P       S       
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDC---- 241

Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLTELENDELFKSH 331
                 E L +  LV        P KR T+ +++    +  G  +++L      EL  S 
Sbjct: 242 ------ENLLKRFLVL------NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 289

Query: 332 QV 333
           Q 
Sbjct: 290 QK 291

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 38/214 (17%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGY 102
            LG G  G V        G + A+K L      +      EV+   +     +++ +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL----YDSPKARQ-EVDHHWQASGGPHIVCILDV 90

Query: 103 CAEGQER----LIVYDYMPNLSLLSHLHGQHS--------SECLLNWNRRMDIAIGSAEG 150
                      LI+ + M    L S +  +          +E +    R +         
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM----RDI------GTA 140

Query: 151 IVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           I +LH H   +I HRD+K  N+L    + D   ++ DFGFAK     A  + T    T  
Sbjct: 141 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPY 194

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
           Y+APE     K  +SCD++S G+++  L  G  P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 78/378 (20%), Positives = 140/378 (37%), Gaps = 61/378 (16%)

Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYD---NKLGEGGFGSVYWG-QLWDGSQI 65
                     ++ P + + S  ++       +Y      LG G  G V          + 
Sbjct: 31  PPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKF 90

Query: 66  AVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQER----LIVYDYMPNLS 120
           A+K L+            EVE+  R  +  +++ +              LIV + +    
Sbjct: 91  ALKMLQ----DCPKARR-EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 145

Query: 121 LLSHLHGQHS--------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV 172
           L S +  +          SE + +        IG A  I YLH     +I HRD+K  N+
Sbjct: 146 LFSRIQDRGDQAFTEREASEIMKS--------IGEA--IQYLHSI---NIAHRDVKPENL 192

Query: 173 LL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFG 229
           L      +   ++ DFGFAK      + +TT    T  Y+APE     K  +SCD++S G
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLG 250

Query: 230 ILLLELASGKKP-----IEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELK 284
           +++  L  G  P        ++  +K  I         + +F     P    + V EE+K
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISPGMKTRI------RMGQYEF-----PNPEWSEVSEEVK 299

Query: 285 RVVLVALTCAHSKPEKRPTMLEVLD--LLKGESKEKLTELENDELFKSHQVADYNDGKAV 342
            ++   L    ++P +R T+ E ++   +   +K   T L    + K  +    +  + +
Sbjct: 300 MLIRNLLK---TEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEM 356

Query: 343 AEDSAEKLAELENDELFK 360
               A    + E  ++ K
Sbjct: 357 TSALATMRVDYEQIKIKK 374

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 47/247 (19%), Positives = 88/247 (35%), Gaps = 33/247 (13%)

Query: 11  KVSDRKEKGKKQPTWRIFSLKELHSATNNFN--YD--NKLGEGGFGSVYWG-QLWDGSQI 65
                      +  W+ +  + +     +    YD   +LG G FG V+   +   G   
Sbjct: 20  GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79

Query: 66  AVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL 125
             K +       +     E+ I+ ++ H  L++L     +  E +++ +++    L   +
Sbjct: 80  VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 139

Query: 126 --HGQHSSECLLNWNRRMDIA-----IGSAEGIVYLHHHATPHIIHRDIKASNVLL---- 174
                  SE         ++          EG+ ++H H    I+H DIK  N++     
Sbjct: 140 AAEDYKMSE--------AEVINYMRQA--CEGLKHMHEH---SIVHLDIKPENIMCETKK 186

Query: 175 DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLE 234
            +  K  + DFG A  +      V      T  + APE           D+++ G+L   
Sbjct: 187 ASSVK--IIDFGLATKLNPD-EIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242

Query: 235 LASGKKP 241
           L SG  P
Sbjct: 243 LLSGLSP 249

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 55/250 (22%), Positives = 100/250 (40%), Gaps = 31/250 (12%)

Query: 11  KVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKR 69
           K ++        P   +            ++  + +G G    V        G + AVK 
Sbjct: 67  KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126

Query: 70  L---KVWSNKAEMEFAV-----EVEILARVR-HKNLLSLRGYCAEGQERLIVYDYMPNLS 120
           +       +  ++E        E  IL +V  H ++++L           +V+D M    
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186

Query: 121 LLSHL--HGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD 177
           L  +L      S  E      R +  ++   E + +LH +   +I+HRD+K  N+LLD +
Sbjct: 187 LFDYLTEKVALSEKET-----RSIMRSL--LEAVSFLHAN---NIVHRDLKPENILLDDN 236

Query: 178 FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE------YAMLGKASESCDVYSFGIL 231
            + +++DFGF+  +  G       + GT GYLAPE              +  D+++ G++
Sbjct: 237 MQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

Query: 232 LLELASGKKP 241
           L  L +G  P
Sbjct: 295 LFTLLAGSPP 304

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 37/221 (16%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME----FAV-EVEILA 89
                +    K+GEG +G VY  +   G  +A+KR+++    AE E     A+ E+ +L 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIREISLLK 74

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPN-LSLLSHLHGQHSSEC--------LLNWNRR 140
            + H N++SL       +   +V+++M   L  +   +     +         LL     
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL----- 129

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
                    G+ + H H    I+HRD+K  N+L+++D   ++ADFG A+         T 
Sbjct: 130 --------RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

Query: 201 RVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
            V  TL Y AP+  ++G    S S D++S G +  E+ +GK
Sbjct: 179 EVV-TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 36/220 (16%)

Query: 37  TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN 95
              +     LG G FG V+   +         K +KV     ++    E+ IL   RH+N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMDIA-----IGSA 148
           +L L       +E +++++++  L +   +       +E         +I      +   
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE--------REIVSYVHQV--C 112

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGFAKLIPDGATHVTTRVKG 204
           E + +LH H   +I H DI+  N++      +  K    +FG A+ +  G  +       
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI--IEFGQARQLKPG-DNFRLLF-T 165

Query: 205 TLGYLAPE---YAMLGKASESCDVYSFGILLLELASGKKP 241
              Y APE   + ++  A    D++S G L+  L SG  P
Sbjct: 166 APEYYAPEVHQHDVVSTA---TDMWSLGTLVYVLLSGINP 202

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 44/224 (19%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
           N+F+Y   LG+G FG V   +     +  A+K L+    K  +    EV        +L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQ 60

Query: 90  RVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNWN 138
             RH  L +L+ Y  +  +RL  V +Y     L  HL  +            +E +    
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS--- 116

Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATH 197
                       + YLH      +++RDIK  N++LD D   ++ DFG  K  I DGAT 
Sbjct: 117 -----------ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 161

Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
                 GT  YLAPE         + D +  G+++ E+  G+ P
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 20/215 (9%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV------EVEI 87
           S+++ F    KLG G + +VY G     G  +A+K +K+     + E         E+ +
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-----DSEEGTPSTAIREISL 56

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPN-LSLLSHLHGQHSSECLLNWNRRMDIAIG 146
           +  ++H+N++ L        +  +V+++M N L          ++   L  N        
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
             +G+ + H +    I+HRD+K  N+L++   + ++ DFG A+         ++ V  TL
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172

Query: 207 GYLAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
            Y AP+  ++G    S S D++S G +L E+ +GK
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 42/250 (16%)

Query: 10  GKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKR 69
           G   +  +   K         K        +     +G G FG V+  +L +  ++A+K+
Sbjct: 12  GVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK 71

Query: 70  LKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGYCAEGQERL------IVYDYMP-NLSL 121
           +       +  F   E++I+  V+H N++ L+ +     ++       +V +Y+P  +  
Sbjct: 72  VLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR 126

Query: 122 LSHLHGQHSSECLLNWNRRMDIA-IGS-----AEGIVYLHHHATPHIIHRDIKASNVLLD 175
            S  + +          + M +  I          + Y+H      I HRDIK  N+LLD
Sbjct: 127 ASRHYAKL--------KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLD 175

Query: 176 AD-FKAQVADFGFAK-LIPDGA-TH-VTTRVKGTLGYLAPEYAMLG--KASESCDVYSFG 229
                 ++ DFG AK LI        + +R      Y APE  + G    + + D++S G
Sbjct: 176 PPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE-LIFGATNYTTNIDIWSTG 229

Query: 230 ILLLELASGK 239
            ++ EL  G+
Sbjct: 230 CVMAELMQGQ 239

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 51/220 (23%), Positives = 85/220 (38%), Gaps = 46/220 (20%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAV-----EVEILARVRHKNL 96
           LG G FG V+         ++ VK   + KV  +    +  +     E+ IL+RV H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 97  LSLRG-------------YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDI 143
           + +                   G +   ++ ++     L                  +  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLD---LFAFIDRHPRLD------EPLA-----SYIFR 137

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVK 203
            + SA  + YL       IIHRDIK  N+++  DF  ++ DFG A  +  G     T   
Sbjct: 138 QLVSA--VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFC- 190

Query: 204 GTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKP 241
           GT+ Y APE  ++G        +++S G+ L  L   + P
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 39/225 (17%)

Query: 37  TNNFN--YD--NKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILA 89
           +  F+  YD   +LG+G F  V        G + A K +      A     +  E  I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLL------SHLHGQHSSECLLNWNRRMDI 143
           +++H N++ L     E     +V+D +    L              +S C+    +++  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQI-- 114

Query: 144 AIGSAEGIVYLHHHATPHIIHRDIKASNVLL-----DADFKAQVADFGFAKLIPDGATHV 198
                E I Y H +    I+HR++K  N+LL      A  K   ADFG A  + D     
Sbjct: 115 ----LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL--ADFGLAIEVNDS--EA 163

Query: 199 TTRVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKP 241
                GT GYL+PE  +L K   S+  D+++ G++L  L  G  P
Sbjct: 164 WHGFAGTPGYLSPE--VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 71/344 (20%), Positives = 132/344 (38%), Gaps = 56/344 (16%)

Query: 37  TNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK------VWSNKAEMEFAV--EVEI 87
            + +     LG G  G V    +     ++A+K +         + +A+    V  E+EI
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 88  LARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHS-SECLLNWNRRMDIA 144
           L ++ H  ++ ++ +  + ++  IV + M    L   +  + +   + C     +     
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-----KLYFYQ 122

Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTR 201
           +     + YLH +    IIHRD+K  NVLL   + D   ++ DFG +K++ +    +   
Sbjct: 123 M--LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRT 175

Query: 202 VKGTLGYLAPE---YAMLGKASESCDVYSFGILLLELASGKKP--IEKVNSAIKRTITDW 256
           + GT  YLAPE          + + D +S G++L    SG  P    +   ++K  I   
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--- 232

Query: 257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKG 313
               + +  F            V E+   +V   L      P+ R T  E L    L   
Sbjct: 233 ---TSGKYNFIPEVWAE-----VSEKALDLVKKLLVV---DPKARFTTEEALRHPWLQDE 281

Query: 314 ESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEKLAELENDE 357
           + K K  +L       S +       + +A+ S  +    E + 
Sbjct: 282 DMKRKFQDL------LSEENESTALPQVLAQPSTSRKRPREGEA 319

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 47/240 (19%), Positives = 92/240 (38%), Gaps = 29/240 (12%)

Query: 16  KEKGKKQPTWRIFSLKELHSATNNFN--YD--NKLGEGGFGSVYWG-QLWDGSQIAVKRL 70
                    W+ +  + +    ++    YD   +LG G FG V+   +   G+  A K +
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 190

Query: 71  KVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQ 128
                  +     E++ ++ +RH  L++L     +  E +++Y++M    L   +     
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250

Query: 129 HSSECLLNWNRRMDIA-----IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV- 182
             SE         +       +   +G+ ++H +   + +H D+K  N++       ++ 
Sbjct: 251 KMSE--------DEAVEYMRQV--CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELK 297

Query: 183 -ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             DFG    +      V     GT  + APE A         D++S G+L   L SG  P
Sbjct: 298 LIDFGLTAHLDPK-QSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 45/222 (20%)

Query: 38  NNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEF-------AV-EVEIL 88
             +   +KLGEG + +VY G      + +A+K ++       +E        A+ EV +L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLL 54

Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPN-LSLLSHLHGQHSSEC--------LLNWNR 139
             ++H N+++L       +   +V++Y+   L       G   +          LL    
Sbjct: 55  KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL---- 110

Query: 140 RMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT 199
                     G+ Y H      ++HRD+K  N+L++   + ++ADFG A+          
Sbjct: 111 ---------RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158

Query: 200 TRVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
             V  TL Y  P+  +LG    S   D++  G +  E+A+G+
Sbjct: 159 NEVV-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 65/288 (22%)

Query: 45  KLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           +LG G    VY  +        A+K LK    K   +  V  E+ +L R+ H N++ L+ 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 102 YCAEGQERLIVYDYMPNLSLLSHL--HGQHS----SECLLNWNRRMDIAIGSAEGIVYLH 155
                 E  +V + +    L   +   G +S    ++ +    +++       E + YLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV----KQI------LEAVAYLH 165

Query: 156 HHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
            +    I+HRD+K  N+L      D   ++ADFG +K++      +   V GT GY APE
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPE 220

Query: 213 YAMLGKAS--ESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA 270
             +L   +     D++S GI+   L  G +P              +      ER    + 
Sbjct: 221 --ILRGCAYGPEVDMWSVGIITYILLCGFEPF-------------YD-----ERGDQFMF 260

Query: 271 DPRLNGNF---------VEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
              LN  +         V    K +V   +      P+KR T  + L 
Sbjct: 261 RRILNCEYYFISPWWDEVSLNAKDLVRKLIV---LDPKKRLTTFQALQ 305

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEME----FAV-EVEILARVR 92
             ++   K+GEG +G VY  Q   G   A+K++++   + E E      + E+ IL  ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL---EKEDEGIPSTTIREISILKELK 58

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPN-L-SLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
           H N++ L       +  ++V++++   L  LL    G   S    ++  ++        G
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNG 112

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           I Y H      ++HRD+K  N+L++ + + ++ADFG A+         T  +  TL Y A
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRA 168

Query: 211 PEYAMLGKA--SESCDVYSFGILLLELASGK 239
           P+  ++G    S + D++S G +  E+ +G 
Sbjct: 169 PD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 38/216 (17%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRL--KVWSNKAEMEFAVEVEILARVRH 93
           T  +    +LG+G F  V        G + A   +  K  S +   +   E  I   ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQHS----SECLLNWNRRMDIAIGS 147
            N++ L    +E     +++D +    L   +     +S    S C+    +++      
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI----QQI------ 119

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLL-----DADFKAQVADFGFAKLIPDGATHVTTRV 202
            E +++ H      ++HR++K  N+LL      A  K   ADFG A  +           
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL--ADFGLAIEVEGEQQAWFGFA 174

Query: 203 KGTLGYLAPEYAMLGKA--SESCDVYSFG----ILL 232
            GT GYL+PE  +L K    +  D+++ G    ILL
Sbjct: 175 -GTPGYLSPE--VLRKDPYGKPVDLWACGVILYILL 207

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 40/224 (17%)

Query: 38  NNFNYDNKLGEGGFGSVY---WGQLWDGSQI-AVKRLK---VWSNKAEMEFA-VEVEILA 89
             F     LG+GG+G V+        +  +I A+K LK   +  N  +      E  IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 90  RVRHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNWN 138
            V+H  ++ L  Y  +   +L ++ +Y+    L   L  +            +E  +   
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM--- 132

Query: 139 RRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATH 197
                       + +LH      II+RD+K  N++L+     ++ DFG  K  I DG   
Sbjct: 133 -----------ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV- 177

Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
            T    GT+ Y+APE  M    + + D +S G L+ ++ +G  P
Sbjct: 178 -THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 48/226 (21%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEF------AV-EVEILA 89
           + +    KLGEG +G VY          +A+KR+++     E E       A+ EV +L 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLK 88

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA-IGS- 147
            ++H+N++ L+          ++++Y            ++  +  ++ N  + +  I S 
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYA-----------ENDLKKYMDKNPDVSMRVIKSF 137

Query: 148 ----AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ-----VADFGFAKL--IPDGA- 195
                 G+ + H       +HRD+K  N+LL     ++     + DFG A+   IP    
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194

Query: 196 THVTTRVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
           TH    +  TL Y  PE  +LG    S S D++S   +  E+    
Sbjct: 195 TH---EII-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 38/222 (17%)

Query: 38  NNFNYDNKLGEGGFGSVY---WGQLWDGSQI-AVKRLK--VWSNKAEMEFAVEVEILARV 91
           + F     LG+G FG V+        D  Q+ A+K LK      +  +   +E +IL  V
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 92  RHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNWNRR 140
            H  ++ L  Y  + + +L ++ D++    L + L  +            +E  L     
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL----- 137

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVT 199
                     + +LH      II+RD+K  N+LLD +   ++ DFG +K  I        
Sbjct: 138 ---------ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--A 183

Query: 200 TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
               GT+ Y+APE       ++S D +SFG+L+ E+ +G  P
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 54/227 (23%), Positives = 85/227 (37%), Gaps = 42/227 (18%)

Query: 37  TNNFNYDNKLGEGGFGSVYW------GQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILA 89
            + ++   +LG G F  V        G  +    I  ++ +        E    EV IL 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMDIA---- 144
           +V H N+++L        + +++ + +    L   L   +  SE         +      
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIK 122

Query: 145 -IGSAEGIVYLHHHATPHIIHRDIKASNVLL------DADFKAQVADFGFAKLIPDGATH 197
            I   +G+ YLH      I H D+K  N++L          K    DFG A  I DG   
Sbjct: 123 QI--LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL--IDFGLAHEIEDG-VE 174

Query: 198 VTTRVKGTLGYLAPE---YAMLGKASESCDVYSFGILLLELASGKKP 241
                 GT  ++APE   Y  LG      D++S G++   L SG  P
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASP 217

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 19/212 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK--VWSNKAEMEFA-VEVEILARV-R 92
            +FN+   LG+G FG V   +     ++ AVK LK  V     ++E   VE  +LA   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGSAEG 150
              L  L   C +  +RL  V +Y+    L+ H+       E        +  A   A G
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE-----PHAVFYAAEIAIG 454

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTTRVKGTLGYL 209
           + +L       II+RD+K  NV+LD++   ++ADFG  K  I DG T  T    GT  Y+
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYI 509

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKP 241
           APE        +S D ++FG+LL E+ +G+ P
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 48/235 (20%), Positives = 91/235 (38%), Gaps = 54/235 (22%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEV------EI 87
            AT+ +    ++G G +G+VY  +    G  +A+K ++V            +      E+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---PNGGGGGGGLPISTVREV 62

Query: 88  -----LARVRHKNLLSLR----GYCAEGQERL-IVYDYMPN--LSLLSHLHGQHSSEC-- 133
                L    H N++ L         + + ++ +V++++     + L             
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122

Query: 134 ------LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
                  L              G+ +LH +    I+HRD+K  N+L+ +    ++ADFG 
Sbjct: 123 KDLMRQFL-------------RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166

Query: 188 AKL--IPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGK 239
           A++       T     V  TL Y APE  +L    +   D++S G +  E+   K
Sbjct: 167 ARIYSYQMALTP---VVV-TLWYRAPE-VLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 35/243 (14%)

Query: 15  RKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLKVW 73
               G++      F +      ++N++   +LG+G F  V        G + A K +   
Sbjct: 6   SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65

Query: 74  SNKAEMEFAV--EVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLL------SHL 125
              A     +  E  I  +++H N++ L     E     +V+D +    L          
Sbjct: 66  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125

Query: 126 HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL-----DADFKA 180
               +S C+    +++       E I Y H +    I+HR++K  N+LL      A  K 
Sbjct: 126 SEADASHCI----QQI------LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASG 238
             ADFG A  + D          GT GYL+PE  +L K   S+  D+++ G++L  L  G
Sbjct: 173 --ADFGLAIEVNDS--EAWHGFAGTPGYLSPE--VLKKDPYSKPVDIWACGVILYILLVG 226

Query: 239 KKP 241
             P
Sbjct: 227 YPP 229

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 54/233 (23%), Positives = 89/233 (38%), Gaps = 60/233 (25%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAV--EVEILARVRHKNLLSL 99
           LGEG +G V          + AVK   + K+       E  V  E+++L R+RHKN++ L
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 100 RG---------------YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA 144
                            YC  G + +   D +P                     +R  + 
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEM--LDSVPE--------------------KRFPVC 109

Query: 145 IGSA------EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP---DGA 195
                     +G+ YLH      I+H+DIK  N+LL      +++  G A+ +       
Sbjct: 110 QAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166

Query: 196 THVTTRVKGTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKPIEKVN 246
           T  T++  G+  +  PE A      +    D++S G+ L  + +G  P E  N
Sbjct: 167 TCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 29/241 (12%)

Query: 13  SDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWG-QLWDGSQIAVKRLK 71
            D            + + +   ++    +    LG G FG V+   +   G ++A K +K
Sbjct: 64  VDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123

Query: 72  VWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL--HGQH 129
               K + E   E+ ++ ++ H NL+ L        + ++V +Y+    L   +     +
Sbjct: 124 TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN 183

Query: 130 SSECLLNWNRRMDIA-----IGSAEGIVYLHHHATPHIIHRDIKASNVLL----DADFKA 180
            +E        +D       I   EGI ++H     +I+H D+K  N+L         K 
Sbjct: 184 LTE--------LDTILFMKQI--CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK- 229

Query: 181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
            + DFG A+        +     GT  +LAPE       S   D++S G++   L SG  
Sbjct: 230 -IIDFGLARRYKPR-EKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286

Query: 241 P 241
           P
Sbjct: 287 P 287

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG G FG V  G+    G ++AVK   R K+ S     +   E++ L   RH +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 102 YCAEGQERLIVYDYMPNLSLLSHL--HGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             +   +  +V +Y+    L  ++  HG+    E      RR+   I SA  + Y H H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----RRLFQQILSA--VDYCHRH- 130

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              ++HRD+K  NVLLDA   A++ADFG + ++ DG    T+   G+  Y APE  + G+
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGR 185

Query: 219 --ASESCDVYSFGILLLELASGKKP 241
             A    D++S G++L  L  G  P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP 210

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.1 bits (188), Expect = 7e-16
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 45/217 (20%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           LGEG +G V           +AVK +        +    +  E+ I   + H+N++   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 102 YCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMD-----------IAIGSA 148
           +  EG  + +  +Y     L   +                 M            +A    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMA---- 116

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT--HVTTRVKGTL 206
            G+VYLH      I HRDIK  N+LLD     +++DFG A +         +     GTL
Sbjct: 117 -GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTL 171

Query: 207 GYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKP 241
            Y+APE  +  +   +E  DV+S GI+L  + +G+ P
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 53/239 (22%), Positives = 90/239 (37%), Gaps = 53/239 (22%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK------------------------RLKVWSNKAEME 80
           +G+G +G V       D +  A+K                                    
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 81  FAV--EVEILARVRHKNLLSLRGYCAEGQERLI--VYDYMPNLSLLSHL-HGQHSSECLL 135
             V  E+ IL ++ H N++ L     +  E  +  V++ +    ++        S +   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
            + +  D+  G    I YLH+     IIHRDIK SN+L+  D   ++ADFG +       
Sbjct: 141 FYFQ--DLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 196 THVTTRVKGTLGYLAPE--------YAMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
             ++  V GT  ++APE        ++  GKA    DV++ G+ L     G+ P     
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFS--GKAL---DVWAMGVTLYCFVFGQCPFMDER 244

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 42/227 (18%)

Query: 37  TNNFNYDNKLGEGGFGSVYW------GQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILA 89
            +++    +LG G F  V        G+ +    I  +RL         E    EV IL 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMDIA---- 144
            +RH N+++L        + +++ + +    L   L   +  +E         +      
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLK 115

Query: 145 -IGSAEGIVYLHHHATPHIIHRDIKASNVLL------DADFKAQVADFGFAKLIPDGATH 197
            I   +G+ YLH      I H D+K  N++L      +   K    DFG A  I  G   
Sbjct: 116 QI--LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKL--IDFGIAHKIEAG-NE 167

Query: 198 VTTRVKGTLGYLAPE---YAMLGKASESCDVYSFGILLLELASGKKP 241
                 GT  ++APE   Y  LG      D++S G++   L SG  P
Sbjct: 168 FKNIF-GTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASP 210

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 37/221 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK--VWSNKAEMEFA-VEVEILAR-VR 92
           ++F++   +G+G FG V   +        AVK L+      K E +    E  +L + V+
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNWNRRM 141
           H  L+ L  +  +  ++L  V DY+    L  HL  +           ++E         
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS------ 150

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTT 200
                    + YLH     +I++RD+K  N+LLD+     + DFG  K  I   +T  T+
Sbjct: 151 --------ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TS 197

Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
              GT  YLAPE         + D +  G +L E+  G  P
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 45/225 (20%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
            +F     LG+G FG V+  +    +Q  A+K LK    K  +    +VE       +L+
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLS 72

Query: 90  RV-RHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNW 137
               H  L  +     + +E L  V +Y+    L+ H+   H          ++E +L  
Sbjct: 73  LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL-- 129

Query: 138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGAT 196
                       G+ +LH      I++RD+K  N+LLD D   ++ADFG  K  +   A 
Sbjct: 130 ------------GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174

Query: 197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             T    GT  Y+APE  +  K + S D +SFG+LL E+  G+ P
Sbjct: 175 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 44/259 (16%)

Query: 5   SIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWD-GS 63
           S F   KVS  K+  K                  ++     +G G FG VY  +L D G 
Sbjct: 21  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80

Query: 64  QIAVKRLKVWSNKAEMEFAV-EVEILARVRHKNLLSLRGYCAEGQERL------IVYDYM 116
            +A+K++       +  F   E++I+ ++ H N++ LR +     E+       +V DY+
Sbjct: 81  LVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135

Query: 117 P-NLSLLSHLHGQHSSECLLNWNRRM-DIAIGS-----AEGIVYLHHHATPHIIHRDIKA 169
           P  +  ++  + +          + +  I +          + Y+H      I HRDIK 
Sbjct: 136 PETVYRVARHYSRA--------KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKP 184

Query: 170 SNVLLDAD-FKAQVADFGFAK-LIPDGA-TH-VTTRVKGTLGYLAPEYAMLG--KASESC 223
            N+LLD D    ++ DFG AK L+        + +R      Y APE  + G    + S 
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE-LIFGATDYTSSI 238

Query: 224 DVYSFGILLLELASGKKPI 242
           DV+S G +L EL  G +PI
Sbjct: 239 DVWSAGCVLAELLLG-QPI 256

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 18/209 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEF-AV-EVEILARVRHK 94
             +    K+GEG +G V+  +    G  +A+K+     +   ++  A+ E+ +L +++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 95  NLLSLRGYCAEGQERLIVYDYMPN--LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           NL++L       +   +V++Y  +  L  L           + +   +        + + 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT------LQAVN 116

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           + H H   + IHRD+K  N+L+      ++ DFGFA+L+   + +    V  T  Y +PE
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPE 172

Query: 213 YAMLGKA--SESCDVYSFGILLLELASGK 239
             ++G        DV++ G +  EL SG 
Sbjct: 173 -LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 51/224 (22%), Positives = 82/224 (36%), Gaps = 36/224 (16%)

Query: 37  TNNFNYDNKLGEGGFGSVYW------GQLWDGSQIAVKRLKVWSNKAEME-FAVEVEILA 89
            + ++   +LG G F  V        G  +    I  ++ +        E    EV IL 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMDIA---- 144
           +V H N+++L        + +++ + +    L   L   +  SE         +      
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIK 122

Query: 145 -IGSAEGIVYLHHHATPHIIHRDIKASNVLL------DADFKAQVADFGFAKLIPDGATH 197
            I   +G+ YLH      I H D+K  N++L          K    DFG A  I DG   
Sbjct: 123 QI--LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL--IDFGLAHEIEDG-VE 174

Query: 198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
                 GT  ++APE           D++S G++   L SG  P
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LG G FG V  G+    G ++AVK   R K+ S     +   E++ L   RH +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 102 YCAEGQERLIVYDYMPNLSLLSHL--HGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHA 158
             +   +  +V +Y+    L  ++  +G+    E      RR+   I S   + Y H H 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILSG--VDYCHRH- 135

Query: 159 TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK 218
              ++HRD+K  NVLLDA   A++ADFG + ++ DG    T+   G+  Y APE  + G+
Sbjct: 136 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGR 190

Query: 219 --ASESCDVYSFGILLLELASGKKP 241
             A    D++S G++L  L  G  P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLP 215

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 18/209 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEF-AV-EVEILARVRHK 94
             +     +GEG +G V   +    G  +A+K+     +   ++  A+ E+++L ++RH+
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 95  NLLSLRGYCAEGQERLIVYDYMPN--LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           NL++L   C + +   +V++++ +  L  L         + +  +  ++        GI 
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI------INGIG 138

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           + H H   +IIHRDIK  N+L+      ++ DFGFA+ +          V  T  Y APE
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194

Query: 213 YAMLGKA--SESCDVYSFGILLLELASGK 239
             ++G     ++ DV++ G L+ E+  G+
Sbjct: 195 -LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 45/217 (20%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV--EVEILARVRHKNLLSLRG 101
           LGEG +G V           +AVK +        +    +  E+ I   + H+N++   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 102 YCAEGQERLIVYDYMPNLSLLSHL--HGQHSSECLLNWNRRMD-----------IAIGSA 148
           +  EG  + +  +Y     L   +                 M            +A    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMA---- 116

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT--HVTTRVKGTL 206
            G+VYLH      I HRDIK  N+LLD     +++DFG A +         +     GTL
Sbjct: 117 -GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTL 171

Query: 207 GYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKP 241
            Y+APE  +  +   +E  DV+S GI+L  + +G+ P
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 53/227 (23%), Positives = 83/227 (36%), Gaps = 42/227 (18%)

Query: 37  TNNFNYDNKLGEGGFGSVYW------GQLWDGSQIAVKRLKVWSNKAEMEFAV-EVEILA 89
            + ++   +LG G F  V        G  +    I  +R K        E    EV IL 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHL-HGQHSSECLLNWNRRMDIA---- 144
            ++H N+++L        + +++ + +    L   L   +  +E         +      
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLK 121

Query: 145 -IGSAEGIVYLHHHATPHIIHRDIKASNVLL------DADFKAQVADFGFAKLIPDGATH 197
            I    G+ YLH      I H D+K  N++L          K    DFG A  I  G   
Sbjct: 122 QI--LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI--IDFGLAHKIDFG-NE 173

Query: 198 VTTRVKGTLGYLAPE---YAMLGKASESCDVYSFGILLLELASGKKP 241
                 GT  ++APE   Y  LG      D++S G++   L SG  P
Sbjct: 174 FKNIF-GTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASP 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 45/225 (20%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
            +FN+   LG+G FG V   +     ++ AVK LK    K  +    +VE       +LA
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLA 75

Query: 90  RV-RHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNW 137
              +   L  L   C +  +RL  V +Y+    L+ H+              ++E  +  
Sbjct: 76  LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-- 132

Query: 138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGAT 196
                       G+ +L       II+RD+K  NV+LD++   ++ADFG  K  I DG T
Sbjct: 133 ------------GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177

Query: 197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             T    GT  Y+APE        +S D ++FG+LL E+ +G+ P
Sbjct: 178 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 56/235 (23%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWGQ--LWDGSQIAVKRLKVWSNKAEMEF------AV-EV 85
            A   +    ++GEG +G V+  +     G  +A+KR++V     +          + EV
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREV 62

Query: 86  EIL---ARVRHKNLLSLR----GYCAEGQERL-IVYDYMPN--LSLLSHLHGQHSSEC-- 133
            +L       H N++ L         + + +L +V++++     + L  +          
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 134 ------LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF 187
                 LL              G+ +LH H    ++HRD+K  N+L+ +  + ++ADFG 
Sbjct: 123 KDMMFQLL-------------RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166

Query: 188 AKL--IPDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGK 239
           A++       T V      TL Y APE  +L  + +   D++S G +  E+   K
Sbjct: 167 ARIYSFQMALTSVVV----TLWYRAPE-VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 45/225 (20%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLKVWSNKAEMEFAVEVE-------ILA 89
           +NF +   LG+G FG V   ++ +   + AVK LK    K  +    +VE       IL+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK----KDVILQDDDVECTMTEKRILS 78

Query: 90  RV-RHKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNW 137
               H  L  L   C +  +RL  V +++    L+ H+              ++E +   
Sbjct: 79  LARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS-- 135

Query: 138 NRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGAT 196
                        +++LH      II+RD+K  NVLLD +   ++ADFG  K  I +G T
Sbjct: 136 ------------ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180

Query: 197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
             T    GT  Y+APE         + D ++ G+LL E+  G  P
Sbjct: 181 --TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK--VWSNKAEMEFA-VEVEILARV-R 92
            +F+    +G G +  V   +L    +I A+K +K  + ++  ++++   E  +  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNWNRRM 141
           H  L+ L   C + + RL  V +Y+    L+ H+  Q           S+E  L      
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ 121

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTT 200
                    + YLH      II+RD+K  NVLLD++   ++ D+G  K  +  G T  T+
Sbjct: 122 --------ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TS 168

Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
              GT  Y+APE         S D ++ G+L+ E+ +G+ P
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)

Query: 38  NNFNYDNKLGEGGFGSVY---WGQLWDGSQI-AVKRLK---VWSNKAEMEFA-VEVEILA 89
            NF     LG G +G V+        D  ++ A+K LK   +       E    E ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 90  RVRHKN-LLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIG- 146
            +R    L++L  Y  + + +L ++ DY+    L +HL              R       
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL--SQR--------ERFTEHEVQ 162

Query: 147 --SAE---GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR 201
               E    + +LH      II+RDIK  N+LLD++    + DFG +K      T     
Sbjct: 163 IYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219

Query: 202 VKGTLGYLAPEYAMLGKA--SESCDVYSFGILLLELASGKKP 241
             GT+ Y+AP+    G +   ++ D +S G+L+ EL +G  P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 40/217 (18%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAV--EVEILARVRH-KNLLSLR 100
           +LG G F  V        G + A K LK      +    +  E+ +L   +    +++L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 101 GYCAEGQERLIVYDYMPNLSLLSHL---HGQHSSECLLNWNRRMDIA-----IGSAEGIV 152
                  E +++ +Y     + S       +  SE         D+      I   EG+ 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQI--LEGVY 145

Query: 153 YLHHHATPHIIHRDIKASNVLL-----DADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           YLH +   +I+H D+K  N+LL       D K    DFG ++ I      +   + GT  
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKI--VDFGMSRKIGHA-CELREIM-GTPE 198

Query: 208 YLAPE---YAMLGKASESCDVYSFGILLLELASGKKP 241
           YLAPE   Y  +  A    D+++ GI+   L +   P
Sbjct: 199 YLAPEILNYDPITTA---TDMWNIGIIAYMLLTHTSP 232

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQI-AVKRLK--VWSNKAEMEFA-VEVEILARV-R 92
            +F+    +G G +  V   +L    +I A++ +K  + ++  ++++   E  +  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 93  HKNLLSLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQH----------SSECLLNWNRRM 141
           H  L+ L   C + + RL  V +Y+    L+ H+  Q           S+E  L      
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ 164

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL-IPDGATHVTT 200
                    + YLH      II+RD+K  NVLLD++   ++ D+G  K  +  G T  T+
Sbjct: 165 --------ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TS 211

Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
              GT  Y+APE         S D ++ G+L+ E+ +G+ P
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 49/239 (20%), Positives = 92/239 (38%), Gaps = 52/239 (21%)

Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAV------- 83
            ELH+  + +     +  G +G+V  G   +G  +A+KR+    +       +       
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74

Query: 84  ----EVEILARVRHKNLLSLRG-YCAEGQERL----IVYDYMP---------NLSLLSHL 125
               E+ +L    H N+L LR  +    +  +    +V + M             ++S  
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ 134

Query: 126 HGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF 185
           H Q+    +L              G+  LH      ++HRD+   N+LL  +    + DF
Sbjct: 135 HIQYFMYHILL-------------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDF 178

Query: 186 GFAKLIPDGAT---HVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
             A+     A    +VT R      Y APE  ++     ++  D++S G ++ E+ + K
Sbjct: 179 NLAREDTADANKTHYVTHRW-----YRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.6 bits (176), Expect = 6e-14
 Identities = 49/221 (22%), Positives = 97/221 (43%), Gaps = 40/221 (18%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRH 93
              +     +G G +GSV        G ++A+K+L + + ++   + A  E+ +L  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 94  KNLLSLR------GYCAEGQERLIVYDYMP-NL-----SLLSHLHGQHSSECLLNWNRRM 141
           +N++ L              +  +V  +M  +L        S    Q+    +L      
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK----- 137

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-VTT 200
                   G+ Y+H   +  ++HRD+K  N+ ++ D + ++ DFG A+      T  V T
Sbjct: 138 --------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186

Query: 201 RVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
           R      Y APE  +L     +++ D++S G ++ E+ +GK
Sbjct: 187 RW-----YRAPE-VILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 57/281 (20%), Positives = 89/281 (31%), Gaps = 84/281 (29%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-EFAVEVE---- 86
           +       LG G FG V     +          +AVK LK  +  +E      E++    
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 87  -----------------------ILARVRHKNLLS--------LRGYCAEGQERLIVYDY 115
                                  I+   +  NL +           Y  +G       DY
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 116 MPN--------LSLLSHLHGQHSSECL---------------------LNWNRRMDIAIG 146
           +          L  ++      SS  +                     L     +  +  
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
            A+G+ +L   A+   IHRD+ A N+LL      ++ DFG A+ I     +    V+   
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGD 254

Query: 207 GYL-----APEYAMLGKASESCDVYSFGILLLELAS-GKKP 241
             L     APE       +   DV+SFG+LL E+ S G  P
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 35/211 (16%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           LGEG FG V          ++A+K   R  +  +   M    E+  L  +RH +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 102 YCAEGQERLIV--------YDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGSAEGIV 152
                 + ++V        +DY+           + +  E      RR    I  A  I 
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVE-------KKRMTEDEG-----RRFFQQIICA--IE 122

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           Y H H    I+HRD+K  N+LLD +   ++ADFG + ++ DG    T+   G+  Y APE
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177

Query: 213 YAMLGK--ASESCDVYSFGILLLELASGKKP 241
             + GK  A    DV+S GI+L  +  G+ P
Sbjct: 178 -VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 52/211 (24%), Positives = 79/211 (37%), Gaps = 36/211 (17%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVK---RLKVWSNKAEMEFAVEVEILARVRHKNLLSLRG 101
           +G G FG     +       +AVK   R        + E    +     +RH N++  + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 102 YCAEGQERLIVYDYMPNLSLLSHL--HGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHA 158
                    I+ +Y     L   +   G+ S  E      R     + S   + Y H   
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLSG--VSYCHSM- 135

Query: 159 TPHIIHRDIKASNVLLDADFKAQ--VADFGFAKLIPDGATHVTTRVKGTLGYLAPE---- 212
              I HRD+K  N LLD     +  + DFG++K     +   +T   GT  Y+APE    
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 191

Query: 213 --YAMLGKASESCDVYSFGILLLELASGKKP 241
             Y   GK +   DV+S G+ L  +  G  P
Sbjct: 192 QEYD--GKIA---DVWSCGVTLYVMLVGAYP 217

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 52/234 (22%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV----EVEILARV 91
            + F  +   G+G FG+V  G+    G  +A+K  KV  +     F       ++ LA +
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQDP---RFRNRELQIMQDLAVL 76

Query: 92  RHKNLLSLRGYCAEGQER-------LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIA 144
            H N++ L+ Y     ER        +V +Y+P       LH             R  +A
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR------CCRNYYRRQVA 125

Query: 145 IGSAE----------GIVYLHHHATPHIIHRDIKASNVLLD-ADFKAQVADFGFAK-LIP 192
                           I  LH   + ++ HRDIK  NVL++ AD   ++ DFG AK L P
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184

Query: 193 DGA-TH-VTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPI 242
                  + +R      Y APE  + G    + + D++S G +  E+  G +PI
Sbjct: 185 SEPNVAYICSRY-----YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 36/171 (21%)

Query: 84  EVEILARVRHKNLLSLR------GYCAEGQERLIVYDYMP-NL-----SLLSHLHGQHSS 131
           E+ ++  V HKN++ L           E Q+  IV + M  NL       L H    +  
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL 133

Query: 132 ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI 191
             +L              GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+  
Sbjct: 134 YQMLC-------------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177

Query: 192 PDGAT---HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK 239
                   +V TR      Y APE  +     E+ D++S G ++ E+  G 
Sbjct: 178 GTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 37/183 (20%), Positives = 62/183 (33%), Gaps = 45/183 (24%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS----- 98
           K+G GGFG +Y         + A   +KV   +    F  E++   RV  K+ +      
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIER 102

Query: 99  ----------LRGY----CAEGQERLIVYDYM-PNLSLLSHLHGQHSSECLLNWNRRMD- 142
                       G           R +V + +  +L            + +   N     
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL------------QKISGQNGTFKK 150

Query: 143 -----IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV--ADFGFAKLIPDGA 195
                + I   + + Y+H +     +H DIKA+N+LL      QV  AD+G +       
Sbjct: 151 STVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

Query: 196 THV 198
            H 
Sbjct: 208 NHK 210

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 41/213 (19%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSLR-- 100
           +G G +G+V        G+++A+K+L + + ++   + A  E+ +L  +RH+N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 101 ----GYCAEGQERLIVYDYMP-NLS------LLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
                   +  +  +V  +M  +L        L     Q     +L              
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK------------- 139

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGY 208
           G+ Y+H      IIHRD+K  N+ ++ D + ++ DFG A+      T +V TR      Y
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 209 LAPEYAMLG--KASESCDVYSFGILLLELASGK 239
            APE  +L   + +++ D++S G ++ E+ +GK
Sbjct: 192 RAPE-VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 39/214 (18%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV-EVEILARVRHKNLLSLR 100
             +G G  G V           +A+K+L + + N+   + A  E+ ++  V HKN++SL 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 101 ------GYCAEGQERLIVYDYMP-NL-----SLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
                     E Q+  +V + M  NL       L H    +    +L             
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC------------ 175

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT---HVTTRVKGT 205
            GI +LH   +  IIHRD+K SN+++ +D   ++ DFG A+          +V TR    
Sbjct: 176 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 228

Query: 206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGK 239
             Y APE  +     E+ D++S G ++ E+   K
Sbjct: 229 --YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 45/226 (19%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHK 94
              +   + +GEG +G V       +  ++A+K++  + ++   +  + E++IL R RH+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 95  NLLSLRG-YCAEGQERL----IVYDYMP-NLS------LLSHLHGQHSSECLLNWNRRMD 142
           N++ +     A   E++    IV D M  +L        LS+ H  +    +L       
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR------ 139

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH----- 197
                  G+ Y+H   + +++HRD+K SN+LL+     ++ DFG A++      H     
Sbjct: 140 -------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 198 --VTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
             V TR      Y APE  ML     ++S D++S G +L E+ S +
Sbjct: 190 EYVATR-----WYRAPE-IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 46/231 (19%), Positives = 92/231 (39%), Gaps = 35/231 (15%)

Query: 25  WRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV 83
           W   S        +++    KLG G +  V+    + +  ++ VK LK      + +   
Sbjct: 23  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKR 79

Query: 84  EVEILARVR-HKNLLSLRGYCAEGQERLIVY--DYMPNLSL------LSHLHGQHSSECL 134
           E++IL  +R   N+++L     +   R      +++ N         L+    +     +
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI 139

Query: 135 LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA-QVADFGFAKLIPD 193
           L             + + Y H      I+HRD+K  NV++D + +  ++ D+G A+    
Sbjct: 140 L-------------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183

Query: 194 GATHVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPI 242
           G  +   RV  +  +  PE  ++       S D++S G +L  +   K+P 
Sbjct: 184 GQEY-NVRV-ASRYFKGPE-LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 68/241 (28%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAV----EVE 86
           +++F   + LGEG +G V             G  +A+K+++ +       FA+    E++
Sbjct: 10  SSDFQLKSLLGEGAYGVV-----CSATHKPTGEIVAIKKIEPFDKP---LFALRTLREIK 61

Query: 87  ILARVRHKNLLSLRG-YCAEGQERL----IVYDYMP-NLS------LLSHLHGQHSSECL 134
           IL   +H+N++++      +  E      I+ + M  +L       +LS  H Q+     
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121

Query: 135 LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG 194
           L               +  LH     ++IHRD+K SN+L++++   +V DFG A++I + 
Sbjct: 122 LR-------------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 195 AT--------------HVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASG 238
           A                V TR      Y APE  ML   K S + DV+S G +L EL   
Sbjct: 166 AADNSEPTGQQSGMVEFVATR-----WYRAPE-VMLTSAKYSRAMDVWSCGCILAELFLR 219

Query: 239 K 239
           +
Sbjct: 220 R 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 38/172 (22%)

Query: 84  EVEILARVRHKNLLSLR------GYCAEGQERLIVYDYMP-NLS------LLSHLHGQHS 130
           E+ +L  ++H+N++ L           E  +  +V   M  +L+       L+  H Q  
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137

Query: 131 SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
              +L              G+ Y+H   +  IIHRD+K SN+ ++ D + ++ DFG A+ 
Sbjct: 138 IYQILR-------------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181

Query: 191 IPDGAT-HVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGK 239
             D  T +V TR      Y APE  ML     +++ D++S G ++ EL +G+
Sbjct: 182 TADEMTGYVATRW-----YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 40/221 (18%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFA-VEVEILARVR-------- 92
           KLG G F +V+     D    + +A+K ++   +K   E A  E+++L RV         
Sbjct: 26  KLGWGHFSTVW--LAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 93  ---HKNLLSLRGY----CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAI 145
                ++L L  +       G   ++V++ +   +LL+ +         L + ++  I+ 
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISK 138

Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ------VADFGFAKLIPDGATHVT 199
               G+ Y+H      IIH DIK  NVL++     +      +AD G A    +   H T
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYT 193

Query: 200 TRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGK 239
             ++ T  Y +PE  +LG       D++S   L+ EL +G 
Sbjct: 194 NSIQ-TREYRSPE-VLLGAPWGCGADIWSTACLIFELITGD 232

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKN 95
           N F    K+G G FG +Y G  +    ++A+K   V +   ++ +  E +I   ++    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64

Query: 96  LLSLRGYCAEGQERLIVYDYM-PNLS-LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           + ++R +  EG   ++V D + P+L  L +    + S + +L       +A      + +
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM------LADQMINRVEF 118

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQ---VADFGFAKLIPDGAT--HVTTRVK----G 204
           +H       +HRDIK  N L+    +A    + DFG AK   D +T  H+  R      G
Sbjct: 119 VHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

Query: 205 TLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKP 241
           T  Y A     LG   S   D+ S G +L+    G  P
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 37/179 (20%), Positives = 67/179 (37%), Gaps = 34/179 (18%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKR---LKVWSNKA-----EMEF---AVEVEILARVRH 93
            +G+GGFG +Y   +     +       +KV  +       E++F   A + E + +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 94  KNLLSLRG-----YCAEGQERLIVYDYM------PNLSLLSHLHGQH-SSECLLNWNRRM 141
              L   G           +    Y +M       +L  +   + +  S + +L      
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ----- 156

Query: 142 DIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV--ADFGFAKLIPDGATHV 198
            +++   + + Y+H H     +H DIKASN+LL+     QV   D+G A        H 
Sbjct: 157 -LSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 49/220 (22%), Positives = 85/220 (38%), Gaps = 28/220 (12%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH-KN 95
            ++    ++GEG FG ++ G  L +  Q+A+K     S+  ++    E      +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTG 67

Query: 96  LLSLRGYCAEGQERLIVYDYM-PNLS-LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           + ++  +  EG   ++V D + P+L  LL     + S + +         A      +  
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM------AAKQMLARVQS 121

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQ-----VADFGFAKLIPDGAT--HVTTRVK--- 203
           +H      +++RDIK  N L+            V DFG  K   D  T  H+  R K   
Sbjct: 122 IHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178

Query: 204 -GTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKP 241
            GT  Y       LG+  S   D+ + G + +    G  P
Sbjct: 179 SGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 49/248 (19%), Positives = 89/248 (35%), Gaps = 59/248 (23%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHK 94
           +  ++    LG G FG V      + G + A+K++       +  +   E++I+  + H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNW----------------- 137
           N++ L  Y     +        P+            +    +                  
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 138 ----NRRMDIAIGSAE----------------GIVYLHHHATPHIIHRDIKASNVLLDA- 176
               ++ +   I S                   + ++H      I HRDIK  N+L+++ 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSK 177

Query: 177 DFKAQVADFGFAKLIPDGATH---VTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGIL 231
           D   ++ DFG AK +         + +R      Y APE  MLG  + + S D++S G +
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL-MLGATEYTPSIDLWSIGCV 231

Query: 232 LLELASGK 239
             EL  GK
Sbjct: 232 FGELILGK 239

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 49/241 (20%), Positives = 103/241 (42%), Gaps = 66/241 (27%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAV-EVEILA 89
            + +     LG GG G V     +         ++A+K++ V ++   ++ A+ E++I+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLV-----FSAVDNDCDKRVAIKKI-VLTDPQSVKHALREIKIIR 63

Query: 90  RVRHKNLLSLR--------------GYCAEGQERLIVYDYMP-NLS------LLSHLHGQ 128
           R+ H N++ +               G   E     IV +YM  +L+       L   H +
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR 123

Query: 129 HSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGF 187
                LL              G+ Y+H   + +++HRD+K +N+ ++  D   ++ DFG 
Sbjct: 124 LFMYQLLR-------------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167

Query: 188 AKLIPDGATH-------VTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASG 238
           A+++    +H       + T+      Y +P   +L     +++ D+++ G +  E+ +G
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTK-----WYRSPR-LLLSPNNYTKAIDMWAAGCIFAEMLTG 221

Query: 239 K 239
           K
Sbjct: 222 K 222

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 26/218 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH-KN 95
           N +    K+G G FG +Y G  +  G ++A+K   V +   ++    E +I   ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66

Query: 96  LLSLRGYCAEGQERLIVYDYM-PNLS-LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           + ++R   AEG   ++V + + P+L  L +    + S + +L       +A      I Y
Sbjct: 67  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL------LADQMISRIEY 120

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQ---VADFGFAKLIPDGAT--HVTTRVK----G 204
           +H     + IHRD+K  N L+    K     + DFG AK   D  T  H+  R      G
Sbjct: 121 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177

Query: 205 TLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKP 241
           T  Y A     LG   S   D+ S G +L+    G  P
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 25/192 (13%), Positives = 61/192 (31%), Gaps = 46/192 (23%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ---------LWDGSQIAVK----------RLKVWSNKAE 78
             +   +       G +Y                 + ++K              +   A+
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 79  MEFAVEVEILARVRHKNLLSLRGY-CAEGQERLIVYDYM-PNLSLLSHLHGQHSSECLLN 136
                + + L       + +  G+   + + R +V   +  +L            +  L+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSL------------QSALD 149

Query: 137 WNRRMD--------IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV--ADFG 186
            + +          +A    + + +LH +     +H ++ A N+ +D + ++QV  A +G
Sbjct: 150 VSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYG 206

Query: 187 FAKLIPDGATHV 198
           FA        HV
Sbjct: 207 FAFRYCPSGKHV 218

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 20/169 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH-KN 95
            NF    K+G G FG +  G+ L+    +A+K   + S   ++    E     ++     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66

Query: 96  LLSLRGYCAEGQERLIVYDYM-PNLS-LLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           +  +  +   G+   +V + + P+L  L        S + +L       IAI     + Y
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLM------IAIQLISRMEY 120

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQ-----VADFGFAKLIPDGATH 197
           +H     ++I+RD+K  N L+            + DF  AK   D  T 
Sbjct: 121 VHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 53/266 (19%), Positives = 93/266 (34%), Gaps = 78/266 (29%)

Query: 38  NNFNYDNK------LGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAV----EV 85
            N +  +       +G G +G VY          +A+K++ +++ +            E+
Sbjct: 20  KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI---DCKRILREI 76

Query: 86  EILARVRHKNLLSLRG-YCAEGQERL----IVYDYMP-NLS-------LLSHLHGQHSSE 132
            IL R++   ++ L      +   +     IV +    +L         L+  H +    
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY 136

Query: 133 CLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP 192
            LL              G  ++H      IIHRD+K +N LL+ D   +V DFG A+ I 
Sbjct: 137 NLLL-------------GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 193 DGAT--------------------------HVTTRVKGTLGYLAPEYAMLGKA--SESCD 224
                                         HV TR      Y APE  +L +   ++S D
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPE-LILLQENYTKSID 234

Query: 225 VYSFGILLLELASGKKPIEKVNSAIK 250
           ++S G +  EL +  +      +   
Sbjct: 235 IWSTGCIFAELLNMLQSHINDPTNRF 260

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 50/254 (19%), Positives = 85/254 (33%), Gaps = 75/254 (29%)

Query: 33  LHSATNNFNYDNK---------------------LGEGGFGSVYWGQLWD---GSQIAVK 68
           +    NN  YD+                      +G+G FG V   + +D      +A+K
Sbjct: 71  MTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVV--KAYDHKVHQHVALK 128

Query: 69  RLKVWSNKAEMEFA--VEVEILARVRHKNLLSLRGYCAEGQERLI-VYDYMPNLSLLSHL 125
            ++   N+         E+ IL          LR    +    +I + +           
Sbjct: 129 MVR---NEKRFHRQAAEEIRILEH--------LRKQDKDNTMNVIHMLEN--------FT 169

Query: 126 HGQH---SSECL---------------LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDI 167
              H   + E L                +       A    + +  LH +    IIH D+
Sbjct: 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDL 226

Query: 168 KASNVLLDADFKAQ--VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDV 225
           K  N+LL    ++   V DFG +         V T ++ +  Y APE  +  +     D+
Sbjct: 227 KPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFYRAPEVILGARYGMPIDM 282

Query: 226 YSFGILLLELASGK 239
           +S G +L EL +G 
Sbjct: 283 WSLGCILAELLTGY 296

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 48/214 (22%), Positives = 74/214 (34%), Gaps = 58/214 (27%)

Query: 45  KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRG- 101
            LG G  G V          + A+K L+            EVE+  R  +  +++ +   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPK-ARREVELHWRASQCPHIVRIVDV 79

Query: 102 YCAEGQERLIVYDYMPNLS-------LLSHLHGQHS----SECLLNWNRRMDIAIGSAEG 150
           Y      R  +   M  L        +        +    SE + +        IG A  
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS--------IGEA-- 129

Query: 151 IVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
           I YLH     +I HRD+K  N+L      +   ++ DFGFAK         T        
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTGE-----K 174

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
           Y            +SCD++S G+++  L  G  P
Sbjct: 175 Y-----------DKSCDMWSLGVIMYILLCGYPP 197

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 39/197 (19%), Positives = 77/197 (39%), Gaps = 42/197 (21%)

Query: 13  SDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL- 70
             RK+    +PT  +          + +   + +G G +G V       +   +A+K++ 
Sbjct: 28  QQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL 87

Query: 71  KVWSNKAEMEFAV-EVEILARVRHKNLLSL----RGYCAEGQERL-IVYDYMPNLSLLSH 124
           +V+ +  + +  + E+ IL R+ H +++ +         E  + L +V +        S 
Sbjct: 88  RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SD 142

Query: 125 LH-----GQHSSEC--------LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN 171
                    + +E         LL              G+ Y+H      I+HRD+K +N
Sbjct: 143 FKKLFRTPVYLTELHIKTLLYNLLV-------------GVKYVHSA---GILHRDLKPAN 186

Query: 172 VLLDADFKAQVADFGFA 188
            L++ D   +V DFG A
Sbjct: 187 CLVNQDCSVKVCDFGLA 203

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 68/239 (28%)

Query: 44  NKLGEGGFGSVYWGQLW------DGSQIAVKRL-KVWSNKAEMEFAV----EVEILARVR 92
            KLG+G +G V     W       G  +AVK++   + N      A     E+ IL  + 
Sbjct: 15  KKLGKGAYGIV-----WKSIDRRTGEVVAVKKIFDAFQNS---TDAQRTFREIMILTELS 66

Query: 93  -HKNLLSLRG-YCAEGQERL-IVYDYMP-NLS------LLSHLHGQHSSECLLNWNRRMD 142
            H+N+++L     A+    + +V+DYM  +L       +L  +H Q+    L+       
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK------ 120

Query: 143 IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
                   I YLH   +  ++HRD+K SN+LL+A+   +VADFG ++   +         
Sbjct: 121 -------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 203 KGTLG--------------------YLAPEYAMLGKA--SESCDVYSFGILLLELASGK 239
                                    Y APE  +LG    ++  D++S G +L E+  GK
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPE-ILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 4e-08
 Identities = 62/408 (15%), Positives = 117/408 (28%), Gaps = 105/408 (25%)

Query: 20  KKQPTWRIFSLKELHSATNNFNYDNKL---GEGGFG-SVYWGQLWDGSQIAVKRLKVWSN 75
            K    R+    +L  A         +   G  G G +           +A+     +  
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW----------VALDVCLSYKV 176

Query: 76  KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLL 135
           + +M+F +             L+L   C   +  L          LL  +    +S    
Sbjct: 177 QCKMDFKI-----------FWLNL-KNCNSPETVLE-----MLQKLLYQIDPNWTSRSDH 219

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPH--IIHRDIKASNVLLDA-DFKAQVADFGFAKLIP 192
           + N ++ I    AE    L      +  ++  +++ +    +A +   ++       L  
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW-NAFNLSCKI-------L-- 269

Query: 193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVY----SFGILL--LELASGKKPIE--K 244
                +TTR K    +L+                       +LL  L+      P E   
Sbjct: 270 -----LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324

Query: 245 VN----SAIKRTITDWA------LPLACERKFSELADPRLNGNFVEEELKR-----VVLV 289
            N    S I  +I D          + C+ K + + +  LN      E ++      V  
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCD-KLTTIIESSLN-VLEPAEYRKMFDRLSVF- 381

Query: 290 ALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDELFKSHQVADYNDGKAVAEDSAEK 349
                   P        +L L+  +  +    +  ++L K            V +   E 
Sbjct: 382 --------PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY---------SLVEKQPKES 424

Query: 350 LAEL---------ENDELFKSHQ--VADYNDGKAVAEDSTDSISEEKD 386
              +         + +  +  H+  V  YN  K    DS D I    D
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF--DSDDLIPPYLD 470

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 4e-05
 Identities = 62/447 (13%), Positives = 128/447 (28%), Gaps = 123/447 (27%)

Query: 9   CGK---VSD--RKEKGKKQPTWRIF--SLKELHSAT------NNFNY--DNKLGEGGFGS 53
            GK     D     K + +  ++IF  +LK  +S            Y  D         S
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220

Query: 54  ------VYWGQLWDGSQIAVKRLK--------VWSNKAEMEFAVEVEILARVRHKNLLSL 99
                 ++  Q      +  K  +        V + KA   F +  +IL   R K +   
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF 280

Query: 100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNW-NRRMD-------------IAI 145
               A     + +  +   L+             LL + + R               ++I
Sbjct: 281 LS--AATTTHISLDHHSMTLTP------DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332

Query: 146 GSAEGIVYLHH-----HATPHIIHRDIKAS-NVLLDADFKAQVADFGFAKLIPDGATHVT 199
            +      L       H     +   I++S NVL  A+++          + P    H+ 
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS---VFPPS-AHIP 388

Query: 200 TRVKGTL-GYLAPE-----------YAMLGKASESCDVYSFGILLLELASG-------KK 240
           T +   +   +              Y+++ K  +   +    I L             + 
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448

Query: 241 PIEKVNSAIKRTITDWALPLACE------------------RKFSELADPRLNGNFVEEE 282
            ++  N  I +T     L                        + +      L+  F+E++
Sbjct: 449 IVDHYN--IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK 506

Query: 283 LKRVVLVALTCAHSKPEKRPTMLEVLDLLKG---ESKEKLTELEND----------ELFK 329
           ++       + A +        L+ L   K    ++  K   L N            L  
Sbjct: 507 IRHD-----STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLIC 561

Query: 330 SH-----QVADYNDGKAVAEDSAEKLA 351
           S      ++A   + +A+ E++ +++ 
Sbjct: 562 SKYTDLLRIALMAEDEAIFEEAHKQVQ 588

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 51/287 (17%), Positives = 99/287 (34%), Gaps = 92/287 (32%)

Query: 1   MAFGSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNK--------------- 45
           +   +++     S +KE+                    N  YD+                
Sbjct: 13  LGTENLYFQSMSSHKKERKV-----------------YNDGYDDDNYDYIVKNGEKWMDR 55

Query: 46  ------LGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFA--VEVEILARVRHK 94
                 +G+G FG V   + +D      +A+K +K   NK        +EV +L      
Sbjct: 56  YEIDSLIGKGSFGQVV--KAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLEL---- 106

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSH-LHGQH---SSECL---------------L 135
               +  +  E +  ++         L  H +   H     E L               +
Sbjct: 107 ----MNKHDTEMKYYIV--------HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ--VADFGFAKLIPD 193
           + N     A      +++L       IIH D+K  N+LL    ++   + DFG +  +  
Sbjct: 155 SLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213

Query: 194 GATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGK 239
               +   ++ +  Y +PE  +LG     + D++S G +L+E+ +G+
Sbjct: 214 ---RIYQYIQ-SRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.0 bits (121), Expect = 3e-07
 Identities = 32/214 (14%), Positives = 57/214 (26%), Gaps = 55/214 (25%)

Query: 36  ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN--------KAEMEFAVEVEI 87
            T       K+GEG FG V+     D + +A+K + +           K   E   E+ I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 88  L---------ARVRHKNLLSLRG-YCAEG-----------------------------QE 108
                        R +  + L   +C +G                              +
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIK 168
             IV ++      L  +  +     L +      I       +            HRD+ 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEAS--LRFEHRDLH 189

Query: 169 ASNVLLDADFKAQVADFGFAKLIPDGATHVTTRV 202
             NVLL      ++      K     +  +   +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 50/279 (17%), Positives = 88/279 (31%), Gaps = 92/279 (32%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAV-EVEILARVRHK 94
              ++   KLG G F +V+    +     +A+K +K  S +   E A+ E+ +L  VR+ 
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNS 93

Query: 95  NLLSLRGYC-------------AEGQERLIVYDYM-PNLSLLSHLHGQHSSECLLNWNRR 140
           +  +                    G    +V++ +  +L                +  + 
Sbjct: 94  DP-NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK----------SNYQG 142

Query: 141 MD------IAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD----------------- 177
           +       I     +G+ YLH      IIH DIK  N+LL  +                 
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 178 --------------------------------FKAQVADFGFAKLIPDGATHVTTRVKGT 205
                                            K ++AD G A  +    T        T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----T 256

Query: 206 LGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIE 243
             Y + E  ++G   +   D++S   +  ELA+G    E
Sbjct: 257 RQYRSLE-VLIGSGYNTPADIWSTACMAFELATGDYLFE 294

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 48/236 (20%), Positives = 79/236 (33%), Gaps = 66/236 (27%)

Query: 45  KLGEGGFGSVY--WGQLWDGSQIAVKRLKVWSNKAEMEFA--VEVEILARVRHK------ 94
            LGEG FG V          SQ+A+K ++   N  +   A  +E+ +L +++ K      
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENKF 82

Query: 95  NLLSLRGY-------CAEGQERLIVYDYM-PNLSLLSHLHGQHSSECLLNWNRRMDIAIG 146
             + +  +       C       I ++ +  N       +                +A  
Sbjct: 83  LCVLMSDWFNFHGHMC-------IAFELLGKNTFEFLKENNFQP----YPLPHVRHMAYQ 131

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA-------------------DFGF 187
               + +LH +    + H D+K  N+L        +                    DFG 
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 188 AKLIPDGATHVT---TRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGK 239
           A    D   H T   TR      Y  PE  +L    ++ CDV+S G +L E   G 
Sbjct: 189 A--TFDHEHHTTIVATRH-----YRPPE-VILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 54/238 (22%), Positives = 85/238 (35%), Gaps = 70/238 (29%)

Query: 45  KLGEGGFGSVYWGQLWD----GSQIAVKRLKVWSNKAEMEFA--VEVEILARVRHK---- 94
            LGEG FG V   +  D    G  +AVK +K   N      A   E+++L  +       
Sbjct: 21  TLGEGAFGKVV--ECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 95  --NLLSLRGY-------CAEGQERLIVYDYM-PNLSLLSHLHGQHSSECLLNWNRRMDIA 144
               + +  +       C       IV++ +  +       +G          +    +A
Sbjct: 76  TFRCVQMLEWFEHHGHIC-------IVFELLGLSTYDFIKENGFLP----FRLDHIRKMA 124

Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLL-DADFKAQ------------------VADF 185
               + + +LH +    + H D+K  N+L   +D+                     V DF
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 186 GFAKLIPDGATHVT---TRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGK 239
           G A    D   H T   TR      Y APE  +L    S+ CDV+S G +L+E   G 
Sbjct: 182 GSA--TYDDEHHSTLVSTRH-----YRAPE-VILALGWSQPCDVWSIGCILIEYYLGF 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 49/241 (20%), Positives = 86/241 (35%), Gaps = 72/241 (29%)

Query: 45  KLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEMEFA--VEVEILARVRH-----K 94
           K+G+G FG V              AVK ++   N  +   +  +E +IL ++++      
Sbjct: 42  KMGDGTFGRVL--LCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 95  NLLSLRGY-------CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS 147
           N++   G        C       ++++ +   SL   +    ++    +        I  
Sbjct: 97  NIVKYHGKFMYYDHMC-------LIFEPL-GPSLYEII--TRNNYNGFHIEDIKLYCIEI 146

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ-------------------------V 182
            + + YL       + H D+K  N+LLD  +  +                         +
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 183 ADFGFAKLIPDGATH---VTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASG 238
            DFG A        H   + TR      Y APE  +L      S D++SFG +L EL +G
Sbjct: 204 IDFGCA--TFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCVLAELYTG 255

Query: 239 K 239
            
Sbjct: 256 S 256

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	400
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.23
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.18
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.1
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.09
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.71
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.48
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.42
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.41
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.34
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.65
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.31
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.65
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.44
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.85

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.5e-60  Score=440.73  Aligned_cols=258  Identities=26%  Similarity=0.453  Sum_probs=211.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ++|.+.+.||+|+||.||+|.+.      ++..||||+++.........|.+|+++|++|+|||||+++|+|.+++..||
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57889999999999999999753      477899999987777777889999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC---------CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEE
Q 015797          112 VYDYMPNLSLLSHLHGQH---------SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV  182 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl  182 (400)
                      |||||++|+|.++|....         .....++|..++.++.|++.||.|||+++   ||||||||+||||+.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997542         22335999999999999999999999998   999999999999999999999


Q ss_pred             EecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccc
Q 015797          183 ADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALP  259 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~  259 (400)
                      +|||+++......... .....||+.|||||++.++.|+.++|||||||+||||+| |+.||...+... ...+..... 
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-  248 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-  248 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            9999998765433222 223469999999999999999999999999999999999 899998755321 111111000 


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                                  +..+    ...+..+.++|.+||+.||++|||+.+|++.|+.+.
T Consensus       249 ------------~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          249 ------------LQRP----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             ------------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------CCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                        0011    112346788899999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-59  Score=436.58  Aligned_cols=259  Identities=30%  Similarity=0.495  Sum_probs=201.6

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +...+++.+.+.||+|+||+||+|.+.  ..||||+++..  .......|.+|+.+|+.++|||||++++++.+ +.+||
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            344578889999999999999999743  46999998743  34445679999999999999999999998865 56899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |||||++|+|.++|.....   .+++..++.|+.|++.||.|||+++   ||||||||+||||+.++.+||+|||+|+..
T Consensus       109 VmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            9999999999999975432   4999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC-ceeeeecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhcccc
Q 015797          192 PDGA-THVTTRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERK  265 (400)
Q Consensus       192 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~  265 (400)
                      .... .......+||+.|||||++.+   +.|+.++|||||||+||||+||+.||...+..  ....+...         
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~---------  253 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG---------  253 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT---------
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC---------
Confidence            5322 222344679999999999974   45899999999999999999999999765422  11111110         


Q ss_pred             cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                         ...+.+. ......+..+.++|.+||+.||.+|||+.+|++.|+.+
T Consensus       254 ---~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          254 ---YASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             ---CCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               0000000 11112234678889999999999999999999988644

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-58  Score=435.27  Aligned_cols=258  Identities=27%  Similarity=0.442  Sum_probs=205.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .+|.+.+.||+|+||.||+|.+.      +++.||||+++.........|.+|+++|+.|+|||||+++|+|.+++..||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56777889999999999999753      478899999987777777889999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCc-----------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcE
Q 015797          112 VYDYMPNLSLLSHLHGQHSS-----------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA  180 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~  180 (400)
                      |||||++|+|.+++......           ...++|..++.++.|++.||.|||+++   ||||||||+||||+.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            99999999999999754321           235899999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccc
Q 015797          181 QVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWA  257 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~  257 (400)
                      ||+|||+++....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||....... ...+....
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~  277 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR  277 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999987644322 22334569999999999999999999999999999999999 899998654321 11111100


Q ss_pred             cchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                                   .+..+.    .....+.++|.+||+.||++|||+.||++.|+.+.
T Consensus       278 -------------~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          278 -------------ELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             -------------CCCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------------CCCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence                         001111    12346788899999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.2e-59  Score=434.25  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=207.8

Q ss_pred             cCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      +++++.+.||+|+||+||+|.+      .+++.||||+++... ......|.+|+.+|+.|+|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            4567789999999999999975      246789999997533 333567999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          111 IVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      +|||||++|+|.++|..+..            ....++|..++.++.||+.||.|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999965421            1235899999999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhc
Q 015797          179 KAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITD  255 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~  255 (400)
                      .+||+|||+++....... .......||+.|||||++.++.|+.++|||||||+||||+| |..||...+... ...+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987643322 22334569999999999999999999999999999999999 899998755321 111111


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ..        .     +..    ....+..+.++|.+||+.||.+|||+.+|++.|+..
T Consensus       263 ~~--------~-----~~~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          263 RQ--------V-----LPC----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TC--------C-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CC--------C-----CCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            00        0     001    111234678899999999999999999999999754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-58  Score=437.64  Aligned_cols=250  Identities=25%  Similarity=0.391  Sum_probs=201.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      -++|++++.||+|+||+||+|.+ .+|+.||||++...  .......+.+|+++|+.|+|||||++++++.+++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999965 56999999999753  3444567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||+||+|.++|.....  ..+++..++.|+.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+++.+..
T Consensus       103 Ey~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999975432  24788899999999999999999998   99999999999999999999999999987643


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+... ...+.....|             
T Consensus       178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------------  243 (350)
T 4b9d_A          178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------------  243 (350)
T ss_dssp             HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------------
T ss_pred             Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-------------
Confidence            21 12234579999999999999999999999999999999999999997654321 1111111000             


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ......    ...+.+||.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 PVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            011111    246778889999999999999999987

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-58  Score=433.36  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=207.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      ..|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5699999999999999999965 569999999997654444556889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      +||+|.+++...     .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999998643     3899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                       .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.... ..+.....             +.+ 
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-------------~~~-  290 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-------------PRL-  290 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-------------CCC-
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-------------CCC-
Confidence             23456799999999999999999999999999999999999999976543211 11111000             000 


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       .........+.+||.+||+.||.+|||+.|+++
T Consensus       291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             011112346778889999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.3e-58  Score=425.99  Aligned_cols=246  Identities=23%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++++.||+|+||+||+|.+ .+++.||+|++....   ......+.+|+++|+.|+||||+++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999965 579999999997422   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||+||+|.+++....    .+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999997543    3899999999999999999999998   99999999999999999999999999997754


Q ss_pred             CC-ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccC
Q 015797          194 GA-THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .. .....+.+||+.|||||++.+..|+.++|||||||++|+|+||+.||...+.. ....+....        +     
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------~-----  251 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--------Y-----  251 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------C-----
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------C-----
Confidence            32 23344567999999999999999999999999999999999999999765432 111111100        0     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL  308 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell  308 (400)
                       .+....    ...+.+||.+||+.||.+|||+.|++
T Consensus       252 -~~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 -DFPEKF----FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -CCCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -CCCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence             011112    23567788999999999999998864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-57  Score=418.62  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=197.7

Q ss_pred             cCC-CcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe----CCeE
Q 015797           38 NNF-NYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE----GQER  109 (400)
Q Consensus        38 ~~y-~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~  109 (400)
                      ++| ++.+.||+|+||+||+|.+ .++..||+|.+...  .......+.+|+.+|+.|+|||||+++++|.+    ++.+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            455 6778899999999999965 56899999999743  34445679999999999999999999999865    3568


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecCCc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFA  188 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~  188 (400)
                      |||||||+||+|.+++....    .+++..+..|+.||+.||.|||+++ ++||||||||+||||+. +|.+||+|||+|
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            99999999999999997543    4899999999999999999999875 45999999999999984 799999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERKF  266 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~  266 (400)
                      +.....   ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||......  ....+.....|.      
T Consensus       180 ~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~------  249 (290)
T 3fpq_A          180 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------  249 (290)
T ss_dssp             GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG------
T ss_pred             EeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC------
Confidence            864332   2345679999999998865 6999999999999999999999999754321  111111111110      


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                            ......    ...+.++|.+||+.||.+|||+.|+++
T Consensus       250 ------~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 ------SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  000011    235778889999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.3e-57  Score=435.48  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .+.|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46799999999999999999965 56999999999865555556688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      |+||+|.+++...     .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999998643     2899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      . .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... ..+....             .+.+
T Consensus       302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------~~~~  367 (423)
T 4fie_A          302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------PPRL  367 (423)
T ss_dssp             C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------CCCC
T ss_pred             c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------CCCC
Confidence            2 23456799999999999999999999999999999999999999976543211 1111100             0000


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .  ........+.+||.+||..||.+|||+.|+++
T Consensus       368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  00111246778889999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-57  Score=427.65  Aligned_cols=253  Identities=23%  Similarity=0.259  Sum_probs=202.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ..+.|++.+.||+|+||.||+|.+ .+|+.||||+++....     ..+|+.+|+.|+|||||++++++.+++.+|||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            345688888999999999999965 5699999999975322     2469999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCccccCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKLIPD  193 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~~~~~  193 (400)
                      ||+||+|.++|....    .+++..+..++.|++.||.|||+++   ||||||||+||||+.+| ++||+|||+++.+..
T Consensus       131 y~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            999999999997543    3899999999999999999999998   99999999999999998 699999999987654


Q ss_pred             CCce----eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhccccccc
Q 015797          194 GATH----VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSE  268 (400)
Q Consensus       194 ~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ....    .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.. ....+.....+      +. 
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------~~-  276 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP------IR-  276 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG------GG-
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC------ch-
Confidence            3211    122357999999999999999999999999999999999999999764421 11111110000      00 


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                          .+.    +.....+.++|.+||+.||.+|||+.||++.|....
T Consensus       277 ----~~~----~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          277 ----EIP----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             ----GSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----hcC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                011    112346777889999999999999999999876543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.2e-57  Score=412.84  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=189.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++....   ......+.+|+++|+.++||||+++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            37999999999999999999965 569999999997432   22345688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||| +|+|.+++..+.    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        92 mEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            9999 689999987543    3899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccccccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELA  270 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ...  ...+.+||+.|||||++.+..| +.++|||||||++|+|+||+.||...+... ...+.....            
T Consensus       164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~------------  229 (275)
T 3hyh_A          164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY------------  229 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------------
T ss_pred             CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            332  2334579999999999998876 589999999999999999999997654321 111111000            


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        .+....    ...+.+++.+||+.||.+|||+.|+++
T Consensus       230 --~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 --TLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              011111    235677889999999999999999997

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-56  Score=427.08  Aligned_cols=267  Identities=24%  Similarity=0.380  Sum_probs=213.9

Q ss_pred             cHHHHHHHccCCCcCCcccccCceEEEEEEEcC------CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCC-Cccceee
Q 015797           29 SLKELHSATNNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRH-KNLLSLR  100 (400)
Q Consensus        29 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h-pnIv~~~  100 (400)
                      ...+++...++|++++.||+|+||.||+|.+..      ++.||||.+.... ......+..|+.+|..+.| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345566677899999999999999999996532      3579999997644 3445679999999999965 8999999


Q ss_pred             eEEEeC-CeEEEEEEccCCCChhhhhhcCCCc------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 015797          101 GYCAEG-QERLIVYDYMPNLSLLSHLHGQHSS------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDI  167 (400)
Q Consensus       101 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~di  167 (400)
                      |+|.+. +.+|||||||++|+|.++|......            ...+++..++.++.||+.||.|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            999764 5689999999999999999754321            234899999999999999999999998   999999


Q ss_pred             CCCCeEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhh
Q 015797          168 KASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV  245 (400)
Q Consensus       168 kp~NIlv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~  245 (400)
                      ||+|||++.++.+||+|||+|+.+..... .......||+.|||||++.++.|+.++|||||||+||||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654333 23344679999999999999999999999999999999998 99999765


Q ss_pred             hh--hhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          246 NS--AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       246 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..  .....+....             .+..+...    ...+.++|.+||+.||.+|||+.+|++.|..+.
T Consensus       292 ~~~~~~~~~i~~g~-------------~~~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          292 KIDEEFCRRLKEGT-------------RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCSHHHHHHHHHTC-------------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCC-------------CCCCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            32  1111111110             01111111    246778889999999999999999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.8e-56  Score=416.89  Aligned_cols=272  Identities=22%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----eEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----ERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~  113 (400)
                      .+|.+.+.||+|+||+||+|.+ +|+.||||+++..... ...+..|+..+..++||||++++++|.+++    .+||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4678889999999999999975 7899999998653221 222344666677899999999999998654    579999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA-----TPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      |||++|+|.+++...     .++|..++.++.|++.||+|||++.     .++||||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999754     3899999999999999999999761     234999999999999999999999999999


Q ss_pred             cccCCCCcee---eeecccccCcCChhhhccC------CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhh--c
Q 015797          189 KLIPDGATHV---TTRVKGTLGYLAPEYAMLG------KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTIT--D  255 (400)
Q Consensus       189 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~--~  255 (400)
                      +.........   ....+||+.|||||++.+.      .++.++|||||||+||||+||..||......  +.....  .
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8765433221   2235699999999999764      4678999999999999999999887543211  000000  0


Q ss_pred             cccchhcccccccccCccCCCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          256 WALPLACERKFSELADPRLNGN-FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ...............++.+... ...+....+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0000000000111112222211 123456778899999999999999999999999876543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.4e-57  Score=418.34  Aligned_cols=246  Identities=23%  Similarity=0.300  Sum_probs=194.5

Q ss_pred             cCCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ++|++++.||+|+||+||+|+.    .+++.||+|+++...  ......+..|+.+|+.++||||+++++++.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999965    247899999986422  2223457889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |||||+||+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999997543    4899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ..... ...+.+||+.|||||++.+..|+.++|||||||++|||+||+.||...+... ...+.....            
T Consensus       177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------  243 (304)
T 3ubd_A          177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL------------  243 (304)
T ss_dssp             ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred             cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------
Confidence            43322 2334679999999999999999999999999999999999999998654321 111111000            


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM-----LEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~  309 (400)
                        .+....    ...+.+||.+||+.||.+|||+     +|+++
T Consensus       244 --~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 --GMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --CCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --CCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              011111    2367778899999999999984     67765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-54  Score=405.59  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=189.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCC--------
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ--------  107 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------  107 (400)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++..... .....+.+|+.+|+.|+|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4689999999999999999965 5799999999975443 34467889999999999999999999987654        


Q ss_pred             ----eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          108 ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       108 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                          .+|+|||||++|+|.+++...... ....+..++.++.|++.||.|||+++   |+||||||+||||+.+|.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                368999999999999999765432 23566778899999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCce-----------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-
Q 015797          184 DFGFAKLIPDGATH-----------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-  251 (400)
Q Consensus       184 Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-  251 (400)
                      |||+|+.+......           .....+||+.|||||++.+..|+.++|||||||++|||++   ||......... 
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            99999876543221           1223569999999999999999999999999999999996   77543221110 


Q ss_pred             -hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          252 -TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       252 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       .+.....|                 .........+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~p-----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          238 TDVRNLKFP-----------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHTTCCC-----------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCC-----------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             01110000                 011222345667899999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.8e-52  Score=390.90  Aligned_cols=289  Identities=37%  Similarity=0.634  Sum_probs=237.4

Q ss_pred             CcccccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           24 TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        24 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      +..+++..++..++++|++.+.||+|+||.||+|...+++.||+|++..........+.+|+.+++.++||||+++++++
T Consensus        25 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             -----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             cceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34577888888999999999999999999999998778999999998876666677899999999999999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                      .+.+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence            9999999999999999999999765544446899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhc
Q 015797          184 DFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC  262 (400)
Q Consensus       184 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  262 (400)
                      |||++........ .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.............+......
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            9999986543222 122334589999999999999999999999999999999999999975432211111122211222


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ...+....++.......+.....+.+++.+||+.||.+|||+.++++.|+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            23344555555556677888899999999999999999999999999987654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-52  Score=403.40  Aligned_cols=266  Identities=20%  Similarity=0.286  Sum_probs=200.1

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe------CC
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE------GQ  107 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~  107 (400)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++...  .......+.+|+++|+.|+|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36899999999999999999965 57999999999643  23344578899999999999999999998754      36


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      .+|||||||. |+|.+++....    .+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence            7899999996 78999986543    4999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCC---ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hh-hccccchh
Q 015797          188 AKLIPDGA---THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TI-TDWALPLA  261 (400)
Q Consensus       188 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~-~~~~~~~~  261 (400)
                      ++.+....   .....+.+||+.|+|||++.+. .++.++||||+|||+|||+||++||...+..... .+ .....|..
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            98764322   1223456799999999998875 5699999999999999999999999765432111 11 00000000


Q ss_pred             --cc----ccccc---ccCccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 --CE----RKFSE---LADPRLNGN---FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 --~~----~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ..    .....   ...+.....   ..+.....+.+||.+||..||.+|||+.|+++.
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              00    00000   000000000   001112467788999999999999999999973

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-51  Score=394.67  Aligned_cols=203  Identities=27%  Similarity=0.431  Sum_probs=172.8

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEe
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAE  105 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  105 (400)
                      +.+....++|++.+.||+|+||+||+|...    +++.||+|.+....  ....+.+|+++|+.+ +||||+++++++.+
T Consensus        14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            344566789999999999999999999643    46789999886533  345678899999988 69999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-CcEEEEe
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVAD  184 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~~kl~D  184 (400)
                      .+.+|+|||||++|+|.+++.       .+++..+..++.|++.||.|||+++   |+||||||+|||++.+ +.+||+|
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            999999999999999999884       2788999999999999999999999   9999999999999876 8999999


Q ss_pred             cCCccccCCCCc---------------------------eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHH
Q 015797          185 FGFAKLIPDGAT---------------------------HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELA  236 (400)
Q Consensus       185 fgl~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~ell  236 (400)
                      ||+|+.......                           ......+||+.|+|||++.+. .|+.++||||+||++|+|+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            999976543211                           112234699999999999875 5899999999999999999


Q ss_pred             hCCCChhhh
Q 015797          237 SGKKPIEKV  245 (400)
Q Consensus       237 tg~~Pf~~~  245 (400)
                      ||+.||...
T Consensus       242 ~G~~Pf~~~  250 (361)
T 4f9c_A          242 SGRYPFYKA  250 (361)
T ss_dssp             HTCSSSSCC
T ss_pred             HCCCCCCCC
Confidence            999999643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.6e-51  Score=388.36  Aligned_cols=294  Identities=47%  Similarity=0.800  Sum_probs=243.0

Q ss_pred             CCCCcccccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCcccee
Q 015797           21 KQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSL   99 (400)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~   99 (400)
                      .......|+..++..+.++|++.+.||+|+||.||+|...+++.||+|++...... ....+..|+.+++.++||||+++
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            33456789999999999999999999999999999998778999999998753322 22368899999999999999999


Q ss_pred             eeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      ++++.+.+..++||||+.+|+|.+++.........+++..++.++.|++.||.|||+...+.++||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            99999999999999999999999999876655556999999999999999999999991112999999999999999999


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccc
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWA  257 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~  257 (400)
                      +||+|||++...............||+.|+|||++.+..++.++|||||||++|+|+||+.||.......  ......+.
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999998776544444455669999999999999999999999999999999999999996433211  11122222


Q ss_pred             cchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ........+....+..............+.+++.+||+.||.+|||+.+|++.|++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            222233445556666666777888899999999999999999999999999999753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.2e-51  Score=412.35  Aligned_cols=252  Identities=19%  Similarity=0.318  Sum_probs=209.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+.+|+.|+||||++++++|.+++.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            47899999999999999999965 57999999999876666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC--CcEEEEecCCccccCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD--FKAQVADFGFAKLIPD  193 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~--~~~kl~Dfgl~~~~~~  193 (400)
                      |+||+|.++|.....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+..
T Consensus       236 ~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999865432   3889999999999999999999998   9999999999999854  8999999999998754


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...  ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...+.... ..+......      +    ..
T Consensus       310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~------~----~~  377 (573)
T 3uto_A          310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN------M----DD  377 (573)
T ss_dssp             TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC------C----CS
T ss_pred             CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC------C----Cc
Confidence            332  3345799999999999999999999999999999999999999976553211 111110000      0    00


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          .........+.+||.+||+.||.+|||+.|+++.
T Consensus       378 ----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0001112366788899999999999999999983

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.1e-50  Score=405.40  Aligned_cols=250  Identities=22%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC------hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS------NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|++++.||+|+||.||+|+. .+|+.||+|++....      .........++.+++.++|||||+++++|.+.+.
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            357899999999999999999965 569999999996421      1111223345677788899999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      +|||||||+||+|.++|....    .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|
T Consensus       267 lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence            999999999999999997543    3899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      +.+....   ..+.+||+.|||||++.+ ..|+.++|||||||+||||+||+.||..........+.....    ..   
T Consensus       340 ~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~---  409 (689)
T 3v5w_A          340 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TM---  409 (689)
T ss_dssp             EECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HC---
T ss_pred             eecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CC---
Confidence            8765432   234579999999999975 579999999999999999999999997543211100000000    00   


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                         ...+...+    ...+.+||.+||+.||.+|++     +.||++
T Consensus       410 ---~~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 ---AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---CCCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---CCCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               00111112    235677889999999999998     688886

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-48  Score=365.63  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=208.3

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            3567899999999999999999964 679999999997655555667889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++...     .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.....
T Consensus        97 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            999999999998754     2888999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .... .....||+.|+|||++.+..++.++|||||||++|+|+||..||.......... ......+        ..   
T Consensus       169 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~---  236 (297)
T 3fxz_A          169 EQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------EL---  236 (297)
T ss_dssp             TTCC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC--------CC---
T ss_pred             cccc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CC---
Confidence            3322 234569999999999999999999999999999999999999997654321111 0000000        00   


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          .........+.+++.+||+.||.+|||+.++++.
T Consensus       237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 ----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                0011123467788999999999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=367.38  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=210.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|.+..........+..|+.+++.++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46889999999999999999965 46899999998776777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999976432   3899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cee-------------eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhc
Q 015797          196 THV-------------TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC  262 (400)
Q Consensus       196 ~~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  262 (400)
                      ...             .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............  .    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--~----  236 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--V----  236 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--H----
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--h----
Confidence            211             113469999999999999999999999999999999999999986533211000000  0    


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .........+        .....+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       237 ~~~~~~~~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          237 RGFLDRYCPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHHHTCCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccccccCCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0000000011        112357788899999999999999999999876643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-48  Score=367.27  Aligned_cols=271  Identities=30%  Similarity=0.475  Sum_probs=206.1

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEE
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCA  104 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  104 (400)
                      .++...+....++|++.+.||+|+||.||+|.. .++.||+|++....  ......+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            455556667778999999999999999999974 78899999987543  334467889999999999999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVAD  184 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~D  184 (400)
                      +.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++++||||||+|||++.++.+||+|
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECC
Confidence            99999999999999999999975432 224889999999999999999999885 3499999999999999999999999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      ||++........ ......||+.|+|||++.+..++.++|||||||++|+|+||+.||................      
T Consensus       183 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~------  255 (309)
T 3p86_A          183 FGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------  255 (309)
T ss_dssp             CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC------
T ss_pred             CCCCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------
Confidence            999975443221 2233469999999999999999999999999999999999999998654321111100000      


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                           ......    ......+.+++.+||+.||.+|||+.++++.|+...+
T Consensus       256 -----~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          256 -----KRLEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -----CCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -----CCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 000111    1122467888999999999999999999999976654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.9e-48  Score=365.82  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=207.1

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .....++|++.+.||+|+||.||+|.+ .+|+.||+|++...  .......+.+|+++|+.++||||+++++++.+.+..
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            345568999999999999999999965 67999999999753  344556788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             EEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            99999999999999986543    3889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCC-CccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKAS-ESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      .......  ....+||+.|+|||++.+..++ .++|||||||++|+|+||+.||...+.... ..+...        .. 
T Consensus       163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--------~~-  231 (328)
T 3fe3_A          163 EFTVGGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--------KY-  231 (328)
T ss_dssp             GGSSSCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------CC-
T ss_pred             ecCCCCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------CC-
Confidence            6654322  2345699999999999988875 799999999999999999999976543211 111110        00 


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           .....    ....+.+++.+||+.||.+|||+.++++.
T Consensus       232 -----~~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 -----RIPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -----CCCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -----CCCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 00001    12367788899999999999999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-47  Score=357.33  Aligned_cols=261  Identities=24%  Similarity=0.365  Sum_probs=205.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+...   .......+.+|+.+++.++||||+++++++.+++..|+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            357899999999999999999964 56899999998642   33345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            999999999999987543    3899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  270 (400)
                      ............||+.|+|||++.+..++.++||||||+++|+|+||+.||......... .......+.     ...  
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~--  234 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-----VTT--  234 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-----HHH--
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-----cch--
Confidence            544333334456999999999999999999999999999999999999999765432110 000000000     000  


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhcccch
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-TMLEVLDLLKGESK  316 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~~~~  316 (400)
                        .    ........+.+++.+||+.||.+|| ++.++.+.|.....
T Consensus       235 --~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          235 --D----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             --H----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             --h----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence              0    0111234677888999999999998 89999998876543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.1e-47  Score=351.40  Aligned_cols=257  Identities=29%  Similarity=0.445  Sum_probs=211.7

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ..++|++.+.||+|+||.||+|...++..||+|++...... ...+..|+.+++.++||||+++++++.+.+..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            45789999999999999999998888889999999754432 35688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++|+|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999987542   24899999999999999999999998   9999999999999999999999999998765544


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhh-hhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRT-ITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ........+|+.|+|||++.+..++.++||||||+++|+|+| |..||.......... .....          ....+ 
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~-  227 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH----------RLYRP-  227 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----------CCCCC-
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC----------CCCCC-
Confidence            333333457788999999999999999999999999999999 999997654321111 10000          00000 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         ...   ...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       228 ---~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          228 ---HLA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---TTS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CcC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               011   2367788899999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.6e-48  Score=362.61  Aligned_cols=273  Identities=22%  Similarity=0.368  Sum_probs=206.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~  109 (400)
                      .++|++.+.||+|+||.||+|..     .+++.||+|++..........+.+|+.+++.++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            47899999999999999999973     36889999999877766677899999999999999999999998553  568


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999975432   3889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCce--eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGATH--VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      ........  ......+++.|+|||++.+..++.++||||||+++|+|+||..||.........................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76543221  1222347788999999999999999999999999999999999986543322111111000000000000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..................+.+++.+||+.||.+|||+.++++.|..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            000000000111122357888999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-46  Score=356.21  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=213.9

Q ss_pred             ccccHHHHHHHccC----------CCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCC
Q 015797           26 RIFSLKELHSATNN----------FNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK   94 (400)
Q Consensus        26 ~~~~~~~~~~~~~~----------y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp   94 (400)
                      ..|+.+++..+++.          |...+.||+|+||.||+|... +|+.||||++..........+..|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            46888888887765          777789999999999999764 7999999999876655667788999999999999


Q ss_pred             ccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797           95 NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus        95 nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                      ||+++++++...+..++||||+++|+|.+++...     .+++..++.++.|++.||.|||+.+   ++||||||+|||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999988643     3899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhh
Q 015797          175 DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTI  253 (400)
Q Consensus       175 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~  253 (400)
                      +.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..+
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~  253 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  253 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999876543222 2335699999999999999999999999999999999999999975443211 111


Q ss_pred             hccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          254 TDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .....+             ...  ........+.+++.+||+.||.+|||+.++++.
T Consensus       254 ~~~~~~-------------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          254 RDSPPP-------------KLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHSSCC-------------CCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcCCCC-------------CcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            110000             000  011122467788899999999999999999974

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-47  Score=353.12  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=209.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            4688999999999999999998878899999999754332 356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            99999999975432   4889999999999999999999998   99999999999999999999999999986644322


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ..+...             .....
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-------------~~~~~  228 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-------------FRLYK  228 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------------CCCCC
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-------------ccCCC
Confidence            22223447788999999999999999999999999999999 9999976543211 111100             00000


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ...    ....+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       229 ~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          229 PRL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCc----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            011    12467788899999999999999999999976543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=363.52  Aligned_cols=257  Identities=25%  Similarity=0.440  Sum_probs=206.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|++... .......+..|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467899999999999999999753    3446999999754 34445678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999965432   3899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCce--eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          192 PDGATH--VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      ......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ ..+....          
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----------  271 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY----------  271 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------
Confidence            543222  1222346788999999999999999999999999999999 9999976543211 1111100          


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         ...    ........+.+++.+||+.||.+|||+.+|++.|..+..
T Consensus       272 ---~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          272 ---RLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               000    011123467888999999999999999999999976643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-47  Score=368.86  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=208.8

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAE  105 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  105 (400)
                      ..++|++.+.||+|+||.||+|.+.        ++..||+|++.... ......+..|+.+++.+ +||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3478999999999999999999642        34579999987543 33456789999999999 89999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL  173 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIl  173 (400)
                      .+..|+||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+++   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            9999999999999999999976432            1234789999999999999999999998   999999999999


Q ss_pred             ECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-
Q 015797          174 LDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-  250 (400)
Q Consensus       174 v~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-  250 (400)
                      ++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||........ 
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999999866543221 1222347889999999999999999999999999999999 9999976442211 


Q ss_pred             hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          251 RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..+....             ...    ........+.++|.+||+.||.+|||+.++++.|..+.
T Consensus       316 ~~~~~~~-------------~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          316 KLLKEGH-------------RMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHHHTTC-------------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcCC-------------CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1110000             000    11112346788899999999999999999999997654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-47  Score=357.48  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=205.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            357899999999999999999965 468899999987543 345568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC--CCcEEEEecCCccccC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA--DFKAQVADFGFAKLIP  192 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~--~~~~kl~Dfgl~~~~~  192 (400)
                      ||++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.  ++.+||+|||++....
T Consensus        82 ~~~g~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           82 FISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             eCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            9999999999965432   3899999999999999999999998   999999999999987  7899999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+.....+.. ..       
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~-------  225 (321)
T 1tki_A          156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EE-------  225 (321)
T ss_dssp             TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-HH-------
T ss_pred             CCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-hh-------
Confidence            4332  234569999999999999889999999999999999999999997654321 111111000000 00       


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            ........+.+++.+||..||.+|||+.++++.
T Consensus       226 ------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          226 ------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  000113467888999999999999999999983

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.7e-46  Score=349.84  Aligned_cols=285  Identities=35%  Similarity=0.615  Sum_probs=225.5

Q ss_pred             CCCCcccccHHHHHHHccCCCcC------CcccccCceEEEEEEEcCCCEEEEEEEecC----ChHHHHHHHHHHHHHhc
Q 015797           21 KQPTWRIFSLKELHSATNNFNYD------NKLGEGGFGSVYWGQLWDGSQIAVKRLKVW----SNKAEMEFAVEVEILAR   90 (400)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~y~~~------~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~   90 (400)
                      .+.+...|+..++..++++|...      +.||+|+||.||+|.. +++.||+|.+...    .......+.+|+.+++.
T Consensus         8 ~~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~   86 (307)
T 2nru_A            8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK   86 (307)
T ss_dssp             ---CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred             CCCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence            34466889999999999998877      8999999999999974 7899999998642    23345678899999999


Q ss_pred             CCCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 015797           91 VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKAS  170 (400)
Q Consensus        91 l~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~  170 (400)
                      ++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus        87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~  162 (307)
T 2nru_A           87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSA  162 (307)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred             cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHH
Confidence            999999999999999999999999999999999986432 2235899999999999999999999998   999999999


Q ss_pred             CeEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh
Q 015797          171 NVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI  249 (400)
Q Consensus       171 NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~  249 (400)
                      ||+++.++.+||+|||++......... ......||+.|+|||++.+ .++.++||||||+++|+|+||..||.......
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            999999999999999999876543222 2233569999999998864 58999999999999999999999997543210


Q ss_pred             -hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          250 -KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                       ...+....  ......+....++.+ ..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       242 ~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          242 LLLDIKEEI--EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             BTTHHHHHH--HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHh--hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             00000000  000111222222222 234566778899999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-46  Score=361.32  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|.+.+.||+|+||.||+|.. .+|+.||+|++......      ....+..|+.+|+.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            457899999999999999999965 46999999999754322      24578899999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC----cEEEEe
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF----KAQVAD  184 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~----~~kl~D  184 (400)
                      .|+||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            999999999999999996533    3899999999999999999999998   99999999999998877    799999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACE  263 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~  263 (400)
                      ||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+......    
T Consensus       163 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----  236 (361)
T 2yab_A          163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD----  236 (361)
T ss_dssp             CSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC----
T ss_pred             cCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Confidence            999987654322  234569999999999999999999999999999999999999997654321 1111110000    


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        +    ++.    ........+.++|.+||..||.+|||+.++++.
T Consensus       237 --~----~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          237 --F----DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             --C----CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --C----Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0    000    001112467788899999999999999999973

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.5e-48  Score=363.91  Aligned_cols=273  Identities=26%  Similarity=0.316  Sum_probs=206.0

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----eE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----ER  109 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~  109 (400)
                      .-..++|++.+.||+|+||.||+|.. .++.||+|++.... ........|+.+++.++||||+++++++.+..    ..
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            34557899999999999999999975 48999999986533 23345566999999999999999999998744    47


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCCeEECCCCc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH----------ATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      ++|||||++|+|.+++...     .+++..++.++.|++.||.|||+.          +   ++||||||+|||++.++.
T Consensus        98 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCC
T ss_pred             EEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCe
Confidence            9999999999999999753     289999999999999999999998          7   999999999999999999


Q ss_pred             EEEEecCCccccCCCCce-eeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhh
Q 015797          180 AQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTI  253 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~  253 (400)
                      +||+|||++......... ......||+.|+|||++.+     ..++.++|||||||++|+|+||+.||...........
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            999999999876543322 1223469999999999986     3566789999999999999999999975332110000


Q ss_pred             hcc-----ccchhcccccccccCccCCCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          254 TDW-----ALPLACERKFSELADPRLNGN-FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       254 ~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ...     ...............+.+... ........+.++|.+||+.||.+|||+.++++.|+.+.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            000     000000000001111111111 112345678899999999999999999999999976643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-47  Score=355.04  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=208.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ....++|++.+.||+|+||.||+|...++..||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            4556789999999999999999998888889999999754332 356889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999975322   3899999999999999999999998   99999999999999999999999999986644


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccC
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ..........+|+.|+|||++.+..++.++||||||+++|+|+| |+.||........ ..+....             .
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------~  239 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------------R  239 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------------C
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-------------C
Confidence            32222223347788999999999999999999999999999998 9999976543211 1111100             0


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..... .   ....+.+++.+||+.||.+|||+.++++.|..+.
T Consensus       240 ~~~~~-~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          240 LYRPH-L---ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CCCCT-T---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC-c---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            00000 1   1246778889999999999999999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.4e-47  Score=359.45  Aligned_cols=248  Identities=23%  Similarity=0.302  Sum_probs=203.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.+|+.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            46899999999999999999965 469999999997431   22345678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++....
T Consensus        84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999986532    3889999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ...+...        .      
T Consensus       157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------~------  221 (337)
T 1o6l_A          157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--------E------  221 (337)
T ss_dssp             CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------C------
T ss_pred             cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--------C------
Confidence            2222 2334569999999999999999999999999999999999999997544321 1111100        0      


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                      ..+...    ....+.++|.+||+.||.+||     ++.++++.
T Consensus       222 ~~~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 IRFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            001111    124677888999999999999     89999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.8e-47  Score=362.04  Aligned_cols=256  Identities=21%  Similarity=0.272  Sum_probs=205.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-----hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-----NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....     ......+.+|+.+++.++||||+++++++.+++..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            346899999999999999999965 568999999986421     11346788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc---EEEEecC
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVADFG  186 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~---~kl~Dfg  186 (400)
                      |+|||||++|+|.+.+.........+++..++.++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999888654333334889999999999999999999998   999999999999987654   9999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF  266 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  266 (400)
                      ++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........+........ ...+
T Consensus       179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~-~~~~  256 (351)
T 3c0i_A          179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN-PRQW  256 (351)
T ss_dssp             TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCC-HHHH
T ss_pred             ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCC-cccc
Confidence            9987654322 2233469999999999999999999999999999999999999997654322222111100000 0000


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                                   ......+.+++.+||+.||.+|||+.++++
T Consensus       257 -------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          257 -------------SHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                         011246778899999999999999999996

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-47  Score=368.48  Aligned_cols=261  Identities=26%  Similarity=0.389  Sum_probs=209.5

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      +....++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+++|+.++||||+++++++.+.+..+
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            3445678999999999999999999764 78999999987543 333456889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++|+|.+++....   ..+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.
T Consensus       189 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            9999999999999997532   24889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCceee-eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          191 IPDGATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ......... ....+++.|+|||++.++.++.++|||||||++|||+| |..||.................         
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------  333 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---------  333 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC---------
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            543221111 11235778999999999999999999999999999998 9999976543221111110000         


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                         ....    ......+.++|.+||+.||.+|||+.+|++.|..+.
T Consensus       334 ---~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          334 ---LPCP----ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ---CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence               0000    111246778899999999999999999999997654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.6e-47  Score=377.30  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=212.2

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ...+....++|.+.+.||+|+||.||+|....+..||||++.... .....+..|+.+|+.++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344566678899999999999999999988788899999997543 23567999999999999999999999986 6678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            99999999999999997432  124788899999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      ..............+|+.|+|||++.++.++.++|||||||++|||+| |+.||........ ..+....          
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----------  402 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----------  402 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----------
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence            764322211222346788999999999999999999999999999999 9999976543211 1111100          


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         ....    .......+.++|.+||+.||.+|||+.+|++.|..+..
T Consensus       403 ---~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 ---RMPR----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence               0000    01123467888999999999999999999999987643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.5e-47  Score=355.04  Aligned_cols=268  Identities=22%  Similarity=0.297  Sum_probs=202.7

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +...++|++.+.||+|+||+||+|.+.+++.||+|++.....  .....+.+|+.+++.++||||+++++++.++...++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            456689999999999999999999887899999999875332  224568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||++ |+|.+.+.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        97 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           97 VFEFME-KDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEECCS-EEHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEcCCC-CCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence            999998 588888865432   3889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhh--ccccchhccc--
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTIT--DWALPLACER--  264 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~--~~~~~~~~~~--  264 (400)
                      ...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  ....  ....+..+..  
T Consensus       170 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          170 GIPVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             TSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             CCCccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence            433222 223458999999999876 5689999999999999999999999975432211  0000  0000000000  


Q ss_pred             ccccc---cCccCCCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSEL---ADPRLNGN----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~---~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .....   ........    ..+.....+.+++.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00000   00000000    01112346788999999999999999999997

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=368.40  Aligned_cols=254  Identities=20%  Similarity=0.280  Sum_probs=204.4

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ...++|++.+.||+|+||.||+|.. .+++.+|+|++....  ......+.+|+.+++.++||||+++++++.+++..|+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            4567899999999999999999954 578999999997543  2334568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC---CCCcEEEEecCCc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD---ADFKAQVADFGFA  188 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~---~~~~~kl~Dfgl~  188 (400)
                      |||||.+|+|.+.+....    .+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||++
T Consensus        88 v~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            999999999999987643    3889999999999999999999998   99999999999998   4678999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+......        
T Consensus       161 ~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------  231 (444)
T 3soa_A          161 IEVEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--------  231 (444)
T ss_dssp             BCCCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred             EEecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--------
Confidence            876543322 233569999999999999999999999999999999999999997654321 1111110000        


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ...+     ........+.+++.+||+.||.+|||+.++++.
T Consensus       232 -~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          232 -FPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             0000     001112467788899999999999999999984

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.8e-47  Score=366.69  Aligned_cols=269  Identities=24%  Similarity=0.375  Sum_probs=213.6

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccce
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLS   98 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~   98 (400)
                      .+....+....++|++.+.||+|+||.||+|.+      .+++.||+|++.... ......+..|+.++..+ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            344666777889999999999999999999963      245789999997643 33456789999999999 7899999


Q ss_pred             eeeEEEeCCe-EEEEEEccCCCChhhhhhcCCCc----------------------------------------------
Q 015797           99 LRGYCAEGQE-RLIVYDYMPNLSLLSHLHGQHSS----------------------------------------------  131 (400)
Q Consensus        99 ~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------  131 (400)
                      +++++.+.+. .++|||||++|+|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 89999999999999999765321                                              


Q ss_pred             ----------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          132 ----------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       132 ----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                                      ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            112889999999999999999999998   9999999999999999999999999998664432


Q ss_pred             c-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--hhhhhhccccchhcccccccccC
Q 015797          196 T-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--IKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       196 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      . .......||+.|+|||++.+..++.++|||||||++|+|+| |..||......  ....+...             ..
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------~~  314 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------------TR  314 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-------------CC
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-------------CC
Confidence            2 22334568999999999999999999999999999999998 99999754321  11111100             00


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ......    ....+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       315 ~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          315 MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            001111    1236778889999999999999999999997654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=354.04  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=204.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|++......      ....+.+|+.+|+.++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            346799999999999999999965 46899999999753322      34678899999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC----cEEEEe
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF----KAQVAD  184 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~----~~kl~D  184 (400)
                      .++||||+++|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++    .+||+|
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            999999999999999986532    3889999999999999999999998   99999999999999887    799999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACE  263 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~  263 (400)
                      ||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..+......    
T Consensus       162 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----  235 (326)
T 2y0a_A          162 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----  235 (326)
T ss_dssp             CTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC----
T ss_pred             CCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC----
Confidence            999987653322  2234699999999999999999999999999999999999999975432211 111100000    


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ..    .    .........+.+++.+||+.||.+|||+.++++.
T Consensus       236 --~~----~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 --FE----D----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --CC----H----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --cC----c----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              00    0    0001112467788999999999999999999974

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-46  Score=360.13  Aligned_cols=253  Identities=18%  Similarity=0.283  Sum_probs=207.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.+|+.++||||+++++++.+....++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            457899999999999999999965 4689999999987666666778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC--CCcEEEEecCCccccC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA--DFKAQVADFGFAKLIP  192 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~--~~~~kl~Dfgl~~~~~  192 (400)
                      |+.+|+|.+++....   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.  ++.+||+|||++....
T Consensus       129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999999987543   23899999999999999999999998   999999999999974  4779999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ....  .....||+.|+|||++.+..++.++|||||||++|+|+||..||....... ...+......          ..
T Consensus       203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------~~  270 (387)
T 1kob_A          203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE----------FD  270 (387)
T ss_dssp             TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC----------CC
T ss_pred             CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------CC
Confidence            4332  223469999999999999999999999999999999999999997654321 1111110000          00


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .    .........+.++|.+||+.||.+|||+.++++.
T Consensus       271 ~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 E----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             S----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             c----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0    0111123467788999999999999999999974

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.8e-47  Score=357.40  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=211.8

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEE
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCA  104 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  104 (400)
                      ++....++|.+.+.||+|+||.||+|..      .++..||+|++.... ......+..|+.+++.++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3444568899999999999999999964      235789999987533 344567889999999999999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCC--------------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHS--------------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIH  164 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  164 (400)
                      +.+..++||||+++|+|.+++.....                    ....+++..++.++.|++.||.|||+++   ++|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence            99999999999999999999976432                    1234889999999999999999999998   999


Q ss_pred             cCCCCCCeEECCCCcEEEEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCCh
Q 015797          165 RDIKASNVLLDADFKAQVADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPI  242 (400)
Q Consensus       165 ~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf  242 (400)
                      |||||+||+++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|+| |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998765433221 223347889999999999999999999999999999999 99999


Q ss_pred             hhhhhhhhh-hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          243 EKVNSAIKR-TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ......... .+....             ...    ........+.+++.+||+.||.+|||+.++++.|..+.
T Consensus       254 ~~~~~~~~~~~~~~~~-------------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          254 PGIPPERLFNLLKTGH-------------RME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             TTCCGGGHHHHHHTTC-------------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHhhcCC-------------cCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            765432111 111000             000    11112346788899999999999999999999987653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.4e-47  Score=356.97  Aligned_cols=254  Identities=23%  Similarity=0.343  Sum_probs=201.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            4578999999999999999999654 799999999875433 22356889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            9999999999986432    3899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCc-eeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          194 GAT-HVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ... .......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||......... ...+....       ....
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~-------~~~~  229 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKK-------TYLN  229 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTC-------TTST
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhccc-------ccCC
Confidence            222 12234569999999999988776 78999999999999999999999754321110 00000000       0000


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            ........+.+++.+||+.||.+|||+.|+++.
T Consensus       230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                  001123467788999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.9e-47  Score=347.58  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=194.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChH----HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNK----AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.+ .++.||+|++......    ....+..|+.+++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            47899999999999999999975 5899999998653322    235688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC--------CCcEEEEe
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA--------DFKAQVAD  184 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~--------~~~~kl~D  184 (400)
                      |||+++++|.+++...     .+++..++.++.|++.||.|||+++..+++||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999988533     3889999999999999999999987555889999999999986        77899999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      ||++........   ....||+.|+|||++.+..++.++||||||+++|+|+||+.||.............       ..
T Consensus       160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~  229 (271)
T 3dtc_A          160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-------MN  229 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-------TS
T ss_pred             CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-------cC
Confidence            999986543322   23459999999999999999999999999999999999999997654321111000       00


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      ..    ...    ........+.+++.+||+.||.+|||+.++++.|+.
T Consensus       230 ~~----~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          230 KL----ALP----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CC----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CC----CCC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            00    000    111123467888999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3e-46  Score=358.89  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=205.3

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++...  .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34567899999999999999999965 46899999999753  3344567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC---cEEEEecCC
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF---KAQVADFGF  187 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~---~~kl~Dfgl  187 (400)
                      +||||+.+|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||+
T Consensus       105 lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            9999999999999986543    3889999999999999999999998   99999999999998654   599999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhccccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKF  266 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~  266 (400)
                      +........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.......      
T Consensus       178 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------  249 (362)
T 2bdw_A          178 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------  249 (362)
T ss_dssp             CBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------
T ss_pred             ceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence            987654322  22356999999999999999999999999999999999999999765432 111111100000      


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ..     .........+.+++.+||+.||.+|||+.++++.
T Consensus       250 ---~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 ---PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---CT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               00     0001112467788899999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-46  Score=362.18  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=197.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|.+.+.||+|+||.||+|...    .+..||+|.+... .......+..|+.+++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            468999999999999999999654    5778999998754 34445679999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       124 v~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999975432   4899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhh-hhhccccchhcccccc
Q 015797          192 PDGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKR-TITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~  267 (400)
                      ........  ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... .+....         .
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~---------~  268 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---------R  268 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE---------E
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------C
Confidence            54322111  12235788999999999999999999999999999998 99999765432111 111000         0


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                          ..    ........+.+++.+||+.||.+||++.++++.|..+..
T Consensus       269 ----~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          269 ----LP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ----CC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                00    001123467889999999999999999999999876643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.1e-46  Score=352.14  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ------  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------  107 (400)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+|+.++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3467999999999999999999764 79999999997533 334567899999999999999999999986654      


Q ss_pred             ---------------------------------------------------eEEEEEEccCCCChhhhhhcCCCcccccC
Q 015797          108 ---------------------------------------------------ERLIVYDYMPNLSLLSHLHGQHSSECLLN  136 (400)
Q Consensus       108 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~  136 (400)
                                                                         ..++|||||++|+|.+++..... .....
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  162 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE  162 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence                                                               37999999999999999976543 23456


Q ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce-----------eeeecccc
Q 015797          137 WNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-----------VTTRVKGT  205 (400)
Q Consensus       137 ~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-----------~~~~~~gt  205 (400)
                      +..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.........           ......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            6778999999999999999998   999999999999999999999999999876543211           11234699


Q ss_pred             cCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHH
Q 015797          206 LGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKR  285 (400)
Q Consensus       206 ~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (400)
                      +.|+|||++.+..++.++|||||||++|+|++|..|+.......... .....|                 .........
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~  301 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDV-RNLKFP-----------------LLFTQKYPQ  301 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHH-HTTCCC-----------------HHHHHHCHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHh-hccCCC-----------------cccccCChh
Confidence            99999999999999999999999999999999998875433211111 110000                 011223346


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHH
Q 015797          286 VVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       286 l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +.+++.+||+.||.+|||+.++++.
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhhc
Confidence            7789999999999999999999973

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-47  Score=361.96  Aligned_cols=264  Identities=23%  Similarity=0.385  Sum_probs=208.2

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      +....++|++.+.||+|+||.||+|...      .+..||+|++.... ......+..|+.+++.+ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4456689999999999999999999752      35689999987432 23345788999999999 8999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCc-------------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSS-------------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHR  165 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~  165 (400)
                      ..+..++||||+++|+|.+++......                   ...+++..++.++.|++.||.|||+++   ++||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999999764321                   123789999999999999999999998   9999


Q ss_pred             CCCCCCeEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChh
Q 015797          166 DIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIE  243 (400)
Q Consensus       166 dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~  243 (400)
                      ||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986644322 22233457889999999999999999999999999999998 999997


Q ss_pred             hhhhh--hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          244 KVNSA--IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       244 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .....  ....+...             ....    ........+.+++.+||+.||.+|||+.++++.|.....
T Consensus       277 ~~~~~~~~~~~~~~~-------------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          277 GIPVDANFYKLIQNG-------------FKMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TCCCSHHHHHHHHTT-------------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCcHHHHHHHHhcC-------------CCCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            64321  11111100             0000    011113467888999999999999999999999976543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.6e-47  Score=374.37  Aligned_cols=254  Identities=28%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC-eEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ-ERLI  111 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~l  111 (400)
                      +....++|++.+.||+|+||.||+|.. .++.||||+++...  ....+..|+.+|+.++||||+++++++.+.. ..|+
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            344567899999999999999999975 57899999997543  3457899999999999999999999987765 7899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus       265 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            9999999999999975432  23788999999999999999999998   999999999999999999999999999854


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  269 (400)
                      ....    ....+++.|+|||++.+..++.++|||||||++|||+| |..||........ ..+..        +     
T Consensus       340 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--------~-----  402 (450)
T 1k9a_A          340 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------G-----  402 (450)
T ss_dssp             C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT--------T-----
T ss_pred             cccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------C-----
Confidence            3221    12247899999999999999999999999999999998 9999976542111 11100        0     


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ....    ........+.++|.+||+.||.+|||+.+|++.|..+.
T Consensus       403 ~~~~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          403 YKMD----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            0000    11112347788899999999999999999999987654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-46  Score=349.17  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=198.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHH--HHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA--EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||+|+||.||+|.+.+++.||+|++.......  ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5899999999999999999987789999999987543322  35688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +.+ +|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            985 99998875432   3888999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhcccc------chhc-ccc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWAL------PLAC-ERK  265 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~------~~~~-~~~  265 (400)
                      .. .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||........  ........      +... ...
T Consensus       155 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cc-cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            21 2234589999999999764 589999999999999999999999976442211  11000000      0000 000


Q ss_pred             ccccc---CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELA---DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +....   .+.............+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000   000000011112346778899999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.4e-47  Score=351.89  Aligned_cols=258  Identities=21%  Similarity=0.318  Sum_probs=195.5

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ...++|++.+.||+|+||.||+|....    +..||+|.+.... ......+..|+.+++.++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            445789999999999999999996532    4568999886533 344567889999999999999999999984 5678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence            999999999999999975432   3889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...+....          
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~----------  234 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------  234 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC----------
Confidence            765433322333457889999999999999999999999999999997 999997544221 11111000          


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         ....    .......+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       235 ---~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          235 ---RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ---CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               0001    11123467788999999999999999999999976643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=351.70  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=195.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--------------------------HHHHHHHHHHHHh
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--------------------------AEMEFAVEVEILA   89 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~   89 (400)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++......                          ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            57899999999999999999965 56889999998643211                          1245788999999


Q ss_pred             cCCCCccceeeeEEEe--CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 015797           90 RVRHKNLLSLRGYCAE--GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDI  167 (400)
Q Consensus        90 ~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~di  167 (400)
                      .++||||+++++++.+  ....++||||+++|+|.+++...     .+++..++.++.|++.||.|||+++   ++||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence            9999999999999987  57889999999999998865432     3899999999999999999999998   999999


Q ss_pred             CCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCC---CCCccceehhhHHHHHHHhCCCChhh
Q 015797          168 KASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK---ASESCDVYSFGILLLELASGKKPIEK  244 (400)
Q Consensus       168 kp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDIwSlGiil~elltg~~Pf~~  244 (400)
                      ||+|||++.++.+||+|||++......... .....||+.|+|||++.+..   ++.++|||||||++|+|++|+.||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999999876543322 23356999999999998765   47889999999999999999999975


Q ss_pred             hhhhhh-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          245 VNSAIK-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       245 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ...... ..+.....+         .  + ..    ......+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~---------~--~-~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMCLHSKIKSQALE---------F--P-DQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHHHHHHHHHCCCC---------C--C-SS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHHHHHHHhcccCC---------C--C-Cc----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            432211 111100000         0  0 00    011246778889999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.8e-47  Score=379.10  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=211.7

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +.....+|++.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+|+.++||||++++++|.+....++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3445678899999999999999999765 488999999875432 35678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++......  .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       294 v~E~~~~g~L~~~l~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEccCCCCHHHHHHhcCcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999754322  4889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  269 (400)
                      ............+++.|+|||++.++.++.++|||||||++|||+| |..||........ ..+..         .    
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------~----  435 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---------D----  435 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---------T----
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------C----
Confidence            5433322223446789999999999999999999999999999999 9999976542211 11100         0    


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ....    ........+.++|.+||+.||.+|||+.+|++.|+.+.
T Consensus       436 ~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 YRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCC----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            0000    11112346788899999999999999999999997664

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.6e-46  Score=349.66  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=198.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhc--CCCCccceeeeEEEe----CCeE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR--VRHKNLLSLRGYCAE----GQER  109 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~----~~~~  109 (400)
                      ..++|++.+.||+|+||.||+|.. +++.||+|++...   ....+..|.+++..  ++||||+++++++.+    ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            457899999999999999999975 7899999998643   33445566666665  799999999998654    3558


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH--------HHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                      ++||||+++|+|.+++...     .+++..++.++.|++.||.|||        +.+   ++||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence            9999999999999999543     3899999999999999999999        777   99999999999999999999


Q ss_pred             EEecCCccccCCCCcee---eeecccccCcCChhhhccC------CCCCccceehhhHHHHHHHhC----------CCCh
Q 015797          182 VADFGFAKLIPDGATHV---TTRVKGTLGYLAPEYAMLG------KASESCDVYSFGILLLELASG----------KKPI  242 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDIwSlGiil~elltg----------~~Pf  242 (400)
                      |+|||++..........   .....||+.|+|||++.+.      .++.++|||||||++|+|+||          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999997665433322   1224699999999999876      456799999999999999999          7777


Q ss_pred             hhhhhhh--hhhhhccccchhcccccccccCccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          243 EKVNSAI--KRTITDWALPLACERKFSELADPRLN-GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       243 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      .......  ........        ......+... ..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVV--------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHHHHH--------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhhHHH--------hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            5432110  00000000        0000001111 112334567889999999999999999999999998653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=360.54  Aligned_cols=253  Identities=25%  Similarity=0.291  Sum_probs=200.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|..+++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            457899999999999999999965 468999999997432   22334577899999988 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|||||++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++..
T Consensus       101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999987543    3899999999999999999999998   99999999999999999999999999985


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ...+.....           
T Consensus       174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----------  241 (353)
T 3txo_A          174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-----------  241 (353)
T ss_dssp             SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred             cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            43222 22334569999999999999999999999999999999999999997654321 111111000           


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHH--Hhccc
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM------LEVLD--LLKGE  314 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~ell~--~L~~~  314 (400)
                         .....    ....+.+++.+||+.||.+||++      .++++  .++++
T Consensus       242 ---~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          242 ---VYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             ---CCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             ---CCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence               00001    12367778899999999999998      78886  34444

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=347.99  Aligned_cols=272  Identities=20%  Similarity=0.261  Sum_probs=210.7

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC--eEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ--ERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~l  111 (400)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            3578999999999999999999654 58999999997533 233456789999999999999999999998765  7899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----CCCCcEEEEecCC
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGF  187 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv----~~~~~~kl~Dfgl  187 (400)
                      ||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+
T Consensus        87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999975432 223899999999999999999999998   9999999999999    7888899999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhc--------cCCCCCccceehhhHHHHHHHhCCCChhhhhhh-----hhhhhh
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAM--------LGKASESCDVYSFGILLLELASGKKPIEKVNSA-----IKRTIT  254 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-----~~~~~~  254 (400)
                      +........  .....||+.|+|||++.        +..++.++|||||||++|+|+||+.||......     ....+.
T Consensus       163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            987654332  22346999999999987        578899999999999999999999999643211     111111


Q ss_pred             ccccchhccccccccc--------CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          255 DWALPLACERKFSELA--------DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       255 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      .. .|......+....        ...............+.+++.+||+.||.+|||+.|+++.....
T Consensus       241 ~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HH-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cC-CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            00 0100000000000        01112244567777888999999999999999999999887543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.4e-47  Score=352.13  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=214.0

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +....++|++.+.||+|+||.||+|.+. ++..||+|.+.... .....+..|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3456788999999999999999999654 58899999987533 345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999976433  24889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............            ...
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~------------~~~  229 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------KDY  229 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH------------TTC
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh------------ccC
Confidence            6544444444557889999999999999999999999999999999 999997644221111000            000


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ...    ........+.+++.+||+.||.+|||+.++++.|+....
T Consensus       230 ~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 RME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            000    011122467888999999999999999999999876644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-46  Score=367.72  Aligned_cols=269  Identities=21%  Similarity=0.283  Sum_probs=212.3

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChH---HHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNK---AEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      +.+.++....++|++.+.||+|+||.||+|... +++.||+|++......   ....+..|..++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345667777899999999999999999999764 5788999999742211   122378899999999999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                      .+.+..|+|||||++|+|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+||||+.+|.+||+
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence            999999999999999999999975322   3899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWA  257 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~  257 (400)
                      |||+++.............+||+.|+|||++.     .+.++.++|||||||++|||+||+.||...+... ...+....
T Consensus       218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  297 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  297 (437)
T ss_dssp             CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence            99999876554444444467999999999997     5678999999999999999999999997654321 11111100


Q ss_pred             cchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHH--Hhcccc
Q 015797          258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK--RPTMLEVLD--LLKGES  315 (400)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~--~L~~~~  315 (400)
                      ...    .+     +.....    ....+.++|.+||..+|++  ||++.++++  .++++.
T Consensus       298 ~~~----~~-----p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          298 ERF----QF-----PTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             HHC----CC-----CSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             ccc----cC-----Cccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            000    00     000001    1236677889999888888  999999997  344443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=364.45  Aligned_cols=263  Identities=26%  Similarity=0.390  Sum_probs=211.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYC  103 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  103 (400)
                      ....++|.+.+.||+|+||.||+|...        .+..||+|++.... ......+..|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            345578999999999999999999642        23579999997543 34456788999999999 999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      .+++..++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999976532            1234899999999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI  249 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~  249 (400)
                      |||+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.......
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654322 12223457889999999999999999999999999999999 999997654321


Q ss_pred             h-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          250 K-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       250 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      . ..+....             ......    .....+.+++.+||+.||.+|||+.+|++.|..+..
T Consensus       302 ~~~~~~~~~-------------~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          302 LFKLLKEGH-------------RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             HHHHHHTTC-------------CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCC-------------CCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1 1111100             000011    112467888999999999999999999999976643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=344.28  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=209.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||+|+||.||+|...+++.||+|.+...... ...+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            4689999999999999999998778889999999754332 356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++++|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             TTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            99999999975432   3889999999999999999999998   99999999999999999999999999986543222


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ..+....             ....
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-------------~~~~  226 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------------RLYK  226 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------------CCCC
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-------------cCCC
Confidence            22223447889999999999999999999999999999999 8999976443211 1111000             0000


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ..    .....+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       227 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          227 PR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Cc----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            00    112467788899999999999999999999976543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-46  Score=357.57  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=201.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH---HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK---AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++......   ....+.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            357999999999999999999965 67899999998742211   12468899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+ +|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus        87 v~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             EEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            99999 689999886543    3899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      .....  ....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||........  ..          .+... 
T Consensus       159 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~----------~i~~~-  223 (336)
T 3h4j_B          159 TDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FK----------KVNSC-  223 (336)
T ss_dssp             TTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BC----------CCCSS-
T ss_pred             cCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HH----------HHHcC-
Confidence            54322  233469999999999988776 7899999999999999999999975432100  00          00000 


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .....    ......+.+++.+||+.||.+|||+.++++.
T Consensus       224 ~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          224 VYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            00011    1112467788899999999999999999873

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-46  Score=365.73  Aligned_cols=259  Identities=20%  Similarity=0.247  Sum_probs=207.1

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      ...+....++|++.+.||+|+||.||+|.. .+++.||+|++.....   .....+..|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            344556678999999999999999999965 4588999999864211   112347789999999999999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      ....|+|||||+||+|.+++...     .+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999998653     2888999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCC----CCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccch
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK----ASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPL  260 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~  260 (400)
                      |++..............+||+.|+|||++.+..    ++.++|||||||++|+|+||+.||...+.. ....+...... 
T Consensus       213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-  291 (410)
T 3v8s_A          213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-  291 (410)
T ss_dssp             TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred             ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-
Confidence            999876654443444567999999999998765    889999999999999999999999765432 11111111000 


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEK--RPTMLEVLDL  310 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~  310 (400)
                           +   .-+. . ..   ....+.++|.+||+.+|.+  ||++.+|++.
T Consensus       292 -----~---~~p~-~-~~---~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          292 -----L---TFPD-D-ND---ISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -----C---CCCT-T-CC---CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -----c---cCCC-c-cc---ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                 0   0000 0 01   1236777889999999988  9999999974

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4e-46  Score=354.90  Aligned_cols=266  Identities=23%  Similarity=0.385  Sum_probs=212.5

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      ..+....++|++.+.||+|+||.||+|...      +++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344556789999999999999999999753      34789999987543 34456789999999999999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCCc--------------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHSS--------------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHII  163 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  163 (400)
                      .+.+..++||||+++|+|.+++......                    ...+++..++.++.|++.||.|||+++   ++
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            9999999999999999999999764211                    135899999999999999999999998   99


Q ss_pred             ecCCCCCCeEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCC
Q 015797          164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKP  241 (400)
Q Consensus       164 H~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~P  241 (400)
                      ||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|+| |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999976543221 12223458899999999999999999999999999999999 9999


Q ss_pred             hhhhhhhhh-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          242 IEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       242 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      |........ ..+...        ...     ...    ......+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       277 ~~~~~~~~~~~~~~~~--------~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDG--------NIL-----ACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTSCHHHHHHHHHTT--------CCC-----CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCChHHHHHHHhCC--------CcC-----CCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            976543211 111110        000     001    1122467888999999999999999999999987643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-46  Score=350.17  Aligned_cols=244  Identities=28%  Similarity=0.338  Sum_probs=201.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.+++.++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            46799999999999999999965 469999999997432   12245677899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++....
T Consensus        85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999997543    3888999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ..    ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ...+....        +     
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------~-----  220 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--------L-----  220 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--------C-----
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------C-----
Confidence            32    223569999999999999999999999999999999999999997544321 11111100        0     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  309 (400)
                       .+...    ....+.+++.+||+.||.+||     ++.++++
T Consensus       221 -~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 -RFPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -CCCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence             01111    123677888999999999999     8999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.3e-46  Score=360.92  Aligned_cols=257  Identities=21%  Similarity=0.310  Sum_probs=199.8

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  109 (400)
                      ...++|++.+.||+|+||.||+|+. .+++.||+|++....   ......+..|..++..+ +||||+++++++.+.+..
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            3457899999999999999999965 458899999997532   22233577899999877 899999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+||||+++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+++
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence            99999999999999987543    3899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchhcccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~  267 (400)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ...............  
T Consensus       202 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--  278 (396)
T 4dc2_A          202 EGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--  278 (396)
T ss_dssp             CCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred             ecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence            533222 223445799999999999999999999999999999999999999964321100  000000000000000  


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM------LEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~ell~  309 (400)
                          ..+...    ....+.++|.+||+.||.+||++      .++++
T Consensus       279 ----~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 ----IRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ----CCCCTT----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ----cCCCCc----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                011111    22467788899999999999985      67776

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.4e-46  Score=350.19  Aligned_cols=270  Identities=24%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             cCCCcCCcccccCceEEEEEE-----EcCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQ-----LWDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QER  109 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~  109 (400)
                      .+|++.+.||+|+||.||+|.     ..+++.||+|++.... ......+..|+.+++.++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            558999999999999999997     2468899999987433 23346788999999999999999999999876  668


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            999999999999999864332   3899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCce--eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGATH--VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      ........  ......||+.|+|||++.+..++.++||||||+++|+|+||..|+..................... .+.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~  253 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT-RLV  253 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH-HHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH-HHH
Confidence            76544322  222345888899999999999999999999999999999999997644322111111000000000 000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ..................+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            00000000011122235788899999999999999999999998654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-46  Score=371.56  Aligned_cols=263  Identities=29%  Similarity=0.448  Sum_probs=206.4

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      ...+....++|++.+.||+|+||.||+|.+..+..||+|++..... ....+.+|+.+|+.++||||+++++++.+ +..
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            3444556788999999999999999999877778899999875432 34578999999999999999999999876 678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence            99999999999999996432  224889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      ..............+++.|+|||++.++.++.++|||||||++|+|+| |+.||........ ..+....          
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----------  398 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------  398 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence            765433222223447889999999999999999999999999999999 9999976543211 1111000          


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         ...    ........+.++|.+||+.||.+|||+.+|++.|.....
T Consensus       399 ---~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          399 ---RMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ---CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ---CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence               000    011123467888999999999999999999999987643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-46  Score=356.55  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=198.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCE----EEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQ----IAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+... .......+.+|+.+++.++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            467999999999999999999643 4444    577777532 2334567899999999999999999999998765 78


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|++|+.+|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence            99999999999999976433   3899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          191 IPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|+|+| |+.||................          
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----------  236 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----------  236 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC----------
Confidence            6543322 2223447889999999999999999999999999999999 999997654321111110000          


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                        ..    .........+..++.+||+.||.+|||+.++++.|.....
T Consensus       237 --~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 --RL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --CC----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --CC----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              00    0011123467888999999999999999999999876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.7e-46  Score=350.62  Aligned_cols=265  Identities=22%  Similarity=0.314  Sum_probs=188.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            457899999999999999999965 4689999999975432 23356888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC--CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          114 DYMPNLSLLSHLHGQH--SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||++ |+|.+++....  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 69999886432  11224888999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhcc-c------cchh-
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDW-A------LPLA-  261 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~-~------~~~~-  261 (400)
                      ...... .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||......... .+... .      .+.. 
T Consensus       159 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            432221 223458999999999986 46899999999999999999999999765432111 01000 0      0000 


Q ss_pred             ccccc------------ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          262 CERKF------------SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       262 ~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....+            .....+....    .....+.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00000            0000000001    12246888999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.7e-46  Score=357.89  Aligned_cols=212  Identities=25%  Similarity=0.306  Sum_probs=185.7

Q ss_pred             CcccccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-----CCccc
Q 015797           24 TWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-----HKNLL   97 (400)
Q Consensus        24 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----hpnIv   97 (400)
                      ....|++.......++|++.+.||+|+||.||+|.+ .+++.||+|++.. .......+..|+.+++.+.     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            456788888888899999999999999999999965 5689999999864 2344556778999999886     99999


Q ss_pred             eeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-
Q 015797           98 SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-  176 (400)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-  176 (400)
                      ++++++...+..++||||+ +++|.+++......  .+++..++.++.|++.||.|||+++   |+||||||+|||++. 
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence            9999999999999999999 89999999765433  3888999999999999999999998   999999999999975 


Q ss_pred             ------------------------CCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHH
Q 015797          177 ------------------------DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILL  232 (400)
Q Consensus       177 ------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil  232 (400)
                                              ++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                    7889999999998654322    234699999999999999999999999999999


Q ss_pred             HHHHhCCCChhhhh
Q 015797          233 LELASGKKPIEKVN  246 (400)
Q Consensus       233 ~elltg~~Pf~~~~  246 (400)
                      |+|+||+.||....
T Consensus       250 ~ell~g~~pf~~~~  263 (360)
T 3llt_A          250 AELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHSSCSCCCSS
T ss_pred             HHHHHCCCCCCCCc
Confidence            99999999997543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.5e-46  Score=355.07  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=195.6

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEcC-C---CEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLWD-G---SQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCA  104 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~---~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  104 (400)
                      +++....++|++.+.||+|+||.||+|.+.. +   ..||+|++...  .......+.+|+.+++.++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3345566899999999999999999996543 3   27999998753  3445567899999999999999999999998


Q ss_pred             eCCeE------EEEEEccCCCChhhhhhcCC--CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC
Q 015797          105 EGQER------LIVYDYMPNLSLLSHLHGQH--SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA  176 (400)
Q Consensus       105 ~~~~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~  176 (400)
                      .....      ++||||+.+|+|.+++....  .....+++..++.++.|++.||.|||+++   ++||||||+|||++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence            87665      99999999999999986432  11224889999999999999999999998   999999999999999


Q ss_pred             CCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhh
Q 015797          177 DFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTI  253 (400)
Q Consensus       177 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~  253 (400)
                      ++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|+| |..||........ ..+
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  252 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL  252 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            999999999999876443221 1223347889999999999999999999999999999999 9999976543211 111


Q ss_pred             hccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          254 TDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ....             ...    ........+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       253 ~~~~-------------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          253 IGGN-------------RLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HTTC-------------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCC-------------CCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1000             000    111123467889999999999999999999999876643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.7e-46  Score=345.92  Aligned_cols=259  Identities=18%  Similarity=0.221  Sum_probs=207.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+..|+.+++.+ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            357899999999999999999965 679999999986432  233578899999999 8999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc-----EEEEecCCc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK-----AQVADFGFA  188 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~-----~kl~Dfgl~  188 (400)
                      ||+ +++|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.     +||+|||++
T Consensus        86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999 8999999975432   3899999999999999999999998   999999999999987776     999999999


Q ss_pred             cccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh----hhhhcccc
Q 015797          189 KLIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK----RTITDWAL  258 (400)
Q Consensus       189 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~----~~~~~~~~  258 (400)
                      .........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........    ..+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            876543221      12345699999999999999999999999999999999999999976431100    01100000


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      +    .......         ......+.+++.+||+.||.+|||+.+|++.|..+..
T Consensus       239 ~----~~~~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          239 S----TPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             H----SCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             C----ccHHHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            0    0000000         0112477888999999999999999999999987654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=351.98  Aligned_cols=244  Identities=23%  Similarity=0.287  Sum_probs=191.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC--ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW--SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++.+.||+|+||+||+|.+. +++.||||++...  ..........|+..+..+ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            78999999999999999999764 7999999998643  233334455566555554 9999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+ +++|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 6799998875432   4899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCcc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ...  .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+......  ..+.....+            +.
T Consensus       210 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~~~------------~~  272 (311)
T 3p1a_A          210 AGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW--QQLRQGYLP------------PE  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH--HHHTTTCCC------------HH
T ss_pred             CCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHHhccCCC------------cc
Confidence            222  233459999999998875 7999999999999999999997665433211  111110000            00


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                          ........+.+++.+||+.||.+|||+.++++
T Consensus       273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                01112347888999999999999999999996

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-45  Score=343.92  Aligned_cols=264  Identities=21%  Similarity=0.282  Sum_probs=199.3

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++....  ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            6899999999999999999965 468999999997533  3334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      |+.+ +|.+.+.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9975 66666654322   3899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CceeeeecccccCcCChhhhccCC-CCCccceehhhHHHHHHHhCCCChhhhhhh---hhhhhhccccchh-cccccccc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPIEKVNSA---IKRTITDWALPLA-CERKFSEL  269 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDIwSlGiil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~-~~~~~~~~  269 (400)
                      ... .....||+.|+|||++.+.. ++.++|||||||++|+|+||..||......   ..........+.. ........
T Consensus       155 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccc-ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            222 22345899999999998765 799999999999999999988886432211   1111000000000 00000000


Q ss_pred             c---------CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 A---------DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .         .........+.....+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0         000001112223456778899999999999999999996

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=363.95  Aligned_cols=260  Identities=28%  Similarity=0.372  Sum_probs=206.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .++|++.+.||+|+||.||+|...      ++..||+|++... .......+..|+.+++.++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            478999999999999999999732      4668999998653 344556788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCC---cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC---cEEEE
Q 015797          110 LIVYDYMPNLSLLSHLHGQHS---SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF---KAQVA  183 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~---~~kl~  183 (400)
                      ++|||||++|+|.+++.....   ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999975431   1234889999999999999999999998   99999999999999555   49999


Q ss_pred             ecCCccccCCCC-ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhh-hhhccccch
Q 015797          184 DFGFAKLIPDGA-THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKR-TITDWALPL  260 (400)
Q Consensus       184 Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~-~~~~~~~~~  260 (400)
                      |||+++...... ........||+.|+|||++.+..++.++|||||||++|+|+| |..||......... .+....   
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~---  303 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---  303 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            999997542211 111223458999999999999999999999999999999998 99999765432111 111100   


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                ....    .......+.+++.+||+.||.+|||+.+|++.|.....
T Consensus       304 ----------~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          304 ----------RMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             ----------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                      0000    11112367788999999999999999999999876543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-46  Score=357.80  Aligned_cols=251  Identities=26%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  107 (400)
                      .....++|.+.+.||+|+||.||+|.. .+++.||+|++....   ......+..|..++..+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            345678999999999999999999975 468899999997432   22334577889999876 9999999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..|+||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence            9999999999999999987533    3889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      +........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ...+....         
T Consensus       165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  234 (345)
T 1xjd_A          165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------  234 (345)
T ss_dssp             CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------
Confidence            986432222 2334569999999999999999999999999999999999999997654321 11111100         


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML-EVLD  309 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~  309 (400)
                           +.....    ....+.+++.+||..||.+||++. ++++
T Consensus       235 -----~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 -----PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -----CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -----CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                 001111    124677888999999999999997 7764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-46  Score=353.51  Aligned_cols=263  Identities=21%  Similarity=0.233  Sum_probs=202.5

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-----ChHHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-----SNKAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      -..+....++|++.+.||+|+||.||+|.. .++..||+|++...     .......+..|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   97 (345)
T 3hko_A           18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY   97 (345)
T ss_dssp             CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence            334566778999999999999999999965 56889999998642     234456788999999999999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCC------------------------------------cccccChHHHHHHHHHH
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHS------------------------------------SECLLNWNRRMDIAIGS  147 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~qi  147 (400)
                      .+.+..++|||||++|+|.+++.....                                    ....+++..++.++.|+
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            999999999999999999998852110                                    01124567788899999


Q ss_pred             HHHHHHHHhcCCCCeEecCCCCCCeEECCCC--cEEEEecCCccccCCCCc---eeeeecccccCcCChhhhcc--CCCC
Q 015797          148 AEGIVYLHHHATPHIIHRDIKASNVLLDADF--KAQVADFGFAKLIPDGAT---HVTTRVKGTLGYLAPEYAML--GKAS  220 (400)
Q Consensus       148 ~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s  220 (400)
                      +.||.|||+.+   ++||||||+|||++.++  .+||+|||++........   .......||+.|+|||++.+  ..++
T Consensus       178 ~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  254 (345)
T 3hko_A          178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG  254 (345)
T ss_dssp             HHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred             HHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence            99999999998   99999999999998776  899999999986533211   12234569999999999975  6789


Q ss_pred             CccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCC
Q 015797          221 ESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPE  299 (400)
Q Consensus       221 ~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  299 (400)
                      .++|||||||++|+|++|+.||........ ..+.......         ..     .........+.+++.+||+.||.
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~-----~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF---------EN-----PNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT---------TS-----GGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc---------CC-----cccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999999999976543211 1111100000         00     00011234677889999999999


Q ss_pred             CCCCHHHHHH
Q 015797          300 KRPTMLEVLD  309 (400)
Q Consensus       300 ~Rps~~ell~  309 (400)
                      +|||+.++++
T Consensus       321 ~Rps~~~~l~  330 (345)
T 3hko_A          321 ERFDAMRALQ  330 (345)
T ss_dssp             TSCCHHHHHH
T ss_pred             HCCCHHHHhc
Confidence            9999999997

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=363.19  Aligned_cols=263  Identities=22%  Similarity=0.259  Sum_probs=208.4

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      +...++....++|++.+.||+|+||.||+|+. .+++.||+|++.....   .....+..|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            34556667789999999999999999999965 4699999999974221   1223478899999999999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                      .+.+..|+||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|++||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence            999999999999999999999975322   3889999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhc-------cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM-------LGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITD  255 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~  255 (400)
                      |||++..............+||+.|+|||++.       +..++.++|||||||++|||++|+.||...+... ...+..
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  284 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH  284 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999876554433334457999999999997       3578999999999999999999999997654321 111111


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR---PTMLEVLDL  310 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~ell~~  310 (400)
                      +...         +..+...    ......+.++|.+||. +|.+|   |++.++++.
T Consensus       285 ~~~~---------~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          285 YKEH---------LSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHH---------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             cccC---------cCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1000         0000000    1112467788899999 99998   589999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.3e-46  Score=352.81  Aligned_cols=272  Identities=24%  Similarity=0.316  Sum_probs=211.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEE--eCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA--EGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~  109 (400)
                      .++|++.+.||+|+||.||+|..     .+++.||+|++..........+.+|+++++.++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46899999999999999999973     468899999998777777778999999999999999999999986  45678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence            999999999999999875322   4899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||................. .....+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  254 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV-PALSRLL  254 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C-CHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc-ccHHHHH
Confidence            765433221  2234588889999999999999999999999999999999999975543221111000000 0000000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..................+.+++.+||+.||.+|||+.++++.|+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            000000111112223357888899999999999999999999997653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-46  Score=347.55  Aligned_cols=261  Identities=27%  Similarity=0.439  Sum_probs=210.0

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ++....++|++.+.||+|+||.||+|...++..||+|.+..... ....+..|+++++.++||||+++++++. .+..++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence            34455688999999999999999999877788999999875432 3457889999999999999999999886 456899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++....  ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            999999999999986432  224889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ............+++.|+|||++.++.++.++||||||+++|+|++ |+.||....... ...+...         .   
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---------~---  227 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---------Y---  227 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---------C---
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc---------c---
Confidence            5443322233447889999999999999999999999999999999 999997644321 1111100         0   


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                       .....    ......+.+++.+||+.||.+|||+.++++.|.....
T Consensus       228 -~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          228 -RMVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             -CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCc----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence             00001    1122467888899999999999999999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.4e-46  Score=348.40  Aligned_cols=273  Identities=22%  Similarity=0.347  Sum_probs=202.8

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec---CChHHHHHHHHHHHHHhcCCCCccceeeeE
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV---WSNKAEMEFAVEVEILARVRHKNLLSLRGY  102 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  102 (400)
                      .+....-....++|++.+.||+|+||.||+|.. .+++.||+|++..   ........+..|+.+++.++||||++++++
T Consensus        21 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  100 (310)
T 2wqm_A           21 ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS  100 (310)
T ss_dssp             CCCGGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCCCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            334444445667899999999999999999965 5799999999874   234445678899999999999999999999


Q ss_pred             EEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEE
Q 015797          103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV  182 (400)
Q Consensus       103 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl  182 (400)
                      +.+.+..++||||+.+|+|.+++.........+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             EEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred             EEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEE
Confidence            99999999999999999999998653222335889999999999999999999998   999999999999999999999


Q ss_pred             EecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhc
Q 015797          183 ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLAC  262 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  262 (400)
                      +|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...............     
T Consensus       178 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----  251 (310)
T 2wqm_A          178 GDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-----  251 (310)
T ss_dssp             CCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-----
T ss_pred             EeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-----
Confidence            99999986543322 122345899999999999999999999999999999999999999653311111000000     


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ....     +....   ......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       252 ~~~~-----~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          252 QCDY-----PPLPS---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             TTCS-----CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccC-----CCCcc---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            0000     00000   1112467788899999999999999999999987644

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.2e-46  Score=352.03  Aligned_cols=264  Identities=26%  Similarity=0.406  Sum_probs=212.0

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcC-CCCccceeeeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARV-RHKNLLSLRGYCA  104 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  104 (400)
                      +....++|++.+.||+|+||.||+|..      .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            344567899999999999999999964      2467899999975433 3456788999999999 9999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCc--------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSS--------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKAS  170 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~  170 (400)
                      +++..++||||+++|+|.+++......              ...+++..++.++.|++.||.|||+++   ++||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            999999999999999999999765321              124899999999999999999999998   999999999


Q ss_pred             CeEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh
Q 015797          171 NVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA  248 (400)
Q Consensus       171 NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~  248 (400)
                      ||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999999999999999999876543332 2223457889999999999999999999999999999999 99999754321


Q ss_pred             --hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          249 --IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       249 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                        ....+...             ......    ......+.+++.+||+.||.+|||+.++++.|.....
T Consensus       255 ~~~~~~~~~~-------------~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          255 SKFYKMIKEG-------------FRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             HHHHHHHHHT-------------CCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHhccC-------------CCCCCc----ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence              11111000             000000    1123467888999999999999999999999976543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.9e-46  Score=351.90  Aligned_cols=257  Identities=18%  Similarity=0.233  Sum_probs=206.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+..|+.+++.+ +||||+++++++.+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            47899999999999999999965 6789999999875332  23578899999999 99999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc-----EEEEecCCcc
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK-----AQVADFGFAK  189 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~-----~kl~Dfgl~~  189 (400)
                      |+ +++|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||++.
T Consensus        86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 8999999875422   4899999999999999999999998   999999999999999887     9999999998


Q ss_pred             ccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhh---hhhccccc
Q 015797          190 LIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKR---TITDWALP  259 (400)
Q Consensus       190 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~---~~~~~~~~  259 (400)
                      ........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...   .+.....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            76443221      123456999999999999999999999999999999999999999764321 111   11000000


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ..    ....     . ...   . .+..++..||+.||.+||++.+|++.|.....
T Consensus       239 ~~----~~~~-----~-~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          239 TP----IEVL-----C-ENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             SC----HHHH-----T-TTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CC----HHHH-----h-ccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            00    0000     0 011   2 78888899999999999999999999876543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=353.95  Aligned_cols=249  Identities=22%  Similarity=0.268  Sum_probs=197.8

Q ss_pred             CCCc--CCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           39 NFNY--DNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        39 ~y~~--~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .|.+  .+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            3444  46799999999999965 56999999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE--CCCCcEEEEecCCccccCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL--DADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv--~~~~~~kl~Dfgl~~~~~~  193 (400)
                      +++|+|.+++....   ..+++..++.++.|++.||.|||+.+   |+||||||+|||+  +.++.+||+|||++.....
T Consensus       168 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          168 VDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             CTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            99999999886543   24889999999999999999999998   9999999999999  5678999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..+.....+      .   .. 
T Consensus       242 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------~---~~-  309 (373)
T 2x4f_A          242 REK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------L---ED-  309 (373)
T ss_dssp             TCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------S---CS-
T ss_pred             ccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------C---Ch-
Confidence            332  2234599999999999999999999999999999999999999976543211 111110000      0   00 


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                          .........+.+++.+||+.||.+|||+.++++
T Consensus       310 ----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 ----EEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                000112346788899999999999999999997

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.5e-46  Score=345.98  Aligned_cols=259  Identities=30%  Similarity=0.494  Sum_probs=195.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ...++|++.+.||+|+||.||+|..  ...+|+|++...  .......+.+|+.+++.++||||+++++++ .....++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            3468999999999999999999974  346999998753  334456789999999999999999999965 56678999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+.+++|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence            99999999999986443   24899999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCC-ceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhccccc
Q 015797          193 DGA-THVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLACERKF  266 (400)
Q Consensus       193 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~  266 (400)
                      ... ........||+.|+|||++.   +..++.++||||||+++|+|++|+.||.......  .........+    ..+
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~  247 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS----PDL  247 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC----CCT
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC----cch
Confidence            322 12223356999999999997   6678899999999999999999999997643211  1111110000    000


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .         .........+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       248 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 S---------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             T---------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             h---------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            0         011122357888999999999999999999999997654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=352.94  Aligned_cols=273  Identities=22%  Similarity=0.357  Sum_probs=208.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC--eE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ--ER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~  109 (400)
                      .++|++.+.||+|+||.||+|..     .+++.||+|++..........+.+|+.+++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46689999999999999999973     368899999998766666778999999999999999999999986654  68


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            999999999999999976432   3889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          190 LIPDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .........  .....+++.|+|||++.+..++.++||||||+++|+|+||..||.......................+.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            765433221  122347788999999999999999999999999999999999987543221111100000000000000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..................+.++|.+||+.||.+|||+.+|++.|+.+.
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            000000000011122346888999999999999999999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.9e-46  Score=345.31  Aligned_cols=253  Identities=20%  Similarity=0.352  Sum_probs=202.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CC-------CEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DG-------SQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      .++|.+.+.||+|+||.||+|.+. ++       ..||+|++..........+.+|+.+++.++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            478999999999999999999543 33       4799999976666667789999999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc--------E
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK--------A  180 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~--------~  180 (400)
                      .++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999975432   3889999999999999999999998   999999999999998887        9


Q ss_pred             EEEecCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCC-CChhhhhhhhhhhhhcccc
Q 015797          181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGK-KPIEKVNSAIKRTITDWAL  258 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~-~Pf~~~~~~~~~~~~~~~~  258 (400)
                      ||+|||++......     ....||+.|+|||++.+ ..++.++|||||||++|+|+||. +||............... 
T Consensus       161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~-  234 (289)
T 4fvq_A          161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-  234 (289)
T ss_dssp             EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-
T ss_pred             eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc-
Confidence            99999998754322     22358999999999987 77999999999999999999954 555443322111111000 


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchhh
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEK  318 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  318 (400)
                           ....    ..    .    ...+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       235 -----~~~~----~~----~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          235 -----HQLP----AP----K----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             -----CCCC----CC----S----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             -----CCCC----CC----C----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                 0000    00    0    125677889999999999999999999998775533

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=354.03  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=196.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCC--CccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRH--KNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|++.+.||+|+||.||++...+++.||+|++...  .......+..|+.+|+.++|  |||+++++++.+++..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            45789999999999999999998788999999998753  33445678899999999976  999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||| +.+|+|.+++....    .+++..++.++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||++...
T Consensus        87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 56789999997643    3889999999999999999999998   99999999999997 678999999999876


Q ss_pred             CCCCce-eeeecccccCcCChhhhcc-----------CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccc
Q 015797          192 PDGATH-VTTRVKGTLGYLAPEYAML-----------GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALP  259 (400)
Q Consensus       192 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~  259 (400)
                      ...... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||........... .    
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~----  232 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-A----  232 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH-H----
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH-H----
Confidence            543322 2234569999999999975           6789999999999999999999999975432211100 0    


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                               ..++.....+.......+.+++.+||+.||.+|||+.++++.
T Consensus       233 ---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          233 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                     000000000111112467788899999999999999999974

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.5e-46  Score=342.40  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=203.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC--CeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG--QERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.+ .++.||+|++...  .......+.+|+.+++.++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            46899999999999999999975 5899999999754  334456789999999999999999999999887  788999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++ +.++||||||+||+++.++.++|+|||+.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999976432  24899999999999999999999875 349999999999999999999999998876433


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCC---ccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASE---SCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSE  268 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  268 (400)
                      ..      ...||+.|+|||++.+..++.   ++|||||||++|+|+||+.||........ .....            .
T Consensus       165 ~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------~  226 (271)
T 3kmu_A          165 SP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL------------E  226 (271)
T ss_dssp             CT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH------------S
T ss_pred             cc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh------------c
Confidence            22      234899999999998766554   79999999999999999999976543211 01000            0


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ...+....    .....+.+++.+||+.||.+|||+.++++.|..+
T Consensus       227 ~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          227 GLRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             CCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            00011111    1234678888999999999999999999998765

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-45  Score=353.38  Aligned_cols=244  Identities=24%  Similarity=0.268  Sum_probs=202.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....   .....+..|+.+|+.++||||+++++++.+....|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            47899999999999999999965 4699999999864321   2245678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++....
T Consensus       120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999997543    3889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ...    ....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+....        .     
T Consensus       193 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------~-----  255 (350)
T 1rdq_E          193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------V-----  255 (350)
T ss_dssp             SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------C-----
T ss_pred             CCc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--------C-----
Confidence            322    23469999999999999999999999999999999999999997654321 11111100        0     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                       .+...    ....+.++|.+||+.||.+||+     +.++++
T Consensus       256 -~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 -RFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             01111    1246778889999999999998     888886

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-45  Score=350.29  Aligned_cols=248  Identities=23%  Similarity=0.302  Sum_probs=193.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecCC----hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS----NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      .++|++.+.||+|+||.||+|..    .+++.||+|++....    ......+..|+.+|+.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            47899999999999999999976    478999999987532    2234457789999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .|+||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999987533    3788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+....        . 
T Consensus       169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--------~-  238 (327)
T 3a62_A          169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--------L-  238 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------C-
T ss_pred             cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------C-
Confidence            75432221 2234569999999999999999999999999999999999999997654321 11111100        0 


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                           .+.    ......+.+++.+||+.||.+||     ++.++++.
T Consensus       239 -----~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 -----NLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -----CCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -----CCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                 000    11124677888999999999999     78888873

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.4e-46  Score=357.06  Aligned_cols=253  Identities=20%  Similarity=0.276  Sum_probs=192.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ...++|++.+.||+|+||.||++... +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            34678999999999999999999654 799999999975332 2345789999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc--EEEEecCCcccc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK--AQVADFGFAKLI  191 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~--~kl~Dfgl~~~~  191 (400)
                      ||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||++...
T Consensus        96 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           96 EYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            9999999999986533    3889999999999999999999998   999999999999987765  999999999743


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCc-cceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASES-CDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLACERKFSE  268 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  268 (400)
                      ....  ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......  ...+.... .    .... 
T Consensus       169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-~----~~~~-  240 (361)
T 3uc3_A          169 VLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL-S----VKYS-  240 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH-T----TCCC-
T ss_pred             cccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh-c----CCCC-
Confidence            2221  1233469999999999998888765 899999999999999999997543210  00000000 0    0000 


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ...      .......+.++|.+||+.||.+|||+.++++.
T Consensus       241 -~~~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 -IPD------DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -CCT------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCC------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             000      00112467788999999999999999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=357.93  Aligned_cols=250  Identities=22%  Similarity=0.299  Sum_probs=200.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.+|+.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            47899999999999999999965 468899999987422   22245688899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+.+|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++....
T Consensus        94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999997543    3899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ....  .....||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.................     .    
T Consensus       167 ~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-----~----  235 (384)
T 4fr4_A          167 RETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-----T----  235 (384)
T ss_dssp             TTCC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-----C----
T ss_pred             CCCc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-----c----
Confidence            4322  334569999999999974   4589999999999999999999999974332111111000000     0    


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-MLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~ell~  309 (400)
                       ...    +.......+.++|.+||+.||.+||+ +.++++
T Consensus       236 -~~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 -VVT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -ccC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             000    01111246788899999999999998 777775

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-45  Score=348.31  Aligned_cols=272  Identities=27%  Similarity=0.369  Sum_probs=208.1

Q ss_pred             HccCC-CcCCcccccCceEEEEEEE-----cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEe--C
Q 015797           36 ATNNF-NYDNKLGEGGFGSVYWGQL-----WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAE--G  106 (400)
Q Consensus        36 ~~~~y-~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~  106 (400)
                      ..++| ++.+.||+|+||.||++..     .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+  .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            34556 9999999999999988753     368899999998643 3445678999999999999999999999987  4


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      ...++||||+++|+|.+++....     +++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred             ceEEEEEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcc
Confidence            67899999999999999996542     889999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCce--eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          187 FAKLIPDGATH--VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       187 l~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      ++.........  ......||+.|+|||++.+..++.++|||||||++|+|+||..||............ +........
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~  258 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-IAQGQMTVL  258 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC-SCCHHHHHH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc-ccccchhHH
Confidence            99877554322  122345888999999999999999999999999999999999999754322111100 000000000


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .+...................+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            0000010111111112223578889999999999999999999999976643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-45  Score=351.42  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=200.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++...   .......+..|..++..+ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            46799999999999999999965 46889999999753   233445688899999987 89999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++...
T Consensus        88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999999986533    3889999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh--hhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~  269 (400)
                      .... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ..............    
T Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            3222 1233456999999999999999999999999999999999999999643211000  00000000000000    


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM------LEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~ell~  309 (400)
                        ..+...    ....+.+++.+||+.||.+||++      .++++
T Consensus       236 --~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 --IRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             --CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             --CCCCCC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence              001111    22467788899999999999995      67765

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-45  Score=339.42  Aligned_cols=250  Identities=20%  Similarity=0.307  Sum_probs=203.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ..++|++.+.||+|+||.||+|.. .++..+|+|.+..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            457899999999999999999965 4578999999986555556778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---CCCCcEEEEecCCcccc
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLI  191 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv---~~~~~~kl~Dfgl~~~~  191 (400)
                      |+++++|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999886533    3889999999999999999999998   9999999999999   78899999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  270 (400)
                      .....  .....||+.|+|||++.+ .++.++||||||+++|+|+||..||........ ..+.....+.. ...     
T Consensus       160 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~-----  230 (277)
T 3f3z_A          160 KPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP-EKD-----  230 (277)
T ss_dssp             CTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-HHH-----
T ss_pred             cCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-chh-----
Confidence            54332  223459999999998865 499999999999999999999999976543211 11111000000 000     


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                              .......+.+++.+||+.||.+|||+.++++
T Consensus       231 --------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          231 --------WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    0011346788899999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-45  Score=356.73  Aligned_cols=272  Identities=19%  Similarity=0.257  Sum_probs=204.8

Q ss_pred             HHHccCCCcCCccccc--CceEEEEEEEc-CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           34 HSATNNFNYDNKLGEG--GFGSVYWGQLW-DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G--~~g~Vy~a~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ....++|++.+.||+|  +||.||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++.+++.
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            3556889999999999  99999999654 69999999997532  3445668889999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .|+|||||++|+|.+++......  .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            99999999999999999765322  3889999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCc------eeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccc
Q 015797          189 KLIPDGAT------HVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALP  259 (400)
Q Consensus       189 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~  259 (400)
                      ........      .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||......... .......+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            65432111      11112368999999999987  67999999999999999999999999754321100 00000000


Q ss_pred             hhc------ccc-------------cccccC---c------cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LAC------ERK-------------FSELAD---P------RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~------~~~-------------~~~~~~---~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...      ...             +.....   +      .............+.+||.+||+.||.+|||+.++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000      000             000000   0      00000112223568889999999999999999999964

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-45  Score=355.36  Aligned_cols=269  Identities=17%  Similarity=0.203  Sum_probs=203.3

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEcC------CCEEEEEEEecCChHHHH-----------HHHHHHHHHhcCCCCccc
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLWD------GSQIAVKRLKVWSNKAEM-----------EFAVEVEILARVRHKNLL   97 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~hpnIv   97 (400)
                      ...++|++.+.||+|+||.||+|.+..      ++.||+|++.........           .+..|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            356799999999999999999997644      478999998765432211           233466677888999999


Q ss_pred             eeeeEEEeC----CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 015797           98 SLRGYCAEG----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL  173 (400)
Q Consensus        98 ~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIl  173 (400)
                      ++++++...    ...++||||+ +++|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+|||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil  184 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL  184 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence            999998765    4589999999 9999999976422   4899999999999999999999998   999999999999


Q ss_pred             EC--CCCcEEEEecCCccccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          174 LD--ADFKAQVADFGFAKLIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       174 v~--~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      ++  .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  8899999999999766432211      112345999999999999999999999999999999999999999854


Q ss_pred             hhhhhhh-hhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchh
Q 015797          246 NSAIKRT-ITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE  317 (400)
Q Consensus       246 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  317 (400)
                      ....... ...    ......+..+.++.+.....   ...+.+++..||+.||.+||++.+|++.|......
T Consensus       265 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          265 LKDPKYVRDSK----IRYRENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             TTCHHHHHHHH----HHHHHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHH----HHhhhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            3211100 000    00011111222211111111   24677888999999999999999999999776543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.4e-46  Score=351.24  Aligned_cols=269  Identities=24%  Similarity=0.381  Sum_probs=213.6

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCcccee
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSL   99 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~   99 (400)
                      +....+....++|++.+.||+|+||.||+|.+      .+++.||+|++.... ......+..|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44556677789999999999999999999963      346789999997543 33456788999999999 79999999


Q ss_pred             eeEEEeCC-eEEEEEEccCCCChhhhhhcCCCc------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 015797          100 RGYCAEGQ-ERLIVYDYMPNLSLLSHLHGQHSS------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRD  166 (400)
Q Consensus       100 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~d  166 (400)
                      ++++...+ ..++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.+   ++|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987754 489999999999999999765432            112788999999999999999999998   99999


Q ss_pred             CCCCCeEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhh
Q 015797          167 IKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEK  244 (400)
Q Consensus       167 ikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~  244 (400)
                      |||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|+| |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987644332 22233458899999999999999999999999999999998 9999975


Q ss_pred             hhhh--hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          245 VNSA--IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       245 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ....  ....+....             .......    ....+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       254 ~~~~~~~~~~~~~~~-------------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          254 VKIDEEFCRRLKEGT-------------RMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCCSHHHHHHHHHTC-------------CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHhccCc-------------cCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            4321  111111000             0001111    12467788899999999999999999999976643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.4e-45  Score=337.98  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=203.7

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            468999999999999999999965 46899999998753  344456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc---EEEEecCCcc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~---~kl~Dfgl~~  189 (400)
                      |||+++|+|.+.+....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++.
T Consensus        84 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999999886543    3889999999999999999999998   999999999999987655   9999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSE  268 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  268 (400)
                      .......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ..+......         
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  225 (284)
T 3kk8_A          157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD---------  225 (284)
T ss_dssp             ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred             EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc---------
Confidence            6654322  2234699999999999999999999999999999999999999976543211 111100000         


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ...+     ........+.+++.+||+.||.+|||+.++++
T Consensus       226 ~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 YPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000     00111246778889999999999999999997

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=345.61  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=197.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++.....  .....+..|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            46899999999999999999965 4589999999865433  23456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999988876432    3889999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhc---cccch-----hcc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITD---WALPL-----ACE  263 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~---~~~~~-----~~~  263 (400)
                      .... .....||+.|+|||++.+ ..++.++||||||+++|+|+||..||.......... +..   ...+.     ...
T Consensus       155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          155 PSDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            3222 223458999999999986 678999999999999999999999997654321110 000   00000     000


Q ss_pred             cccccc--cCccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 RKFSEL--ADPRLNGN---FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 ~~~~~~--~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ......  .++.....   ..+.....+.+++.+||+.||.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000  00000000   001223467889999999999999999999973

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=352.18  Aligned_cols=272  Identities=21%  Similarity=0.292  Sum_probs=210.1

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEE-
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA-  104 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-  104 (400)
                      .++-+.+....++|++.+.||+|+||.||++.. .+++.||+|++..........+..|+.+++.++||||+++++++. 
T Consensus        18 ~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           18 YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             SEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             eecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            333444455678999999999999999999965 679999999998766667778999999999999999999999986 


Q ss_pred             ---eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          105 ---EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       105 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                         .....++||||+.+|+|.+++.........+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~k  174 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPV  174 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEE
Confidence               345789999999999999998754333345899999999999999999999998   99999999999999999999


Q ss_pred             EEecCCccccCCCCce--------eeeecccccCcCChhhhccCC---CCCccceehhhHHHHHHHhCCCChhhhhhhhh
Q 015797          182 VADFGFAKLIPDGATH--------VTTRVKGTLGYLAPEYAMLGK---ASESCDVYSFGILLLELASGKKPIEKVNSAIK  250 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~  250 (400)
                      |+|||++.........        ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||........
T Consensus       175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  254 (317)
T 2buj_A          175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD  254 (317)
T ss_dssp             ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred             EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence            9999998764321110        001234799999999987554   68999999999999999999999975332110


Q ss_pred             hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          251 RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ......      .....    ..    ........+.+++.+||+.||.+|||+.++++.|..+.
T Consensus       255 ~~~~~~------~~~~~----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          255 SVALAV------QNQLS----IP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             CHHHHH------HCC------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhhHHh------hccCC----CC----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            000000      00000    00    00112246888899999999999999999999997654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=351.36  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=190.6

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .....++|++.+.||+|+||.||+|... +++.||+|++....  ....+..|+.+++.++||||+++++++.+....++
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            3456688999999999999999999764 58899999987532  34567889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEEecCCc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFA  188 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~Dfgl~  188 (400)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+|||++
T Consensus       126 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EECCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            999999999999986543    3889999999999999999999998   999999999999975   889999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLACERKF  266 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~  266 (400)
                      .......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ...+......       
T Consensus       199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-------  269 (349)
T 2w4o_A          199 KIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-------  269 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-------
T ss_pred             cccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-------
Confidence            8654322  1233569999999999999999999999999999999999999996543221  1111110000       


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ...+     ........+.+++.+||+.||.+|||+.++++.
T Consensus       270 --~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 --FISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             --CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --cCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000     111123467788999999999999999999974

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-45  Score=349.77  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=199.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCE----EEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQ----IAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+.... ......+..|+.+++.++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            468999999999999999999653 4544    7778775332 222345778999999999999999999886 46689


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+.+|+|.+++....   ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence            9999999999999997542   24889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          191 IPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ....... ......||+.|+|||++.++.++.++|||||||++|+|+| |..||.................    .... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~-  239 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----LAQP-  239 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----CCCC-
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----CCCC-
Confidence            6543322 2233458889999999999999999999999999999999 9999976542211111100000    0000 


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         .        .....+.+++.+||+.||.+|||+.++++.|+....
T Consensus       240 ---~--------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          240 ---Q--------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ---T--------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ---C--------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               0        011246678899999999999999999999976644

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-45  Score=365.15  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=194.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...   .......+..|+.+++.++||||+++++++.+.+..|+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            457899999999999999999964 56999999999742   23334567789999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+ .+   |+||||||+||||+.++.+||+|||++..
T Consensus       226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999986533    48899999999999999999998 87   99999999999999999999999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+....            
T Consensus       299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------  365 (446)
T 4ejn_A          299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------  365 (446)
T ss_dssp             TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred             ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------------
Confidence            433222 2334569999999999999999999999999999999999999997654321 11111000            


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  309 (400)
                        ..+...    ....+.++|.+||+.||.+||     ++.++++
T Consensus       366 --~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 --IRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              000111    124677888999999999999     9999997

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.2e-46  Score=350.47  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=193.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe---
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE---  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---  108 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            457899999999999999999965 678999999997532   2334568899999999999999999999876543   


Q ss_pred             -EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          109 -RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       109 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                       .|+||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence             499999999999999986533    3889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCce--eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchhcc
Q 015797          188 AKLIPDGATH--VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLACE  263 (400)
Q Consensus       188 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~  263 (400)
                      +.........  ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........  ........+.   
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---  239 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---  239 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---
Confidence            9866443221  22234699999999999999999999999999999999999999976543211  1111100000   


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                          ...        .......+.+++.+||+.||.+||++.+++.
T Consensus       240 ----~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          240 ----SAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             ----HHH--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             ----ccc--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence                000        0011246778889999999999998776664

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-45  Score=353.23  Aligned_cols=248  Identities=26%  Similarity=0.328  Sum_probs=201.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC---hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS---NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999764 58899999997432   12345677899999988 8999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||++||+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++..
T Consensus        98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999987533    3889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ....+....        +   
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------~---  238 (353)
T 2i0e_A          171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------V---  238 (353)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------C---
T ss_pred             cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------C---
Confidence            43222 1233456999999999999999999999999999999999999999765432 111111100        0   


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                         .+.    ......+.+++.+||+.||.+||+     +.++++
T Consensus       239 ---~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 ---AYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ---CCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ---CCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               001    112246778889999999999995     577776

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.7e-45  Score=344.86  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=204.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|.+......      ....+..|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            456799999999999999999965 46899999999753321      24678899999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC----cEEEEe
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF----KAQVAD  184 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~----~~kl~D  184 (400)
                      .++||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++    .+||+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            999999999999999997543    3888999999999999999999998   99999999999999888    799999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACE  263 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~  263 (400)
                      ||++........  .....||+.|+|||++.+..++.++|||||||++|+|+||..||........ ..+......    
T Consensus       163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----  236 (321)
T 2a2a_A          163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD----  236 (321)
T ss_dssp             CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC----
T ss_pred             CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc----
Confidence            999987654322  2234599999999999999999999999999999999999999975442211 111100000    


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        +    ++.    ........+.+++.+||+.||.+|||+.++++.
T Consensus       237 --~----~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          237 --F----DEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --C----CHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --c----Chh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0    000    001112467788999999999999999999974

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.2e-46  Score=343.59  Aligned_cols=256  Identities=21%  Similarity=0.300  Sum_probs=201.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..++|++.+.||+|+||.||+|....    +..||+|.+... .......+..|+.+++.++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            45789999999999999999996432    235999998754 34455678999999999999999999999865 4568


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++++|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            99999999999999975432   3889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  268 (400)
                      .............+|+.|+|||++.+..++.++||||||+++|+|+| |+.||........ ..+....           
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-----------  231 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-----------  231 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-----------
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-----------
Confidence            65433322333457889999999999999999999999999999998 9999975432211 1110000           


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                        ......    .....+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       232 --~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          232 --RLPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             --CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence              000000    11246778889999999999999999999987654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-45  Score=346.10  Aligned_cols=269  Identities=26%  Similarity=0.389  Sum_probs=202.5

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhc--CCCCccceeeeEEEe
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR--VRHKNLLSLRGYCAE  105 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~  105 (400)
                      .+...-....++|++.+.||+|+||.||+|.. .++.||+|++....   ...+..|.+++..  ++||||+++++++..
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            34444556678999999999999999999975 58999999986432   3344555555554  499999999999988


Q ss_pred             C----CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc--------CCCCeEecCCCCCCeE
Q 015797          106 G----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH--------ATPHIIHRDIKASNVL  173 (400)
Q Consensus       106 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~~~~iiH~dikp~NIl  173 (400)
                      .    ...++||||+++|+|.+++...     .+++..++.++.|++.||.|||+.        +   ++||||||+|||
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil  174 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL  174 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence            7    7899999999999999999653     388999999999999999999988        7   999999999999


Q ss_pred             ECCCCcEEEEecCCccccCCCCcee---eeecccccCcCChhhhccCCCCCc------cceehhhHHHHHHHhC------
Q 015797          174 LDADFKAQVADFGFAKLIPDGATHV---TTRVKGTLGYLAPEYAMLGKASES------CDVYSFGILLLELASG------  238 (400)
Q Consensus       174 v~~~~~~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------sDIwSlGiil~elltg------  238 (400)
                      ++.++.+||+|||++..........   .....||+.|+|||++.+..++.+      +|||||||++|+|+||      
T Consensus       175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~  254 (337)
T 3mdy_A          175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI  254 (337)
T ss_dssp             ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence            9999999999999997664432221   123469999999999988777665      9999999999999999      


Q ss_pred             ----CCChhhhhhhhh--hhhhccccchhcccccccccCccCCCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 015797          239 ----KKPIEKVNSAIK--RTITDWALPLACERKFSELADPRLNGN-FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLL  311 (400)
Q Consensus       239 ----~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  311 (400)
                          ..||........  .....        ........+..... ........+.+++.+||+.||.+|||+.++++.|
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          255 VEEYQLPYHDLVPSDPSYEDMRE--------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHH--------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cccccccHhhhcCCCCchhhhHH--------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence                555543211000  00000        00000011111111 1225567889999999999999999999999999


Q ss_pred             cccch
Q 015797          312 KGESK  316 (400)
Q Consensus       312 ~~~~~  316 (400)
                      +.+..
T Consensus       327 ~~l~~  331 (337)
T 3mdy_A          327 AKMSE  331 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            76644

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-45  Score=341.62  Aligned_cols=258  Identities=26%  Similarity=0.350  Sum_probs=206.4

Q ss_pred             ccCCCcCC-cccccCceEEEEEEE---cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDN-KLGEGGFGSVYWGQL---WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~-~LG~G~~g~Vy~a~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|.+.+ .||+|+||.||+|..   .++..||+|++.... ......+..|+.+++.++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            45677776 999999999999964   357789999997643 34456788999999999999999999999 5567899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhCCc---cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999864322   4899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          192 PDGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      ........  ....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||........ ..+....          
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~----------  230 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------  230 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----------
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC----------
Confidence            54332221  22346889999999999999999999999999999999 9999976543211 1111100          


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchhh
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEK  318 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  318 (400)
                         .+.    ........+.+++.+||+.||.+|||+.++++.|.......
T Consensus       231 ---~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          231 ---RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             ---CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---cCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence               000    11122347788899999999999999999999998765433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.8e-46  Score=352.16  Aligned_cols=263  Identities=24%  Similarity=0.390  Sum_probs=210.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEc--------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYC  103 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  103 (400)
                      ....++|++.+.||+|+||.||+|.+.        ++..||+|++.... ......+..|+.+++.+ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            344689999999999999999999752        46789999987543 34456788999999999 899999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCCc------------ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHSS------------ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      .+.+..++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence            9999999999999999999999765321            124889999999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI  249 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~  249 (400)
                      |+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.......
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            99999999999999999876543322 1223347889999999999999999999999999999999 999997654321


Q ss_pred             h-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          250 K-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       250 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      . ..+....             .....    ......+..++.+||+.||.+|||+.++++.|..+..
T Consensus       268 ~~~~~~~~~-------------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 LFKLLKEGH-------------RMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HHHHHHHTC-------------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCC-------------CCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1 1111100             00011    1122467888999999999999999999999976643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-45  Score=356.55  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=192.4

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec--CChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCC--e
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV--WSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQ--E  108 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~--~  108 (400)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++..  ........+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3468999999999999999999964 5799999999853  33445567889999999997 999999999997544  6


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .|+|||||. |+|.+++...     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999997 6999988753     3888999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCC--------------------ceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhh
Q 015797          189 KLIPDGA--------------------THVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNS  247 (400)
Q Consensus       189 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~  247 (400)
                      +......                    .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8653211                    111233569999999999986 6789999999999999999999999975442


Q ss_pred             hhh--hhhhccccchhccccccccc------------------CccCCCCCcH-------------HHHHHHHHHHHhcc
Q 015797          248 AIK--RTITDWALPLACERKFSELA------------------DPRLNGNFVE-------------EELKRVVLVALTCA  294 (400)
Q Consensus       248 ~~~--~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~-------------~~~~~l~~li~~cl  294 (400)
                      ...  ..+.....|.  ...+..+.                  ..... ...+             .....+.+|+.+||
T Consensus       237 ~~~~~~i~~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L  313 (388)
T 3oz6_A          237 MNQLERIIGVIDFPS--NEDVESIQSPFAKTMIESLKEKVEIRQSNKR-DIFTKWKNLLLKINPKADCNEEALDLLDKLL  313 (388)
T ss_dssp             HHHHHHHHHHHCCCC--HHHHHTSCCSSHHHHHHHHHHHCC-----CC-CCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred             HHHHHHHHHhcCCCC--HHHHHhccCHHHHHHHHhCcccccccCCCHH-HhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence            211  1110000000  00000000                  00000 0000             11346788999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 015797          295 HSKPEKRPTMLEVLDL  310 (400)
Q Consensus       295 ~~dP~~Rps~~ell~~  310 (400)
                      +.||.+|||+.++++.
T Consensus       314 ~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          314 QFNPNKRISANDALKH  329 (388)
T ss_dssp             CSSGGGSCCHHHHTTS
T ss_pred             ccCcccCCCHHHHhCC
Confidence            9999999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=343.71  Aligned_cols=267  Identities=25%  Similarity=0.338  Sum_probs=197.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-----HHHHHHHHHHHHHhcC---CCCccceeeeEEEeC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-----KAEMEFAVEVEILARV---RHKNLLSLRGYCAEG  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~  106 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....     .....+..|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            468999999999999999999965 5789999999874321     1123455666666665   599999999999876


Q ss_pred             C-----eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          107 Q-----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       107 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                      .     ..++||||+. |+|.+++......  .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            5     5799999997 5999998765432  3899999999999999999999998   99999999999999999999


Q ss_pred             EEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccc
Q 015797          182 VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP  259 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~  259 (400)
                      |+|||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ........+
T Consensus       161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999986643222  2345699999999999999999999999999999999999999975543211  111000000


Q ss_pred             --hhcccccc---cccCccCCC---CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 --LACERKFS---ELADPRLNG---NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 --~~~~~~~~---~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ..+.....   ....+....   ...+.....+.+++.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence              00000000   000000000   0011123567888999999999999999999963

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.5e-45  Score=339.59  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=199.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +.++|++.+.||+|+||.||+|.. .++..||+|++.....   .....+.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            457899999999999999999965 4578999999864322   123568889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999999999986543    3889999999999999999999998   999999999999999999999999998654


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  270 (400)
                      ....   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......... .+....             
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  223 (279)
T 3fdn_A          160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------------  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------
T ss_pred             Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-------------
Confidence            3322   22346999999999999999999999999999999999999999754432111 111000             


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ...    .......+.+++.+||+.||.+|||+.++++.
T Consensus       224 -~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 -FTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -CCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -CCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             000    01112467788899999999999999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.1e-46  Score=350.69  Aligned_cols=272  Identities=22%  Similarity=0.389  Sum_probs=216.7

Q ss_pred             cccccHHHHHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccc
Q 015797           25 WRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLL   97 (400)
Q Consensus        25 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv   97 (400)
                      ...+..+++....++|++.+.||+|+||.||+|...      .++.||+|.+.... ......+.+|+.+++.++||||+
T Consensus        12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~   91 (322)
T 1p4o_A           12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV   91 (322)
T ss_dssp             CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred             ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            345667777888899999999999999999999643      46789999987533 34455788999999999999999


Q ss_pred             eeeeEEEeCCeEEEEEEccCCCChhhhhhcCCC------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797           98 SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHS------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      ++++++.+.+..++||||+++|+|.+++.....      ....+++..++.++.|++.||.|||+++   ++||||||+|
T Consensus        92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N  168 (322)
T 1p4o_A           92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARN  168 (322)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGG
T ss_pred             eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccce
Confidence            999999999999999999999999999864321      0124688999999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI  249 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~  249 (400)
                      |+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.......
T Consensus       169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            99999999999999999865432221 1122347889999999999999999999999999999999 899997654321


Q ss_pred             h-hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          250 K-RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       250 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      . ..+...        ...     .    ........+.+++.+||+.||.+|||+.++++.|+....
T Consensus       249 ~~~~~~~~--------~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVMEG--------GLL-----D----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHTT--------CCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHcC--------CcC-----C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1 111110        000     0    011123467788899999999999999999999976643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-45  Score=356.82  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=195.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCC--CCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVR--HKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ..+|++.+.||+|+||.||+|....++.||+|++...  .......+.+|+.+|+.++  ||||+++++++..++..|+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999998777999999999753  3344567899999999996  59999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      || +.+++|.+++....    .+++..++.++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||++....
T Consensus       135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 56789999997643    3788899999999999999999998   99999999999995 5899999999998765


Q ss_pred             CCCce-eeeecccccCcCChhhhcc-----------CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccch
Q 015797          193 DGATH-VTTRVKGTLGYLAPEYAML-----------GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL  260 (400)
Q Consensus       193 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~  260 (400)
                      ..... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......... +..     
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~~-----  279 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHA-----  279 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHH-----
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-HHH-----
Confidence            43222 2234569999999999875           46899999999999999999999999754321110 000     


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                              +.++.....+.......+.+++.+||+.||.+|||+.++++.
T Consensus       280 --------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                    000000000000012467788899999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-45  Score=353.32  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=199.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ...+|++.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            345689999999999999999965 578999999997532   2233568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+. |+|.+++....   ..+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++...
T Consensus       132 v~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            999997 68888875432   24899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      ...     ....||+.|+|||++.   ++.++.++|||||||++|+|+||+.||........ ..+.....         
T Consensus       205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---------  270 (348)
T 1u5q_A          205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------  270 (348)
T ss_dssp             SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------
T ss_pred             CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------
Confidence            432     2345999999999985   56789999999999999999999999976543211 01110000         


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                          +......   ....+.+++.+||+.||.+|||+.++++.
T Consensus       271 ----~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 ----PALQSGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ----CCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ----CCCCCCC---CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                0010111   12357788899999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-45  Score=340.70  Aligned_cols=255  Identities=21%  Similarity=0.352  Sum_probs=199.0

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ...++|.+.+.||+|+||.||+|.. .++..+|+|.+.... ......+..|+++++.++||||+++++++.+....++|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            3447899999999999999999965 568999999987533 23356788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---CCCCcEEEEecCCcc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv---~~~~~~kl~Dfgl~~  189 (400)
                      |||+++|+|.+++.........+++..++.++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999998654322345899999999999999999999998   9999999999999   456889999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .......  .....||+.|+|||++. +.++.++||||||+++|+|++|+.||................+     ...  
T Consensus       176 ~~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~--  245 (285)
T 3is5_A          176 LFKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-----NYA--  245 (285)
T ss_dssp             C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCC--
T ss_pred             ecCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-----ccc--
Confidence            6543322  23345999999999886 5789999999999999999999999976543211111110000     000  


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         .....    ....+.+++.+||+.||.+|||+.++++
T Consensus       246 ---~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 ---VECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---C--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---cccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00000    1246778899999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=356.98  Aligned_cols=275  Identities=20%  Similarity=0.257  Sum_probs=211.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC--eEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ--ERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~l  111 (400)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+..  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            3578999999999999999999654 58999999997533 223456788999999999999999999998765  7799


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----CCCCcEEEEecCC
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL----DADFKAQVADFGF  187 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv----~~~~~~kl~Dfgl  187 (400)
                      |||||++|+|.+++..... ...+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+
T Consensus        87 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999875432 223899999999999999999999998   9999999999999    7788899999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhcc--------CCCCCccceehhhHHHHHHHhCCCChhhhhhh-----hhhhhh
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAML--------GKASESCDVYSFGILLLELASGKKPIEKVNSA-----IKRTIT  254 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-----~~~~~~  254 (400)
                      +........  .....||+.|+|||++.+        ..++.++|||||||++|+|+||+.||......     ....+.
T Consensus       163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             CEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             ceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            987654322  223469999999999875        56788999999999999999999999643211     111111


Q ss_pred             ccccchhcccccccc--------cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchh
Q 015797          255 DWALPLACERKFSEL--------ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE  317 (400)
Q Consensus       255 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  317 (400)
                      .. .|......+...        ................+..++.+||+.||++|||+.++++.+..+...
T Consensus       241 ~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            10 010000000000        011112234566777888999999999999999999999988766543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.7e-45  Score=342.03  Aligned_cols=261  Identities=20%  Similarity=0.233  Sum_probs=198.1

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++....   ......+..|+.+++.++||||+++++++..++..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            3458999999999999999999965 468899999987532   223467889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus       111 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            9999999999999987532    3889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      .............||+.|+|||++.+..++.++||||||+++|+|+||+.||................+     ... ..
T Consensus       184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~-~~  257 (309)
T 2h34_A          184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP-----RPS-TV  257 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCC-----CGG-GT
T ss_pred             ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCC-----Ccc-cc
Confidence            654333333345699999999999999999999999999999999999999976543211111110000     000 00


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhcccch
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-TMLEVLDLLKGESK  316 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~~~~  316 (400)
                              .......+.+++.+||+.||.+|| ++.++++.|.....
T Consensus       258 --------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          258 --------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             --------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             --------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                    011123677888999999999999 99999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-45  Score=340.33  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=200.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH--H-----HHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA--E-----MEFAVEVEILARVRHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~--~-----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  107 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.......  .     ..+..|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            347899999999999999999965 578999999986432211  1     56889999999999999999999987665


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc-----EEE
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK-----AQV  182 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~-----~kl  182 (400)
                        ++||||+++|+|.+.+.....   .+++..++.++.|++.||.|||+++ ++++||||||+|||++.++.     +||
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             --eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence              699999999999998875432   4899999999999999999999885 34999999999999988776     999


Q ss_pred             EecCCccccCCCCceeeeecccccCcCChhhhc--cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccch
Q 015797          183 ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM--LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL  260 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~  260 (400)
                      +|||++.....    ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...............   
T Consensus       171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---  243 (287)
T 4f0f_A          171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---  243 (287)
T ss_dssp             CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH---
T ss_pred             CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh---
Confidence            99999975432    223356999999999984  456789999999999999999999999754321111000000   


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                        .    ....+...    ......+.+++.+||+.||.+|||+.++++.|+.
T Consensus       244 --~----~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 --E----EGLRPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             --H----SCCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --c----cCCCCCCC----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence              0    00001111    1123467888999999999999999999998864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4e-45  Score=362.17  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=203.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|.+.+.||+|+||.||+|.+ .+|+.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            357899999999999999999965 4799999999974322   223568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        94 v~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            999999999999986533    3899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .....  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ....+...        ..   
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------~~---  233 (476)
T 2y94_A          167 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--------IF---  233 (476)
T ss_dssp             CTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--------CC---
T ss_pred             ccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--------Cc---
Confidence            54322  234569999999999998766 78999999999999999999999754321 11111110        00   


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         ......    ...+.+++.+||+.||.+|||+.++++
T Consensus       234 ---~~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 ---YTPQYL----NPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ---CCCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CCCccC----CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence               000011    236778889999999999999999997

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.3e-45  Score=345.86  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=196.8

Q ss_pred             ccCCCcC-CcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEE
Q 015797           37 TNNFNYD-NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        37 ~~~y~~~-~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      .++|++. +.||+|+||.||+|.+ .+++.||+|++..........+.+|+.++..+ +||||+++++++.+++..|+||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678885 7899999999999964 57999999999865555567789999999885 7999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc---EEEEecCCccc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVADFGFAKL  190 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~---~kl~Dfgl~~~  190 (400)
                      ||+++|+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.   +||+|||++..
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999997543    3889999999999999999999998   999999999999998776   99999999876


Q ss_pred             cCCCCc------eeeeecccccCcCChhhhcc-----CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccc
Q 015797          191 IPDGAT------HVTTRVKGTLGYLAPEYAML-----GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALP  259 (400)
Q Consensus       191 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~  259 (400)
                      ......      .......||+.|+|||++.+     ..++.++|||||||++|+|+||+.||................+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            532111      11123459999999999975     5689999999999999999999999975431100000000000


Q ss_pred             hhcccccccccCccCCCCCcH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LACERKFSELADPRLNGNFVE----EELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .........+.....  .+..    .....+.+++.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000000000000000  0000    123467889999999999999999999984

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=338.21  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=183.0

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH---HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK---AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++......   ....+..|+.+++.++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            3457899999999999999999965 57999999998643221   2356889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        88 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            99999999999999875432   4899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELA  270 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  ......        ..   
T Consensus       162 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~--------~~---  227 (278)
T 3cok_A          162 LKMPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TLNKVV--------LA---  227 (278)
T ss_dssp             CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CC--------SS---
T ss_pred             ccCCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--HHHHHh--------hc---
Confidence            6432221 223458999999999999999999999999999999999999997543210  000000        00   


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +.....    .....+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 DYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccCCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            000111    11246778889999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=349.48  Aligned_cols=257  Identities=24%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCE----EEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQ----IAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .++|++.+.||+|+||.||+|.+ .+++.    ||+|.+... .......+..|+.+++.++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            47899999999999999999964 34554    477776532 3344567899999999999999999999998765 78


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|++|+.+|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            99999999999999976433   3889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          191 IPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       191 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||................          
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----------  236 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----------  236 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------
Confidence            6433221 1222347889999999999999999999999999999999 999997654321111110000          


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                        ...    ........+..++.+||+.||.+|||+.++++.|..+..
T Consensus       237 --~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 --RLP----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             --CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              000    011122367788999999999999999999999876643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.5e-46  Score=353.38  Aligned_cols=266  Identities=26%  Similarity=0.426  Sum_probs=210.6

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEcC-C-----CEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLWD-G-----SQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGY  102 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  102 (400)
                      +.+....++|++.+.||+|+||.||+|.... +     ..||+|.+.... ......+..|+.+++.+ +||||++++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3456667899999999999999999997532 2     479999997543 34456788999999999 89999999999


Q ss_pred             EEeCCeEEEEEEccCCCChhhhhhcCCC----------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797          103 CAEGQERLIVYDYMPNLSLLSHLHGQHS----------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus       103 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                      +.+.+..++||||+++|+|.+++.....          ....+++..++.++.|++.||.|||+++   ++||||||+||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV  195 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence            9999999999999999999999864321          0124788999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--
Q 015797          173 LLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--  248 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--  248 (400)
                      |++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|+| |..||......  
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            999999999999999986543322 22233457889999999999999999999999999999999 99999754321  


Q ss_pred             hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ........             ......    ......+.+++.+||+.||.+|||+.++++.|.....
T Consensus       276 ~~~~~~~~-------------~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          276 FYKLVKDG-------------YQMAQP----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HHHHHHHT-------------CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcC-------------CCCCCC----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            10110000             000000    0112467888999999999999999999999876543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-45  Score=348.40  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=179.5

Q ss_pred             cCCCcC---CcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYD---NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~---~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|.+.   +.||+|+||.||+|.+ .+++.||+|++...   ....+..|+.+++.+. ||||+++++++.++...|+|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            345554   7899999999999965 46899999998643   3456778999999997 99999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC---cEEEEecCCcc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF---KAQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~---~~kl~Dfgl~~  189 (400)
                      |||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||++.
T Consensus        85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           85 MELLNGGELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             ECCCCSCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999999999997643    3899999999999999999999998   99999999999998766   89999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............        .....+
T Consensus       158 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--------~~~~~i  228 (325)
T 3kn6_A          158 LKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV--------EIMKKI  228 (325)
T ss_dssp             ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH--------HHHHHH
T ss_pred             ecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH--------HHHHHH
Confidence            6544322 2233458999999999999999999999999999999999999997543210000000        000000


Q ss_pred             cCcc--CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPR--LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....  ............+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            0000  000011122357788999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-45  Score=349.71  Aligned_cols=272  Identities=19%  Similarity=0.267  Sum_probs=193.7

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEE
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCA  104 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~  104 (400)
                      .+...-....++|++.+.||+|+||.||+|.+ .+++.||+|++......  ....+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (329)
T 3gbz_A           24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH  103 (329)
T ss_dssp             --------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred             eccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence            33334455678999999999999999999964 57899999998754332  2345778999999999999999999999


Q ss_pred             eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-----CCCCc
Q 015797          105 EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL-----DADFK  179 (400)
Q Consensus       105 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv-----~~~~~  179 (400)
                      ++...++||||+. |+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||+     +.++.
T Consensus       104 ~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  175 (329)
T 3gbz_A          104 HNHRLHLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPV  175 (329)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCE
T ss_pred             cCCEEEEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccce
Confidence            9999999999998 59999987543    3889999999999999999999998   9999999999999     45556


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhcc
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDW  256 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~  256 (400)
                      +||+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||........  ......
T Consensus       176 ~kl~Dfg~a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  254 (329)
T 3gbz_A          176 LKIGDFGLARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL  254 (329)
T ss_dssp             EEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEECcCCCccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence            999999999876433222 2234589999999999874 489999999999999999999999975442211  111000


Q ss_pred             ccchh--c-----ccccccccCccCCCCCcHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          257 ALPLA--C-----ERKFSELADPRLNGNFVEE-----ELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       257 ~~~~~--~-----~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..|..  .     ...+.... +.........     ....+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSF-PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTC-CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhhhhhhhhh-hhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000  0     00000000 0000111111     2356788999999999999999999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=347.03  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=199.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcC-----CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWD-----GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      .++|.+.+.||+|+||.||+|....     +..||+|.+.... ......+..|+.+++.++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3677888999999999999996432     2359999987543 344557889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus       123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999975432   3899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          191 IPDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       191 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      ........  .....+|+.|+|||++.+..++.++|||||||++|+|+| |..||....... ...+....         
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~---------  267 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---------  267 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---------
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC---------
Confidence            64432211  112346789999999999999999999999999999999 999997554321 11111100         


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                          ....    .......+.+++.+||+.||.+||++.++++.|..+..
T Consensus       268 ----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          268 ----RLPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ----CCCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----cCCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                0000    01123467888999999999999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=346.66  Aligned_cols=264  Identities=19%  Similarity=0.286  Sum_probs=193.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHH-HHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAE-MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||+|+||.||+|... +++.||+|++........ ..+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            68999999999999999999654 789999999875332221 2355799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +. |+|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 599998875433   4888999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccc-----
Q 015797          196 THVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL-----  269 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  269 (400)
                      .. .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||..................+....+...     
T Consensus       155 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          155 KT-YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             cc-cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            22 223458999999999886 56899999999999999999999999765432111100000000000000000     


Q ss_pred             ----cCccCCCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ----ADPRLNGNF----VEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ----~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                          ..+......    .+.....+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                000000000    0112346788999999999999999999997

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.5e-46  Score=373.37  Aligned_cols=263  Identities=29%  Similarity=0.457  Sum_probs=210.9

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .+.+....++|++.+.||+|+||.||+|.+..+..||||++..... ....+.+|+.+|+.++||||+++++++.+ +..
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            3444556788999999999999999999877778899999975432 34578999999999999999999999876 678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+||||+.+|+|.+++....  ...+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            99999999999999996432  124889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ..............+++.|+|||++.++.++.++|||||||+||||+| |+.||....... ...+...         . 
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~---------~-  481 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---------Y-  481 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT---------C-
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------C-
Confidence            664322111222346788999999999999999999999999999999 999997654321 1111100         0 


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                         ...    ........+.++|.+||+.||++|||+.+|++.|+.+..
T Consensus       482 ---~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          482 ---RMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ---CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ---CCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence               000    011123467888999999999999999999999987643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-45  Score=336.34  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=202.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999654 68999999987533 344567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999886432    3889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCc-eeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          194 GAT-HVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+...     . . ...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-----~-~-~~~  229 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK-----K-T-YLN  229 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTT-----C-T-TST
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhc-----c-c-ccC
Confidence            221 11233568999999999987765 78999999999999999999999754321100 0000000     0 0 000


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                            ........+.+++.+||+.||.+|||+.++++
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                  00112346778899999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-45  Score=347.20  Aligned_cols=257  Identities=27%  Similarity=0.439  Sum_probs=202.4

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEE--EEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQI--AVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~v--avK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|++.+.||+|+||.||+|.. .++..+  |+|.+.... ......+..|+.+++.+ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            6899999999999999999964 456544  899887532 33345688999999999 999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC------------CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcE
Q 015797          113 YDYMPNLSLLSHLHGQH------------SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA  180 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~  180 (400)
                      |||+++|+|.+++....            .....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999997553            12235899999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhcccc
Q 015797          181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWAL  258 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~  258 (400)
                      ||+|||++.......  ......+++.|+|||++.+..++.++|||||||++|+|+| |..||........ ..+...  
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~--  257 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--  257 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT--
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC--
Confidence            999999987432211  1122347889999999999999999999999999999998 9999976543211 111100  


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                 .....    .......+.+++.+||+.||.+|||+.++++.|.....
T Consensus       258 -----------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          258 -----------YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             -----------CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                       00000    11112467888999999999999999999999876644

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=347.49  Aligned_cols=263  Identities=17%  Similarity=0.194  Sum_probs=196.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecCChHHH-----------HHHHHHHHHHhcCCCCccceeee
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVWSNKAE-----------MEFAVEVEILARVRHKNLLSLRG  101 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~~~~  101 (400)
                      .++|.+.+.||+|+||.||+|...    .+..+|+|++........           ..+..|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            478999999999999999999754    678899999875432211           23557889999999999999999


Q ss_pred             EEEe----CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC
Q 015797          102 YCAE----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD  177 (400)
Q Consensus       102 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~  177 (400)
                      ++..    ....|+||||+ +++|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence            9988    78899999999 999999986543    4899999999999999999999998   9999999999999988


Q ss_pred             C--cEEEEecCCccccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh
Q 015797          178 F--KAQVADFGFAKLIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI  249 (400)
Q Consensus       178 ~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~  249 (400)
                      +  .+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999866432111      1123469999999999999999999999999999999999999996432111


Q ss_pred             h--hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          250 K--RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       250 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .  ........+ .....+....    ...   .....+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       268 ~~~~~~~~~~~~-~~~~~~~~~~----~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 VAVQTAKTNLLD-ELPQSVLKWA----PSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHHH-TTTHHHHHHS----CTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHHHhhcc-cccHHHHhhc----ccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1  000000000 0000000000    000   11246788889999999999999999999997653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.3e-45  Score=339.23  Aligned_cols=266  Identities=21%  Similarity=0.298  Sum_probs=200.5

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEE-EeCCeEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC-AEGQERLIV  112 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv  112 (400)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ...+..|+.+++.++|++++..+..+ .+....++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            4568999999999999999999965 6789999998764322  23478899999999988877766655 677888999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---CCCCcEEEEecCCcc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv---~~~~~~kl~Dfgl~~  189 (400)
                      |||+ +|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||+   +.++.+||+|||++.
T Consensus        84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 8999999874332   3899999999999999999999998   9999999999999   788999999999998


Q ss_pred             ccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcc
Q 015797          190 LIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACE  263 (400)
Q Consensus       190 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  263 (400)
                      ........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....................
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            76543321      122356999999999999999999999999999999999999999754321100000000000000


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchhh
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEK  318 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  318 (400)
                      .....     ..    ......+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       237 ~~~~~-----~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          237 TPIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             SCHHH-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chhhh-----hh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            00000     00    011247888999999999999999999999998765433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=348.58  Aligned_cols=243  Identities=23%  Similarity=0.322  Sum_probs=201.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--------HHHHHHHHHHHHhcCCCCccceeeeEEEeC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--------AEMEFAVEVEILARVRHKNLLSLRGYCAEG  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  106 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++......        ....+..|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999964 56889999999753311        223567799999999999999999999999


Q ss_pred             CeEEEEEEccCCC-ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 QERLIVYDYMPNL-SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      +..++||||+.+| +|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 9999887543    3899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      |++........  .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........           
T Consensus       175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----------  241 (335)
T 3dls_A          175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI-----------  241 (335)
T ss_dssp             TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCC-----------
T ss_pred             ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhcc-----------
Confidence            99987654332  223469999999999998877 8899999999999999999999975432110000           


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           ..+    ..   ....+.+++.+||+.||.+|||+.++++.
T Consensus       242 -----~~~----~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          242 -----HPP----YL---VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----CCS----SC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----CCC----cc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000    00   12367788899999999999999999984

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-44  Score=358.45  Aligned_cols=264  Identities=22%  Similarity=0.243  Sum_probs=196.9

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----  106 (400)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+|+.++||||+++++++...     
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3468999999999999999999964 56899999999743  344456788999999999999999999999654     


Q ss_pred             -CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 -QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       ...|+||||+.+ +|.+.+..      .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEE
Confidence             467999999975 57776642      2788999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccc--hh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP--LA  261 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~--~~  261 (400)
                      |+++......  ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+....  ..+.....|  ..
T Consensus       209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          209 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             CCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             EeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9998654322  23345699999999999999999999999999999999999999976442111  000000000  00


Q ss_pred             c------------------ccccccccCccC-CC--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 C------------------ERKFSELADPRL-NG--NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~------------------~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .                  ...+........ ..  .........+.+|+.+||..||.+|||+.|+++.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0                  000000000000 00  0111225678899999999999999999999984

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-45  Score=341.58  Aligned_cols=262  Identities=24%  Similarity=0.309  Sum_probs=206.2

Q ss_pred             HHHHHHHccCCCcCC-cccccCceEEEEEEE---cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           30 LKELHSATNNFNYDN-KLGEGGFGSVYWGQL---WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~-~LG~G~~g~Vy~a~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      ..++....++|.+.+ .||+|+||.||+|..   ..++.||+|++....  ......+..|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A            8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344445567888888 999999999999943   246789999987532  23356788999999999999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                       ..+..++||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEc
Confidence             6677899999999999999997543    3889999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhh-hhhccccc
Q 015797          184 DFGFAKLIPDGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKR-TITDWALP  259 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~-~~~~~~~~  259 (400)
                      |||++...........  ....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||......... .+....  
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--  237 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--  237 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--
Confidence            9999987654433221  22346789999999999999999999999999999999 99999765432111 111100  


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                 .+..    .......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       238 -----------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          238 -----------RMGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -----------CCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       0001    11123467888999999999999999999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.2e-44  Score=337.24  Aligned_cols=250  Identities=27%  Similarity=0.386  Sum_probs=205.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ...+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.+++.++||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            456799999999999999999964 568999999997543 334567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999998642     3889999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCcc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............            ....+.
T Consensus       172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~  238 (303)
T 3a7i_A          172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP------------KNNPPT  238 (303)
T ss_dssp             TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------HSCCCC
T ss_pred             ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh------------cCCCCC
Confidence            322 1233459999999999999999999999999999999999999997654321111000            000011


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +....    ...+.+++.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          239 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             Ccccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11111    2367788899999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=348.36  Aligned_cols=267  Identities=23%  Similarity=0.358  Sum_probs=201.1

Q ss_pred             CCCCcccccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccce
Q 015797           21 KQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLS   98 (400)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~   98 (400)
                      +..+...++..++....++|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+..|+.+++.+ +||||++
T Consensus         7 ~~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~   85 (326)
T 2x7f_A            7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIAT   85 (326)
T ss_dssp             ---------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCC
T ss_pred             CCCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeee
Confidence            344556677788888999999999999999999999965 578999999987543 2345688999999998 8999999


Q ss_pred             eeeEEEe------CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797           99 LRGYCAE------GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus        99 ~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                      +++++..      ....++||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NI  160 (326)
T 2x7f_A           86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV  160 (326)
T ss_dssp             EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGE
T ss_pred             eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHE
Confidence            9999987      5688999999999999999976432  24888999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhh
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNS  247 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~  247 (400)
                      +++.++.+||+|||++........ ......||+.|+|||++.     +..++.++|||||||++|+|+||..||.....
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  239 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP  239 (326)
T ss_dssp             EECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             EEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence            999999999999999986543222 122345999999999997     56789999999999999999999999976543


Q ss_pred             hhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          248 AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .......    +   ....     +......   ....+.+++.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~----~---~~~~-----~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          240 MRALFLI----P---RNPA-----PRLKSKK---WSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHH----H---HSCC-----CCCSCSC---SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHh----h---cCcc-----ccCCccc---cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            2111100    0   0000     0000011   1246778889999999999999999997

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-45  Score=353.91  Aligned_cols=245  Identities=26%  Similarity=0.318  Sum_probs=190.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHH-HhcCCCCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEI-LARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++....   ......+..|..+ ++.++||||+++++++.+.+..|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            457899999999999999999965 458899999997532   2233456667766 56789999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|++||+|||+++.
T Consensus       116 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            9999999999999987533    3888999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+... ...+....        +   
T Consensus       189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------~---  256 (373)
T 2r5t_A          189 NIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------L---  256 (373)
T ss_dssp             GBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------C---
T ss_pred             cccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------c---
Confidence            433221 2334569999999999999999999999999999999999999997654321 11111100        0   


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLE  306 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  306 (400)
                         .+...    ....+.+++.+||+.||.+||++.+
T Consensus       257 ---~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 ---QLKPN----ITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ---CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ---CCCCC----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence               01111    1236777889999999999999753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-44  Score=335.71  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=203.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe---------
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE---------  105 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---------  105 (400)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+....    ..+.+|+.+++.++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4478999999999999999999764 79999999997543    246789999999999999999998864         


Q ss_pred             -------CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797          106 -------GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus       106 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                             ....++||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                   4557999999999999999975432  24889999999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhcccc
Q 015797          179 KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWAL  258 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~  258 (400)
                      .+||+|||++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..|+........ .+..   
T Consensus       160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~---  233 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT-DLRD---  233 (284)
T ss_dssp             EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH-HHHT---
T ss_pred             CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH-Hhhc---
Confidence            999999999987654322  2234599999999999999999999999999999999999999864332111 0000   


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                           ..        +...+    ...+.+++.+||+.||.+|||+.++++.|....
T Consensus       234 -----~~--------~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 -----GI--------ISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -----TC--------CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -----cc--------ccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                 00        11111    235677889999999999999999999987654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5e-45  Score=343.16  Aligned_cols=266  Identities=26%  Similarity=0.347  Sum_probs=199.3

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEc----CCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLW----DGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      ..++....++|.+.+.||+|+||.||+|...    .+..||+|.+...  .......+..|+.+++.++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3445566788999999999999999999643    3457999998753  334456788999999999999999999999


Q ss_pred             EeCCe-----EEEEEEccCCCChhhhhhcCC--CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC
Q 015797          104 AEGQE-----RLIVYDYMPNLSLLSHLHGQH--SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA  176 (400)
Q Consensus       104 ~~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~  176 (400)
                      .+...     .++||||+++|+|.+++....  .....+++..++.++.|++.||.|||+++   ++||||||+||+++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence            87653     499999999999999985322  12235899999999999999999999998   999999999999999


Q ss_pred             CCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhh
Q 015797          177 DFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTI  253 (400)
Q Consensus       177 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~  253 (400)
                      ++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ...
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            999999999999866443221 1223447889999999999999999999999999999999 9999975443211 111


Q ss_pred             hccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          254 TDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ....             ..    .........+.+++.+||+.||.+|||+.++++.|..+.
T Consensus       263 ~~~~-------------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          263 LHGH-------------RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HTTC-------------CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCC-------------CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0000             00    011112346788899999999999999999999997654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-44  Score=343.79  Aligned_cols=270  Identities=23%  Similarity=0.349  Sum_probs=209.5

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhc--CCCCccceeeeEEE
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILAR--VRHKNLLSLRGYCA  104 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~  104 (400)
                      ..+...-....++|++.+.||+|+||.||+|.. +++.||+|++...   ....+..|++++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            444555566778999999999999999999975 6899999998642   34567788888887  79999999999998


Q ss_pred             eCC----eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCe
Q 015797          105 EGQ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH--------HHATPHIIHRDIKASNV  172 (400)
Q Consensus       105 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiH~dikp~NI  172 (400)
                      ...    ..++||||+++|+|.+++...     .+++..++.++.|++.||.|||        +.+   ++||||||+||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI  178 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI  178 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence            876    789999999999999999753     3889999999999999999999        777   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCce---eeeecccccCcCChhhhccC------CCCCccceehhhHHHHHHHhC-----
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATH---VTTRVKGTLGYLAPEYAMLG------KASESCDVYSFGILLLELASG-----  238 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDIwSlGiil~elltg-----  238 (400)
                      |++.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++|||||||++|+|+||     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            9999999999999999876544322   12334699999999999865      334789999999999999999     


Q ss_pred             -----CCChhhhhhhh--hhhhhccccchhcccccccccCccCCCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          239 -----KKPIEKVNSAI--KRTITDWALPLACERKFSELADPRLNGN-FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       239 -----~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                           ..||.......  ......        ........+.+... ........+.+++.+||+.||.+|||+.++++.
T Consensus       259 ~~~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPSVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHH--------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccccccCccccCcCcccHHHHHH--------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 67876432100  000000        00000111111111 123556788899999999999999999999999


Q ss_pred             hcccch
Q 015797          311 LKGESK  316 (400)
Q Consensus       311 L~~~~~  316 (400)
                      |+.+.+
T Consensus       331 L~~i~~  336 (342)
T 1b6c_B          331 LSQLSQ  336 (342)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            987644

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=342.76  Aligned_cols=252  Identities=29%  Similarity=0.495  Sum_probs=194.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||+|+||.||+|.. .++.||+|.+..  ......+..|+.+++.++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            46789999999999999999975 578999999864  3345678899999999999999999998764  478999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh---cCCCCeEecCCCCCCeEECCCCc-EEEEecCCccccC
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH---HATPHIIHRDIKASNVLLDADFK-AQVADFGFAKLIP  192 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~~~~~iiH~dikp~NIlv~~~~~-~kl~Dfgl~~~~~  192 (400)
                      ++|+|.+++..... ...+++..++.++.|++.||.|||+   ++   ++||||||+|||++.++. +||+|||++....
T Consensus        82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999999975432 2247888999999999999999999   56   999999999999998886 7999999997653


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...    ....||+.|+|||++.+..++.++||||||+++|+|+||+.||.............  ..   ...     .+
T Consensus       158 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~---~~~-----~~  223 (307)
T 2eva_A          158 THM----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--VH---NGT-----RP  223 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH--HH---TTC-----CC
T ss_pred             ccc----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH--Hh---cCC-----CC
Confidence            321    22359999999999999999999999999999999999999997543211110000  00   000     00


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .    ........+.+++.+||+.||.+|||+.++++.|..+.
T Consensus       224 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          224 P----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             C----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             C----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            0    11112246778889999999999999999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.9e-44  Score=336.22  Aligned_cols=260  Identities=22%  Similarity=0.317  Sum_probs=203.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEE-EeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC-AEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ...+..|+.+++.++|++++..+..+ .+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            467899999999999999999965 6799999999875432  23588999999999988876666555 6678889999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC---CCCcEEEEecCCccc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD---ADFKAQVADFGFAKL  190 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~---~~~~~kl~Dfgl~~~  190 (400)
                      ||+ +++|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++   .++.+||+|||++..
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 8999999874332   3899999999999999999999998   99999999999994   888999999999987


Q ss_pred             cCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh----hhhhccccch
Q 015797          191 IPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK----RTITDWALPL  260 (400)
Q Consensus       191 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~----~~~~~~~~~~  260 (400)
                      .......      ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........    ..+.....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            6543321      12335699999999999999999999999999999999999999975432100    0000000000


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchh
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE  317 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  317 (400)
                          ....     +.    ......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       238 ----~~~~-----~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          238 ----PIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ----CHHH-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----chHH-----HH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence                0000     00    01124688899999999999999999999999876543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-44  Score=337.48  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=204.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|.+.+.||+|+||.||+|.+. +++.+|+|++...   .......+..|+.+++.++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            4578999999999999999999654 5889999998643   33445678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        93 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            999999999999886532    3889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  270 (400)
                      ...... .....||+.|+|||++.+..++.++||||||+++|+|+||+.||......... .....        ..    
T Consensus       166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------~~----  232 (294)
T 2rku_A          166 EYDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------EY----  232 (294)
T ss_dssp             CSTTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------CC----
T ss_pred             ccCccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--------cC----
Confidence            432221 22345999999999999999999999999999999999999999765432110 00000        00    


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        .....    ....+.+++.+||+.||.+|||+.++++.
T Consensus       233 --~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 --SIPKH----INPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --CCccc----cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              00111    12367788899999999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-44  Score=334.29  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=200.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChH------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNK------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .++|++.+.||+|+||.||+|... +++.||+|.+......      ....+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999654 6899999998753221      256788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC----cEEEEec
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF----KAQVADF  185 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~----~~kl~Df  185 (400)
                      ++||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999986532    3899999999999999999999998   99999999999998877    7999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchhccc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLACER  264 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~  264 (400)
                      |++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||......... .+......     
T Consensus       157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  229 (283)
T 3bhy_A          157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD-----  229 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-----
T ss_pred             ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC-----
Confidence            99987644322  22345999999999999999999999999999999999999999765432111 11000000     


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       .    ..    .........+.+++.+||+.||.+|||+.++++
T Consensus       230 -~----~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          230 -F----DE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -C----CH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -C----cc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence             0    00    000111246788899999999999999999997

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.9e-46  Score=342.05  Aligned_cols=261  Identities=21%  Similarity=0.298  Sum_probs=204.6

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQER  109 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~  109 (400)
                      +..++|++.+.||+|+||.||+|.. .+++.||+|.+...  .......+..|+.+++.++||||+++++++.+  ....
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            3467899999999999999999965 46899999999753  33445678899999999999999999998854  5788


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA--TPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+  ..+++||||||+||+++.++.+||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999998754333345899999999999999999999875  12399999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      +......... .....||+.|+|||++.+..++.++||||||+++|+|+||..||....... ...+...        ..
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------~~  233 (279)
T 2w5a_A          163 ARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--------KF  233 (279)
T ss_dssp             HHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------CC
T ss_pred             heeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc--------cc
Confidence            9876433221 223458999999999999999999999999999999999999997654321 1111110        00


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      .     .+..    .....+.+++.+||+.||.+|||+.+|++.+..
T Consensus       234 ~-----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 R-----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             C-----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             c-----cCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            0     0111    122467888899999999999999999987643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.9e-45  Score=361.86  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=201.3

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ...++|++.+.||+|+||+||+|.. .+++.||+|++...  .......+.+|+.+|+.++||||+++++++.+....|+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            4557899999999999999999965 47999999998642  12234678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC---CCCcEEEEecCCc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD---ADFKAQVADFGFA  188 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~---~~~~~kl~Dfgl~  188 (400)
                      |||||.+|+|.+.+....    .+++..++.++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||++
T Consensus        99 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            999999999999886543    3889999999999999999999998   99999999999995   4567999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ...+.....+.. ...  
T Consensus       172 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~--  245 (486)
T 3mwu_A          172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-LPQ--  245 (486)
T ss_dssp             TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-SGG--
T ss_pred             eECCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-Ccc--
Confidence            86644322  233469999999999875 69999999999999999999999997654321 111111100000 000  


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                 .......+.++|.+||+.||.+|||+.++++.
T Consensus       246 -----------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          246 -----------WRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                       01112467788899999999999999999984

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-44  Score=334.82  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC--ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW--SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+..|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999654 7999999998753  334456788899999998 99999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC--------------
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD--------------  177 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~--------------  177 (400)
                      ||||+++|+|.+++.........+++..++.++.|++.||.|||+++   ++||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999754322235899999999999999999999998   9999999999999844              


Q ss_pred             -----CcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh
Q 015797          178 -----FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR  251 (400)
Q Consensus       178 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~  251 (400)
                           ..+||+|||++........     ..||+.|+|||++.+. .++.++|||||||++|+|++|.+|+......  .
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~  238 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--H  238 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--H
T ss_pred             ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--H
Confidence                 4799999999987654322     2499999999999876 5678999999999999999999876533211  0


Q ss_pred             hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          252 TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+..        ...     +.+...    ....+.+++.+||+.||.+|||+.++++.
T Consensus       239 ~~~~--------~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          239 EIRQ--------GRL-----PRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHT--------TCC-----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHc--------CCC-----CCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1110        000     011111    12467788899999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.8e-44  Score=344.77  Aligned_cols=258  Identities=23%  Similarity=0.356  Sum_probs=205.2

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh----H----HHHHHHHHHHHHhcC-CCCcccee
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN----K----AEMEFAVEVEILARV-RHKNLLSL   99 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~----~----~~~~~~~E~~~l~~l-~hpnIv~~   99 (400)
                      ........++|.+.+.||+|+||.||+|.+. +|+.||||++.....    .    ....+..|+.+++.+ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444566788999999999999999999764 699999999875331    1    134577899999999 89999999


Q ss_pred             eeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      ++++......|+||||+++|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.+|.
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            999999999999999999999999987432    3899999999999999999999998   999999999999999999


Q ss_pred             EEEEecCCccccCCCCceeeeecccccCcCChhhhcc------CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hh
Q 015797          180 AQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML------GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RT  252 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~  252 (400)
                      +||+|||++..+.....  .....||+.|+|||++.+      ..++.++|||||||++|+|+||..||........ ..
T Consensus       239 ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  316 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM  316 (365)
T ss_dssp             EEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99999999987654322  233569999999999874      3588999999999999999999999975432211 11


Q ss_pred             hhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          253 ITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +........ ...+             ......+.+++.+||+.||.+|||+.++++.
T Consensus       317 i~~~~~~~~-~~~~-------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          317 IMEGQYQFS-SPEW-------------DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHTCCCCC-HHHH-------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhCCCCCC-Cccc-------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            110000000 0000             0012467788999999999999999999973

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.7e-44  Score=349.85  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=189.7

Q ss_pred             HccCCCcC-CcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHh-cCCCCccceeeeEEEe----CCe
Q 015797           36 ATNNFNYD-NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILA-RVRHKNLLSLRGYCAE----GQE  108 (400)
Q Consensus        36 ~~~~y~~~-~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~----~~~  108 (400)
                      ..++|.+. +.||+|+||.||+|.+ .+++.||+|++...     ..+..|+.++. .++||||+++++++..    ...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            34567766 6899999999999965 46899999998632     34667888774 5589999999999876    567


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEEec
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADF  185 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~Df  185 (400)
                      .|+|||||++|+|.+++.....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.   ++.+||+||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence            8999999999999999976432  24899999999999999999999998   999999999999997   788999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-----hhhhhccccch
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-----KRTITDWALPL  260 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-----~~~~~~~~~~~  260 (400)
                      |++.......  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     ...+..     
T Consensus       209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-----  281 (400)
T 1nxk_A          209 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----  281 (400)
T ss_dssp             TTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-----
T ss_pred             ccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-----
Confidence            9998654322  1234568999999999999999999999999999999999999997543210     000000     


Q ss_pred             hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ..+. +..+     ........+.++|.+||+.||.+|||+.++++.
T Consensus       282 ---~~~~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 ---GQYE-FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ---TCCC-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---Cccc-CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               0000 0000     001123467888999999999999999999984

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-45  Score=341.45  Aligned_cols=252  Identities=28%  Similarity=0.405  Sum_probs=197.6

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-CeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-QERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~  113 (400)
                      ...++|++.+.||+|+||.||+|.. .++.||+|.+....  ....+..|+.+++.++||||+++++++.+. +..++||
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            3457899999999999999999975 58899999987533  446788999999999999999999997654 4789999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            99999999999865322  23788999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccC
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ..    ....+++.|+|||++.+..++.++||||||+++|+|+| |..||........ ..+...             ..
T Consensus       170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-------------~~  232 (278)
T 1byg_A          170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------------YK  232 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------CC
T ss_pred             cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------CC
Confidence            21    12347899999999999999999999999999999998 9999975432111 111000             00


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ...    .......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       233 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          233 MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            011    1112346788889999999999999999999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-44  Score=339.65  Aligned_cols=250  Identities=21%  Similarity=0.353  Sum_probs=201.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            457899999999999999999965 4799999999986554455678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---CCCCcEEEEecCCcccc
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKLI  191 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv---~~~~~~kl~Dfgl~~~~  191 (400)
                      |+++|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999999986533    3889999999999999999999998   9999999999999   78899999999999754


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELA  270 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+.....+         . 
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------~-  226 (304)
T 2jam_A          160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE---------F-  226 (304)
T ss_dssp             CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------C-
T ss_pred             CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------C-
Confidence            3321   223459999999999999999999999999999999999999997644221 1111110000         0 


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..    .........+.+++.+||+.||.+|||+.++++
T Consensus       227 ~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 ES----PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CT----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00    011112346788899999999999999999996

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.1e-45  Score=339.66  Aligned_cols=261  Identities=28%  Similarity=0.407  Sum_probs=202.6

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEE-eC
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCA-EG  106 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~  106 (400)
                      +.....+|++.+.||+|+||.||+|....    ...+|+|.+.... ......+..|+.+++.++||||+++++++. .+
T Consensus        20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            34456778999999999999999996432    2358899887533 344567889999999999999999999864 55


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      +..++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             CceEEEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence            678999999999999999975432   3788999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCce---eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchh
Q 015797          187 FAKLIPDGATH---VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLA  261 (400)
Q Consensus       187 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~  261 (400)
                      ++.........   ......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||........ .......    
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~----  249 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----  249 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC----
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC----
Confidence            99866443221   1223457889999999999999999999999999999999 6666654432111 0000000    


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                               ..... ..   ....+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       250 ---------~~~~~-~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          250 ---------RLLQP-EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ---------CCCCC-TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCC-cc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                     00000 11   12367888899999999999999999999976543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-44  Score=360.85  Aligned_cols=252  Identities=22%  Similarity=0.354  Sum_probs=197.9

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ...++|++.+.||+|+||.||+|.. .++..||+|++....  ......+.+|+.+++.++||||+++++++.+....|+
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456799999999999999999965 468999999987532  2234568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC---CcEEEEecCCc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD---FKAQVADFGFA  188 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~---~~~kl~Dfgl~  188 (400)
                      |||||++|+|.+.+....    .+++..++.++.|++.||.|||+++   |+||||||+|||++..   +.+||+|||++
T Consensus       114 v~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            999999999999886543    3889999999999999999999998   9999999999999764   55999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFS  267 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  267 (400)
                      ........  .....||+.|+|||++. +.++.++|||||||++|+|++|..||....... ...+.....+.       
T Consensus       187 ~~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------  256 (494)
T 3lij_A          187 AVFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF-------  256 (494)
T ss_dssp             EECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred             eECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence            87654322  23356999999999886 579999999999999999999999997654321 11111100000       


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ..+.     .......+.+++.+||+.||.+|||+.++++.
T Consensus       257 --~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 --DSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             --CSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --Cchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence              0000     01112467788899999999999999999963

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-44  Score=335.91  Aligned_cols=245  Identities=24%  Similarity=0.373  Sum_probs=201.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            468999999999999999999654 578899999864321   1235688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999987543    3889999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ...   .....|++.|+|||++.+..++.++||||||+++|+|++|..||........ ..+....              
T Consensus       166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------  228 (284)
T 2vgo_A          166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--------------  228 (284)
T ss_dssp             SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------------
T ss_pred             ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--------------
Confidence            322   2234599999999999999999999999999999999999999975443211 1111000              


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .....    .....+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 LKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            00111    11246778889999999999999999996

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-44  Score=344.08  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=204.3

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ...++|.+.+.||+|+||.||++.+ .+++.+|+|++...   .......+..|+.+++.++||||+++++++.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            3457899999999999999999965 45889999998743   3344567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+.+++|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++..
T Consensus       118 lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  190 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK  190 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence            9999999999999886532    3889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  269 (400)
                      ....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ..+...        ..   
T Consensus       191 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------~~---  258 (335)
T 2owb_A          191 VEYDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------EY---  258 (335)
T ss_dssp             CCSTTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------CC---
T ss_pred             cccCccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--------CC---
Confidence            6432221 2334599999999999999999999999999999999999999975432211 001000        00   


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         .+....    ...+.+++.+||+.||.+|||+.++++
T Consensus       259 ---~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 ---SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               001111    235777889999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=337.90  Aligned_cols=256  Identities=24%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             CCCcCCcccccCceEEEEEEEc-CCC---EEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE-EEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQLW-DGS---QIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER-LIV  112 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~~-~~~---~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-~lv  112 (400)
                      .|.+.+.||+|+||.||+|.+. ++.   .+|+|.+..... .....+..|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999643 333   689999875433 4456788999999999999999999999876665 999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+.+|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999975332   3788999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCc---eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCC-hhhhhhhhhhhhhccccchhccccccc
Q 015797          193 DGAT---HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP-IEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       193 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      ....   .......+|+.|+|||.+.+..++.++|||||||++|+|+||..| |...............           
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----------  244 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-----------  244 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-----------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-----------
Confidence            3221   112234588999999999999999999999999999999995555 4433221111100000           


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                       ......    ......+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       245 -~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          245 -RRLPQP----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             -CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCC----ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             000000    1112467888999999999999999999999976644

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=372.72  Aligned_cols=255  Identities=25%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             cCCCcCC-cccccCceEEEEEEEc---CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDN-KLGEGGFGSVYWGQLW---DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~-~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +++.+.+ .||+|+||.||+|...   ++..||||+++... ......+.+|+++|+.++||||+++++++.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999653   45679999997543 3345679999999999999999999999976 568999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||.+|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       414 ~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EECCTTCBHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEeCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999999965432   4899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCceee--eecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhccccccc
Q 015797          193 DGATHVT--TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSE  268 (400)
Q Consensus       193 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  268 (400)
                      .......  ....+|+.|+|||++.++.++.++|||||||++|||+| |+.||....... ...+....           
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-----------  556 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-----------  556 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-----------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            3322111  12236789999999999999999999999999999998 999997654321 11111100           


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                        ...    ........+.++|.+||+.||.+||++.+|++.|+....
T Consensus       557 --~~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          557 --RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             --CCC----CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              000    111123478889999999999999999999999976543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.4e-44  Score=359.49  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-------------HHHHHHHHHHHHHhcCCCCcccee
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-------------KAEMEFAVEVEILARVRHKNLLSL   99 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~   99 (400)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++.....             .....+..|+.+|+.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            45678999999999999999999965 4688999999875321             223568899999999999999999


Q ss_pred             eeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-
Q 015797          100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-  178 (400)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-  178 (400)
                      ++++.+....|+|||||++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++ 
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS  184 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence            999999999999999999999999886543    3899999999999999999999998   99999999999998776 


Q ss_pred             --cEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhc
Q 015797          179 --KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITD  255 (400)
Q Consensus       179 --~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~  255 (400)
                        .+||+|||++........  .....||+.|+|||++. +.++.++|||||||++|+|++|..||....... ...+..
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence              699999999987654322  23346999999999987 569999999999999999999999997654321 111111


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...... ...+             ......+.+++.+||+.||.+|||+.++++.
T Consensus       262 ~~~~~~-~~~~-------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          262 GKYYFD-FNDW-------------KNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCCC-HHHH-------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCC-cccc-------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000000 0000             0112467888999999999999999999973

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-45  Score=349.27  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=198.0

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++.....    ....|++++..+ +||||+++++++.++...|+|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3467899999999999999999965 4688999999975432    244678888877 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC----CcEEEEecCCc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD----FKAQVADFGFA  188 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~----~~~kl~Dfgl~  188 (400)
                      ||||++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||+..+    +.+||+|||++
T Consensus        95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            99999999999987543    3899999999999999999999998   9999999999998543    35999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh----hhhhhhccccchhccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA----IKRTITDWALPLACER  264 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~----~~~~~~~~~~~~~~~~  264 (400)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||......    ....+...        
T Consensus       168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--------  238 (342)
T 2qr7_A          168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------  238 (342)
T ss_dssp             EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--------
T ss_pred             ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--------
Confidence            87654332 223456999999999999888999999999999999999999999753211    11111100        


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+.      ............+.+++.+||+.||.+|||+.++++.
T Consensus       239 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          239 KFS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             Ccc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000      0000111123467788899999999999999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.4e-45  Score=350.47  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=202.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++... .......+..|+.+++.++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            478999999999999999999654 6899999998764 34445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||++.....
T Consensus       112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999997543    388899999999999999999985 7   99999999999999999999999999875432


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccc-----cchhc-----c
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWA-----LPLAC-----E  263 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~-----~  263 (400)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...............     .+...     .
T Consensus       185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1   122346999999999999999999999999999999999999999754432111100000     00000     0


Q ss_pred             -----------------cccc---cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 -----------------RKFS---ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 -----------------~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                       ....   ....+....   ......+.+++.+||+.||.+|||+.++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCT---TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCc---ccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                             0000   000000010   1123467888999999999999999999973

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.8e-45  Score=345.70  Aligned_cols=267  Identities=24%  Similarity=0.344  Sum_probs=199.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++....  ......+..|+.+++.++||||+++++++.+.+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            3457899999999999999999965 458999999986533  2334567889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       102 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            999999988888765332    3889999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh--hhh--ccccch-----h
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TIT--DWALPL-----A  261 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~--~~~--~~~~~~-----~  261 (400)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........  ...  ....+.     .
T Consensus       175 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          175 AAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            43222 22234599999999999875 7899999999999999999999999754422110  000  000000     0


Q ss_pred             cccccccccCccCCCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          262 CERKFSELADPRLNGNF-----VEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..........+......     .+.....+.+++.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000111111111000     1122457888999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.4e-44  Score=334.93  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=197.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe----CCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE----GQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~  109 (400)
                      ...|++.+.||+|+||.||+|.+ .++..||+|.+...  .......+..|+.+++.++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            34578889999999999999965 56889999998743  34455678899999999999999999999865    4568


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-CCCcEEEEecCCc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-ADFKAQVADFGFA  188 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-~~~~~kl~Dfgl~  188 (400)
                      ++||||+++|+|.+++....    .+++..++.++.|++.||.|||+.+ ++++||||||+|||++ .++.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            99999999999999997532    3888999999999999999999875 3499999999999998 7899999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchhccccc
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLACERKF  266 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~  266 (400)
                      .......   .....||+.|+|||++. +.++.++|||||||++|+|++|+.||........  ........+.    . 
T Consensus       180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~-  250 (290)
T 1t4h_A          180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----S-  250 (290)
T ss_dssp             GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----G-
T ss_pred             ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc----c-
Confidence            7654332   22345999999999886 5699999999999999999999999975432111  1111100000    0 


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                                 ........+.+++.+||+.||.+|||+.++++
T Consensus       251 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 -----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                       00111236788899999999999999999996

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=348.93  Aligned_cols=269  Identities=23%  Similarity=0.306  Sum_probs=195.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHH--HHHHhcCCCCccceeeeEEEe-----CCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVE--VEILARVRHKNLLSLRGYCAE-----GQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E--~~~l~~l~hpnIv~~~~~~~~-----~~~  108 (400)
                      ..++|++.+.||+|+||.||+|.. +++.||+|++....   ...+..|  +..+..++||||+++++.+..     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            457899999999999999999964 78999999987433   2233344  444556899999999986532     336


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCCeEECCCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH---------ATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      .++|||||++|+|.+++....     .++..++.++.|++.||.|||+.         +   |+||||||+|||++.++.
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred             EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence            789999999999999996543     57888999999999999999998         7   999999999999999999


Q ss_pred             EEEEecCCccccCCCCc-------eeeeecccccCcCChhhhcc-------CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          180 AQVADFGFAKLIPDGAT-------HVTTRVKGTLGYLAPEYAML-------GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      +||+|||++........       .......||+.|+|||++.+       ..++.++|||||||++|+|+||..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999999987643221       11223469999999999986       45678999999999999999998887543


Q ss_pred             hhhhhh--hhh--ccccchhc---ccccccccCccCCC--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          246 NSAIKR--TIT--DWALPLAC---ERKFSELADPRLNG--NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       246 ~~~~~~--~~~--~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ......  ...  ....+...   .........+.+..  .........+.++|.+||+.||.+|||+.++++.|..+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            211000  000  00000000   00000000111111  1122355678899999999999999999999999876643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=334.95  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=197.9

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      +|.....||+|+||.||+|.+ .+++.||+|.+..........+..|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            445556999999999999965 5688999999987666666779999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEecCCccccCCCCc
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      +++|.+++..... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++. ++.+||+|||++........
T Consensus       103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999875432 224678889999999999999999998   999999999999987 89999999999987643222


Q ss_pred             eeeeecccccCcCChhhhccCC--CCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~--~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                       ......||+.|+|||++.++.  ++.++||||||+++|+|++|+.||...............     .     ...+.+
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~-----~~~~~~  247 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-----F-----KVHPEI  247 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-----H-----CCCCCC
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-----c-----cccccc
Confidence             122345999999999998654  889999999999999999999999754322111100000     0     000111


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..    .....+.+++.+||+.||.+|||+.++++
T Consensus       248 ~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 PE----SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11    12246778889999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=346.05  Aligned_cols=270  Identities=21%  Similarity=0.275  Sum_probs=196.1

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH-----HHHHHHHHHHHhcCCCCccceeeeEEEeC
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA-----EMEFAVEVEILARVRHKNLLSLRGYCAEG  106 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  106 (400)
                      +....++|++.+.||+|+||.||+|.+ .+++.||+|++.......     ...+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            345678999999999999999999965 458999999987432211     23577899999999999999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      +..++||||+.+ +|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             CceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999999985 8988886543   24888999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccch--h
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPL--A  261 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~--~  261 (400)
                      ++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.......  ...+.....+.  .
T Consensus       158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence            9987643322 22334689999999999764 58999999999999999999999997654221  11111100000  0


Q ss_pred             ccc--ccccccCccCCCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CER--KFSELADPRLNGNF-----VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~~--~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +..  ..............     .......+.+++.+||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000  00000000000000     01123578889999999999999999999974

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-45  Score=347.65  Aligned_cols=264  Identities=15%  Similarity=0.166  Sum_probs=202.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc---------CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccce---------
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW---------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLS---------   98 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~---------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~---------   98 (400)
                      .++|++.+.||+|+||.||+|...         .++.||+|++...     ..+..|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            479999999999999999999754         3789999998753     35788999999999999988         


Q ss_pred             ------eeeEEEe-CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797           99 ------LRGYCAE-GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus        99 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                            +++++.. +...++||||+ +|+|.+++....  ...+++..++.++.|++.||.|||+++   ++||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence                  6777776 78889999999 999999997642  234899999999999999999999998   9999999999


Q ss_pred             eEECCCC--cEEEEecCCccccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChh
Q 015797          172 VLLDADF--KAQVADFGFAKLIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE  243 (400)
Q Consensus       172 Ilv~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~  243 (400)
                      ||++.++  .+||+|||++.........      ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999865432211      1123469999999999999999999999999999999999999998


Q ss_pred             hhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchh
Q 015797          244 KVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE  317 (400)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  317 (400)
                      .............. .  .......+.......   ......+.+++.+||+.||.+|||+.+|++.|..+...
T Consensus       270 ~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          270 NCLPNTEDIMKQKQ-K--FVDKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             GGTTCHHHHHHHHH-H--HHHSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCcCHHHHHHHHH-h--ccCChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            65321111100000 0  000011111111000   01124678888999999999999999999999876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-44  Score=364.19  Aligned_cols=255  Identities=27%  Similarity=0.337  Sum_probs=205.4

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ...++|++.+.||+|+||.||+|.. .+|+.||+|++....   ......+..|+.+|+.++||||+++++++.+.+..|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            3457899999999999999999965 479999999996422   222356788999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||++||+|.+++.....  ..+++..++.++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||++..
T Consensus       261 lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence            99999999999999875432  23899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  269 (400)
                      ......  ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..+....         .. 
T Consensus       336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i---------~~-  403 (576)
T 2acx_A          336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---------KE-  403 (576)
T ss_dssp             CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH---------HH-
T ss_pred             cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh---------hc-
Confidence            654332  2334699999999999999999999999999999999999999976432100 0000000         00 


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL  310 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~  310 (400)
                      ......    ......+.++|.+||+.||.+||     ++.++++.
T Consensus       404 ~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 VPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            000011    11224677888999999999999     78999873

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=351.77  Aligned_cols=256  Identities=29%  Similarity=0.401  Sum_probs=192.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe-CCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE-GQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~l  111 (400)
                      ..|.+.+.||+|+||.||+|....    +..||+|.+... .......+..|+.+++.++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            356778899999999999996432    235889988643 33455679999999999999999999998754 567899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus       169 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999975432   3788999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCce---eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          192 PDGATH---VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       192 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      ......   ......+|+.|+|||++.+..++.++|||||||++|+|+| |.+||....... ...+....         
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~---------  313 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---------  313 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC---------
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC---------
Confidence            432211   1122347889999999999999999999999999999999 777886543211 00110000         


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                          ..... .   .....+.++|.+||+.||.+|||+.++++.|..+..
T Consensus       314 ----~~~~p-~---~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 ----RLLQP-E---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ----CCCCC-T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCC-C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                00000 1   112467788899999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-44  Score=361.93  Aligned_cols=251  Identities=25%  Similarity=0.306  Sum_probs=204.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|.+.+.||+|+||.||+|+. .+|+.||+|++.....   .....+..|+.+|+.++||||+++++++.+....|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            47899999999999999999976 4699999999974321   2235688899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||++||+|.+++.........+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999998765433445899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-----hhhhhhccccchhcccccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-----IKRTITDWALPLACERKFS  267 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~  267 (400)
                      ..... ....+||+.|+|||++.+..++.++|||||||++|+|+||+.||......     ....+...        .  
T Consensus       341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--------~--  409 (543)
T 3c4z_A          341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--------A--  409 (543)
T ss_dssp             TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--------C--
T ss_pred             CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--------c--
Confidence            43322 23346999999999999999999999999999999999999999754311     11111000        0  


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM-----LEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~  309 (400)
                          ....    ......+.+++.+||+.||.+||++     .++++
T Consensus       410 ----~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 ----VTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ----CCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ----cCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                0011    1122467778899999999999964     67775

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-44  Score=361.40  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=203.7

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3457899999999999999999965 479999999986432   334567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---CCCCcEEEEecCC
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGF  187 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv---~~~~~~kl~Dfgl  187 (400)
                      +|||||.+|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            9999999999999987543    3889999999999999999999998   9999999999999   5678999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      +........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ...+........ ..  
T Consensus       176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~--  249 (484)
T 3nyv_A          176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-LP--  249 (484)
T ss_dssp             HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-SG--
T ss_pred             eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-Cc--
Confidence            987654332  233469999999999875 79999999999999999999999997654321 111111000000 00  


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                 ........+.+++.+||+.||.+|||+.++++.
T Consensus       250 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          250 -----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                       001122467788899999999999999999973

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=338.37  Aligned_cols=253  Identities=27%  Similarity=0.356  Sum_probs=198.2

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ....++|++.+.||+|+||.||+|... +++.||+|.+....  ....+..|+.+++.++||||+++++++.+.+..++|
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            345678999999999999999999654 58999999987533  235688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             eecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999986332   24889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||................    ...+   .  
T Consensus       177 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~---~--  246 (314)
T 3com_A          177 DTMAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP----PPTF---R--  246 (314)
T ss_dssp             TTBSC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----CCCC---S--
T ss_pred             hhccc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC----Cccc---C--
Confidence            43222 223458999999999999999999999999999999999999997654321111000000    0000   0  


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                           ........+.+++.+||+.||.+|||+.++++
T Consensus       247 -----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 -----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 01111246788899999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.9e-44  Score=341.68  Aligned_cols=259  Identities=21%  Similarity=0.305  Sum_probs=203.7

Q ss_pred             HHHHHHccCCCcC-CcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEe
Q 015797           31 KELHSATNNFNYD-NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAE  105 (400)
Q Consensus        31 ~~~~~~~~~y~~~-~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  105 (400)
                      .......++|.+. +.||+|+||.||+|.. .+++.||+|++...  .......+..|+.++..+ +||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3446667889888 8999999999999965 46999999998743  233356788999999998 56999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEE
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQV  182 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl  182 (400)
                      .+..++||||+.+|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+|||++.   ++.+||
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence            9999999999999999999864322  24899999999999999999999998   999999999999998   789999


Q ss_pred             EecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhccccchh
Q 015797          183 ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITDWALPLA  261 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~  261 (400)
                      +|||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+......  
T Consensus       176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--  251 (327)
T 3lm5_A          176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD--  251 (327)
T ss_dssp             CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--
T ss_pred             eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc--
Confidence            99999987643322  22346999999999999999999999999999999999999999765432111 11100000  


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                  ............+.+++.+||+.||.+|||+.++++.
T Consensus       252 ------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          252 ------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                        0000111123467788999999999999999999863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-44  Score=346.52  Aligned_cols=286  Identities=20%  Similarity=0.274  Sum_probs=206.9

Q ss_pred             cccCCCCCCcccccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCC
Q 015797           16 KEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRH   93 (400)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h   93 (400)
                      +.+..+....+.....++....++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.++|
T Consensus         5 ~~~~~~~~~~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h   84 (364)
T 3qyz_A            5 HHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH   84 (364)
T ss_dssp             ----------CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC
T ss_pred             hHHHHHhhcceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCC
Confidence            34455555666666667777788999999999999999999965 468899999997533 3334678899999999999


Q ss_pred             CccceeeeEEEeC-----CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 015797           94 KNLLSLRGYCAEG-----QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIK  168 (400)
Q Consensus        94 pnIv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dik  168 (400)
                      |||+++++++...     ...|+||||+. |+|.+++...     .+++..++.++.|++.||.|||+++   |+|||||
T Consensus        85 ~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  155 (364)
T 3qyz_A           85 ENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLK  155 (364)
T ss_dssp             TTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             CCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence            9999999999765     46899999997 5999988653     2888999999999999999999998   9999999


Q ss_pred             CCCeEECCCCcEEEEecCCccccCCCCcee--eeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          169 ASNVLLDADFKAQVADFGFAKLIPDGATHV--TTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       169 p~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      |+|||++.++.+||+|||++..........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       156 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999999999998764322211  233469999999998765 45899999999999999999999999754


Q ss_pred             hhhhh-hhhhcc-ccchh--c--------ccccccccCccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          246 NSAIK-RTITDW-ALPLA--C--------ERKFSELADPRLN--GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       246 ~~~~~-~~~~~~-~~~~~--~--------~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..... ..+... ..|..  .        .............  ....+.....+.+++.+||+.||.+|||+.++++.
T Consensus       236 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            32110 000000 00000  0        0000000000000  00001123467889999999999999999999973

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-45  Score=354.83  Aligned_cols=243  Identities=15%  Similarity=0.142  Sum_probs=189.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEec---CChHHHHHHHHHH---HHHhcCCCCccceee-------eE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKV---WSNKAEMEFAVEV---EILARVRHKNLLSLR-------GY  102 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~hpnIv~~~-------~~  102 (400)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++..   ........+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            57899999999999999999975 5699999999973   3344556788999   555566899999998       66


Q ss_pred             EEeCC-----------------eEEEEEEccCCCChhhhhhcCCC---cccccChHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015797          103 CAEGQ-----------------ERLIVYDYMPNLSLLSHLHGQHS---SECLLNWNRRMDIAIGSAEGIVYLHHHATPHI  162 (400)
Q Consensus       103 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  162 (400)
                      +.+.+                 ..|+||||+ +|+|.+++.....   ....+++..++.++.|++.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            66554                 278999999 6899999875321   1123445888899999999999999998   9


Q ss_pred             EecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC-----------CCCCccceehhhHH
Q 015797          163 IHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-----------KASESCDVYSFGIL  231 (400)
Q Consensus       163 iH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDIwSlGii  231 (400)
                      +||||||+|||++.++.+||+|||++.....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986332    2334557 999999999987           89999999999999


Q ss_pred             HHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          232 LLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       232 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +|+|+||+.||........               ...+....  ...    ...+.++|.+||+.||.+|||+.++++
T Consensus       303 l~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG---------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CC---------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccc---------------hhhhhhhc--cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999975432110               00000000  011    246778889999999999999999996

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.3e-45  Score=349.57  Aligned_cols=277  Identities=19%  Similarity=0.223  Sum_probs=202.7

Q ss_pred             cccccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCC-----------hHHHHHHHHHHHHHhcCCC
Q 015797           25 WRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS-----------NKAEMEFAVEVEILARVRH   93 (400)
Q Consensus        25 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~h   93 (400)
                      ..+..++++....++|++.+.||+|+||.||+|.+..+..||+|++....           ......+.+|+.+++.++|
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   88 (362)
T 3pg1_A            9 AMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH   88 (362)
T ss_dssp             HHHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC
Confidence            34566788999999999999999999999999987789999999985422           1223678899999999999


Q ss_pred             CccceeeeEEEe-----CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 015797           94 KNLLSLRGYCAE-----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIK  168 (400)
Q Consensus        94 pnIv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dik  168 (400)
                      |||+++++++..     ....|+||||+. |+|.+.+.....   .+++..++.++.|++.||.|||+++   ++|||||
T Consensus        89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  161 (362)
T 3pg1_A           89 PNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI---VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH  161 (362)
T ss_dssp             TTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred             cCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence            999999999854     346899999998 689888875432   4899999999999999999999998   9999999


Q ss_pred             CCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhh
Q 015797          169 ASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNS  247 (400)
Q Consensus       169 p~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~  247 (400)
                      |+|||++.++.+||+|||++........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             hHHEEEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999975433222  233468999999999987 6789999999999999999999999975432


Q ss_pred             hhh-hhhhc-cccchh------cccc----cccccCccCCC---CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          248 AIK-RTITD-WALPLA------CERK----FSELADPRLNG---NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       248 ~~~-~~~~~-~~~~~~------~~~~----~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ... ..+.. ...+..      ....    +..........   ...+.....+.+++.+||+.||.+|||+.++++.
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            110 00000 000000      0000    00000000000   0011123467889999999999999999999973

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8e-45  Score=337.87  Aligned_cols=257  Identities=28%  Similarity=0.404  Sum_probs=196.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc--CCC--EEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW--DGS--QIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|++.+.||+|+||.||+|.+.  ++.  .||+|++...   .......+..|+.+++.++||||+++++++.+.. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            3478999999999999999999642  333  6899988643   2334567889999999999999999999998765 


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence            889999999999999987542   24889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhccc
Q 015797          189 KLIPDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACER  264 (400)
Q Consensus       189 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~  264 (400)
                      ..........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ..+.....      
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------  242 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE------  242 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC------
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC------
Confidence            8765433221  223457889999999999999999999999999999999 9999976543211 11100000      


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                            ...    ........+.+++.+||+.||.+|||+.++++.|....
T Consensus       243 ------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 ------RLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ------CCC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                  000    01112346788899999999999999999999987654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-45  Score=349.79  Aligned_cols=255  Identities=24%  Similarity=0.311  Sum_probs=200.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecCC----hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS----NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  106 (400)
                      ..++|++.+.||+|+||.||+|..    .+++.||+|++....    ......+..|+++++.+ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            347899999999999999999976    378999999986421    12234567799999999 799999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      +..++||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             ceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence            99999999999999999997543    3889999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACE  263 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~  263 (400)
                      ++...............||+.|+|||++.+  ..++.++|||||||++|+|+||+.||........ ..+.....     
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----  279 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-----  279 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-----
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-----
Confidence            998664433333334569999999999986  3478999999999999999999999964321100 00000000     


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHh
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDLL  311 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~L  311 (400)
                          . ..+..    .......+.+++.+||+.||.+||     |+.++++..
T Consensus       280 ----~-~~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          280 ----K-SEPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ----H-CCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ----c-cCCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                0 00001    111224677888999999999999     999999753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=343.87  Aligned_cols=257  Identities=16%  Similarity=0.107  Sum_probs=202.2

Q ss_pred             HHHHHccCCCcCCcccccCceEEEEE------EEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC---CCccceeeeE
Q 015797           32 ELHSATNNFNYDNKLGEGGFGSVYWG------QLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR---HKNLLSLRGY  102 (400)
Q Consensus        32 ~~~~~~~~y~~~~~LG~G~~g~Vy~a------~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~  102 (400)
                      ++....++|.+.+.||+|+||.||+|      ....++.||+|++....   ...+..|++++..++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            34455688999999999999999999      34568999999987543   345677777777776   9999999999


Q ss_pred             EEeCCeEEEEEEccCCCChhhhhhcCCC-cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-----
Q 015797          103 CAEGQERLIVYDYMPNLSLLSHLHGQHS-SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-----  176 (400)
Q Consensus       103 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-----  176 (400)
                      +...+..|+|||||++|+|.+++..... ....+++..++.++.|++.||.|||+++   |+||||||+||||+.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence            9999999999999999999999964211 2234999999999999999999999998   999999999999998     


Q ss_pred             ------CCcEEEEecCCccccCC-CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh
Q 015797          177 ------DFKAQVADFGFAKLIPD-GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI  249 (400)
Q Consensus       177 ------~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~  249 (400)
                            ++.+||+|||++..+.. ..........||+.|+|||++.+..++.++|||||||++|+|+||+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976432 22233344679999999999999999999999999999999999999986433210


Q ss_pred             hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHhcccc
Q 015797          250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKR-PTMLEVLDLLKGES  315 (400)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~ell~~L~~~~  315 (400)
                            +        ......    ......   ..+..++..|++.+|.+| |++.++.+.|....
T Consensus       293 ------~--------~~~~~~----~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          293 ------C--------KPEGLF----RRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             ------E--------EECSCC----TTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             ------e--------eechhc----cccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence                  0        000111    111122   345567789999999999 67888887776554

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-44  Score=352.20  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=190.8

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--------HHHHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--------KAEMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      ...++|.+.+.||+|+||.||+|.. .+++.||+|++.....        .....+..|+.+|+.++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4568999999999999999999954 5689999999874321        11224788999999999999999999975 


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC---cEEE
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF---KAQV  182 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~---~~kl  182 (400)
                      .+..++||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++   .+||
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence            456899999999999999886543    3899999999999999999999998   99999999999997544   5999


Q ss_pred             EecCCccccCCCCceeeeecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccc
Q 015797          183 ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWA  257 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~  257 (400)
                      +|||++.......  ......||+.|+|||++.+   ..++.++|||||||++|+|+||..||......  ....+....
T Consensus       284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            9999998764322  2334569999999999863   67889999999999999999999999753321  111111000


Q ss_pred             cchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          258 LPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+     ....         ........+.+++.+||+.||.+|||+.++++.
T Consensus       362 ~~-----~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          362 YN-----FIPE---------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             CC-----CCHH---------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CC-----CCch---------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00     0000         000123467889999999999999999999974

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=346.66  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=193.2

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEE-
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCA-  104 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~-  104 (400)
                      +.-+.+.....+|++.+.||+|+||.||+|.+ .+++.||+|++..........+..|+.++..+. ||||+++++++. 
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            33444555667999999999999999999965 478999999997776666778899999999996 999999999984 


Q ss_pred             -------eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC
Q 015797          105 -------EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD  177 (400)
Q Consensus       105 -------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~  177 (400)
                             .....++||||+. |+|.+++..... ...+++..++.++.|++.||.|||+.+ ++++||||||+|||++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTT
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCC
Confidence                   3455799999996 799998864211 224899999999999999999999875 349999999999999999


Q ss_pred             CcEEEEecCCccccCCCCcee-----------eeecccccCcCChhhh---ccCCCCCccceehhhHHHHHHHhCCCChh
Q 015797          178 FKAQVADFGFAKLIPDGATHV-----------TTRVKGTLGYLAPEYA---MLGKASESCDVYSFGILLLELASGKKPIE  243 (400)
Q Consensus       178 ~~~kl~Dfgl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~ksDIwSlGiil~elltg~~Pf~  243 (400)
                      +.+||+|||++..........           .....||+.|+|||++   .+..++.++|||||||++|+|+||..||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999998765432211           1134589999999998   56778999999999999999999999997


Q ss_pred             hhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          244 KVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      ......  .. .        .....    ......    ...+.+++.+||+.||.+|||+.++++.|.....
T Consensus       255 ~~~~~~--~~-~--------~~~~~----~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          255 DGAKLR--IV-N--------GKYSI----PPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------------------CCC----CTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHH--hh-c--------CcccC----Cccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            543210  00 0        00000    000001    1246678899999999999999999999976644

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.9e-45  Score=344.11  Aligned_cols=261  Identities=28%  Similarity=0.375  Sum_probs=203.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|++.+.||+|+||.||+|..      .++..||+|.+... .......+..|+.+++.++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            457899999999999999999963      35778999998743 34455678899999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCc---ccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEE
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSS---ECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQV  182 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl  182 (400)
                      .++||||+++|+|.+++......   ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999765321   134888999999999999999999998   999999999999984   446999


Q ss_pred             EecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccc
Q 015797          183 ADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALP  259 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~  259 (400)
                      +|||++........ .......||+.|+|||++.+..++.++|||||||++|+|+| |..||........ ..+..... 
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-  263 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-  263 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC-
Confidence            99999975533221 12223458899999999999999999999999999999998 9999976543211 11111000 


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                  ....    ......+.+++.+||+.||.+|||+.++++.|.....
T Consensus       264 ------------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          264 ------------MDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             ------------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                        0001    1112467788999999999999999999999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.5e-44  Score=344.06  Aligned_cols=267  Identities=20%  Similarity=0.284  Sum_probs=199.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--HHHHHHHHHHHHHhcCCCCccceeeeEEEe--------
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--KAEMEFAVEVEILARVRHKNLLSLRGYCAE--------  105 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------  105 (400)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....  .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            47899999999999999999976 5789999999864332  223467889999999999999999999987        


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      .+..++||||+. |+|.+.+.....   .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence            456899999997 488887765433   3899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCc---eeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhc---cc
Q 015797          186 GFAKLIPDGAT---HVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITD---WA  257 (400)
Q Consensus       186 gl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~---~~  257 (400)
                      |++........   .......||+.|+|||++.+ ..++.++|||||||++|+|+||..||.......... +..   ..
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99987643221   12233468999999999976 458999999999999999999999997654321111 100   00


Q ss_pred             c----chhcccc-cccccCccCCCCCcHHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          258 L----PLACERK-FSELADPRLNGNFVEEE------LKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       258 ~----~~~~~~~-~~~~~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .    +...... ...+.............      ...+.+++.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            0    0000000 00000000000111111      2357789999999999999999999973

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=345.82  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=195.1

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----  107 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----  107 (400)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++...  .......+.+|+.+|+.++||||+++++++....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            3468899999999999999999965 57999999998542  3334567889999999999999999999997763    


Q ss_pred             --eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          108 --ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       108 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                        ..|+||||+ +++|.+++...     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEee
Confidence              469999999 78999988753     3888999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccc-hh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP-LA  261 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~-~~  261 (400)
                      |+++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  ........| ..
T Consensus       173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~  248 (367)
T 1cm8_A          173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  248 (367)
T ss_dssp             TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999875432    223468999999999987 6899999999999999999999999975442110  000000000 00


Q ss_pred             cc------------cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CE------------RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..            ..+.......+. ...+.....+.+++.+||..||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          249 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            00            000000000000 0111223467888999999999999999999983

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.7e-45  Score=340.33  Aligned_cols=253  Identities=25%  Similarity=0.328  Sum_probs=198.5

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++..........+..|+.+++.++||||+++++++..++..++||
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            46688999999999999999999764 58999999987655555677899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+++++|.+++.....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             ECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999998865322   3889999999999999999999998   99999999999999999999999998754321


Q ss_pred             CCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFS  267 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~  267 (400)
                      .. .......||+.|+|||++.     +..++.++||||||+++|+|++|..||........ ........+        
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  240 (302)
T 2j7t_A          170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP--------  240 (302)
T ss_dssp             HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------
T ss_pred             cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc--------
Confidence            11 1112245899999999984     66789999999999999999999999976543211 001000000        


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ...       ........+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 TLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000       01111246788899999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.9e-44  Score=330.13  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=194.8

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4578999999999999999999754 799999999874321   223468899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      ||||+++++|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999999999986543    3888999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      .....  .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ...+....            
T Consensus       162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------  227 (276)
T 2h6d_A          162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV------------  227 (276)
T ss_dssp             CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred             CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Confidence            44322  223458999999999987765 689999999999999999999997543211 11111000            


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ......    ....+.+++.+||+.||.+|||+.++++.
T Consensus       228 --~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 --FYIPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --ccCchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              000011    12367788899999999999999999973

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-43  Score=341.45  Aligned_cols=263  Identities=22%  Similarity=0.234  Sum_probs=194.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC-----
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ-----  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----  107 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            458999999999999999999965 46889999998753  3344567889999999999999999999997665     


Q ss_pred             -eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          108 -ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       108 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                       ..|+||||+. |+|.+.+..      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          103 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence             7899999997 588888752      2788999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccc--hh-
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP--LA-  261 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~--~~-  261 (400)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ..+.....|  .. 
T Consensus       173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998654322  22334699999999999999999999999999999999999999976543211  000000000  00 


Q ss_pred             -----------------cccccccccCccCCC---CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 -----------------CERKFSELADPRLNG---NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 -----------------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                       ....+..........   .........+.+++.+||..||.+|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                             000000000000000   0112235678899999999999999999999973

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8e-45  Score=337.72  Aligned_cols=254  Identities=23%  Similarity=0.286  Sum_probs=186.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHH-HHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAE-MEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ... ..+.++...++.++||||+++++++.+++..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            457899999999999999999965 5789999999875432 222 3344555668889999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |||++ |+|.+++.........+++..++.++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 588887754322233589999999999999999999998 8   999999999999999999999999999866


Q ss_pred             CCCCceeeeecccccCcCChhhh----ccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYA----MLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      .....  .....||+.|+|||++    .+..++.++|||||||++|+|+||+.||..............      ...  
T Consensus       161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~--  230 (290)
T 3fme_A          161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV------EEP--  230 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH------HSC--
T ss_pred             ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh------ccC--
Confidence            44322  2223599999999996    566789999999999999999999999974322111100000      000  


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         .+....   ......+.+++.+||+.||.+|||+.++++
T Consensus       231 ---~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ---SPQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---CCCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence               000000   111246788889999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-43  Score=330.90  Aligned_cols=253  Identities=26%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---------hHHHHHHHHHHHHHhcCC-CCccceeeeE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---------NKAEMEFAVEVEILARVR-HKNLLSLRGY  102 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-hpnIv~~~~~  102 (400)
                      ....++|++.+.||+|+||.||+|.+ .+++.||+|++....         ......+..|+.+++.+. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            45568999999999999999999965 468899999997543         122345778999999995 9999999999


Q ss_pred             EEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEE
Q 015797          103 CAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQV  182 (400)
Q Consensus       103 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl  182 (400)
                      +..++..++||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence            999999999999999999999987532    3889999999999999999999998   999999999999999999999


Q ss_pred             EecCCccccCCCCceeeeecccccCcCChhhhc------cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hhhc
Q 015797          183 ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM------LGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TITD  255 (400)
Q Consensus       183 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~~~  255 (400)
                      +|||++........  .....||+.|+|||++.      ...++.++||||||+++|+|++|..||......... .+..
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          166 TDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            99999987654322  22345899999999986      456889999999999999999999999754432111 1110


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....         ...     .........+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~---------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 GNYQ---------FGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             TCCC---------CCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCcc---------cCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            0000         000     001122346788899999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-43  Score=351.66  Aligned_cols=195  Identities=22%  Similarity=0.313  Sum_probs=154.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe-----CC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE-----GQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~  107 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++...  .......+.+|+.+|+.++||||+++++++..     ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            347899999999999999999954 57999999998642  33445678899999999999999999999843     35


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..|+||||+. |+|.+++....    .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence            7899999985 79999886542    3899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCc--------------------------eeeeecccccCcCChhhh-ccCCCCCccceehhhHHHHHHHhC
Q 015797          188 AKLIPDGAT--------------------------HVTTRVKGTLGYLAPEYA-MLGKASESCDVYSFGILLLELASG  238 (400)
Q Consensus       188 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDIwSlGiil~elltg  238 (400)
                      ++.......                          ......+||+.|+|||++ .+..++.++||||||||+|||+||
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            987643211                          112335689999999986 456799999999999999999993

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-44  Score=346.49  Aligned_cols=267  Identities=22%  Similarity=0.273  Sum_probs=194.9

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe------
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE------  105 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------  105 (400)
                      +....++|++.+.||+|+||.||+|.+ .+++.||+|++.....    ...+|+.+++.++||||+++++++..      
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345678999999999999999999965 5799999999864322    23469999999999999999999844      


Q ss_pred             --------------------------------CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHH
Q 015797          106 --------------------------------GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY  153 (400)
Q Consensus       106 --------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~y  153 (400)
                                                      ....++||||++ |+|.+.+.........+++..++.++.|++.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            334889999998 58887775432223358999999999999999999


Q ss_pred             HHhcCCCCeEecCCCCCCeEEC-CCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHH
Q 015797          154 LHHHATPHIIHRDIKASNVLLD-ADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGIL  231 (400)
Q Consensus       154 LH~~~~~~iiH~dikp~NIlv~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGii  231 (400)
                      ||+.+   |+||||||+|||++ .++.+||+|||++........  .....||+.|+|||++.+. .++.++|||||||+
T Consensus       157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99998   99999999999997 689999999999987644332  2234589999999998875 48999999999999


Q ss_pred             HHHHHhCCCChhhhhhhh--hhhhhccccchh-----cccccccccCccCCCC-----CcHHHHHHHHHHHHhccccCCC
Q 015797          232 LLELASGKKPIEKVNSAI--KRTITDWALPLA-----CERKFSELADPRLNGN-----FVEEELKRVVLVALTCAHSKPE  299 (400)
Q Consensus       232 l~elltg~~Pf~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~  299 (400)
                      +|+|++|+.||.......  ...+.....|..     .........-+.....     +.......+.+++.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            999999999997644221  111100000000     0000000000000000     1111234678899999999999


Q ss_pred             CCCCHHHHHH
Q 015797          300 KRPTMLEVLD  309 (400)
Q Consensus       300 ~Rps~~ell~  309 (400)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999996

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-44  Score=342.64  Aligned_cols=262  Identities=21%  Similarity=0.308  Sum_probs=203.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHH-----------------HHHHHHHHHHHhcCCCCcccee
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA-----------------EMEFAVEVEILARVRHKNLLSL   99 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~hpnIv~~   99 (400)
                      .++|++.+.||+|+||.||+|.. +++.||+|.+.......                 ...+..|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999999987 99999999987422111                 1678899999999999999999


Q ss_pred             eeEEEeCCeEEEEEEccCCCChhhh------hhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCe
Q 015797          100 RGYCAEGQERLIVYDYMPNLSLLSH------LHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNV  172 (400)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NI  172 (400)
                      ++++.+.+..++||||+++|+|.++      +....  ...+++..++.++.|++.||.|||+ .+   ++||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence            9999999999999999999999998      54321  2358999999999999999999999 88   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccC-CCCC-ccceehhhHHHHHHHhCCCChhhhhh--h
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASE-SCDVYSFGILLLELASGKKPIEKVNS--A  248 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDIwSlGiil~elltg~~Pf~~~~~--~  248 (400)
                      +++.++.+||+|||++......   ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||.....  .
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9999999999999999876443   23345699999999999877 6666 99999999999999999999975432  1


Q ss_pred             hhhhhhccccchhcccccccccCccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          249 IKRTITDWALPLACERKFSELADPRLN---GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....+.....+...  .......+...   ..........+.+++.+||+.||.+|||+.++++
T Consensus       261 ~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPL--DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCC--SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCcc--chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111111000  00000000000   0001222357788999999999999999999997

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-43  Score=349.03  Aligned_cols=200  Identities=25%  Similarity=0.330  Sum_probs=167.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----C
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----Q  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~  107 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+|+.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            468999999999999999999965 56889999999753  334456788999999999999999999998776     5


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..|+||||+. |+|.+++....    .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence            7899999986 69999987542    3899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCce---------------------eeeecccccCcCChhhh-ccCCCCCccceehhhHHHHHHHhCCCChh
Q 015797          188 AKLIPDGATH---------------------VTTRVKGTLGYLAPEYA-MLGKASESCDVYSFGILLLELASGKKPIE  243 (400)
Q Consensus       188 ~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDIwSlGiil~elltg~~Pf~  243 (400)
                      ++........                     .....+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            9876433211                     12445699999999986 55679999999999999999998655553

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.5e-44  Score=346.73  Aligned_cols=254  Identities=11%  Similarity=0.048  Sum_probs=181.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcC--CCCccceee-------eEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARV--RHKNLLSLR-------GYC  103 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~hpnIv~~~-------~~~  103 (400)
                      ..+|.+.+.||+|+||.||+|.+ .+++.||+|++.....   .....+.+|+.+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            44599999999999999999975 4789999999986442   3344577785444444  699987754       555


Q ss_pred             EeC-----------------CeEEEEEEccCCCChhhhhhcCCCcccccChHHH------HHHHHHHHHHHHHHHhcCCC
Q 015797          104 AEG-----------------QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRR------MDIAIGSAEGIVYLHHHATP  160 (400)
Q Consensus       104 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~~~~  160 (400)
                      ...                 ...|+|||||+ |+|.+++.....   .+.+..+      +.++.|++.||+|||+++  
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            443                 34799999999 899999975422   2455556      678899999999999998  


Q ss_pred             CeEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhC
Q 015797          161 HIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASG  238 (400)
Q Consensus       161 ~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg  238 (400)
                       |+||||||+||||+.++.+||+|||++......    .....+|+.|+|||++.+  ..++.++|||||||++|+|+||
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence             999999999999999999999999999865421    213457899999999987  7899999999999999999999


Q ss_pred             CCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          239 KKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       239 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +.||.................        ..................+.++|.+||+.||.+|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKRPSLR--------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCCCBCCTT--------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccchhhhhhh--------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999986543211111100000        000000000001122347788889999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=331.98  Aligned_cols=251  Identities=23%  Similarity=0.270  Sum_probs=196.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC----hHHHHHHHHHHHHHhcCCCCccceeeeEEE--eCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS----NKAEMEFAVEVEILARVRHKNLLSLRGYCA--EGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~  108 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++....    ......+..|+.+++.++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            357999999999999999999965 468899999987432    234567889999999999999999999984  4567


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .++||||+.++ |.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence            89999999876 7777765432  24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCC-ceeeeecccccCcCChhhhccCC--CCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccc
Q 015797          189 KLIPDGA-THVTTRVKGTLGYLAPEYAMLGK--ASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACER  264 (400)
Q Consensus       189 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~  264 (400)
                      ....... ........||+.|+|||++.+..  ++.++||||||+++|+|++|..||....... ...+...        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------  228 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------  228 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--------
Confidence            8764322 22233456999999999998644  3789999999999999999999997644221 1111100        


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..      .....    ....+.+++.+||+.||.+|||+.++++.
T Consensus       229 ~~------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          229 SY------AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CC------CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CC------CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00      01111    12367788899999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.2e-44  Score=338.96  Aligned_cols=265  Identities=22%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             CCcccccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCC--CCccce
Q 015797           23 PTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVR--HKNLLS   98 (400)
Q Consensus        23 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~   98 (400)
                      ++-+.++.+.+....++|++.+.||+|+||.||+|.+.+++.||+|++...  .......+.+|+.+++.++  ||||++
T Consensus        13 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           13 LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             -------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            344566677777888999999999999999999998778999999999753  3344567889999999997  599999


Q ss_pred             eeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC
Q 015797           99 LRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF  178 (400)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~  178 (400)
                      +++++.+++..++||| +.+++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++ ++
T Consensus        93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~  163 (313)
T 3cek_A           93 LYDYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DG  163 (313)
T ss_dssp             EEEEEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TT
T ss_pred             EEEEeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CC
Confidence            9999999999999999 56789999997543    3888999999999999999999998   99999999999996 48


Q ss_pred             cEEEEecCCccccCCCCce-eeeecccccCcCChhhhcc-----------CCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          179 KAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAML-----------GKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      .+||+|||++......... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....
T Consensus       164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            9999999999876443221 1223459999999999875           478899999999999999999999997543


Q ss_pred             hhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          247 SAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...... .....+     .    ........    ....+.+++.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~-~~~~~~-----~----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          244 NQISKL-HAIIDP-----N----HEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             SHHHHH-HHHHCT-----T----SCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHH-HHHHhc-----c----cccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            221110 000000     0    00000011    12467788899999999999999999973

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-44  Score=338.34  Aligned_cols=265  Identities=25%  Similarity=0.352  Sum_probs=185.9

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.+++.++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            44568999999999999999999964 468999999886433 2334568889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcC----CCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          112 VYDYMPNLSLLSHLHGQ----HSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ||||+++|+|.+++...    ......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999988631    111234889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCc----eeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhccccchh
Q 015797          188 AKLIPDGAT----HVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDWALPLA  261 (400)
Q Consensus       188 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~  261 (400)
                      +........    .......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.......... ......+  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--  245 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP--  245 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC--
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC--
Confidence            976543211    11223469999999999876 578999999999999999999999997643221110 0000000  


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ........+.....    ....+.+++.+||+.||.+|||+.++++
T Consensus       246 --~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 --SLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             --CTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --ccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              00000011111111    2246778889999999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-43  Score=334.77  Aligned_cols=255  Identities=18%  Similarity=0.280  Sum_probs=198.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEe--CCeEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAE--GQERLI  111 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~l  111 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++....   ...+..|+.+++.++ ||||+++++++.+  ....++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            357899999999999999999964 678999999987433   356889999999997 9999999999988  677899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKL  190 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~~  190 (400)
                      ||||+++++|.+++..       +++..++.++.|++.||.|||+++   ++||||||+|||++.++ .+||+|||++..
T Consensus       111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            9999999999998742       778899999999999999999998   99999999999999777 899999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh---------------hh
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT---------------IT  254 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~---------------~~  254 (400)
                      ......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........               +.
T Consensus       181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            654332  223458999999999987 678999999999999999999999994322110000               00


Q ss_pred             cccc---ch-------hcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          255 DWAL---PL-------ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       255 ~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ....   +.       .....+.....    ..........+.+++.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVH----SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCC----TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             Hhccccccchhhhhhhccccchhhhcc----ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000   00       00001111111    1111112457888999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.3e-44  Score=367.11  Aligned_cols=247  Identities=24%  Similarity=0.320  Sum_probs=195.6

Q ss_pred             CcccccCceEEEEEEEc---CCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||.||+|.+.   .++.||||+++...  ......+..|+++|+.++||||+++++++.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999542   46789999997532  3345679999999999999999999999864 558899999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce-
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH-  197 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-  197 (400)
                      |+|.+++....    .+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... 
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999996543    3889999999999999999999998   999999999999999999999999999876543321 


Q ss_pred             -eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          198 -VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       198 -~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                       ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||........ ..+....             ... 
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-------------~~~-  592 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------------RMG-  592 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------CCC-
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------CCC-
Confidence             1222347889999999999999999999999999999998 9999976543211 1111100             000 


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                         ........+.++|.+||+.||.+|||+.+|++.|+...
T Consensus       593 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               01112347888999999999999999999999987654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1e-43  Score=366.76  Aligned_cols=248  Identities=26%  Similarity=0.341  Sum_probs=202.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC---ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW---SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  110 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++...   .......+..|..+|..+ +||||+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            457899999999999999999965 46889999999742   122334577899999987 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +||||+++|+|.+++....    .+++..++.++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999997543    3899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.. ....+.....           
T Consensus       492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----------  559 (674)
T 3pfq_A          492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----------  559 (674)
T ss_dssp             CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-----------
T ss_pred             cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            432222 234467999999999999999999999999999999999999999765432 1111111000           


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTM-----LEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~  309 (400)
                         .    +.......+.+||.+||+.||.+||++     .+|++
T Consensus       560 ---~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 ---A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---C----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---C----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               0    111123467888899999999999997     77776

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-43  Score=347.09  Aligned_cols=201  Identities=19%  Similarity=0.246  Sum_probs=172.7

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcC------CCCccceeeeEEEeCC
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARV------RHKNLLSLRGYCAEGQ  107 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~  107 (400)
                      ....+|++.+.||+|+||.||+|.+ .+++.||+|++... ......+..|+.+++.+      +|+||+++++++...+
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            3456899999999999999999965 45889999998743 33345677788888776      5789999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc--EEEEec
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK--AQVADF  185 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~--~kl~Df  185 (400)
                      ..++||||+. ++|.+++......  .+++..++.++.|++.||.|||+.+   |+||||||+||||+.++.  +||+||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             eEEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence            9999999996 6999998765432  3889999999999999999999998   999999999999999987  999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      |++......    .....||+.|+|||++.+..++.++|||||||++|+|+||..||....
T Consensus       247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999764432    223469999999999999999999999999999999999999997544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.7e-44  Score=345.86  Aligned_cols=263  Identities=22%  Similarity=0.259  Sum_probs=184.0

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----  106 (400)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            4468999999999999999999964 56899999998642  334456788999999999999999999998654     


Q ss_pred             -CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          107 -QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       107 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                       ...|+||||+ +++|.+++...     .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCCCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-
T ss_pred             CCeEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeec
Confidence             5679999999 68999988642     3889999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccch--
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPL--  260 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~--  260 (400)
                      |+++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  ........|.  
T Consensus       177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  252 (367)
T 2fst_X          177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  252 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999865432    223469999999999987 6889999999999999999999999976543211  0000000000  


Q ss_pred             hcc----cccccc---cCccCCCCC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          261 ACE----RKFSEL---ADPRLNGNF---VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       261 ~~~----~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...    ......   ........+   .......+.+|+.+||..||.+|||+.++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000    000000   000000000   00113467889999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-43  Score=335.41  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=194.6

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh--------HHHHHHHHHHHHHhcCCCCccceeeeEEEeC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN--------KAEMEFAVEVEILARVRHKNLLSLRGYCAEG  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  106 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....        .....+..|+.+++.++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            346899999999999999999965 4688999999864321        1223478899999999999999999998765


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc---EEEE
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVA  183 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~---~kl~  183 (400)
                      . .|+||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 899999999999999886432    3889999999999999999999998   999999999999987664   9999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhcccc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWAL  258 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~  258 (400)
                      |||++.......  ......||+.|+|||++.   +..++.++|||||||++|+|++|..||......  ....+.....
T Consensus       160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            999998764322  122345999999999974   467899999999999999999999999754321  1111110000


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +     ....         ........+.+++.+||+.||.+|||+.++++.
T Consensus       238 ~-----~~~~---------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          238 N-----FIPE---------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             C-----CCHH---------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             c-----cCch---------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            0     0000         000113467889999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=332.83  Aligned_cols=265  Identities=20%  Similarity=0.278  Sum_probs=194.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEE----------
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA----------  104 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----------  104 (400)
                      ..++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            3578999999999999999999654 58999999998776666778999999999999999999999873          


Q ss_pred             ----eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-CCCc
Q 015797          105 ----EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-ADFK  179 (400)
Q Consensus       105 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-~~~~  179 (400)
                          +....++||||+. |+|.+++...     .+++..++.++.|++.||.|||+++   ++||||||+||+++ .++.
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence                4578899999998 6999988642     3888999999999999999999998   99999999999997 5679


Q ss_pred             EEEEecCCccccCCCCc--eeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhcc
Q 015797          180 AQVADFGFAKLIPDGAT--HVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDW  256 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~  256 (400)
                      +||+|||++........  .......+|+.|+|||.+.+ ..++.++|||||||++|+|+||+.||..............
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999987643211  11223457999999998875 6789999999999999999999999976543211100000


Q ss_pred             ccchhcccccccc------------cCccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          257 ALPLACERKFSEL------------ADPRLN-GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       257 ~~~~~~~~~~~~~------------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ..+.........+            ..+... ....+.....+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000000000000            000000 0000112357888999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.5e-44  Score=367.66  Aligned_cols=261  Identities=21%  Similarity=0.322  Sum_probs=204.8

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      .......++|++.+.||+|+||.||+|.+..    +..||+|.+... .......+..|+.+++.++||||+++++++. 
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            3444556789999999999999999996532    457899988753 3344467899999999999999999999985 


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      ++..++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence            4668999999999999999975432   3889999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACE  263 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~  263 (400)
                      |++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||........ ..+....      
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~------  609 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------  609 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC------
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------
Confidence            9998765443333333457889999999999999999999999999999997 9999976543211 1111100      


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                             .....    ......+.++|.+||+.||.+|||+.+|++.|..+.
T Consensus       610 -------~~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          610 -------RLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCC----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                   00011    112346778899999999999999999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-43  Score=328.48  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=192.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe---------
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE---------  105 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---------  105 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.+++.++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            357899999999999999999965 57999999998642 3345678899999999999999999998865         


Q ss_pred             ----CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          106 ----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       106 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                          ....++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence                456799999999999999997543   23788899999999999999999998   99999999999999999999


Q ss_pred             EEecCCccccCCCC-------------ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhh
Q 015797          182 VADFGFAKLIPDGA-------------THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNS  247 (400)
Q Consensus       182 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~  247 (400)
                      |+|||++.......             ........||+.|+|||++.+. .++.++|||||||++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999998654321             1112234589999999999864 78999999999999999998   4432211


Q ss_pred             h--hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          248 A--IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       248 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .  ....+...              .......+.......+.+++.+||+.||.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 RVNILKKLRSV--------------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHHST--------------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHhcccc--------------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1  11111100              0001111222233467788899999999999999999974

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5e-43  Score=332.37  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=201.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE--cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCC------ccceeeeEEEeCC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL--WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK------NLLSLRGYCAEGQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~  107 (400)
                      ..++|++.+.||+|+||.||+|.+  .+++.||+|++... ......+..|+.+++.++|+      +++++++++.+.+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            357999999999999999999965  36889999998643 33455688899999888665      4999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-----------
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-----------  176 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-----------  176 (400)
                      ..++||||+ +++|.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+|||++.           
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            999999999 8899999876543  24888999999999999999999998   999999999999987           


Q ss_pred             --------CCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh
Q 015797          177 --------DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA  248 (400)
Q Consensus       177 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~  248 (400)
                              ++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    6689999999998654322    2345999999999999999999999999999999999999999754432


Q ss_pred             hhhh-hhccc--cchhc-----cc--------ccc----------cccCcc-CCCCCcHHHHHHHHHHHHhccccCCCCC
Q 015797          249 IKRT-ITDWA--LPLAC-----ER--------KFS----------ELADPR-LNGNFVEEELKRVVLVALTCAHSKPEKR  301 (400)
Q Consensus       249 ~~~~-~~~~~--~~~~~-----~~--------~~~----------~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~R  301 (400)
                      .... +....  .|...     ..        .+.          ....+. ............+.+++.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            1110 00000  00000     00        000          000000 0001122345678899999999999999


Q ss_pred             CCHHHHHH
Q 015797          302 PTMLEVLD  309 (400)
Q Consensus       302 ps~~ell~  309 (400)
                      ||+.|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.7e-43  Score=340.77  Aligned_cols=263  Identities=23%  Similarity=0.255  Sum_probs=200.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC--------CCccceeeeEEE--
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR--------HKNLLSLRGYCA--  104 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~~~--  104 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.+++.++        ||||+++++++.  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            358999999999999999999965 56889999998643 344567888999999885        788999999987  


Q ss_pred             --eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCC---
Q 015797          105 --EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADF---  178 (400)
Q Consensus       105 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~---  178 (400)
                        .....++||||+ +++|.+.+......  .+++..++.++.|++.||.|||++ +   |+||||||+|||++.++   
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQ--GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence              556889999999 56777777654322  389999999999999999999998 8   99999999999999775   


Q ss_pred             ----------------------------------------------cEEEEecCCccccCCCCceeeeecccccCcCChh
Q 015797          179 ----------------------------------------------KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE  212 (400)
Q Consensus       179 ----------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE  212 (400)
                                                                    .+||+|||++......    .....||+.|+|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence                                                          7999999999875432    22345999999999


Q ss_pred             hhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-------hhhhhcccc--ch--hc-----------cccccccc
Q 015797          213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-------KRTITDWAL--PL--AC-----------ERKFSELA  270 (400)
Q Consensus       213 ~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-------~~~~~~~~~--~~--~~-----------~~~~~~~~  270 (400)
                      ++.+..++.++|||||||++|+|+||+.||.......       ...+.....  |.  ..           ...+..+.
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999996432110       000000000  00  00           00000000


Q ss_pred             Ccc---------CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPR---------LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      ...         ............+.+|+.+||+.||.+|||+.++++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000         001234566778999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-43  Score=344.16  Aligned_cols=265  Identities=21%  Similarity=0.277  Sum_probs=192.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC------eE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ------ER  109 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~  109 (400)
                      ...+|++.+.||+|+||.||+|.+..+..+|+|++.....    ...+|+++++.++||||+++++++...+      ..
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3567999999999999999999877777799998764322    1236999999999999999999986543      37


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-CCCcEEEEecCCc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-ADFKAQVADFGFA  188 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-~~~~~kl~Dfgl~  188 (400)
                      ++||||+++ ++.+.+.........+++..++.++.|++.||.|||+++   |+||||||+||||+ .++.+||+|||++
T Consensus       114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            899999986 444443321112234889999999999999999999998   99999999999999 7999999999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhcccc-------
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWAL-------  258 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~-------  258 (400)
                      +.......  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......  .........       
T Consensus       190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            87644332  2234689999999999765 58999999999999999999999997654221  111000000       


Q ss_pred             ---chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          259 ---PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       259 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         +......+.......+...+.......+.+++.+||+.||.+|||+.++++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence               0000000000000000000111123478889999999999999999999973

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.1e-43  Score=348.37  Aligned_cols=263  Identities=21%  Similarity=0.294  Sum_probs=204.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC-CccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH-KNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++.....  ...+..|+.+++.|.| ++|..+..++.+....++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            357899999999999999999965 5699999998875332  2347889999999977 56666777778888999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---CCCCcEEEEecCCccc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL---DADFKAQVADFGFAKL  190 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv---~~~~~~kl~Dfgl~~~  190 (400)
                      ||+ +++|.+++.....   .+++..++.++.||+.||.|||+++   |+||||||+||||   +.++.+||+|||++..
T Consensus        83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999 8999999974332   3899999999999999999999998   9999999999999   5889999999999987


Q ss_pred             cCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          191 IPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       191 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      .......      ......||+.|+|||++.+..++.++|||||||+||+|++|+.||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            6543321      1224569999999999999999999999999999999999999997643211000000000000000


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .+..+.         ......+.+++..||+.||.+||++.+|++.|+.+..
T Consensus       236 ~~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          236 SIEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             CHHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cHHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            000000         0112478889999999999999999999999876644

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=340.84  Aligned_cols=265  Identities=25%  Similarity=0.368  Sum_probs=202.0

Q ss_pred             ccHHHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           28 FSLKELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      ...+++....++|++.+.||+|+||.||+|....  .+|+|++....  ......+.+|+.+++.++||||+++++++.+
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            3455666678999999999999999999997533  48999886432  2223457789999999999999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      .+..++||||+++++|.+++....   ..+++..++.++.|++.||.|||+++   ++||||||+||+++ ++.+||+||
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeec
Confidence            999999999999999999997543   24889999999999999999999998   99999999999998 679999999


Q ss_pred             CCccccCCCCc----eeeeecccccCcCChhhhcc---------CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-h
Q 015797          186 GFAKLIPDGAT----HVTTRVKGTLGYLAPEYAML---------GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-R  251 (400)
Q Consensus       186 gl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~  251 (400)
                      |++........    .......||+.|+|||++.+         ..++.++|||||||++|+|++|..||........ .
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  253 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW  253 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99875432111    11222458999999999975         4578999999999999999999999976543211 1


Q ss_pred             hhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccchh
Q 015797          252 TITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKE  317 (400)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  317 (400)
                      .+.....+        .....    .    ....+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       254 ~~~~~~~~--------~~~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          254 QMGTGMKP--------NLSQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHHTTCCC--------CCCCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HhccCCCC--------CCCcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            11110000        00000    0    112577888999999999999999999999877543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.8e-43  Score=332.95  Aligned_cols=268  Identities=23%  Similarity=0.348  Sum_probs=199.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE--cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcC---CCCccceeeeEEE--
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL--WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARV---RHKNLLSLRGYCA--  104 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~--~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~--  104 (400)
                      ..+.++|++.+.||+|+||.||+|.+  .+++.||+|++......  ....+..|+.+++.+   +||||+++++++.  
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            34668999999999999999999976  45788999998643221  122455677666665   8999999999987  


Q ss_pred             ---eCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          105 ---EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       105 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                         .....++||||+. |+|.+++......  .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEE
Confidence               5677899999998 6999998765432  3889999999999999999999998   99999999999999999999


Q ss_pred             EEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccc
Q 015797          182 VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP  259 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~  259 (400)
                      |+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........  ........+
T Consensus       161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (326)
T 1blx_A          161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  238 (326)
T ss_dssp             ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999998654322  12234589999999999999999999999999999999999999976443211  111000000


Q ss_pred             --hhccccc---ccccC---ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          260 --LACERKF---SELAD---PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       260 --~~~~~~~---~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ..+....   .....   ......+.......+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000000   00000   00000011122346778889999999999999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.8e-43  Score=325.14  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=201.2

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ....++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999654 6899999998643  2234567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC---CcEEEEecCC
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD---FKAQVADFGF  187 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~---~~~kl~Dfgl  187 (400)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            9999999999999886433    3889999999999999999999998   9999999999999764   4699999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKF  266 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~  266 (400)
                      +........  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ...+.....+.    ..
T Consensus       171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~  243 (287)
T 2wei_A          171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF----DL  243 (287)
T ss_dssp             GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CS
T ss_pred             ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----Cc
Confidence            986644322  223358999999998875 58999999999999999999999997654321 11111100000    00


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                           +     ........+.+++.+||+.||.+|||+.++++
T Consensus       244 -----~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          244 -----P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -----G-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----h-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                 0     00111246788899999999999999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.2e-43  Score=337.49  Aligned_cols=209  Identities=20%  Similarity=0.278  Sum_probs=175.6

Q ss_pred             cccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CC-----cccee
Q 015797           27 IFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HK-----NLLSL   99 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~   99 (400)
                      .|.+..-....++|++.+.||+|+||.||+|.+ .+++.||+|++... ......+..|+.+++.++ |+     +|+++
T Consensus        43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            345555566789999999999999999999965 46889999998742 333456778888888874 44     49999


Q ss_pred             eeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh--cCCCCeEecCCCCCCeEEC--
Q 015797          100 RGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH--HATPHIIHRDIKASNVLLD--  175 (400)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~~~~iiH~dikp~NIlv~--  175 (400)
                      ++++...+..|+||||+. |+|.+++......  .+++..++.++.|++.||.|||.  .+   |+||||||+|||++  
T Consensus       122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~  195 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNP  195 (382)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESST
T ss_pred             eeeeccCCceEEEEecCC-CCHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecC
Confidence            999999999999999996 5999998765432  38899999999999999999995  45   99999999999995  


Q ss_pred             CCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          176 ADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       176 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      .++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|+||+.||....
T Consensus       196 ~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          196 KRSAIKIVDFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TSCCEEECCCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCcEEEEeccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            47789999999998764322    23469999999999999999999999999999999999999997544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.9e-43  Score=343.53  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=188.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEEEEcc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....   ...+..|+.+|+.+ +||||+++++++.+++..|+|||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4455668899999999988766789999999986532   34577899999876 8999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccc---cChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-------------CcE
Q 015797          117 PNLSLLSHLHGQHSSECL---LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-------------FKA  180 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-------------~~~  180 (400)
                      . |+|.+++.........   ..+..++.++.|++.||.|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 6999999765432211   133456789999999999999998   9999999999999754             489


Q ss_pred             EEEecCCccccCCCCce---eeeecccccCcCChhhhcc-------CCCCCccceehhhHHHHHHHh-CCCChhhhhhhh
Q 015797          181 QVADFGFAKLIPDGATH---VTTRVKGTLGYLAPEYAML-------GKASESCDVYSFGILLLELAS-GKKPIEKVNSAI  249 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~  249 (400)
                      ||+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|+|+| |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543321   1223469999999999976       678999999999999999999 999997543221


Q ss_pred             hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          250 KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...... ..      ..     +.............+.+++.+||+.||.+|||+.++++.
T Consensus       248 ~~i~~~-~~------~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 SNIIRG-IF------SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHHT-CC------CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHhcC-CC------Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            111110 00      00     001111233455678899999999999999999999973

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-43  Score=339.24  Aligned_cols=274  Identities=22%  Similarity=0.238  Sum_probs=190.1

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ........++|++.+.||+|+||.||+|.+ .+++.||+|++.... ........+++.++.++||||+++++++...+.
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            345567789999999999999999999965 468999999886432 222346678888899999999999999866433


Q ss_pred             -------EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCeEECC-CC
Q 015797          109 -------RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH--HHATPHIIHRDIKASNVLLDA-DF  178 (400)
Q Consensus       109 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~~~~iiH~dikp~NIlv~~-~~  178 (400)
                             .++||||+.+ +|.+.+.........+++..++.++.|++.||.|||  +.+   |+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence                   7899999986 665554432222335888999999999999999999  887   999999999999996 89


Q ss_pred             cEEEEecCCccccCCCCceeeeecccccCcCChhhhccCC-CCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhc-
Q 015797          179 KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITD-  255 (400)
Q Consensus       179 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~-  255 (400)
                      .+||+|||++........  .....||+.|+|||++.+.. ++.++|||||||++|+|+||+.||........ ..+.. 
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            999999999987654332  22346899999999987654 89999999999999999999999976543211 01000 


Q ss_pred             cccch------hccc-ccccccC-c-----cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          256 WALPL------ACER-KFSELAD-P-----RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       256 ~~~~~------~~~~-~~~~~~~-~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...+.      .... ....... .     .............+.+++.+||+.||.+|||+.++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000      0000 0000000 0     00001111234578889999999999999999999973

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.2e-43  Score=334.30  Aligned_cols=267  Identities=23%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeC-----C
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEG-----Q  107 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~  107 (400)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            35689999999999999999999654 68899999997533 33455788999999999999999999987654     6


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..++||||+. |+|.+++...     .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccc
Confidence            7899999997 6999988753     3889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCce---------eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhc-
Q 015797          188 AKLIPDGATH---------VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITD-  255 (400)
Q Consensus       188 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~-  255 (400)
                      +.........         ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.. 
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            9876432211         1122468999999998765 678999999999999999999999997654221100 000 


Q ss_pred             cccchhc-------ccccccccC--ccCCCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          256 WALPLAC-------ERKFSELAD--PRLNGN----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       256 ~~~~~~~-------~~~~~~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...+...       .........  +.....    ..+.....+.+++.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000       000000000  000000    001123467889999999999999999999973

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-43  Score=345.77  Aligned_cols=264  Identities=24%  Similarity=0.317  Sum_probs=192.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC------CeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG------QER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~  109 (400)
                      ..+|++.+.||+|+||.||+|.+ .+++.||||++.....    ...+|+++|+.++||||++++++|...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            44799999999999999999976 4699999999864321    234699999999999999999988542      236


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC-CcEEEEecCCc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFA  188 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~-~~~kl~Dfgl~  188 (400)
                      ++||||+++ +|.+.+.........+++..++.++.|++.||.|||+++   |+||||||+||||+.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999985 676665432222234899999999999999999999998   9999999999999965 67899999999


Q ss_pred             cccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchh----
Q 015797          189 KLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLA----  261 (400)
Q Consensus       189 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~----  261 (400)
                      +.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......  ....+.....|..    
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            87644332  2234689999999999765 7999999999999999999999999765421  1111110000000    


Q ss_pred             -cccccccccCccCCCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 -CERKFSELADPRLNGN-----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 -~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       .......+.-+.+...     +.......+.+|+.+||..||.+|||+.++++.
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence             0000001100100000     111123478889999999999999999999973

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.6e-43  Score=330.82  Aligned_cols=257  Identities=25%  Similarity=0.341  Sum_probs=177.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHH-HHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVE-ILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+..|+. +++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            358899999999999999999965 468999999997643 333445556665 77788999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC-CcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          113 YDYMPNLSLLSHLHGQH-SSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      |||+.+ +|.+++.... .....+++..++.++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999984 8877765211 1122488999999999999999999998 8   99999999999999999999999999986


Q ss_pred             cCCCCceeeeecccccCcCChhhh----ccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYA----MLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF  266 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  266 (400)
                      ......  .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||......... +...          
T Consensus       176 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~----------  242 (327)
T 3aln_A          176 LVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-LTQV----------  242 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCC----------
T ss_pred             cccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-HHHH----------
Confidence            643322  2223599999999998    4567899999999999999999999999754321100 0000          


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .....+.+...........+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000001111111112346788889999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=332.05  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=190.5

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH------HHHHHHHHHHHHhcC----CCCccce
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK------AEMEFAVEVEILARV----RHKNLLS   98 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~   98 (400)
                      ........++|++.+.||+|+||.||+|.. .+++.||+|++......      ....+..|+.++..+    +||||++
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            344566778999999999999999999965 56889999998653321      222355689999888    8999999


Q ss_pred             eeeEEEeCCeEEEEEEc-cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-C
Q 015797           99 LRGYCAEGQERLIVYDY-MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-A  176 (400)
Q Consensus        99 ~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-~  176 (400)
                      +++++.+.+..++|||| +.+++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++ .
T Consensus       103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR  175 (312)
T ss_dssp             EEEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred             EEEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence            99999999999999999 78999999997533    3899999999999999999999998   99999999999999 8


Q ss_pred             CCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCC-CccceehhhHHHHHHHhCCCChhhhhhhhhhhhhc
Q 015797          177 DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKAS-ESCDVYSFGILLLELASGKKPIEKVNSAIKRTITD  255 (400)
Q Consensus       177 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~  255 (400)
                      ++.+||+|||++.......   .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||..........   
T Consensus       176 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---  249 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAE---  249 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTC---
T ss_pred             CCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhc---
Confidence            8999999999998765432   2234599999999999877764 58999999999999999999997543211100   


Q ss_pred             cccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                              ..        +...    ....+.+++.+||+.||.+|||+.++++.
T Consensus       250 --------~~--------~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          250 --------LH--------FPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --------CC--------CCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------cC--------Cccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    00        0011    12367788899999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=344.61  Aligned_cols=204  Identities=24%  Similarity=0.389  Sum_probs=156.1

Q ss_pred             HccCCCc-CCcccccCceEEEEEEEc---CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeE
Q 015797           36 ATNNFNY-DNKLGEGGFGSVYWGQLW---DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQER  109 (400)
Q Consensus        36 ~~~~y~~-~~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~  109 (400)
                      ..+.|.+ +++||+|+||.||+|...   +++.||+|++.....  ...+.+|+.+|+.++||||+++++++..  +...
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3455666 568999999999999754   578999999874332  2457889999999999999999999954  6789


Q ss_pred             EEEEEccCCCChhhhhhcCC-----CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----CCCCcE
Q 015797          110 LIVYDYMPNLSLLSHLHGQH-----SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL----DADFKA  180 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv----~~~~~~  180 (400)
                      |+||||+. |+|.+++....     .....+++..++.++.|++.||.|||+.+   |+||||||+||||    +.++.+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence            99999997 58888775321     11224889999999999999999999998   9999999999999    677899


Q ss_pred             EEEecCCccccCCCCc--eeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhh
Q 015797          181 QVADFGFAKLIPDGAT--HVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKV  245 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~  245 (400)
                      ||+|||++........  .......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||...
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999999987653221  12234569999999999987 45899999999999999999999999643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=332.01  Aligned_cols=259  Identities=19%  Similarity=0.272  Sum_probs=195.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe-----
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE-----  108 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----  108 (400)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||+|++...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            57899999999999999999965 56899999998653  33335678899999999999999999999987654     


Q ss_pred             -EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          109 -RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       109 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                       .|+||||+. |+|.+++..      .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 688887742      2888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccc-hhcc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALP-LACE  263 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~-~~~~  263 (400)
                      +......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .........+ ....
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9864332    223458999999999987 678999999999999999999999997644211  0000000000 0000


Q ss_pred             ------------cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          264 ------------RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       264 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                  ..+.......+. ...+.....+.+++.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                        000000000000 1112234578888999999999999999999973

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.3e-42  Score=333.11  Aligned_cols=261  Identities=19%  Similarity=0.276  Sum_probs=196.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeE---
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQER---  109 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~---  109 (400)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++...  .......+..|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            468999999999999999999965 56899999999753  333356788999999999999999999999887765   


Q ss_pred             ---EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          110 ---LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       110 ---~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                         ++||||+. ++|.+.+..      .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence               99999997 688887742      2888999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccc-hhc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALP-LAC  262 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~-~~~  262 (400)
                      ++......    .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||........  ..+.....+ ...
T Consensus       190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            99865332    223468999999999987 7899999999999999999999999975442110  000000000 000


Q ss_pred             ccc--------cccccCccCCCCC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          263 ERK--------FSELADPRLNGNF---VEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       263 ~~~--------~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...        +...........+   .+.....+.+++.+||+.||.+|||+.++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000        0000000000000   01123578889999999999999999999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-42  Score=332.88  Aligned_cols=262  Identities=21%  Similarity=0.267  Sum_probs=198.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-----------CCccceeeeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-----------HKNLLSLRGYCA  104 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~  104 (400)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++.. .......+..|+.+++.++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            47899999999999999999965 5789999999874 3334556788999998886           899999999987


Q ss_pred             eCC----eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEC----
Q 015797          105 EGQ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLD----  175 (400)
Q Consensus       105 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~----  175 (400)
                      ..+    ..++||||+ +++|.+++......  .+++..++.++.|++.||.|||++ +   |+||||||+|||++    
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            654    789999999 89999998764332  388999999999999999999998 8   99999999999994    


Q ss_pred             --CCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh----
Q 015797          176 --ADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI----  249 (400)
Q Consensus       176 --~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~----  249 (400)
                        ..+.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|+||+.||.......    
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence              44589999999998654322    23459999999999999999999999999999999999999997543110    


Q ss_pred             ---hhhhhccc--cchh--c-----------ccccccccCc---------cCCCCCcHHHHHHHHHHHHhccccCCCCCC
Q 015797          250 ---KRTITDWA--LPLA--C-----------ERKFSELADP---------RLNGNFVEEELKRVVLVALTCAHSKPEKRP  302 (400)
Q Consensus       250 ---~~~~~~~~--~~~~--~-----------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  302 (400)
                         ...+....  .|..  .           ...+..+...         .....+.......+.++|.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence               00000000  0000  0           0000000000         001123456678899999999999999999


Q ss_pred             CHHHHHH
Q 015797          303 TMLEVLD  309 (400)
Q Consensus       303 s~~ell~  309 (400)
                      |+.++++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-42  Score=329.26  Aligned_cols=263  Identities=21%  Similarity=0.277  Sum_probs=198.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc-CC-CEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc------cceeeeEEEeCC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW-DG-SQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN------LLSLRGYCAEGQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~  107 (400)
                      ..++|++.+.||+|+||.||+|... ++ +.||+|++... ......+..|+.+++.++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3589999999999999999999653 34 68999998642 344566888999999987665      899999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-------------
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL-------------  174 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv-------------  174 (400)
                      ..++||||+ +++|.+++......  .+++..++.++.|++.||.|||+++   |+||||||+|||+             
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQ--PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eEEEEEecc-CCChHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            999999999 67888877654322  4889999999999999999999998   9999999999999             


Q ss_pred             ------CCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh
Q 015797          175 ------DADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA  248 (400)
Q Consensus       175 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~  248 (400)
                            +.++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|+||..||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  567899999999998644322    2346999999999999999999999999999999999999999754432


Q ss_pred             hhh-hhhccc--cchhcc-----c--------cccc----------ccCc-cCCCCCcHHHHHHHHHHHHhccccCCCCC
Q 015797          249 IKR-TITDWA--LPLACE-----R--------KFSE----------LADP-RLNGNFVEEELKRVVLVALTCAHSKPEKR  301 (400)
Q Consensus       249 ~~~-~~~~~~--~~~~~~-----~--------~~~~----------~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~R  301 (400)
                      ... .+....  .|....     .        .+..          ...+ .............+.+++.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            110 000000  000000     0        0000          0000 00001122335578899999999999999


Q ss_pred             CCHHHHHH
Q 015797          302 PTMLEVLD  309 (400)
Q Consensus       302 ps~~ell~  309 (400)
                      ||+.++++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.3e-43  Score=331.33  Aligned_cols=254  Identities=21%  Similarity=0.245  Sum_probs=173.3

Q ss_pred             HHccCCCcCC-cccccCceEEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe----CCe
Q 015797           35 SATNNFNYDN-KLGEGGFGSVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE----GQE  108 (400)
Q Consensus        35 ~~~~~y~~~~-~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~  108 (400)
                      ...++|.+.+ .||+|+||.||+|.+. +++.||+|++....    ....+....++.+.||||+++++++..    ...
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            4567899865 6999999999999654 69999999986421    112223344567799999999999876    455


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEEec
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADF  185 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~Df  185 (400)
                      .++||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+|||++.   ++.+||+||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence            8999999999999999976533  24899999999999999999999998   999999999999986   455999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhccccchhccc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDWALPLACER  264 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~  264 (400)
                      |++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .....    ...
T Consensus       176 g~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~  248 (336)
T 3fhr_A          176 GFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI----RLG  248 (336)
T ss_dssp             TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh----hcc
Confidence            9998654322   223458999999999998899999999999999999999999997544221100 00000    000


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ..      .............+.+++.+||+.||.+|||+.++++.
T Consensus       249 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          249 QY------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cc------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00      00000011123467788899999999999999999983

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-43  Score=333.89  Aligned_cols=252  Identities=24%  Similarity=0.369  Sum_probs=199.3

Q ss_pred             ccccHHHHHHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH------HHHHHHHHHHHHhcCC--CCcc
Q 015797           26 RIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK------AEMEFAVEVEILARVR--HKNL   96 (400)
Q Consensus        26 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--hpnI   96 (400)
                      ...+........++|++.+.||+|+||.||+|.. .+++.||+|++......      ....+..|+.+++.++  ||||
T Consensus        31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            3445566677789999999999999999999964 56889999998753221      1234667999999996  5999


Q ss_pred             ceeeeEEEeCCeEEEEEEccCC-CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC
Q 015797           97 LSLRGYCAEGQERLIVYDYMPN-LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD  175 (400)
Q Consensus        97 v~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~  175 (400)
                      +++++++...+..++|||++.+ ++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+|||++
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  183 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID  183 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEe
Confidence            9999999999999999999976 89999987532    3889999999999999999999998   99999999999999


Q ss_pred             -CCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhhhhhh
Q 015797          176 -ADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTI  253 (400)
Q Consensus       176 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~  253 (400)
                       .++.+||+|||++.......   .....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||...........
T Consensus       184 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  260 (320)
T 3a99_A          184 LNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV  260 (320)
T ss_dssp             TTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCC
T ss_pred             CCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccc
Confidence             78999999999998765432   223459999999999987776 6889999999999999999999975432111000


Q ss_pred             hccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          254 TDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                     ..    ....    ...+.+++.+||+.||.+|||+.++++.
T Consensus       261 ---------------~~----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          261 ---------------FF----RQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---------------CC----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------------cc----cccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           00    0111    2367788899999999999999999973

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=339.72  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=189.6

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .....+|.+.+.||+|+||+||.....+++.||||++.....   ..+.+|+.+|+.+ +||||+++++++.+....|+|
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            444567999999999999997766567899999999864322   2356799999999 899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-----CCcEEEEecCC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-----DFKAQVADFGF  187 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-----~~~~kl~Dfgl  187 (400)
                      ||||. |+|.+++......   ..+..++.++.|++.||.|||+++   |+||||||+|||++.     ...+||+|||+
T Consensus        97 ~E~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EECCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99996 6999999765432   445567889999999999999998   999999999999953     23588999999


Q ss_pred             ccccCCCCc--eeeeecccccCcCChhhhc---cCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhhhhhhccccchh
Q 015797          188 AKLIPDGAT--HVTTRVKGTLGYLAPEYAM---LGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLA  261 (400)
Q Consensus       188 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  261 (400)
                      +........  .......||+.|+|||++.   +..++.++|||||||++|+|+| |..||...............    
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~----  245 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC----  245 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC----
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC----
Confidence            987653321  1223456999999999997   4567889999999999999999 99999654322111111000    


Q ss_pred             cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ..     ....  ........+.++|.+||+.||.+|||+.++++.
T Consensus       246 ---~~-----~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          246 ---SL-----DCLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ---CC-----TTSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---Cc-----cccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence               00     0000  011223456788999999999999999999963

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=321.69  Aligned_cols=252  Identities=23%  Similarity=0.313  Sum_probs=179.1

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH-HH-HHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK-AE-MEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ....++|++.+.||+|+||.||+|.+ .+++.||+|++...... .. ..+.++..+++.++||||+++++++.+.+..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            34467899999999999999999976 46899999999754332 22 33445556788889999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH-ATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      +||||+ ++.+..+.....   ..+++..++.++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++.
T Consensus       101 lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            999999 445555443221   2488999999999999999999985 8   9999999999999999999999999997


Q ss_pred             ccCCCCceeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLAC  262 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~  262 (400)
                      .......  .....||+.|+|||++.     ...++.++|||||||++|+|++|+.||.......  .........+   
T Consensus       174 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  248 (318)
T 2dyl_A          174 RLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP---  248 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC---
T ss_pred             hccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC---
Confidence            6543222  22345999999999994     5678999999999999999999999997533211  1111110000   


Q ss_pred             ccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                                ....  .......+.+++.+||+.||.+|||+.++++
T Consensus       249 ----------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 ----------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ----------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                      0000  0011236778889999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1e-41  Score=346.35  Aligned_cols=268  Identities=23%  Similarity=0.294  Sum_probs=198.1

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe------C
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE------G  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~  106 (400)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++... .......+..|+.+++.++||||+++++++..      +
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3448999999999999999999965 56899999998753 44455678999999999999999999998765      6


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc---EEEE
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK---AQVA  183 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~---~kl~  183 (400)
                      +..++|||||++|+|.+++..... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.   +||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence            778999999999999999976432 224888999999999999999999998   999999999999997765   9999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhh--hhhccccch-
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITDWALPL-  260 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~--~~~~~~~~~-  260 (400)
                      |||++........  .....||+.|+|||++.+..++.++|||||||++|+|+||..||.........  ......... 
T Consensus       167 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          167 DLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             SCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             ccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            9999987654322  23356999999999999999999999999999999999999999653221100  000000000 


Q ss_pred             h----cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 015797          261 A----CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL  308 (400)
Q Consensus       261 ~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell  308 (400)
                      .    ..+.+...................+.+++.+||..||.+|||+.+++
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0    00000000000111223344567888999999999999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.2e-41  Score=346.12  Aligned_cols=240  Identities=20%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             HccCCCcCCcccccCceEEEEEEEc--CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe----
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLW--DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE----  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----  108 (400)
                      ..++|++.+.||+|+||.||+|.+.  +++.||+|++.... ......+..|+.+++.++||||+++++++...+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3489999999999999999999764  58999999886433 3445578899999999999999999999987655    


Q ss_pred             -EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          109 -RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       109 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                       .|+||||+++++|.+++..      .+++..++.++.|++.||.|||+++   |+||||||+|||++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence             7999999999999987653      3899999999999999999999998   9999999999999885 899999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS  267 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  267 (400)
                      +......     ....||+.|+|||++.++ ++.++|||||||++|+|++|..||......                .+.
T Consensus       228 a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~~  285 (681)
T 2pzi_A          228 VSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GLP  285 (681)
T ss_dssp             CEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SCC
T ss_pred             chhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------------ccc
Confidence            9876543     234599999999998765 489999999999999999999998642110                000


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHhccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-MLEVLDLLKGE  314 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~ell~~L~~~  314 (400)
                             ...........+.+++.+||+.||.+||+ +.++.+.|...
T Consensus       286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                   00111122356788999999999999996 55566655543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.9e-40  Score=306.22  Aligned_cols=230  Identities=13%  Similarity=0.051  Sum_probs=180.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEEc-CCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.++..++||||+++++++.+++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            478999999999999999999654 58999999997533   33346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||++|++|.+++...      .....+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+++       
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~-------  173 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP-------  173 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec-------
Confidence            9999999999998532      344567889999999999999998   999999999999999999999743       


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccc-ccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE-LAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  271 (400)
                                    .|++|       ++.++|||||||++|+|+||+.||.............        ..... ...
T Consensus       174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~  224 (286)
T 3uqc_A          174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIE  224 (286)
T ss_dssp             --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------BCTTSCBCC
T ss_pred             --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------HHhccCCCC
Confidence                          34443       6899999999999999999999997644210000000        00000 000


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      +.   .........+.+++.+||+.||.+| |+.++++.|....
T Consensus       225 ~~---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          225 PA---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HH---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hh---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            00   0001123467888999999999999 9999999997653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-39  Score=305.07  Aligned_cols=229  Identities=22%  Similarity=0.295  Sum_probs=178.1

Q ss_pred             HccCCCcC-CcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHH-hcCCCCccceeeeEEEe----CCe
Q 015797           36 ATNNFNYD-NKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEIL-ARVRHKNLLSLRGYCAE----GQE  108 (400)
Q Consensus        36 ~~~~y~~~-~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~----~~~  108 (400)
                      ..++|.+. +.||+|+||.||+|.+ .+++.||+|++...     ..+..|+.++ +.++||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            44678777 7899999999999965 57899999998642     3466788887 56699999999999887    677


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEEec
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADF  185 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~Df  185 (400)
                      .++||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+++   ++||||||+|||++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence            8999999999999999976543  24889999999999999999999998   999999999999998   788999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERK  265 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  265 (400)
                      |++....                       +..++.++|||||||++|+|+||+.||...........           .
T Consensus       165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-----------~  210 (299)
T 3m2w_A          165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----------M  210 (299)
T ss_dssp             TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----------S
T ss_pred             ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----------H
Confidence            9986432                       24567899999999999999999999965432110000           0


Q ss_pred             cccccCccCCCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          266 FSELADPRLNGNFV----EEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       266 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ...+.....  ...    ......+.+++.+||+.||.+|||+.++++.
T Consensus       211 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 KTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000000000  000    1123478889999999999999999999973

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-40  Score=315.21  Aligned_cols=240  Identities=17%  Similarity=0.165  Sum_probs=183.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh--------HHHHHHHHHHHHHhcCC---------CCcccee
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN--------KAEMEFAVEVEILARVR---------HKNLLSL   99 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---------hpnIv~~   99 (400)
                      .++|++.+.||+|+||.||+|.+ +++.||+|++.....        .....+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            47799999999999999999976 789999999975432        22356788888888875         6666666


Q ss_pred             eeEE-----------------Ee-------------CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHH
Q 015797          100 RGYC-----------------AE-------------GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE  149 (400)
Q Consensus       100 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~  149 (400)
                      .+++                 .+             .+..|+|||||++|++.+.+...     .+++..++.++.|++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHH
Confidence            5553                 32             78899999999999887777532     3789999999999999


Q ss_pred             HHHHHH-hcCCCCeEecCCCCCCeEECCCC--------------------cEEEEecCCccccCCCCceeeeecccccCc
Q 015797          150 GIVYLH-HHATPHIIHRDIKASNVLLDADF--------------------KAQVADFGFAKLIPDGATHVTTRVKGTLGY  208 (400)
Q Consensus       150 aL~yLH-~~~~~~iiH~dikp~NIlv~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y  208 (400)
                      ||.||| +++   |+||||||+|||++.++                    .+||+|||+++.....      ...||+.|
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence            999999 898   99999999999999887                    8999999999876432      23599999


Q ss_pred             CChhhhccCCCCCccceehhhHH-HHHHHhCCCChhhhhh--hhhhhhhccccchhcccccccccCccCCCCCcHHHHHH
Q 015797          209 LAPEYAMLGKASESCDVYSFGIL-LLELASGKKPIEKVNS--AIKRTITDWALPLACERKFSELADPRLNGNFVEEELKR  285 (400)
Q Consensus       209 ~aPE~~~~~~~s~ksDIwSlGii-l~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (400)
                      +|||++.+.. +.++||||||++ .+++++|..||.....  .....+...       ..    ................
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-------~~----~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ-------MT----FKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT-------CC----CSSCCCSHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh-------hc----cCcccchhhhhhcCHH
Confidence            9999998766 899999998777 7889999999965321  000010000       00    0000111123445678


Q ss_pred             HHHHHHhccccCCCCCCCHHHHH
Q 015797          286 VVLVALTCAHSKPEKRPTMLEVL  308 (400)
Q Consensus       286 l~~li~~cl~~dP~~Rps~~ell  308 (400)
                      +.+||.+||+.|     |+.|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            899999999976     999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.9e-40  Score=319.72  Aligned_cols=244  Identities=15%  Similarity=0.102  Sum_probs=179.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH---HHHHHHHHHHHhcCCC-Cccce------------
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA---EMEFAVEVEILARVRH-KNLLS------------   98 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h-pnIv~------------   98 (400)
                      ...+|...+.||+|+||.||+|.+ .+++.||||++.......   ...+.+|+.+++.+.| +|...            
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            344577889999999999999964 569999999987433222   4578899999999977 32211            


Q ss_pred             ---------eeeEEEe-----CCeEEEEEEccCCCChhhhhhcC---CCcccccChHHHHHHHHHHHHHHHHHHhcCCCC
Q 015797           99 ---------LRGYCAE-----GQERLIVYDYMPNLSLLSHLHGQ---HSSECLLNWNRRMDIAIGSAEGIVYLHHHATPH  161 (400)
Q Consensus        99 ---------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~  161 (400)
                               +..++..     ....+++|+++ +++|.+++...   ......+++..++.++.|++.||.|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                     1111111     22456777766 57999888411   122334788899999999999999999998   


Q ss_pred             eEecCCCCCCeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhh----------ccCCCCCccceehhhHH
Q 015797          162 IIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA----------MLGKASESCDVYSFGIL  231 (400)
Q Consensus       162 iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDIwSlGii  231 (400)
                      |+||||||+||||+.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++|||||||+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999998864322    334558 999999999          55568899999999999


Q ss_pred             HHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          232 LLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       232 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      +|+|+||+.||.......               ....+.....  ..    ...+.++|.+||+.||.+|||+.++++
T Consensus       307 l~elltg~~Pf~~~~~~~---------------~~~~~~~~~~--~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALG---------------GSEWIFRSCK--NI----PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGS---------------CSGGGGSSCC--CC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCCCCCCCcchhh---------------hHHHHHhhcc--cC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999997544210               0000111000  11    246888889999999999999998875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=9.4e-34  Score=286.58  Aligned_cols=187  Identities=16%  Similarity=0.111  Sum_probs=133.1

Q ss_pred             cccccCceEEEEE-EEcCCCEEEEEEEecCC----------hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEE
Q 015797           45 KLGEGGFGSVYWG-QLWDGSQIAVKRLKVWS----------NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        45 ~LG~G~~g~Vy~a-~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++.|+.|.+..+ +...|+.+++|++....          .....++.+|+++|+++ +|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4567777777776 55679999999986421          22335688999999999 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||+|++|.++|.....    ++..   .|+.||+.||.|||++|   ||||||||+||||+.+|.+||+|||+++...
T Consensus       321 MEyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            999999999999976432    5443   47899999999999999   9999999999999999999999999998765


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChh
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE  243 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~  243 (400)
                      .... ...+.+||+.|||||++.+ .+..++|+||+|+++++|.++..|+.
T Consensus       391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~  439 (569)
T 4azs_A          391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWL  439 (569)
T ss_dssp             ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHHH
T ss_pred             CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchhH
Confidence            4332 2334679999999999875 56788999999999999988776653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.1e-29  Score=253.37  Aligned_cols=184  Identities=17%  Similarity=0.166  Sum_probs=145.7

Q ss_pred             CcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh--H------HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           41 NYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN--K------AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        41 ~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~--~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ...+.||+|+||.||+|. ..+..+++|.......  .      ....+.+|+++++.++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            446799999999999994 6788999998653221  1      123478999999999999999766666678888999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||+++|+|.+++..            ++.++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999864            4478999999999999998   999999999999999  99999999999775


Q ss_pred             CCCcee------eeecccccCcCChhhhcc--CCCCCccceehhhHHHHHHHhCCCCh
Q 015797          193 DGATHV------TTRVKGTLGYLAPEYAML--GKASESCDVYSFGILLLELASGKKPI  242 (400)
Q Consensus       193 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDIwSlGiil~elltg~~Pf  242 (400)
                      ......      .....||+.|||||++..  ..|+..+|+||..+-..+.+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            432211      124579999999999987  67888999999999888888877766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=5.9e-26  Score=209.94  Aligned_cols=164  Identities=17%  Similarity=0.087  Sum_probs=129.9

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh------------------HHHHHHHHHHHHHhcCC
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN------------------KAEMEFAVEVEILARVR   92 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~   92 (400)
                      ..+......|.+++.||+|+||.||+|.+.+|+.||+|.+.....                  .....+..|+.+|+.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            345555667778899999999999999777799999999864221                  13456889999999999


Q ss_pred             CCccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797           93 HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus        93 hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                        | +++.+++.. +..|+||||++||+|.+ +..          .....++.|++.||.|||+.+   ++||||||+||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI  224 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV  224 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence              5 666665544 56699999999999998 421          124469999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhcc----------CCCCCccceeh
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML----------GKASESCDVYS  227 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~ksDIwS  227 (400)
                      |++ ++.+||+|||++.              .+..++|||++..          ..|+..+|+|.
T Consensus       225 Ll~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSV--------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEE-TTEEEECCCTTCE--------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEE-CCcEEEEECCCCe--------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999 9999999999986              4556899998854          34555666654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=4.1e-21  Score=175.19  Aligned_cols=138  Identities=17%  Similarity=0.218  Sum_probs=106.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCE--EEEEEEecCChH------------------------HHHHHHHHHHHHhc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQ--IAVKRLKVWSNK------------------------AEMEFAVEVEILAR   90 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~   90 (400)
                      .-|.+.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+..|+.+|..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999976 67888  999987532111                        11357789999999


Q ss_pred             CCCCcc--ceeeeEEEeCCeEEEEEEccCC-C----ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHH-hcCCCCe
Q 015797           91 VRHKNL--LSLRGYCAEGQERLIVYDYMPN-L----SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH-HHATPHI  162 (400)
Q Consensus        91 l~hpnI--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~i  162 (400)
                      +.|+++  ..+++.    ...++||||+.+ |    +|.+....       .++..+..++.|++.||.||| ..+   +
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---i  192 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---L  192 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence            988764  333332    356899999942 4    56555421       224567789999999999999 888   9


Q ss_pred             EecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          163 IHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       163 iH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      +||||||+|||++.  .++|+|||++...
T Consensus       193 vHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=7.4e-18  Score=160.34  Aligned_cols=139  Identities=13%  Similarity=0.121  Sum_probs=101.0

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh-----------------HHH-----HHHHHHHHHHhcCCCC
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN-----------------KAE-----MEFAVEVEILARVRHK   94 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~-----------------~~~-----~~~~~E~~~l~~l~hp   94 (400)
                      ..-|+++..||.|++|.||+|...+|+.||||+++....                 ...     .....|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            334999999999999999999888899999998752100                 000     1123467777777554


Q ss_pred             ccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 015797           95 NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLL  174 (400)
Q Consensus        95 nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv  174 (400)
                      ++.-..-+...  ..+|||||+.|++|.++...          .....++.|++.+|.|||..|   ||||||||.|||+
T Consensus       174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl  238 (397)
T 4gyi_A          174 GFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI  238 (397)
T ss_dssp             TCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             CCCCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence            43322211122  23799999999888765421          123467899999999999998   9999999999999


Q ss_pred             CCCC----------cEEEEecCCccc
Q 015797          175 DADF----------KAQVADFGFAKL  190 (400)
Q Consensus       175 ~~~~----------~~kl~Dfgl~~~  190 (400)
                      +.+|          .+.|+||+-+..
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             eCCCCcccccccccceEEEEeCCccc
Confidence            8776          389999987754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.7e-13  Score=124.56  Aligned_cols=147  Identities=11%  Similarity=0.046  Sum_probs=114.1

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEE
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  111 (400)
                      +......|++...++.|+.+.||++.. .++.+++|+...........+..|+.+++.+. +.++.++++++.+.+..|+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            344556799889999999999999974 47899999986422122335888999999884 6778899999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA---------------------------------  158 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------  158 (400)
                      ||||++|.+|.+.+..         ......++.+++.+|..||...                                 
T Consensus        88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999998876321         1223467889999999999811                                 


Q ss_pred             -----------------------CCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          159 -----------------------TPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       159 -----------------------~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                                             .+.++|||++|.||+++.++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   1338999999999999876556799998775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=2.9e-12  Score=115.94  Aligned_cols=141  Identities=14%  Similarity=0.077  Sum_probs=101.9

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc--cceeeeEEEeCCeEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN--LLSLRGYCAEGQERLI  111 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~l  111 (400)
                      ......|.+....+.|..+.||++...+|..+++|.....   ....+..|+.+++.+.+.+  +.+++++...++..++
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            3444556654444466679999997666788999987543   2235778999998885444  5568888888888999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA---------------------------------  158 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------  158 (400)
                      ||||++|.+|.  ...       .+   ...++.+++..|..||...                                 
T Consensus        93 v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           93 LLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            99999998884  211       11   1246677778888888642                                 


Q ss_pred             ----------------------CCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          159 ----------------------TPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       159 ----------------------~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                                            ...++|||++|.||+++.++.+.|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                  1129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=8.7e-11  Score=111.79  Aligned_cols=142  Identities=11%  Similarity=0.152  Sum_probs=104.7

Q ss_pred             cCCcccccCceEEEEEEEcCCCEEEEEEEe--cCC-hHHHHHHHHHHHHHhcCC--CCccceeeeEEEeC---CeEEEEE
Q 015797           42 YDNKLGEGGFGSVYWGQLWDGSQIAVKRLK--VWS-NKAEMEFAVEVEILARVR--HKNLLSLRGYCAEG---QERLIVY  113 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~---~~~~lv~  113 (400)
                      ..+.|+.|.++.||++.. .+..+++|+..  ... ......+..|+.+++.|.  +.++.+++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~-~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT-PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC-SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEE-CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            456799999999999975 45678888765  221 122346788999999986  45678888888776   4589999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA-----------------------------------  158 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------------  158 (400)
                      ||++|..+.+...   .   .++......++.+++.+|+.||...                                   
T Consensus       121 e~v~G~~l~~~~~---~---~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQSL---P---GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTTC---T---TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCcc---c---cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999888754221   1   2566778889999999999999731                                   


Q ss_pred             --------------------CCCeEecCCCCCCeEECCCCc--EEEEecCCccc
Q 015797          159 --------------------TPHIIHRDIKASNVLLDADFK--AQVADFGFAKL  190 (400)
Q Consensus       159 --------------------~~~iiH~dikp~NIlv~~~~~--~kl~Dfgl~~~  190 (400)
                                          .+.++|||++|.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                245999999999999997753  68999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=6.8e-11  Score=109.85  Aligned_cols=187  Identities=17%  Similarity=0.149  Sum_probs=122.9

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcC-CCCc--cceeeeEEEeCC---eEEEEEEcc
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKN--LLSLRGYCAEGQ---ERLIVYDYM  116 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~~~~~~~~~~---~~~lv~e~~  116 (400)
                      .+.++.|.+..||++.    ..+++|...  .......+..|+.+|+.+ .+..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999873    557888754  223456788899999887 3333  334444433333   347899999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA--------------------------------------  158 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------------  158 (400)
                      +|.+|.+....      .++...+..++.+++..|+.||...                                      
T Consensus        99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99888754321      2566677778888888888888621                                      


Q ss_pred             -----------------CCCeEecCCCCCCeEECC--CCcEEEEecCCccccCCCCceeeeecccccCc---CChhhhcc
Q 015797          159 -----------------TPHIIHRDIKASNVLLDA--DFKAQVADFGFAKLIPDGATHVTTRVKGTLGY---LAPEYAML  216 (400)
Q Consensus       159 -----------------~~~iiH~dikp~NIlv~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  216 (400)
                                       .+.++|||++|.||+++.  ++.+.|+||+.+..-.. ....    .....+   ..|+....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl----~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDF----ISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHH----HTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHH----HHHHhhccccCHHHHHH
Confidence                             134899999999999998  45678999999864321 1100    011111   23332211


Q ss_pred             -----CCC---------CCccceehhhHHHHHHHhCCCChhhhh
Q 015797          217 -----GKA---------SESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       217 -----~~~---------s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                           +..         ....+.|++|.++|.+.+|..||....
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g  291 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEG  291 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHH
Confidence                 111         123689999999999999999986544

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.68  E-value=1.9e-07  Score=84.70  Aligned_cols=134  Identities=15%  Similarity=0.140  Sum_probs=96.8

Q ss_pred             cccccCce-EEEEEEEc-CCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           45 KLGEGGFG-SVYWGQLW-DGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        45 ~LG~G~~g-~Vy~a~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      .+..|..| .||+.... .+..+++|+-..   .....+..|+..|+.|. +-.+.+++.++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44555555 68988543 466788887542   23456788999998884 33467888899999999999999999888


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA-------------------------------------------  158 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------------------  158 (400)
                      .+.....        ......+..+++..|..||...                                           
T Consensus       108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            7765321        1233456667777777787431                                           


Q ss_pred             ------------CCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          159 ------------TPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       159 ------------~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                                  .+.++|||+.+.||+++.++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        1128999999999999987767799998875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=3.8e-07  Score=84.58  Aligned_cols=135  Identities=20%  Similarity=0.183  Sum_probs=91.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCC---ccceeeeEEE-eCCeEEEEEEccCCC
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK---NLLSLRGYCA-EGQERLIVYDYMPNL  119 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~-~~~~~~lv~e~~~~g  119 (400)
                      +.++.|....||+.    +..+++|+-.  .......+..|+.+|+.|.+.   .+.+++.++. ..+..++||++++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            56888999999988    5677888742  333456788999999999652   3556666664 455678999999998


Q ss_pred             ChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 015797          120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH------------------------------------------  157 (400)
Q Consensus       120 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~------------------------------------------  157 (400)
                      ++.+.....      ++......++.+++..|+.||..                                          
T Consensus        99 ~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           99 ILGEDGMAV------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             ECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             ECchhhhhh------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            876632110      23334444445555555555432                                          


Q ss_pred             ---------------CCCCeEecCCCCCCeEECC---CCc-EEEEecCCccc
Q 015797          158 ---------------ATPHIIHRDIKASNVLLDA---DFK-AQVADFGFAKL  190 (400)
Q Consensus       158 ---------------~~~~iiH~dikp~NIlv~~---~~~-~kl~Dfgl~~~  190 (400)
                                     ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2234799999999999987   455 48999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=6.3e-07  Score=84.76  Aligned_cols=80  Identities=9%  Similarity=0.036  Sum_probs=53.7

Q ss_pred             Ccc-cccCceEEEEEEEc-------CCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCC-C--CccceeeeEEEeC---
Q 015797           44 NKL-GEGGFGSVYWGQLW-------DGSQIAVKRLKVWS---NKAEMEFAVEVEILARVR-H--KNLLSLRGYCAEG---  106 (400)
Q Consensus        44 ~~L-G~G~~g~Vy~a~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~---  106 (400)
                      +.| +.|....+|+....       ++..+++|......   ......+..|+.+++.|. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88999999998643       26678888754321   001234677888888774 2  3567788777654   


Q ss_pred             CeEEEEEEccCCCChhh
Q 015797          107 QERLIVYDYMPNLSLLS  123 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~  123 (400)
                      +..++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999876643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.23  E-value=6.4e-06  Score=77.05  Aligned_cols=141  Identities=16%  Similarity=0.245  Sum_probs=77.5

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-----CCccceee-e--EEEeCCeEEEEEEc
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-----HKNLLSLR-G--YCAEGQERLIVYDY  115 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~-~--~~~~~~~~~lv~e~  115 (400)
                      +.|+.|..+.||++...++ .+++|+... ..   ..+..|+.+++.|.     .|.++... |  +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999975444 588888764 21   22334455555442     34444311 1  22346778999999


Q ss_pred             cCCCChh--------------hhhhcCCC----c-c-----cccChHHHH------------------------------
Q 015797          116 MPNLSLL--------------SHLHGQHS----S-E-----CLLNWNRRM------------------------------  141 (400)
Q Consensus       116 ~~~gsL~--------------~~l~~~~~----~-~-----~~l~~~~~~------------------------------  141 (400)
                      ++|.++.              ..++....    . .     ....|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11111000    0 0     001222110                              


Q ss_pred             -HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          142 -DIAIGSAEGIVYLHH----------HATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       142 -~i~~qi~~aL~yLH~----------~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                       .+...+..++.+|+.          ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             111123345666653          123459999999999999888889999999775

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.18  E-value=4.2e-06  Score=80.38  Aligned_cols=75  Identities=13%  Similarity=0.145  Sum_probs=48.5

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-------HHHHHHHHHHHHHhcCCC--Ccc-ceeeeEEEeCCeEEE
Q 015797           43 DNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-------KAEMEFAVEVEILARVRH--KNL-LSLRGYCAEGQERLI  111 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--pnI-v~~~~~~~~~~~~~l  111 (400)
                      .+.||.|.++.||++.. .+++.+++|.......       .....+..|+++|+.+..  |.. .+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            45799999999999964 3568899997653211       112346778888887732  433 455543  4455689


Q ss_pred             EEEccCCC
Q 015797          112 VYDYMPNL  119 (400)
Q Consensus       112 v~e~~~~g  119 (400)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.10  E-value=2.4e-05  Score=72.43  Aligned_cols=74  Identities=15%  Similarity=0.117  Sum_probs=59.1

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC---CCccceeeeEEEeCCeEEEEEEccCCCC
Q 015797           44 NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR---HKNLLSLRGYCAEGQERLIVYDYMPNLS  120 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~gs  120 (400)
                      +.|+.|....+|+... ++..+++|+....   ....+..|+..|+.|.   ...+.+++.++...+..++||||+++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            5689999999999974 5778889876532   2456788999998883   3568888888888889999999999876


Q ss_pred             h
Q 015797          121 L  121 (400)
Q Consensus       121 L  121 (400)
                      +
T Consensus       118 ~  118 (312)
T 3jr1_A          118 N  118 (312)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.09  E-value=1e-05  Score=74.06  Aligned_cols=78  Identities=17%  Similarity=0.179  Sum_probs=55.3

Q ss_pred             CCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCC---ccceeeeEEEeCCeEEEEEEcc
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK---NLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      ..-.+.+|.|..+.||+.+..+|+.+++|+-..........+..|+..|+.|.-.   .+.+++.+  +  ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEee
Confidence            4445779999999999999889999999986543333334577899999988422   24445443  2  237899999


Q ss_pred             CCCCh
Q 015797          117 PNLSL  121 (400)
Q Consensus       117 ~~gsL  121 (400)
                      .++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=6e-05  Score=72.84  Aligned_cols=73  Identities=12%  Similarity=0.196  Sum_probs=44.0

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecC----ChH-----HHHHHHHHHHHHh-cCCCCccceeeeEEEeCCeEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW----SNK-----AEMEFAVEVEILA-RVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~----~~~-----~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .+.||.|..+.||++.. ++..+++|.....    ...     ....+..|+..+. ......+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            46799999999999963 5778999943211    111     1222333332222 12234566666654  5677899


Q ss_pred             EEcc-CC
Q 015797          113 YDYM-PN  118 (400)
Q Consensus       113 ~e~~-~~  118 (400)
                      ||++ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.71  E-value=0.00052  Score=63.62  Aligned_cols=97  Identities=11%  Similarity=0.012  Sum_probs=61.9

Q ss_pred             CCcccccHHHHHHHccCCCcC-----CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCC--c
Q 015797           23 PTWRIFSLKELHSATNNFNYD-----NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHK--N   95 (400)
Q Consensus        23 ~~~~~~~~~~~~~~~~~y~~~-----~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp--n   95 (400)
                      .++...+.+.+......|.+.     ..|+ |....||++...+|+.+++|....... ....+..|..+++.|...  .
T Consensus         6 ~~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~   83 (328)
T 1zyl_A            6 FTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVP   83 (328)
T ss_dssp             CCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCS
T ss_pred             CCCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCe
Confidence            456677788887777766542     3466 888899998766677899998763211 233456677777776321  2


Q ss_pred             cceeeeE-----EEeCCeEEEEEEccCCCCh
Q 015797           96 LLSLRGY-----CAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        96 Iv~~~~~-----~~~~~~~~lv~e~~~~gsL  121 (400)
                      +.+++..     ....+..+++|++++|.++
T Consensus        84 vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~  114 (328)
T 1zyl_A           84 VAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  114 (328)
T ss_dssp             BCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ecceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence            3333332     2335667889999987543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.66  E-value=0.00028  Score=65.26  Aligned_cols=160  Identities=16%  Similarity=0.190  Sum_probs=87.8

Q ss_pred             cccHHHHHHHccCCCcC-----CcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-----CCcc
Q 015797           27 IFSLKELHSATNNFNYD-----NKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-----HKNL   96 (400)
Q Consensus        27 ~~~~~~~~~~~~~y~~~-----~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----hpnI   96 (400)
                      .++.+++.....+|.+.     +.|+.|....+|+....++ .+++|.....  .....+..|+.++..|.     -|.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            45677777777778763     3466788899999976555 6778877642  11223455677766663     2333


Q ss_pred             ceee-e--EEEeCCeEEEEEEccCCCChhh--------------hhhcC----CCcc----cccChHHHHH---------
Q 015797           97 LSLR-G--YCAEGQERLIVYDYMPNLSLLS--------------HLHGQ----HSSE----CLLNWNRRMD---------  142 (400)
Q Consensus        97 v~~~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~~----~~l~~~~~~~---------  142 (400)
                      +... |  +....+..+++|+|++|..+..              .++..    ....    ....|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            3211 1  1223467789999998765321              01110    0000    0011221110         


Q ss_pred             ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          143 ---IAIGSAEGIVYLHHH----ATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       143 ---i~~qi~~aL~yLH~~----~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                         +...+...+..++..    ....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               001133445555532    12348999999999999887666899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.48  E-value=0.00016  Score=66.35  Aligned_cols=71  Identities=8%  Similarity=0.034  Sum_probs=43.6

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEEEcc-CCCC
Q 015797           43 DNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVYDYM-PNLS  120 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~-~~gs  120 (400)
                      .+.|+.|....+|+.     ..+++|+..... ........|+.+++.+...++ .+++..  +...-++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678999999999998     567788765321 111123467777776643233 355543  333457899999 6544


Q ss_pred             h
Q 015797          121 L  121 (400)
Q Consensus       121 L  121 (400)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.00059  Score=63.51  Aligned_cols=142  Identities=13%  Similarity=0.070  Sum_probs=70.7

Q ss_pred             CcccccCceE-EEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC--CccceeeeEEEeCCeEEEEEEccCCCC
Q 015797           44 NKLGEGGFGS-VYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH--KNLLSLRGYCAEGQERLIVYDYMPNLS  120 (400)
Q Consensus        44 ~~LG~G~~g~-Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~gs  120 (400)
                      +.|+.|+... +|+....++..+++|.......   ..+..|+.+++.|..  -.+.+++.+..+.+  +++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4566665555 6677543467777775433210   234456666666632  23455665533333  78999997766


Q ss_pred             hhhhhhcCCCc---------------------c-cccChHHHH-------HHH-------------HHHHHHHHHHH---
Q 015797          121 LLSHLHGQHSS---------------------E-CLLNWNRRM-------DIA-------------IGSAEGIVYLH---  155 (400)
Q Consensus       121 L~~~l~~~~~~---------------------~-~~l~~~~~~-------~i~-------------~qi~~aL~yLH---  155 (400)
                      +.+++......                     . ..++.....       .+.             ..+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65444321100                     0 001111000       000             01111222221   


Q ss_pred             hcCCCCeEecCCCCCCeEECCC----CcEEEEecCCccc
Q 015797          156 HHATPHIIHRDIKASNVLLDAD----FKAQVADFGFAKL  190 (400)
Q Consensus       156 ~~~~~~iiH~dikp~NIlv~~~----~~~kl~Dfgl~~~  190 (400)
                      ....+.++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123359999999999999875    6799999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.42  E-value=0.00021  Score=69.25  Aligned_cols=73  Identities=15%  Similarity=0.210  Sum_probs=48.0

Q ss_pred             CCcccccCceEEEEEEEcC--------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVY  113 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~  113 (400)
                      .+.|+.|....+|++...+        +..+++|+......  ...+..|+.+++.|...++ .++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            3568889999999997542        57888887743111  1344578888888853334 55666543  2  2899


Q ss_pred             EccCCCCh
Q 015797          114 DYMPNLSL  121 (400)
Q Consensus       114 e~~~~gsL  121 (400)
                      ||++|-+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.41  E-value=0.00031  Score=66.78  Aligned_cols=141  Identities=15%  Similarity=0.173  Sum_probs=78.9

Q ss_pred             CcccccCceEEEEEEEc--------CCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeEEEEEE
Q 015797           44 NKLGEGGFGSVYWGQLW--------DGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN-LLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e  114 (400)
                      +.|..|....+|+....        ++..+++++.... ......+.+|+++++.|.--+ ..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56878888999999753        2478888875321 122345668999988874222 3556655543    29999


Q ss_pred             ccCCCChhhh--------------h---hcCCC-cccccC--hHHHHHHHHHHHH-------------------HHHHHH
Q 015797          115 YMPNLSLLSH--------------L---HGQHS-SECLLN--WNRRMDIAIGSAE-------------------GIVYLH  155 (400)
Q Consensus       115 ~~~~gsL~~~--------------l---~~~~~-~~~~l~--~~~~~~i~~qi~~-------------------aL~yLH  155 (400)
                      |++|.+|..-              |   +.... -.....  +.++..|..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9987555311              1   11100 000111  3344445443321                   122332


Q ss_pred             ----hcC-CCCeEecCCCCCCeEECCC----CcEEEEecCCcc
Q 015797          156 ----HHA-TPHIIHRDIKASNVLLDAD----FKAQVADFGFAK  189 (400)
Q Consensus       156 ----~~~-~~~iiH~dikp~NIlv~~~----~~~kl~Dfgl~~  189 (400)
                          ..+ ...++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                211 2248999999999999876    789999998875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.37  E-value=0.00065  Score=58.61  Aligned_cols=103  Identities=16%  Similarity=0.078  Sum_probs=66.7

Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      -||.+.|.....   ++++.++|.++.|.+.+|.-+-.+..  -..+=+.|..|++..+|.|-+.+ +.+.         
T Consensus        33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence            478898875543   59999999999999998876622111  11333457999999999988764 1110         


Q ss_pred             eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCC
Q 015797          199 TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP  241 (400)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~P  241 (400)
                          .....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1233567888653 3556788999999999999875554

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.34  E-value=0.00066  Score=66.19  Aligned_cols=73  Identities=10%  Similarity=0.053  Sum_probs=46.0

Q ss_pred             CcccccCceEEEEEEEcC-CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           44 NKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      +.|+.|-...+|++...+ +..+++|+..... ........|+.+++.|...++ .++++.+.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            568889899999997544 4778888764321 111123578888988865554 45666652  3  259999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.10  E-value=0.0027  Score=59.24  Aligned_cols=31  Identities=29%  Similarity=0.360  Sum_probs=27.1

Q ss_pred             CCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          160 PHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       160 ~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3499999999999999888899999987753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.08  E-value=0.00051  Score=64.98  Aligned_cols=74  Identities=8%  Similarity=0.003  Sum_probs=42.9

Q ss_pred             CCcccccCceEEEEEEEcC---------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWD---------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN-LLSLRGYCAEGQERLIV  112 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv  112 (400)
                      .+.|+.|....+|+....+         +..+++|+.... .........|+.+++.|...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567888889999996543         267888875432 111122456888888774333 34565543  2  2689


Q ss_pred             EEccCCCCh
Q 015797          113 YDYMPNLSL  121 (400)
Q Consensus       113 ~e~~~~gsL  121 (400)
                      |+|++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.31  E-value=0.0036  Score=60.22  Aligned_cols=73  Identities=8%  Similarity=0.075  Sum_probs=46.2

Q ss_pred             CcccccCceEEEEEEEcC--------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeEEEEEE
Q 015797           44 NKLGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN-LLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e  114 (400)
                      +.|..|-...+|+....+        +..+++++..... ....+...|+.+++.|...+ ..++++.+  .+  ++||+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            567788889999997542        5788888754322 11223457888888774323 34455433  22  68999


Q ss_pred             ccCCCCh
Q 015797          115 YMPNLSL  121 (400)
Q Consensus       115 ~~~~gsL  121 (400)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.65  E-value=0.017  Score=55.10  Aligned_cols=28  Identities=29%  Similarity=0.527  Sum_probs=24.1

Q ss_pred             eEecCCCCCCeEE------CCCCcEEEEecCCcc
Q 015797          162 IIHRDIKASNVLL------DADFKAQVADFGFAK  189 (400)
Q Consensus       162 iiH~dikp~NIlv------~~~~~~kl~Dfgl~~  189 (400)
                      ++|+|+.+.|||+      +.+..+.++||..+.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456779999998875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.44  E-value=0.36  Score=41.37  Aligned_cols=119  Identities=8%  Similarity=0.049  Sum_probs=80.6

Q ss_pred             CCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 015797           92 RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASN  171 (400)
Q Consensus        92 ~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~N  171 (400)
                      .||+.++. .+-.+.+.+.|.++.-..+.-...+..       .+...++.++.+|+....+++.     -+|--|+|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            68888877 566666776666665543322332432       6678899999999887755543     4888999999


Q ss_pred             eEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          172 VLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       172 Ilv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      ++++.++.+++.-.|+-..+...             =+.+|-+          .-.+=|++..+++++..|...-
T Consensus       110 L~f~~~~~p~i~~RGik~~l~P~-------------~~~ee~f----------L~qyKAliiall~~K~~Fe~l~  161 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVDPL-------------PVSEAEF----------LTRYKALVICAFNEKQSFDALV  161 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBSCC-------------CCCHHHH----------HHHHHHHHHHHHCTTCCHHHHH
T ss_pred             EEEcCCCCEEEEEccCccCCCCC-------------CCCHHHH----------HHHHHHHHHHHHcCCCCHHHHH
Confidence            99999999999877764432211             1122222          1256788999999999997543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.85  E-value=0.66  Score=39.87  Aligned_cols=118  Identities=11%  Similarity=0.102  Sum_probs=79.9

Q ss_pred             CCCccceeeeEEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 015797           92 RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV-YLHHHATPHIIHRDIKAS  170 (400)
Q Consensus        92 ~hpnIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~~~iiH~dikp~  170 (400)
                      .||++  --.+-.+++.+.|.++.-+++.-...+..       ++...++.++.+++.... +++.     -+|--|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            67888  33445677777777776645444444532       666888888888877655 4443     588899999


Q ss_pred             CeEECCCCcEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          171 NVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       171 NIlv~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      |++++.++.+++.-.|+-..+.             |.=+.+|-+.          -++=|++..++.++..|...-
T Consensus       114 NL~f~~~~~p~i~hRGi~~~lp-------------P~e~~ee~fl----------~qyKali~all~~K~~Fe~l~  166 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESLP-------------PDEWDDERLL----------REVKATVLALTEGEYRFDEYL  166 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTBS-------------SCSCCHHHHH----------HHHHHHHHHHTTCSSCHHHHH
T ss_pred             eEEEeCCCcEEEEEcCCcccCC-------------CCCCCHHHHH----------HHHHHHHHHHHcCCCCHHHHH
Confidence            9999999999998777654322             1112333332          256688889999999987543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	400
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-67
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-67
 Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 22/279 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
                  ++G G FG+VY G+      + +  +   + +    F  EV +L + RH N+L
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
              GY     +  IV  +    SL  HLH   +        + +DIA  +A+G+ YLH  
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK 123

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG-ATHVTTRVKGTLGYLAPEYAML 216
               IIHRD+K++N+ L  D   ++ DFG A +      +H   ++ G++ ++APE   +
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 217 ---GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR 273
                 S   DVY+FGI+L EL +G+ P   +N+          +     R +      +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSPDLSK 233

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
           +  N   + +KR++     C   K ++RP   ++L  ++
Sbjct: 234 VRSN-CPKAMKRLM---AECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-62
 Identities = 71/275 (25%), Positives = 125/275 (45%), Gaps = 22/275 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
                  +LG G FG V+ G     +++AVK LK   + +   F  E  ++ +++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L     +     I+ +YM N SL+  L      +  L  N+ +D+A   AEG+ ++   
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER 128

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
              + IHRD++A+N+L+      ++ADFG A+LI D         K  + + APE    G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN 277
             +   DV+SFGILL E+ +  +      +  +         +    +   +  P    +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRMVRP----D 233

Query: 278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
              EEL +++     C   +PE RPT   +  +L+
Sbjct: 234 NCPEELYQLM---RLCWKERPEDRPTFDYLRSVLE 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-62
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 24/276 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
            +  +  +LG G FG V +G+      +A+K +K   + +E EF  E +++  + H+ L+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C + +   I+ +YM N  LL++L             + +++     E + YL   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK 119

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
                +HRD+ A N L++     +V+DFG ++ + D     +   K  + +  PE  M  
Sbjct: 120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 218 KASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
           K S   D+++FG+L+ E+ S GK P E+  ++         L L      SE        
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 228

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                   +V  +  +C H K ++RPT   +L  + 
Sbjct: 229 --------KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 5e-62
 Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 22/275 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
            +   + KLG+G FG V+ G     +++A+K LK     +   F  E +++ ++RH+ L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L       +   IV +YM   SLL  L G+          + +D+A   A G+ Y+   
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVERM 132

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
              + +HRD++A+N+L+  +   +VADFG A+LI D         K  + + APE A+ G
Sbjct: 133 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN 277
           + +   DV+SFGILL EL +  +                       R+  +  +      
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NREVLDQVERGYRMP 234

Query: 278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
              E  + +  +   C   +PE+RPT   +   L+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 7e-62
 Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 22/275 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           +   +  ++G G FG V+ G   +  ++A+K ++     +E +F  E E++ ++ H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L G C E     +V+++M +  L  +L  Q     L      + + +   EG   + + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEG---MAYL 117

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               +IHRD+ A N L+  +   +V+DFG  + + D     +T  K  + + +PE     
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 218 KASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGN 277
           + S   DV+SFG+L+ E+ S  K   +  S  +         +        L  PRL   
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRL--- 226

Query: 278 FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                + +++     C   +PE RP    +L  L 
Sbjct: 227 -ASTHVYQIM---NHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 9e-59
 Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 30/297 (10%)

Query: 45  KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCA 104
            +G+G FG V+ G+ W G ++AVK       +       E+     +RH+N+L       
Sbjct: 10  SIGKGRFGEVWRGK-WRGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 105 EGQ----ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA-- 158
           +      +  +V DY  + SL  +L+        +     + +A+ +A G+ +LH     
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 159 ---TPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV---TTRVKGTLGYLAPE 212
               P I HRD+K+ N+L+  +    +AD G A         +        GT  Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 213 Y------AMLGKASESCDVYSFGILLLELASGKKPIEKVNSA----IKRTITDWALPLAC 262
                      ++ +  D+Y+ G++  E+A                     +D ++    
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 263 ERKFSELADPRLNGNFVEEELKRVVL-VALTCAHSKPEKRPTMLEVLDLLKGESKEK 318
           +    +   P +   +   E  RV+  +   C ++    R T L +   L   S+++
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 9e-58
 Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 31/302 (10%)

Query: 31  KELHSATNNFNY-DNKLGEGGFGSVYWGQL---WDGSQIAVKRLKVWSNKAEME-FAVEV 85
           K+L    +N    D +LG G FGSV  G          +A+K LK  + KA+ E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 86  EILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAI 145
           +I+ ++ +  ++ L G C + +  ++V +      L   L G+      +  +   ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116

Query: 146 GSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VK 203
             + G+ YL      + +HRD+ A NVLL     A+++DFG +K +    ++ T R   K
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLE-LASGKKPIEKVNSAIKRTITDWALPLAC 262
             L + APE     K S   DV+S+G+ + E L+ G+KP +K+         +    + C
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233

Query: 263 ERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTEL 322
             +                EL  ++     C   K E RP  L V   ++       +++
Sbjct: 234 PPECP-------------PELYALM---SDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

Query: 323 EN 324
           E 
Sbjct: 278 EG 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-57
 Identities = 77/281 (27%), Positives = 120/281 (42%), Gaps = 30/281 (10%)

Query: 41  NYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAEME-FAVEVEILARVRHKN 95
           +++  +G G FG VY G L D        AVK L   ++  E+  F  E  I+    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 96  LLSLRGYCAEGQER-LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           +LSL G C   +   L+V  YM +  L + +  +  +         +   +  A+G   +
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKG---M 143

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG---ATHVTTRVKGTLGYLAP 211
              A+   +HRD+ A N +LD  F  +VADFG A+ + D    + H  T  K  + ++A 
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
           E     K +   DV+SFG+LL EL +   P             D  + L   R+      
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGRRL----- 253

Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
             L   +  + L     V L C H K E RP+  E++  + 
Sbjct: 254 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 289

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (476), Expect = 2e-57
 Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 22/282 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ-IAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
            +    +KLG G +G VY G     S  +AVK LK  + + E EF  E  ++  ++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           + L G C       I+ ++M   +LL +L   +  E  ++    + +A   +  + YL  
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK 133

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
               + IHRD+ A N L+  +   +VADFG ++L+           K  + + APE    
Sbjct: 134 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
            K S   DV++FG+LL E+A+                           +  EL +     
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVYELLEKDYRM 235

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEK 318
              E   ++V  +   C    P  RP+  E+    +   +E 
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 61/305 (20%), Positives = 114/305 (37%), Gaps = 44/305 (14%)

Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRH 93
             ++F   ++LG G  G V+       G  +A K + +    A       E+++L     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
             ++   G      E  I  ++M   SL   L         +       ++I   +G+ Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           L       I+HRD+K SN+L+++  + ++ DFG +  + D    +     GT  Y++PE 
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPER 174

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEKVNS-----------------------AIK 250
                 S   D++S G+ L+E+A G+ PI   ++                          
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 251 RTITDWALPLACERKFSELAD-------PRLNGNFVEEELKRVVLVALTCAHSKPEKRPT 303
           R ++ + +         EL D       P+L       E +  V     C    P +R  
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV---NKCLIKNPAERAD 291

Query: 304 MLEVL 308
           + +++
Sbjct: 292 LKQLM 296

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 69/306 (22%), Positives = 129/306 (42%), Gaps = 45/306 (14%)

Query: 28  FSLKELHSATNNFN---------YDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLK-VW 73
           F+ ++ + A   F           +  +G G FG V  G L    +    +A+K LK  +
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 74  SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSEC 133
           + K   +F  E  I+ +  H N++ L G   +    +I+ ++M N SL S L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 134 LLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD 193
                + + +  G A G+ YL      + +HRD+ A N+L++++   +V+DFG ++ + D
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 194 GATHVTTR----VKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
             +  T       K  + + APE     K + + DV+S+GI++ E+ S G++P   + + 
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 249 --IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLE 306
             I     D+ LP                     +    +  + L C       RP   +
Sbjct: 241 DVINAIEQDYRLP------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 307 VLDLLK 312
           +++ L 
Sbjct: 283 IVNTLD 288

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-56
 Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 36/291 (12%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
                   +G+G FG V  G  + G+++AVK +K  ++     F  E  ++ ++RH NL+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63

Query: 98  SLRGYCAEGQERL-IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
            L G   E +  L IV +YM   SL+ +L  +  S  +L  +  +  ++   E + YL  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEG 121

Query: 157 HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
           +   + +HRD+ A NVL+  D  A+V+DFG  K             K  + + APE    
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE 174

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
            K S   DV+SFGILL E+ S  +                 +P   +    +  D     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYKMDAPD----- 223

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTELENDEL 327
                 +  V+     C H     RP+ L++ + L+         ++  EL
Sbjct: 224 -GCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLE--------HIKTHEL 262

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 58/282 (20%), Positives = 102/282 (36%), Gaps = 24/282 (8%)

Query: 35  SATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARV 91
           S   ++     +G G +G     +   DG  +  K L   S           EV +L  +
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 92  RHKNLLSLRGYCAEGQERL--IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
           +H N++       +       IV +Y     L S +         L+    + +      
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 150 GIVYLHHH--ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            +   H        ++HRD+K +NV LD     ++ DFG A+++    T       GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPY 179

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFS 267
           Y++PE       +E  D++S G LL EL +   P    +                  K  
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------------QKELAGKIR 227

Query: 268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
           E    R+   +  +EL  ++       + K   RP++ E+L+
Sbjct: 228 EGKFRRIPYRY-SDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (466), Expect = 7e-56
 Identities = 62/314 (19%), Positives = 112/314 (35%), Gaps = 50/314 (15%)

Query: 29  SLKELHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKV-WSNKAEMEF 81
            L  L    NN  Y   +GEG FG V+  +          + +AVK LK   S   + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 82  AVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECL------- 134
             E  ++A   + N++ L G CA G+   ++++YM    L   L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 135 -------------LNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ 181
                        L+   ++ IA   A G+ YL        +HRD+   N L+  +   +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 182 VADFGFAKLIPDG-ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKK 240
           +ADFG ++ I               + ++ PE     + +   DV+++G++L E+ S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 241 PI--EKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKP 298
                  +  +   + D  +                     E     +  +   C    P
Sbjct: 241 QPYYGMAHEEVIYYVRDGNIL-----------------ACPENCPLELYNLMRLCWSKLP 283

Query: 299 EKRPTMLEVLDLLK 312
             RP+   +  +L+
Sbjct: 284 ADRPSFCSIHRILQ 297

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 7e-56
 Identities = 62/284 (21%), Positives = 127/284 (44%), Gaps = 29/284 (10%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ-----IAVKRLKV-WSNKAEMEFAVEVEILARV 91
           +       +G G FG VY G L   S      +A+K LK  ++ K  ++F  E  I+ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 92  RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGI 151
            H N++ L G  ++ +  +I+ +YM N +L          +   +  + + +  G A G+
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGM 123

Query: 152 VYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG--ATHVTTRVKGTLGYL 209
            YL +    + +HRD+ A N+L++++   +V+DFG ++++ D   AT+ T+  K  + + 
Sbjct: 124 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
           APE     K + + DV+SFGI++ E+ +  +      S                 +  + 
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------------NHEVMKA 225

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG 313
            +         +    +  + + C   +  +RP   +++ +L  
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-55
 Identities = 71/303 (23%), Positives = 124/303 (40%), Gaps = 40/303 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEME-FAVEVEILAR 90
           N  ++   LG G FG V     +          +AVK LK  ++  E E    E+++L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSS--------------ECLL 135
           +  H N+++L G C  G   L++ +Y     LL+ L  +  S              E  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
           +    +  +   A+G+ +L      + IHRD+ A N+LL      ++ DFG A+ I + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 196 TH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT 254
            + V    +  + ++APE       +   DV+S+GI L EL S                 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253

Query: 255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE 314
                   + KF ++          E     +  +  TC  + P KRPT  +++ L++ +
Sbjct: 254 --------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

Query: 315 SKE 317
             E
Sbjct: 306 ISE 308

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 7e-55
 Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 32/287 (11%)

Query: 43  DNKLGEGGFGSVYWGQLWD---GSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKNLL 97
           D +LG G FG+V  G          +AVK LK  +N   +  E   E  ++ ++ +  ++
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            + G C E +  ++V +      L  +L         +     +++    + G+ YL   
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 126

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTR--VKGTLGYLAPEYAM 215
              + +HRD+ A NVLL     A+++DFG +K +     +   +   K  + + APE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 216 LGKASESCDVYSFGILLLE-LASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRL 274
             K S   DV+SFG+L+ E  + G+KP   +  +    + +    + C            
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP------- 236

Query: 275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTE 321
                  E+  ++     C     E RP    V   L+    + + E
Sbjct: 237 ------REMYDLM---NLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 9e-55
 Identities = 62/280 (22%), Positives = 117/280 (41%), Gaps = 35/280 (12%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKV--WSNKAEMEFAVEVEILARVRHKNL 96
             +D ++G G F +VY G   +   ++A   L+    +      F  E E+L  ++H N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 97  LSLRGYCAEGQER----LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           +          +     ++V + M + +L ++L         +             +G+ 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQ 126

Query: 153 YLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAP 211
           +LH   TP IIHRD+K  N+ +       ++ D G A L           V GT  ++AP
Sbjct: 127 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAP 182

Query: 212 EYAMLGKASESCDVYSFGILLLELASGKKPIEKVNS--AIKRTITDWALPLACERKFSEL 269
           E     K  ES DVY+FG+ +LE+A+ + P  +  +   I R +T    P + ++     
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI-- 239

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                       E+K ++     C     ++R ++ ++L+
Sbjct: 240 -----------PEVKEII---EGCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 4e-54
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 37/293 (12%)

Query: 40  FNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVRHKN 95
           F+   ++G G FG+VY+ + + +   +A+K++      SN+   +   EV  L ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
            +  RG         +V +Y    +       +      L       +  G+ +G+ YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH 132

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H   ++IHRD+KA N+LL      ++ DFG A ++            GT  ++APE  +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 216 L---GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADP 272
               G+     DV+S GI  +ELA  K P+  +N             ++     ++   P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------------AMSALYHIAQNESP 232

Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLTEL 322
            L      E  +  V    +C    P+ RPT   +L    +L+      + +L
Sbjct: 233 ALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 4e-54
 Identities = 65/296 (21%), Positives = 119/296 (40%), Gaps = 33/296 (11%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN 95
            + +    +LG+G FG VY  Q        A K +   S +   ++ VE++ILA   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L           I+ ++    ++ + +         L  ++   +   + + + YLH
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLH 127

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            +    IIHRD+KA N+L   D   ++ADFG +           + + GT  ++APE  M
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183

Query: 216 LGKA-----SESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERKFSE 268
              +         DV+S GI L+E+A  + P  ++N    + +        LA   ++S 
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS- 242

Query: 269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD--LLKGESKEKLTEL 322
                          K  +     C     + R T  ++L    +  +S + + EL
Sbjct: 243 ------------SNFKDFL---KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 6e-54
 Identities = 65/306 (21%), Positives = 123/306 (40%), Gaps = 47/306 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ------IAVKRLKVWSNKAEME-FAVEVEILAR 90
            N  +   LG G FG V     +  S+      +AVK LK  ++ +E E    E++++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 91  V-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ-------------------HS 130
           +  H+N+++L G C       ++++Y     LL++L  +                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 131 SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL 190
              +L +   +  A   A+G+ +L        +HRD+ A NVL+      ++ DFG A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 191 IPDGATHVT-TRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA 248
           I   + +V     +  + ++APE    G  +   DV+S+GILL E+ S G  P   +   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272

Query: 249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                         +  F +L       +      + + ++  +C      KRP+   + 
Sbjct: 273 --------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 309 DLLKGE 314
             L  +
Sbjct: 319 SFLGCQ 324

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-53
 Identities = 71/277 (25%), Positives = 111/277 (40%), Gaps = 33/277 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVRH 93
            +F     LG+G FG+VY  +       +A+K L    +     E +   EVEI + +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
            N+L L GY  +     ++ +Y P  ++   L          +  R        A  + Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
            H      +IHRDIK  N+LL +  + ++ADFG++   P         + GTL YL PE 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                  E  D++S G+L  E   GK P E        + I+                  
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----------- 224

Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
               +FV E  + ++          P +RP + EVL+
Sbjct: 225 ----DFVTEGARDLI---SRLLKHNPSQRPMLREVLE 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 8e-53
 Identities = 69/312 (22%), Positives = 130/312 (41%), Gaps = 38/312 (12%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ---IAVKRLKVWSNKAEM-EFAVEVEILARV-R 92
           N+  + + +GEG FG V   ++         A+KR+K +++K +  +FA E+E+L ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQH------------SSECLLNWNRR 140
           H N+++L G C       +  +Y P+ +LL  L                S+   L+  + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
           +  A   A G   + + +    IHRD+ A N+L+  ++ A++ADFG ++          T
Sbjct: 130 LHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPL 260
             +  + ++A E       + + DV+S+G+LL E+ S         +             
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----------CA 233

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLT 320
               K  +        N  +E    V  +   C   KP +RP+  ++L  L     E+  
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN-RMLEERK 288

Query: 321 ELENDELFKSHQ 332
              N  L++   
Sbjct: 289 TYVNTTLYEKFT 300

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-52
 Identities = 74/286 (25%), Positives = 113/286 (39%), Gaps = 34/286 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLK---VWSNKAEMEFAVEVEILAR 90
            +     KLG+G FG V  G+          +AVK LK   +   +A  +F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
           + H+NL+ L G       + +V +  P  SLL  L                  A+  AEG
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEG 123

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH--VTTRVKGTLGY 208
           + YL        IHRD+ A N+LL      ++ DFG  + +P    H  +    K    +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVN-SAIKRTITDWALPLACERKF 266
            APE       S + D + FG+ L E+ + G++P   +N S I   I      L      
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                         +++  V+   + C   KPE RPT + + D L 
Sbjct: 241 P-------------QDIYNVM---VQCWAHKPEDRPTFVALRDFLL 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 28/275 (10%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN 95
              +    K+G+G  G+VY    +  G ++A++++ +     +     E+ ++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           +++       G E  +V +Y+   SL   +             +   +     + + +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH 133

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            +    +IHRDIK+ N+LL  D   ++ DFGF   I    +  +T V GT  ++APE   
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNS--AIKRTITDWALPLACERKFSELADPR 273
                   D++S GI+ +E+  G+ P    N   A+    T+    L    K S      
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS------ 243

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                     +  +     C     EKR +  E+L
Sbjct: 244 -------AIFRDFL---NRCLDMDVEKRGSAKELL 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 8e-52
 Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 25/275 (9%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKN 95
            +++    LGEG +G V           +AVK + +            E+ I   + H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++   G+  EG  + +  +Y     L   +         +              G+VYLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEYA 214
                 I HRDIK  N+LLD     +++DFG A +   +    +  ++ GTL Y+APE  
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 215 MLGK-ASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR 273
              +  +E  DV+S GI+L  + +G+ P ++ + + +               + E     
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------YSDWKEKKTYL 226

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                ++     ++          P  R T+ ++ 
Sbjct: 227 NPWKKIDSAPLALL---HKILVENPSARITIPDIK 258

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-51
 Identities = 66/319 (20%), Positives = 126/319 (39%), Gaps = 33/319 (10%)

Query: 40  FNYDNKLGEGGFGSVYWGQLWDGSQ-----IAVKRLK-VWSNKAEMEFAVEVEILARVRH 93
           F     LG G FG+VY G      +     +A+K L+   S KA  E   E  ++A V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
            ++  L G C     +LI             L      +  +     ++  +  A+G+ Y
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPE 212
           L       ++HRD+ A NVL+      ++ DFG AKL+  +   +     K  + ++A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 213 YAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIKRTITDWALPLACERKFSELAD 271
             +    +   DV+S+G+ + EL + G KP + + ++   +I +    L      +    
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI--- 240

Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK--EKLTELENDELFK 329
                         V ++ + C     + RP   E++      ++  ++   ++ DE   
Sbjct: 241 -------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287

Query: 330 SHQVADYNDGKAVAEDSAE 348
                D N  +A+ ++   
Sbjct: 288 LPSPTDSNFYRALMDEEDM 306

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 3e-50
 Identities = 62/301 (20%), Positives = 127/301 (42%), Gaps = 36/301 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRL-KVWSNKAEMEFAVEVEILAR 90
                  +LG+G FG VY G           +++A+K + +  S +  +EF  E  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLH------GQHSSECLLNWNRRMDIA 144
               +++ L G  ++GQ  L++ + M    L S+L         +      + ++ + +A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 145 IGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG-ATHVTTRVK 203
              A+G+ YL+ +     +HRD+ A N ++  DF  ++ DFG  + I +        +  
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 204 GTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPI--EKVNSAIKRTITDWALPLA 261
             + +++PE    G  +   DV+SFG++L E+A+  +       N  + R + +  L   
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL-- 254

Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESKEKLTE 321
                          +  +     +  +   C    P+ RP+ LE++  +K E +    E
Sbjct: 255 ---------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

Query: 322 L 322
           +
Sbjct: 300 V 300

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 2e-49
 Identities = 60/333 (18%), Positives = 130/333 (39%), Gaps = 31/333 (9%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           ++++   +LG G FG V+       G+  A K +       +     E++ ++ +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 97  LSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH 156
           ++L     +  E +++Y++M    L   +  +H+    ++ +  ++      +G+ ++H 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHE 142

Query: 157 HATPHIIHRDIKASNVLLDADF--KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
           +   + +H D+K  N++       + ++ DFG    +    +   T   GT  + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197

Query: 215 MLGKASESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACERKFSELADPR 273
                    D++S G+L   L SG  P    N     R +       +C+    + A   
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDWNMDDSAFSG 251

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD---LLKGESKEKLTELENDELFKS 330
           ++     E+ K  +   L      P  R T+ + L+   L  G +  + +++ +    K 
Sbjct: 252 IS-----EDGKDFIRKLLLA---DPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303

Query: 331 HQVADYNDGKAVAEDSAEKLAELENDELFKSHQ 363
                         +    L  + N    + H+
Sbjct: 304 RDSIKTK--YDAWPEPLPPLGRISNYSSLRKHR 334

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-48
 Identities = 63/283 (22%), Positives = 109/283 (38%), Gaps = 33/283 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQ----IAVKRLKVWSNKAEME-FAVEVEILARVR 92
                   +GEG FG V+ G           +A+K  K  ++ +  E F  E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           H +++ L G   E     I+ +      L S L  +  S   L+    +  A   +  + 
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALA 122

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           YL        +HRDI A NVL+ ++   ++ DFG ++ + D   +  ++ K  + ++APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 213 YAMLGKASESCDVYSFGILLLE-LASGKKPIEKVN--SAIKRTITDWALPLACERKFSEL 269
                + + + DV+ FG+ + E L  G KP + V     I R      LP+         
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP-------- 231

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                        L  ++     C    P +RP   E+   L 
Sbjct: 232 -------PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-47
 Identities = 62/277 (22%), Positives = 105/277 (37%), Gaps = 31/277 (11%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVRHK 94
           +F +   LGEG F +V   + L    + A+K L+   +           E ++++R+ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
             + L     + ++      Y  N  LL ++    S     +              + YL
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI-PDGATHVTTRVKGTLGYLAPEY 213
           H      IIHRD+K  N+LL+ D   Q+ DFG AK++ P+          GT  Y++PE 
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACERKFSELADP 272
                A +S D+++ G ++ +L +G  P    N   I + I           KF      
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFF----- 234

Query: 273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                    + + +V   L        KR    E+  
Sbjct: 235 --------PKARDLVEKLLVL---DATKRLGCEEMEG 260

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  161 bits (408), Expect = 1e-46
 Identities = 57/293 (19%), Positives = 111/293 (37%), Gaps = 26/293 (8%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           +LG G FG V+       G     K +       +     E+ I+ ++ H  L++L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 104 AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHII 163
            +  E +++ +++    L   +  +      ++    ++    + EG+ ++H H    I+
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHEH---SIV 149

Query: 164 HRDIKASNVLLDADFKAQV--ADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASE 221
           H DIK  N++ +    + V   DFG A  +      +      T  + APE         
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGF 207

Query: 222 SCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNGNFVEE 281
             D+++ G+L   L SG  P    +      +        C+ +F E A   ++      
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVKRCDWEFDEDAFSSVS-----P 257

Query: 282 ELKRVVLVALTCAHSKPEKRPTMLEVLD--LLKGESKEKLTELENDELFKSHQ 332
           E K  +         +P KR T+ + L+   LKG+     + + +    K  Q
Sbjct: 258 EAKDFI---KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-45
 Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 41/298 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQL--------WDGSQIAVKRLKVWSNKAEM-EFAVEVEIL 88
           +       LGEG FG V   +            +++AVK LK  + + ++ +   E+E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 89  ARV-RHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQ------------HSSECLL 135
             + +HKN+++L G C +     ++ +Y    +L  +L  +            H+ E  L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 136 NWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA 195
           +    +  A   A G+ YL        IHRD+ A NVL+  D   ++ADFG A+ I    
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 196 THVTTRV-KGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTIT 254
            +  T   +  + ++APE       +   DV+SFG+LL E+ +                 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 243

Query: 255 DWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
           +    L  E    +             EL  ++     C H+ P +RPT  ++++ L 
Sbjct: 244 EELFKLLKEGHRMDKPS------NCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLD 292

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 4e-45
 Identities = 67/297 (22%), Positives = 117/297 (39%), Gaps = 39/297 (13%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNKAEM-EFAVEVEILAR 90
           +       LG G FG V     +          +AVK LK  +  +E      E++IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 91  -VRHKNLLSLRGYCAE-GQERLIVYDYMPNLSLLSHLHGQHS------------SECLLN 136
              H N+++L G C + G   +++ ++    +L ++L  + +             +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 137 WNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT 196
               +  +   A+G+ +L        IHRD+ A N+LL      ++ DFG A+ I     
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 197 HV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITD 255
           +V     +  L ++APE       +   DV+SFG+LL E+ S               I +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDE 244

Query: 256 WALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                  E       D      +   E+ + +   L C H +P +RPT  E+++ L 
Sbjct: 245 EFCRRLKEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  154 bits (391), Expect = 4e-44
 Identities = 77/384 (20%), Positives = 145/384 (37%), Gaps = 45/384 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAE------MEFAVEVEILAR 90
           N+F+    +G GGFG VY  +    G   A+K L     K +      +   + + +++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
                ++ +        +   + D M    L  HL          +       A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
           + ++H+     +++RD+K +N+LLD     +++D G A        H +    GT GY+A
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173

Query: 211 PEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSEL 269
           PE    G A   S D +S G +L +L  G  P  +  +  K  I    L +A E      
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 229

Query: 270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML-----EVLD--LLKGESKEKLTEL 322
                  +    EL+ ++   L        +R   L     EV +    +    + +   
Sbjct: 230 -------DSFSPELRSLLEGLLQR---DVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQ 279

Query: 323 ENDELFK----SHQVADYNDGKAVAEDSAEKLAELEND-ELFKSHQ-VADYNDGKAVAED 376
           +              AD  D  +  E+  + +  L++D EL+++          + VAE 
Sbjct: 280 KYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAET 339

Query: 377 STDSISEEKDLKQVKEEIEPEKAQ 400
             D+I+ E D  + +++ + ++  
Sbjct: 340 VFDTINAETDRLEARKKTKNKQLG 363

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 4e-44
 Identities = 65/282 (23%), Positives = 108/282 (38%), Gaps = 30/282 (10%)

Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILA 89
           KEL+     +     LG G FG V+             K +KV     ++    E+ IL 
Sbjct: 1   KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILN 56

Query: 90  RVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAE 149
             RH+N+L L       +E +++++++  L +   ++   +S   LN    +       E
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCE 113

Query: 150 GIVYLHHHATPHIIHRDIKASNVLLDADFKAQV--ADFGFAKLIPDGATHVTTRVKGTLG 207
            + +LH H   +I H DI+  N++      + +   +FG A+ +  G             
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPE 168

Query: 208 YLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE-KVNSAIKRTITDWALPLACERKF 266
           Y APE       S + D++S G L+  L SG  P   + N  I   I      +  E  F
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTF 222

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
            E A   ++      E    V   L     + + R T  E L
Sbjct: 223 DEEAFKEIS-----IEAMDFVDRLLV---KERKSRMTASEAL 256

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (384), Expect = 5e-44
 Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 36/290 (12%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVR 92
           ++ +     LG GG   V+  + L     +AVK L+          + F  E +  A + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 93  HKNLLSLRGYCAE----GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
           H  ++++          G    IV +Y+  ++L   +H +      +   R +++   + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV--TTRVKGTL 206
           + + + H +    IIHRD+K +N+++ A    +V DFG A+ I D    V  T  V GT 
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN--SAIKRTITDWALPLACER 264
            YL+PE A         DVYS G +L E+ +G+ P    +  S   + + +  +P     
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----- 233

Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-TMLEVL-DLLK 312
                  P      +  +L  VVL AL      PE R  T  E+  DL++
Sbjct: 234 -------PSARHEGLSADLDAVVLKAL---AKNPENRYQTAAEMRADLVR 273

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 6e-43
 Identities = 54/281 (19%), Positives = 100/281 (35%), Gaps = 23/281 (8%)

Query: 31  KELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRL-KVWSNKAEMEFAVEVEIL 88
           K+     + +++ + LG G F  V   +       +A+K + K      E     E+ +L
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
            +++H N+++L      G    ++   +    L   +  +              +     
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
           + + YLH     H   +        LD D K  ++DFG +K+   G   V +   GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACERKFS 267
           +APE       S++ D +S G++   L  G  P    N + +   I              
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF------- 228

Query: 268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                    + + +  K  +   +      PEKR T  + L
Sbjct: 229 ----DSPYWDDISDSAKDFIRHLM---EKDPEKRFTCEQAL 262

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (372), Expect = 3e-42
 Identities = 68/288 (23%), Positives = 105/288 (36%), Gaps = 41/288 (14%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSN---------KAEMEFAVEVEIL 88
           N+     LG G    V          + AVK + V            +       EV+IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 89  ARVR-HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGS 147
            +V  H N++ L+          +V+D M    L  +L  + +    L+      I    
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119

Query: 148 AEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLG 207
            E I  LH     +I+HRD+K  N+LLD D   ++ DFGF+  +  G       V GT  
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPS 174

Query: 208 YLAPEYAMLGKA------SESCDVYSFGILLLELASGKKPIEKVNS-AIKRTITDWALPL 260
           YLAPE              +  D++S G+++  L +G  P        + R I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                           +   + +K +V   L     +P+KR T  E L
Sbjct: 235 -----------GSPEWDDYSDTVKDLVSRFLVV---QPQKRYTAEEAL 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (373), Expect = 6e-42
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 15/213 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVRH 93
            +F     LG G FG V+  +   +G   A+K LK   V   K       E  +L+ V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
             ++ + G   + Q+  ++ DY+    L S L         +      ++ +        
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------A 116

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           L +  +  II+RD+K  N+LLD +   ++ DFGFAK +PD    VT  + GT  Y+APE 
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEV 172

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
                 ++S D +SFGIL+ E+ +G  P    N
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 48/285 (16%), Positives = 104/285 (36%), Gaps = 21/285 (7%)

Query: 39  NFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKN 95
           NF    K+GEG +G VY  +    G  +A+K++++ +    +      E+ +L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L        +  +V++++ +  L   +     +   +             +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
            H    ++HRD+K  N+L++ +   ++ADFG A+         T  V             
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSA--------IKRTITDWALPLACERKFS 267
               S + D++S G +  E+ + +      +             T  +   P        
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 268 ELADPRLNGNFVEEELKRVVLVALT----CAHSKPEKRPTMLEVL 308
           + + P+       + +  +     +      H  P KR +    L
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 56/286 (19%), Positives = 98/286 (34%), Gaps = 29/286 (10%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
           N +    K+G G FG +Y G  +  G ++A+K   V       +  +E +I   ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64

Query: 97  LSLRGYC-AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           +    +C AEG   ++V + +                   +    + +A      I Y+H
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIH 120

Query: 156 HHATPHIIHRDIKASNVL---LDADFKAQVADFGFAKLIPDGATHV------TTRVKGTL 206
                + IHRD+K  N L           + DFG AK   D  TH          + GT 
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF 266
            Y +    +  + S   D+ S G +L+    G  P + + +A     T          K 
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-----TKRQKYERISEKK 232

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
                  L   +   E    +     C   + + +P    +  L +
Sbjct: 233 MSTPIEVLCKGY-PSEFATYL---NFCRSLRFDDKPDYSYLRQLFR 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 55/293 (18%), Positives = 109/293 (37%), Gaps = 24/293 (8%)

Query: 36  ATNNFNYDNKLGEGGFGSVYWGQ--LWDGSQIAVKRLKVWSNKAEMEFAVEVEI-----L 88
           A   +    ++GEG +G V+  +     G  +A+KR++V + +  M  +   E+     L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 89  ARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLS--HLHGQHSSECLLNWNRRMDIAIG 146
               H N++ L   C   +        +    +      +     E  +      D+   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 147 SAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTL 206
              G+ +LH H    ++HRD+K  N+L+ +  + ++ADFG A++         T V  TL
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKP------IEKVNSAIKRTITDWALPL 260
            Y APE  +    +   D++S G +  E+   K        ++++   +           
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 261 ACERKFSELADPRLNGNFVEEELKRVVLVALT----CAHSKPEKRPTMLEVLD 309
             +      A    +   +E+ +  +  +       C    P KR +    L 
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 4e-40
 Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 32/277 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARV-R 92
            +F     LG+G FG V+  +        A+K LK   V  +       VE  +L+    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 93  HKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV 152
           H  L  +       +    V +Y+    L+ H+   H      + +R    A     G+ 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117

Query: 153 YLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPE 212
           +LH      I++RD+K  N+LLD D   ++ADFG  K    G     T   GT  Y+APE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173

Query: 213 YAMLGKASESCDVYSFGILLLELASGKKPIEKVN-SAIKRTITDWALPLACERKFSELAD 271
             +  K + S D +SFG+LL E+  G+ P    +   +  +I                  
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP---------- 223

Query: 272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVL 308
                 ++E+E K +++        +PEKR  +   +
Sbjct: 224 -----RWLEKEAKDLLVKLFVR---EPEKRLGVRGDI 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  142 bits (358), Expect = 4e-40
 Identities = 55/286 (19%), Positives = 104/286 (36%), Gaps = 21/286 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHKN 95
             ++   K+GEG +G VY  Q   G   A+K++++      +      E+ IL  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L       +  ++V++++           +      L         +    GI Y H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH 117

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM 215
                 ++HRD+K  N+L++ + + ++ADFG A+         T  +             
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 216 LGKASESCDVYSFGILLLELASGKKPIEKVNSA--------IKRTITDWALPLACERKFS 267
             K S + D++S G +  E+ +G      V+ A        I  T      P   E    
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 268 ELADPRLNGNFVEEELKRVVLVAL----TCAHSKPEKRPTMLEVLD 309
           +           E  LK +    +          P +R T  + L+
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 9e-40
 Identities = 66/291 (22%), Positives = 105/291 (36%), Gaps = 29/291 (9%)

Query: 39  NFNYDNKLGEGGFGSVYWGQLWD-GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLL 97
           ++     +G G FG VY  +L D G  +A+K++     + +     E++I+ ++ H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76

Query: 98  SLRGYCAEGQER------LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGI 151
            LR +     E+       +V DY+P        H   + + L                +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-PVIYVKLYMYQLFRSL 135

Query: 152 VYLHHHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLA 210
            Y+H      I HRDIK  N+LLD D    ++ DFG AK +  G     + +        
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAP 191

Query: 211 PEYAMLGKASESCDVYSFGILLLELASGKKP------------IEKVNSAIKRTITDWAL 258
                    + S DV+S G +L EL  G+              I KV     R       
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
           P   E KF ++        F        + +        P  R T LE   
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-39
 Identities = 61/287 (21%), Positives = 105/287 (36%), Gaps = 32/287 (11%)

Query: 44  NKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWS-----NKAEMEFAVEVEILARVRHKNLL 97
           + LGEG F +VY  +       +A+K++K+       +        E+++L  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 98  SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH 157
            L           +V+D+M     +            L  +      + + +G+ YLH H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQH 119

Query: 158 ATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLG 217
               I+HRD+K +N+LLD +   ++ADFG AK         T +V  T  Y APE     
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 218 KA-SESCDVYSFGILLLELASGKKP------------IEKVNSAIKRTITDWALPLACER 264
           +      D+++ G +L EL                  I +               L    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 265 KFSELADPRLNGNF--VEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            F       L+  F    ++L  ++          P  R T  + L 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF---NPCARITATQALK 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 57/291 (19%), Positives = 111/291 (38%), Gaps = 23/291 (7%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME-FAVEVEILARVRHK 94
              +   + +GEG +G V       +  ++A+K++  + ++   +    E++IL R RH+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           N++ +           +   Y+    L+     +      L+ +           G+ Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVT--TRVKGTLGYLAPE 212
           H     +++HRD+K SN+LL+     ++ DFG A++      H    T    T  Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 213 YAMLGKA-SESCDVYSFGILLLELASGKKP----------IEKVNSAIKRTITDWALPLA 261
             +  K  ++S D++S G +L E+ S +               +      +  D    + 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 262 CERKFSELADPRLNGNFVEEELKRVVLVALT----CAHSKPEKRPTMLEVL 308
            + +   L+ P  N              AL          P KR  + + L
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 74/336 (22%), Positives = 129/336 (38%), Gaps = 37/336 (11%)

Query: 46  LGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARV-RHKNLLSLRGYC 103
           LG G  G V          + A+K L+            EVE+  R  +  +++ +    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPK-ARREVELHWRASQCPHIVRIVDVY 74

Query: 104 ----AEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHAT 159
               A  +  LIV + +    L S +  +             +I     E I YLH    
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI-- 130

Query: 160 PHIIHRDIKASNVLLDA---DFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAML 216
            +I HRD+K  N+L  +   +   ++ DFGFAK      +  T     T  Y+APE    
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187

Query: 217 GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPRLNG 276
            K  +SCD++S G+++  L  G  P    +          +  +    +  +   P    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPEW 241

Query: 277 NFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD--LLKGESKEKLTELENDELFKSHQVA 334
           + V EE+K ++        ++P +R T+ E ++   +   +K   T L    + K     
Sbjct: 242 SEVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE---- 294

Query: 335 DYNDGKAVAEDSAEKLAELEND-ELFKSHQVADYND 369
           D    + V E+    LA +  D E  K  ++ D ++
Sbjct: 295 DKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  136 bits (344), Expect = 5e-38
 Identities = 46/288 (15%), Positives = 90/288 (31%), Gaps = 31/288 (10%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL 96
            ++    ++GEG FG ++ G  L +  Q+A+K           +   E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62

Query: 97  L-SLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           + ++  +  EG   ++V D +      S            +       A      +  +H
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 156 HHATPHIIHRDIKASNVLLDADFKAQ-----VADFGFAKLIPDGATHV------TTRVKG 204
                 +++RDIK  N L+            V DFG  K   D  T           + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 205 TLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER 264
           T  Y++    +  + S   D+ + G + +    G  P + + +A  +   +         
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235

Query: 265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK 312
              EL           EE  + +       +   +  P    +  L  
Sbjct: 236 PLRELCA------GFPEEFYKYM---HYARNLAFDATPDYDYLQGLFS 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-37
 Identities = 55/283 (19%), Positives = 102/283 (36%), Gaps = 33/283 (11%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM------EFAVEVEILAR 90
           + ++   +LG G F  V   +    G Q A K +K    K+        +   EV IL  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 91  VRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEG 150
           ++H N+++L        + +++ + +        L    + +  L      +       G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 151 IVYLHHHATPHIIHRDIKASNVLLDAD----FKAQVADFGFAKLIPDGATHVTTRVKGTL 206
              +++  +  I H D+K  N++L        + ++ DFG A  I  G  +    + GT 
Sbjct: 126 ---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTP 180

Query: 207 GYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKF 266
            ++APE           D++S G++   L SG  P               A   A   +F
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQETLANVSAVNYEF 235

Query: 267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
            +      +        K  +   L      P+KR T+ + L 
Sbjct: 236 EDEYFSNTS-----ALAKDFIRRLL---VKDPKKRMTIQDSLQ 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 2e-37
 Identities = 48/288 (16%), Positives = 107/288 (37%), Gaps = 23/288 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHK 94
             +    K+GEG +G+V+  +       +A+KR+++  +   +      E+ +L  ++HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYL 154
           N++ L       ++  +V+++              S    L+            +G+ + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 155 HHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
           H     +++HRD+K  N+L++ + + ++A+FG A+         +  V            
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 215 MLGKASESCDVYSFGILLLELASGKKPIEKVNS---------AIKRTITDWALPLACERK 265
                S S D++S G +  ELA+  +P+   N           +  T T+   P   +  
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 266 FSELADPRLNGNFVEEELKRVVLVALT----CAHSKPEKRPTMLEVLD 309
             +          +   + ++               P +R +  E L 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-37
 Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 43/276 (15%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEME------FAVEVEILARVR--HKN 95
            LG GGFGSVY G  + D   +A+K ++        E        +EV +L +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 96  LLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLH 155
           ++ L  +       +++ +    +  L     +  +   L             E + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127

Query: 156 HHATPHIIHRDIKASNVLLDAD-FKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYA 214
           +     ++HRDIK  N+L+D +  + ++ DFG   L+ D    V T   GT  Y  PE+ 
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWI 181

Query: 215 MLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELADPR 273
              +    S  V+S GILL ++  G  P E     I+         +   ++ S      
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-------QVFFRQRVS------ 228

Query: 274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD 309
                   E + ++     C   +P  RPT  E+ +
Sbjct: 229 -------SECQHLI---RWCLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 6e-36
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 12/213 (5%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK---VWSNKAEMEFAVEVEILARVRH 93
           N+F+Y   LG+G FG V   +    G   A+K L+   + +         E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
             L +L+           V +Y     L  HL      E +    R        AE +  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYG---AEIVSA 117

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           L +  +  +++RDIK  N++LD D   ++ DFG  K        + T   GT  YLAPE 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV 176

Query: 214 AMLGKASESCDVYSFGILLLELASGKKPIEKVN 246
                   + D +  G+++ E+  G+ P    +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-35
 Identities = 56/295 (18%), Positives = 113/295 (38%), Gaps = 23/295 (7%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRHK 94
           + +    K+G+G FG V+  +    G ++A+K++ + + K         E++IL  ++H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 95  NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIV-Y 153
           N+++L   C               L      H        +     +       + ++  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT---HVTTRVKGTLGYLA 210
           L++     I+HRD+KA+NVL+  D   ++ADFG A+          +  T    TL Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 211 PEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVN--------SAIKRTITDWALPLA 261
           PE  +  +      D++  G ++ E+ +    ++           S +  +IT    P  
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 262 CERK-FSELADPRLNGNFVEEELKRVVLVALT------CAHSKPEKRPTMLEVLD 309
              + + +L   +     V++ LK  V                P +R    + L+
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 55/303 (18%), Positives = 106/303 (34%), Gaps = 27/303 (8%)

Query: 28  FSLKELHSAT----NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM--E 80
           F  +E+          +     +G G +G+V        G+++A+K+L            
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 81  FAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRR 140
              E+ +L  +RH+N++ L       +      D+   +  +    G+      L  +R 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 141 MDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTT 200
             +     +G+ Y+H      IIHRD+K  N+ ++ D + ++ DFG A+        +T 
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTG 177

Query: 201 RVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP----------IEKVNSAIK 250
            V               + +++ D++S G ++ E+ +GK             E +     
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 251 RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT----CAHSKPEKRPTMLE 306
                     + E K      P L        L     +A+           E+R T  E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 307 VLD 309
            L 
Sbjct: 298 ALA 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (309), Expect = 1e-32
 Identities = 61/235 (25%), Positives = 93/235 (39%), Gaps = 22/235 (9%)

Query: 11  KVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKR 69
           K  +   K  + P+     L       + F+    LG G FG V   +    G+  A+K 
Sbjct: 21  KAKEDFLKKWETPSQNTAQL-------DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73

Query: 70  L---KVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLH 126
           L   KV   K       E  IL  V    L+ L     +     +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133

Query: 127 GQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG 186
                    +       A        YLH      +I+RD+K  N+L+D     QV DFG
Sbjct: 134 RIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP 241
           FAK +          + GT   LAPE  +    +++ D ++ G+L+ E+A+G  P
Sbjct: 187 FAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (299), Expect = 2e-31
 Identities = 57/332 (17%), Positives = 110/332 (33%), Gaps = 42/332 (12%)

Query: 4   GSIFCCGKVSDRKEKGKKQPTWRIFSLKELHSATNNFNYDNKLGEGGFGSVYWGQ-LWDG 62
           G +    +V       + +  W   S        +++    KLG G +  V+    + + 
Sbjct: 1   GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60

Query: 63  SQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQERLI--VYDYMPNL 119
            ++ VK LK      + +   E++IL  +R   N+++L     +   R    V++++ N 
Sbjct: 61  EKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117

Query: 120 SLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF- 178
                          L             + + Y H      I+HRD+K  NV++D +  
Sbjct: 118 DFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHR 167

Query: 179 KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAM-LGKASESCDVYSFGILLLELAS 237
           K ++ D+G A+    G  +       +  +  PE  +       S D++S G +L  +  
Sbjct: 168 KLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225

Query: 238 GKKPIEKVNSAIK-----RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALT 292
            K+P    +           +           K++   DPR N        KR      +
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285

Query: 293 ----------------CAHSKPEKRPTMLEVL 308
                                 + R T  E +
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-31
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 18/215 (8%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLK----VWSNKAEMEFAVEVEILA 89
            NF     LG G +G V+  +       G   A+K LK    V   K       E ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 90  RVRHK-NLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
            +R    L++L        +  ++ DY+    L +HL  +             +I +   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA-- 141

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
                L H     II+RDIK  N+LLD++    + DFG +K      T       GT+ Y
Sbjct: 142 -----LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 209 LAPEYAMLGKA--SESCDVYSFGILLLELASGKKP 241
           +AP+    G +   ++ D +S G+L+ EL +G  P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 3e-26
 Identities = 54/289 (18%), Positives = 102/289 (35%), Gaps = 23/289 (7%)

Query: 37  TNNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEM--EFAVEVEILARVRH 93
              +   + +G G +GSV        G ++AVK+L               E+ +L  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           +N++ L       +      D      L+            L  +    +      G+ Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEY 213
           +H      IIHRD+K SN+ ++ D + ++ DFG A+   D    +T  V           
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190

Query: 214 AMLGKASESCDVYSFGILLLELASGKKP------IEKVNSAIKRTITDWALPLACERKFS 267
                 +++ D++S G ++ EL +G+        I+++   ++   T  A  L      S
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 268 ELADPRLNGNFVEEELKRVVLVA--------LTCAHSKPEKRPTMLEVL 308
                +      +     V + A                +KR T  + L
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 5e-26
 Identities = 58/305 (19%), Positives = 104/305 (34%), Gaps = 46/305 (15%)

Query: 38  NNFNYDNKLGEGGFGSVYWGQ-LWDGSQIAVKRLK--VWSNKAEMEFAVEVEILARVRHK 94
             +     +G G  G V           +A+K+L     +         E+ ++  V HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 95  NLLSLRGYCA------EGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSA 148
           N++SL           E Q+  +V + M                   +  R   +     
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQML 129

Query: 149 EGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHVTTRVKGTLGY 208
            GI +LH      IIHRD+K SN+++ +D   ++ DFG A+      + + T    T  Y
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYY 184

Query: 209 LAPEYAMLGKASESCDVYSFGILLLELASGKKP---------IEKVNSAIKRTITDWALP 259
            APE  +     E+ D++S G ++ E+   K             KV   +     ++   
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSK----------------PEKRPT 303
           L    +      P+  G    +     +  A +  +                  P KR +
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 304 MLEVL 308
           + + L
Sbjct: 305 VDDAL 309

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 4e-24
 Identities = 44/212 (20%), Positives = 76/212 (35%), Gaps = 18/212 (8%)

Query: 45  KLGEGGFGSVYWGQ-LWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYC 103
           KLG G F +V+  + + + + +A+K ++      E     E+++L RV   +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78

Query: 104 AEGQERLIVY--DYMPNLSLLSHLHGQHSSECLLNWNRRMD----------IAIGSAEGI 151
           A    +L+ +     PN   +  +        L    +             I+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 152 VYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADFGFAKLIPDGATHVTTR-VKGTLGYL 209
            Y+H      IIH DIK  NVL++  D    +     A L               T  Y 
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 210 APEYAMLGKASESCDVYSFGILLLELASGKKP 241
           +PE  +        D++S   L+ EL +G   
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 4e-20
 Identities = 34/203 (16%), Positives = 66/203 (32%), Gaps = 29/203 (14%)

Query: 44  NKLGEGGFGSVYWGQLWDGSQIAVKRLKV----------WSNKAEMEFAVEVEILARVRH 93
             +GEG   +V+        +  VK  KV            +  ++ F+V     AR   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 94  KNLLSLRGYCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVY 153
           + L  L+G           Y +  N  L+  +  +      +       +     E +  
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118

Query: 154 LHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI--PDGATHVTTRVKGTLGYLAP 211
            +H     I+H D+   NVL+  +    + DF  +  +        +   V+  + Y + 
Sbjct: 119 FYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174

Query: 212 EYAMLGKASESCDVYSFGILLLE 234
            Y          D+ S    +L+
Sbjct: 175 TY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	400
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.87
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.35
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.87
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.13
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.05
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.97

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=415.37  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=206.6

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++.+.||+|+||+||+|.+ .+|+.||+|++..........+.+|+.+|+.++||||+++++++.+++..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            35899999999999999999965 56999999999865544556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      |+||+|.+++...     .+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+++.+....
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999999987643     3889999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      . .....+||+.|+|||++.++.|+.++|||||||++|+|+||+.||...+.... ........+     .   +     
T Consensus       171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-----~---~-----  236 (293)
T d1yhwa1         171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-----E---L-----  236 (293)
T ss_dssp             C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-----C---C-----
T ss_pred             c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----C---C-----
Confidence            2 23345699999999999999999999999999999999999999976543211 111000000     0   0     


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        .........+.++|.+||+.||.+|||+.|+++
T Consensus       237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              011112346778889999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-57  Score=412.43  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            357899999999999999999965 5699999999975432 23456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        83 Ey~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            9999999999986432    4899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc-eeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhcccccccccC
Q 015797          194 GAT-HVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      ... ......+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||........... .....    ...   . 
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~~~----~~~---~-  226 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEK----KTY---L-  226 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHHTT----CTT---S-
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHhcC----CCC---C-
Confidence            332 22344679999999999998876 5789999999999999999999975432211100 00000    000   0 


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                           .........+.+++.+||+.||.+|||+.|+++
T Consensus       227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 000111246677889999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-57  Score=414.16  Aligned_cols=254  Identities=26%  Similarity=0.443  Sum_probs=198.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccC
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMP  117 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  117 (400)
                      ++|++.+.||+|+||.||+|.+.+++.||||+++.... ...++.+|+++++.++||||++++|+|.+++..++|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            57899999999999999999887888999999875333 34579999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCce
Q 015797          118 NLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATH  197 (400)
Q Consensus       118 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~  197 (400)
                      +|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++........
T Consensus        84 ~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          84 HGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            9999999875432   4889999999999999999999998   999999999999999999999999999876554443


Q ss_pred             eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhC-CCChhhhhhh-hhhhhhccccchhcccccccccCccCC
Q 015797          198 VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASG-KKPIEKVNSA-IKRTITDWALPLACERKFSELADPRLN  275 (400)
Q Consensus       198 ~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg-~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (400)
                      ......||+.|+|||++.++.|+.++|||||||++|||+|+ .+||...... ....+.....             ....
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------------~~~p  224 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------------LYKP  224 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-------------CCCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-------------CCCc
Confidence            33445699999999999999999999999999999999995 5555543321 1111111000             0000


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          276 GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       276 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                          ......+.++|.+||+.||.+|||+++|++.|+++.
T Consensus       225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                111246788999999999999999999999987653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-57  Score=419.86  Aligned_cols=259  Identities=25%  Similarity=0.339  Sum_probs=211.2

Q ss_pred             HHHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           34 HSATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        34 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      +...++|++.+.||+|+||+||+|.+ .+++.||||+++.... ....+.+|+++|+.++||||++++++|.+++..++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            34457899999999999999999965 4588999999875433 345789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||++|+|.+++......  .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        92 ~E~~~~g~l~~~l~~~~~~--~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             eecccCcchHHHhhhcccc--chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999998754332  4899999999999999999999998   9999999999999999999999999999776


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhh-hhhh-hhhhhccccchhccccccccc
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKV-NSAI-KRTITDWALPLACERKFSELA  270 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~  270 (400)
                      ...........||+.|+|||++.++.|+.++|||||||++|||+||..||... .... ...+...             .
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-------------~  233 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------------Y  233 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------------C
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-------------C
Confidence            55444444456899999999999999999999999999999999977665432 2211 1111110             0


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .+...    ......+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus       234 ~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         234 RMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCC----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            01111    112346788899999999999999999999887653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=407.19  Aligned_cols=244  Identities=28%  Similarity=0.427  Sum_probs=203.5

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++++.||+|+||+||+|.+ .+++.||+|++....   ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999965 468999999986422   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999987543    3899999999999999999999998   99999999999999999999999999986644


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.... ..+....              .
T Consensus       159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------------~  221 (263)
T d2j4za1         159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--------------F  221 (263)
T ss_dssp             CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------------C
T ss_pred             Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------C
Confidence            32   2345699999999999999999999999999999999999999976543211 1111100              0


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .++..    ....+.+++.+||+.||.+|||+.|+++
T Consensus       222 ~~p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TFPDF----VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            01111    1246777889999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-57  Score=413.23  Aligned_cols=258  Identities=29%  Similarity=0.485  Sum_probs=201.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||+||+|+.  +..||||+++..  .......|.+|+.+|+.++||||+++++++.+ +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES--SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE--CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            458899999999999999999974  346999998643  34456679999999999999999999998754 5689999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++.....   .+++..++.++.|++.||+|||+++   ||||||||+||||+.++.+||+|||+++....
T Consensus        83 Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             ecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999999975432   4899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc-eeeeecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhcccccc
Q 015797          194 GAT-HVTTRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLACERKFS  267 (400)
Q Consensus       194 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~  267 (400)
                      ... .......||+.|||||++.+   +.|+.++|||||||+||||+||+.||.......  .........    ...+.
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~p~~~  232 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL----SPDLS  232 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC----CCCGG
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----CCcch
Confidence            322 22344579999999999975   358999999999999999999999997654221  111111000    00011


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .     .    .......+.++|.+||+.||.+|||+.+|++.|+.+.
T Consensus       233 ~-----~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         233 K-----V----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             G-----S----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             h-----c----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            0     1    1112346788899999999999999999999987543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-56  Score=402.82  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=211.1

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++.+.||+|+||+||+|+..+++.||||+++.... ....+.+|+.+++.++||||++++|+|.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            368999999999999999999888888999999986443 3457999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....   .+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            99999998764433   4889999999999999999999998   99999999999999999999999999987655444


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...+.... ..+....             ....
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-------------~~~~  222 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------------RLYR  222 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------------CCCC
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-------------CCCC
Confidence            33444569999999999999999999999999999999998 8999987654321 1111100             0000


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                      ..    .....+.++|.+||+.||++|||+.+|++.|..
T Consensus       223 p~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 PH----LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cc----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            11    112467888999999999999999999998743

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=408.58  Aligned_cols=254  Identities=21%  Similarity=0.333  Sum_probs=194.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--CCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--GQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv  112 (400)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|.+...  .......+.+|+++|+.++||||+++++++.+  ++.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6799999999999999999965 56899999998753  33345568899999999999999999999865  4568999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA--TPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      ||||++|+|.+++.........+++..++.++.|++.||.|||+++  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998654333345999999999999999999999864  12499999999999999999999999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      +..... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||...+... ...+..        ....  
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--------~~~~--  232 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--------GKFR--  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------TCCC--
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc--------CCCC--
Confidence            654332 2334569999999999999999999999999999999999999997654321 111111        0111  


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         .+...+    ...+.++|.+||+.||.+|||+.|+++
T Consensus       233 ---~~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ---RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               111112    236778889999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=412.29  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=206.9

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ...++|++.+.||+|+||.||+|...+++.||||+++.... ....+.+|+.+|+.++||||+++++++.+ +..++|||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            34578999999999999999999887888999999975433 34579999999999999999999998754 56799999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      ||++|+|.+++....  ...+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999875432  234899999999999999999999998   999999999999999999999999999987655


Q ss_pred             CceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCC-hhhhhhh-hhhhhhccccchhcccccccccCc
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKP-IEKVNSA-IKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~P-f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      .........||+.|+|||++.++.++.++|||||||++|||+||..| |...... ....+...             ..+
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-------------~~~  229 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------------YRM  229 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------CCC
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------CCC
Confidence            44444445699999999999999999999999999999999996555 4433221 11111110             001


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      .....    ....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       230 ~~p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         230 VRPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            11111    224678889999999999999999999988754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=410.67  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=204.6

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      +.|++.+.||+|+||.||+|.+ .+++.||+|++..........+.+|+++|+.++||||+++++++.+++..|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5789999999999999999965 568999999998766666677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....   .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        92 ~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             TTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            99999998764322   3899999999999999999999998   99999999999999999999999999976432211


Q ss_pred             eeeeecccccCcCChhhhc-----cCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhccccccccc
Q 015797          197 HVTTRVKGTLGYLAPEYAM-----LGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELA  270 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  270 (400)
                       ......||+.|+|||++.     +..|+.++|||||||++|+|+||+.||...+.... ..+.....+        .+ 
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~--------~~-  235 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP--------TL-  235 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC--------CC-
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--------CC-
Confidence             122356999999999984     45689999999999999999999999976543211 111110000        00 


Q ss_pred             CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          271 DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       271 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                            .........+.++|.+||+.||.+|||+.|+++
T Consensus       236 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 ------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  011122346788899999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.7e-56  Score=411.10  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=196.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CC---CEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DG---SQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|++.+.||+|+||+||+|... ++   ..||||.+... .......|.+|+++|+.++||||++++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            56788899999999999999653 23   25888887653 344456799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||++|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999998875432   3899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcee----eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhccccc
Q 015797          193 DGATHV----TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKF  266 (400)
Q Consensus       193 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~  266 (400)
                      ......    .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||........ ..+....         
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~---------  250 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---------  250 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence            432221    112357999999999999999999999999999999998 8999976543211 1111100         


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                          ...    ........+.++|.+||+.||.+|||+.+|++.|+.+.
T Consensus       251 ----~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         251 ----RLP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             ----CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                000    01112346788899999999999999999999987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=400.32  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=197.4

Q ss_pred             ccCC-CcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe----CCe
Q 015797           37 TNNF-NYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE----GQE  108 (400)
Q Consensus        37 ~~~y-~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~  108 (400)
                      .++| ++.+.||+|+||+||+|.+ .+++.||+|.+...  .......+.+|+++|+.++||||+++++++.+    +..
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            3455 6778899999999999965 46889999998753  34445678899999999999999999999865    456


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC-CCCcEEEEecCC
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD-ADFKAQVADFGF  187 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~-~~~~~kl~Dfgl  187 (400)
                      +|+|||||++|+|.+++....    .+++..++.++.|++.||.|||+++ ++|+||||||+|||++ .++.+||+|||+
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEEeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            899999999999999996543    3889999999999999999999875 3499999999999997 578999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh--hhhhhhccccchhcccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA--IKRTITDWALPLACERK  265 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~  265 (400)
                      ++......   .....||+.|+|||++.+ .++.++|||||||++|||+||+.||......  ....+.....|      
T Consensus       162 a~~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~------  231 (270)
T d1t4ha_         162 ATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------  231 (270)
T ss_dssp             GGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------
T ss_pred             ceeccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC------
Confidence            98654322   234579999999998865 6999999999999999999999999754321  11111111111      


Q ss_pred             cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                            ..+...    ....+.++|.+||+.||++|||+.|+++
T Consensus       232 ------~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ------ASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ------GGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------cccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                  000011    1235777889999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-55  Score=401.67  Aligned_cols=253  Identities=26%  Similarity=0.357  Sum_probs=203.6

Q ss_pred             cCCCcCCc-ccccCceEEEEEEEc---CCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNK-LGEGGFGSVYWGQLW---DGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~-LG~G~~g~Vy~a~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|.+.+. ||+|+||.||+|...   ++..||||+++... ......|.+|+++|+.++||||+++++++.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            56677774 999999999999542   35579999997543 4445679999999999999999999999865 568999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||++|+|.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 mE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999998764332   4899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCcee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhccccccc
Q 015797          193 DGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSE  268 (400)
Q Consensus       193 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  268 (400)
                      ......  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||....... ...+....           
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-----------  229 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-----------  229 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-----------
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            543322  223458999999999999999999999999999999998 999998654321 11111100           


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                        .+...    ...+..+.++|.+||+.||++|||+.+|++.|+..
T Consensus       230 --~~~~p----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         230 --RMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             --CCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCC----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              01111    11234677889999999999999999999988654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.6e-54  Score=408.43  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=208.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+|+.+|+.++||||+++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999965 56999999999876666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC--CCcEEEEecCCccccCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA--DFKAQVADFGFAKLIPD  193 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~--~~~~kl~Dfgl~~~~~~  193 (400)
                      |+||+|.+++.....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+..
T Consensus       105 ~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999864432   3899999999999999999999998   999999999999964  57899999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+... ...+......      .      
T Consensus       179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------~------  244 (350)
T d1koaa2         179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN------M------  244 (350)
T ss_dssp             TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------S------
T ss_pred             ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------C------
Confidence            333  334569999999999999999999999999999999999999997654321 1111110000      0      


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                        ...........+.+||.+||+.||.+|||+.|+++.
T Consensus       245 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000111123467788899999999999999999984

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=405.24  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++++.||+|+||+||+|.+ .+++.||||++....   ......+.+|+++|+.++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999965 569999999987422   223356889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+++.+..
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999887543    3899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CC-ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          194 GA-THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       194 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .. ........||+.|+|||++.+..|+.++|||||||++|+|+||+.||...+... ...+....        +     
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--------~-----  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--------Y-----  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--------C-----
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--------C-----
Confidence            32 223344579999999999999999999999999999999999999997654321 11111100        0     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       .+....    ...+.+||.+||+.||.+|||+.|+++
T Consensus       228 -~~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 -DFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -CCCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             011111    236778889999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-55  Score=407.27  Aligned_cols=253  Identities=22%  Similarity=0.349  Sum_probs=190.8

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh-HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN-KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++..... .....+.+|+.+|+.++||||+++++++.+++..|+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3457899999999999999999965 4689999999975432 2334577899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC---CCCcEEEEecCCcc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD---ADFKAQVADFGFAK  189 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~---~~~~~kl~Dfgl~~  189 (400)
                      ||||+||+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||+++
T Consensus        86 mE~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EeccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence            99999999999997543    3899999999999999999999998   99999999999995   57899999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSE  268 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  268 (400)
                      .......  ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||...... ....+.....+         
T Consensus       159 ~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---------  227 (307)
T d1a06a_         159 MEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE---------  227 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC---------
T ss_pred             EccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC---------
Confidence            6543322  23456999999999999999999999999999999999999999765432 11111110000         


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ...    .........+.+++.+||+.||.+|||+.|+++.
T Consensus       228 -~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 -FDS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -CCT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CCC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             000    0111122467788899999999999999999973

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-55  Score=410.08  Aligned_cols=201  Identities=25%  Similarity=0.355  Sum_probs=177.3

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||+|+++.. .......+.+|+.+|+.++||||++++++|.+++..|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            457899999999999999999965 46899999999753 3344567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      |||++|+|.+++.+..    .+++..+..++.|++.||.|||+ ++   |+||||||+||||+.+|.+||+|||+|....
T Consensus        84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            9999999999997543    38999999999999999999997 47   9999999999999999999999999998654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhh
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVN  246 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~  246 (400)
                      ...   ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+
T Consensus       157 ~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         157 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            321   234579999999999999999999999999999999999999997543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.4e-54  Score=407.03  Aligned_cols=252  Identities=18%  Similarity=0.285  Sum_probs=208.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|++..........+.+|+.+|+.++||||+++++++.+++.+|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46799999999999999999965 57999999999876666667788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEC--CCCcEEEEecCCccccCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLD--ADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~--~~~~~kl~Dfgl~~~~~~  193 (400)
                      |+||+|.+++.....   .+++..++.++.||+.||.|||+++   |+||||||+||||+  .++.+||+|||++..+..
T Consensus       108 ~~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         108 LSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCChHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999998765432   3899999999999999999999998   99999999999998  678999999999988765


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ..+.....+             
T Consensus       182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------------  246 (352)
T d1koba_         182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-------------  246 (352)
T ss_dssp             TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred             CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence            433  3345699999999999999999999999999999999999999976543211 111110000             


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                       ............+.+||.+||+.||.+|||+.|+++.
T Consensus       247 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 -FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0000111123467788999999999999999999873

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=409.18  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=204.3

Q ss_pred             HHccCCCcCCcccccCceEEEEEEEcC-C-----CEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQLWD-G-----SQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  106 (400)
                      ...++|++++.||+|+||+||+|.... +     ..||+|.+.... ......+.+|+.+|..+ +||||+++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            344789999999999999999996543 2     268999886432 33345688999999998 899999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCC-------------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHS-------------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDI  167 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~di  167 (400)
                      +..|+|||||++|+|.++|.....                   ....+++..++.++.|++.||.|||+++   ||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            999999999999999999975432                   1124889999999999999999999998   999999


Q ss_pred             CCCCeEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhh
Q 015797          168 KASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKV  245 (400)
Q Consensus       168 kp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~  245 (400)
                      ||+|||++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543332 2334568999999999999999999999999999999998 89999764


Q ss_pred             hhh--hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 015797          246 NSA--IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLK  312 (400)
Q Consensus       246 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  312 (400)
                      ...  ....+....             .+..    .......+.+||.+||+.||++|||+.||++.|.
T Consensus       271 ~~~~~~~~~~~~~~-------------~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDANFYKLIQNGF-------------KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSHHHHHHHHTTC-------------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHhcCC-------------CCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            321  111111100             0001    1112346788899999999999999999999884

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=397.19  Aligned_cols=246  Identities=24%  Similarity=0.325  Sum_probs=196.6

Q ss_pred             CcccccCceEEEEEEEc---CCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEccCC
Q 015797           44 NKLGEGGFGSVYWGQLW---DGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYMPN  118 (400)
Q Consensus        44 ~~LG~G~~g~Vy~a~~~---~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  118 (400)
                      +.||+|+||+||+|.+.   .++.||||+++..  .......+.+|+.+|+.++||||++++++|.+ +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999643   3568999998643  23345679999999999999999999999865 457899999999


Q ss_pred             CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCcee
Q 015797          119 LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGATHV  198 (400)
Q Consensus       119 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~~~  198 (400)
                      |+|.+++....    .+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.......
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999987543    3899999999999999999999998   9999999999999999999999999998765443322


Q ss_pred             --eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccccCccC
Q 015797          199 --TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       199 --~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                        .....||+.|+|||++.++.++.++|||||||++|||+| |+.||....... ...+....             .+..
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-------------~~~~  231 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------------RMGC  231 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------CCCC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-------------CCCC
Confidence              223568999999999999999999999999999999998 899998654321 11111100             0011


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      +.    ..+..+.++|.+||+.||.+|||+.+|++.|+..
T Consensus       232 p~----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         232 PA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             Cc----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            11    1234677889999999999999999999888654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=398.25  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=197.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCC-----CEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDG-----SQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      +.|++.+.||+|+||.||+|....+     ..||||++.... ......+.+|+.+|+.++||||++++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688899999999999999965432     369999997543 3445578999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |||||.+|++.+.+.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999998765433   4899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCce--eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhh-hhhh-hhhhhhccccchhcccccc
Q 015797          192 PDGATH--VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEK-VNSA-IKRTITDWALPLACERKFS  267 (400)
Q Consensus       192 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~-~~~~-~~~~~~~~~~~~~~~~~~~  267 (400)
                      ......  ......||+.|+|||++.++.++.++|||||||++|||+||..|+.. .... ....+...           
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-----------  229 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----------  229 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----------
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-----------
Confidence            543222  12234589999999999999999999999999999999996665543 2221 11111110           


Q ss_pred             cccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          268 ELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                        ..+..    .......+.++|.+||+.||++|||+.+|++.|..+.
T Consensus       230 --~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         230 --FRLPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             --CCCCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --CCCCC----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence              00111    1112346788999999999999999999999887654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-54  Score=405.18  Aligned_cols=244  Identities=27%  Similarity=0.415  Sum_probs=199.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh---HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN---KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ..|+..+.||+|+||+||+|.+ .+++.||||++.....   .....+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4589999999999999999965 5688999999975432   23356889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||.+|+|..++....    .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||++.....
T Consensus        95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999877665432    4899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCceeeeecccccCcCChhhhcc---CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAML---GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSEL  269 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  269 (400)
                      .     ....||+.|+|||++.+   +.|+.++|||||||++|||++|..||........ ..+.....+          
T Consensus       168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~----------  232 (309)
T d1u5ra_         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------  232 (309)
T ss_dssp             B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred             C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence            2     23469999999999864   4689999999999999999999999976543211 111110000          


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         .+....   ....+.++|.+||+.||.+|||+.++++
T Consensus       233 ---~~~~~~---~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ---ALQSGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CCSCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCC---CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               011111   1246778889999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=394.35  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=204.9

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCCh------HHHHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSN------KAEMEFAVEVEILARVRHKNLLSLRGYCAEGQE  108 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  108 (400)
                      ..++|++++.||+|+||+||+|.+ .+|+.||||++.....      .....+.+|+.+|+.++||||+++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            346899999999999999999975 5799999999964321      124678999999999999999999999999999


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC----cEEEEe
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF----KAQVAD  184 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~----~~kl~D  184 (400)
                      .|+|||||++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++    .+||+|
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence            999999999999999987543    3899999999999999999999998   99999999999998876    499999


Q ss_pred             cCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcc
Q 015797          185 FGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACE  263 (400)
Q Consensus       185 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~  263 (400)
                      ||++........  .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.... ..+......    
T Consensus       161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~----  234 (293)
T d1jksa_         161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----  234 (293)
T ss_dssp             CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC----
T ss_pred             hhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----
Confidence            999987654332  2345699999999999999999999999999999999999999976543211 111110000    


Q ss_pred             cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          264 RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ...        ...+.....+.++|.+||+.||.+|||+.|+++
T Consensus       235 --~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 --FED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --CCH--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCc--------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000        000112346778899999999999999999997

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=399.49  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=199.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEcc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDYM  116 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  116 (400)
                      .++|++++.||+|+||.||+|.+.+++.||||+++.... ....|.+|+.+++.++||||+++++++.+ +..++|||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            468999999999999999999887888899999975433 34679999999999999999999999854 5679999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|..++.....  ..++|..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus        94 ~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          94 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999998865322  24899999999999999999999998   99999999999999999999999999987654443


Q ss_pred             eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChh-hhhhh-hhhhhhccccchhcccccccccCccC
Q 015797          197 HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIE-KVNSA-IKRTITDWALPLACERKFSELADPRL  274 (400)
Q Consensus       197 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (400)
                      .......||+.|+|||++.++.++.++|||||||++|||+||..|+. ..... ....+...             .....
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-------------~~~~~  235 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------------YRMPC  235 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------CCCCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------CCCCC
Confidence            33444569999999999999999999999999999999999665554 33221 11111100             00011


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          275 NGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       275 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                          .......+.++|.+||+.||++|||+.+|++.|....
T Consensus       236 ----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         236 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                1112346788899999999999999999999887654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=395.19  Aligned_cols=256  Identities=21%  Similarity=0.323  Sum_probs=195.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcC----CCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWD----GSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .++|++++.||+|+||.||+|.+..    +..||+|.+.... ......+.+|+.+|+.++||||+++++++. ++..|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999996532    3468888886533 334567999999999999999999999985 467899


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      |||||++|+|.+++.....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        85 v~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999998765432   4899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhcccccccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSEL  269 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  269 (400)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |.+||....... ...+....            
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~------------  226 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------------  226 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------------
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence            5544444445568999999999999999999999999999999998 899997654321 11111100            


Q ss_pred             cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          270 ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       270 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                       .+..    .+.....+.++|.+||+.||.+|||+.+|++.|+.+..
T Consensus       227 -~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         227 -RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             0001    11123467888999999999999999999999876543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=397.61  Aligned_cols=247  Identities=23%  Similarity=0.311  Sum_probs=204.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      .++|++++.||+|+||.||+|++ .+|+.||+|++....   ......+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999965 579999999997422   22345688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||+||+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+++...
T Consensus        84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999987543    3888999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .... .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+... .......        .      
T Consensus       157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--------~------  221 (337)
T d1o6la_         157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--------E------  221 (337)
T ss_dssp             CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------C------
T ss_pred             cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------C------
Confidence            3322 2334579999999999999999999999999999999999999998655321 1111110        0      


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                      ..+....    ...+.+||.+||+.||.+||+     +.++++
T Consensus       222 ~~~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 IRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            0011112    235677889999999999995     888886

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=389.43  Aligned_cols=249  Identities=29%  Similarity=0.419  Sum_probs=195.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEe-CCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE-GQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~  115 (400)
                      .++|++++.||+|+||.||+|+. .|..||||+++..  .....+.+|+.++++++||||++++|+|.+ ++.+|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35788999999999999999985 6889999998643  334678999999999999999999999865 4668999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +++|+|.+++.....  ..+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             CTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence            999999999965422  24899999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh-hhhhhhccccchhcccccccccCcc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA-IKRTITDWALPLACERKFSELADPR  273 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  273 (400)
                          ....+|+.|+|||++.++.+++++|||||||++|||+| |++||...... ....+...             ..+.
T Consensus       158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-------------~~~~  220 (262)
T d1byga_         158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------------YKMD  220 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------CCCC
T ss_pred             ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------------CCCC
Confidence                23458999999999999999999999999999999998 78888654422 11111110             0111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          274 LNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       274 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      .    .......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       221 ~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         221 A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1    111224677889999999999999999999998765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=389.79  Aligned_cols=253  Identities=29%  Similarity=0.418  Sum_probs=194.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEc--CC--CEEEEEEEecC---ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW--DG--SQIAVKRLKVW---SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERL  110 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~--~~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  110 (400)
                      ++|++.+.||+|+||.||+|...  ++  ..||||+++..   .......|.+|+.+|+.++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            67999999999999999999643  23  36899988642   23344678999999999999999999999965 5678


Q ss_pred             EEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccc
Q 015797          111 IVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKL  190 (400)
Q Consensus       111 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~  190 (400)
                      +|||||++|++.+++.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            99999999999998865432   4999999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCcee--eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-hhhhccccchhccccc
Q 015797          191 IPDGATHV--TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-RTITDWALPLACERKF  266 (400)
Q Consensus       191 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~  266 (400)
                      ........  .....||+.|+|||++.+..++.++|||||||++|||+| |..||...+.... ..+....         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~---------  231 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG---------  231 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC---------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC---------
Confidence            75543322  223457889999999999999999999999999999998 8999976543211 1111100         


Q ss_pred             ccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 015797          267 SELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKG  313 (400)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  313 (400)
                         ..+..    ....+..+.+++.+||+.||++|||+.+|++.|++
T Consensus       232 ---~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ---ERLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ---CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               00001    11112467789999999999999999999998864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-52  Score=391.97  Aligned_cols=249  Identities=28%  Similarity=0.335  Sum_probs=205.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++++.||+|+||+||+|++ .+|+.||||++....   ......+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999975 569999999997422   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      |||+||+|..++.....    +++..+..++.|++.||.|||+++   |+||||||+||||+.+|.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999998875543    778888999999999999999998   99999999999999999999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..    ...+||+.|+|||++.+..|+.++|||||||++|+|+||+.||...+... ...+.....              
T Consensus       157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------------  218 (316)
T d1fota_         157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------------  218 (316)
T ss_dssp             CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--------------
T ss_pred             cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------------
Confidence            32    24569999999999999999999999999999999999999997654321 111111000              


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH--hcccc
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLDL--LKGES  315 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~--L~~~~  315 (400)
                      .....    ....+.+++.+||..||.+||     |+.++++.  ++++.
T Consensus       219 ~~p~~----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         219 RFPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             CCCCC----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            00111    123677888999999999996     89999873  55543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-53  Score=394.65  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCC----EEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGS----QIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLI  111 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  111 (400)
                      .+|++++.||+|+||+||+|.+. +|+    .||+|.+... .......+.+|+.+++.++||||++++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            56999999999999999999653 444    5888888642 333456799999999999999999999999875 5678


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLI  191 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~  191 (400)
                      +|||+.+|+|.+.+.....   .+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence            8999999999998875533   4899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhh-hhhhhccccchhccccccc
Q 015797          192 PDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAI-KRTITDWALPLACERKFSE  268 (400)
Q Consensus       192 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  268 (400)
                      ....... .....||+.|+|||++.++.++.++|||||||++|||+| |..||....... ...+.....          
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~----------  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC----------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            5433322 233468999999999999999999999999999999998 899987654321 111111000          


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                         +..    .......+.+++.+||+.||.+|||+.+|++.|..+.
T Consensus       232 ---~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         232 ---LPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ---CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCC----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence               001    1112246788899999999999999999999886543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.6e-52  Score=384.29  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=198.4

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----e
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----E  108 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~  108 (400)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|+++...   ......+.+|+++|+.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            47899999999999999999965 579999999997432   333457889999999999999999999987653    3


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .|+|||||+||+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            789999999999999886543    3899999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCc--eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccchhccc
Q 015797          189 KLIPDGAT--HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPLACER  264 (400)
Q Consensus       189 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~  264 (400)
                      ........  .......||+.|+|||++.+..+++++|||||||++|+|+||+.||...+....  ..+.....+     
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~-----  233 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-----  233 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-----
Confidence            76543222  223345699999999999999999999999999999999999999976543211  111110000     


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccc
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRP-TMLEVLDLLKGE  314 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~~  314 (400)
                        ..    ...    ......+.+++.+||+.||.+|| |++++++.|..+
T Consensus       234 --~~----~~~----~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 --PS----ARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             --GG----GTS----SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --Cc----hhc----cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence              00    000    11124677888999999999999 899998877543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-53  Score=393.71  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=210.6

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecCChH-HHHHHHHHHHHHhcCCCCccceeeeEE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVWSNK-AEMEFAVEVEILARVRHKNLLSLRGYC  103 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~  103 (400)
                      .+++-..++|++++.||+|+||+||+|+..      +++.||||+++..... ....+.+|+.+|+.++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556789999999999999999999753      3578999998754433 356799999999999999999999999


Q ss_pred             EeCCeEEEEEEccCCCChhhhhhcCCC--------------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 015797          104 AEGQERLIVYDYMPNLSLLSHLHGQHS--------------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHII  163 (400)
Q Consensus       104 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  163 (400)
                      .+.+..+++|||+++|+|.+++.....                    ....+++..++.++.|++.||+|||+++   +|
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence            999999999999999999999864321                    1224788999999999999999999998   99


Q ss_pred             ecCCCCCCeEECCCCcEEEEecCCccccCCCCc-eeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCC-CC
Q 015797          164 HRDIKASNVLLDADFKAQVADFGFAKLIPDGAT-HVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK-KP  241 (400)
Q Consensus       164 H~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~-~P  241 (400)
                      ||||||+||||+.++.+||+|||+++...+... .......||+.|+|||.+.+..|+.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999999999986644322 2233456899999999999999999999999999999999985 57


Q ss_pred             hhhhhhhh-hhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          242 IEKVNSAI-KRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       242 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      |....... ...+.....+             ....    ..+.++.++|.+||+.||.+||||.+|++.|+++
T Consensus       243 ~~~~~~~e~~~~v~~~~~~-------------~~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDGNIL-------------ACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTSCHHHHHHHHHTTCCC-------------CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHcCCCC-------------CCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            76554321 1111111110             0111    1224678899999999999999999999998765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=388.18  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=204.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|+++.... ....+.+|+++|+.++||||+++++++.+++.+|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            47899999999999999999965 4688999999976443 345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCC--CcEEEEecCCccccCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDAD--FKAQVADFGFAKLIPD  193 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~--~~~kl~Dfgl~~~~~~  193 (400)
                      |+||+|.+++.....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||++.....
T Consensus        83 ~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            999999999975432   3899999999999999999999998   9999999999999854  4799999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhh-hhhhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSA-IKRTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ...  .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||...+.. ....+......      +..    
T Consensus       157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~------~~~----  224 (321)
T d1tkia_         157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT------FDE----  224 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------CCH----
T ss_pred             CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------CCh----
Confidence            332  33456999999999999999999999999999999999999999765432 11111110000      000    


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                          .........+.+++.+||..||.+|||+.|+++
T Consensus       225 ----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 ----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000011236778899999999999999999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-51  Score=378.99  Aligned_cols=250  Identities=26%  Similarity=0.330  Sum_probs=203.1

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH---------HHHHHHHHHHHHhcCC-CCccceeeeEEEe
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK---------AEMEFAVEVEILARVR-HKNLLSLRGYCAE  105 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  105 (400)
                      .++|++.+.||+|+||+||+|++ .+++.||||++......         ....+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999965 57899999999753211         1235788999999997 9999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      ++..|+|||||++|+|.+++....    .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence            999999999999999999996543    4899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhcc------CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhcccc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAML------GKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWAL  258 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~  258 (400)
                      |++........  .....||+.|+|||.+.+      ..++.++||||+||++|+|+||+.||........ ..+.... 
T Consensus       155 G~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-  231 (277)
T d1phka_         155 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-  231 (277)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred             hheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC-
Confidence            99987654332  234569999999999864      3568899999999999999999999986653211 1111100 


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                             ..      ............+.+++.+||+.||.+|||+.|+++
T Consensus       232 -------~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 -------YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -------CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -------CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   00      000111122346788899999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-52  Score=393.16  Aligned_cols=243  Identities=24%  Similarity=0.267  Sum_probs=202.5

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  113 (400)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++....   ......+.+|+++|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999965 579999999986422   222356889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCC
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPD  193 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~  193 (400)
                      ||+.+|+|.+++....    .+++..++.++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+++.+..
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999987543    3899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccCc
Q 015797          194 GATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELADP  272 (400)
Q Consensus       194 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  272 (400)
                      ..    ....||+.|||||++.+..++.++|||||||++|+|+||+.||...+.... ..+....              .
T Consensus       194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--------------~  255 (350)
T d1rdqe_         194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------------V  255 (350)
T ss_dssp             CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------C
T ss_pred             cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--------------C
Confidence            32    235699999999999999999999999999999999999999976543211 1111100              0


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015797          273 RLNGNFVEEELKRVVLVALTCAHSKPEKRP-----TMLEVLD  309 (400)
Q Consensus       273 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  309 (400)
                      .....    ....+.+++.+||+.||.+|+     |+.++++
T Consensus       256 ~~p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 RFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCcc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            00111    123677888999999999994     8999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=389.58  Aligned_cols=266  Identities=24%  Similarity=0.369  Sum_probs=199.0

Q ss_pred             HHHHHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcC-CCCccceeee
Q 015797           30 LKELHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVW-SNKAEMEFAVEVEILARV-RHKNLLSLRG  101 (400)
Q Consensus        30 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~  101 (400)
                      ...++...++|++++.||+|+||.||+|...      +++.||||+++.. .......+..|...+.++ +||||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3444455578999999999999999999643      2468999998753 334455677888888776 7899999999


Q ss_pred             EEEeC-CeEEEEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 015797          102 YCAEG-QERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIK  168 (400)
Q Consensus       102 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dik  168 (400)
                      ++.+. ...++|||||++|+|.+++.....            ....+++..++.++.|++.||.|||+++   |+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence            98764 568999999999999999965432            1234889999999999999999999998   9999999


Q ss_pred             CCCeEECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhC-CCChhhhh
Q 015797          169 ASNVLLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASG-KKPIEKVN  246 (400)
Q Consensus       169 p~NIlv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg-~~Pf~~~~  246 (400)
                      |+||||+.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+|| ..||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999866443322 23345699999999999999999999999999999999996 56776543


Q ss_pred             hh--hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          247 SA--IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       247 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      ..  ....+....             .+.....    ....+.++|.+||+.||.+|||+.+|++.|..+.
T Consensus       242 ~~~~~~~~~~~~~-------------~~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         242 IDEEFCRRLKEGT-------------RMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CSHHHHHHHHHTC-------------CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCC-------------CCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            21  111111100             0111111    1246788899999999999999999999987653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-51  Score=393.25  Aligned_cols=249  Identities=22%  Similarity=0.283  Sum_probs=197.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH---HHHHH---HHHHHHHhcCCCCccceeeeEEEeCCeE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK---AEMEF---AVEVEILARVRHKNLLSLRGYCAEGQER  109 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~---~~~~~---~~E~~~l~~l~hpnIv~~~~~~~~~~~~  109 (400)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|++......   ....+   ..++.+++.++||||+++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            36899999999999999999965 46999999998642211   11223   3457778888999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      |+|||||+||+|.+++....    .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence            99999999999999997543    3788999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccccccc
Q 015797          190 LIPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACERKFSE  268 (400)
Q Consensus       190 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (400)
                      .+....   .....||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||..........+......         
T Consensus       156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---------  223 (364)
T d1omwa3         156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------  223 (364)
T ss_dssp             ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS---------
T ss_pred             ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Confidence            765432   223469999999999975 5689999999999999999999999975432111111000000         


Q ss_pred             ccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          269 LADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       269 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                       .........    ...+.++|.+||+.||.+|||     +.++++
T Consensus       224 -~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 -MAVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -CCCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CCCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             000111111    236778889999999999999     688886

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=387.66  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=197.7

Q ss_pred             ccCCCcCC-cccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhc-CCCCccceeeeEEEe----CCeE
Q 015797           37 TNNFNYDN-KLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILAR-VRHKNLLSLRGYCAE----GQER  109 (400)
Q Consensus        37 ~~~y~~~~-~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~----~~~~  109 (400)
                      .++|.+.. .||+|+||+||+|.+ .+++.||||+++..     ..+.+|+.++.+ ++||||++++++|.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898875 699999999999965 57999999998642     346779988654 589999999999875    4678


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEEecC
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFG  186 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~Dfg  186 (400)
                      |+|||||+||+|.+++..+..  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence            999999999999999976432  24899999999999999999999998   999999999999985   5679999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERK  265 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~  265 (400)
                      +++.......  .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||...+.... ..+..         .
T Consensus       160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---------~  228 (335)
T d2ozaa1         160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---------R  228 (335)
T ss_dssp             TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------C
T ss_pred             eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---------H
Confidence            9987654332  2345699999999999999999999999999999999999999975432110 00000         0


Q ss_pred             cccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          266 FSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      +. .....+...........+.+||.+||+.||.+|||+.|+++.
T Consensus       229 i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 IR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CC-SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Hh-cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00 000001111122334578889999999999999999999973

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=388.46  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=208.4

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE------cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL------WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARV-RHKNLLSLRGYCAEG  106 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  106 (400)
                      ...++|++++.||+|+||.||+|..      ..++.||||+++... ......+.+|+.+++.+ +||||++++++|.++
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            3447899999999999999999964      245689999997644 33455788999999999 699999999999999


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCC--------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHS--------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNV  172 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NI  172 (400)
                      +..++|||||++|+|.+++.....              ....+++..++.++.||+.||+|||+++   ++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            999999999999999999875432              2235889999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhh--
Q 015797          173 LLDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSA--  248 (400)
Q Consensus       173 lv~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~--  248 (400)
                      +++.++.+|++|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |.+||......  
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999877654332 2334679999999999999999999999999999999999 55555443321  


Q ss_pred             hhhhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          249 IKRTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ....+....             .+..    .......+.+||.+||+.||.+|||+.+|++.|++.
T Consensus       257 ~~~~i~~~~-------------~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 FYKMIKEGF-------------RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHHHHTC-------------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCC-------------CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            111111100             0111    111234678889999999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=384.46  Aligned_cols=272  Identities=22%  Similarity=0.308  Sum_probs=198.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----eEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----ERLIVY  113 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~  113 (400)
                      .+|.+.+.||+|+||.||+|+ .+|+.||||++..... .......|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~-~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEE-ETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEE-ECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            567888999999999999997 4789999999864322 1122334555666789999999999997654    579999


Q ss_pred             EccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          114 DYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA-----TPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       114 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      |||++|+|.+++.+.     .++|..++.++.|++.||.|||...     .++|+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999754     3899999999999999999999631     123999999999999999999999999999


Q ss_pred             cccCCCCce---eeeecccccCcCChhhhccCC------CCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhcc-
Q 015797          189 KLIPDGATH---VTTRVKGTLGYLAPEYAMLGK------ASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDW-  256 (400)
Q Consensus       189 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~-  256 (400)
                      .........   ......||+.|+|||++.+..      ++.++|||||||+||||+||..||........  ...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            877543332   223456999999999987643      57799999999999999999988754321100  000000 


Q ss_pred             -ccchhcccccccccCccCCCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          257 -ALPLACERKFSELADPRLNGN-FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       257 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                       ..............++.+... ...+....+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence             000000000111111111111 133456678899999999999999999999999976643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=387.67  Aligned_cols=246  Identities=27%  Similarity=0.362  Sum_probs=199.0

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC---hHHHHHHHHHHHHHh-cCCCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS---NKAEMEFAVEVEILA-RVRHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|++++.||+|+||+||+|.+ .+++.||||++....   ......+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999965 569999999997421   122334556666654 78999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccC
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIP  192 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~  192 (400)
                      ||||++|+|.+++....    .+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999997543    3888999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhccccchhcccccccccC
Q 015797          193 DGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITDWALPLACERKFSELAD  271 (400)
Q Consensus       193 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .... ......||+.|+|||++.++.|+.++|||||||++|+|+||+.||...+.... ..+...              .
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------------~  219 (320)
T d1xjda_         155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--------------N  219 (320)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------C
T ss_pred             cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------C
Confidence            4332 23345699999999999999999999999999999999999999976543211 111100              0


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTML-EVLD  309 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~  309 (400)
                      +......    ...+.+|+.+||+.||.+|||+. ++++
T Consensus       220 ~~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            0111111    23577888999999999999985 7765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=386.41  Aligned_cols=257  Identities=27%  Similarity=0.428  Sum_probs=201.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEc-CCC--EEEEEEEecC-ChHHHHHHHHHHHHHhcC-CCCccceeeeEEEeCCeEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLW-DGS--QIAVKRLKVW-SNKAEMEFAVEVEILARV-RHKNLLSLRGYCAEGQERLIV  112 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  112 (400)
                      ++|++.+.||+|+||.||+|.+. ++.  .||||.+... .......+.+|+++|+.+ +||||++++++|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67889999999999999999654 444  4778887643 333445799999999998 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC------------CcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcE
Q 015797          113 YDYMPNLSLLSHLHGQH------------SSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKA  180 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~  180 (400)
                      ||||++|+|.+++....            .....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            99999999999986542            12235899999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCC-CChhhhhhh-hhhhhhcccc
Q 015797          181 QVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK-KPIEKVNSA-IKRTITDWAL  258 (400)
Q Consensus       181 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~-~Pf~~~~~~-~~~~~~~~~~  258 (400)
                      ||+|||+++.......  .....||+.|+|||.+.++.++.++|||||||++|||++|. +||...+.. ....+.....
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            9999999976533221  12345899999999999999999999999999999999975 567654422 1111111110


Q ss_pred             chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          259 PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                                   +..    .......+.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus       245 -------------~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         245 -------------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             -------------CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                         111    11123467888899999999999999999999877644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=383.15  Aligned_cols=251  Identities=28%  Similarity=0.387  Sum_probs=198.4

Q ss_pred             CCcccccCceEEEEEEEcCC----CEEEEEEEec-CChHHHHHHHHHHHHHhcCCCCccceeeeEEEe-CCeEEEEEEcc
Q 015797           43 DNKLGEGGFGSVYWGQLWDG----SQIAVKRLKV-WSNKAEMEFAVEVEILARVRHKNLLSLRGYCAE-GQERLIVYDYM  116 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~~----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~  116 (400)
                      .++||+|+||+||+|....+    ..||||+++. ........|.+|+++|++++||||++++|++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            56899999999999975332    3589999974 344455789999999999999999999999876 56889999999


Q ss_pred             CCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCCc
Q 015797          117 PNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGAT  196 (400)
Q Consensus       117 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~~  196 (400)
                      ++|+|.+++.....   .+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999998875443   3778889999999999999999998   99999999999999999999999999987654322


Q ss_pred             e---eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccchhcccccccccC
Q 015797          197 H---VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALPLACERKFSELAD  271 (400)
Q Consensus       197 ~---~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  271 (400)
                      .   ......||+.|+|||.+.++.++.++|||||||++|||+||..||.......  ...+....             .
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-------------~  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------------R  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-------------C
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------------C
Confidence            2   1223468999999999999999999999999999999999888875432210  01111000             0


Q ss_pred             ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          272 PRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       272 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      +...    ......+.++|.+||+.||.+|||+.||++.|+.+..
T Consensus       253 ~~~p----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         253 LLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCc----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            0011    1112467788899999999999999999999976643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=381.27  Aligned_cols=260  Identities=22%  Similarity=0.255  Sum_probs=192.7

Q ss_pred             cCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHH-----HHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           42 YDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKA-----EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        42 ~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      .++.||+|+||+||+|.+ .+|+.||||+++......     ...+.+|+.+|+.++||||+++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999965 569999999986433221     23588999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      |.++++..++...    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9987777665432    23888999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhh-hhhhc-cccc--hhcccccc--c
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIK-RTITD-WALP--LACERKFS--E  268 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~-~~~~~-~~~~--~~~~~~~~--~  268 (400)
                      .. ....+||+.|+|||++.+. .|+.++|||||||++|||+||..||........ ..+.. ...|  ........  .
T Consensus       155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence            22 2335699999999998754 679999999999999999999999975443211 00000 0000  00000000  0


Q ss_pred             -ccCccCCCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          269 -LADPRLNGN----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       269 -~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       .........    ..+.....+.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence             000000000    00112346888999999999999999999997

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=383.79  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=203.5

Q ss_pred             HccCCCcCCcccccCceEEEEEEEcC--------CCEEEEEEEecCCh-HHHHHHHHHHHHHhcC-CCCccceeeeEEEe
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSN-KAEMEFAVEVEILARV-RHKNLLSLRGYCAE  105 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  105 (400)
                      ..++|++++.||+|+||.||+|+...        +..||||+++.... .....+..|...+..+ +||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34689999999999999999996422        24799999876443 4456788899999888 79999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCC------------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHS------------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVL  173 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIl  173 (400)
                      ++..++|||||++|+|.+++.....            ....+++..++.++.|++.||.|||+.+   ||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence            9999999999999999999975432            1235899999999999999999999998   999999999999


Q ss_pred             ECCCCcEEEEecCCccccCCCCce-eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHh-CCCChhhhhhhhh-
Q 015797          174 LDADFKAQVADFGFAKLIPDGATH-VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELAS-GKKPIEKVNSAIK-  250 (400)
Q Consensus       174 v~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~ellt-g~~Pf~~~~~~~~-  250 (400)
                      ++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |..||........ 
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            999999999999999876543322 2333568999999999999999999999999999999998 7888875543211 


Q ss_pred             hhhhccccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 015797          251 RTITDWALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGE  314 (400)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  314 (400)
                      ..+....             .+......    ...+.++|.+||+.||++|||+.||++.|+++
T Consensus       248 ~~i~~~~-------------~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         248 KLLKEGH-------------RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHTTC-------------CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCC-------------CCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1111100             01111111    23678899999999999999999999998655

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=384.93  Aligned_cols=264  Identities=23%  Similarity=0.392  Sum_probs=209.5

Q ss_pred             HHHHccCCCcCCcccccCceEEEEEEEc------CCCEEEEEEEecC-ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe
Q 015797           33 LHSATNNFNYDNKLGEGGFGSVYWGQLW------DGSQIAVKRLKVW-SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE  105 (400)
Q Consensus        33 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  105 (400)
                      ++...++|++.+.||+|+||.||+|.+.      ++..||||+++.. .......+.+|+.+++.++||||+++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3444578899999999999999999642      3578999999753 33444568999999999999999999999999


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCC------cccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCc
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHS------SECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFK  179 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~  179 (400)
                      ++..++|||||++|+|.+++.....      ....+++..++.++.|++.||.|||+++   |+||||||+||||+.++.
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence            9999999999999999998864321      1123688899999999999999999998   999999999999999999


Q ss_pred             EEEEecCCccccCCCCcee-eeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCC-CChhhhhhhhh-hhhhcc
Q 015797          180 AQVADFGFAKLIPDGATHV-TTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGK-KPIEKVNSAIK-RTITDW  256 (400)
Q Consensus       180 ~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~-~Pf~~~~~~~~-~~~~~~  256 (400)
                      +||+|||+++......... .....||+.|+|||.+.++.++.++|||||||++|||+||. .||...+.... ..+...
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9999999998765433222 23346899999999999999999999999999999999984 77765443211 111110


Q ss_pred             ccchhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccch
Q 015797          257 ALPLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGESK  316 (400)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  316 (400)
                      .        .     +.....    ....+.++|.+||+.||++|||+.+|++.|+....
T Consensus       252 ~--------~-----~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         252 G--------L-----LDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             C--------C-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             C--------C-----CCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0        0     001111    12468888999999999999999999999976543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-51  Score=377.60  Aligned_cols=266  Identities=20%  Similarity=0.293  Sum_probs=198.3

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH--HHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK--AEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++++.||+|+||+||+|.+ .+++.||+|++......  ....+.+|+++|+.++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999965 56999999999653322  24568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      ||.+ ++.+++......  .+++..+..++.|++.||.|||+++   ||||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~-~~~~~~~~~~~~--~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSE-EHHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCC-chhhhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence            9975 555544333222  3899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CceeeeecccccCcCChhhhccCC-CCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhccccch-hcccccc---
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWALPL-ACERKFS---  267 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~~~-~~~~~~~---  267 (400)
                      ... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||...+....  ........+. .......   
T Consensus       156 ~~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         156 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             SBC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             ccc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            322 23346999999999887665 48899999999999999999999975542211  1000000000 0000000   


Q ss_pred             ---cccCccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          268 ---ELADPRLNGN---FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       268 ---~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                         ..........   ........+.+|+.+||..||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               0000000000   011123567888999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=376.80  Aligned_cols=240  Identities=24%  Similarity=0.376  Sum_probs=194.8

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChH------HHHHHHHHHHHHhcCC--CCccceeeeEEEeCC
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNK------AEMEFAVEVEILARVR--HKNLLSLRGYCAEGQ  107 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~  107 (400)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++......      ....+..|+.+|+.++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            57899999999999999999965 56899999998742211      1223668999999986  899999999999999


Q ss_pred             eEEEEEEccCC-CChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-CCcEEEEec
Q 015797          108 ERLIVYDYMPN-LSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-DFKAQVADF  185 (400)
Q Consensus       108 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-~~~~kl~Df  185 (400)
                      ..|+||||+.+ +++.+++....    .+++..++.++.|++.||.|||+++   |+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence            99999999976 57777775432    3899999999999999999999998   999999999999985 479999999


Q ss_pred             CCccccCCCCceeeeecccccCcCChhhhccCCC-CCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhccccchhccc
Q 015797          186 GFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKA-SESCDVYSFGILLLELASGKKPIEKVNSAIKRTITDWALPLACER  264 (400)
Q Consensus       186 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  264 (400)
                      |++.......   .....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||..........           .
T Consensus       156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~-----------~  221 (273)
T d1xwsa_         156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ-----------V  221 (273)
T ss_dssp             TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCC-----------C
T ss_pred             ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcc-----------c
Confidence            9998654322   234569999999999988766 577999999999999999999997543211100           0


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                              ......    ...+.+++.+||+.||.+|||+.|+++
T Consensus       222 --------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 --------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                    001111    236778889999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-50  Score=372.68  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=198.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHH--HHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEEc
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKA--EMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYDY  115 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  115 (400)
                      ++|++.+.||+|+||+||+|.+.+|+.||||++.......  ...+.+|+.+|+.++||||+++++++.+++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999988889999999997543322  46788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCCC
Q 015797          116 MPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDGA  195 (400)
Q Consensus       116 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~~  195 (400)
                      +.++.+..+.....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            98766666554332    3899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhccccc--hhc-----ccc
Q 015797          196 THVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWALP--LAC-----ERK  265 (400)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~~--~~~-----~~~  265 (400)
                      .. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+...  .........+  ..+     ...
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            22 2334589999999999764 56999999999999999999999997543211  1100000000  000     000


Q ss_pred             ccccc---CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          266 FSELA---DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       266 ~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .....   .+.............+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000   000000111122346778899999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=374.19  Aligned_cols=267  Identities=21%  Similarity=0.303  Sum_probs=194.2

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cC-CCEEEEEEEecCCh--HHHHHHHHHHHHHhcC---CCCccceeeeEEEe---
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WD-GSQIAVKRLKVWSN--KAEMEFAVEVEILARV---RHKNLLSLRGYCAE---  105 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~---  105 (400)
                      ..++|++++.||+|+||+||+|.+ .+ ++.||||++.....  .....+.+|+.+|+.|   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357999999999999999999975 34 56799999864322  1223455677766655   89999999999853   


Q ss_pred             --CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEE
Q 015797          106 --GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVA  183 (400)
Q Consensus       106 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~  183 (400)
                        ....+++||||.++++........   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence              356789999999877655444322   23889999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhc--cccc
Q 015797          184 DFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITD--WALP  259 (400)
Q Consensus       184 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~--~~~~  259 (400)
                      |||++.......  ......||+.|+|||++.+..|+.++|||||||++|||+||+.||...+....  .....  ...+
T Consensus       159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            999987653322  23345699999999999999999999999999999999999999976543211  10000  0000


Q ss_pred             hhcccc--cc-cc---cCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          260 LACERK--FS-EL---ADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       260 ~~~~~~--~~-~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      ......  .. ..   ........+.......+.+|+.+||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000  00 00   00000001111123466778899999999999999999873

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=364.74  Aligned_cols=267  Identities=19%  Similarity=0.253  Sum_probs=194.5

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe--------
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE--------  105 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------  105 (400)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++...  .......+.+|+.+|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            48999999999999999999965 57999999998643  22334568899999999999999999999855        


Q ss_pred             CCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEec
Q 015797          106 GQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADF  185 (400)
Q Consensus       106 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Df  185 (400)
                      ....|+|||||.++.+........    .++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence            346899999998766655443222    3888899999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCCCc---eeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhc---cc
Q 015797          186 GFAKLIPDGAT---HVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITD---WA  257 (400)
Q Consensus       186 gl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~---~~  257 (400)
                      |++........   .......||+.|+|||++.+. .+++++|||||||++|+|+||+.||.......... +..   ..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987653222   122234699999999999865 68999999999999999999999997544321111 000   00


Q ss_pred             cchhccc----ccc-cccCccCCCCCcHHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          258 LPLACER----KFS-ELADPRLNGNFVEEE------LKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       258 ~~~~~~~----~~~-~~~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                      .+.....    ... .+...........+.      ...+.+||.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0000000    000 000000001111111      2356789999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=369.99  Aligned_cols=268  Identities=21%  Similarity=0.265  Sum_probs=195.7

Q ss_pred             HHccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC-hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC----e
Q 015797           35 SATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS-NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ----E  108 (400)
Q Consensus        35 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~  108 (400)
                      ..+.+|++++.||+|+||+||+|.+ .+|+.||||++.... ......+.+|+.+|+.++||||+++++++....    .
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            3457899999999999999999954 679999999997543 344567889999999999999999999987653    2


Q ss_pred             EEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCc
Q 015797          109 RLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFA  188 (400)
Q Consensus       109 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~  188 (400)
                      .+++++|+.+|+|.+++...     .+++..++.++.|++.||.|||+++   ||||||||+|||++.++.+||+|||++
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCce
Confidence            34555667799999998653     2899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCce--eeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhhhhc--cccchhc-
Q 015797          189 KLIPDGATH--VTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIKRTITD--WALPLAC-  262 (400)
Q Consensus       189 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~~~~--~~~~~~~-  262 (400)
                      .........  .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.............  ...+... 
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            865432221  1234569999999999854 567899999999999999999999997543211110000  0000000 


Q ss_pred             ------cccccccc-CccCCCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          263 ------ERKFSELA-DPRLNGN----FVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       263 ------~~~~~~~~-~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                            ........ .+.....    ..+.....+.+|+.+||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00000000 0000000    001112367789999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=366.88  Aligned_cols=261  Identities=22%  Similarity=0.297  Sum_probs=192.1

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEeCC-----
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQ-----  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----  107 (400)
                      ..++|++++.||+|+||+||+|.+ .+|+.||||++...  .......+.+|+++|+.++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            357999999999999999999965 56999999999743  3334557889999999999999999999997665     


Q ss_pred             -eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          108 -ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       108 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                       .+|+||||| +++|..++...     .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence             569999999 56777766532     3899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhc-ccc-chh-
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITD-WAL-PLA-  261 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~-~~~-~~~-  261 (400)
                      ++.......    ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+...... ... ... +.. 
T Consensus       167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         167 LARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             TCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            998764332    234699999999998764 56899999999999999999999997543221100 000 000 000 


Q ss_pred             -----------cccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          262 -----------CERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       262 -----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                 ....+.......+. .........+.+||.+||..||.+|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                       00000000000000 0111122366788999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.8e-48  Score=357.84  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=195.9

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++.....  ...+..|+++++.++|+|+ +.+.+++.+++..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            36899999999999999999965 5689999999875332  2347889999999987664 555666688889999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC---CCcEEEEecCCcccc
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA---DFKAQVADFGFAKLI  191 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~---~~~~kl~Dfgl~~~~  191 (400)
                      |+. |+|.+.+.....   .+++..++.++.|++.||.|||+++   |+||||||+|||++.   +..+||+|||+++..
T Consensus        84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CCC-CBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EcC-CchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            994 677776654332   3899999999999999999999998   999999999999864   456999999999877


Q ss_pred             CCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhhhh-hhccccchhccc
Q 015797          192 PDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIKRT-ITDWALPLACER  264 (400)
Q Consensus       192 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~  264 (400)
                      ......      ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ....... ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KMST  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH-HHHS
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc-cCCC
Confidence            543321      1234569999999999999999999999999999999999999997543221111 0000000 0000


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                      .....     .    ...+..+.++|..||+.+|++||++.++.+.|+...
T Consensus       236 ~~~~~-----~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         236 PIEVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             CHHHH-----T----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             ChhHh-----c----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            00000     0    011246788889999999999999999988886553

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=353.92  Aligned_cols=264  Identities=20%  Similarity=0.243  Sum_probs=201.5

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCC--hHHHHHHHHHHHHHhcCCCCccceeeeEEEeCCeEEEEEE
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWS--NKAEMEFAVEVEILARVRHKNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  114 (400)
                      ++|++++.||+|+||+||+|.+ .+++.||||+++...  ......+.+|+.+|+.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999965 578999999997533  3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCCccccCCC
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGFAKLIPDG  194 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~~~~~~  194 (400)
                      ++.+++|..++....    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.+......
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999988888775433    3888999999999999999999998   999999999999999999999999999876543


Q ss_pred             CceeeeecccccCcCChhhhccCC-CCCccceehhhHHHHHHHhCCCChhhhhhhh--hhhhhcccc-c------hhcc-
Q 015797          195 ATHVTTRVKGTLGYLAPEYAMLGK-ASESCDVYSFGILLLELASGKKPIEKVNSAI--KRTITDWAL-P------LACE-  263 (400)
Q Consensus       195 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDIwSlGiil~elltg~~Pf~~~~~~~--~~~~~~~~~-~------~~~~-  263 (400)
                      ... .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.......  ...+..... +      .... 
T Consensus       155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            322 22334788999999988665 6899999999999999999999975332211  011100000 0      0000 


Q ss_pred             ---cccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          264 ---RKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       264 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                         ......................+.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000000000001111222346778889999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-47  Score=355.14  Aligned_cols=257  Identities=18%  Similarity=0.226  Sum_probs=202.2

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC-CccceeeeEEEeCCeEEEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH-KNLLSLRGYCAEGQERLIVYD  114 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e  114 (400)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++.....  ...+..|++.++.|+| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            47899999999999999999965 4689999998865332  2347788999999965 899999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECC-----CCcEEEEecCCcc
Q 015797          115 YMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDA-----DFKAQVADFGFAK  189 (400)
Q Consensus       115 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~-----~~~~kl~Dfgl~~  189 (400)
                      |+ +|+|.+++.....   .+++..+..++.|++.||.|||+++   |+||||||+|||++.     ++.+||+|||+++
T Consensus        82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 6899998865443   3889999999999999999999998   999999999999974     5789999999998


Q ss_pred             ccCCCCce------eeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh----hhhhccccc
Q 015797          190 LIPDGATH------VTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK----RTITDWALP  259 (400)
Q Consensus       190 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~----~~~~~~~~~  259 (400)
                      ........      ......||+.|||||++.+..++.++|||||||++|||+||..||........    ..+.....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            76543221      12345699999999999999999999999999999999999999975432110    001000000


Q ss_pred             hhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 015797          260 LACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDLLKGES  315 (400)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  315 (400)
                          .....+.     ..    .+..+..++..||..+|++||++..+.+.|....
T Consensus       235 ----~~~~~l~-----~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         235 ----TPLRELC-----AG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             ----SCHHHHT-----TT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ----CChHHhc-----CC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                0001110     11    1246777889999999999999999888876554

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=366.76  Aligned_cols=261  Identities=25%  Similarity=0.292  Sum_probs=190.1

Q ss_pred             CCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCccceeeeEEEeC------CeEEE
Q 015797           39 NFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNLLSLRGYCAEG------QERLI  111 (400)
Q Consensus        39 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~l  111 (400)
                      +|+..++||+|+||+||+|.+ .+|+.||||++.....    ...+|+++|+.++||||++++++|...      ..+|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688899999999999999975 4699999999975332    234699999999999999999998543      34789


Q ss_pred             EEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCccc
Q 015797          112 VYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKL  190 (400)
Q Consensus       112 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~~  190 (400)
                      |||||+++. .+.+.........+++..+..++.|++.||.|||+++   |+||||||+|||++.++ .+||+|||++..
T Consensus        97 v~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            999998654 3333222122235899999999999999999999998   99999999999999775 899999999987


Q ss_pred             cCCCCceeeeecccccCcCChhhhcc-CCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhcccc---------
Q 015797          191 IPDGATHVTTRVKGTLGYLAPEYAML-GKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWAL---------  258 (400)
Q Consensus       191 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~---------  258 (400)
                      +.....  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........  ..+.....         
T Consensus       173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            654332  233469999999998875 5789999999999999999999999965432110  00000000         


Q ss_pred             -chhcccccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          259 -PLACERKFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       259 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                       +......+...................+.+|+.+||..||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000000000000000011112346778889999999999999999996

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.8e-47  Score=357.46  Aligned_cols=258  Identities=18%  Similarity=0.268  Sum_probs=194.7

Q ss_pred             ccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEe--CCeEEEE
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAE--GQERLIV  112 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv  112 (400)
                      .++|++++.||+|+||+||+|++ .+++.||+|+++...   ...+.+|+.+|+.++ ||||+++++++..  ....++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            46899999999999999999965 568999999987533   356788999999995 9999999999974  4568999


Q ss_pred             EEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCC-cEEEEecCCcccc
Q 015797          113 YDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADF-KAQVADFGFAKLI  191 (400)
Q Consensus       113 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~-~~kl~Dfgl~~~~  191 (400)
                      ||||.+|+|.....       .+++..+..++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||++...
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence            99999999987642       2888999999999999999999999   99999999999998655 6999999999876


Q ss_pred             CCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh--hhhc---------cccc
Q 015797          192 PDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR--TITD---------WALP  259 (400)
Q Consensus       192 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~--~~~~---------~~~~  259 (400)
                      .....  .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.........  .+..         +...
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            54322  2344699999999998765 4799999999999999999999999643321100  0000         0000


Q ss_pred             --hhccccccccc--------CccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          260 --LACERKFSELA--------DPRLNGNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       260 --~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                        ...........        ...............+.+||.+||..||.+|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000000000        000111111122346788899999999999999999997

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=362.21  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             ccCCCcCCcccccCceEEEEEEE----cCCCEEEEEEEecCC----hHHHHHHHHHHHHHhcCCC-CccceeeeEEEeCC
Q 015797           37 TNNFNYDNKLGEGGFGSVYWGQL----WDGSQIAVKRLKVWS----NKAEMEFAVEVEILARVRH-KNLLSLRGYCAEGQ  107 (400)
Q Consensus        37 ~~~y~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~  107 (400)
                      .++|++++.||+|+||+||+|..    .+|+.||+|+++...    ......+.+|+++|+.++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            36799999999999999999964    247899999986321    2223457789999999966 89999999999999


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..+++|||+.+|+|.+++....    .++...+..++.|++.||.|||+.+   ++||||||+|||++.+|.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence            9999999999999999987544    2678889999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccC--CCCCccceehhhHHHHHHHhCCCChhhhhhhh-hhhhhccccchhccc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLG--KASESCDVYSFGILLLELASGKKPIEKVNSAI-KRTITDWALPLACER  264 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~  264 (400)
                      +..+............|++.|+|||.+.+.  .++.++|||||||+||+|+||+.||...+... ...+....       
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------  248 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------  248 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-------
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-------
Confidence            987655444444456799999999999765  46889999999999999999999997654211 00000000       


Q ss_pred             ccccccCccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015797          265 KFSELADPRLNGNFVEEELKRVVLVALTCAHSKPEKRPT-----MLEVLD  309 (400)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~  309 (400)
                       ...  .+..    .......+.+++.+||+.||.+|||     ++|+++
T Consensus       249 -~~~--~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 -LKS--EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -HHC--CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -ccC--CCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             000  0001    1112347788899999999999994     788886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=359.34  Aligned_cols=263  Identities=22%  Similarity=0.233  Sum_probs=190.8

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe------C
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE------G  106 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~  106 (400)
                      ..++|++++.||+|+||+||+|.+ .+|+.||||++...  .......+.+|+.+|+.++||||++++++|..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            447899999999999999999965 46999999999743  33444578899999999999999999999963      4


Q ss_pred             CeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecC
Q 015797          107 QERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFG  186 (400)
Q Consensus       107 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfg  186 (400)
                      ...|+|||||.+ ++.+.+..      .+++..++.++.|++.||.|||+.|   |+||||||+|||++.++.+|++|||
T Consensus        95 ~~~~iv~Ey~~~-~l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ceeEEEEeccch-HHHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechh
Confidence            688999999975 45555532      2788999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhhh--hhhhcccc--chhc
Q 015797          187 FAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAIK--RTITDWAL--PLAC  262 (400)
Q Consensus       187 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~--~~~~~~~~--~~~~  262 (400)
                      +++......  ......||+.|+|||++.+..+++++||||+||++|+|++|+.||...+....  ........  +..+
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            988654322  23345699999999999999999999999999999999999999965432111  00000000  0000


Q ss_pred             ------------------ccccccccC-ccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015797          263 ------------------ERKFSELAD-PRLN--GNFVEEELKRVVLVALTCAHSKPEKRPTMLEVLDL  310 (400)
Q Consensus       263 ------------------~~~~~~~~~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  310 (400)
                                        ......... ....  ..........+.+|+.+||..||++|||++|+|+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                              000000000 0000  11123345678899999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-47  Score=358.36  Aligned_cols=262  Identities=22%  Similarity=0.255  Sum_probs=193.0

Q ss_pred             HccCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecC--ChHHHHHHHHHHHHHhcCCCCccceeeeEEEe-----CC
Q 015797           36 ATNNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVW--SNKAEMEFAVEVEILARVRHKNLLSLRGYCAE-----GQ  107 (400)
Q Consensus        36 ~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~  107 (400)
                      ..++|++++.||+|+||+||+|.+ .+|+.||||++...  .......+.+|+++|+.++||||+++++++..     +.
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            367899999999999999999965 57999999999743  33444578899999999999999999999863     33


Q ss_pred             eEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEEEEecCC
Q 015797          108 ERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQVADFGF  187 (400)
Q Consensus       108 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl  187 (400)
                      ..+++|+|+.+|+|.+++..+     .+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+|++|||+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             ceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence            456777888899999988543     3899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCceeeeecccccCcCChhhhccC-CCCCccceehhhHHHHHHHhCCCChhhhhhhhhh-hh-hccccch--hc
Q 015797          188 AKLIPDGATHVTTRVKGTLGYLAPEYAMLG-KASESCDVYSFGILLLELASGKKPIEKVNSAIKR-TI-TDWALPL--AC  262 (400)
Q Consensus       188 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~~~-~~-~~~~~~~--~~  262 (400)
                      +......    .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..... .+ .....+.  ..
T Consensus       168 a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         168 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             --CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            9754322    2234599999999987765 4689999999999999999999999654322110 00 0000000  00


Q ss_pred             c-------cccccccCccCCCCC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015797          263 E-------RKFSELADPRLNGNF---VEEELKRVVLVALTCAHSKPEKRPTMLEVLD  309 (400)
Q Consensus       263 ~-------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  309 (400)
                      .       ...............   .......+.+||.+||..||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0       000000000000000   0011246778899999999999999999997

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.6e-41  Score=319.94  Aligned_cols=263  Identities=21%  Similarity=0.191  Sum_probs=188.4

Q ss_pred             cCCCcCCcccccCceEEEEEEE-cCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-----------CCccceeeeEEEe
Q 015797           38 NNFNYDNKLGEGGFGSVYWGQL-WDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-----------HKNLLSLRGYCAE  105 (400)
Q Consensus        38 ~~y~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~  105 (400)
                      ++|++++.||+|+||+||+|++ .+|+.||||+++... .....+.+|+++++.++           ||||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            5799999999999999999965 579999999997532 23456778888888775           5789999988754


Q ss_pred             --CCeEEEEEEccCCCChhhh-hhcCCCcccccChHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEECCCC---
Q 015797          106 --GQERLIVYDYMPNLSLLSH-LHGQHSSECLLNWNRRMDIAIGSAEGIVYLHH-HATPHIIHRDIKASNVLLDADF---  178 (400)
Q Consensus       106 --~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH~dikp~NIlv~~~~---  178 (400)
                        ....+++|+++..+..... .....  ...+++..+..++.|++.||.|||+ .+   |+||||||+||||+.++   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             ccccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence              4566777777655543332 22222  2248889999999999999999997 76   99999999999998665   


Q ss_pred             ---cEEEEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhHHHHHHHhCCCChhhhhhhh------
Q 015797          179 ---KAQVADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGILLLELASGKKPIEKVNSAI------  249 (400)
Q Consensus       179 ---~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGiil~elltg~~Pf~~~~~~~------  249 (400)
                         .++++|||.+.......    ....||+.|+|||++.+..++.++||||+||++++|++|+.||.......      
T Consensus       167 ~~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               39999999998654322    23469999999999999999999999999999999999999996432110      


Q ss_pred             --hhhh--hccc-cchh--------------cccccccccCc------cCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 015797          250 --KRTI--TDWA-LPLA--------------CERKFSELADP------RLNGNFVEEELKRVVLVALTCAHSKPEKRPTM  304 (400)
Q Consensus       250 --~~~~--~~~~-~~~~--------------~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  304 (400)
                        ...+  .... ....              ....+......      .............+.+|+.+||..||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence              0000  0000 0000              00000000000      00112345667789999999999999999999


Q ss_pred             HHHHHH
Q 015797          305 LEVLDL  310 (400)
Q Consensus       305 ~ell~~  310 (400)
                      .|+|+.
T Consensus       323 ~e~L~H  328 (362)
T d1q8ya_         323 GGLVNH  328 (362)
T ss_dssp             HHHHTC
T ss_pred             HHHhcC
Confidence            999973

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.1e-25  Score=193.95  Aligned_cols=168  Identities=14%  Similarity=0.079  Sum_probs=120.2

Q ss_pred             CCcCCcccccCceEEEEEEEcCCCEEEEEEEecCCh------------------HHHHHHHHHHHHHhcCCCCccceeee
Q 015797           40 FNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSN------------------KAEMEFAVEVEILARVRHKNLLSLRG  101 (400)
Q Consensus        40 y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~~~~  101 (400)
                      |.+++.||+|+||+||+|.+.+|+.||||++.....                  ........|...+..+.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            457889999999999999888899999998753111                  01123456889999999999998876


Q ss_pred             EEEeCCeEEEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEECCCCcEE
Q 015797          102 YCAEGQERLIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHATPHIIHRDIKASNVLLDADFKAQ  181 (400)
Q Consensus       102 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH~dikp~NIlv~~~~~~k  181 (400)
                      +.    ..+++|||++++.+.+           ++......++.|++.+|.|||.++   |+||||||+|||++.+ .++
T Consensus        82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred             ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence            53    2379999998765543           333445678999999999999998   9999999999999865 589


Q ss_pred             EEecCCccccCCCCceeeeecccccCcCChhhhccCCCCCccceehhhH
Q 015797          182 VADFGFAKLIPDGATHVTTRVKGTLGYLAPEYAMLGKASESCDVYSFGI  230 (400)
Q Consensus       182 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDIwSlGi  230 (400)
                      |+|||++...........  ...+... -.+ .....|+.++|+||..-
T Consensus       143 liDFG~a~~~~~~~~~~~--l~rd~~~-~~~-~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         143 IIDFPQSVEVGEEGWREI--LERDVRN-IIT-YFSRTYRTEKDINSAID  187 (191)
T ss_dssp             ECCCTTCEETTSTTHHHH--HHHHHHH-HHH-HHHHHHCCCCCHHHHHH
T ss_pred             EEECCCcccCCCCCcHHH--HHHHHHH-HHH-HHcCCCCCcccHHHHHH
Confidence            999999976543221100  0000000 011 12367889999999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.87  E-value=8.2e-09  Score=91.17  Aligned_cols=149  Identities=11%  Similarity=0.066  Sum_probs=104.6

Q ss_pred             HHHHHHccCCCcCCcccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-CCccceeeeEEEeCCeE
Q 015797           31 KELHSATNNFNYDNKLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-HKNLLSLRGYCAEGQER  109 (400)
Q Consensus        31 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  109 (400)
                      .++......|++.+..+.++.+.||+.. .+++.+++|+...........+..|...+..|. +-.+.+++.++.+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            3456666788887776666667999986 467778888876443333345677888887774 33366778888888999


Q ss_pred             EEEEEccCCCChhhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 015797          110 LIVYDYMPNLSLLSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHHA-------------------------------  158 (400)
Q Consensus       110 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------  158 (400)
                      ++||++++|.++.+.....         .....++.+++..++.||...                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999988876654211         112234556666677777432                               


Q ss_pred             -------------------------CCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          159 -------------------------TPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       159 -------------------------~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                                               .+.++|+|+.|.||++++++..-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1127999999999999987666799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.35  E-value=7.9e-07  Score=77.58  Aligned_cols=130  Identities=16%  Similarity=0.088  Sum_probs=84.9

Q ss_pred             cccccC-ceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCC--CccceeeeEEEeCCeEEEEEEccCCCCh
Q 015797           45 KLGEGG-FGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRH--KNLLSLRGYCAEGQERLIVYDYMPNLSL  121 (400)
Q Consensus        45 ~LG~G~-~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~gsL  121 (400)
                      .+..|. .+.||+.....+..+++|......   ...+..|+..|+.|..  -.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444454 368999987777788888765332   2246677787777632  3366778888888899999999987665


Q ss_pred             hhhhhcCCCcccccChHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 015797          122 LSHLHGQHSSECLLNWNRRMDIAIGSAEGIVYLHHH--------------------------------------------  157 (400)
Q Consensus       122 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------------------------------------------  157 (400)
                      .+..         ..   ....+.++...|+-||..                                            
T Consensus        94 ~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            4311         00   011122333344444421                                            


Q ss_pred             -----------CCCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          158 -----------ATPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       158 -----------~~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                                 ..+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                       11127999999999999987667799998775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.87  E-value=5.3e-05  Score=70.27  Aligned_cols=77  Identities=13%  Similarity=0.131  Sum_probs=48.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEEecC-------ChHHHHHHHHHHHHHhcCC-C-C-ccceeeeEEEeCCeEEE
Q 015797           43 DNKLGEGGFGSVYWGQLW-DGSQIAVKRLKVW-------SNKAEMEFAVEVEILARVR-H-K-NLLSLRGYCAEGQERLI  111 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-h-p-nIv~~~~~~~~~~~~~l  111 (400)
                      .+.||.|....||++... +++.+++|.-...       -.....+...|+..|+.+. + | .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            357999999999999654 4678899864321       0112234556888887662 2 3 34555543  4556679


Q ss_pred             EEEccCCCCh
Q 015797          112 VYDYMPNLSL  121 (400)
Q Consensus       112 v~e~~~~gsL  121 (400)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.13  E-value=0.00039  Score=64.22  Aligned_cols=73  Identities=15%  Similarity=0.234  Sum_probs=48.1

Q ss_pred             CCcccccCceEEEEEEEcC--------CCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeEEEEE
Q 015797           43 DNKLGEGGFGSVYWGQLWD--------GSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKNL-LSLRGYCAEGQERLIVY  113 (400)
Q Consensus        43 ~~~LG~G~~g~Vy~a~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~  113 (400)
                      ++.|+.|-.-.+|++...+        ...|++++.. .. ........|..+++.++-.++ .++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3678899999999997543        2456665544 22 223456678888888853344 467766542    5899


Q ss_pred             EccCCCCh
Q 015797          114 DYMPNLSL  121 (400)
Q Consensus       114 e~~~~gsL  121 (400)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.05  E-value=0.003  Score=55.90  Aligned_cols=159  Identities=11%  Similarity=0.072  Sum_probs=84.2

Q ss_pred             ccHHHHHHHccCCCcCCccc-----ccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCC-----CCccc
Q 015797           28 FSLKELHSATNNFNYDNKLG-----EGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVR-----HKNLL   97 (400)
Q Consensus        28 ~~~~~~~~~~~~y~~~~~LG-----~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----hpnIv   97 (400)
                      .+.+++.....+|.+++...     .|.--+.|+.....| .+++|+.....  ....+..|+.++..|.     .|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            56788899999998875543     566678899976655 48888875421  2223445566666653     23322


Q ss_pred             eeee---EEEeCCeEEEEEEccCCCChhhh--------------hh---cCCCccc--------------------ccCh
Q 015797           98 SLRG---YCAEGQERLIVYDYMPNLSLLSH--------------LH---GQHSSEC--------------------LLNW  137 (400)
Q Consensus        98 ~~~~---~~~~~~~~~lv~e~~~~gsL~~~--------------l~---~~~~~~~--------------------~l~~  137 (400)
                      ...+   +.........++.+..+......              ++   .......                    ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2211   12334556677777665333110              00   0000000                    0011


Q ss_pred             HHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeEECCCCcEEEEecCCcc
Q 015797          138 NRRMDIAIGSAEGIVYLHHHA-TPHIIHRDIKASNVLLDADFKAQVADFGFAK  189 (400)
Q Consensus       138 ~~~~~i~~qi~~aL~yLH~~~-~~~iiH~dikp~NIlv~~~~~~kl~Dfgl~~  189 (400)
                      ......+..+...+.-.+... ...+||+|+.++||+++.+...-+.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222223233222211 1138999999999999988777899999885

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.97  E-value=0.002  Score=57.60  Aligned_cols=95  Identities=12%  Similarity=0.023  Sum_probs=57.7

Q ss_pred             CcccccHHHHHHHccCCCcC---C--cccccCceEEEEEEEcCCCEEEEEEEecCChHHHHHHHHHHHHHhcCCCCc---
Q 015797           24 TWRIFSLKELHSATNNFNYD---N--KLGEGGFGSVYWGQLWDGSQIAVKRLKVWSNKAEMEFAVEVEILARVRHKN---   95 (400)
Q Consensus        24 ~~~~~~~~~~~~~~~~y~~~---~--~LG~G~~g~Vy~a~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn---   95 (400)
                      ++...+++.+..+...+-+.   +  .| .+.--.||++...+|+.+++|+..... .....+..|...+..|...+   
T Consensus         4 ~f~~L~pd~i~~al~~~g~~~~~~~~~L-~s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv   81 (325)
T d1zyla1           4 TFQTLHPDTIMDALFEHGIRVDSGLTPL-NSYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV   81 (325)
T ss_dssp             CCCCCCHHHHHHHHHHTTCCCCSCCEEE-CCSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred             CccccCHHHHHHHHHHcCCCCCcCcccc-ccccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCC
Confidence            45566677776665544221   1  12 233458999988889999999876432 23455777888887774221   


Q ss_pred             --cceee--eEEEeCCeEEEEEEccCCCC
Q 015797           96 --LLSLR--GYCAEGQERLIVYDYMPNLS  120 (400)
Q Consensus        96 --Iv~~~--~~~~~~~~~~lv~e~~~~gs  120 (400)
                        .+..-  ..+...+..+.+++++.|..
T Consensus        82 ~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          82 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             CCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             CCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence              11211  12355677889999987643